Citrus Sinensis ID: 013737
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 437 | 2.2.26 [Sep-21-2011] | |||||||
| Q9CAL2 | 646 | Cysteine-rich receptor-li | yes | no | 0.993 | 0.671 | 0.658 | 1e-171 | |
| Q9FNE1 | 651 | Cysteine-rich receptor-li | no | no | 0.906 | 0.608 | 0.491 | 1e-107 | |
| Q9CAL3 | 649 | Cysteine-rich receptor-li | no | no | 0.972 | 0.654 | 0.433 | 3e-92 | |
| Q9LMB9 | 615 | Cysteine-rich receptor-li | no | no | 0.951 | 0.676 | 0.429 | 7e-92 | |
| Q9M0G5 | 625 | Putative cysteine-rich re | no | no | 0.965 | 0.675 | 0.358 | 2e-71 | |
| Q9T0J1 | 665 | Cysteine-rich receptor-li | no | no | 0.919 | 0.604 | 0.357 | 1e-61 | |
| Q9M0X5 | 675 | Cysteine-rich receptor-li | no | no | 0.901 | 0.583 | 0.341 | 2e-57 | |
| Q8S9L6 | 679 | Cysteine-rich receptor-li | no | no | 0.929 | 0.597 | 0.330 | 4e-57 | |
| O65476 | 662 | Putative cysteine-rich re | no | no | 0.929 | 0.613 | 0.337 | 4e-53 | |
| O65405 | 683 | Cysteine-rich receptor-li | no | no | 0.917 | 0.587 | 0.323 | 1e-52 |
| >sp|Q9CAL2|CRK3_ARATH Cysteine-rich receptor-like protein kinase 3 OS=Arabidopsis thaliana GN=CRK3 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 601 bits (1549), Expect = e-171, Method: Compositional matrix adjust.
Identities = 289/439 (65%), Positives = 347/439 (79%), Gaps = 5/439 (1%)
Query: 1 MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLA 60
MD V+PL+ + Y VVNGTG +VYA+GEC+KDL DC+LCFAQ K +V +CLPFQ
Sbjct: 52 MDAVSPLVEAKGYGQVVNGTGNLTVYAYGECIKDLDKKDCDLCFAQIKAKVPRCLPFQKG 111
Query: 61 TRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGG-NNTVFGANAIELVRNLSVQ 119
TRGG+VF DGCY+RYDDY+F+NE+LS QDRTVC K+ G N TVF NA ELV+N+SV+
Sbjct: 112 TRGGQVFSDGCYIRYDDYNFYNETLSLQDRTVCAPKEITGVNRTVFRDNAAELVKNMSVE 171
Query: 120 AVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLN 179
AV+N GF+ G V + NV+VHGLAQCWE +N S C CL A RI SC EEGRVL+
Sbjct: 172 AVRNGGFYAGFV--DRHNVTVHGLAQCWETLNRSGCVECLSKASVRIGSCLVNEEGRVLS 229
Query: 180 AGCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILA--TSAVALLLVFSLVAFFVRRKLLQ 237
AGCY+R+STQ+FYNNSG GNGG N L VILA +S VA +L+ S F ++++ +
Sbjct: 230 AGCYMRFSTQKFYNNSGNSTSDGNGGHNHLGVILAVTSSVVAFVLLVSAAGFLLKKRHAK 289
Query: 238 KRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVA 297
K+RE+KQLG+L + NKS L FSYE LE+AT+YF + NKLGQGGSGSVYKG L G+ VA
Sbjct: 290 KQREKKQLGSLFMLANKSNLCFSYENLERATDYFSDKNKLGQGGSGSVYKGVLTNGKTVA 349
Query: 298 VKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF 357
VKRLF+NT QWVDHFFNEVNLIS ++HKNLVKLLGCSITGPESLLVYE++ NQSL D LF
Sbjct: 350 VKRLFFNTKQWVDHFFNEVNLISQVDHKNLVKLLGCSITGPESLLVYEYIANQSLHDYLF 409
Query: 358 VRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417
VR+DV+PL+W R+KIIL TAEG+AYLHEES LRIIHRDIKLSNILL+++FT +IADFGL
Sbjct: 410 VRKDVQPLNWAKRFKIILGTAEGMAYLHEESNLRIIHRDIKLSNILLEDDFTPRIADFGL 469
Query: 418 VRLFPEDITHISATLAGTL 436
RLFPED THIS +AGTL
Sbjct: 470 ARLFPEDKTHISTAIAGTL 488
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9FNE1|CRK42_ARATH Cysteine-rich receptor-like protein kinase 42 OS=Arabidopsis thaliana GN=CRK42 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 389 bits (1000), Expect = e-107, Method: Compositional matrix adjust.
Identities = 206/419 (49%), Positives = 265/419 (63%), Gaps = 23/419 (5%)
Query: 22 TASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFYDGCYLRYDDYDFF 81
T S+YA +C DLSP+DC LC+A +T++ +CLP + R+F DGC+LRY+ Y+F+
Sbjct: 81 TTSIYALIQCHDDLSPSDCQLCYAIARTRIPRCLP----SSSARIFLDGCFLRYETYEFY 136
Query: 82 NESLS-SQDRTVCGSKDFGGNNTVFGAN-AIELVRNLSVQAVKNDGFFVGSVTFSKGNVS 139
+ES+S + D C N+TV ++ + AV+ GF V G
Sbjct: 137 DESVSDASDSFSCS------NDTVLDPRFGFQVSETAARVAVRKGGFGVA------GENG 184
Query: 140 VHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLNAGCYLRYSTQRFYNNSGPDP 199
VH LAQCWE + C CLE AV + C + EGR +N GCYLRYS +FYN G
Sbjct: 185 VHALAQCWESLGKEDCRVCLEKAVKEVKRCVSRREGRAMNTGCYLRYSDHKFYNGDGHHK 244
Query: 200 --VPGNGGDNKLAVILATSAVALLLVFSLVAFFVRRKLLQKRRERKQLGALQVAVNKSKL 257
V N G +A++L TSA +L++ L + + K+ + ++E++ LG + N SK
Sbjct: 245 FHVLFNKG-VIVAIVLTTSAFVMLIL--LATYVIMTKVSKTKQEKRNLGLVSRKFNNSKT 301
Query: 258 NFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVN 317
F YETLEKAT+YF LGQGG+G+V+ G LP G+ VAVKRL +NT WV+ FFNEVN
Sbjct: 302 KFKYETLEKATDYFSHKKMLGQGGNGTVFLGILPNGKNVAVKRLVFNTRDWVEEFFNEVN 361
Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST 377
LISGI HKNLVKLLGCSI GPESLLVYE+VPN+SL LF + L+W R IIL T
Sbjct: 362 LISGIQHKNLVKLLGCSIEGPESLLVYEYVPNKSLDQFLFDESQSKVLNWSQRLNIILGT 421
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
AEGLAYLH S +RIIHRDIK SN+LLD++ KIADFGL R F D TH+S +AGTL
Sbjct: 422 AEGLAYLHGGSPVRIIHRDIKTSNVLLDDQLNPKIADFGLARCFGLDKTHLSTGIAGTL 480
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9CAL3|CRK2_ARATH Cysteine-rich receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=CRK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 338 bits (868), Expect = 3e-92, Method: Compositional matrix adjust.
Identities = 192/443 (43%), Positives = 264/443 (59%), Gaps = 18/443 (4%)
Query: 1 MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLA 60
M+ ++ + + + GTG + Y +C DL NDC LC+A+ +T + +C P
Sbjct: 59 MEKISTQVQTSGFGVALTGTGPDANYGLAQCYGDLPLNDCVLCYAEARTMLPQCYP---- 114
Query: 61 TRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGGNNTVFGANAIELVRNLSVQA 120
GGR+F DGC++R ++Y F+NE +D VCG+ N FG + +RN +A
Sbjct: 115 QNGGRIFLDGCFMRAENYSFYNEYKGPEDSIVCGNTT--RKNKTFGDAVRQGLRNAVTEA 172
Query: 121 VKNDGFFVGSVTFSKG-NVSVHGLAQCWEFVNGSACENCLENA-VSRIASCTQKEEGRVL 178
G+ S + + S LA CW ++ +C+ CLENA S + C EGR L
Sbjct: 173 SGTGGYARASAKAGESESESAFVLANCWRTLSPDSCKQCLENASASVVKGCLPWSEGRAL 232
Query: 179 NAGCYLRYSTQRFYNNSGPDPVPGNG---GDNKLAVILATSAVALLLVFSLVAFFV--RR 233
+ GC+LRYS Q F N +P NG G + V+ S+V + ++ V+ ++ RR
Sbjct: 233 HTGCFLRYSDQDFLNK-----IPRNGRSRGSVVVIVVSVLSSVVVFMIGVAVSVYICKRR 287
Query: 234 KLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGG 293
+ +KRR K + + + S LNF Y TLEKAT F +NKLGQGG G+VYKG LP G
Sbjct: 288 TIKRKRRGSKDVEKMAKTLKDSSLNFKYSTLEKATGSFDNANKLGQGGFGTVYKGVLPDG 347
Query: 294 EAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLL 353
+AVKRLF+N F+NEVN+IS + HKNLV+LLGCS +GPESLLVYE++ N+SL
Sbjct: 348 RDIAVKRLFFNNRHRATDFYNEVNMISTVEHKNLVRLLGCSCSGPESLLVYEYLQNKSLD 407
Query: 354 DNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIA 413
+F + L W+ RY II+ TAEGL YLHE+S ++IIHRDIK SNILLD + AKIA
Sbjct: 408 RFIFDVNRGKTLDWQRRYTIIVGTAEGLVYLHEQSSVKIIHRDIKASNILLDSKLQAKIA 467
Query: 414 DFGLVRLFPEDITHISATLAGTL 436
DFGL R F +D +HIS +AGTL
Sbjct: 468 DFGLARSFQDDKSHISTAIAGTL 490
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMB9|CRK1_ARATH Cysteine-rich receptor-like protein kinase 1 OS=Arabidopsis thaliana GN=CRK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 338 bits (866), Expect = 7e-92, Method: Compositional matrix adjust.
Identities = 193/449 (42%), Positives = 270/449 (60%), Gaps = 33/449 (7%)
Query: 1 MDIVTPLIARQRYAAVVNGTGTAS-VYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQL 59
M V I + V + T + +Y F +C +DLS +DC CF + + ++ + +
Sbjct: 55 MSSVNDFITNDKLWVVSSITDVSPPIYVFLQCREDLSVSDCRHCFNESRLELER----KC 110
Query: 60 ATRGGRVFYDGCYLRYDDYDFFNESLSSQ-DRTVCGSKDFGGNNTVFGANAIELVRNLSV 118
+ GGR+ D C+LR+DD DF E + D+ C ++ G F E + N+++
Sbjct: 111 SGSGGRIHSDRCFLRFDDRDFSEEFVDPTFDKANC--EETGTGFGEFWRFLDEALVNVTL 168
Query: 119 QAVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVL 178
+AVKN GF SV ++ +V+ LAQCW+ ++ + C CL NA S + +C E R
Sbjct: 169 KAVKNGGFGAASVIKTE---AVYALAQCWQTLDENTCRECLVNARSSLRAC-DGHEARAF 224
Query: 179 NAGCYLRYSTQRFYNNSG---PDPVPGN--------GGDNKLAVILATSAVALLLVFSLV 227
GCYL+YST +F++++ PD N ++ LA +A++L ++ SL
Sbjct: 225 FTGCYLKYSTHKFFDDAAEHKPDADQRNFIRSSFFPHLSDRDVTRLAIAAISLSILTSLG 284
Query: 228 AFFVRRKLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYK 287
AF R++ +KR+ A S +NF YE LEKAT FH+S KLGQGG+GSVYK
Sbjct: 285 AFISYRRVSRKRK----------AQVPSCVNFKYEMLEKATESFHDSMKLGQGGAGSVYK 334
Query: 288 GTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347
G LP G VAVK+LF+NT +W D FFNEVNLISG+ HKNLV+LLGCSI GP+SLLVYE+V
Sbjct: 335 GILPDGRIVAVKKLFFNTREWADQFFNEVNLISGVQHKNLVRLLGCSIEGPKSLLVYEYV 394
Query: 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE 407
N+SL LF++ V LSW+ R+ II+ +EGL YLH S+++IIHRDIK SNILLD
Sbjct: 395 HNRSLDQILFMKNTVHILSWKQRFNIIIGISEGLEYLHRGSEVKIIHRDIKTSNILLDRN 454
Query: 408 FTAKIADFGLVRLFPEDITHISATLAGTL 436
+ KIADFGL+R D T + +AGTL
Sbjct: 455 LSPKIADFGLIRSMGTDKTQTNTGIAGTL 483
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M0G5|CRK43_ARATH Putative cysteine-rich receptor-like protein kinase 43 OS=Arabidopsis thaliana GN=CRK43 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 269 bits (688), Expect = 2e-71, Method: Compositional matrix adjust.
Identities = 165/460 (35%), Positives = 239/460 (51%), Gaps = 38/460 (8%)
Query: 1 MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLA 60
+D + + ++ +G +Y +C+ DLS ++C+LC+++ + +C P
Sbjct: 55 LDAIRGDMRHVKFGTHEHGDPPERMYVLSQCVSDLSSDECSLCWSRATDLLSQCFP---- 110
Query: 61 TRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGGNNTVFGANAIELVRNLSVQA 120
GG DGC++R D+Y F+ E +S QD +C S + F E+ +++ A
Sbjct: 111 ATGGWFHLDGCFVRADNYSFYQEPVSHQDTKICASDK--EKSAEFKGLVKEVTKSIVEAA 168
Query: 121 VKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLNA 180
+ GF V + +++V+GL CW +N C+ CL + + SC +EG LNA
Sbjct: 169 PYSRGFSVAKMGIR--DLTVYGLGVCWRTLNDELCKLCLADGALSVTSCLPSKEGFALNA 226
Query: 181 GCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILATSAVALLLV----FSLVAFFVRRK-- 234
GCYLRYS FYN G + + L I S V +L + + F++R
Sbjct: 227 GCYLRYSNYTFYNERGL--LAMSFTKENLTYIFVISMVGVLAIAAGFWCGKCFYMRTSPK 284
Query: 235 ------------LLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGS 282
L R K+ + + ++F Y TL+KATN F+ES KLG GG
Sbjct: 285 KKIKGTKTKKFHLFGHLRIEKE--SESICTESHLMSFEYSTLKKATNNFNESCKLGVGGY 342
Query: 283 GSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342
G V+KGTL G +A+KRL + + D NE+++IS HKNLV+LLGC T S +
Sbjct: 343 GEVFKGTLSDGREIAIKRLHVSGKKPRDEIHNEIDVISRCQHKNLVRLLGCCFTNMNSFI 402
Query: 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNI 402
VYEF+ N SL LF + + L W+ R IIL TAEGL YLHE K IIHRDIK SNI
Sbjct: 403 VYEFLANTSLDHILFNPEKKKELDWKKRRTIILGTAEGLEYLHETCK--IIHRDIKASNI 460
Query: 403 LLDEEFTAKIADFGLVRLFPEDITHISA------TLAGTL 436
LLD ++ KI+DFGL + +PE I A ++AGTL
Sbjct: 461 LLDLKYKPKISDFGLAKFYPEGGKDIPASSLSPSSIAGTL 500
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9T0J1|CRK26_ARATH Cysteine-rich receptor-like protein kinase 26 OS=Arabidopsis thaliana GN=CRK26 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 238 bits (606), Expect = 1e-61, Method: Compositional matrix adjust.
Identities = 157/439 (35%), Positives = 226/439 (51%), Gaps = 37/439 (8%)
Query: 19 GTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFYDGCYLRYDDY 78
G V + +C D+ C C A +++ P Q + ++YD C RY +
Sbjct: 71 GDSDEKVNSISQCRGDVKLEVCINCIAMAGKRLVTLCPVQ---KEAIIWYDKCTFRYSNR 127
Query: 79 DFFNESLSSQDRTVCGSKDFGGNNTVFGANAIELVRNL----SVQAVKNDGFFVGSVTFS 134
FN S ++ G+++F G+ + + L+ L SV F VG T
Sbjct: 128 TIFNRLEISPHTSITGTRNFTGDRDSWEKSLRGLLEGLKNRASVIGRSKKNFVVGE-TSG 186
Query: 135 KGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGR-VLNAGCYLRYSTQRFYN 193
++ GL QC ++ C CL +++I SC + G V++ C L Y+ RFY+
Sbjct: 187 PSFQTLFGLVQCTPDISEEDCSYCLSQGIAKIPSCCDMKMGSYVMSPSCMLAYAPWRFYD 246
Query: 194 ---NSGPDPVPG--------------NGGDNK---LAVILATSAVALLLVFSLVAFF--- 230
P VP G N+ A+I A+++VA++++F ++
Sbjct: 247 PVDTDDPSSVPATPSRPPKNETRSVTQGDKNRGVPKALIFASASVAIVVLFIVLLVVFLK 306
Query: 231 VRRKLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTL 290
+RRK + E K ++ + F + L+ AT++F NKLG+GG G+VYKG L
Sbjct: 307 LRRKENIRNSENKHENE---NISTDSMKFDFSVLQDATSHFSLENKLGEGGFGAVYKGVL 363
Query: 291 PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350
G+ +AVKRL N Q F NE L++ + H+NLVKLLG SI G E LLVYEF+P+
Sbjct: 364 SDGQKIAVKRLSKNAQQGETEFKNEFLLVAKLQHRNLVKLLGYSIEGTERLLVYEFLPHT 423
Query: 351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410
SL +F L WE+RYKII A GL YLH++S+LRIIHRD+K SNILLDEE T
Sbjct: 424 SLDKFIFDPIQGNELEWEIRYKIIGGVARGLLYLHQDSRLRIIHRDLKASNILLDEEMTP 483
Query: 411 KIADFGLVRLFPEDITHIS 429
KIADFG+ RLF DI H +
Sbjct: 484 KIADFGMARLF--DIDHTT 500
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 223 bits (568), Expect = 2e-57, Method: Compositional matrix adjust.
Identities = 147/431 (34%), Positives = 215/431 (49%), Gaps = 37/431 (8%)
Query: 25 VYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFYDGCYLRYDDYDFFNES 84
VY C D+S C C A + L+ P + + ++YD C +RY N+S
Sbjct: 82 VYGVFLCRGDVSAEICRDCVAFAANETLQRCPRE---KVAVIWYDECMVRYS-----NQS 133
Query: 85 LSSQDRTVCG----SKDFGGNNTV--FGANAIELVRNLSVQAVKNDGFFVGSVTFSKGNV 138
+ Q R G +K N V F + L+ +++V+A + F
Sbjct: 134 IVGQMRIRPGVFLTNKQNITENQVSRFNESLPALLIDVAVKAALSSRKFATEKANFTVFQ 193
Query: 139 SVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEG-RVLNAGCYLRYSTQRFYNNS-- 195
+++ L QC + CE+CL ++ + C + G RV+ C RY FYN +
Sbjct: 194 TIYSLVQCTPDLTNQDCESCLRQVINYLPRCCDRSVGGRVIAPSCSFRYELYPFYNETIA 253
Query: 196 --------------GPDPVPGNGGDNKLAVILATS-----AVALLLVFSLVAFFVRRKLL 236
P +P G K ++ T+ +V +LL+ ++ RR+
Sbjct: 254 AAPMAPPPSSTVTAPPLNIPSEKGKGKNLTVIVTAIAVPVSVCVLLLGAMCWLLARRRNN 313
Query: 237 QKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAV 296
+ E + L + ++ L F + +E ATN F ESNKLG GG G VYKG L GE V
Sbjct: 314 KLSAETEDLDEDGITSTET-LQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGETV 372
Query: 297 AVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL 356
A+KRL +TQ + F NEV++++ + H+NL KLLG + G E +LVYEFVPN+SL L
Sbjct: 373 AIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFL 432
Query: 357 FVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416
F + L W+ RYKII A G+ YLH +S+L IIHRD+K SNILLD + KI+DFG
Sbjct: 433 FDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFG 492
Query: 417 LVRLFPEDITH 427
+ R+F D T
Sbjct: 493 MARIFGVDQTQ 503
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8S9L6|CRK29_ARATH Cysteine-rich receptor-like protein kinase 29 OS=Arabidopsis thaliana GN=CRK29 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 222 bits (566), Expect = 4e-57, Method: Compositional matrix adjust.
Identities = 148/448 (33%), Positives = 222/448 (49%), Gaps = 42/448 (9%)
Query: 25 VYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFYDGCYLRYDDYDFFNES 84
YA G C +++ +DC C + K P T+ V+Y C RY + +
Sbjct: 82 AYAIGLCRREVKRDDCVSCIQTAARNLTKQCPL---TKQAVVWYTHCMFRYSNRTIYGRK 138
Query: 85 LSSQDRTVCGSKDFGGNNTVF---GANAIELVRNLSVQAVKNDGFFVGSVTFSKGNVSVH 141
++ + ++ N F ++ ++ ++ N + G+ + S G +
Sbjct: 139 ETNPTKAFIAGEEISANRDDFERLQRGLLDRLKGIAAAGGPNRKYAQGNGSASAGYRRFY 198
Query: 142 GLAQCWEFVNGSACENCLENAVSRIASCTQKEEG-RVLNAGCYLRYSTQRFYNNSG---P 197
G QC ++ C +CL I SC E G R + C R+ T RFY P
Sbjct: 199 GTVQCTPDLSEQDCNDCLVFGFENIPSCCDAEIGLRWFSPSCNFRFETWRFYEFDADLEP 258
Query: 198 DPVP------------------GNGGDNKL-AVILATSAVALLLVFSLVAFFVRRKLLQK 238
DP G GG + A+++ VALL + + R+ +
Sbjct: 259 DPPAIQPADSPQSAARTERTGKGKGGSKVIIAIVIPILLVALLAICLCLVLKWRKN--KS 316
Query: 239 RRERKQLGALQVAVNKSKLNFS--------YETLEKATNYFHESNKLGQGGSGSVYKGTL 290
+ K LG ++ + ++ FS +ETL+ AT+ F N+LG+GG GSVYKG
Sbjct: 317 GYKNKVLGKSPLSGSIAEDEFSNTESLLVHFETLKTATDNFSSENELGRGGFGSVYKGVF 376
Query: 291 PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350
P G+ +AVKRL N+ Q + F NE+ L++ + H+NLV+L+G I G E LLVYEF+ N
Sbjct: 377 PQGQEIAVKRLSGNSGQGDNEFKNEILLLAKLQHRNLVRLIGFCIQGEERLLVYEFIKNA 436
Query: 351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410
SL +F + + L W VRYK+I A GL YLHE+S+ RIIHRD+K SNILLD+E
Sbjct: 437 SLDQFIFDTEKRQLLDWVVRYKMIGGIARGLLYLHEDSRFRIIHRDLKASNILLDQEMNP 496
Query: 411 KIADFGLVRLFP--EDITH-ISATLAGT 435
KIADFGL +LF + +TH ++ +AGT
Sbjct: 497 KIADFGLAKLFDSGQTMTHRFTSRIAGT 524
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65476|CRK16_ARATH Putative cysteine-rich receptor-like protein kinase 16 OS=Arabidopsis thaliana GN=CRK16 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 209 bits (531), Expect = 4e-53, Method: Compositional matrix adjust.
Identities = 144/427 (33%), Positives = 206/427 (48%), Gaps = 21/427 (4%)
Query: 19 GTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFYD--GCYLRYD 76
G G +YA G C++ P C+ C +V+K Q F + C +RY
Sbjct: 68 GQGPDRLYASGTCIQGSEPELCSACIDSAFIRVIKKCHNQTEALDWSSFNEEYPCMIRYS 127
Query: 77 DYDFFNESLSSQDRTVCGSKDFGGNNTVFGANAIELVRNLSVQAVKN-DGFFVGSVTFSK 135
+ FF + + DF N T F L+ + A+ + + F G+ T
Sbjct: 128 NRSFFGLLEMTPFFKNYNATDFQVNLTEFYQKWEALMLGVIADAISSPNPKFYGAGTGKI 187
Query: 136 GNVSVHGLAQCWEFVNGSACENCLENAVSRIA-SCTQKEEGRVLNAGCYLRYSTQRFYN- 193
G +V+ C + ++ C CL V SC+ K G + CY+R+ +FY
Sbjct: 188 GIQTVYAFVLCSKDISPWNCSRCLRGNVDNYKLSCSGKPRGHSFSPSCYMRWDLYQFYGF 247
Query: 194 ---NSGP---------DPVPGNGGDNKLAVILATSAVALLLVFSLVAFFVRRKLLQKRRE 241
+ P + +GG IL + + L F + V L +RR+
Sbjct: 248 IEYRASPTLPREKGRISELSDDGGKISTRNILG---ITVALAFFITVLLVLGYALSRRRK 304
Query: 242 RKQLGALQVAVNKS-KLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKR 300
Q A + + S L F ++ +E ATN F +SNKLG GG G V+KGT P G VAVKR
Sbjct: 305 AYQEFATENDITTSGSLQFDFKAIEAATNNFQKSNKLGHGGFGEVFKGTFPNGTEVAVKR 364
Query: 301 LFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQ 360
L + Q + F NEV L++ + H+NLV+LLG S+ G E +LVYE++PN+SL LF +
Sbjct: 365 LSKISGQGEEEFKNEVLLVAKLQHRNLVRLLGFSVEGEEKILVYEYMPNKSLDYFLFDHR 424
Query: 361 DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420
L W RY II G+ YLH++S+L IIHRD+K NILLD + KIADFG+ R
Sbjct: 425 RRGQLDWRTRYNIIRGVTRGILYLHQDSRLTIIHRDLKAGNILLDVDMNPKIADFGVARN 484
Query: 421 FPEDITH 427
F D T
Sbjct: 485 FRVDQTE 491
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65405|CRK28_ARATH Cysteine-rich receptor-like protein kinase 28 OS=Arabidopsis thaliana GN=CRK28 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 207 bits (527), Expect = 1e-52, Method: Compositional matrix adjust.
Identities = 147/455 (32%), Positives = 213/455 (46%), Gaps = 54/455 (11%)
Query: 25 VYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFYDGCYLRYDDYDFFNES 84
YA G C +++ +DC C +++ P T V+Y C RY + +
Sbjct: 84 AYAIGLCRREVKRDDCLSCIQIAARNLIEQCPL---TNQAVVWYTHCMFRYSNMIIYGRK 140
Query: 85 LSSQDRTVCGSKDFGGNNTVFGANAIELV---RNLSVQAVKNDGFFVGSVTFSKGNVSVH 141
++ + K+ N F IEL+ + ++ N + GS + G +
Sbjct: 141 ETTPTLSFQAGKNISANRDEFDRLQIELLDRLKGIAAAGGPNRKYAQGSGSGVAGYPQFY 200
Query: 142 GLAQCWEFVNGSACENCLENAVSRIASCTQKEEG-RVLNAGCYLRYSTQRFYNNSG---P 197
G A C ++ C +CL +I C + G R C R+ T RFY P
Sbjct: 201 GSAHCTPDLSEQDCNDCLVFGFEKIPGCCAGQVGLRWFFPSCSYRFETWRFYEFDADLEP 260
Query: 198 DPVP------------------GNGGDNKLAVILATSAVALLLVFSLVAFFVRRKLLQKR 239
DP G GG + I+ L L LL K
Sbjct: 261 DPPAIQPADSPTSAARTERTGKGKGGSKVIVAIVIPIVFVALFAICLC-------LLLKW 313
Query: 240 RERKQLGALQ----------VAVNKSKLNFS------YETLEKATNYFHESNKLGQGGSG 283
++ K +G ++ + + K FS +ETL+ AT+ F N+LG+GG G
Sbjct: 314 KKNKSVGRVKGNKHNLLLLVIVILLQKDEFSDSLVVDFETLKAATDNFSPENELGRGGFG 373
Query: 284 SVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343
SVYKG GG+ +AVKRL + Q F NE+ L++ + H+NLV+LLG I G E +LV
Sbjct: 374 SVYKGVFSGGQEIAVKRLSCTSGQGDSEFKNEILLLAKLQHRNLVRLLGFCIEGQERILV 433
Query: 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNIL 403
YEF+ N SL + +F + + L W VRYK+I A GL YLHE+S+ RIIHRD+K SNIL
Sbjct: 434 YEFIKNASLDNFIFDLKKRQLLDWGVRYKMIGGVARGLLYLHEDSRYRIIHRDLKASNIL 493
Query: 404 LDEEFTAKIADFGLVRLFPEDIT---HISATLAGT 435
LD+E KIADFGL +L+ D T ++ +AGT
Sbjct: 494 LDQEMNPKIADFGLAKLYDTDQTSTHRFTSKIAGT 528
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 437 | ||||||
| 255573959 | 649 | kinase, putative [Ricinus communis] gi|2 | 0.990 | 0.667 | 0.733 | 0.0 | |
| 225425611 | 649 | PREDICTED: cysteine-rich receptor-like p | 0.990 | 0.667 | 0.728 | 0.0 | |
| 147767572 | 690 | hypothetical protein VITISV_005912 [Viti | 0.990 | 0.627 | 0.730 | 0.0 | |
| 449434953 | 651 | PREDICTED: cysteine-rich receptor-like p | 0.990 | 0.665 | 0.696 | 1e-174 | |
| 15223170 | 646 | cysteine-rich receptor-like protein kina | 0.993 | 0.671 | 0.658 | 1e-169 | |
| 356502033 | 648 | PREDICTED: cysteine-rich receptor-like p | 0.990 | 0.668 | 0.659 | 1e-168 | |
| 356567656 | 656 | PREDICTED: cysteine-rich receptor-like p | 0.990 | 0.660 | 0.657 | 1e-167 | |
| 297841809 | 649 | kinase family protein [Arabidopsis lyrat | 0.993 | 0.668 | 0.652 | 1e-165 | |
| 255567375 | 605 | kinase, putative [Ricinus communis] gi|2 | 0.963 | 0.695 | 0.502 | 1e-111 | |
| 449446869 | 601 | PREDICTED: cysteine-rich receptor-like p | 0.970 | 0.705 | 0.480 | 1e-109 |
| >gi|255573959|ref|XP_002527897.1| kinase, putative [Ricinus communis] gi|223532672|gb|EEF34454.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 671 bits (1730), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 322/439 (73%), Positives = 377/439 (85%), Gaps = 6/439 (1%)
Query: 1 MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLA 60
+D VTPL+ARQ+Y AV+NGTG +VY +GECMKDL DCNLCFAQCKTQ+L+CLPFQLA
Sbjct: 56 LDAVTPLVARQQYGAVINGTGNTTVYTYGECMKDLDQTDCNLCFAQCKTQILRCLPFQLA 115
Query: 61 TRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDF-GGNNTVFGANAIELVRNLSVQ 119
TRGGR+FYDGCYLRYDDY FFNESL SQDRTVC S+DF GGN T++ NA+EL+RNLSV
Sbjct: 116 TRGGRLFYDGCYLRYDDYYFFNESLDSQDRTVCASEDFNGGNKTLYSDNAMELMRNLSVL 175
Query: 120 AVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLN 179
KNDGFFVGSV +KGN+SV+GLAQCWE VN SACE CL +AVS+I +CT KEEGRVLN
Sbjct: 176 TPKNDGFFVGSV--NKGNISVYGLAQCWELVNTSACETCLADAVSKITNCTPKEEGRVLN 233
Query: 180 AGCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILATSAVALLLVFSL--VAFFVRRKLLQ 237
+GCYLRYSTQ+FYNNSGP NGG + LAVILA ++ ++ +V + FF+++++ +
Sbjct: 234 SGCYLRYSTQKFYNNSGPANA-DNGGSSHLAVILAAASSSVAVVLLVATAVFFMKKRVAE 292
Query: 238 KRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVA 297
KRR+RK+LGAL +AVN SKLNF+YE+LEKATNYFH SNKLGQGGSGSVYKG LP G+AVA
Sbjct: 293 KRRQRKELGALLIAVNNSKLNFTYESLEKATNYFHLSNKLGQGGSGSVYKGILPDGKAVA 352
Query: 298 VKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF 357
+KRL +NT QWVDHFFNEVNLIS I HKNLVKLLGCSITGPESLLVYE+VPNQSL D LF
Sbjct: 353 IKRLLFNTRQWVDHFFNEVNLISNIQHKNLVKLLGCSITGPESLLVYEYVPNQSLHDYLF 412
Query: 358 VRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417
V ++V+PL+WE+RYKIIL TAEGLAYLHEE++LRIIHRD+KLSN+LLDE+F KIADFGL
Sbjct: 413 VAKNVQPLTWEMRYKIILGTAEGLAYLHEETELRIIHRDVKLSNVLLDEDFLPKIADFGL 472
Query: 418 VRLFPEDITHISATLAGTL 436
RLFPED THIS +AGTL
Sbjct: 473 ARLFPEDKTHISTAIAGTL 491
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225425611|ref|XP_002266015.1| PREDICTED: cysteine-rich receptor-like protein kinase 3 [Vitis vinifera] gi|297739090|emb|CBI28579.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 652 bits (1682), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 319/438 (72%), Positives = 372/438 (84%), Gaps = 5/438 (1%)
Query: 1 MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLA 60
MD VTPLI+ QRYA V +GTG+ +V+ FGECM+DLS NDCNLCFA CKTQ+L+C+PFQ +
Sbjct: 58 MDQVTPLISTQRYADVTSGTGSTAVFLFGECMEDLSQNDCNLCFALCKTQLLRCVPFQKS 117
Query: 61 TRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGGNNTVFGANAIELVRNLSVQA 120
TRGGR FYDGCY+RYDDY FF+E+LS++D+TVCG+KDF G+ TVF ANAIELVRNLSV+A
Sbjct: 118 TRGGRSFYDGCYIRYDDYKFFDEALSAEDKTVCGTKDFSGDQTVFRANAIELVRNLSVEA 177
Query: 121 VKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLNA 180
NDGFFVGSV ++ N+SV+GLAQCWEFV GSAC CL NA SRI C KEEGRVLNA
Sbjct: 178 PGNDGFFVGSV--NRSNISVYGLAQCWEFVKGSACAECLANATSRIGLCPPKEEGRVLNA 235
Query: 181 GCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILA--TSAVALLLVFSLVAFFVRRKLLQK 238
GCYLRYSTQ+FY+NS D V N G ++LA+IL +S+ ALLL+ ++ FFVR+K ++
Sbjct: 236 GCYLRYSTQKFYDNSTSDFVEENEGSSRLAIILGVTSSSFALLLIIAMTVFFVRKKRAKR 295
Query: 239 RRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAV 298
RRE+KQLG L VNKSKLNFSYETLEKATNYFH SNKLGQGGSGSVYKG +P G+ VA+
Sbjct: 296 RREKKQLGDLLATVNKSKLNFSYETLEKATNYFHHSNKLGQGGSGSVYKGIMPDGKVVAI 355
Query: 299 KRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV 358
KRLF+N+ QWVDHFFNEVNLISGI+HKNLVKLLGCSITGPESLLVYE+VPNQSL D L V
Sbjct: 356 KRLFFNSRQWVDHFFNEVNLISGIDHKNLVKLLGCSITGPESLLVYEYVPNQSLHDYL-V 414
Query: 359 RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418
+++ PL+WE+RYKI+L AEGLAYLHEES LRIIHRDIKLSN+LLDE+F AKIADFGL
Sbjct: 415 KRNAPPLAWEMRYKILLGIAEGLAYLHEESMLRIIHRDIKLSNVLLDEDFAAKIADFGLA 474
Query: 419 RLFPEDITHISATLAGTL 436
RLFPED THIS +AGTL
Sbjct: 475 RLFPEDKTHISTAIAGTL 492
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147767572|emb|CAN64525.1| hypothetical protein VITISV_005912 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 650 bits (1677), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 320/438 (73%), Positives = 372/438 (84%), Gaps = 5/438 (1%)
Query: 1 MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLA 60
MD VTPLI+ QRYA V +GTG+ +V+ FGECM+DLS NDCNLCFA CKTQ+L+C+PFQ +
Sbjct: 15 MDQVTPLISTQRYADVTSGTGSTAVFLFGECMEDLSQNDCNLCFALCKTQLLRCVPFQKS 74
Query: 61 TRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGGNNTVFGANAIELVRNLSVQA 120
TRGGR FYDGCY+RYDDY FF+E+LS++D+TVCG+KDF G+ TVF ANAIELVRNLSV+A
Sbjct: 75 TRGGRSFYDGCYIRYDDYKFFDEALSAEDKTVCGTKDFSGDQTVFRANAIELVRNLSVEA 134
Query: 121 VKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLNA 180
NDGFFVGSV ++ N+SV+GLAQCWEFV GSAC CL NA SRI C KEEGRVLNA
Sbjct: 135 PGNDGFFVGSV--NRSNISVYGLAQCWEFVKGSACAECLANATSRIGLCPPKEEGRVLNA 192
Query: 181 GCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILA--TSAVALLLVFSLVAFFVRRKLLQK 238
GCYLRYSTQ+FY+NS D V N G ++LA+IL +S+ ALLL+ ++ FFVR+K ++
Sbjct: 193 GCYLRYSTQKFYDNSTSDFVEENEGSSRLAIILGVTSSSFALLLIIAMTVFFVRKKRAKR 252
Query: 239 RRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAV 298
RRERKQLG L VNKSKLNFSYETLEKATNYFH SNKLGQGGSGSVYKG +P G+ VA+
Sbjct: 253 RRERKQLGDLLATVNKSKLNFSYETLEKATNYFHHSNKLGQGGSGSVYKGIMPDGKVVAI 312
Query: 299 KRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV 358
KRLF+N+ QWVDHFFNEVNLISGI+HKNLVKLLGCSITGPESLLVYE+VPNQSL D L V
Sbjct: 313 KRLFFNSRQWVDHFFNEVNLISGIDHKNLVKLLGCSITGPESLLVYEYVPNQSLHDYL-V 371
Query: 359 RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418
+++ PL+WE+RYKI+L AEGLAYLHEES LRIIHRDIKLSN+LLDE+F AKIADFGL
Sbjct: 372 KRNAPPLAWEMRYKILLGIAEGLAYLHEESMLRIIHRDIKLSNVLLDEDFAAKIADFGLA 431
Query: 419 RLFPEDITHISATLAGTL 436
RLFPED THIS +AGTL
Sbjct: 432 RLFPEDKTHISTAIAGTL 449
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449434953|ref|XP_004135260.1| PREDICTED: cysteine-rich receptor-like protein kinase 3-like [Cucumis sativus] gi|449516641|ref|XP_004165355.1| PREDICTED: cysteine-rich receptor-like protein kinase 3-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 616 bits (1589), Expect = e-174, Method: Compositional matrix adjust.
Identities = 305/438 (69%), Positives = 351/438 (80%), Gaps = 5/438 (1%)
Query: 1 MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLA 60
MD VTPLIA QR+AAV+NGTG +VYAFGECM DLS DC+LCFAQ KTQVL+CLPFQLA
Sbjct: 60 MDAVTPLIASQRFAAVINGTGNTTVYAFGECMNDLSQADCDLCFAQMKTQVLRCLPFQLA 119
Query: 61 TRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGGNNTVFGANAIELVRNLSVQA 120
TRGGR+FYDGC++RYD Y+FFNESLS+ DRTVCG D+ GN +VF +A++L RNLSV A
Sbjct: 120 TRGGRLFYDGCFVRYDYYNFFNESLSAVDRTVCGKLDYSGNRSVFSDSAMKLARNLSVVA 179
Query: 121 VKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLNA 180
KNDGF VGSV F NVSV+GL QCW+FV GS+C CL +A I SC K EGRVLNA
Sbjct: 180 PKNDGFAVGSVDFR--NVSVYGLGQCWKFVRGSSCSKCLVDAAKEIGSCPPKSEGRVLNA 237
Query: 181 GCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILATSAVALLLVF--SLVAFFVRRKLLQK 238
GCY RYST++FY N+ GN +LA+ILA+ + A+ S V F RR++L+K
Sbjct: 238 GCYFRYSTEKFYFNTTATATGGNNS-RRLAIILASVSAAVAAALIISTVLFCARRRVLRK 296
Query: 239 RRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAV 298
R E++QLG L VNKSKLNFSYETLEKATNYF +SNKLGQGGSGSVYKGTL G VA+
Sbjct: 297 RNEKRQLGPLVAIVNKSKLNFSYETLEKATNYFDQSNKLGQGGSGSVYKGTLSDGRVVAI 356
Query: 299 KRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV 358
KRLF+NT QWVDHFFNEVNLISGI HKNLV LLGCSITGPESLLVYE+VPNQSL D LF
Sbjct: 357 KRLFFNTRQWVDHFFNEVNLISGIRHKNLVGLLGCSITGPESLLVYEYVPNQSLHDYLFG 416
Query: 359 RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418
++V+PLSW+ R+KI+L TAEGLAYLHEES ++IIHRDIKLSNILLD +FT KIADFGL
Sbjct: 417 NKNVQPLSWQSRFKIVLGTAEGLAYLHEESNVKIIHRDIKLSNILLDYDFTPKIADFGLA 476
Query: 419 RLFPEDITHISATLAGTL 436
RL PED THIS +AGTL
Sbjct: 477 RLLPEDKTHISTAIAGTL 494
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15223170|ref|NP_177210.1| cysteine-rich receptor-like protein kinase 3 [Arabidopsis thaliana] gi|75333658|sp|Q9CAL2.1|CRK3_ARATH RecName: Full=Cysteine-rich receptor-like protein kinase 3; Short=Cysteine-rich RLK3; Flags: Precursor gi|12325043|gb|AAG52470.1|AC010796_9 putative protein kinase; 41292-38663 [Arabidopsis thaliana] gi|332196954|gb|AEE35075.1| cysteine-rich receptor-like protein kinase 3 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 601 bits (1549), Expect = e-169, Method: Compositional matrix adjust.
Identities = 289/439 (65%), Positives = 347/439 (79%), Gaps = 5/439 (1%)
Query: 1 MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLA 60
MD V+PL+ + Y VVNGTG +VYA+GEC+KDL DC+LCFAQ K +V +CLPFQ
Sbjct: 52 MDAVSPLVEAKGYGQVVNGTGNLTVYAYGECIKDLDKKDCDLCFAQIKAKVPRCLPFQKG 111
Query: 61 TRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGG-NNTVFGANAIELVRNLSVQ 119
TRGG+VF DGCY+RYDDY+F+NE+LS QDRTVC K+ G N TVF NA ELV+N+SV+
Sbjct: 112 TRGGQVFSDGCYIRYDDYNFYNETLSLQDRTVCAPKEITGVNRTVFRDNAAELVKNMSVE 171
Query: 120 AVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLN 179
AV+N GF+ G V + NV+VHGLAQCWE +N S C CL A RI SC EEGRVL+
Sbjct: 172 AVRNGGFYAGFV--DRHNVTVHGLAQCWETLNRSGCVECLSKASVRIGSCLVNEEGRVLS 229
Query: 180 AGCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILA--TSAVALLLVFSLVAFFVRRKLLQ 237
AGCY+R+STQ+FYNNSG GNGG N L VILA +S VA +L+ S F ++++ +
Sbjct: 230 AGCYMRFSTQKFYNNSGNSTSDGNGGHNHLGVILAVTSSVVAFVLLVSAAGFLLKKRHAK 289
Query: 238 KRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVA 297
K+RE+KQLG+L + NKS L FSYE LE+AT+YF + NKLGQGGSGSVYKG L G+ VA
Sbjct: 290 KQREKKQLGSLFMLANKSNLCFSYENLERATDYFSDKNKLGQGGSGSVYKGVLTNGKTVA 349
Query: 298 VKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF 357
VKRLF+NT QWVDHFFNEVNLIS ++HKNLVKLLGCSITGPESLLVYE++ NQSL D LF
Sbjct: 350 VKRLFFNTKQWVDHFFNEVNLISQVDHKNLVKLLGCSITGPESLLVYEYIANQSLHDYLF 409
Query: 358 VRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417
VR+DV+PL+W R+KIIL TAEG+AYLHEES LRIIHRDIKLSNILL+++FT +IADFGL
Sbjct: 410 VRKDVQPLNWAKRFKIILGTAEGMAYLHEESNLRIIHRDIKLSNILLEDDFTPRIADFGL 469
Query: 418 VRLFPEDITHISATLAGTL 436
RLFPED THIS +AGTL
Sbjct: 470 ARLFPEDKTHISTAIAGTL 488
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356502033|ref|XP_003519826.1| PREDICTED: cysteine-rich receptor-like protein kinase 3-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 598 bits (1543), Expect = e-168, Method: Compositional matrix adjust.
Identities = 290/440 (65%), Positives = 353/440 (80%), Gaps = 7/440 (1%)
Query: 1 MDIVTPLIARQRYAAVVNGT--GTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQ 58
++ +T L+ RQ+YA VV GT A+VYAFGEC KDL+ DC++CFAQCKT+VL+C PFQ
Sbjct: 52 LEALTALVTRQKYAFVVKGTTQNNATVYAFGECRKDLTKPDCDVCFAQCKTRVLRCSPFQ 111
Query: 59 LATRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGGNNTVFGANAIELVRNLSV 118
GG F+DGC+LRYD Y+FFNESLS QD TVCG++DF GN +V+ AN +ELVRNLS+
Sbjct: 112 RGIDGGMFFFDGCFLRYDGYNFFNESLSPQDFTVCGTEDFSGNWSVYKANTVELVRNLSI 171
Query: 119 QAVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVL 178
+A KN+GFFVG V S+ NV+V+GLAQCW+F+NGSAC+NCL AV+RI SC K EG+ L
Sbjct: 172 EAPKNEGFFVGYV--SQRNVTVYGLAQCWKFMNGSACQNCLVEAVTRIDSCASKAEGKAL 229
Query: 179 NAGCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILA--TSAVALLLVFSLVAFFVRRKLL 236
NAGCYLRYST FYN+S + N G LA+I+A ++++ALLL+ + V FFVR LL
Sbjct: 230 NAGCYLRYSTHNFYNSSNNNVPHENQGHKNLAIIVAVASASLALLLIVATVVFFVRTNLL 289
Query: 237 QKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAV 296
++RRER+Q GAL VNKSKLN YE LEKAT+YF SNKLG+GGSGSVYKG LP G +
Sbjct: 290 KRRRERRQFGALLNTVNKSKLNMPYEILEKATDYFSHSNKLGEGGSGSVYKGVLPDGNTM 349
Query: 297 AVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL 356
A+KRL +NT+QW DHFFNEVNLISGI+HKNLVKLLGCSITGPESLLVYEFVPN SL D+L
Sbjct: 350 AIKRLSFNTSQWADHFFNEVNLISGIHHKNLVKLLGCSITGPESLLVYEFVPNHSLYDHL 409
Query: 357 FVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416
R++ + L+WEVR+KIIL TAEGLAYLHEES+ RIIHRDIKL+NIL+D+ FT KIADFG
Sbjct: 410 SGRKNSQQLTWEVRHKIILGTAEGLAYLHEESQ-RIIHRDIKLANILVDDNFTPKIADFG 468
Query: 417 LVRLFPEDITHISATLAGTL 436
L RLFPED +H+S + GTL
Sbjct: 469 LARLFPEDKSHLSTAICGTL 488
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356567656|ref|XP_003552033.1| PREDICTED: cysteine-rich receptor-like protein kinase 3-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 595 bits (1533), Expect = e-167, Method: Compositional matrix adjust.
Identities = 296/450 (65%), Positives = 348/450 (77%), Gaps = 17/450 (3%)
Query: 1 MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLA 60
MD +TPL + AV NG+ A+VYAFGECM+DLS NDCNLC AQCKTQ+L CLPFQ
Sbjct: 54 MDALTPLTTSHGHGAVSNGSQNATVYAFGECMRDLSRNDCNLCLAQCKTQLLACLPFQRG 113
Query: 61 TRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDF------------GGNNTVFGAN 108
TRGGR+F+DGCYLRYDDY+FF E+ S QD TVCG+ ++ V+ AN
Sbjct: 114 TRGGRLFFDGCYLRYDDYNFFGETRSDQDTTVCGNNSNNNNSNSVANSATNSSSGVYKAN 173
Query: 109 AIELVRNLSVQAVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIAS 168
A+ LV NLS A K+DGFFVGSV + NV V+GLAQCWE+VNGSACE CL +AV+RI S
Sbjct: 174 AMALVLNLSELAPKSDGFFVGSV--ERKNVRVYGLAQCWEYVNGSACERCLADAVTRIGS 231
Query: 169 CTQKEEGRVLNAGCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILATSAVALLL--VFSL 226
C +E R LNAGCYLRYS Q+FYNNSG P G G +LA ILA S+ AL L V +
Sbjct: 232 CA-TQEARALNAGCYLRYSAQKFYNNSGVVPTAGKHGKRRLAKILAASSAALALLLVIAT 290
Query: 227 VAFFVRRKLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVY 286
V FF+R+ ++ +RRER+Q GAL VNKSKLN YE LEKATNYF+E+NKLGQGGSGSVY
Sbjct: 291 VVFFIRKNVVTRRRERRQFGALLDTVNKSKLNMPYEVLEKATNYFNEANKLGQGGSGSVY 350
Query: 287 KGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346
KG +P G VA+KRL +NTTQW DHFFNEVNLISGI+HKNLVKLLGCSITGPESLLVYE+
Sbjct: 351 KGVMPDGITVAIKRLSFNTTQWADHFFNEVNLISGIHHKNLVKLLGCSITGPESLLVYEY 410
Query: 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE 406
VPNQSL D+ VR+ +PL+WE+R+KI+L AEG+AYLHEES +RIIHRDIKLSNILL+E
Sbjct: 411 VPNQSLHDHFSVRRTSQPLTWEIRHKILLGIAEGMAYLHEESHVRIIHRDIKLSNILLEE 470
Query: 407 EFTAKIADFGLVRLFPEDITHISATLAGTL 436
+FT KIADFGL RLFPED +HIS +AGTL
Sbjct: 471 DFTPKIADFGLARLFPEDKSHISTAIAGTL 500
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297841809|ref|XP_002888786.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297334627|gb|EFH65045.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 588 bits (1517), Expect = e-165, Method: Compositional matrix adjust.
Identities = 287/440 (65%), Positives = 343/440 (77%), Gaps = 6/440 (1%)
Query: 1 MDIVTPLIARQRYAAVVN-GTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQL 59
MD V+PL+ + Y VVN G +VYA+GEC+KDL+ DC+LCFAQ K +V CLPFQ
Sbjct: 54 MDAVSPLVEAKGYGQVVNNANGNLTVYAYGECIKDLNKKDCDLCFAQIKAKVPICLPFQR 113
Query: 60 ATRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGG-NNTVFGANAIELVRNLSV 118
TRGG+VF DGCY+RYDDY+FFNE+L QDRTVC K+ G N TVF NA ELV+N+SV
Sbjct: 114 GTRGGQVFSDGCYIRYDDYNFFNETLGLQDRTVCAPKEITGVNRTVFRDNAAELVKNMSV 173
Query: 119 QAVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVL 178
+AV+N GF+ G V + NV+VHGLAQCWE +N S C CL A I SC EEGRVL
Sbjct: 174 EAVRNGGFYAGFV--DRHNVTVHGLAQCWETLNRSGCVECLSKASVSIGSCLVNEEGRVL 231
Query: 179 NAGCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILA--TSAVALLLVFSLVAFFVRRKLL 236
+AGCY+R+STQ+FYNNSG GNGG N L VILA +S VA +L+ S F ++++
Sbjct: 232 SAGCYMRFSTQKFYNNSGNSTSDGNGGHNHLGVILAVTSSVVAFVLLVSAAGFLLKKRHA 291
Query: 237 QKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAV 296
+K+RE+KQLG+L + NKS L FSYE LE+AT+YF + NKLGQGGSGSVYKG L G+ V
Sbjct: 292 KKQREKKQLGSLFMLANKSNLCFSYENLERATDYFSDKNKLGQGGSGSVYKGVLTNGKTV 351
Query: 297 AVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL 356
AVKRLF+NT QWVDHFFNEVNLIS +NHKNLVKLLGCSITGPESLLVYE++ NQSL D L
Sbjct: 352 AVKRLFFNTKQWVDHFFNEVNLISQVNHKNLVKLLGCSITGPESLLVYEYIANQSLHDYL 411
Query: 357 FVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416
FVR+DV+PL+W R+KIIL TAEG+AYLHEES LRIIHRDIKLSNILL+++FT +IADFG
Sbjct: 412 FVRKDVQPLNWAKRFKIILGTAEGMAYLHEESNLRIIHRDIKLSNILLEDDFTPRIADFG 471
Query: 417 LVRLFPEDITHISATLAGTL 436
L RLFPED THIS +AGTL
Sbjct: 472 LARLFPEDKTHISTAIAGTL 491
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255567375|ref|XP_002524667.1| kinase, putative [Ricinus communis] gi|223536028|gb|EEF37686.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 409 bits (1051), Expect = e-111, Method: Compositional matrix adjust.
Identities = 224/446 (50%), Positives = 293/446 (65%), Gaps = 25/446 (5%)
Query: 1 MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLA 60
M+ ++ LI +A + + +Y +C +DLS DC LC+A +T++ +CLP
Sbjct: 1 METLSQLITNSHFA-TYHLNSSLPMYVLAQCHQDLSQTDCLLCYAVSRTKIPRCLP---- 55
Query: 61 TRGGRVFYDGCYLRYDDYDFFNESLS-SQDRTVCGSKDFGGNN-----TVFGANAIELVR 114
+ R+F DGC+LRYD+Y+FF ES+S S D C ++ G+N F + +
Sbjct: 56 SVSARIFLDGCFLRYDNYNFFEESVSVSFDEVKCSQENVSGSNGENDKLRFVKSVEHAIG 115
Query: 115 NLSVQAVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEE 174
N+S +AV+N GF V + V+ LAQCWE V C CL A + C K+E
Sbjct: 116 NVSSKAVENGGFGVVGIE------GVYALAQCWESVGKDGCRECLRKAGKEVKGCGAKKE 169
Query: 175 GRVLNAGCYLRYSTQRFYNNSGP----DPVPGNGGDNKLAVILATSAVALLLVFSLVAFF 230
GR LNAGCYLRYST+RFYN G + G G +AV+LA +AV +L +F++ A +
Sbjct: 170 GRGLNAGCYLRYSTERFYNVGGELEAGHTISGLG--VAIAVVLAAAAVLMLSIFAVYAVY 227
Query: 231 VRRKLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTL 290
VRR ++ + ER L + + +K+ LNF YETLEKAT+YF+ S K+GQGG+GSVY GTL
Sbjct: 228 VRR--MKNKAERINLEKISINFSKTSLNFKYETLEKATDYFNASRKIGQGGAGSVYAGTL 285
Query: 291 PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350
P GE VAVKRL +NT QWVD FFNEVNLISGI HKNLVKLLGCSI GPESLLVYE+VPN+
Sbjct: 286 PNGETVAVKRLTFNTRQWVDEFFNEVNLISGIQHKNLVKLLGCSIEGPESLLVYEYVPNK 345
Query: 351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410
SL +F + L+W+ R+ II+ TAEGLAYLH S+ RIIHRDIK SN+LLDE+FT
Sbjct: 346 SLDQFIFGKDKPTTLNWKQRFDIIVGTAEGLAYLHGGSQERIIHRDIKSSNVLLDEDFTP 405
Query: 411 KIADFGLVRLFPEDITHISATLAGTL 436
KIADFGLVR F D +H+S +AGT+
Sbjct: 406 KIADFGLVRCFGADKSHLSTGIAGTM 431
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449446869|ref|XP_004141193.1| PREDICTED: cysteine-rich receptor-like protein kinase 42-like [Cucumis sativus] gi|449515394|ref|XP_004164734.1| PREDICTED: cysteine-rich receptor-like protein kinase 42-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 402 bits (1033), Expect = e-109, Method: Compositional matrix adjust.
Identities = 212/441 (48%), Positives = 279/441 (63%), Gaps = 17/441 (3%)
Query: 1 MDIVTPLIARQRYAA-VVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQL 59
M+ ++ L+ + + VN T ++A +C DLS DC LC+A +T + +CLP
Sbjct: 1 MEAISELLTTRSWTTHFVNST--PPMFALSQCFNDLSHTDCLLCYAASRTSLPRCLP--- 55
Query: 60 ATRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFG----GNNTVFGANAIELVRN 115
R+F DGC+LRYD+Y F+ ES S +V + + G VFG N +V
Sbjct: 56 -AISARIFLDGCFLRYDNYSFYKESTDSVRDSVNCTSELGEIDQSERLVFGENVRVVVET 114
Query: 116 LSVQAVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEG 175
++ +A++ GF +G V+ + GLAQCW V C CLE A I SC +EG
Sbjct: 115 VTTKAMEKGGFGMGEVS------GMFGLAQCWGSVEPEGCRACLEKAKRSIGSCLPSKEG 168
Query: 176 RVLNAGCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILATSAVALLLVFSLVAFFVRRKL 235
R +NAGCYLRYST +FYN+ D + V +A ++ A L++F F ++
Sbjct: 169 RAMNAGCYLRYSTVKFYNDKDEDRDHDGFSGRRAVVTIALASAASLIIFFSAVFACYTRI 228
Query: 236 LQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEA 295
+ ++E+K+ + V++ S LNF YETLEKATNYF+ SNK+GQGG+GSVYKGTLP G+
Sbjct: 229 SKFKKEKKRQSLIPVSLKDSDLNFKYETLEKATNYFNLSNKIGQGGAGSVYKGTLPNGQI 288
Query: 296 VAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDN 355
VAVKRL ++T QWVD FFNEVNLI GI HKNLV LLGCSI GPESLLVYEFV N SL
Sbjct: 289 VAVKRLVFHTRQWVDEFFNEVNLIRGIQHKNLVALLGCSIEGPESLLVYEFVSNGSLDHF 348
Query: 356 LFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415
+F + + LSW+ R+ II+ TAEGLA+LHE K+RIIHRDIK SN+LLDE F KIADF
Sbjct: 349 IFDKNKAQILSWKQRFNIIVGTAEGLAHLHEGCKIRIIHRDIKSSNVLLDENFNPKIADF 408
Query: 416 GLVRLFPEDITHISATLAGTL 436
GL R F D +H+S +AGTL
Sbjct: 409 GLARHFGADQSHLSTGIAGTL 429
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 437 | ||||||
| TAIR|locus:2026785 | 646 | CRK3 "cysteine-rich RLK (RECEP | 0.437 | 0.295 | 0.753 | 2.7e-141 | |
| TAIR|locus:2026821 | 649 | CRK2 "cysteine-rich RLK (RECEP | 0.416 | 0.280 | 0.609 | 1.3e-86 | |
| TAIR|locus:2139845 | 625 | AT4G28670 [Arabidopsis thalian | 0.407 | 0.284 | 0.516 | 6e-69 | |
| TAIR|locus:2141762 | 665 | CRK26 "cysteine-rich RLK (RECE | 0.398 | 0.261 | 0.539 | 1.2e-59 | |
| TAIR|locus:2141201 | 679 | CRK29 "cysteine-rich RLK (RECE | 0.418 | 0.269 | 0.505 | 1e-55 | |
| TAIR|locus:2115728 | 675 | CRK25 "cysteine-rich RLK (RECE | 0.409 | 0.265 | 0.511 | 1.8e-53 | |
| TAIR|locus:2123126 | 666 | CRK31 "cysteine-rich RLK (RECE | 0.389 | 0.255 | 0.523 | 4e-52 | |
| TAIR|locus:2123111 | 669 | CRK34 "cysteine-rich RLK (RECE | 0.409 | 0.267 | 0.5 | 1.9e-50 | |
| TAIR|locus:2137144 | 646 | CRK37 "cysteine-rich RLK (RECE | 0.416 | 0.281 | 0.524 | 2.3e-50 | |
| TAIR|locus:2125766 | 654 | CRK40 "cysteine-rich RLK (RECE | 0.407 | 0.272 | 0.530 | 4.7e-50 |
| TAIR|locus:2026785 CRK3 "cysteine-rich RLK (RECEPTOR-like protein kinase) 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 757 (271.5 bits), Expect = 2.7e-141, Sum P(2) = 2.7e-141
Identities = 144/191 (75%), Positives = 165/191 (86%)
Query: 246 GALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT 305
G+L + NKS L FSYE LE+AT+YF + NKLGQGGSGSVYKG L G+ VAVKRLF+NT
Sbjct: 298 GSLFMLANKSNLCFSYENLERATDYFSDKNKLGQGGSGSVYKGVLTNGKTVAVKRLFFNT 357
Query: 306 TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPL 365
QWVDHFFNEVNLIS ++HKNLVKLLGCSITGPESLLVYE++ NQSL D LFVR+DV+PL
Sbjct: 358 KQWVDHFFNEVNLISQVDHKNLVKLLGCSITGPESLLVYEYIANQSLHDYLFVRKDVQPL 417
Query: 366 SWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425
+W R+KIIL TAEG+AYLHEES LRIIHRDIKLSNILL+++FT +IADFGL RLFPED
Sbjct: 418 NWAKRFKIILGTAEGMAYLHEESNLRIIHRDIKLSNILLEDDFTPRIADFGLARLFPEDK 477
Query: 426 THISATLAGTL 436
THIS +AGTL
Sbjct: 478 THISTAIAGTL 488
|
|
| TAIR|locus:2026821 CRK2 "cysteine-rich RLK (RECEPTOR-like protein kinase) 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 565 (203.9 bits), Expect = 1.3e-86, Sum P(2) = 1.3e-86
Identities = 111/182 (60%), Positives = 134/182 (73%)
Query: 255 SKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFN 314
S LNF Y TLEKAT F +NKLGQGG G+VYKG LP G +AVKRLF+N F+N
Sbjct: 309 SSLNFKYSTLEKATGSFDNANKLGQGGFGTVYKGVLPDGRDIAVKRLFFNNRHRATDFYN 368
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
EVN+IS + HKNLV+LLGCS +GPESLLVYE++ N+SL +F + L W+ RY II
Sbjct: 369 EVNMISTVEHKNLVRLLGCSCSGPESLLVYEYLQNKSLDRFIFDVNRGKTLDWQRRYTII 428
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG 434
+ TAEGL YLHE+S ++IIHRDIK SNILLD + AKIADFGL R F +D +HIS +AG
Sbjct: 429 VGTAEGLVYLHEQSSVKIIHRDIKASNILLDSKLQAKIADFGLARSFQDDKSHISTAIAG 488
Query: 435 TL 436
TL
Sbjct: 489 TL 490
|
|
| TAIR|locus:2139845 AT4G28670 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 431 (156.8 bits), Expect = 6.0e-69, Sum P(2) = 6.0e-69
Identities = 96/186 (51%), Positives = 122/186 (65%)
Query: 257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEV 316
++F Y TL+KATN F+ES KLG GG G V+KGTL G +A+KRL + + D NE+
Sbjct: 317 MSFEYSTLKKATNNFNESCKLGVGGYGEVFKGTLSDGREIAIKRLHVSGKKPRDEIHNEI 376
Query: 317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS 376
++IS HKNLV+LLGC T S +VYEF+ N SL LF + + L W+ R IIL
Sbjct: 377 DVISRCQHKNLVRLLGCCFTNMNSFIVYEFLANTSLDHILFNPEKKKELDWKKRRTIILG 436
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE---DITHIS---A 430
TAEGL YLHE K IIHRDIK SNILLD ++ KI+DFGL + +PE DI S +
Sbjct: 437 TAEGLEYLHETCK--IIHRDIKASNILLDLKYKPKISDFGLAKFYPEGGKDIPASSLSPS 494
Query: 431 TLAGTL 436
++AGTL
Sbjct: 495 SIAGTL 500
|
|
| TAIR|locus:2141762 CRK26 "cysteine-rich RLK (RECEPTOR-like protein kinase) 26" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 463 (168.0 bits), Expect = 1.2e-59, Sum P(2) = 1.2e-59
Identities = 95/176 (53%), Positives = 119/176 (67%)
Query: 252 VNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDH 311
++ + F + L+ AT++F NKLG+GG G+VYKG L G+ +AVKRL N Q
Sbjct: 325 ISTDSMKFDFSVLQDATSHFSLENKLGEGGFGAVYKGVLSDGQKIAVKRLSKNAQQGETE 384
Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY 371
F NE L++ + H+NLVKLLG SI G E LLVYEF+P+ SL +F L WE+RY
Sbjct: 385 FKNEFLLVAKLQHRNLVKLLGYSIEGTERLLVYEFLPHTSLDKFIFDPIQGNELEWEIRY 444
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
KII A GL YLH++S+LRIIHRD+K SNILLDEE T KIADFG+ RLF DI H
Sbjct: 445 KIIGGVARGLLYLHQDSRLRIIHRDLKASNILLDEEMTPKIADFGMARLF--DIDH 498
|
|
| TAIR|locus:2141201 CRK29 "cysteine-rich RLK (RECEPTOR-like protein kinase) 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 449 (163.1 bits), Expect = 1.0e-55, Sum P(2) = 1.0e-55
Identities = 94/186 (50%), Positives = 125/186 (67%)
Query: 253 NKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHF 312
N L +ETL+ AT+ F N+LG+GG GSVYKG P G+ +AVKRL N+ Q + F
Sbjct: 339 NTESLLVHFETLKTATDNFSSENELGRGGFGSVYKGVFPQGQEIAVKRLSGNSGQGDNEF 398
Query: 313 FNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYK 372
NE+ L++ + H+NLV+L+G I G E LLVYEF+ N SL +F + + L W VRYK
Sbjct: 399 KNEILLLAKLQHRNLVRLIGFCIQGEERLLVYEFIKNASLDQFIFDTEKRQLLDWVVRYK 458
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP--EDITH-IS 429
+I A GL YLHE+S+ RIIHRD+K SNILLD+E KIADFGL +LF + +TH +
Sbjct: 459 MIGGIARGLLYLHEDSRFRIIHRDLKASNILLDQEMNPKIADFGLAKLFDSGQTMTHRFT 518
Query: 430 ATLAGT 435
+ +AGT
Sbjct: 519 SRIAGT 524
|
|
| TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 450 (163.5 bits), Expect = 1.8e-53, Sum P(2) = 1.8e-53
Identities = 92/180 (51%), Positives = 118/180 (65%)
Query: 257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEV 316
L F + +E ATN F ESNKLG GG G VYKG L GE VA+KRL +TQ + F NEV
Sbjct: 333 LQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGETVAIKRLSQGSTQGAEEFKNEV 392
Query: 317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS 376
++++ + H+NL KLLG + G E +LVYEFVPN+SL LF + L W+ RYKII
Sbjct: 393 DVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFLFDNEKRRVLDWQRRYKIIEG 452
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT-LAGT 435
A G+ YLH +S+L IIHRD+K SNILLD + KI+DFG+ R+F D T + + GT
Sbjct: 453 IARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMARIFGVDQTQANTKRIVGT 512
|
|
| TAIR|locus:2123126 CRK31 "cysteine-rich RLK (RECEPTOR-like protein kinase) 31" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 415 (151.1 bits), Expect = 4.0e-52, Sum P(2) = 4.0e-52
Identities = 89/170 (52%), Positives = 109/170 (64%)
Query: 257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEV 316
L F + T+E AT+ F +NKLGQGG G VYKG LP +AVKRL N+ Q F NEV
Sbjct: 325 LQFDFTTIEVATDNFSRNNKLGQGGFGEVYKGMLPNETEIAVKRLSSNSGQGTQEFKNEV 384
Query: 317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS 376
+++ + HKNLV+LLG I E +LVYEFV N+SL LF + L W+ RY II
Sbjct: 385 VIVAKLQHKNLVRLLGFCIERDEQILVYEFVSNKSLDYFLFDPKMKSQLDWKRRYNIIGG 444
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426
GL YLH++S+L IIHRDIK SNILLD + KIADFG+ R F D T
Sbjct: 445 VTRGLLYLHQDSRLTIIHRDIKASNILLDADMNPKIADFGMARNFRVDQT 494
|
|
| TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 427 (155.4 bits), Expect = 1.9e-50, Sum P(2) = 1.9e-50
Identities = 90/180 (50%), Positives = 117/180 (65%)
Query: 257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEV 316
L FS++T+E AT+ F +SN +G+GG G VY+G L G VAVKRL + Q + F NE
Sbjct: 331 LQFSFKTIEAATDKFSDSNMIGRGGFGEVYRGKLSSGPEVAVKRLSKTSGQGAEEFKNEA 390
Query: 317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS 376
L+S + HKNLV+LLG + G E +LVYEFVPN+SL LF L W RY II
Sbjct: 391 VLVSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLFDPAKQGELDWTRRYNIIGG 450
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT-LAGT 435
A G+ YLH++S+L IIHRD+K SNILLD + KIADFG+ R+F D + + +AGT
Sbjct: 451 IARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGVDQSQANTRRIAGT 510
|
|
| TAIR|locus:2137144 CRK37 "cysteine-rich RLK (RECEPTOR-like protein kinase) 37" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 441 (160.3 bits), Expect = 2.3e-50, Sum P(2) = 2.3e-50
Identities = 96/183 (52%), Positives = 118/183 (64%)
Query: 254 KSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFF 313
+S L F + ATN F NKLGQGG GSVYKG LP G+ +AVKRL + Q F
Sbjct: 328 QSMLRFDLRMIVTATNNFSLENKLGQGGFGSVYKGILPSGQEIAVKRLRKGSGQGGMEFK 387
Query: 314 NEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI 373
NEV L++ + H+NLVKLLG E +LVYEFVPN SL +F + L+W+VRY I
Sbjct: 388 NEVLLLTRLQHRNLVKLLGFCNEKDEEILVYEFVPNSSLDHFIFDEEKRRVLTWDVRYTI 447
Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH-ISATL 432
I A GL YLHE+S+LRIIHRD+K SNILLD E K+ADFG+ RLF D T ++ +
Sbjct: 448 IEGVARGLLYLHEDSQLRIIHRDLKASNILLDAEMNPKVADFGMARLFDMDETRGQTSRV 507
Query: 433 AGT 435
GT
Sbjct: 508 VGT 510
|
|
| TAIR|locus:2125766 CRK40 "cysteine-rich RLK (RECEPTOR-like protein kinase) 40" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 442 (160.7 bits), Expect = 4.7e-50, Sum P(2) = 4.7e-50
Identities = 96/181 (53%), Positives = 117/181 (64%)
Query: 257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEV 316
L F + AT+ F N LGQGG G+VYKGT P G+ VAVKRL + Q F NEV
Sbjct: 334 LRFDLGMIVMATDDFSSENTLGQGGFGTVYKGTFPNGQEVAVKRLTKGSGQGDMEFKNEV 393
Query: 317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPL-SWEVRYKIIL 375
+L++ + HKNLVKLLG G E +LVYEFVPN SL D+ +D L +WEVR++II
Sbjct: 394 SLLTRLQHKNLVKLLGFCNEGDEEILVYEFVPNSSL-DHFIFDEDKRSLLTWEVRFRIIE 452
Query: 376 STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT-LAG 434
A GL YLHE+S+L+IIHRD+K SNILLD E K+ADFG RLF D T +AG
Sbjct: 453 GIARGLLYLHEDSQLKIIHRDLKASNILLDAEMNPKVADFGTARLFDSDETRAETKRIAG 512
Query: 435 T 435
T
Sbjct: 513 T 513
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9CAL2 | CRK3_ARATH | 2, ., 7, ., 1, 1, ., - | 0.6583 | 0.9931 | 0.6718 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | AT1G70530 | protein kinase family protein; protein kinase family protein; FUNCTIONS IN- kinase activity; INVOLVED IN- protein amino acid phosphorylation; LOCATED IN- plasma membrane; EXPRESSED IN- 23 plant structures; EXPRESSED DURING- 14 growth stages; CONTAINS InterPro DOMAIN/s- Protein kinase, ATP binding site (InterPro-IPR017441), Protein kinase, core (InterPro-IPR000719), Protein of unknown function DUF26 (InterPro-IPR002902), Serine/threonine protein kinase-related (InterPro-IPR017442), Protein kinase-like (InterPro-IPR011009), Serine/threonine protein kinase, active site (InterPro-IPR008271 [...] (646 aa) | |||||||||
(Arabidopsis thaliana) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | AT1G70520 | protein kinase family protein; protein kinase family protein; FUNCTIONS IN- kinase activity; IN [...] (649 aa) | • | • | 0.675 | ||||||
 | AT4G08520 | clathrin adaptor complex small chain family protein; clathrin adaptor complex small chain famil [...] (181 aa) | • | 0.597 | |||||||
 | AT4G23460 | beta-adaptin, putative; beta-adaptin, putative; FUNCTIONS IN- protein transporter activity, pro [...] (893 aa) | • | 0.591 | |||||||
 | MLO2 | MLO2 (MILDEW RESISTANCE LOCUS O 2); calmodulin binding; A member of a large family of seven-tra [...] (573 aa) | • | 0.508 | |||||||
 | AT3G11130 | clathrin heavy chain, putative; clathrin heavy chain, putative; FUNCTIONS IN- protein binding, [...] (1705 aa) | • | 0.507 | |||||||
 | SCL1 | SCL1 (SCARECROW-LIKE 1); transcription factor; Encodes a scarecrow-like protein (SCL1). Member [...] (593 aa) | • | 0.475 | |||||||
 | AT-HSFA4A | AT-HSFA4A; DNA binding / transcription factor; member of Heat Stress Transcription Factor (Hsf) [...] (401 aa) | • | 0.469 | |||||||
 | anac053 | anac053 (Arabidopsis NAC domain containing protein 53); transcription factor; Arabidopsis NAC d [...] (549 aa) | • | 0.466 | |||||||
 | PSKR1 | PSKR1 (PHYTOSULFOKIN RECEPTOR 1); ATP binding / peptide receptor/ protein serine/threonine kina [...] (1008 aa) | • | • | 0.434 | ||||||
 | AT1G18390 | ATP binding / kinase/ protein kinase/ protein serine/threonine kinase/ protein tyrosine kinase; [...] (654 aa) | • | • | 0.414 | ||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 437 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-40 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-36 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-34 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-34 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-33 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-33 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-32 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-18 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-18 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-17 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-17 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-17 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-16 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-16 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 5e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-16 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-15 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-14 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-13 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-13 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 4e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-13 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-12 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-12 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-11 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-11 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-10 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-09 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-09 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-07 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-06 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-06 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-06 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-06 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-05 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-05 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-05 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-05 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-05 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-04 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-04 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 8e-04 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.001 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.001 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 0.001 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.001 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 0.001 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.001 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.001 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.001 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 0.001 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.002 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 0.002 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 0.002 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 0.002 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 0.002 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.003 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.003 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 0.004 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 5e-40
Identities = 57/163 (34%), Positives = 85/163 (52%), Gaps = 9/163 (5%)
Query: 277 LGQGGSGSVYKGTLPG-GEAVAVKRL-FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
LG+GG G+VY G+ VA+K + +++ ++ E+ ++ +NH N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
LV E+ SL D ++++ LS + +I+L EGL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKD--LLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIH 115
Query: 395 RDIKLSNILLDE-EFTAKIADFGLVRLFPEDITHISATLAGTL 436
RD+K NILLD K+ADFGL +L D + T+ GT
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSD-KSLLKTIVGTP 157
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 59/170 (34%), Positives = 81/170 (47%), Gaps = 10/170 (5%)
Query: 271 FHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDH--FFNEVNLISGINHKNL 327
+ KLG G G+VYK G G+ VAVK L + + E+ ++ ++H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
V+L+ LV E+ L D L PLS + KI L GL YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG---PLSEDEAKKIALQILRGLEYLHSN 117
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLF 437
IIHRD+K NILLDE KIADFGL + + + ++ T GT +
Sbjct: 118 ---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLT-TFVGTPW 163
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-34
Identities = 57/156 (36%), Positives = 83/156 (53%), Gaps = 13/156 (8%)
Query: 276 KLGQGGSGSVYKGTL-----PGGEAVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLV 328
KLG+G G VYKGTL VAVK L + + + F E +++ ++H N+V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREE-FLEEASIMKKLSHPNIV 64
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
+LLG G +V E++P LLD F+R+ E L+ + ++ L A+G+ YL S
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLD--FLRKHGEKLTLKDLLQMALQIAKGMEYLE--S 120
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
K +HRD+ N L+ E KI+DFGL R ED
Sbjct: 121 K-NFVHRDLAARNCLVTENLVVKISDFGLSRDIYED 155
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 6e-34
Identities = 52/156 (33%), Positives = 73/156 (46%), Gaps = 13/156 (8%)
Query: 276 KLGQGGSGSVYKGTL-----PGGEAVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLV 328
KLG+G G VYKG L VAVK L + + Q + F E ++ ++H N+V
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEE-FLREARIMRKLDHPNVV 64
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
KLLG +V E++ LL ++R++ LS L A G+ YL
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLS--YLRKNRPKLSLSDLLSFALQIARGMEYLES-- 120
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
IHRD+ N L+ E KI+DFGL R +D
Sbjct: 121 -KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 155
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 3e-33
Identities = 51/166 (30%), Positives = 72/166 (43%), Gaps = 12/166 (7%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRL-FYNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
KLG+G G VY G+ VA+K + + + E+ ++ + H N+V+L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLS-WEVRYKIILSTAEGLAYLHEESKLR 391
+ LV E+ L D L + LS E R+ + L YLH
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARF-YLRQILSALEYLH---SKG 117
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLF 437
I+HRD+K NILLDE+ K+ADFGL R T GT
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL--TTFVGTPE 161
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 3e-33
Identities = 51/157 (32%), Positives = 74/157 (47%), Gaps = 16/157 (10%)
Query: 275 NKLGQGGSGSVYKGTLPGGE----AVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLV 328
KLG+G G VYKG L G + VAVK L + + D F E ++ + H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKD-FLKEARVMKKLGHPNVV 59
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLD------NLFVRQDVEPLSWEVRYKIILSTAEGLA 382
+LLG LV E++ LLD +F + LS + + A+G+
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
YL + +HRD+ N L+ E+ KI+DFGL R
Sbjct: 120 YLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR 153
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 55/157 (35%), Positives = 76/157 (48%), Gaps = 14/157 (8%)
Query: 276 KLGQGGSGSVYKGTL-----PGGEAVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLV 328
KLG+G G VYKGTL VAVK L + Q + F E ++ ++H N+V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEE-FLREARIMRKLDHPNIV 64
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEE 387
KLLG ++V E++P LLD ++R+ + LS L A G+ YL
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLD--YLRKNRPKELSLSDLLSFALQIARGMEYLES- 121
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
IHRD+ N L+ E KI+DFGL R +D
Sbjct: 122 --KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-29
Identities = 55/172 (31%), Positives = 86/172 (50%), Gaps = 18/172 (10%)
Query: 275 NKLGQGGSGSVYKGTLPG-GEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKNLVKLL 331
LG+G GSVY GE +AVK L ++ + ++ E+ ++S + H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 332 GCSIT-GPESLLVY-EFVPNQSLLDNLFVRQDVEPLSWEV--RY-KIILSTAEGLAYLHE 386
G +L ++ E+V SL + + L V +Y + IL EGLAYLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSS---LLKKFGKLPEPVIRKYTRQIL---EGLAYLHS 119
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLF 437
I+HRDIK +NIL+D + K+ADFG RL + + ++ GT +
Sbjct: 120 N---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPY 168
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 51/171 (29%), Positives = 88/171 (51%), Gaps = 12/171 (7%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNL 327
+ + +G+G G VYKG L G+ VA+K++ + + E++L+ + H N+
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
VK +G T ++ E+ N SL + + P + + +GLAYLHE+
Sbjct: 62 VKYIGSIETSDSLYIILEYAENGSLRQ---IIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLF 437
+IHRDIK +NIL ++ K+ADFG+ +L D++ A++ GT +
Sbjct: 119 G---VIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTPY 164
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-27
Identities = 55/170 (32%), Positives = 79/170 (46%), Gaps = 10/170 (5%)
Query: 270 YFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV 328
F K+G+GG G VYK G+ VA+K + + + + NE+ ++ H N+V
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
K G + E +V EF SL D L S + Y + +GL YLH
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ-IAY-VCKELLKGLEYLH--- 115
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLF 437
IIHRDIK +NILL + K+ DFGL +L + T+ GT +
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPY 162
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 55/162 (33%), Positives = 76/162 (46%), Gaps = 10/162 (6%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINH-KN 326
+ KLG+G G VY + VA+K L + ++ V+ F E+ +++ +NH N
Sbjct: 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
+VKL LV E+V SL D L PLS I+ L YLH
Sbjct: 60 IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119
Query: 387 ESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFPEDITH 427
IIHRDIK NILLD + K+ DFGL +L P+ +
Sbjct: 120 ---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158
|
Length = 384 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 53/161 (32%), Positives = 79/161 (49%), Gaps = 17/161 (10%)
Query: 274 SNKLGQGGSGSVYKGTL--PG---GEAVAVKRLFYNTTQWVDH---FFNEVNLISGINHK 325
+LG+G G V G GE VAVK L N + H F E+ ++ ++H+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL--NHSGEEQHRSDFEREIEILRTLDHE 66
Query: 326 NLVKLLGCS--ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
N+VK G G L+ E++P+ SL D L +D L + + +G+ Y
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFS--SQICKGMDY 124
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
L + R IHRD+ NIL++ E KI+DFGL ++ PED
Sbjct: 125 LGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 1e-22
Identities = 49/143 (34%), Positives = 71/143 (49%), Gaps = 10/143 (6%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
KLG+G GSVYK G+ VA+K + + E++++ + +VK G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIK--VVPVEEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIIL-STAEGLAYLHEESKLRII 393
+ +V E+ S+ D + + L+ E IL T +GL YLH + I
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNK--TLT-EEEIAAILYQTLKGLEYLH---SNKKI 121
Query: 394 HRDIKLSNILLDEEFTAKIADFG 416
HRDIK NILL+EE AK+ADFG
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFG 144
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 6e-21
Identities = 57/172 (33%), Positives = 81/172 (47%), Gaps = 30/172 (17%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRL--------FYNTTQWVDHFFNEVNLISGINHKN 326
KLG+G G VYK GE VA+K++ +T E++L+ + H N
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA------LREISLLKELKHPN 59
Query: 327 LVKLLGCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
+VKLL I L LV+E+ + LD + P ++ I+ GLAY
Sbjct: 60 IVKLL-DVIHTERKLYLVFEYCDMDLKKYLDKR--PGPLSPN--LIKS-IMYQLLRGLAY 113
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI---THISATL 432
H RI+HRD+K NIL++ + K+ADFGL R F + TH TL
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTL 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 6e-21
Identities = 58/154 (37%), Positives = 79/154 (51%), Gaps = 12/154 (7%)
Query: 276 KLGQGGSGSVYKGTL--PGGE--AVAVKRLFY-NTTQWVDHFFNEVNLISGINHKNLVKL 330
KLG G G V +G GG+ VAVK L + +D F E ++ ++H+NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESK 389
G +T P ++V E P SLLD L +S Y + A G+ YL ESK
Sbjct: 62 YGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAV--QIANGMRYL--ESK 116
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
R IHRD+ NILL + KI DFGL+R P+
Sbjct: 117 -RFIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 9e-21
Identities = 48/143 (33%), Positives = 76/143 (53%), Gaps = 6/143 (4%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT 336
+G+G G V G G + VAVK L ++T F E ++++ + H NLV+LLG +
Sbjct: 14 IGKGEFGDVMLGDYRG-QKVAVKCLKDDSTA-AQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 337 GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRD 396
G +V E++ SL+D L R ++ + L EG+ YL E K +HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYL--EEK-NFVHRD 127
Query: 397 IKLSNILLDEEFTAKIADFGLVR 419
+ N+L+ E+ AK++DFGL +
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 8e-20
Identities = 47/150 (31%), Positives = 74/150 (49%), Gaps = 7/150 (4%)
Query: 268 TNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN 326
+ K+G+G SG VYK T G+ VA+K++ Q + NE+ ++ H N
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRL-RKQNKELIINEILIMKDCKHPN 76
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
+V + G E +V E++ SL D + Q+ ++ + +GL YLH
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTD--IITQNFVRMNEPQIAYVCREVLQGLEYLH- 133
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFG 416
+IHRDIK NILL ++ + K+ADFG
Sbjct: 134 --SQNVIHRDIKSDNILLSKDGSVKLADFG 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-19
Identities = 56/165 (33%), Positives = 78/165 (47%), Gaps = 24/165 (14%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
F KLG G G V++G VA+K L + F EV + + HK+L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 331 LG-CSITGPESLLVYEFVPNQSLLDNLFVR------QDVEPL---SWEVRYKIILSTAEG 380
CS+ P ++ E + SLL F+R V L + +V AEG
Sbjct: 68 FAVCSVGEP-VYIITELMEKGSLLA--FLRSPEGQVLPVASLIDMACQV--------AEG 116
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425
+AYL E+ IHRD+ NIL+ E+ K+ADFGL RL ED+
Sbjct: 117 MAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 1e-19
Identities = 53/149 (35%), Positives = 70/149 (46%), Gaps = 15/149 (10%)
Query: 275 NKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQW---VDHFFNEVNLISGINHKNLVKL 330
+G G + VY LP E VA+KR+ + + VD EV +S NH N+VK
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRI--DLEKCQTSVDELRKEVQAMSQCNHPNVVKY 64
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNL--FVRQDVEPLSWEVRYKIIL-STAEGLAYLHEE 387
+ G E LV ++ SLLD + + E +L +GL YLH
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD---EAIIATVLKEVLKGLEYLH-- 119
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFG 416
IHRDIK NILL E+ + KIADFG
Sbjct: 120 -SNGQIHRDIKAGNILLGEDGSVKIADFG 147
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 1e-19
Identities = 56/153 (36%), Positives = 74/153 (48%), Gaps = 11/153 (7%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG-CS 334
KLG G G V+ GT G VAVK L T + F E ++ + H LV+L CS
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST--AEGLAYLHEESKLRI 392
P +V E++ SLLD L + E + + ++ AEG+AYL
Sbjct: 72 EEEP-IYIVTEYMSKGSLLDFL---KSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NY 124
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425
IHRD+ NIL+ E KIADFGL RL +D
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDE 157
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 3e-19
Identities = 51/152 (33%), Positives = 76/152 (50%), Gaps = 6/152 (3%)
Query: 275 NKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
+KLG G G VY+G VAVK L +T + V+ F E ++ I H NLV+LLG
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
P ++ EF+ +LLD L + + ++ V + + + YL +++ I
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 126
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425
HRD+ N L+ E K+ADFGL RL D
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 3e-19
Identities = 52/169 (30%), Positives = 85/169 (50%), Gaps = 15/169 (8%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL-FYNTTQWVDH-FFNEVNLISGINHKNL 327
+ ++G+G G V+K GE VA+K++ + + E+ + H +
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYV 61
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLS-WEVRYKIILSTAEGLAYLHE 386
VKLL G +LV E++P+ L + L R + PL +V+ + +G+AY+H
Sbjct: 62 VKLLDVFPHGSGFVLVMEYMPS-DLSEVL--RDEERPLPEAQVK-SYMRMLLKGVAYMH- 116
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI----THISAT 431
I+HRD+K +N+L+ + KIADFGL RLF E+ +H AT
Sbjct: 117 --ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVAT 163
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 1e-18
Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 21/157 (13%)
Query: 275 NKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHF----FNEVNLISGINHKNLVK 329
++G+G G VYK GE VA+K++ + F E+ L+ + H N+V+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 330 LLG--CSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILST-AEGLAYL 384
L S +V+E++ + LLD+ V+ + E + K + EGL YL
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK-----FT-ESQIKCYMKQLLEGLQYL 116
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
H I+HRDIK SNIL++ + K+ADFGL R +
Sbjct: 117 HSN---GILHRDIKGSNILINNDGVLKLADFGLARPY 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 1e-18
Identities = 52/167 (31%), Positives = 86/167 (51%), Gaps = 24/167 (14%)
Query: 277 LGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKL 330
LG G G+VYKG +P GE VA+K L T+ + +E +++ ++H ++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP------LSWEVRYKIILSTAEGLAYL 384
LG ++ + L+ + +P LLD +VR + L+W V+ A+G++YL
Sbjct: 75 LGICLS-SQVQLITQLMPLGCLLD--YVRNHKDNIGSQYLLNWCVQ------IAKGMSYL 125
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
E+ R++HRD+ N+L+ KI DFGL +L D A
Sbjct: 126 EEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAE 169
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 52/171 (30%), Positives = 80/171 (46%), Gaps = 25/171 (14%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHF----FNEVNLISGINHK 325
+ KLG+G G VYK + G VA+K++ + + D F E+ ++ + H
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKKLKHP 67
Query: 326 NLVKLLGCSITGPESLL-----VYEFVPNQ-----SLLDNLFVRQDVEPLSWEVRYKIIL 375
N+V L+ ++ P+ VY P LL+N V+ + + +L
Sbjct: 68 NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK--LTESQIKCYMLQLL 125
Query: 376 STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426
EG+ YLHE I+HRDIK +NIL+D + KIADFGL R +
Sbjct: 126 ---EGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 3e-18
Identities = 50/151 (33%), Positives = 80/151 (52%), Gaps = 10/151 (6%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
KLG G G V+ G G VA+K L + + F E NL+ + H LV+L +
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAV-V 70
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST--AEGLAYLHEESKLRII 393
T ++ E++ N SL+D F++ E + + I ++ AEG+A++ ++ I
Sbjct: 71 TQEPIYIITEYMENGSLVD--FLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YI 124
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
HRD++ +NIL+ E KIADFGL RL ++
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDN 155
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 4e-18
Identities = 53/163 (32%), Positives = 74/163 (45%), Gaps = 18/163 (11%)
Query: 276 KLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDH-FFNEVNLISGINHKNLVKLLGC 333
LGQG SG VYK P G+ A+K++ + + E+ + +VK G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
E +V E++ SL D + + V + V I +GL YLH +K II
Sbjct: 68 FYKEGEISIVLEYMDGGSLAD---LLKKVGKIPEPVLAYIARQILKGLDYLH--TKRHII 122
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
HRDIK SN+L++ + KIADFG IS L TL
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFG-----------ISKVLENTL 154
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 5e-18
Identities = 53/151 (35%), Positives = 74/151 (49%), Gaps = 16/151 (10%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVDHFFN--EVNLISGIN-HKNLV 328
+LG G GSVY GE VA+K++ FY+ W + N EV + +N H N+V
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYS---W-EECMNLREVKSLRKLNEHPNIV 61
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
KL E V+E++ +L L + +P S V II +GLA++H
Sbjct: 62 KLKEVFRENDELYFVFEYM-EGNLYQ-LMKDRKGKPFSESVIRSIIYQILQGLAHIH--- 116
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
K HRD+K N+L+ KIADFGL R
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 9e-18
Identities = 54/165 (32%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 275 NKLGQGGSGSVYKGT--LPGGE--AVAVKRLFYNTTQW-VDHFFNEVNLISGINHKNLVK 329
+LG G GSV KG + G+ VAVK L F E ++++ ++H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
L+G G +LV E P LL L R+++ + + A G+AYL ESK
Sbjct: 61 LIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKE---LAHQVAMGMAYL--ESK 114
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG 434
+HRD+ N+LL AKI+DFG+ R + AT AG
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAG 158
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 9e-18
Identities = 48/148 (32%), Positives = 69/148 (46%), Gaps = 9/148 (6%)
Query: 272 HESNKLGQGGSGSVYKG-TLPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKNLV 328
NK+G G G VY L GE +AVK R+ N + + +E+ ++ + H NLV
Sbjct: 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
K G + + + E+ + L+ L + Y + L EGLAYLH
Sbjct: 63 KYYGVEVHREKVYIFMEYC-SGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLHSH- 118
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFG 416
I+HRDIK +NI LD K+ DFG
Sbjct: 119 --GIVHRDIKPANIFLDHNGVIKLGDFG 144
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 1e-17
Identities = 40/165 (24%), Positives = 71/165 (43%), Gaps = 8/165 (4%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKR--LFYNTTQWVDHFFNEVNLISGINHKNLVKLL 331
++G+G G VY G+ +K L + + + NEV ++ +NH N++K
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
+ +V E+ L + + ++ +P E + L YLH
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR--- 122
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
+I+HRDIK NI L K+ DFG+ ++ ++ T+ GT
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVL-SSTVDLAKTVVGT 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 47/152 (30%), Positives = 72/152 (47%), Gaps = 15/152 (9%)
Query: 276 KLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFN--EVNLISGINHKNLVKLLG 332
K+G+G G VYK GE VA+K++ E+ L+ +NH N++KLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 333 CSITGPESL-LVYEFVPNQSLLDNL--FVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
L LV+EF + +L ++ L + + +GLA+ H
Sbjct: 66 V-FRHKGDLYLVFEF-----MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---S 116
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
I+HRD+K N+L++ E K+ADFGL R F
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARSF 148
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 53/145 (36%), Positives = 74/145 (51%), Gaps = 6/145 (4%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLLGCS 334
K+G+G G VYKG L G VAVK + F E ++ +H N+VKL+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
+ +V E VP SLL F+R+ L+ + ++ L A G+ YL ESK IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLT--FLRKKKNRLTVKKLLQMSLDAAAGMEYL--ESK-NCIH 116
Query: 395 RDIKLSNILLDEEFTAKIADFGLVR 419
RD+ N L+ E KI+DFG+ R
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 17/157 (10%)
Query: 277 LGQGGSGSVYKGTLPG---GEA---VAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVK 329
LGQG G VY+G G GE VA+K + N + + F NE +++ N ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQD-------VEPLSWEVRYKIILSTAEGLA 382
LLG TG +L+V E + L L R+ + P + + ++ A+G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
YL + +HRD+ N ++ E+ T KI DFG+ R
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 3e-17
Identities = 50/153 (32%), Positives = 75/153 (49%), Gaps = 11/153 (7%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG-CS 334
KLG G G V++G VAVK L T F E ++ + H L++L C+
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST--AEGLAYLHEESKLRI 392
+ P +V E + SLL+ L Q + ++ I ++ A G+AYL ++
Sbjct: 72 LEEP-IYIVTELMKYGSLLEYL---QGGAGRALKLPQLIDMAAQVASGMAYLEAQN---Y 124
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425
IHRD+ N+L+ E K+ADFGL R+ EDI
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDI 157
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 3e-17
Identities = 56/168 (33%), Positives = 77/168 (45%), Gaps = 21/168 (12%)
Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVK 329
LG+G G V K T G+ A+K L + V+H E N++S INH +VK
Sbjct: 1 LGKGSFGKVLLVRKKDT---GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 330 LLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS-TAEGLAYLHEE 387
L + E L LV E+ P L +L S E R + + L YLH
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFS-EERARFYAAEIVLALEYLHS- 111
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
L II+RD+K NILLD + K+ DFGL + + + + T GT
Sbjct: 112 --LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN-TFCGT 156
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 5e-17
Identities = 52/151 (34%), Positives = 73/151 (48%), Gaps = 20/151 (13%)
Query: 277 LGQGGSGSVYKG-TLPGGEAVAVKRLF-----YNTTQWVDHFFNEVNLISGINHKNLVKL 330
LG G GSVY+G L G+ AVK + + V E+ L+S + H N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 331 LGCSITGPESLLVY-EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYLHE 386
LG ++L ++ E VP SL L + V I L T + GL YLH+
Sbjct: 68 LGTEREE-DNLYIFLELVPGGSLAKLL---KKYGSFPEPV---IRLYTRQILLGLEYLHD 120
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417
+HRDIK +NIL+D K+ADFG+
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGM 148
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 6e-17
Identities = 53/164 (32%), Positives = 79/164 (48%), Gaps = 13/164 (7%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+ ++G G G VYK + GE VA+K + + E++++ H N+V
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
G + + +V E+ SL D V + PLS + T +GLAYLHE K
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETGK 122
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA 433
IHRDIK +NILL E+ K+ADFG+ ++AT+A
Sbjct: 123 ---IHRDIKGANILLTEDGDVKLADFGVS-------AQLTATIA 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 7e-17
Identities = 59/174 (33%), Positives = 80/174 (45%), Gaps = 39/174 (22%)
Query: 270 YFHESNKLGQGGSGSV----YKGTLPG-GEAVAVKRL-----FYNTTQWVDHFFNEVNLI 319
Y + LG+G G V Y G GE VAVK L NT+ W E+N++
Sbjct: 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWK----KEINIL 60
Query: 320 SGINHKNLVKLLGCSITGPES--LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST 377
+ H+N+VK GC L+ E+VP SL D L P ++K+ L+
Sbjct: 61 KTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-------P-----KHKLNLAQ 108
Query: 378 --------AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
EG+AYLH + IHRD+ N+LLD + KI DFGL + PE
Sbjct: 109 LLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 43/149 (28%), Positives = 77/149 (51%), Gaps = 12/149 (8%)
Query: 277 LGQGGSGSVYKGTL--PGGE--AVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKL 330
+G G G V +G L PG + VA+K L + Q +D F E +++ +H N+++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIMGQFDHPNIIRL 70
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
G +++ E++ N SL + F+R++ + ++ A G+ YL S++
Sbjct: 71 EGVVTKSRPVMIITEYMENGSL--DKFLRENDGKFTVGQLVGMLRGIASGMKYL---SEM 125
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVR 419
+HRD+ NIL++ K++DFGL R
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 54/162 (33%), Positives = 83/162 (51%), Gaps = 26/162 (16%)
Query: 277 LGQGGSGSVYK--------GTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV 328
LG+G GSV T GE VAVK+L ++T + + F E+ ++ + H N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNT---GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIV 68
Query: 329 KLLG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA----EGLA 382
K G C G +L LV E++P SL D L ++ + ++ +L A +G+
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRE------RLDHRKLLLYASQICKGME 122
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
YL R +HRD+ NIL++ E KI DFGL ++ P+D
Sbjct: 123 YL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 3e-16
Identities = 58/158 (36%), Positives = 87/158 (55%), Gaps = 16/158 (10%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWV-DHFFNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA----EGLAY 383
VKLL T + LV+EF+ +Q L + D PLS + +I S +GLA+
Sbjct: 62 VKLLDVIHTENKLYLVFEFL-HQDLKKFM----DASPLS-GIPLPLIKSYLFQLLQGLAF 115
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
H R++HRD+K N+L++ E K+ADFGL R F
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-16
Identities = 53/180 (29%), Positives = 86/180 (47%), Gaps = 32/180 (17%)
Query: 277 LGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQ----------WVDHFFNEVNLISGINHK 325
+G+G G VY + GE +AVK++ T V +E+ + ++H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 326 NLVKLLGCSITGPESLLVY-EFVPNQSLLDNL-----FVRQDVEPLSWEVRYKIILSTAE 379
N+V+ LG T E L ++ E+VP S+ L F Q V + + E
Sbjct: 69 NIVQYLGFE-TTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------VLE 119
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA--GTLF 437
GLAYLH + I+HRD+K N+L+D + KI+DFG+ + +DI ++ G++F
Sbjct: 120 GLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK-SDDIYDNDQNMSMQGSVF 175
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 58/162 (35%), Positives = 87/162 (53%), Gaps = 23/162 (14%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHF----FNEVNLISGINHK 325
F + N++G+G G VY+ GE VA+K++ + + D E+ L+ + H
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER--DGIPISSLREITLLLNLRHP 66
Query: 326 NLVKLLGCSITGP--ESL-LVYEFVPNQ--SLLDNLFVRQDVEPLSWEVRYK-IILSTAE 379
N+V+L + G +S+ LV E+ SLLDN+ P S E + K ++L
Sbjct: 67 NIVELKEV-VVGKHLDSIFLVMEYCEQDLASLLDNM-----PTPFS-ESQVKCLMLQLLR 119
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
GL YLHE IIHRD+K+SN+LL ++ KIADFGL R +
Sbjct: 120 GLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 4e-16
Identities = 53/165 (32%), Positives = 73/165 (44%), Gaps = 25/165 (15%)
Query: 277 LGQGGSGSVYKGTL--PGGE----AVAVKRLF-YNTTQWVDHFFNEVNLISGINHKNLVK 329
LG+G G VYKG L P +VA+K L + F E L+S + H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 330 LLG-CSITGPESLLVYEFVPNQSLLDNLFVR---QDVE----------PLSWEVRYKIIL 375
LLG C+ P +L +E++ + L + L DV L I +
Sbjct: 73 LLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131
Query: 376 STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420
A G+ YL S +HRD+ N L+ E T KI+DFGL R
Sbjct: 132 QIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRD 173
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-16
Identities = 26/72 (36%), Positives = 43/72 (59%), Gaps = 3/72 (4%)
Query: 9 ARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFY 68
+ + +AA +G +VY +C DLS +DC C A +++ +C P + +GGR++Y
Sbjct: 38 SGKGFAAGTSGAAPDTVYGLAQCRGDLSASDCRSCLATAVSELRRCCPNK---KGGRIWY 94
Query: 69 DGCYLRYDDYDF 80
D C+LRY+ Y F
Sbjct: 95 DSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 7e-16
Identities = 53/144 (36%), Positives = 73/144 (50%), Gaps = 6/144 (4%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVKLLGCSI 335
LG+G G V+KGTL VAVK + Q + F +E ++ +H N+VKL+G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHR 395
+V E VP L F+R+ + L + K L A G+AYL ESK IHR
Sbjct: 63 QRQPIYIVMELVPGGDFLS--FLRKKKDELKTKQLVKFALDAAAGMAYL--ESK-NCIHR 117
Query: 396 DIKLSNILLDEEFTAKIADFGLVR 419
D+ N L+ E KI+DFG+ R
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 7e-16
Identities = 44/163 (26%), Positives = 70/163 (42%), Gaps = 25/163 (15%)
Query: 277 LGQGGSGSVYKGTL----PGGEA--VAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVK 329
LG+G G V+ G P + VAVK L + F E L++ H+N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVR-------------QDVEPLSWEVRYKIILS 376
G G ++V+E++ + L N F+R + L+ +I +
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDL--NKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
A G+ YL + +HRD+ N L+ + KI DFG+ R
Sbjct: 131 IASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 9e-16
Identities = 48/147 (32%), Positives = 75/147 (51%), Gaps = 14/147 (9%)
Query: 277 LGQGGSGSVYKG-TLPGGEAVAVKRLFYN-----TTQWVDHFFNEVNLISGINHKNLVKL 330
LGQG G VY + G +AVK++ ++ T + V+ E+ L+ + H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 331 LGCSITGPESLLVY-EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
GC + E+L ++ E++P S+ D L + L+ V K EG+ YLH
Sbjct: 70 YGC-LRDDETLSIFMEYMPGGSVKDQL---KAYGALTETVTRKYTRQILEGVEYLHSN-- 123
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFG 416
I+HRDIK +NIL D K+ DFG
Sbjct: 124 -MIVHRDIKGANILRDSAGNVKLGDFG 149
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 60/164 (36%), Positives = 80/164 (48%), Gaps = 17/164 (10%)
Query: 259 FSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQ----WVDHFF 313
FS + EK E +G G G+VY + E VA+K++ Y+ Q W D
Sbjct: 8 FSKDDPEKLFTDLRE---IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD-II 63
Query: 314 NEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI 373
EV + + H N ++ GC + + LV E+ S D L V + +PL EV
Sbjct: 64 KEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVHK--KPLQ-EVEIAA 119
Query: 374 ILSTA-EGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416
I A +GLAYLH + IHRDIK NILL E T K+ADFG
Sbjct: 120 ICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFG 160
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 51/154 (33%), Positives = 76/154 (49%), Gaps = 15/154 (9%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
KLG G G V+ G VAVK L T V F E NL+ + H LV+L
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQD-----VEPLSWEVRYKIILSTAEGLAYLHEESKL 390
++ E++ SLLD F++ D + P + +I AEG+AY+ ++
Sbjct: 72 KEEPIYIITEYMAKGSLLD--FLKSDEGGKVLLPKLIDFSAQI----AEGMAYIERKN-- 123
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
IHRD++ +N+L+ E KIADFGL R+ ++
Sbjct: 124 -YIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 52/154 (33%), Positives = 83/154 (53%), Gaps = 12/154 (7%)
Query: 277 LGQGGSGSVYKGT-LPGGEAV----AVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVKL 330
LG G G+VYKG +P GE V A+K L T + F +E +++ ++H +LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
LG ++ P LV + +P+ LLD +V + + + ++ + A+G+ YL E
Sbjct: 75 LGVCLS-PTIQLVTQLMPHGCLLD--YVHEHKDNIGSQLLLNWCVQIAKGMMYLEER--- 128
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
R++HRD+ N+L+ KI DFGL RL D
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-15
Identities = 52/150 (34%), Positives = 77/150 (51%), Gaps = 8/150 (5%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
KLGQG G V+ GT G VA+K L T + F E ++ + H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
P +V EF+ SLLD F+++ D + L + A+G+AY+ ++ IH
Sbjct: 72 EEP-IYIVTEFMGKGSLLD--FLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIH 125
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPED 424
RD++ +NIL+ + KIADFGL RL ++
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDN 155
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 6e-15
Identities = 56/154 (36%), Positives = 77/154 (50%), Gaps = 11/154 (7%)
Query: 276 KLGQGGSGSVYKGT--LPGGE--AVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKL 330
+G+G G VY+G P E AVAVK T+ V + F E ++ +H ++VKL
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
+G IT +V E P L L V + L+ + Y LSTA LAYL ESK
Sbjct: 73 IGV-ITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTA--LAYL--ESK- 126
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
R +HRDI N+L+ K+ DFGL R ++
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 7e-15
Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 8/149 (5%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG-CSI 335
LG G G V+ G G VA+K + D F E ++ ++H NLV+L G C+
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMS-EDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHR 395
P +V E++ N LL+ ++R+ L E + E + YL IHR
Sbjct: 71 QRP-IFIVTEYMANGCLLN--YLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHR 124
Query: 396 DIKLSNILLDEEFTAKIADFGLVRLFPED 424
D+ N L+ E+ K++DFGL R +D
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDD 153
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 48/175 (27%), Positives = 75/175 (42%), Gaps = 17/175 (9%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFY--NTTQWVDHFFNEVNLISGINHKNLV 328
E ++LG+G GSV K L + + E+ + +V
Sbjct: 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIV 62
Query: 329 KLLGCSITGPESLL--VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE----GLA 382
K G + S + E+ SL D+++ + V+ + K++ AE GL+
Sbjct: 63 KYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKK--VKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLF 437
YLH +IIHRDIK SNILL + K+ DFG+ E + ++ T GT F
Sbjct: 120 YLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS---GELVNSLAGTFTGTSF 168
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 52/154 (33%), Positives = 77/154 (50%), Gaps = 22/154 (14%)
Query: 277 LGQGGSGSVYKG-TLPGGEAVAVKRLFYNT---------TQWVDHFFNEVNLISGINHKN 326
+G G GSVY G GE +AVK++ + +D E+ L+ + H+N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 327 LVKLLGCSITGPESLLVYEFVPN---QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
+V+ LG S+ + E+VP +LL+N + E L VR + +GL Y
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE--ETL---VR-NFVRQILKGLNY 121
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417
LH IIHRDIK +NIL+D + KI+DFG+
Sbjct: 122 LHNRG---IIHRDIKGANILVDNKGGIKISDFGI 152
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 50/148 (33%), Positives = 84/148 (56%), Gaps = 10/148 (6%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
+G+G G+V +G G + VAVK + + T F E +++ ++HKNLV+LLG I
Sbjct: 13 IIGEGEFGAVLQGEYTG-QKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGV-I 68
Query: 336 TGPESLLVYEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
+V E + +L++ L R + + + +++ L AEG+ YL ESK +++H
Sbjct: 69 LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFS--LDVAEGMEYL--ESK-KLVH 123
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFP 422
RD+ NIL+ E+ AK++DFGL R+
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGS 151
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 53/160 (33%), Positives = 84/160 (52%), Gaps = 12/160 (7%)
Query: 277 LGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVKL 330
LG G G+VYKG +P GE VA+K L NT+ + +E +++G+ + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
LG +T L V + +P LLD +VR++ + + + + A+G++YL E +
Sbjct: 75 LGICLTSTVQL-VTQLMPYGCLLD--YVRENKDRIGSQDLLNWCVQIAKGMSYLEE---V 128
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA 430
R++HRD+ N+L+ KI DFGL RL D T A
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA 168
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 50/152 (32%), Positives = 78/152 (51%), Gaps = 12/152 (7%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
KLG G G V+ T VAVK + + V+ F E N++ + H LVKL +
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKL-HAVV 70
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQD---VEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
T ++ EF+ SLLD F++ D +PL + + AEG+A++ + +
Sbjct: 71 TKEPIYIITEFMAKGSLLD--FLKSDEGSKQPLPKLIDFSA--QIAEGMAFIEQRN---Y 123
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
IHRD++ +NIL+ KIADFGL R+ ++
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDN 155
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 48/167 (28%), Positives = 77/167 (46%), Gaps = 25/167 (14%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFN-----EVNLISGINHKNLV 328
KLG+G VYK G VA+K++ + N E+ L+ + H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 329 KLLGCSITGPESLLVYEFVPN--QSLLDNLFVR---QDVEPLSWEVRYKIILSTAEGLAY 383
LL LV+EF+ + ++ + + D++ S+ +L T GL Y
Sbjct: 66 GLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIK--SY------MLMTLRGLEY 117
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDITH 427
LH I+HRD+K +N+L+ + K+ADFGL R F +TH
Sbjct: 118 LHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTH 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 51/166 (30%), Positives = 79/166 (47%), Gaps = 17/166 (10%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQW-VDHFFNEVNLISGINH---KNLVKLL 331
+G+G G+VY+G +P G VA+K + +T V EV L+S + N+ K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYK--IILSTAEGLAYLHEESK 389
G + GP ++ E+ S VR ++ +Y II L Y+H K
Sbjct: 69 GSYLKGPRLWIIMEYAEGGS------VRTLMKAGPIAEKYISVIIREVLVALKYIH---K 119
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
+ +IHRDIK +NIL+ K+ DFG+ L ++ + S T GT
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRS-TFVGT 164
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-14
Identities = 44/151 (29%), Positives = 69/151 (45%), Gaps = 6/151 (3%)
Query: 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
++G G G V+ G VA+K + D F E ++ ++H LV+L G
Sbjct: 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEED-FIEEAQVMMKLSHPKLVQLYGV 67
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
LV+EF+ + L D ++R S E + L EG+AYL + +I
Sbjct: 68 CTERSPICLVFEFMEHGCLSD--YLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
HRD+ N L+ E K++DFG+ R +D
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 54/171 (31%), Positives = 74/171 (43%), Gaps = 33/171 (19%)
Query: 277 LGQGGSGSVYKGTLPG---GEA---VAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVK 329
+GQG G V++ PG E VAVK L + F E L++ +H N+VK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVR---------------------QDVEPLSWE 368
LLG G L++E++ L N F+R + PLS
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDL--NEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
+ I A G+AYL E + +HRD+ N L+ E KIADFGL R
Sbjct: 131 EQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 4e-14
Identities = 48/149 (32%), Positives = 75/149 (50%), Gaps = 11/149 (7%)
Query: 277 LGQGGSGSVYKGTL----PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLL 331
+G+G G VY GTL AVK L T + V+ F E ++ +H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 332 GCSITGPES-LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
G + S L+V ++ + L + F+R + + + L A+G+ YL +
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRN--FIRSETHNPTVKDLIGFGLQVAKGMEYLASK--- 117
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVR 419
+ +HRD+ N +LDE FT K+ADFGL R
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 5e-14
Identities = 42/156 (26%), Positives = 67/156 (42%), Gaps = 17/156 (10%)
Query: 277 LGQGGSGSVYKGTLPG-GEAVAVKRL---FYNTTQWVDHFFNEVNLISGIN-HKNLVKLL 331
+G+G +V + A+K L + V + E +++ +N H ++KL
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68
Query: 332 GCSITGPESL-LVYEFVPNQSLLD--NLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
+ E+L V E+ PN LL + D + R+ L YLH
Sbjct: 69 -YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK----CTRF-YAAEILLALEYLH--- 119
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
IIHRD+K NILLD++ KI DFG ++ +
Sbjct: 120 SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 5e-14
Identities = 52/157 (33%), Positives = 82/157 (52%), Gaps = 14/157 (8%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKNL 327
+ + K+G+G G VYK GE VA+K RL E++L+ +NH N+
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 328 VKLLGCSITGPESLLVYEFVPNQSL---LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
V+LL + + LV+EF+ + L +D+ + PL Y+++ +G+AY
Sbjct: 61 VRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLL----QGIAYC 115
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
H R++HRD+K N+L+D E K+ADFGL R F
Sbjct: 116 HSH---RVLHRDLKPQNLLIDREGALKLADFGLARAF 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 6e-14
Identities = 43/168 (25%), Positives = 78/168 (46%), Gaps = 8/168 (4%)
Query: 271 FHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDH--FFNEVNLISGINHKNL 327
F NK+G+G G V+K A+K++ + + +E +++ ++ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
++ + + +V E+ N L L Q PL + ++ + GLA+LH +
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHK-LLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
+I+HRDIK N+ LD KI D G+ +L D T+ + T+ GT
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-SDNTNFANTIVGT 164
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 6e-14
Identities = 50/150 (33%), Positives = 74/150 (49%), Gaps = 8/150 (5%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
KLG G G V+ GT G VAVK L T + F E ++ + H LV+L
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS-PESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
P +V E++ SLLD F++ + L + A G+AY+ ++ IH
Sbjct: 72 EEP-IYIVTEYMSKGSLLD--FLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIH 125
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPED 424
RD++ +NIL+ + KIADFGL RL ++
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDN 155
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 57/152 (37%), Positives = 76/152 (50%), Gaps = 14/152 (9%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQ----WVDHFFNEVNLISGINHK 325
F +++G G G+VY T E VAVK++ Y+ Q W D EV + + H
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQD-IIKEVKFLQQLKHP 81
Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA-EGLAYL 384
N ++ GC + + LV E+ S D L V + +PL EV I A +GLAYL
Sbjct: 82 NTIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVHK--KPLQ-EVEIAAITHGALQGLAYL 137
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416
H + IHRDIK NILL E K+ADFG
Sbjct: 138 HSHNM---IHRDIKAGNILLTEPGQVKLADFG 166
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 8e-14
Identities = 49/150 (32%), Positives = 77/150 (51%), Gaps = 8/150 (5%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
KLGQG G V+ GT G VA+K L T + F E ++ + H+ LV+L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 336 TGPESLLVYEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
P +V E++ SLLD F++ + + L + A G+AY+ ++ +H
Sbjct: 72 EEP-IYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 125
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPED 424
RD++ +NIL+ E K+ADFGL RL ++
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDN 155
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 8e-14
Identities = 44/186 (23%), Positives = 79/186 (42%), Gaps = 25/186 (13%)
Query: 261 YETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYN--TTQWVDHFFNEVN 317
YE LE +G+G G+V K G+ + K + Y T + +EVN
Sbjct: 2 YEVLET----------IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVN 51
Query: 318 LISGINHKNLVKLLGCSITGPESLLVY---EFVPN---QSLLDNLFVRQDVEPLSWEVRY 371
++ + H N+V+ I + +Y E+ L+ +++ + + E +
Sbjct: 52 ILRELKHPNIVRYYD-RIIDRSNQTLYIVMEYCEGGDLAQLIQKC--KKERKYIEEEFIW 108
Query: 372 KIILSTAEGLAYLH--EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429
+I+ L H + ++HRD+K +NI LD K+ DFGL ++ D + +
Sbjct: 109 RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD-SSFA 167
Query: 430 ATLAGT 435
T GT
Sbjct: 168 KTYVGT 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 8e-14
Identities = 50/181 (27%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 247 ALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT 305
ALQ+ V+ + N+ K+G+G +G V T G VAVK++
Sbjct: 7 ALQLVVDPG------DPRSYLDNF----VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK 56
Query: 306 TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVEP 364
Q + FNEV ++ H N+V++ + G E +V EF+ +L D + R + E
Sbjct: 57 QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQ 116
Query: 365 LSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
++ + L+ + L++LH + +IHRDIK +ILL + K++DFG ++
Sbjct: 117 IA-----TVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168
Query: 425 I 425
+
Sbjct: 169 V 169
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 8e-14
Identities = 54/181 (29%), Positives = 77/181 (42%), Gaps = 41/181 (22%)
Query: 277 LGQGGSGSVYKGT------LPGGEAVAVKRLFYNTTQW-VDHFFNEVNLISGINHKNLVK 329
LG+G G V K T G VAVK L N + + +E NL+ +NH +++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 330 LLG-CSITGPESLLVYEFV-------------------------PNQSLLDNLFVRQDVE 363
L G CS GP LL+ E+ N S LDN D
Sbjct: 68 LYGACSQDGP-LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN----PDER 122
Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
L+ + G+ YL E ++++HRD+ N+L+ E KI+DFGL R E
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179
Query: 424 D 424
+
Sbjct: 180 E 180
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 9e-14
Identities = 53/185 (28%), Positives = 89/185 (48%), Gaps = 38/185 (20%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL-FYNTTQWVDHF-FNEVNLISGI---NH 324
+ E ++G+G G+VYK L G VA+K++ + + + E+ L+ + H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 325 KNLVKLLGCSITGPES------LLVYEFVPNQSLLDNLFVRQDVEP---------LSWEV 369
N+V+LL GP + LV+E V +Q L ++ + +P L +
Sbjct: 61 PNIVRLLDVC-HGPRTDRELKLTLVFEHV-DQDL--ATYLSKCPKPGLPPETIKDLMRQ- 115
Query: 370 RYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED--ITH 427
+L G+ +LH RI+HRD+K NIL+ + KIADFGL R++ + +T
Sbjct: 116 ----LLR---GVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTS 165
Query: 428 ISATL 432
+ TL
Sbjct: 166 VVVTL 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 46/143 (32%), Positives = 65/143 (45%), Gaps = 9/143 (6%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGC 333
+G+G G VYK + VA+K + + ++ E+ +S + K G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
+ G + ++ E+ S LD L L I+ GL YLHEE K I
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEGK---I 120
Query: 394 HRDIKLSNILLDEEFTAKIADFG 416
HRDIK +NILL EE K+ADFG
Sbjct: 121 HRDIKAANILLSEEGDVKLADFG 143
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 56/180 (31%), Positives = 83/180 (46%), Gaps = 27/180 (15%)
Query: 271 FHESNK---LGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN 326
+ E+ + LG+G G VY L +A+K + +++V E+ L S + H+N
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWE---VRY--KIILSTAEGL 381
+V+ LG + E VP SL L R PL + + K IL EGL
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIIFYTKQIL---EGL 121
Query: 382 AYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFG----LVRLFPEDITHISATLAGTL 436
YLH+ +I+HRDIK N+L++ KI+DFG L + P + T GTL
Sbjct: 122 KYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-----CTETFTGTL 173
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 44/145 (30%), Positives = 71/145 (48%), Gaps = 14/145 (9%)
Query: 277 LGQGGSGSVYKGT--LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
LG G G VYK G A A K + + + ++ F E++++S H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFA-AAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY 71
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQD---VEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
+ ++ EF +L D++ + + EP ++RY + E L +LH +
Sbjct: 72 FYENKLWILIEFCDGGAL-DSIMLELERGLTEP---QIRY-VCRQMLEALNFLHSH---K 123
Query: 392 IIHRDIKLSNILLDEEFTAKIADFG 416
+IHRD+K NILL + K+ADFG
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFG 148
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 1e-13
Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 10/144 (6%)
Query: 276 KLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
K+G+G +G V T G+ VAVK++ Q + FNEV ++ +H+N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 335 ITGPESLLVYEFVPNQSLLDNL-FVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
+ G E +V EF+ +L D + R + E ++ + LS L+YLH + +I
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLHNQG---VI 140
Query: 394 HRDIKLSNILLDEEFTAKIADFGL 417
HRDIK +ILL + K++DFG
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGF 164
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (174), Expect = 2e-13
Identities = 48/165 (29%), Positives = 75/165 (45%), Gaps = 27/165 (16%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDH---FFNEVNLISGINHKNLVKLLG 332
+G G G V G VA+K++ N + E+ L+ + H+N++ LL
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKIS-NVFDDLIDAKRILREIKLLRHLRHENIIGLL- 65
Query: 333 CSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWE-VRYKI--ILSTAEGLA 382
I P S +V E + ++ L + +PL+ + ++Y + IL GL
Sbjct: 66 -DILRPPSPEDFNDVYIVTELM--ETDLHKVIKSP--QPLTDDHIQYFLYQILR---GLK 117
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
YLH + +IHRD+K SNIL++ KI DFGL R D
Sbjct: 118 YLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 47/151 (31%), Positives = 73/151 (48%), Gaps = 12/151 (7%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT------QWVDHFFNEVNLISGINHKNLV 328
LG+G G+VY G G+ +AVK++ +T+ + + EV+L+ + H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
+ LG + + EFVP S+ L PL V K +G+AYLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
++HRDIK +N++L K+ DFG R
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCAR 150
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 46/151 (30%), Positives = 78/151 (51%), Gaps = 10/151 (6%)
Query: 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL 327
Y K+G+G +G V T+ G+ VAVK++ Q + FNEV ++ H+N+
Sbjct: 20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
V++ + G E +V EF+ +L D + R + E ++ + L+ + L+ LH
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHA 134
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417
+ +IHRDIK +ILL + K++DFG
Sbjct: 135 QG---VIHRDIKSDSILLTHDGRVKLSDFGF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 48/160 (30%), Positives = 82/160 (51%), Gaps = 12/160 (7%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINH 324
F + LG G G+VYKG +P GE VA+K L T+ + +E +++ +++
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
++ +LLG +T L + + +P LLD +VR+ + + + + A+G+ YL
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL 125
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
E R++HRD+ N+L+ KI DFGL +L D
Sbjct: 126 EER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 51/158 (32%), Positives = 79/158 (50%), Gaps = 20/158 (12%)
Query: 277 LGQGGSGSVYKGT-LPGGEA----VAVKRLFYNTTQWVDHFFNEVN----LISGINHKNL 327
LG G G+V+KG +P G++ VA+K + + + F E+ + ++H +
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR---QTFQEITDHMLAMGSLDHAYI 71
Query: 328 VKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
V+LLG C G LV + P SLLD VRQ + L + + A+G+ YL E
Sbjct: 72 VRLLGICP--GASLQLVTQLSPLGSLLD--HVRQHRDSLDPQRLLNWCVQIAKGMYYLEE 127
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
R++HR++ NILL + +IADFG+ L D
Sbjct: 128 H---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 55/152 (36%), Positives = 77/152 (50%), Gaps = 14/152 (9%)
Query: 271 FHESNKLGQGGSGSVY-KGTLPGGEAVAVKRLFYN----TTQWVDHFFNEVNLISGINHK 325
F + ++G G G+VY + E VA+K++ Y+ +W D EV + I H
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD-IIKEVKFLQRIKHP 85
Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA-EGLAYL 384
N ++ GC + + LV E+ S D L V + +PL EV I A +GLAYL
Sbjct: 86 NSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHK--KPLQ-EVEIAAITHGALQGLAYL 141
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416
H + +IHRDIK NILL E K+ADFG
Sbjct: 142 HSHN---MIHRDIKAGNILLTEPGQVKLADFG 170
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-13
Identities = 47/158 (29%), Positives = 75/158 (47%), Gaps = 18/158 (11%)
Query: 277 LGQGGSGSVYKGTLPGGEA----VAVK--RLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
LG+G GSV +G L + VAVK +L +T ++ F +E + +H N++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 331 LGCSITG------PESLLVYEFVPNQSLLDNLF-VRQDVEP--LSWEVRYKIILSTAEGL 381
+G P+ +++ F+ + L L R P L + K ++ A G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
YL S IHRD+ N +L E+ T +ADFGL +
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 58/174 (33%), Positives = 86/174 (49%), Gaps = 30/174 (17%)
Query: 277 LGQGGSGSVYKGTLPGGE------AVAVKRLFYNTT-QWVDHFFNEVNLISGI-NHKNLV 328
LG+G G V K G + VAVK L + T + + +E+ ++ I HKN++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 329 KLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQ---------DVEPLSWEVRYKIILS-- 376
LLG C+ GP ++V E+ + +L D L R+ D P + K ++S
Sbjct: 80 NLLGVCTQEGPLYVVV-EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 377 --TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428
A G+ +L SK + IHRD+ N+L+ E+ KIADFGL R DI HI
Sbjct: 139 YQVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHI 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 48/170 (28%), Positives = 72/170 (42%), Gaps = 27/170 (15%)
Query: 261 YETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFN----E 315
YE L +G+G G V K GE VA+K+ + ++ + E
Sbjct: 3 YEVLGV----------VGEGAYGVVLKCRNKATGEIVAIKK--FKESEDDEDVKKTALRE 50
Query: 316 VNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP--LSWEVRYKI 373
V ++ + H+N+V L LV+E+V ++LL+ L + P L +
Sbjct: 51 VKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVE-RTLLELL----EASPGGLPPDAVRSY 105
Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
I + +AY H IIHRDIK NIL+ E K+ DFG R
Sbjct: 106 IWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRA 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-13
Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 1/95 (1%)
Query: 98 FGGNNTVFGANAIELVRNLSVQAVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACEN 157
+ N+ F +N L+ +LS A + G + T +V+GLAQC ++ S C +
Sbjct: 12 YTTANSTFESNLNALLSSLSSNAASSSGKGFAAGTSGAAPDTVYGLAQCRGDLSASDCRS 71
Query: 158 CLENAVSRIAS-CTQKEEGRVLNAGCYLRYSTQRF 191
CL AVS + C K+ GR+ C+LRY + F
Sbjct: 72 CLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 50/158 (31%), Positives = 76/158 (48%), Gaps = 24/158 (15%)
Query: 271 FHESNKLGQGGSGSVY----KGTLPGGEAVAVKRLFYNTTQWVD---HFFNEVNLISGIN 323
F ++GQGG G V+ K T GE VA+KR+ + ++ H E ++++
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDT---GEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK 59
Query: 324 HKNLVKLLGCSITGPESL-LVYEFVPN---QSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
+ LVKLL + E L L E+VP ++LL+NL V + R+ + AE
Sbjct: 60 SEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH-----ARFYM----AE 109
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417
+ +L IHRD+K N L+D K+ DFGL
Sbjct: 110 MFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 5e-13
Identities = 47/154 (30%), Positives = 82/154 (53%), Gaps = 12/154 (7%)
Query: 277 LGQGGSGSVYKGTL--PGGE--AVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKL 330
+G G G V++G L PG + AVA+K L Y Q D F +E +++ +H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD-FLSEASIMGQFSHHNIIRL 71
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
G ++++ E++ N +L D D E S+++ ++ A G+ YL S +
Sbjct: 72 EGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQL-VGMLRGIAAGMKYL---SDM 126
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
+HRD+ NIL++ K++DFGL R+ +D
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 48/148 (32%), Positives = 75/148 (50%), Gaps = 12/148 (8%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLLG 332
N++G G G+VYK P G A+K ++ N V E+ ++ +NH N+VK
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
E ++ EF+ SL + + E +V +I+ G+AYLH + I
Sbjct: 140 MFDHNGEIQVLLEFMDGGSL-EGTHIAD--EQFLADVARQIL----SGIAYLH---RRHI 189
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRL 420
+HRDIK SN+L++ KIADFG+ R+
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRI 217
|
Length = 353 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-12
Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 6/149 (4%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
+LG G G V G G VA+K + + D F E ++ ++H+ LV+L G
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHR 395
+V E++ N LL+ ++R+ + ++ EG+AYL ESK + IHR
Sbjct: 70 KQRPIYIVTEYMSNGCLLN--YLREHGKRFQPSQLLEMCKDVCEGMAYL--ESK-QFIHR 124
Query: 396 DIKLSNILLDEEFTAKIADFGLVRLFPED 424
D+ N L+D++ K++DFGL R +D
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDD 153
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-12
Identities = 43/149 (28%), Positives = 68/149 (45%), Gaps = 6/149 (4%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
+LG G G V+ G VA+K + + F E ++ ++H LV+L G
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHR 395
+V EF+ N LL+ ++RQ LS ++ + EG+ YL S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLN--YLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 396 DIKLSNILLDEEFTAKIADFGLVRLFPED 424
D+ N L+ K++DFG+ R +D
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDD 153
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 50/161 (31%), Positives = 74/161 (45%), Gaps = 10/161 (6%)
Query: 277 LGQGGSGSVYK-GTLPGGEAVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLLGCS 334
LG G GSV K +P G +A K + V E+ ++ +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
+ + EF+ SL D ++ + P+ E+ KI ++ EGL YL+ RI+H
Sbjct: 73 LNENNICMCMEFMDCGSL-DRIY--KKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMH 127
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
RDIK SNIL++ K+ DFG+ E I I+ T GT
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVS---GELINSIADTFVGT 165
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 25/168 (14%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRL-FYNTTQWVDHF-FNEV 316
YE LEK +G+G G+V+K E VA+KR+ + + V E+
Sbjct: 1 KYEKLEK----------IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI 50
Query: 317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL---LDNLFVRQDVEPLSWEVRYKI 373
L+ + HKN+V+L + + LV+E+ +Q L D+ D++P E+
Sbjct: 51 CLLKELKHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSC--NGDIDP---EIVKSF 104
Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
+ +GLA+ H ++HRD+K N+L+++ K+ADFGL R F
Sbjct: 105 MFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAF 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 52/156 (33%), Positives = 81/156 (51%), Gaps = 11/156 (7%)
Query: 267 ATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHF-FNEVNLISGINH 324
AT+Y + KLG+G +VYKG + G+ VA+K + T + V E +L+ G+ H
Sbjct: 4 ATSYLN-LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 325 KNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
N+V LL I E+L V+E++ + L ++ + VR + GLAY
Sbjct: 63 ANIV-LLHDIIHTKETLTFVFEYM--HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAY 118
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
+H + I+HRD+K N+L+ K+ADFGL R
Sbjct: 119 IHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 46/163 (28%), Positives = 78/163 (47%), Gaps = 14/163 (8%)
Query: 263 TLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLF--YNTTQWVDHFFNEVNLI 319
T+ + TN + + +G G G V G+ VA+K++ ++T + E+ L+
Sbjct: 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLL 63
Query: 320 SGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEP-LSWEVRYKIILST 377
+ H+N++ L I+ E + V E + L L + +E Y+I+
Sbjct: 64 KHLRHENIISLSDIFISPLEDIYFVTELLGTD--LHRLLTSRPLEKQFIQYFLYQIL--- 118
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420
GL Y+H ++HRD+K SNIL++E KI DFGL R+
Sbjct: 119 -RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 46/144 (31%), Positives = 73/144 (50%), Gaps = 8/144 (5%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT 336
+G+G G V G G + VAVK + + T F E ++++ + H NLV+LLG +
Sbjct: 14 IGKGEFGDVMLGDYRGNK-VAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 337 GPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHR 395
L +V E++ SL+D L R L + K L E + YL + +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 396 DIKLSNILLDEEFTAKIADFGLVR 419
D+ N+L+ E+ AK++DFGL +
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 52/152 (34%), Positives = 76/152 (50%), Gaps = 14/152 (9%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQ----WVDHFFNEVNLISGINHK 325
F + ++G G G+VY + E VA+K++ Y+ Q W D EV + + H
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKLRHP 75
Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA-EGLAYL 384
N ++ GC + + LV E+ S D L V + +PL EV + A +GLAYL
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHK--KPLQ-EVEIAAVTHGALQGLAYL 131
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416
H + +IHRD+K NILL E K+ DFG
Sbjct: 132 HSHN---MIHRDVKAGNILLSEPGLVKLGDFG 160
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 51/161 (31%), Positives = 70/161 (43%), Gaps = 21/161 (13%)
Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRL-FYNTTQWVDHFFNEVNLISGINHKNL 327
LG G G VY+G G + VAVK L + Q F E ++S NH+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQD----VEPLSWEVR--YKIILSTAEGL 381
V+L+G S ++ E + L F+R++ P S ++ A+G
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKS--FLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 382 AYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVR 419
YL E IHRDI N LL AKIADFG+ R
Sbjct: 130 KYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 46/164 (28%), Positives = 80/164 (48%), Gaps = 18/164 (10%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
LG G +G V+ + VAVK++ Q V H E+ +I ++H N+VK+ +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVY--EV 70
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDV-----------EPLSWEVRYKIILSTAEGLAYL 384
GP + E V + + L+++++ Q+ PLS E + GL Y+
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYI 130
Query: 385 HEESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRLFPEDITH 427
H + ++HRD+K +N+ ++ E+ KI DFGL R+ +H
Sbjct: 131 HSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH 171
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 4e-12
Identities = 48/154 (31%), Positives = 68/154 (44%), Gaps = 17/154 (11%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGC- 333
+G+G G VYK G+ VA+K + + + E N++ NH N+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEE-IKEEYNILRKYSNHPNIATFYGAF 72
Query: 334 -----SITGPESLLVYEFVPNQSLLD---NLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
+ LV E S+ D L R+ + L E I+ T GLAYLH
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGL--RKKGKRLKEEWIAYILRETLRGLAYLH 130
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
E ++IHRDIK NILL + K+ DFG+
Sbjct: 131 EN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA 161
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 6e-12
Identities = 52/166 (31%), Positives = 82/166 (49%), Gaps = 16/166 (9%)
Query: 276 KLGQGGSGSVYKG-TLPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
K+G+G G VYKG G+ VA+K RL E++L+ + H N+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 333 CSITGPESLLVYEFVPN--QSLLDNLFVRQDVEP-LSWEVRYKIILSTAEGLAYLHEESK 389
+ L++EF+ + LD+L Q ++ L Y+I+ +G+ + H
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQIL----QGILFCHSR-- 120
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI---THISATL 432
R++HRD+K N+L+D + K+ADFGL R F + TH TL
Sbjct: 121 -RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTL 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 6e-12
Identities = 46/159 (28%), Positives = 74/159 (46%), Gaps = 27/159 (16%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRL----FY--------NTTQWVDH-FFNEVNLISGI 322
KLG+G GSVYK VKRL FY + +Q NE+ +++ +
Sbjct: 7 KLGKGSYGSVYK----------VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV 56
Query: 323 NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVE-PLSWEVRYKIILSTAEGL 381
NH N++ + G + +V E+ P L + R+ + + ++I + GL
Sbjct: 57 NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420
LHE +I+HRD+K +NILL KI D G+ ++
Sbjct: 117 QALHE---QKILHRDLKSANILLVANDLVKIGDLGISKV 152
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 7e-12
Identities = 42/144 (29%), Positives = 68/144 (47%), Gaps = 6/144 (4%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLG 332
+LG G SG V K P G+ +AVK + E++++ N +V G
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
+ + E++ SL +++ + + KI ++ +GL YLHE K +I
Sbjct: 67 AFYNNGDISICMEYMDGGSLDK--ILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKI 122
Query: 393 IHRDIKLSNILLDEEFTAKIADFG 416
IHRD+K SNIL++ K+ DFG
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFG 146
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 9e-12
Identities = 40/146 (27%), Positives = 67/146 (45%), Gaps = 12/146 (8%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT 336
L G G V+ T PG V ++ T + E L+ +NH +++++ ++
Sbjct: 74 LTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLI-----EAMLLQNVNHPSVIRMKDTLVS 128
Query: 337 GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRD 396
G + +V +P+ S ++ + PL + I EGL YLH + RIIHRD
Sbjct: 129 GAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRD 182
Query: 397 IKLSNILLDEEFTAKIADFGLVRLFP 422
+K NI +++ I D G + FP
Sbjct: 183 VKTENIFINDVDQVCIGDLGAAQ-FP 207
|
Length = 357 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 49/176 (27%), Positives = 85/176 (48%), Gaps = 17/176 (9%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN 323
+K T Y K+GQG SG+V+ + G+ VA+K++ + NE+ ++ +
Sbjct: 19 KKYTRY----EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELK 74
Query: 324 HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA-EGLA 382
+ N+V L + G E +V E++ SL D + E E + + + L
Sbjct: 75 NPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV-----TETCMDEAQIAAVCRECLQALE 129
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLF 437
+LH ++IHRDIK N+LL + + K+ DFG ++ PE +T+ GT +
Sbjct: 130 FLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPY 180
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 57/161 (35%), Positives = 76/161 (47%), Gaps = 22/161 (13%)
Query: 277 LGQGGSGSVYKGTL-----PGGEA--VAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLV 328
LG G G VY+GT PG VAVK L T Q F E +L+S NH N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 329 KLLG-CSITGPESLLVYEFVPNQSLLDNLF-VRQDVEP---LSWEVRYKIILSTAEGLAY 383
KLLG C + P+ +++ E + LL L R + L+ + I L A+G Y
Sbjct: 63 KLLGVCLLNEPQYIIM-ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 384 LHEESKLRIIHRDIKLSNILLDEE-----FTAKIADFGLVR 419
L ++ IHRD+ N L+ E+ KI DFGL R
Sbjct: 122 LE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 25/168 (14%)
Query: 269 NYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHF----FNEVNLISGIN 323
+ + + K+GQG G V+K + VA+K++ + + F E+ ++ +
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK--EGFPITALREIKILQLLK 69
Query: 324 HKNLVKLLG-CSITG-------PESLLVYEFVPNQ--SLLDNLFVRQDVEPLSWEVRYKI 373
H+N+V L+ C LV+EF + LL N V+ + E++ K+
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLS----EIK-KV 124
Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
+ GL Y+H +I+HRD+K +NIL+ ++ K+ADFGL R F
Sbjct: 125 MKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAF 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 47/151 (31%), Positives = 75/151 (49%), Gaps = 13/151 (8%)
Query: 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRL-FYNTTQWVDHFFNEVNLISGINHKNLV 328
F + ++G+G G VYKG E VA+K + ++ E+ ++S + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY--KIILSTAEGLAYLHE 386
+ G + G + ++ E++ S LD L +P E Y I+ +GL YLH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLL------KPGPLEETYIATILREILKGLDYLHS 119
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417
E K IHRDIK +N+LL E+ K+ADFG+
Sbjct: 120 ERK---IHRDIKAANVLLSEQGDVKLADFGV 147
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 49/158 (31%), Positives = 83/158 (52%), Gaps = 17/158 (10%)
Query: 276 KLGQGGSGSVYKGT---LPGGEA---VAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLV 328
+LGQG G VY+G + GEA VAVK + + + + F NE +++ G ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVE------PLSWEVRYKIILSTAEGL 381
+LLG G +L+V E + + L L +R + E P + + ++ A+G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
AYL+ + + +HRD+ N ++ +FT KI DFG+ R
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 49/162 (30%), Positives = 79/162 (48%), Gaps = 11/162 (6%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
K+GQG SG+VY + G+ VA+K++ + NE+ ++ H N+V L
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
+ G E +V E++ SL D + E V + + + L +LH ++IH
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL----QALEFLHSN---QVIH 138
Query: 395 RDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGT 435
RDIK NILL + + K+ DFG ++ PE +T+ GT
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 49/152 (32%), Positives = 68/152 (44%), Gaps = 24/152 (15%)
Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRLFYNTTQW---VDHFFNEVNLISGINHKNLVK 329
+ +G G V+ K T G+ A+K + VD E +++S +VK
Sbjct: 1 ISKGAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 330 LLGCSITGPESL-LVYEFVPN---QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
L S G ++L LV E++P SLL+N V L +V I L YLH
Sbjct: 58 LY-YSFQGKKNLYLVMEYLPGGDLASLLEN------VGSLDEDVARIYIAEIVLALEYLH 110
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417
IIHRD+K NIL+D K+ DFGL
Sbjct: 111 ---SNGIIHRDLKPDNILIDSNGHLKLTDFGL 139
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 49/175 (28%), Positives = 87/175 (49%), Gaps = 32/175 (18%)
Query: 275 NKLGQGGSGSVYKG----TLPGGEAVAVKRLFYNTTQWVDHF----FNEVNLISGINHKN 326
N++ +G G VY+ T GE VA+K+L + + F E+N++ + H N
Sbjct: 11 NRIEEGTYGVVYRARDKKT---GEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPN 65
Query: 327 LVKL----LGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEG 380
+V + +G ++ + +V E+V + +SL++ + +P ++L G
Sbjct: 66 IVTVKEVVVGSNLD--KIYMVMEYVEHDLKSLMETM-----KQPFLQSEVKCLMLQLLSG 118
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI---THISATL 432
+A+LH+ I+HRD+K SN+LL+ KI DFGL R + + T + TL
Sbjct: 119 VAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTL 170
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 46/154 (29%), Positives = 77/154 (50%), Gaps = 12/154 (7%)
Query: 277 LGQGGSGSVYKGTL--PGGEA--VAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKL 330
+G G G V +G L PG VA+K L Y Q D F +E +++ +H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRD-FLSEASIMGQFDHPNIIHL 70
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
G +++ EF+ N +L + F+RQ+ + ++ A G+ YL S++
Sbjct: 71 EGVVTKSRPVMIITEFMENGAL--DSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEM 125
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
+HRD+ NIL++ K++DFGL R +D
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 53/170 (31%), Positives = 78/170 (45%), Gaps = 48/170 (28%)
Query: 275 NKLGQGGSGSVYKG----TLPGGEAVAVKRLFYNTTQWVDHF---------FNEVNLISG 321
KLG+G G V+K T E VA+K++F D F F E+ +
Sbjct: 13 QKLGKGAYGIVWKAIDRRT---KEVVALKKIF-------DAFRNATDAQRTFREIMFLQE 62
Query: 322 I-NHKNLVKLLGC--SITGPESLLVYEF-------VPNQSLLDNLFVRQDVEPLSWEVRY 371
+ +H N+VKLL + + LV+E+ V ++L +DV RY
Sbjct: 63 LGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANIL------EDVH-----KRY 111
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
I+ + L Y+H +IHRD+K SNILL+ + K+ADFGL R
Sbjct: 112 -IMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL 157
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 48/169 (28%), Positives = 75/169 (44%), Gaps = 17/169 (10%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKR--LF-YNTTQWVDHFFNEVNLISGINHKNLVKLL 331
K+G+G VYK L G VA+K+ +F + E++L+ ++H N++K L
Sbjct: 9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 332 GCSITGPESLLVYEFVPNQSL--LDNLFVRQDV---EPLSWEVRYKIILSTAEGLAYLHE 386
I E +V E L + F +Q E W K + L ++H
Sbjct: 69 ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIW----KYFVQLCSALEHMHS 124
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
+ RI+HRDIK +N+ + K+ D GL R F T + +L GT
Sbjct: 125 K---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-TTAAHSLVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 45/146 (30%), Positives = 74/146 (50%), Gaps = 12/146 (8%)
Query: 276 KLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+LG G G VYK G A K + + + ++ + E+ +++ NH +VKLLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQD---VEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
+ ++ EF P ++ D + + D EP +++ I E L YLH ++
Sbjct: 79 YWDGKLWIMIEFCPGGAV-DAIMLELDRGLTEP---QIQV-ICRQMLEALQYLHS---MK 130
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGL 417
IIHRD+K N+LL + K+ADFG+
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGV 156
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 21/162 (12%)
Query: 274 SNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQWVDH---FFNEVNLISGINH 324
S +LGQG G VY+G G VA+K + N + F NE +++ N
Sbjct: 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKEFNC 68
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVE------PLSWEVRYKIILST 377
++V+LLG G +L++ E + L L +R ++E P S + ++
Sbjct: 69 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
A+G+AYL+ + +HRD+ N ++ E+FT KI DFG+ R
Sbjct: 129 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 48/151 (31%), Positives = 72/151 (47%), Gaps = 14/151 (9%)
Query: 277 LGQGGSGSVYKG-TLPGGEAVAVKRLFYN-----TTQWVDHFFNEVNLISGINHKNLVKL 330
LGQG G VY G +AVK++ ++ T++ V+ E+ L+ + H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 331 LGCSITGPESLL--VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
GC E L E +P S+ D L + L+ V K EG++YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYGALTENVTRKYTRQILEGVSYLHSN- 125
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
I+HRDIK +NIL D K+ DFG +
Sbjct: 126 --MIVHRDIKGANILRDSVGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 39/137 (28%), Positives = 53/137 (38%), Gaps = 36/137 (26%)
Query: 313 FNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYK 372
NE ++ +NH LV L Y F +N+++ D+ L ++RY
Sbjct: 48 LNERRILQELNHPFLVNLW------------YSFQDE----ENMYLVVDLL-LGGDLRYH 90
Query: 373 I--------------ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418
+ I L YLH + IIHRDIK NILLDE+ I DF +
Sbjct: 91 LSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIA 147
Query: 419 RLFPED--ITHISATLA 433
D T S T
Sbjct: 148 TKVTPDTLTTSTSGTPG 164
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 56/167 (33%), Positives = 82/167 (49%), Gaps = 28/167 (16%)
Query: 277 LGQGGSGSVYKGTLPGGE--------AVAVKRLFYNTT-QWVDHFFNEVNLISGIN-HKN 326
LG+G G V + G + VAVK L N T + + +E+ L+ I HKN
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQ--------DV-----EPLSWEVRYK 372
++ LLG C+ GP ++V E+ +L + L R+ D+ E LS++
Sbjct: 80 IINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
A G+ YL ES+ R IHRD+ N+L+ E+ KIADFGL R
Sbjct: 139 CAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 48/155 (30%), Positives = 84/155 (54%), Gaps = 10/155 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLV 328
F + KLG+G +VYKG GE VA+K + + + E++L+ + H+N+V
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 329 KLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
+L T + +LV+E++ + +D VR ++P + V+ +G+A+ HE
Sbjct: 62 RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNT--VKS-FTYQLLKGIAFCHE 118
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
R++HRD+K N+L+++ K+ADFGL R F
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAF 150
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 52/182 (28%), Positives = 87/182 (47%), Gaps = 23/182 (12%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDH---FFNEVN 317
+T+ + + + + +G G G V G VA+K+L Q H + E+
Sbjct: 8 KTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKL-SRPFQSAIHAKRTYRELR 66
Query: 318 LISGINHKNLVKLLGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWE-V 369
L+ ++H+N++ LL T SL LV + + L+N+ Q LS + +
Sbjct: 67 LLKHMDHENVIGLLDV-FTPASSLEDFQDVYLVTHLM--GADLNNIVKCQ---KLSDDHI 120
Query: 370 RYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429
++ ++ GL Y+H IIHRD+K SNI ++E+ KI DFGL R +++T
Sbjct: 121 QF-LVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYV 176
Query: 430 AT 431
AT
Sbjct: 177 AT 178
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 5e-11
Identities = 50/164 (30%), Positives = 73/164 (44%), Gaps = 14/164 (8%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
F ++G G G VYK + GE A+K + + E+ ++ H N+V
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
G + + + EF SL D V PLS + T +GL YLH + K
Sbjct: 71 YFGSYLRRDKLWICMEFCGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA 433
+HRDIK +NILL + K+ADFG+ I+AT+A
Sbjct: 128 ---MHRDIKGANILLTDNGHVKLADFGVS-------AQITATIA 161
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 50/161 (31%), Positives = 78/161 (48%), Gaps = 9/161 (5%)
Query: 276 KLGQGGSGSV-YKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
K+G+G +G V G VAVK + Q + FNEV ++ H+N+V++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
+ G E ++ EF+ +L D V Q L+ E + S + L YLH + +IH
Sbjct: 88 LVGEELWVLMEFLQGGALTD--IVSQ--TRLNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
RDIK +ILL + K++DFG +D+ +L GT
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSLVGT 180
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 6e-11
Identities = 53/150 (35%), Positives = 75/150 (50%), Gaps = 20/150 (13%)
Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL----FYNTTQWVDHFFNEVNLISGINHKNLV 328
+G+G G V+ K T G+ A+K L Q + H E ++++ + +V
Sbjct: 9 IGRGAFGEVWLVRDKDT---GQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIV 64
Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
KL S E L LV E++P L+ NL +R+DV P R+ I AE + L
Sbjct: 65 KLY-YSFQDEEHLYLVMEYMPGGDLM-NLLIRKDVFPEET-ARFYI----AELVLALDSV 117
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGL 417
KL IHRDIK NIL+D + K+ADFGL
Sbjct: 118 HKLGFIHRDIKPDNILIDADGHIKLADFGL 147
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 7e-11
Identities = 54/168 (32%), Positives = 77/168 (45%), Gaps = 24/168 (14%)
Query: 274 SNKLGQGGSGSVYKGTL----PGGE-AVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNL 327
S+ L +G G ++ G L PG E V VK + + ++ V E L+ G++H+N+
Sbjct: 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI 70
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST---------- 377
+ +L I E V N L LF++Q E LST
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNL-KLFLQQ---CRLGEANNPQALSTQQLVHMAIQI 126
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPED 424
A G++YLH K +IH+DI N ++DEE KI D L R LFP D
Sbjct: 127 ACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 52/165 (31%), Positives = 80/165 (48%), Gaps = 25/165 (15%)
Query: 276 KLGQGGSGSVYKG--TLPG---GEAVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLV 328
+LG+ G +YKG LPG + VA+K L N QW + F E +L++ ++H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE-FQQEASLMAELHHPNIV 70
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQ---DVEPLSWE---VR--------YKII 374
LLG +++E++ L + L +R DV S E V+ I
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
+ A G+ YL S +H+D+ NIL+ E+ KI+D GL R
Sbjct: 131 IQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 52/160 (32%), Positives = 76/160 (47%), Gaps = 16/160 (10%)
Query: 276 KLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
++G G G VYK L GE AVK + E+ ++ H N+V G
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLS-WEVRYKIILSTAEGLAYLHEESKLRII 393
++ + + E+ SL D V PLS ++ Y + T +GLAYLH + K+
Sbjct: 76 LSREKLWICMEYCGGGSLQDIYHV---TGPLSELQIAY-VCRETLQGLAYLHSKGKM--- 128
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA 433
HRDIK +NILL + K+ADFG+ I+AT+A
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVA-------AKITATIA 161
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 41/146 (28%), Positives = 72/146 (49%), Gaps = 18/146 (12%)
Query: 296 VAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
VAVK L + T+ + F E+ ++S + + N+++LLG ++ ++ E++ N L
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL-- 104
Query: 355 NLFVRQ-----------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNIL 403
N F+ Q ++ +S + + A G+ YL + L +HRD+ N L
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCL 161
Query: 404 LDEEFTAKIADFGLVR-LFPEDITHI 428
+ +T KIADFG+ R L+ D I
Sbjct: 162 VGNHYTIKIADFGMSRNLYSGDYYRI 187
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-10
Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 14/158 (8%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFY--NTTQWVDHFF----NEVNLISGINHKNLVK 329
LG G S Y+ + G +AVK++ Y NT+ + E+ L++ +NH ++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
+LG + L E++ S+ L V GL+YLHE
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLL---SKYGAFKEAVIINYTEQLLRGLSYLHEN-- 122
Query: 390 LRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFPEDIT 426
+IIHRD+K +N+L+D +IADFG T
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 46/148 (31%), Positives = 74/148 (50%), Gaps = 14/148 (9%)
Query: 277 LGQGGSGSVYKG-TLPGGEAVAVKRLFYN-----TTQWVDHFFNEVNLISGINHKNLVKL 330
LGQG G VY + G +A K++ ++ T++ V E+ L+ + H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 331 LGC-SITGPESLLVY-EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
GC ++L ++ E++P S+ D L + L+ V K EG++YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTRKYTRQILEGMSYLHSN- 125
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFG 416
I+HRDIK +NIL D K+ DFG
Sbjct: 126 --MIVHRDIKGANILRDSAGNVKLGDFG 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 57/173 (32%), Positives = 75/173 (43%), Gaps = 29/173 (16%)
Query: 277 LGQGGSGSV----YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGIN---HKN 326
LG+G G V YK T GE A+K L V+ E + N H
Sbjct: 7 LGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYK--IILSTAEGLAYL 384
LV L C T V E+ L+ + + DV V Y ++L GL YL
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLM--MHIHTDVFSEPRAVFYAACVVL----GLQYL 117
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS--ATLAGT 435
HE +I++RD+KL N+LLD E KIADFGL + E + +T GT
Sbjct: 118 HEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGT 164
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 53/166 (31%), Positives = 77/166 (46%), Gaps = 46/166 (27%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
+G G G V Y G+ VA+K+L F N T + E+ L+ +NHKN++ L
Sbjct: 24 IGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTH-AKRAYRELVLMKLVNHKNIIGL 80
Query: 331 LGCSITGPESLLVYEFVPNQSLLD-------------NLF-VRQ---DVEPLSWEVRYKI 373
L F P +SL + NL V Q D E +S+ + Y++
Sbjct: 81 LNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLL-YQM 127
Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
+ G+ +LH IIHRD+K SNI++ + T KI DFGL R
Sbjct: 128 LC----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 50/160 (31%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVA---VKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKL 330
+++G G G V G G + A VK L + T F EV +NH N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNL-----FVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
LG I LLV EF P L + L V Q + +V ++ A GL +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK---DVLQRMACEVASGLLWLH 117
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGL-VRLFPED 424
+ IH D+ L N L + + KI D+GL + +PED
Sbjct: 118 ---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 4e-10
Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 12/154 (7%)
Query: 277 LGQGGSGSVYKG--TLPGGE--AVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKL 330
+G G G V G LPG VA+K L Y Q D F +E +++ +H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD-FLSEASIMGQFDHPNIIHL 70
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
G ++V E++ N SL + F+R+ + ++ A G+ YL S +
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSL--DAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDM 125
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
+HRD+ NIL++ K++DFGL R+ +D
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 5e-10
Identities = 54/173 (31%), Positives = 76/173 (43%), Gaps = 34/173 (19%)
Query: 277 LGQGGSGSV----YKGTLPGGEAVAVKRLFYNTTQW-------VDHFFNEVNLISGINHK 325
LG G G V +KG+ G+ A+K L ++ V+H NE ++ I H
Sbjct: 9 LGTGSFGRVMLVRHKGS---GKYYALKIL----SKAKIVKLKQVEHVLNEKRILQSIRHP 61
Query: 326 NLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRY--KIILSTAEGLA 382
LV L G S +L LV E+VP L + P Y +++L L
Sbjct: 62 FLVNLYG-SFQDDSNLYLVMEYVPGGELFS-HLRKSGRFPEPVARFYAAQVVL----ALE 115
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
YLH I++RD+K N+LLD + KI DFG + T+ TL GT
Sbjct: 116 YLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-TY---TLCGT 161
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 5e-10
Identities = 43/149 (28%), Positives = 70/149 (46%), Gaps = 9/149 (6%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLV 328
F + K+G+G G V+KG + V ++ ++ E+ ++S + +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
K G + + ++ E++ S LD L + PL I+ +GL YLH E
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEK 121
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGL 417
K IHRDIK +N+LL E K+ADFG+
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGV 147
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 6e-10
Identities = 46/158 (29%), Positives = 75/158 (47%), Gaps = 18/158 (11%)
Query: 277 LGQGGSGSVYKGTLP----GGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKL 330
LG+G GSV + L + VAVK L ++ ++ F E + +H N++KL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 331 LGCSITG------PESLLVYEFVPNQSLLDNLFV-RQDVEP--LSWEVRYKIILSTAEGL 381
+G S+ P +++ F+ + L L + R EP L + + ++ A G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
YL S IHRD+ N +L+E T +ADFGL +
Sbjct: 127 EYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 6e-10
Identities = 51/177 (28%), Positives = 85/177 (48%), Gaps = 27/177 (15%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHF----FNEVNLI 319
++ + F ++G+G G VYK GE VA+K++ + + + F E+ ++
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKIL 60
Query: 320 SGINHKNLVKLLGCSITGPESL----------LVYEFVPNQ--SLLDNLFVRQDVEPLSW 367
+NH+N+V L ++L LV+E++ + LL++ V S
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH-----FSE 115
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
+ + EGL Y H K +HRDIK SNILL+ + K+ADFGL RL+ +
Sbjct: 116 DHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 7e-10
Identities = 48/165 (29%), Positives = 80/165 (48%), Gaps = 13/165 (7%)
Query: 276 KLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
K+GQG SG+VY + G+ VA+K++ + NE+ ++ + N+V L
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA-EGLAYLHEESKLRII 393
+ G E +V E++ SL D + E E + + + L +LH ++I
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALDFLHSN---QVI 137
Query: 394 HRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLF 437
HRDIK NILL + + K+ DFG ++ PE +T+ GT +
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPY 180
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 7e-10
Identities = 45/149 (30%), Positives = 73/149 (48%), Gaps = 9/149 (6%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAV-AVKRL-FYNTTQWVDHFFNEVNLISGINHKNLV 328
F + ++G+G G V+KG + V A+K + ++ E+ ++S + +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
K G + G + ++ E++ S LD L + K IL +GL YLH E
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEIL---KGLDYLHSEK 121
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGL 417
K IHRDIK +N+LL E+ K+ADFG+
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGV 147
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 9e-10
Identities = 39/157 (24%), Positives = 70/157 (44%), Gaps = 16/157 (10%)
Query: 277 LGQGGSGSVYK--GTLPGGEAVAVKRLFYNTTQW----------VDHFFNEVNLI-SGIN 323
LG G G VYK G +A+K + + + + +EV +I +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 324 HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSWEVRYKIILSTAEGLA 382
H N+V+ + +V + + L ++ +++ + + E + I + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
YLH+E RI+HRD+ +NI+L E+ I DFGL +
Sbjct: 128 YLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAK 162
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 31/124 (25%), Positives = 60/124 (48%), Gaps = 5/124 (4%)
Query: 314 NEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI 373
NE+ ++S + H N++ + L+ E+ +L D + VRQ + E+
Sbjct: 48 NEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMVLWY 106
Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA 433
+ ++Y+H+ I+HRDIK NI L + K+ DFG+ ++ + + + T+
Sbjct: 107 LFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM-AETVV 162
Query: 434 GTLF 437
GT +
Sbjct: 163 GTPY 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 41/148 (27%), Positives = 73/148 (49%), Gaps = 9/148 (6%)
Query: 276 KLGQGGSGSVYK-GTLPGGEAVAVKRLFYNTTQWVDH--FFNEVNLISGINHKNLVKLLG 332
K+G+G G V+K G+ VA+K+ + V E+ ++ + H NLV L+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
+ LV+E+ + ++L+ L ++ + + KII T + + + H K
Sbjct: 68 VFRRKRKLHLVFEYC-DHTVLNEL--EKNPRGVPEHLIKKIIWQTLQAVNFCH---KHNC 121
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRL 420
IHRD+K NIL+ ++ K+ DFG R+
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARI 149
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 50/164 (30%), Positives = 77/164 (46%), Gaps = 27/164 (16%)
Query: 277 LGQGGSGSVYKGTLPGGEA---VAVKRLFYNTTQWVDH--FFNEVNLISGIN-HKNLVKL 330
+G+G G V K + A+KR+ ++ DH F E+ ++ + H N++ L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINL 73
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQ----DVEP-----------LSWEVRYKIIL 375
LG L E+ P+ +LLD F+R+ + +P LS +
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLD--FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 376 STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
A G+ YL S+ + IHRD+ NIL+ E + AKIADFGL R
Sbjct: 132 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 44/146 (30%), Positives = 68/146 (46%), Gaps = 7/146 (4%)
Query: 276 KLGQGGSGSVYKGTLPGGEA-VAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGC 333
++G+G G V+ G L VAVK F E ++ +H N+V+L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
+V E V L F+R + L + +++ + A G+ YL ESK I
Sbjct: 62 CTQKQPIYIVMELVQGGDFLT--FLRTEGPRLKVKELIQMVENAAAGMEYL--ESK-HCI 116
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVR 419
HRD+ N L+ E+ KI+DFG+ R
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 37/129 (28%), Positives = 57/129 (44%), Gaps = 12/129 (9%)
Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESLL-VYEFVPNQSLLDNLFVRQDVEPLSWEVR 370
F E L + + H N+V LL P L V+E+VP ++L + L L
Sbjct: 25 FRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVL---AADGALPAGET 81
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFP--EDI 425
+++L + LA H + I+HRD+K NI++ AK+ DFG+ L P D
Sbjct: 82 GRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDA 138
Query: 426 THISATLAG 434
+ T
Sbjct: 139 DVATLTRTT 147
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 42/151 (27%), Positives = 71/151 (47%), Gaps = 16/151 (10%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
+G G GSV GE VA+K+L + + + + E+ L+ + H+N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVE-----PLSWEVRYKIILSTAEGLAYLHEES 388
+ +F L +++ D++ PLS + ++ GL Y+H
Sbjct: 83 FTSAVSGDEFQDF-----YLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG 137
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
IIHRD+K N+ ++E+ KI DFGL R
Sbjct: 138 ---IIHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 47/150 (31%), Positives = 75/150 (50%), Gaps = 18/150 (12%)
Query: 277 LGQGGSGSVYKG-TLPGGEAVAVKRLFYN-----TTQWVDHFFNEVNLISGINHKNLVKL 330
LG+G G VY G +AVK++ ++ T++ V+ E+ L+ + H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 331 LGCSITGPE----SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
GC + PE S+ V E++P S+ D L + L+ V + +G++YLH
Sbjct: 70 YGC-LRDPEEKKLSIFV-EYMPGGSIKDQL---KAYGALTENVTRRYTRQILQGVSYLHS 124
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFG 416
I+HRDIK +NIL D K+ DFG
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFG 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 54/176 (30%), Positives = 81/176 (46%), Gaps = 32/176 (18%)
Query: 277 LGQGGSGSVYKGTLPGGEA--------VAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKN 326
LG+G G V G + VAVK L + T+ + +E+ ++ I HKN
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYK 372
++ LLG C+ GP ++V E+ +L + L R+ E LS++
Sbjct: 86 IINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428
A G+ YL + + IHRD+ N+L+ E+ KIADFGL R DI HI
Sbjct: 145 CAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHI 193
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 47/163 (28%), Positives = 73/163 (44%), Gaps = 21/163 (12%)
Query: 261 YETLEKATNYFHESNKLGQGGSGSVYK-GTLPGGEAVAVKRLFYNT--TQWVDHF-FNEV 316
YE L +G+G G V K G+ VA+K+ F + + V E+
Sbjct: 3 YENLGL----------VGEGSYGMVMKCKHKETGQIVAIKK-FLESEDDKMVKKIAMREI 51
Query: 317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS 376
++ + H+NLV L+ LV+EFV + ++LD+L + L K +
Sbjct: 52 RMLKQLRHENLVNLIEVFRRKKRLYLVFEFV-DHTVLDDL--EKYPNGLDESRVRKYLFQ 108
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
G+ + H + IIHRDIK NIL+ + K+ DFG R
Sbjct: 109 ILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 44/144 (30%), Positives = 75/144 (52%), Gaps = 8/144 (5%)
Query: 276 KLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+LG G G VYK G A K + + + ++ + E+++++ +H N+VKLL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIIL-STAEGLAYLHEESKLRII 393
++ EF ++ D + + + PL+ E + +++ T E L YLHE +II
Sbjct: 72 YYENNLWILIEFCAGGAV-DAVMLELE-RPLT-EPQIRVVCKQTLEALNYLHEN---KII 125
Query: 394 HRDIKLSNILLDEEFTAKIADFGL 417
HRD+K NIL + K+ADFG+
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGV 149
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 3e-09
Identities = 44/151 (29%), Positives = 74/151 (49%), Gaps = 11/151 (7%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
K+GQG SG+VY + G+ VA++++ + NE+ ++ + N+V L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA-EGLAYLHEESKLRII 393
+ G E +V E++ SL D + E E + + + L +LH ++I
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 394 HRDIKLSNILLDEEFTAKIADFGL-VRLFPE 423
HRDIK NILL + + K+ DFG ++ PE
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 44/164 (26%), Positives = 70/164 (42%), Gaps = 25/164 (15%)
Query: 276 KLGQGGSGSVY----KGTLPGGEA--VAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+LG+G G V+ LP + VAVK L + F E L++ + H+++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVR--------------QDVEPLSWEVRYKIIL 375
G G L+V+E++ + L N F+R L+ I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDL--NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 376 STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
A G+ YL + L +HRD+ N L+ + KI DFG+ R
Sbjct: 130 QIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 3e-09
Identities = 55/165 (33%), Positives = 80/165 (48%), Gaps = 24/165 (14%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHF-FNEVN 317
SYE LEK LG+G +VYKG + G+ VA+K + + E +
Sbjct: 6 SYEKLEK----------LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREAS 55
Query: 318 LISGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEP--LSWEVRYKII 374
L+ G+ H N+V LL I E+L LV+E+V +L D P L E +
Sbjct: 56 LLKGLKHANIV-LLHDIIHTKETLTLVFEYVHT-----DLCQYMDKHPGGLHPENVKLFL 109
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
GL+Y+H+ I+HRD+K N+L+ + K+ADFGL R
Sbjct: 110 FQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 51/157 (32%), Positives = 76/157 (48%), Gaps = 25/157 (15%)
Query: 277 LGQGGSGSVYKGTLP-GGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
+G G G V+ T P G+ VA+K++ F N F E+ ++ H N++ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVS-CKRVFRELKMLCFFKHDNVLSAL- 65
Query: 333 CSITGPESLLVYE--FVPN---QSLLDNLFVRQDVEPLSWE-VR---YKIILSTAEGLAY 383
I P + +E +V QS L + V +PLS + V+ Y+I+ GL Y
Sbjct: 66 -DILQPPHIDPFEEIYVVTELMQSDLHKIIVSP--QPLSSDHVKVFLYQIL----RGLKY 118
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420
LH I+HRDIK N+L++ KI DFGL R+
Sbjct: 119 LHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 52/162 (32%), Positives = 82/162 (50%), Gaps = 26/162 (16%)
Query: 271 FHESNKLGQGGSG---SVYKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINH 324
+ + +G G G + + L G VAVK+L F N T + E+ L+ +NH
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTH-AKRAYRELVLLKCVNH 79
Query: 325 KNLVKLLGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST 377
KN++ LL T +SL LV E + + +L + + D E +S+ + Y+++
Sbjct: 80 KNIISLLNV-FTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHERMSY-LLYQMLC-- 134
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
G+ +LH IIHRD+K SNI++ + T KI DFGL R
Sbjct: 135 --GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 21/46 (45%), Positives = 30/46 (65%), Gaps = 2/46 (4%)
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417
KI +S + L YLH KL +IHRD+K SN+L++ K+ DFG+
Sbjct: 107 KIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGI 150
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 8/152 (5%)
Query: 269 NYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQW-VDHFFNEVNLISGINH-K 325
N ++G G G VYK G +AVK++ + +++++ +
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCP 74
Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
+VK G IT + + E + + LD L R P+ ++ K+ ++ + L YL
Sbjct: 75 YIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLK 131
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417
E K +IHRD+K SNILLD K+ DFG+
Sbjct: 132 E--KHGVIHRDVKPSNILLDASGNVKLCDFGI 161
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 58/165 (35%), Positives = 80/165 (48%), Gaps = 24/165 (14%)
Query: 277 LGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQWVDH---FFNEVNLISGI-NHKN 326
LG G G V + T G VAVK L T +E+ ++S + NH+N
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKML--KPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEP-LSWEVRYKIILSTAEGLAYL 384
+V LLG C+I GP L++ E+ LL+ F+R+ E L+ E A+G+A+L
Sbjct: 101 IVNLLGACTIGGP-ILVITEYCCYGDLLN--FLRRKRESFLTLEDLLSFSYQVAKGMAFL 157
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429
SK IHRD+ N+LL KI DFGL R DI + S
Sbjct: 158 --ASK-NCIHRDLAARNVLLTHGKIVKICDFGLAR----DIMNDS 195
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 18/197 (9%)
Query: 215 TSAVALLLVFSLVAF---FVR-RKLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNY 270
T + LV +LVAF F+R R L+ +R + G ++ SK++ S T+ +
Sbjct: 633 TCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSI-TINDILSS 691
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF-YNTTQWVDHFFNEVNLISGINHKNLV 328
E N + +G G+ YKG ++ G VK + N+ +E+ + + H N+V
Sbjct: 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-----SSEIADMGKLQHPNIV 746
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
KL+G + + L++E++ ++L + + LSWE R KI + A+ L +LH
Sbjct: 747 KLIGLCRSEKGAYLIHEYIEGKNL------SEVLRNLSWERRRKIAIGIAKALRFLHCRC 800
Query: 389 KLRIIHRDIKLSNILLD 405
++ ++ I++D
Sbjct: 801 SPAVVVGNLSPEKIIID 817
|
Length = 968 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 6e-09
Identities = 42/177 (23%), Positives = 71/177 (40%), Gaps = 42/177 (23%)
Query: 271 FHESNKLGQGGSGSVYKG---TLPGGEAVAVKRLFYNTTQWVDHF----FNEVNLISGIN 323
+ +G+G G VYK G+ A+K+ F + E+ L+ +
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKK-FKGDKEQYTGISQSACREIALLRELK 60
Query: 324 HKNLVKLLGCSITGPESL--LVYEFV-------------PNQSLLDNLFVRQDVEPLSWE 368
H+N+V L+ + + L++++ + + V+ L W+
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKS----LLWQ 116
Query: 369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLVRLF 421
IL G+ YLH ++HRD+K +NIL+ E KI D GL RLF
Sbjct: 117 -----IL---NGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 8e-09
Identities = 55/188 (29%), Positives = 87/188 (46%), Gaps = 29/188 (15%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVK--RLFYNTTQWVDHFFNEV 316
+YE LEK +G+G G VYK G+ VA+K RL + E+
Sbjct: 2 AYEKLEK----------IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREI 51
Query: 317 NLISGINHKN-LVKLLGCSIT----GPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWE 368
+L+ ++ +V+LL G SL LV+E++ + + +D R PL +
Sbjct: 52 SLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMD-SNGRGPGRPLPAK 110
Query: 369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA-KIADFGLVRLFPEDI-- 425
+ +G+A+ H K ++HRD+K N+L+D++ KIAD GL R F +
Sbjct: 111 TIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS 167
Query: 426 -THISATL 432
TH TL
Sbjct: 168 YTHEIVTL 175
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 9e-09
Identities = 44/157 (28%), Positives = 75/157 (47%), Gaps = 17/157 (10%)
Query: 277 LGQGGSGSVYKGTLPGGEA---VAVK--RLFYNTTQWVDHFFNEVNLISGINHKNLVKLL 331
LG+G GSV +G L ++ VAVK ++ T ++ F +E + +H N+++L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 332 GCSITG------PESLLVYEFVPNQSLLDNL-FVRQDVEP--LSWEVRYKIILSTAEGLA 382
G + P +++ F+ + L L + R P L ++ K + A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
YL S IHRD+ N +L+E +ADFGL +
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 40/135 (29%), Positives = 69/135 (51%), Gaps = 8/135 (5%)
Query: 293 GEAVAVKRLF-YNTTQWVDHFFNEVNLISGINHKNLVKLLG-CSITGPESL-LVYEFVPN 349
GE VAVK L + + E+ ++ + H+N+VK G C+ G + L+ EF+P+
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT 409
SL + L ++ L +++Y + +G+ YL + +HRD+ N+L++ E
Sbjct: 93 GSLKEYLPRNKNKINLKQQLKYAV--QICKGMDYLGSR---QYVHRDLAARNVLVESEHQ 147
Query: 410 AKIADFGLVRLFPED 424
KI DFGL + D
Sbjct: 148 VKIGDFGLTKAIETD 162
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 18/152 (11%)
Query: 275 NKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVKLLG 332
+KLG+G +V+KG + VA+K + + EV+L+ + H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 333 CSITGPESLLVYEFVPN--QSLLD---NLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
T LV+E++ + + LD NL +V+ +++ GL+Y H+
Sbjct: 71 IIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQL--------LRGLSYCHKR 122
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
+I+HRD+K N+L++E+ K+ADFGL R
Sbjct: 123 ---KILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 43/167 (25%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLVKLL 331
+ +G+G G V T P G VA+K++ F + T + E+ ++ H+N++ +L
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT-FCQRTLREIKILRRFKHENIIGIL 69
Query: 332 GCSITGPESL-------LVYEFVP--------NQSLLDN---LFVRQDVEPLSWEVRYKI 373
I P S +V E + Q L ++ F+ Y+I
Sbjct: 70 --DIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFL------------YQI 115
Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420
+ GL Y+H + ++HRD+K SN+LL+ KI DFGL R+
Sbjct: 116 L----RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 50/151 (33%), Positives = 67/151 (44%), Gaps = 21/151 (13%)
Query: 277 LGQGGSGSV----YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGI-NHKNLV 328
LG+G G V KGT E AVK L V+ E +++ H L
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY--KIILSTAEGLAYLHE 386
+L C T V E+V L+ ++ R Y +I+L GL +LHE
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHI-QRSGRFDEPRARFYAAEIVL----GLQFLHE 114
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417
II+RD+KL N+LLD E KIADFG+
Sbjct: 115 RG---IIYRDLKLDNVLLDSEGHIKIADFGM 142
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 50/176 (28%), Positives = 79/176 (44%), Gaps = 46/176 (26%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVD-HFFNEVN 317
+Y+ L+K LG+G +VYKG + G+ VA+K + + E +
Sbjct: 6 TYKKLDK----------LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREAS 55
Query: 318 LISGINHKNLVKLLGCSITGPESL-LVYEFV-----------PNQSLLDN--LFVRQDVE 363
L+ + H N+V L I ++L LV+E++ + N LF+ Q
Sbjct: 56 LLKDLKHANIV-TLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQ--- 111
Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
+L GLAY H + R++HRD+K N+L+ E K+ADFGL R
Sbjct: 112 ----------LL---RGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 53/173 (30%), Positives = 77/173 (44%), Gaps = 35/173 (20%)
Query: 261 YETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVK--RLFYNTTQWVDHFFNEVN 317
YE +EK G+G G VYK E +A+K RL E++
Sbjct: 4 YEKVEKI----------GEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREIS 53
Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD-NLFVRQDVEP-LSWEVR----- 370
L+ + H N+V+L + LV+E+ LD +L D P + R
Sbjct: 54 LLKEMQHGNIVRLQDVVHSEKRLYLVFEY------LDLDLKKHMDSSPDFAKNPRLIKTY 107
Query: 371 -YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA-KIADFGLVRLF 421
Y+I+ G+AY H R++HRD+K N+L+D A K+ADFGL R F
Sbjct: 108 LYQIL----RGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153
|
Length = 294 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 36/116 (31%), Positives = 56/116 (48%), Gaps = 14/116 (12%)
Query: 323 NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSW-EVRYKIILSTAEGL 381
++ N +KL T +L+ +++ + L D ++++ LS EV+ KII E L
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD--LLKKE-GKLSEAEVK-KIIRQLVEAL 122
Query: 382 AYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFGLVRLFPEDITHISATLAGTL 436
LH K IIH DIKL N+L D + + D+GL + I + GTL
Sbjct: 123 NDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK-----IIGTPSCYDGTL 170
|
Length = 267 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 47/172 (27%), Positives = 76/172 (44%), Gaps = 33/172 (19%)
Query: 276 KLGQGGSGSVY------------KGTLPGGEA-----VAVKRLFYNTTQWV-DHFFNEVN 317
KLG+G G V+ K A VAVK L + + + F EV
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQ----------DVEPLSW 367
++S ++ N+ +LLG P ++ E++ N L N F+++ + + LS+
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL--NQFLQKHVAETSGLACNSKSLSF 129
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
+ A G+ YL L +HRD+ N L+ + +T KIADFG+ R
Sbjct: 130 STLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 25/46 (54%), Positives = 32/46 (69%), Gaps = 2/46 (4%)
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417
KI ++T + L YL EE L+IIHRD+K SNILLD K+ DFG+
Sbjct: 111 KIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGI 154
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 47/159 (29%), Positives = 79/159 (49%), Gaps = 19/159 (11%)
Query: 276 KLGQGGSGSVYKGT--LPGGEAVAVKRLFYNTTQ--WVDHFFNEVNLISGIN---HKNLV 328
++G+G G V+K GG VA+KR+ T + EV ++ + H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 329 KLLG-CSITGPES----LLVYEFVPNQSLLDNLFVRQDVEP-LSWEVRYKIILSTAEGLA 382
+L C+++ + LV+E V +Q L ++ + EP + E ++ GL
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDL--TTYLDKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
+LH R++HRD+K NIL+ K+ADFGL R++
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 45/152 (29%), Positives = 74/152 (48%), Gaps = 18/152 (11%)
Query: 275 NKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVKLLG 332
KLG+G +V+KG E VA+K + + EV+L+ + H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 333 CSITGPESLLVYEFVPN---QSLLD--NLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
T LV+E++ Q + D N+ +V+ +++ GLAY H
Sbjct: 72 IVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQI--------LRGLAYCH-- 121
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
+ +++HRD+K N+L++E K+ADFGL R
Sbjct: 122 -RRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 43/140 (30%), Positives = 70/140 (50%), Gaps = 20/140 (14%)
Query: 296 VAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKNLVKLLG-CSITGPESLLVYEFVPNQSL 352
VAVK L + T+ + +E+ ++ I HKN++ LLG C+ GP ++V E+ +L
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV-EYASKGNL 108
Query: 353 LDNLFVRQ--------DV-----EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKL 399
+ L R+ D+ E ++++ A G+ YL + + IHRD+
Sbjct: 109 REYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAA 165
Query: 400 SNILLDEEFTAKIADFGLVR 419
N+L+ E KIADFGL R
Sbjct: 166 RNVLVTENNVMKIADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 15/153 (9%)
Query: 277 LGQGGSGSVYKG----TLPGGEA----VAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV 328
LGQG ++KG GE V +K L + + + FF +++S ++HK+LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY-LHEE 387
G + G ES++V E+V SL L +++ +SW+ L A+ LA+ LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK------LEVAKQLAWALHFL 116
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420
+ H ++ N+LL E K + ++L
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKL 149
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 41/141 (29%), Positives = 63/141 (44%), Gaps = 20/141 (14%)
Query: 296 VAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
VAVK L + + + F EV ++S + N+++LLG + ++ E++ N L
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 355 NLFVRQ---------DVEP-------LSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIK 398
L D P +S+ + L A G+ YL S L +HRD+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLA 165
Query: 399 LSNILLDEEFTAKIADFGLVR 419
N L+ E T KIADFG+ R
Sbjct: 166 TRNCLVGENLTIKIADFGMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 4e-08
Identities = 33/95 (34%), Positives = 48/95 (50%), Gaps = 6/95 (6%)
Query: 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSN 401
L+ ++V L +L+ R+ EVR I AE + L +L II+RDIKL N
Sbjct: 82 LILDYVNGGELFTHLYQREHFT--ESEVRVYI----AEIVLALDHLHQLGIIYRDIKLEN 135
Query: 402 ILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
ILLD E + DFGL + F + + + GT+
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTI 170
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 50/157 (31%), Positives = 70/157 (44%), Gaps = 12/157 (7%)
Query: 276 KLGQGGSGSVYKGTLPGG---EAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLL 331
++G G G V G + G V VK L + + Q F E + H NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 332 G-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVR--YKIILSTAEGLAYLHEES 388
G C+ P LLV EF P L L + E ++ + ++ A GL +LH
Sbjct: 62 GQCTEVTP-YLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--- 117
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRL-FPED 424
K IH D+ L N LL + T KI D+GL + ED
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 5e-08
Identities = 38/133 (28%), Positives = 63/133 (47%), Gaps = 12/133 (9%)
Query: 296 VAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL-- 352
VAVK L + + + F E+ ++S + N+++LL IT ++ E++ N L
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 353 ------LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE 406
+ DV +S+ + A G+ YL S L +HRD+ N L+ +
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGK 165
Query: 407 EFTAKIADFGLVR 419
+T KIADFG+ R
Sbjct: 166 NYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 36/152 (23%), Positives = 69/152 (45%), Gaps = 38/152 (25%)
Query: 293 GEAVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350
G+ VA+K++ ++ E+ ++ H N++ + I P
Sbjct: 30 GKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIR--DI----------LRPPG 77
Query: 351 SLLDNLFVRQDV------------EPLSWE-VRYKI--ILSTAEGLAYLHEESKLRIIHR 395
+ +++V D+ +PL+ E +RY + +L GL Y+H + +IHR
Sbjct: 78 ADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLL---RGLKYIHSAN---VIHR 131
Query: 396 DIKLSNILLDEEFTAKIADFGLVRL---FPED 424
D+K SN+L++E+ +I DFG+ R P +
Sbjct: 132 DLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 26/156 (16%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
+G G G V Y L VA+K+L F N T + E+ L+ +NHKN++ L
Sbjct: 25 IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIISL 81
Query: 331 LGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
L T +SL LV E + + +L + + D E +S+ + Y+++ G+ +
Sbjct: 82 LNV-FTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-LLYQMLC----GIKH 134
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
LH IIHRD+K SNI++ + T KI DFGL R
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 7e-08
Identities = 34/106 (32%), Positives = 48/106 (45%), Gaps = 15/106 (14%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLV---YEFVPNQSLLDNLFVRQD-VEPLSWEVR 370
E++++ I+H+ ++ L+ +V Y+ +LF D PL E
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC--------DLFTYVDRSGPLPLEQA 187
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416
I E LAYLH IIHRD+K NI LDE A + DFG
Sbjct: 188 ITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFG 230
|
Length = 392 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 9e-08
Identities = 53/159 (33%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 276 KLGQGGSGSVYKGTLP-GGEAVAVK--RLFYNTTQWVDHFFNEVNLISGI---NHKNLVK 329
++G G G+VYK P G VA+K R+ N EV L+ + +H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 330 LL---GCSITGPES--LLVYEFVPNQSLLDNLFVRQDVEP--LSWEVRYKIILSTAEGLA 382
L+ S T E+ LV+E V +Q L L V P L E ++ GL
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL---DKVPPPGLPAETIKDLMRQFLRGLD 122
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
+LH I+HRD+K NIL+ K+ADFGL R++
Sbjct: 123 FLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 56/162 (34%), Positives = 78/162 (48%), Gaps = 17/162 (10%)
Query: 277 LGQGGSGSVY---KGTLP-GGEAVAVKRLFYNTTQWVDHF--FNEVNLISGINHKNLVKL 330
LGQG G V+ K T P G+ A+K L T + D E ++++ +NH +VKL
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST-AEGLAYLHEESK 389
T + L+ +F+ +LF R E + E K L+ A L +LH
Sbjct: 64 HYAFQTEGKLYLILDFLRG----GDLFTRLSKEVMFTEEDVKFYLAELALALDHLH---S 116
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
L II+RD+K NILLDEE K+ DFGL + E I H
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKA 155
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 45/152 (29%), Positives = 72/152 (47%), Gaps = 18/152 (11%)
Query: 275 NKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVKLLG 332
+KLG+G +VYKG + VA+K + + EV+L+ + H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 333 CSITGPESLLVYEFVPN---QSLLD--NLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
T LV+E++ Q L D N +V+ +++ GL Y H
Sbjct: 72 IIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQL--------LRGLNYCHRR 123
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
+++HRD+K N+L++E K+ADFGL R
Sbjct: 124 ---KVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 1e-07
Identities = 43/162 (26%), Positives = 70/162 (43%), Gaps = 23/162 (14%)
Query: 276 KLGQGGSGSVYKGTL----PGGEA--VAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+LG+G G V+ P + VAVK L + F E L++ + H+++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVR---------QDVEP---LSWEVRYKIILST 377
G + G ++V+E++ + L N F+R + L+ I
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDL--NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
A G+ YL + +HRD+ N L+ E KI DFG+ R
Sbjct: 130 AAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 51/156 (32%), Positives = 79/156 (50%), Gaps = 26/156 (16%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
+G G G V Y L VA+K+L F N T + E+ L+ +NHKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIGL 88
Query: 331 LGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
L T +SL +V E + + +L + + D E +S+ + Y+++ G+ +
Sbjct: 89 LNV-FTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-LLYQMLC----GIKH 141
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
LH IIHRD+K SNI++ + T KI DFGL R
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 42/115 (36%), Positives = 56/115 (48%), Gaps = 11/115 (9%)
Query: 323 NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
NH LV L C T V EFV L+ ++ RQ P Y +S A L
Sbjct: 54 NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM-QRQRKLPEEHARFYSAEISLA--LN 110
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGT 435
+LHE II+RD+KL N+LLD E K+ D+G+ + + P D T +T GT
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGT 159
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-07
Identities = 36/157 (22%), Positives = 61/157 (38%), Gaps = 17/157 (10%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV--KLLGC 333
L G + VY + V +K + + EV ++ + K L K+L
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYV-LK--INPSREKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
+ S L+ E++ ++L + +S E + I AE LA LH+ L +
Sbjct: 62 GESDGWSYLLMEWIEGETL----------DEVSEEEKEDIAEQLAELLAKLHQLPLLVLC 111
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPE--DITHI 428
H D+ NIL+D+ I D+ P D+
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGYGPPAFDLAAA 148
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 12/164 (7%)
Query: 276 KLGQGGSGSVYKGTLPGGEA---VAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLL 331
+LG G G V KG + VA+K L + V D E ++ +++ +V+++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 332 GCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
G + E+L LV E L L ++D +S V +++ + G+ YL ++
Sbjct: 62 G--VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVV--ELMHQVSMGMKYLEGKN-- 115
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG 434
+HRD+ N+LL + AKI+DFGL + D ++ A AG
Sbjct: 116 -FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 49/164 (29%), Positives = 74/164 (45%), Gaps = 26/164 (15%)
Query: 275 NKLGQGGSGSVYKG--TLPGGEAVAVKRLFYN--------TTQWVD----HF--FNEVNL 318
LG+G G V K TL G VA+K++ Q V HF E+ +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKI-VAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST- 377
++ I H+N++ L+ + G LV + + S L + D + E + K IL
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIM--ASDLKKVV---DRKIRLTESQVKCILLQI 128
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
GL LH K +HRD+ +NI ++ + KIADFGL R +
Sbjct: 129 LNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRY 169
|
Length = 335 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 41/162 (25%), Positives = 69/162 (42%), Gaps = 18/162 (11%)
Query: 272 HESNKLGQGGSGSVYKGTLPGGEA------VAVKRLFYNTTQWVDHFFN-EVNLISGINH 324
E LG+G G V+ G E V VK L + + F E+++ ++H
Sbjct: 8 QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSH 67
Query: 325 KNLVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVE------PLSWEVRYKIILST 377
KN+V+LLG C P ++ E+ L L + + PLS + + +
Sbjct: 68 KNVVRLLGLCREAEPH-YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
A G+ +L S R +HRD+ N L+ + K++ L +
Sbjct: 127 ALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 43/161 (26%), Positives = 72/161 (44%), Gaps = 21/161 (13%)
Query: 277 LGQGGSGSVYKGTLP--GGEAVAVKRLFYNTTQWVDH--FFNEVNLISGI-NHKNLVKLL 331
+G+G G V + + G + A ++ DH F E+ ++ + +H N++ LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 332 GCSITGPESLLVYEFVPNQSLLDNL-----------FVRQ--DVEPLSWEVRYKIILSTA 378
G + E+ P +LLD L F ++ L+ + + A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
G+ YL E+ + IHRD+ N+L+ E +KIADFGL R
Sbjct: 130 TGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 47/161 (29%), Positives = 69/161 (42%), Gaps = 21/161 (13%)
Query: 277 LGQGGSGSVYKGTLP--GGEAVAVKRLFYNTTQWVDH--FFNEVNLISGI-NHKNLVKLL 331
+G+G G V K + G A + DH F E+ ++ + +H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 332 GCSITGPESLLVYEFVPNQSLLDNL-----------FVRQ--DVEPLSWEVRYKIILSTA 378
G L E+ P+ +LLD L F LS + A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
G+ YL ++ + IHRD+ NIL+ E + AKIADFGL R
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 26/60 (43%), Positives = 35/60 (58%), Gaps = 8/60 (13%)
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGT 435
A GL +LH + II+RD+KL N++LD E KIADFG+ + +F T T GT
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR---TFCGT 164
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 14/165 (8%)
Query: 276 KLGQGGSGSVYKG---TLPGGEAVAVKRLFY--NTTQWVDHFFNEVNLISGINHKNLVKL 330
+LG G G+V KG + VAVK L N D E N++ +++ +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 331 LGCSITGPES-LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
+G I ES +LV E L N F++++ + +++ + G+ YL E +
Sbjct: 62 IG--ICEAESWMLVMELAELGPL--NKFLQKNKHVTEKNIT-ELVHQVSMGMKYLEETN- 115
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG 434
+HRD+ N+LL + AKI+DFGL + D + A G
Sbjct: 116 --FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 49/167 (29%), Positives = 76/167 (45%), Gaps = 18/167 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISG 321
E+L T+ + +G+G G VYK T ++A ++ + + E N++
Sbjct: 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQS 74
Query: 322 I-NHKNLVKLLGC-----SITGPESLLVYEFVPNQS---LLDNLFVRQDV--EPLSWEVR 370
+ NH N+VK G + G + LV E S L+ L + E + +
Sbjct: 75 LPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYIL 134
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417
Y +L GL +LH RIIHRD+K +NILL E K+ DFG+
Sbjct: 135 YGALL----GLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGV 174
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 50/167 (29%), Positives = 77/167 (46%), Gaps = 28/167 (16%)
Query: 277 LGQGGSGSVYKGTLPGGE--------AVAVKRLFYNTT-QWVDHFFNEVNLISGI-NHKN 326
LG+G G V G + VAVK L + T + + +E+ ++ I HKN
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDV-------------EPLSWEVRYK 372
++ LLG C+ GP +LV E+ +L + L R+ E L+++
Sbjct: 80 IINLLGACTQDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
A G+ YL + + IHRD+ N+L+ E+ KIADFGL R
Sbjct: 139 CAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 43/172 (25%), Positives = 77/172 (44%), Gaps = 13/172 (7%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD-----HFFNEVNLISGINH 324
F K+G+G VY+ T L + VA+K++ + +D E++L+ +NH
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKV--QIFEMMDAKARQDCVKEIDLLKQLNH 61
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVEPLSWEVRYKIILSTAEGLAY 383
N++K L I E +V E L + + ++ + +K + + +
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
+H R++HRDIK +N+ + K+ D GL R F T + +L GT
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 46/167 (27%), Positives = 76/167 (45%), Gaps = 29/167 (17%)
Query: 276 KLGQGGSGSVYKG----TLPG--GEAVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLV 328
+LG+ G VYKG T PG +AVA+K L + + F +E + S + H N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQ---DV-------------EPLSWEVRYK 372
LLG +++ + + L + L +R DV EP +
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF---VH 128
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
I+ A G+ +L S ++H+D+ N+L+ ++ KI+D GL R
Sbjct: 129 IVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 19/166 (11%)
Query: 270 YFHESNKLGQGGSGSV----YKGTLPGGEAVAVKRL--FYNTTQWVDHFFNEVNLISGI- 322
+ +LGQG G V T E VA+K++ ++ E+ L+
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEE-ETVAIKKITNVFSKKILAKRALRELKLLRHFR 59
Query: 323 NHKNLVKLLGCSITGPES---LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYK-IILSTA 378
HKN+ L I P + L +YE + L + +R PL+ + ++ I
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADL--HQIIRSGQ-PLT-DAHFQSFIYQIL 115
Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
GL Y+H + ++HRD+K N+L++ + KI DFGL R F E+
Sbjct: 116 CGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 35/111 (31%), Positives = 58/111 (52%), Gaps = 10/111 (9%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSW 367
V H E ++++ ++ +VKL S L L+ E++P ++ L +++D +
Sbjct: 45 VAHVRAERDILAEADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMM-TLLMKKDT--FTE 100
Query: 368 EV-RYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417
E R+ I AE + + KL IHRDIK N+LLD + K++DFGL
Sbjct: 101 EETRFYI----AETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 44/124 (35%), Positives = 58/124 (46%), Gaps = 16/124 (12%)
Query: 308 WVD---HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP 364
WV H F + + NH LV L C T V E+V L+ ++ RQ P
Sbjct: 41 WVQTEKHVFEQAS-----NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLP 94
Query: 365 LSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFP 422
Y +S A L YLHE II+RD+KL N+LLD E K+ D+G+ + L P
Sbjct: 95 EEHARFYSAEISLA--LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 149
Query: 423 EDIT 426
D T
Sbjct: 150 GDTT 153
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 5e-07
Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 17/162 (10%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVKLLGCS 334
LG G G+VYK L +AVK + + T + +E+ ++ + ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
+ EF+ SL DV + V +I ++ +GL YL L+I+
Sbjct: 69 FVENRISICTEFMDGGSL--------DVYRKIPEHVLGRIAVAVVKGLTYLW---SLKIL 117
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
HRD+K SN+L++ K+ DFG+ + I+ T GT
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTYVGT 156
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 45/165 (27%), Positives = 69/165 (41%), Gaps = 26/165 (15%)
Query: 276 KLGQGGSGSVYKGTL----PGGEA--VAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+LG+G G V+ P + VAVK L T F E L++ + H+++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQ---------DVEP------LSWEVRYKII 374
G G ++V+E++ + L N F+R D +P L I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDL--NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
A G+ YL + +HRD+ N L+ KI DFG+ R
Sbjct: 130 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 6e-07
Identities = 44/159 (27%), Positives = 74/159 (46%), Gaps = 19/159 (11%)
Query: 271 FHESNKLGQGGSGSV-YKGTLPGGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNL 327
+ + ++G G G+V G VA+K+L+ + + + + E+ L+ + H+N+
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76
Query: 328 VKLLGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEG 380
+ LL T SL LV F+ +L E LS + ++ +G
Sbjct: 77 IGLLDV-FTPDLSLDRFHDFYLVMPFMGT-----DLGKLMKHEKLSEDRIQFLVYQMLKG 130
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
L Y+H IIHRD+K N+ ++E+ KI DFGL R
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 7e-07
Identities = 46/149 (30%), Positives = 68/149 (45%), Gaps = 13/149 (8%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH-KNLVKLLGCS 334
+G G G VYKG + G+ A+K + T + E+N++ +H +N+ G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 335 IT-GPESL-----LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
I P + LV EF S+ D L L E I GL++LH+
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHLHQH- 130
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGL 417
++IHRDIK N+LL E K+ DFG+
Sbjct: 131 --KVIHRDIKGQNVLLTENAEVKLVDFGV 157
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 50/175 (28%), Positives = 80/175 (45%), Gaps = 19/175 (10%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL----FYNTTQWVDHFFNEVNLISGINHK 325
F K+G+G VY+ T L G VA+K++ + D E++L+ +NH
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARAD-CIKEIDLLKQLNHP 62
Query: 326 NLVKLLGCSITGPESLLVYEFVP--NQSLLDNLFVRQD---VEPLSWEVRYKIILSTAEG 380
N++K I E +V E + S + F +Q E W +Y + L +A
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW--KYFVQLCSA-- 118
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
L ++H R++HRDIK +N+ + K+ D GL R F T + +L GT
Sbjct: 119 LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 44/175 (25%), Positives = 75/175 (42%), Gaps = 21/175 (12%)
Query: 271 FHESNKLGQGGSGSVY--KGTLPGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKN 326
+ K+G+G G +Y K V +K + + + EV L++ + H N
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV-----EPLSWEVRYKIILSTAEGL 381
+V +V E+ L+ + ++ V + LSW V+ + GL
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GL 114
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFPEDITHISATLAGT 435
++H+ +I+HRDIK NI L + AK+ DFG+ R D ++ T GT
Sbjct: 115 KHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGT 165
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 38/116 (32%), Positives = 57/116 (49%), Gaps = 13/116 (11%)
Query: 323 NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVEPLSWEVRYKIILSTAEGL 381
NH L +L C T V EFV L+ ++ R+ E + +I L
Sbjct: 54 NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIT----SAL 109
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGT 435
+LH++ II+RD+KL N+LLD E K+ADFG+ + E I + ++T GT
Sbjct: 110 MFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 50/189 (26%), Positives = 82/189 (43%), Gaps = 37/189 (19%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
+T+ + + + +G G GSV G VAVK+L + + + E+ L
Sbjct: 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 69
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL----------------LDNLFVRQDV 362
+ + H+N++ LL F P +SL L+N+ Q +
Sbjct: 70 LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 117
Query: 363 EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422
V++ +I GL Y+H IIHRD+K SN+ ++E+ KI DFGL R
Sbjct: 118 T--DDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD 171
Query: 423 EDITHISAT 431
+++T AT
Sbjct: 172 DEMTGYVAT 180
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 41/150 (27%), Positives = 59/150 (39%), Gaps = 22/150 (14%)
Query: 277 LGQGGSGSVYKGTL-PGGEAVAVKRL-----FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
LG GG G V + A+K + Q +H F+E ++ NH +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ--EHIFSEKEILEECNHPFIVKL 58
Query: 331 LGCSITGPESLLVY---EFVPNQSLLDNLFVRQDVEPLS-WEVRYKIILSTAEGLAYLHE 386
T + +Y E+ L L +D + R+ I YLH
Sbjct: 59 YR---TFKDKKYIYMLMEYCLGGELWTIL---RDRGLFDEYTARF-YIACVVLAFEYLHN 111
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFG 416
II+RD+K N+LLD K+ DFG
Sbjct: 112 RG---IIYRDLKPENLLLDSNGYVKLVDFG 138
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 34/98 (34%), Positives = 53/98 (54%), Gaps = 12/98 (12%)
Query: 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRY---KIILSTAEGLAYLHEESKLRIIHRDIK 398
L+ ++V + +L+ R + EVR+ +IIL+ L +LH KL I++RDIK
Sbjct: 82 LILDYVSGGEMFTHLYQRDNFS--EDEVRFYSGEIILA----LEHLH---KLGIVYRDIK 132
Query: 399 LSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
L NILLD E + DFGL + F + + + GT+
Sbjct: 133 LENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTI 170
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 27/96 (28%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY 371
FF +++ ++HK++V L G + E+++V EFV L +LF+ + + L+ ++
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL--DLFMHRKSDVLTTPWKF 108
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE 407
K+ A L+YL ++ ++H ++ NILL E
Sbjct: 109 KVAKQLASALSYLEDK---DLVHGNVCTKNILLARE 141
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 7/149 (4%)
Query: 271 FHESNKLGQGGSGSVYK-GTLPGGEAVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLV 328
F ++LG G G V K P G +A K + + + E+ ++ N +V
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
G + E + E + SL V ++ + + E+ K+ ++ GLAYL E
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQ---VLKEAKRIPEEILGKVSIAVLRGLAYLRE-- 121
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGL 417
K +I+HRD+K SNIL++ K+ DFG+
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGV 150
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 51/164 (31%), Positives = 78/164 (47%), Gaps = 17/164 (10%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKLL 331
+G G GSV Y L + VAVK+L + + + E+ L+ + H+N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 332 GC---SITGPESLLVYEFVPNQSLLD-NLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
+ + VY V N D N V+ + LS E +I GL Y+H
Sbjct: 81 DVFTPATSIENFNEVY-LVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSA 137
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
IIHRD+K SN+ ++E+ +I DFGL R +++T AT
Sbjct: 138 G---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVAT 178
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 31/121 (25%), Positives = 58/121 (47%), Gaps = 8/121 (6%)
Query: 304 NTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV---YEFVPNQSLLDNLFVRQ 360
++ NE+ + +NH+N++K+ + + ++ Y+F + D F +
Sbjct: 202 AGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWK 261
Query: 361 DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420
D PL + R I+ + Y+H++ ++IHRDIKL NI L+ + + DFG
Sbjct: 262 D-RPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMP 316
Query: 421 F 421
F
Sbjct: 317 F 317
|
Length = 501 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 45/157 (28%), Positives = 78/157 (49%), Gaps = 23/157 (14%)
Query: 277 LGQGGSGSVYKGTL----------PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN 326
LGQG ++YKG L PG E V ++ + + FF +L+S ++HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
LVKL G + E+++V E+V L ++F+ ++ +S + + A L YL E
Sbjct: 63 LVKLYGVCVR-DENIMVEEYVKFGPL--DVFLHREKNNVSLHWKLDVAKQLASALHYL-E 118
Query: 387 ESKLRIIHRDIKLSNILL-----DEEFT--AKIADFG 416
+ KL +H ++ NIL+ +E + K++D G
Sbjct: 119 DKKL--VHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 36/100 (36%), Positives = 52/100 (52%), Gaps = 16/100 (16%)
Query: 342 LVYEFVPNQSLLDNL-----FVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRD 396
L+ +++ L +L F Q+V+ S E I+L+ L +LH KL II+RD
Sbjct: 82 LILDYINGGELFTHLSQRERFKEQEVQIYSGE----IVLA----LEHLH---KLGIIYRD 130
Query: 397 IKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
IKL NILLD + DFGL + F ED + + GT+
Sbjct: 131 IKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTI 170
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 22/154 (14%)
Query: 277 LGQGGSGSVYK-GTLPGGEAVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
+G+G G V+K G AVK L ++ + ++ +N + +S +H N+VK G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS--DHPNVVKFYGM 83
Query: 334 -----SITGPESLLVYEFVPNQSLLD---NLFVRQD--VEPLSWEVRYKIILSTAEGLAY 383
G + LV E S+ D R + EP+ + ++ ++ GL +
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM----GLQH 139
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417
LH + IHRD+K +NILL E K+ DFG+
Sbjct: 140 LHVN---KTIHRDVKGNNILLTTEGGVKLVDFGV 170
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 30/144 (20%), Positives = 51/144 (35%), Gaps = 13/144 (9%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+ K P VAVK++ ++ + + E+ + H N++ +
Sbjct: 10 FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 335 ITGPESLLVYEFVPNQS---LLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
I E +V + S LL F E L I+ L Y+H
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFP----EGLPELAIAFILKDVLNALDYIH---SKG 121
Query: 392 IIHRDIKLSNILLDEEFTAKIADF 415
IHR +K S+ILL + ++
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 5e-06
Identities = 22/57 (38%), Positives = 32/57 (56%), Gaps = 8/57 (14%)
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGT 435
L YLH +++RD+KL N++LD++ KI DFGL + E I+ T GT
Sbjct: 108 LGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGT 158
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 21/45 (46%), Positives = 29/45 (64%), Gaps = 2/45 (4%)
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416
KI ++ GL YL E K +I+HRD+K SNIL++ K+ DFG
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFG 145
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 34/127 (26%), Positives = 54/127 (42%), Gaps = 10/127 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWE 368
H NE ++ ++H +++L ++ E+VP L L +
Sbjct: 45 EQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGL 104
Query: 369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428
I+ E YLH I++RD+K NILLD+E K+ DFG F + +
Sbjct: 105 FYASEIVCALE---YLHS---KEIVYRDLKPENILLDKEGHIKLTDFG----FAKKLRDR 154
Query: 429 SATLAGT 435
+ TL GT
Sbjct: 155 TWTLCGT 161
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 41/149 (27%), Positives = 72/149 (48%), Gaps = 7/149 (4%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLV 328
F + ++LG G G V+K + P G +A K + + + E+ ++ N +V
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
G + E + E + SL D + + P ++ K+ ++ +GL YL E+
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIP--EQILGKVSIAVIKGLTYLREKH 123
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGL 417
K I+HRD+K SNIL++ K+ DFG+
Sbjct: 124 K--IMHRDVKPSNILVNSRGEIKLCDFGV 150
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 9e-06
Identities = 49/171 (28%), Positives = 76/171 (44%), Gaps = 21/171 (12%)
Query: 277 LGQGGSGSVYK-----GTLPG---GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV 328
LG+GG G V++ G G V K + H E N++ + H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS-TAEGLAYLHEE 387
L+ TG + L+ E++ LF+ + E + E LS + L +LH
Sbjct: 64 DLIYAFQTGGKLYLILEYLSG----GELFMHLEREGIFMEDTACFYLSEISLALEHLH-- 117
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGTL 436
+ II+RD+K NILLD + K+ DFGL + + +TH T GT+
Sbjct: 118 -QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH---TFCGTI 164
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 9e-06
Identities = 50/178 (28%), Positives = 77/178 (43%), Gaps = 32/178 (17%)
Query: 271 FHESNKLGQGGSGSV----YKGTLPGGEAVAVKRLFYNTT---QWVDHFFNEVNLISGIN 323
F LG G G V +KGT GE A+K L + V H E +++ ++
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 324 HKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNL-----FVRQDVEPLSWEVRYKIILST 377
H +V ++ CS + + EFV L +L F + E+ +L+
Sbjct: 77 HPFIVNMM-CSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAEL----VLA- 130
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
YLH + II+RD+K N+LLD + K+ DFG F + + + TL GT
Sbjct: 131 ---FEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFG----FAKKVPDRTFTLCGT 178
|
Length = 329 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 40/149 (26%), Positives = 65/149 (43%), Gaps = 44/149 (29%)
Query: 293 GEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES-------LL 342
E VA+K++ F N E+ L+ ++H+N++ + I P +
Sbjct: 30 NEKVAIKKIANAFDNRID-AKRTLREIKLLRHLDHENVIAIK--DIMPPPHREAFNDVYI 86
Query: 343 VYEFV---------PNQSLLDN---LFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
VYE + +Q+L D+ F+ Q +L GL Y+H +
Sbjct: 87 VYELMDTDLHQIIRSSQTLSDDHCQYFLYQ-------------LL---RGLKYIHSAN-- 128
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVR 419
++HRD+K SN+LL+ KI DFGL R
Sbjct: 129 -VLHRDLKPSNLLLNANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 36/106 (33%), Positives = 56/106 (52%), Gaps = 9/106 (8%)
Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVR 370
F+ E ++++ N +V+L C+ + L +V E++P L+ NL DV P W
Sbjct: 90 FWEERDIMAFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLV-NLMSNYDV-PEKWAKF 146
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416
Y TAE + L + +IHRD+K N+LLD+ K+ADFG
Sbjct: 147 Y-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 13/149 (8%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH-KNLVKLLGCS 334
+G G G VYKG + G+ A+K + T + E+N++ +H +N+ G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 335 ITGP------ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
I + LV EF S+ D L L + I GLA+LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALKEDWIAYICREILRGLAHLHAH- 140
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGL 417
++IHRDIK N+LL E K+ DFG+
Sbjct: 141 --KVIHRDIKGQNVLLTENAEVKLVDFGV 167
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 20/41 (48%), Positives = 30/41 (73%), Gaps = 3/41 (7%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420
GL +LH++ II+RD+KL N+LLD++ KIADFG+ +
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKE 145
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 23/56 (41%), Positives = 30/56 (53%), Gaps = 5/56 (8%)
Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
P W +Y I G+ LH+ IIHRDIK N+L+D+ K+ DFGL R
Sbjct: 95 PEDWAKQY--IAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSR 145
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 45/157 (28%), Positives = 77/157 (49%), Gaps = 26/157 (16%)
Query: 275 NKLGQGGSGSVYKG-TLPGGEAVAVKRL--FYNTTQWVDHFFNEVNLISGIN-HKNLVKL 330
K+G+G V K + G+ A+K + + + + V++ E+ + ++ H N+++L
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRL 63
Query: 331 LGC---SITGPESL-LVYEFVPNQSLLD-NLF--VRQDVEPLSWEVRYK-IILSTAEGLA 382
+ TG L LV+E L+D NL+ ++ PL E R K + + L
Sbjct: 64 IEVLFDRKTG--RLALVFE------LMDMNLYELIKGRKRPLP-EKRVKSYMYQLLKSLD 114
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
++H I HRDIK NIL+ ++ K+ADFG R
Sbjct: 115 HMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 55/196 (28%), Positives = 86/196 (43%), Gaps = 25/196 (12%)
Query: 252 VNKSKLNFSYETLEKATNYFHES----NKLGQGGSGSVYKGTLPGGE--AVAVKRLFYNT 305
++K K + S + ++ +E LG G G V T + VA+KR +
Sbjct: 9 LHKKKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSK 68
Query: 306 ---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV 362
+ VDH F+E +++ INH V L G LV EFV F+R++
Sbjct: 69 IIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFT--FLRRNK 126
Query: 363 E-PLSWEVRY--KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
P Y +I+L YL L I++RD+K N+LLD++ K+ DFG +
Sbjct: 127 RFPNDVGCFYAAQIVLI----FEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAK 179
Query: 420 LFPEDITHISATLAGT 435
+ + + TL GT
Sbjct: 180 V----VDTRTYTLCGT 191
|
Length = 340 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 32/107 (29%), Positives = 54/107 (50%), Gaps = 9/107 (8%)
Query: 314 NEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI 373
NE ++ ++H N+++ + ++V E+ P +L + ++++ L E
Sbjct: 48 NECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAE--YIQKRCNSLLDE---DT 102
Query: 374 ILS--TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT-AKIADFGL 417
IL LA H +KL I+HRD+K NILLD+ KI DFG+
Sbjct: 103 ILHFFVQILLALHHVHTKL-ILHRDLKTQNILLDKHKMVVKIGDFGI 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 39/111 (35%), Positives = 54/111 (48%), Gaps = 11/111 (9%)
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
LV L C T LV E+V L+ ++ RQ P Y + A L +LHE
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHM-QRQRKLPEEHARFYAAEICIA--LNFLHE 114
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGT 435
II+RD+KL N+LLD + K+ D+G+ + L P D T +T GT
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGT 159
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 20/42 (47%), Positives = 28/42 (66%), Gaps = 3/42 (7%)
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
+ GL +LH II+RD+KL N++LD E KIADFG+ +
Sbjct: 111 SVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 20/40 (50%), Positives = 28/40 (70%), Gaps = 3/40 (7%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
GL +LH + I++RD+KL NILLD + KIADFG+ +
Sbjct: 108 GLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 22/47 (46%), Positives = 29/47 (61%), Gaps = 3/47 (6%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426
GL LH+E RI++RD+K NILLD+ +I+D GL PE T
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 6e-05
Identities = 24/57 (42%), Positives = 33/57 (57%), Gaps = 8/57 (14%)
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGT 435
L +LH +I+RD+KL NILLD E K+ADFG+ + E I + + T GT
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGT 159
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 8e-05
Identities = 26/60 (43%), Positives = 33/60 (55%), Gaps = 8/60 (13%)
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGT 435
A L YLH L II+RD+K NILLD + + DFGL + E I H ++T GT
Sbjct: 106 ASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 9e-05
Identities = 22/58 (37%), Positives = 33/58 (56%), Gaps = 4/58 (6%)
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
A L YLHE+ I+HRD+K N+ L K+ D G+ R+ E+ +++TL GT
Sbjct: 112 AMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMASTLIGT 165
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 28/76 (36%), Positives = 42/76 (55%), Gaps = 6/76 (7%)
Query: 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSN 401
L+ EF+P ++ L +++D LS E I T + +H+ L IHRDIK N
Sbjct: 78 LIMEFLPGGDMM-TLLMKKDT--LSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDN 131
Query: 402 ILLDEEFTAKIADFGL 417
+LLD + K++DFGL
Sbjct: 132 LLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 21/42 (50%), Positives = 29/42 (69%), Gaps = 3/42 (7%)
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
A GL +LH + II+RD+KL N++LD E KIADFG+ +
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 42/147 (28%), Positives = 74/147 (50%), Gaps = 8/147 (5%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKNLVKLL 331
++LG+G GSVYK P G +A+K RL + +++ + E++++ +V
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKF-NQIIMELDILHKAVSPYIVDFY 65
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFV-RQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
G + E++ SL D L+ E + +V +I + +GL +L EE
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--H 122
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGL 417
IIHRD+K +N+L++ K+ DFG+
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGV 149
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 22/52 (42%), Positives = 32/52 (61%), Gaps = 6/52 (11%)
Query: 371 YKIILSTAE---GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
Y+ AE GL +LH + II+RD+KL N++LD + KIADFG+ +
Sbjct: 96 YRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 19/55 (34%), Positives = 30/55 (54%), Gaps = 6/55 (10%)
Query: 372 KIILSTAE---GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
+ I A+ GL +LH+ RI++RD+K N+LLD+ +I+D GL
Sbjct: 96 RAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG 147
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 29/78 (37%), Positives = 40/78 (51%), Gaps = 13/78 (16%)
Query: 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYLHEESKLRIIHRDIK 398
+V E++P L+ NL D+ P W Y TAE L +H + IHRD+K
Sbjct: 120 MVMEYMPGGDLV-NLMSNYDI-PEKWARFY-----TAEVVLALDAIH---SMGFIHRDVK 169
Query: 399 LSNILLDEEFTAKIADFG 416
N+LLD+ K+ADFG
Sbjct: 170 PDNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 27/76 (35%), Positives = 42/76 (55%), Gaps = 6/76 (7%)
Query: 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSN 401
L+ EF+P ++ L +++D L+ E I T + +H+ L IHRDIK N
Sbjct: 78 LIMEFLPGGDMM-TLLMKKDT--LTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDN 131
Query: 402 ILLDEEFTAKIADFGL 417
+LLD + K++DFGL
Sbjct: 132 LLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 22/53 (41%), Positives = 29/53 (54%), Gaps = 3/53 (5%)
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420
E+ K I A L YLH IIHRD+K N+L+ E K+ DFGL ++
Sbjct: 104 EMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 44/170 (25%), Positives = 72/170 (42%), Gaps = 18/170 (10%)
Query: 276 KLGQGGSGSVY---------KGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN 326
+LG+G G+VY + L + + V L N T E L+S ++H
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETV---QANQEAQLLSKLDHPA 63
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSWEVRYKIILSTAEGLAYLH 385
+VK + ++ E+ + L L ++ + LS + + G+ Y+H
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
+ RI+HRD+K NI L KI DFG+ RL ++ T GT
Sbjct: 124 QR---RILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGS-CDLATTFTGT 168
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 28/77 (36%), Positives = 42/77 (54%), Gaps = 8/77 (10%)
Query: 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEV-RYKIILSTAEGLAYLHEESKLRIIHRDIKLS 400
L+ EF+P L+ + ++ D S +V R+ + AE + + KL IHRDIK
Sbjct: 78 LIMEFLPGGDLM-TMLIKYDT--FSEDVTRFYM----AECVLAIEAVHKLGFIHRDIKPD 130
Query: 401 NILLDEEFTAKIADFGL 417
NIL+D K++DFGL
Sbjct: 131 NILIDRGGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 34/105 (32%), Positives = 51/105 (48%), Gaps = 7/105 (6%)
Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY 371
F+ E ++++ N +V+L +V E++P L+ NL DV P W Y
Sbjct: 90 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDV-PEKWARFY 147
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416
TAE + L + IHRD+K N+LLD+ K+ADFG
Sbjct: 148 -----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 28/94 (29%), Positives = 42/94 (44%), Gaps = 11/94 (11%)
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVE------PLSWEVRYKIILSTAEGLAYLH 385
G S G ++ + E P S +D E PL + + A+G+ +L
Sbjct: 172 GFSSQGSDTYV--EMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA 229
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
++ IHRD+ N+LL + AKI DFGL R
Sbjct: 230 SKN---CIHRDVAARNVLLTDGRVAKICDFGLAR 260
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 30/123 (24%), Positives = 57/123 (46%), Gaps = 7/123 (5%)
Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY 371
F E + +H N+V+L G G ++V E++ N +L + F+R+ L
Sbjct: 53 FLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGAL--DSFLRKHEGQLVAGQLM 110
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
++ A G+ YL E + +H+ + +L++ + KI+ F RL + I T
Sbjct: 111 GMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTT 165
Query: 432 LAG 434
++G
Sbjct: 166 MSG 168
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 37/155 (23%), Positives = 73/155 (47%), Gaps = 34/155 (21%)
Query: 277 LGQGGSGSVYKGTL---PGGEAVAVKRLFYNTTQWVDH---------------------- 311
LGQG ++Y G L GGE + + ++
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62
Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVE--PLSWEV 369
FF +L+S ++H +L + G + G E+++V EFV + L ++ +R++ P++W++
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL--DVCLRKEKGRVPVAWKI 120
Query: 370 RYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL 404
L++A L+YL +++ ++H ++ NILL
Sbjct: 121 TVAQQLASA--LSYLEDKN---LVHGNVCAKNILL 150
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 36/150 (24%), Positives = 68/150 (45%), Gaps = 14/150 (9%)
Query: 276 KLGQGGSGSVYKGTL---PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLL 331
++G G G V + G V VK L N +++ + F + + + H N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 332 GCSITGPESLLVYEFVPNQSLLDNL----FVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
G + LLV+E+ L L + R++ + L + ++ A G+ ++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAAGVTHMH-- 116
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGL 417
K +H D+ L N L + T K+ D+G+
Sbjct: 117 -KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 25/60 (41%), Positives = 34/60 (56%), Gaps = 8/60 (13%)
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGT 435
A + YLH L II+RD+K NILLD + + DFGL + + PE+ T +T GT
Sbjct: 106 ASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT---STFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 6e-04
Identities = 18/40 (45%), Positives = 27/40 (67%), Gaps = 2/40 (5%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
L YLH E +++RD+KL N++LD++ KI DFGL +
Sbjct: 107 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 22/56 (39%), Positives = 31/56 (55%), Gaps = 2/56 (3%)
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT-HISATLAGT 435
LA H SK +IHRDIK +NILL K+ DFG +++ ++ + T GT
Sbjct: 154 LAVHHVHSK-HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGT 208
|
Length = 496 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 8e-04
Identities = 44/177 (24%), Positives = 67/177 (37%), Gaps = 48/177 (27%)
Query: 275 NKLGQGGSGSVYKGTL-----PGGEAVAVKRLFYNTTQW--VDHFFNE----------VN 317
KLG+G G VYK +L +K+ T++ V+ + NE +
Sbjct: 138 KKLGEGAFGVVYKASLVNKQSKKEGKYVLKK----ATEYGAVEIWMNERVRRACPNSCAD 193
Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQ---DVEP-LSWEV---- 369
+ G K E LV+ + +L D + ++ +VEP L +V
Sbjct: 194 FVYGFLEPVSSK------KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247
Query: 370 ----RYKIILSTA-----EGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFG 416
R I+ T L LH I+HRD+K NI+ E + KI D G
Sbjct: 248 KGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLG 301
|
Length = 566 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 8e-04
Identities = 21/44 (47%), Positives = 27/44 (61%), Gaps = 3/44 (6%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
GL LH E RI++RD+K NILLD+ +I+D GL PE
Sbjct: 114 GLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 8e-04
Identities = 37/124 (29%), Positives = 62/124 (50%), Gaps = 9/124 (7%)
Query: 299 KRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLF 357
K+ N Q V H E ++++ +++ +VKL S ++L V +++P ++ +L
Sbjct: 36 KKDVLNRNQ-VAHVKAERDILAEADNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMM-SLL 92
Query: 358 VRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417
+R +V P Y L+ A + K+ IHRDIK NIL+D + K+ DFGL
Sbjct: 93 IRMEVFPEVLARFYIAELTLA-----IESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGL 147
Query: 418 VRLF 421
F
Sbjct: 148 CTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 8e-04
Identities = 36/111 (32%), Positives = 50/111 (45%), Gaps = 9/111 (8%)
Query: 311 HFFNEVN-LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEV 369
H E N L+ + H LV L T + V +FV L +L R+ P E
Sbjct: 41 HIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHL-QRERSFP---EP 96
Query: 370 RYKI-ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
R + A L YLH + I++RD+K NILLD + + DFGL +
Sbjct: 97 RARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 18/39 (46%), Positives = 26/39 (66%), Gaps = 3/39 (7%)
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
L YLH +++RDIKL N++LD++ KI DFGL +
Sbjct: 108 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 23/75 (30%), Positives = 37/75 (49%), Gaps = 6/75 (8%)
Query: 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNI 402
V +++P ++ +L +R + Y I + +H K+ IHRDIK NI
Sbjct: 79 VMDYIPGGDMM-SLLIRLGIFEEDLARFY--IAELTCAIESVH---KMGFIHRDIKPDNI 132
Query: 403 LLDEEFTAKIADFGL 417
L+D + K+ DFGL
Sbjct: 133 LIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 25/60 (41%), Positives = 34/60 (56%), Gaps = 8/60 (13%)
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGT 435
A L YLH L I++RD+K NILLD + + DFGL + E+I H ++T GT
Sbjct: 106 ASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 23/57 (40%), Positives = 29/57 (50%), Gaps = 3/57 (5%)
Query: 363 EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
EPL+ E A G+ +L + + IHRD+ NILL E KI DFGL R
Sbjct: 168 EPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 18/38 (47%), Positives = 26/38 (68%), Gaps = 3/38 (7%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417
GL +LH+ RII+RD+K N+LLD + +I+D GL
Sbjct: 109 GLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGL 143
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 33/96 (34%), Positives = 45/96 (46%), Gaps = 18/96 (18%)
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS----------TAEGLAY 383
SIT +S FV +SL D V ++ E YK +L+ A+G+ +
Sbjct: 140 SITSSQSSASSGFVEEKSLSD---VEEEEAE--QEDLYKKVLTLEDLICYSFQVAKGMEF 194
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
L + + IHRD+ NILL E KI DFGL R
Sbjct: 195 L---ASRKCIHRDLAARNILLSENNVVKICDFGLAR 227
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 22/51 (43%), Positives = 26/51 (50%), Gaps = 4/51 (7%)
Query: 376 STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426
S + YLHE RIIHRDIK NI ++ + DFG FP DI
Sbjct: 190 SVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDIN 236
|
Length = 391 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 25/80 (31%), Positives = 38/80 (47%), Gaps = 6/80 (7%)
Query: 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSN 401
V +++P ++ +L +R + P Y AE + K+ IHRDIK N
Sbjct: 78 FVMDYIPGGDMM-SLLIRMGIFPEDLARFY-----IAELTCAVESVHKMGFIHRDIKPDN 131
Query: 402 ILLDEEFTAKIADFGLVRLF 421
IL+D + K+ DFGL F
Sbjct: 132 ILIDRDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 21/56 (37%), Positives = 31/56 (55%), Gaps = 4/56 (7%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
G+ ++HE+ R++HRDIK NI L + K+ DFG RL + + T GT
Sbjct: 112 GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY-ACTYVGT 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
AE + +H +L +HRDIK N+LLD ++ADFG +D T S+ GT
Sbjct: 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGT 166
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 20/44 (45%), Positives = 26/44 (59%), Gaps = 3/44 (6%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
GL L E RI++RD+K NILLD+ +I+D GL PE
Sbjct: 114 GLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 39/130 (30%), Positives = 54/130 (41%), Gaps = 13/130 (10%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWE 368
V H E ++ H L L T V E+V LF E + E
Sbjct: 39 VAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG----GELFFHLSRERVFSE 94
Query: 369 VRYKII-LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
R + L YLH +I++RD+KL N++LD++ KI DFGL + E IT
Sbjct: 95 DRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK---EGITD 148
Query: 428 ISA--TLAGT 435
+ T GT
Sbjct: 149 AATMKTFCGT 158
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 19/44 (43%), Positives = 26/44 (59%), Gaps = 3/44 (6%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
GL LH E+ ++RD+K NILLD+ +I+D GL PE
Sbjct: 114 GLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPE 154
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 17/42 (40%), Positives = 27/42 (64%), Gaps = 3/42 (7%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
L ++H+ +I+HRDIK NI L ++ T K+ DFG+ R+
Sbjct: 113 ALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 22/56 (39%), Positives = 28/56 (50%), Gaps = 3/56 (5%)
Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
PL+ E A G+ +L + + IHRD+ NILL E KI DFGL R
Sbjct: 170 PLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR 222
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 41/128 (32%), Positives = 57/128 (44%), Gaps = 9/128 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSW 367
V H E +++ +N +V L S PE L LV F+ L +L E
Sbjct: 37 VTHTLAERTVLAQVNCPFIVPL-KFSFQSPEKLYLVLAFINGGELFHHL----QREGRFD 91
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
R + TAE L L K +I+RD+K NILLD + + DFGL +L +D
Sbjct: 92 LSRAR--FYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DD 148
Query: 428 ISATLAGT 435
+ T GT
Sbjct: 149 KTNTFCGT 156
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 20/57 (35%), Positives = 31/57 (54%), Gaps = 3/57 (5%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
GL ++H +++RD+K +NILLDE +I+D GL F + H S G +
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYM 162
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.004
Identities = 17/40 (42%), Positives = 23/40 (57%), Gaps = 3/40 (7%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
L Y+H + + HRD+K NIL + + KI DFGL R
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 437 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.98 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.97 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.97 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.97 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.97 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.97 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.97 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.96 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.96 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.96 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.96 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.96 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.95 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.95 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.95 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.95 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.95 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.95 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.95 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.95 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.95 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.94 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.94 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.94 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.94 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.94 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.94 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.94 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.94 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.94 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.94 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.94 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.93 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.93 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.93 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.93 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.93 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.93 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.93 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.93 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.93 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.93 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.93 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.93 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.93 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.93 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.93 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.93 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.93 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.93 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.93 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.93 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.93 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.93 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.93 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.93 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.93 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.93 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.93 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.93 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.93 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.93 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.92 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.92 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.92 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.92 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.92 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.92 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.92 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.92 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.92 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.92 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.92 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.92 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.92 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.92 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.92 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.92 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.92 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.92 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.92 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.92 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.92 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.92 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.92 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.91 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.91 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.91 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.91 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.91 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.91 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.91 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.91 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.91 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.91 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.91 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.91 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.91 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.91 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.91 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.91 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.91 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.91 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.91 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.91 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.91 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.91 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.91 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.91 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.91 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.91 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.91 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.91 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.91 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.91 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.91 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.91 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.91 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.91 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.91 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.91 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.91 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.91 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.91 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.91 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.9 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.9 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.9 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.9 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.9 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.9 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.9 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.9 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.9 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.9 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.9 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.9 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.9 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.9 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.9 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.9 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.9 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.9 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.9 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.9 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.9 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.9 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.9 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.9 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.9 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.9 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.9 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.9 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.9 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.9 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.9 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.9 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.9 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.9 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.9 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.9 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.89 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.89 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.89 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.89 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.89 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.89 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.89 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.89 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.89 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.89 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.89 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.89 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.89 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.89 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.89 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.89 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.89 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.89 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.89 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.89 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.89 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.89 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.89 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.89 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.89 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.89 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.89 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.89 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.89 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.89 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.89 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.89 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.89 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.89 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.89 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.89 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.89 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.88 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.88 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.88 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.88 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.88 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.88 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.88 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.88 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.88 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.88 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.88 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.88 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.88 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.88 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.88 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.88 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.88 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.88 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.88 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.87 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.87 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.87 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.87 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.87 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.87 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.87 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.87 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.87 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.87 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.87 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.87 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.87 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.87 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.87 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.87 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.86 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.86 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.86 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.86 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.86 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.86 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.86 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.86 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.86 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.86 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.86 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.86 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.86 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.86 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.86 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.86 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.85 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.85 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.85 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.85 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.85 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.85 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.85 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.85 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.85 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.85 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.85 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.85 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.85 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.85 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.84 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.84 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.84 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.84 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.84 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.84 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.83 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.83 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.83 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.82 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.82 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.82 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.81 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.81 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.8 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.77 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.76 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.75 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.74 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.74 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.73 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.71 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.71 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.71 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.7 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.68 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.66 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.64 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.58 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.58 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.44 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.43 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.35 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.34 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.34 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.3 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.29 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.28 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.24 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.18 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.08 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.06 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.05 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.02 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.0 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.93 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.92 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.85 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.83 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.72 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.71 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.65 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.59 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.58 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.55 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.55 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.53 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.47 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.45 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.44 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.37 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.33 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.32 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.28 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.26 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.25 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.21 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.09 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.06 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.87 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.86 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.84 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.81 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.66 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.58 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.56 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.41 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.38 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.37 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.27 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.25 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 97.16 | |
| PLN02236 | 344 | choline kinase | 97.15 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.12 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.76 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.76 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.7 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 96.66 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.35 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.22 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.07 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.03 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.96 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.79 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 95.78 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.68 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.56 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.45 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.15 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.12 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 94.57 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.64 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 92.92 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 92.52 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=301.60 Aligned_cols=168 Identities=57% Similarity=0.869 Sum_probs=154.3
Q ss_pred cccccCHHHHHHHhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEE
Q 013737 255 SKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334 (437)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 334 (437)
....|++.+++.+|++|...+.||+|+||.||+|.++++..||||++.....+...+|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999988765433145699999999999999999999999
Q ss_pred eeCC-eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 013737 335 ITGP-ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIA 413 (437)
Q Consensus 335 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~ 413 (437)
.+.+ +.+||+|||++|+|.++|+..... +++|..+++|+.++|+||+|||+..+++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999775544 89999999999999999999999988899999999999999999999999
Q ss_pred ccCCccccCC
Q 013737 414 DFGLVRLFPE 423 (437)
Q Consensus 414 DFG~a~~~~~ 423 (437)
|||+|+..+.
T Consensus 220 DFGLa~~~~~ 229 (361)
T KOG1187|consen 220 DFGLAKLGPE 229 (361)
T ss_pred CccCcccCCc
Confidence 9999987775
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=268.78 Aligned_cols=162 Identities=31% Similarity=0.506 Sum_probs=143.3
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
..+|...+.||.|+|++||+|+++ ++..||||.+... .....+.+..|+.+|+.++|||||+++++++.++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 456888889999999999999974 5899999999765 5666778899999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC------CcEEEcccCCc
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE------FTAKIADFGLV 418 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~------~~~ki~DFG~a 418 (437)
|||.||+|.+++..+ +.+++..+..++.||+.||++||+++ ||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~---~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR---GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 999999999999543 46899999999999999999999998 9999999999999764 46899999999
Q ss_pred cccCCCCcceeeeecccCC
Q 013737 419 RLFPEDITHISATLAGTLF 437 (437)
Q Consensus 419 ~~~~~~~~~~~~~~~Gt~~ 437 (437)
|.+.+.. ...+++||+|
T Consensus 163 R~L~~~~--~a~tlcGSpl 179 (429)
T KOG0595|consen 163 RFLQPGS--MAETLCGSPL 179 (429)
T ss_pred hhCCchh--HHHHhhCCcc
Confidence 9987432 3347888875
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=256.27 Aligned_cols=162 Identities=30% Similarity=0.421 Sum_probs=138.2
Q ss_pred HhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc-------hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT-------TQWVDHFFNEVNLISGINHKNLVKLLGCSITGP 338 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 338 (437)
..+.|-..+.||+|+||.|-+|.. ++|+.||||++.... .......++|+++|++|+|||||++++++..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 456678899999999999999985 679999999996431 112234679999999999999999999999999
Q ss_pred eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC---CcEEEccc
Q 013737 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE---FTAKIADF 415 (437)
Q Consensus 339 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~---~~~ki~DF 415 (437)
..||||||++||+|.+.+-. .+.+.+..-..++.|++.|+.|||++| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 99999999999999998843 344677777889999999999999998 9999999999999765 78999999
Q ss_pred CCccccCCCCcceeeeecccC
Q 013737 416 GLVRLFPEDITHISATLAGTL 436 (437)
Q Consensus 416 G~a~~~~~~~~~~~~~~~Gt~ 436 (437)
|+|+..++. ....|++|||
T Consensus 324 GlAK~~g~~--sfm~TlCGTp 342 (475)
T KOG0615|consen 324 GLAKVSGEG--SFMKTLCGTP 342 (475)
T ss_pred chhhccccc--eehhhhcCCc
Confidence 999998743 2344788987
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=265.76 Aligned_cols=161 Identities=31% Similarity=0.462 Sum_probs=146.1
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
..|...+.||+|+|+.+|+++. .+|+.||+|++.+. .....+.+.+|+++.+.|+|||||+++++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688999999999999999997 88999999999753 4456788999999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
|+|++++|.+++. ..+++++.++..+++||+.||.|||+++ |||||||..|++|++++++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999883 4567999999999999999999999998 999999999999999999999999999998765
Q ss_pred CcceeeeecccC
Q 013737 425 ITHISATLAGTL 436 (437)
Q Consensus 425 ~~~~~~~~~Gt~ 436 (437)
..+ .-|++|||
T Consensus 172 ~Er-k~TlCGTP 182 (592)
T KOG0575|consen 172 GER-KKTLCGTP 182 (592)
T ss_pred ccc-cceecCCC
Confidence 433 34689997
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=256.96 Aligned_cols=162 Identities=29% Similarity=0.426 Sum_probs=137.7
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc--hhhHHHHHHHHHHHcCCCCCceeceeEEEeeC--CeeEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PESLLV 343 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 343 (437)
+.|+..++||+|.||.||+|+. .+|+.||+|++..+. +....-..+||.+|++|+||||++|.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 3466678999999999999995 679999999997653 55566778999999999999999999988876 689999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
+|||++ ||.-++. .....+++.++..++.|++.||+|+|+.+ |+|||||.+|||||++|.+||+|||||+++..
T Consensus 197 FeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred Eecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999974 7777662 33456999999999999999999999998 99999999999999999999999999999887
Q ss_pred CCcceeeeecccC
Q 013737 424 DITHISATLAGTL 436 (437)
Q Consensus 424 ~~~~~~~~~~Gt~ 436 (437)
+.....|..+=|+
T Consensus 271 ~~~~~~T~rVvTL 283 (560)
T KOG0600|consen 271 SGSAPYTSRVVTL 283 (560)
T ss_pred CCCcccccceEEe
Confidence 6655444333343
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=255.01 Aligned_cols=161 Identities=38% Similarity=0.525 Sum_probs=137.0
Q ss_pred CcCCcccccCcccEEEEEeCCCCEEEEEEEeccc--hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC-eeEEEEeccC
Q 013737 272 HESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGP-ESLLVYEFVP 348 (437)
Q Consensus 272 ~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~ 348 (437)
...+.||+|+||+||+|.+++...||||++.... ....+.|.+|+.+|.+++|||||+++|++.++. ...|||||++
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 3455699999999999999866669999997542 222678999999999999999999999999888 7899999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC-cEEEcccCCccccCCCCcc
Q 013737 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRLFPEDITH 427 (437)
Q Consensus 349 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~-~~ki~DFG~a~~~~~~~~~ 427 (437)
+|+|.++++.. ....+++..++.|+.|||+||.|||++++ ||||||||+|||++.++ ++||+|||+++...... .
T Consensus 124 ~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~ 199 (362)
T KOG0192|consen 124 GGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-T 199 (362)
T ss_pred CCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-c
Confidence 99999999654 45679999999999999999999999873 99999999999999997 99999999999776432 1
Q ss_pred eeeeecccC
Q 013737 428 ISATLAGTL 436 (437)
Q Consensus 428 ~~~~~~Gt~ 436 (437)
..+...||+
T Consensus 200 ~~~~~~GT~ 208 (362)
T KOG0192|consen 200 SMTSVAGTY 208 (362)
T ss_pred cccCCCCCc
Confidence 222356664
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=244.47 Aligned_cols=156 Identities=31% Similarity=0.457 Sum_probs=136.6
Q ss_pred CcCCcccccCcccEEEEEeC-CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC-eeEEEEeccC
Q 013737 272 HESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP-ESLLVYEFVP 348 (437)
Q Consensus 272 ~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~ 348 (437)
+..+.||+|..|+|||+.++ +++.+|+|.+..+ ++...+++.+|++++...+||+||.++|.|..++ .+.|+||||.
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 34678999999999999985 6889999999655 4556789999999999999999999999999999 5999999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCCcc
Q 013737 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE-ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (437)
Q Consensus 349 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~~~ 427 (437)
+|+|.+++. ..+.+++...-+|+.+|++||.|||+ ++ ||||||||+|||++..|++||+|||.++.+...
T Consensus 162 gGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 162 GGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred CCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 999999883 33669999999999999999999996 54 999999999999999999999999999987654
Q ss_pred eeeeecccC
Q 013737 428 ISATLAGTL 436 (437)
Q Consensus 428 ~~~~~~Gt~ 436 (437)
...+.+||.
T Consensus 233 ~a~tfvGT~ 241 (364)
T KOG0581|consen 233 IANTFVGTS 241 (364)
T ss_pred hcccccccc
Confidence 223566664
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=244.66 Aligned_cols=162 Identities=31% Similarity=0.367 Sum_probs=143.0
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
.++|+..+.||+|+||+||.++. ++++.+|+|.+++. .....+...+|..+|.+++||.||+++-.|++++.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 46799999999999999999996 55899999998654 334567789999999999999999999999999999999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
+||+.||.|..+| ++...+++..+..++..|+.||.|||+++ ||||||||+|||||++|+++|+|||+++....
T Consensus 104 ld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999988 34456899999999999999999999998 99999999999999999999999999997655
Q ss_pred CCcceeeeecccC
Q 013737 424 DITHISATLAGTL 436 (437)
Q Consensus 424 ~~~~~~~~~~Gt~ 436 (437)
+... +.+++||+
T Consensus 178 ~~~~-t~tfcGT~ 189 (357)
T KOG0598|consen 178 DGDA-TRTFCGTP 189 (357)
T ss_pred CCCc-cccccCCc
Confidence 5432 33578885
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=256.15 Aligned_cols=156 Identities=34% Similarity=0.524 Sum_probs=138.0
Q ss_pred HHHhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 265 EKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 265 ~~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
+...+.++..+.||+|.||+||.|.+++...||+|.++... ...+.|.+|+++|++|+|+|||+++|++..++.++|||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 33334455678999999999999999988899999997653 33567899999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
|||+.|+|.++|.. .....+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+||||||.+.++
T Consensus 281 E~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 99999999999965 34566889999999999999999999998 999999999999999999999999999966555
Q ss_pred C
Q 013737 425 I 425 (437)
Q Consensus 425 ~ 425 (437)
.
T Consensus 357 ~ 357 (468)
T KOG0197|consen 357 E 357 (468)
T ss_pred c
Confidence 4
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=244.19 Aligned_cols=160 Identities=37% Similarity=0.501 Sum_probs=133.5
Q ss_pred hcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcC--CCCCceeceeEEEeeCC----eeE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISG--INHKNLVKLLGCSITGP----ESL 341 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~ 341 (437)
.......++||+|+||.||||.+. ++.||||++.. +..+.|++|-++.+. ++|+||+++++.-.... +++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 344556789999999999999987 48999999854 345567788777654 57999999999877655 889
Q ss_pred EEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 013737 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE------SKLRIIHRDIKLSNILLDEEFTAKIADF 415 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~------~~~~iiHrDlk~~NIll~~~~~~ki~DF 415 (437)
||+||.+.|+|.++| ....++|.+..+|+..+++||+|||+. .+++|+|||||++||||.+|++..|+||
T Consensus 285 LVt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EEeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 999999999999999 345699999999999999999999986 3478999999999999999999999999
Q ss_pred CCccccCCCCcceee-eeccc
Q 013737 416 GLVRLFPEDITHISA-TLAGT 435 (437)
Q Consensus 416 G~a~~~~~~~~~~~~-~~~Gt 435 (437)
|+|..+........+ ..+||
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT 381 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGT 381 (534)
T ss_pred ceeEEecCCCCCcchhhhhhh
Confidence 999988754433222 35565
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=241.34 Aligned_cols=167 Identities=27% Similarity=0.413 Sum_probs=142.5
Q ss_pred cCCCcCCcccccCcccEEEEE-eCCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeE-EEeeCCe-eEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLG-CSITGPE-SLLV 343 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lv 343 (437)
.+|.+.++||+|.||+||++. ..+|..+|.|.++.+ +....+.+..|+.+|++|+|||||++++ -+.++++ ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 346678899999999999998 478999999998754 5556778999999999999999999998 4555555 8999
Q ss_pred EeccCCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 344 YEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLR--IIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
|||+.+|+|..++..-+ ....+++..+++++.|++.||.++|++- ++ |+||||||.||+|+.+|.+||+|||++|.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999999999885433 3456899999999999999999999942 34 99999999999999999999999999999
Q ss_pred cCCCCcceeeeecccCC
Q 013737 421 FPEDITHISATLAGTLF 437 (437)
Q Consensus 421 ~~~~~~~~~~~~~Gt~~ 437 (437)
+..+.+- ....+||||
T Consensus 178 l~s~~tf-A~S~VGTPy 193 (375)
T KOG0591|consen 178 LSSKTTF-AHSLVGTPY 193 (375)
T ss_pred hcchhHH-HHhhcCCCc
Confidence 9876543 346789986
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=227.76 Aligned_cols=151 Identities=32% Similarity=0.467 Sum_probs=133.9
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchh--hHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQ--WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
..|...++||+|.||.||+|++ .+|+.||||+++..... ......+|+..|+.++|+||+.++++|...+..-||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3577788999999999999995 67999999999865322 23467899999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~ 425 (437)
||+ .+|...+.+ +...++..++..++.++++||+|+|++. |+||||||.|+||+++|.+||+|||+|+.+....
T Consensus 82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 996 688887743 4467999999999999999999999998 9999999999999999999999999999987544
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=229.96 Aligned_cols=158 Identities=31% Similarity=0.382 Sum_probs=141.5
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..+.||.|+||.|.+++.+ +|..+|+|++.+. .....+...+|..+|+.+.||+++++++.+.+.+.++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 45777899999999999999974 5889999999754 3344567889999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||++||.|..+| ++.+++++..+..++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+.....
T Consensus 124 eyv~GGElFS~L---rk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYL---RKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHH---HhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 999999999998 44566999999999999999999999998 999999999999999999999999999987643
Q ss_pred CcceeeeecccC
Q 013737 425 ITHISATLAGTL 436 (437)
Q Consensus 425 ~~~~~~~~~Gt~ 436 (437)
+-+++|||
T Consensus 198 ----T~TlCGTP 205 (355)
T KOG0616|consen 198 ----TWTLCGTP 205 (355)
T ss_pred ----EEEecCCc
Confidence 34889996
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=257.66 Aligned_cols=159 Identities=26% Similarity=0.428 Sum_probs=140.6
Q ss_pred CCcCCcccccCcccEEEEEeCC----CCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 271 FHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
.++.++||.|.||+|++|+++- ...||||.++.. .+....+|+.|+.+|.+++||||++|.|+.......+||+|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 4567899999999999999742 357999999876 45567789999999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~ 425 (437)
||++|+|+.+|.. +.+++++.+.+-++++|+.||.||-+.+ +|||||.++|||++.+..+|++|||++|.+.++.
T Consensus 711 yMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 711 YMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 9999999999854 4466999999999999999999999998 9999999999999999999999999999988776
Q ss_pred cceeeeecc
Q 013737 426 THISATLAG 434 (437)
Q Consensus 426 ~~~~~~~~G 434 (437)
....++..|
T Consensus 786 ~~~ytt~GG 794 (996)
T KOG0196|consen 786 EAAYTTLGG 794 (996)
T ss_pred CccccccCC
Confidence 444444444
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=234.55 Aligned_cols=149 Identities=26% Similarity=0.409 Sum_probs=130.4
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
+.|+...++|+|+||.||+++.+ +|+.||||++... ++...+-.++|+++|++++|||+|.|+++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35777889999999999999975 5999999998654 34445667899999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|++..-|.+ |. .....++...+.+++.|+++|+.|+|+++ +|||||||+||||+.++.+||+|||+||.+..
T Consensus 82 ~~dhTvL~e-Le--~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 82 YCDHTVLHE-LE--RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ecchHHHHH-HH--hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 998755544 32 33455889999999999999999999998 99999999999999999999999999998874
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=239.48 Aligned_cols=159 Identities=27% Similarity=0.444 Sum_probs=140.6
Q ss_pred CCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
+|++.+.||+|.||+|-++.. ..|+.||||.++++ +.+++-.+.+|+++|..|+||||+.++++|+..+.+.||||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 466678899999999999985 67999999998654 56667789999999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~ 425 (437)
|..+|.|++++. ....+++.++..+++||..|+.|.|.++ ++|||||.+|||+|+++++||+|||++.++.++.
T Consensus 134 YaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 134 YASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred ecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 999999999994 4556999999999999999999999987 9999999999999999999999999999886543
Q ss_pred cceeeeecccC
Q 013737 426 THISATLAGTL 436 (437)
Q Consensus 426 ~~~~~~~~Gt~ 436 (437)
..++++|++
T Consensus 208 --fLqTFCGSP 216 (668)
T KOG0611|consen 208 --FLQTFCGSP 216 (668)
T ss_pred --HHHHhcCCc
Confidence 223455554
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=226.90 Aligned_cols=152 Identities=29% Similarity=0.421 Sum_probs=130.8
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc--hhhHHHHHHHHHHHcCCCCCceeceeEEEeeC--CeeEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PESLLV 343 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 343 (437)
++|+..+.|++|.||.||+|++ ++++.||+|+++.+. ....-.-++|+.+|.+++|||||.+..+.... +.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 3467788999999999999997 568999999997543 22334567999999999999999999987644 479999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
||||+. +|..++.. ...++...++..++.|+++|++|||... |+||||||+|+|+++.|.+||+|||+||.+++
T Consensus 156 Me~~Eh-DLksl~d~--m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMET--MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHh--ccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999974 78777743 3467999999999999999999999998 99999999999999999999999999999987
Q ss_pred CCc
Q 013737 424 DIT 426 (437)
Q Consensus 424 ~~~ 426 (437)
...
T Consensus 230 p~k 232 (419)
T KOG0663|consen 230 PLK 232 (419)
T ss_pred Ccc
Confidence 743
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-30 Score=241.65 Aligned_cols=152 Identities=31% Similarity=0.423 Sum_probs=133.4
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHH-HHHHHHHHHcCCC-CCceeceeEEEeeCC-eeEEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGIN-HKNLVKLLGCSITGP-ESLLV 343 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~lv 343 (437)
.++|...++||.|.||.||+|+. .+++.||||+++..-..+.+ .=++|+..|++|+ |||||+|.+++.+.+ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 45678889999999999999995 56899999998765433332 2368999999999 999999999999988 89999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
||||+ .+|++++..+ ...+++..+..|+.||++||+|+|.+| +.||||||+|||+.....+||+|||+||.+..
T Consensus 89 fE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred HHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc
Confidence 99995 6999988655 567999999999999999999999998 99999999999999888999999999998865
Q ss_pred CC
Q 013737 424 DI 425 (437)
Q Consensus 424 ~~ 425 (437)
..
T Consensus 163 kp 164 (538)
T KOG0661|consen 163 KP 164 (538)
T ss_pred CC
Confidence 43
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=236.12 Aligned_cols=151 Identities=31% Similarity=0.448 Sum_probs=134.3
Q ss_pred HhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccch-hhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
+.+.....++||+|.||+|.+++..++..||||+++.... ...++|.+|+++|.+|+||||++|+|+|..++.+++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 3455677899999999999999999889999999987644 445899999999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
||++|+|.+++..+.. ..+.....++|+.||+.||+||.+.+ +|||||.++|+|++.++++||+|||++|-+
T Consensus 616 YmEnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred HHhcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccccc
Confidence 9999999999955432 22455667889999999999999987 999999999999999999999999999954
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=239.42 Aligned_cols=153 Identities=29% Similarity=0.376 Sum_probs=135.9
Q ss_pred HHhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCee
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPES 340 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 340 (437)
+...+|..++.||+|+|++|++|+. .+++.+|||++.+. .....+-..+|-+.|.+| .||.|++|+-.|++...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3446788999999999999999995 56899999998543 333345677888899999 799999999999999999
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
|+|+||+++|+|.+++. +.+.+++.....++.+|+.||+|||+.| ||||||||+|||||++|++||+|||-|+.
T Consensus 150 YFvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence 99999999999999993 4467999999999999999999999998 99999999999999999999999999999
Q ss_pred cCCC
Q 013737 421 FPED 424 (437)
Q Consensus 421 ~~~~ 424 (437)
+++.
T Consensus 224 l~~~ 227 (604)
T KOG0592|consen 224 LSPS 227 (604)
T ss_pred CChh
Confidence 8643
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=227.35 Aligned_cols=164 Identities=32% Similarity=0.446 Sum_probs=137.2
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC--eeEEEEe
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP--ESLLVYE 345 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e 345 (437)
.++...+.||+|+||.||++... +|...|||.+........+.+.+|+.+|.+++|||||+++|...... ..++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 44667889999999999999974 48999999987664444777999999999999999999999755444 5889999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC-CCcEEEcccCCccccCC-
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFGLVRLFPE- 423 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~-~~~~ki~DFG~a~~~~~- 423 (437)
|+++|+|.+++..... .+++..+..+..||++||.|||+++ ||||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999844332 6999999999999999999999998 999999999999999 79999999999998764
Q ss_pred -CCcceeeeecccCC
Q 013737 424 -DITHISATLAGTLF 437 (437)
Q Consensus 424 -~~~~~~~~~~Gt~~ 437 (437)
........+.||++
T Consensus 172 ~~~~~~~~~~~Gtp~ 186 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPN 186 (313)
T ss_pred cccccccccccCCcc
Confidence 11112224567653
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-29 Score=216.36 Aligned_cols=163 Identities=31% Similarity=0.413 Sum_probs=140.7
Q ss_pred HhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
.-++|++.+.||+|.||.||.|+. +++..||+|++.+. ..+...++.+|+++-+.|+||||+++++++.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 346788999999999999999996 56789999998654 22335678999999999999999999999999999999
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
++||.++|+|.+.|... ....+++.....++.|+|.||.|+|..+ ||||||||+|+|++.++.+||+|||-+-.-+
T Consensus 100 ilEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999998532 4456888999999999999999999987 9999999999999999999999999987665
Q ss_pred CCCcceeeeecccC
Q 013737 423 EDITHISATLAGTL 436 (437)
Q Consensus 423 ~~~~~~~~~~~Gt~ 436 (437)
.+.. .+++||+
T Consensus 176 ~~kR---~tlcgt~ 186 (281)
T KOG0580|consen 176 SNKR---KTLCGTL 186 (281)
T ss_pred CCCc---eeeeccc
Confidence 3332 2567774
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=229.07 Aligned_cols=151 Identities=30% Similarity=0.381 Sum_probs=128.9
Q ss_pred HHHhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccch--------------hhHHHHHHHHHHHcCCCCCceec
Q 013737 265 EKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTT--------------QWVDHFFNEVNLISGINHKNLVK 329 (437)
Q Consensus 265 ~~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~ 329 (437)
...-++|++.+.||+|.||.|-+|.. .+++.||||++.+... ...++..+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 34456799999999999999999996 4689999999853211 12357899999999999999999
Q ss_pred eeEEEeeC--CeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC
Q 013737 330 LLGCSITG--PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE 407 (437)
Q Consensus 330 l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~ 407 (437)
|+++..++ +.+|||+|||..|.+...- .....+++.++.++++++..||+|||.++ ||||||||+|+||+++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 99998765 4689999999988875432 22233999999999999999999999998 9999999999999999
Q ss_pred CcEEEcccCCcccc
Q 013737 408 FTAKIADFGLVRLF 421 (437)
Q Consensus 408 ~~~ki~DFG~a~~~ 421 (437)
|++||+|||.+..+
T Consensus 247 g~VKIsDFGVs~~~ 260 (576)
T KOG0585|consen 247 GTVKISDFGVSNEF 260 (576)
T ss_pred CcEEeeccceeeec
Confidence 99999999999877
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=236.38 Aligned_cols=164 Identities=26% Similarity=0.386 Sum_probs=140.2
Q ss_pred HHhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc----ch-hhHHHHHHHHHHHcCCC-CCceeceeEEEeeCC
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN----TT-QWVDHFFNEVNLISGIN-HKNLVKLLGCSITGP 338 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 338 (437)
.....|...+.||+|+||+|++|.+ .+++.||+|.+... .. ...+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456789999999999999999986 56899999976543 11 23456778999999999 999999999999999
Q ss_pred eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC-CcEEEcccCC
Q 013737 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGL 417 (437)
Q Consensus 339 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~-~~~ki~DFG~ 417 (437)
..++||||+.+|+|.+++.. .+++.+.++..++.|++.|++|+|+.+ |+||||||+|||++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999843 466888999999999999999999998 9999999999999999 9999999999
Q ss_pred ccccCCCCcceeeeecccC
Q 013737 418 VRLFPEDITHISATLAGTL 436 (437)
Q Consensus 418 a~~~~~~~~~~~~~~~Gt~ 436 (437)
+.... .......+.+||+
T Consensus 168 s~~~~-~~~~~l~t~cGsp 185 (370)
T KOG0583|consen 168 SAISP-GEDGLLKTFCGSP 185 (370)
T ss_pred ccccC-CCCCcccCCCCCc
Confidence 99884 1122334567775
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=234.03 Aligned_cols=150 Identities=25% Similarity=0.328 Sum_probs=136.3
Q ss_pred HhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
..++|+..++||+|+||.||+|+- .+|..+|+|++++. .....+..+.|-.+|...++|+||+|+-.|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 347799999999999999999995 56999999999765 33456678899999999999999999999999999999
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
||||++||++..+| .+...|++..+..++.+++.|++-||..| +|||||||+|+|||..|++||+||||+.-+.
T Consensus 219 iMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999999998 44567999999999999999999999998 9999999999999999999999999997554
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-29 Score=237.80 Aligned_cols=161 Identities=30% Similarity=0.436 Sum_probs=143.9
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
++|...+.||+|+||.||||+.+ +.+.||+|.+.+. .....+.+.+|+++++.++|||||.++++|++..+.|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46788899999999999999964 5889999998654 44567789999999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~ 425 (437)
|+.| +|..+|. ....++++.+..|+.++..||.|||+.+ |+|||+||+|||++..+.+|++|||+||.+..+
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~- 153 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN- 153 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence 9976 9999883 4456999999999999999999999987 999999999999999999999999999998875
Q ss_pred cceeeeecccCC
Q 013737 426 THISATLAGTLF 437 (437)
Q Consensus 426 ~~~~~~~~Gt~~ 437 (437)
+...+.+.|||+
T Consensus 154 t~vltsikGtPl 165 (808)
T KOG0597|consen 154 TSVLTSIKGTPL 165 (808)
T ss_pred ceeeeeccCccc
Confidence 456678889874
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=236.90 Aligned_cols=163 Identities=29% Similarity=0.476 Sum_probs=146.7
Q ss_pred HhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
+...|....+||+|+.|.||.+.. .+++.||||++........+-+.+|+.+|+..+|+|||.+++.+...+++|+|||
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 345688889999999999999984 5688999999987777777789999999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~ 425 (437)
||++|+|.+.+. ...+++.++..|++++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+.+.+
T Consensus 351 ym~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 351 YMEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred ecCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 999999999873 344899999999999999999999998 9999999999999999999999999999998877
Q ss_pred cceeeeecccCC
Q 013737 426 THISATLAGTLF 437 (437)
Q Consensus 426 ~~~~~~~~Gt~~ 437 (437)
... .+++||||
T Consensus 424 ~KR-~TmVGTPY 434 (550)
T KOG0578|consen 424 SKR-STMVGTPY 434 (550)
T ss_pred Ccc-ccccCCCC
Confidence 543 35789986
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=247.42 Aligned_cols=155 Identities=31% Similarity=0.453 Sum_probs=136.1
Q ss_pred HHHHhcCCCcCCcccccCcccEEEEEeC------CCCEEEEEEEeccchh-hHHHHHHHHHHHcCCCCCceeceeEEEee
Q 013737 264 LEKATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSIT 336 (437)
Q Consensus 264 ~~~~~~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 336 (437)
.+....+....+.||+|+||+||+|+.. ....||||.++..... ...+|++|+++|+.|+|||||+|+|+|.+
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 3444455667789999999999999853 2457999999876544 77899999999999999999999999999
Q ss_pred CCeeEEEEeccCCCCccccccccCC-----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC
Q 013737 337 GPESLLVYEFVPNQSLLDNLFVRQD-----------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD 405 (437)
Q Consensus 337 ~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~ 405 (437)
++..++|+|||..|||.++|..+.. ..+++..+.+.|+.|||.||+||-++. +|||||..+|+||.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceec
Confidence 9999999999999999999965431 234899999999999999999999987 99999999999999
Q ss_pred CCCcEEEcccCCcccc
Q 013737 406 EEFTAKIADFGLVRLF 421 (437)
Q Consensus 406 ~~~~~ki~DFG~a~~~ 421 (437)
++..+||+||||+|-+
T Consensus 638 e~l~VKIsDfGLsRdi 653 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDI 653 (774)
T ss_pred cceEEEecccccchhh
Confidence 9999999999999854
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=239.03 Aligned_cols=154 Identities=33% Similarity=0.464 Sum_probs=133.6
Q ss_pred HHHHhcCCCcCCcccccCcccEEEEEeCC--C---CEEEEEEEec---cchhhHHHHHHHHHHHcCCCCCceeceeEEEe
Q 013737 264 LEKATNYFHESNKLGQGGSGSVYKGTLPG--G---EAVAVKRLFY---NTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335 (437)
Q Consensus 264 ~~~~~~~~~~~~~Lg~G~~g~V~~~~~~~--~---~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 335 (437)
|+...++....++||+|+||+||+|.+.. + ..||||..+. .......+|.+|.++|++++|||||+++|+..
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34444455556899999999999999742 2 2389999875 24566789999999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 013737 336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415 (437)
Q Consensus 336 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DF 415 (437)
....++||||+|+||+|.++|.... ..++..+.+.++.+.|.||+|||+++ +|||||.++|+|++.+..+||+||
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcc
Confidence 9999999999999999999994432 36999999999999999999999998 999999999999999999999999
Q ss_pred CCccccC
Q 013737 416 GLVRLFP 422 (437)
Q Consensus 416 G~a~~~~ 422 (437)
|+++.-.
T Consensus 307 GLs~~~~ 313 (474)
T KOG0194|consen 307 GLSRAGS 313 (474)
T ss_pred ccccCCc
Confidence 9988653
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=222.29 Aligned_cols=152 Identities=30% Similarity=0.441 Sum_probs=129.7
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccch--hhHHHHHHHHHHHcCCCCCc-eeceeEEEeeCC------
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTT--QWVDHFFNEVNLISGINHKN-LVKLLGCSITGP------ 338 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------ 338 (437)
..|...++||+|+||+||+|+. .+|+.||+|++..... .......+|+.+++.++|+| |++|++++.+.+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 3455667899999999999996 5689999999976533 23456789999999999999 999999998877
Q ss_pred eeEEEEeccCCCCccccccccCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCC
Q 013737 339 ESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417 (437)
Q Consensus 339 ~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~ 417 (437)
..++|+||++ .+|.+++...... ..++...+..++.||+.||+|||+++ |+||||||+||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 7889999995 6888887543322 45777899999999999999999998 99999999999999999999999999
Q ss_pred ccccCCC
Q 013737 418 VRLFPED 424 (437)
Q Consensus 418 a~~~~~~ 424 (437)
|+.+.-+
T Consensus 167 Ara~~ip 173 (323)
T KOG0594|consen 167 ARAFSIP 173 (323)
T ss_pred HHHhcCC
Confidence 9977643
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=223.34 Aligned_cols=153 Identities=31% Similarity=0.421 Sum_probs=131.3
Q ss_pred HHHhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcC--CCCCceeceeEEEeeCC----
Q 013737 265 EKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISG--INHKNLVKLLGCSITGP---- 338 (437)
Q Consensus 265 ~~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~---- 338 (437)
....+.....+.||+|.||+||+|.|+ |+.||||++...+ ...+.+|.++... |+|+||+.+++.-..++
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 344566778899999999999999998 8899999996443 3356778887765 59999999999766544
Q ss_pred eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-----CCCCeeeCCCCCCCeeeCCCCcEEEc
Q 013737 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-----SKLRIIHRDIKLSNILLDEEFTAKIA 413 (437)
Q Consensus 339 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-----~~~~iiHrDlk~~NIll~~~~~~ki~ 413 (437)
++|||++|.+.|||.++|. ...++....++++..+|.||+|||.. |+|.|.|||||+.|||+..++...|+
T Consensus 283 QLwLvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEEeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 5799999999999999993 35699999999999999999999975 78899999999999999999999999
Q ss_pred ccCCccccCCCC
Q 013737 414 DFGLVRLFPEDI 425 (437)
Q Consensus 414 DFG~a~~~~~~~ 425 (437)
|+|||-..+++.
T Consensus 359 DLGLAv~h~~~t 370 (513)
T KOG2052|consen 359 DLGLAVRHDSDT 370 (513)
T ss_pred eceeeEEecccC
Confidence 999998776553
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=234.18 Aligned_cols=154 Identities=32% Similarity=0.555 Sum_probs=137.6
Q ss_pred cCHHHHHHHhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEee
Q 013737 259 FSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT 336 (437)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 336 (437)
.+.++|+...+.+...+.||+|.||+||+|+|.+ .||||++... .+...+.|++|+..+++-+|.||+-+.|++..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 3446677777778889999999999999999864 6999999765 45578899999999999999999999999988
Q ss_pred CCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccC
Q 013737 337 GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (437)
Q Consensus 337 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG 416 (437)
+.. .||+.+|+|.+|+.+++..+ ..++....+.|+.||++||.|||.++ |||||||..||++.+++.+||+|||
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred Cce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccc
Confidence 877 99999999999999996544 56888999999999999999999998 9999999999999999999999999
Q ss_pred Cccc
Q 013737 417 LVRL 420 (437)
Q Consensus 417 ~a~~ 420 (437)
++..
T Consensus 534 Latv 537 (678)
T KOG0193|consen 534 LATV 537 (678)
T ss_pred ceee
Confidence 9864
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-27 Score=219.35 Aligned_cols=166 Identities=30% Similarity=0.385 Sum_probs=143.8
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
.+.|+..+.||.|..+.||+|.. +.++.||||++..+. ....+.+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 46788999999999999999995 678999999997552 3347899999999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~ 425 (437)
||.+|++.+++...-. ..+++..+..|++++++||.|||.+| .||||||+.||||+++|.+||+|||.+..+-+..
T Consensus 105 fMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 9999999999865443 34899999999999999999999998 9999999999999999999999999887665443
Q ss_pred ccee---eeecccCC
Q 013737 426 THIS---ATLAGTLF 437 (437)
Q Consensus 426 ~~~~---~~~~Gt~~ 437 (437)
.+.. .+++||++
T Consensus 181 ~R~~~rf~tfvgtp~ 195 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPC 195 (516)
T ss_pred ceeeEeeccccCccc
Confidence 3322 35677764
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-27 Score=230.28 Aligned_cols=162 Identities=31% Similarity=0.389 Sum_probs=139.5
Q ss_pred HhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCC-CCceeceeEEEeeCCeeE
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESL 341 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 341 (437)
..++|...++||+|.||+|+++..+ +++.+|||.+++. ..+..+....|.+++.... ||.+++|+.+|++.+++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3467889999999999999999975 5889999999876 3455677888888877664 999999999999999999
Q ss_pred EEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
+||||+.||++..+. ....+++..+..++..|+.||+|||+++ ||+||||.+|||||.+|++||+||||+|.-
T Consensus 446 fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999954433 3456999999999999999999999998 999999999999999999999999999975
Q ss_pred CCCCcceeeeecccC
Q 013737 422 PEDITHISATLAGTL 436 (437)
Q Consensus 422 ~~~~~~~~~~~~Gt~ 436 (437)
..... .+.|++|||
T Consensus 519 m~~g~-~TsTfCGTp 532 (694)
T KOG0694|consen 519 MGQGD-RTSTFCGTP 532 (694)
T ss_pred CCCCC-ccccccCCh
Confidence 43332 445899997
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-27 Score=229.20 Aligned_cols=165 Identities=22% Similarity=0.223 Sum_probs=138.1
Q ss_pred HHHhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCee
Q 013737 265 EKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES 340 (437)
Q Consensus 265 ~~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 340 (437)
....++|+..+.||+|+||.||++... +++.+|+|.+... .......+.+|+.+++.++||||+++++++.+++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 334567999999999999999999975 5889999998642 223345688999999999999999999999999999
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 119 ~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence 999999999999998732 34788999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCcceeeeecccC
Q 013737 421 FPEDITHISATLAGTL 436 (437)
Q Consensus 421 ~~~~~~~~~~~~~Gt~ 436 (437)
+.........+..||+
T Consensus 192 ~~~~~~~~~~~~~gt~ 207 (370)
T cd05621 192 MDETGMVRCDTAVGTP 207 (370)
T ss_pred cccCCceecccCCCCc
Confidence 7543322222344554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-27 Score=231.50 Aligned_cols=161 Identities=29% Similarity=0.432 Sum_probs=139.1
Q ss_pred CCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC------eeEE
Q 013737 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP------ESLL 342 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l 342 (437)
+...+.||+|+||.||+++. .+|+.||||.+... .....+..-+|+++|++++|||||+++++-.+.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 44567899999999999995 57999999998654 3445678889999999999999999999765443 5689
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC--CCC--cEEEcccCCc
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD--EEF--TAKIADFGLV 418 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~--~~~--~~ki~DFG~a 418 (437)
|||||.+|||...|....+...|++.+.+.++.++..||.|||+++ |+||||||.||++- ++| .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999988777788999999999999999999999988 99999999999983 334 5799999999
Q ss_pred cccCCCCcceeeeecccC
Q 013737 419 RLFPEDITHISATLAGTL 436 (437)
Q Consensus 419 ~~~~~~~~~~~~~~~Gt~ 436 (437)
|.++++. .-+.+.||.
T Consensus 172 rel~d~s--~~~S~vGT~ 187 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTE 187 (732)
T ss_pred ccCCCCC--eeeeecCch
Confidence 9998876 456788885
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=225.19 Aligned_cols=155 Identities=29% Similarity=0.408 Sum_probs=130.5
Q ss_pred HHhcCCCcCCcccccCcccEEEEEe------CCCCEEEEEEEeccc-hhhHHHHHHHHHHHcCC-CCCceeceeEEEeeC
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTL------PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG 337 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 337 (437)
.+.++|+..++||+|+||.||+|.+ .++..||||++.... ....+.+.+|+.++.++ +||||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 3456788999999999999999974 235689999987542 33456789999999999 899999999988765
Q ss_pred C-eeEEEEeccCCCCccccccccCC-------------------------------------------------------
Q 013737 338 P-ESLLVYEFVPNQSLLDNLFVRQD------------------------------------------------------- 361 (437)
Q Consensus 338 ~-~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------- 361 (437)
+ ..++||||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4 57899999999999988753211
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 362 ----VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 362 ----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
..++++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~ 226 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 226 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeeccccccccc
Confidence 134788899999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=226.15 Aligned_cols=148 Identities=26% Similarity=0.330 Sum_probs=132.2
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..+.||+|+||.||++... +++.+|+|++... .......+.+|+.++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999864 5889999999653 2233467889999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 99999999998843 356899999999999999999999988 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-27 Score=228.90 Aligned_cols=149 Identities=28% Similarity=0.397 Sum_probs=134.5
Q ss_pred CCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
-|+.++.||.|+.|.|-+|++ .+|+.+|||++... .......+++|+-+|+.|.|||++++++++++..++|+|+|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 477889999999999999996 67999999999654 33345678999999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
|+++|.|++++. ..+++++.++.++++||+.|+.|.|..+ |+||||||+|+|||..+++||+|||||.+-.++
T Consensus 93 yv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 93 YVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred ecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 999999999984 4567999999999999999999999998 999999999999999999999999999875543
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=226.60 Aligned_cols=147 Identities=27% Similarity=0.355 Sum_probs=131.2
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..++||+|+||.||++.. .+++.||||.+... .....+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688899999999999999986 46899999998643 2334567889999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 99999999998843 346889999999999999999999998 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=222.85 Aligned_cols=149 Identities=26% Similarity=0.370 Sum_probs=133.0
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..+.||+|+||.||++++. +++.||+|.+... .....+.+.+|+.++.+++||||+++++++..++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888899999999999999975 5889999998653 2234567899999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
||+++++|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...+
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999988843 345889999999999999999999998 99999999999999999999999999987654
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-26 Score=217.43 Aligned_cols=152 Identities=28% Similarity=0.419 Sum_probs=130.9
Q ss_pred hcCCCcCCcccccCcccEEEEEeCC-----------------CCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceec
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPG-----------------GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVK 329 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 329 (437)
.++|...++||+|+||.||++.+++ +..||+|.+... ......+|.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3568889999999999999998532 346999998754 3344567999999999999999999
Q ss_pred eeEEEeeCCeeEEEEeccCCCCccccccccC----------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCee
Q 013737 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQ----------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393 (437)
Q Consensus 330 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ii 393 (437)
+++++.+.+..++||||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999998874321 1134788899999999999999999987 99
Q ss_pred eCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 394 HRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 394 HrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
||||||+|||+++++.+||+|||+++.+.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~ 189 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLY 189 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecc
Confidence 99999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=225.41 Aligned_cols=148 Identities=26% Similarity=0.330 Sum_probs=132.5
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..+.||+|+||.||+++.. +++.||||++... .......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999974 5899999999753 2334566889999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 99999999998843 345899999999999999999999998 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=225.36 Aligned_cols=146 Identities=25% Similarity=0.326 Sum_probs=130.7
Q ss_pred CCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
.|+..+.||+|+||.||++.. .+++.+|+|++... .......+.+|++++.+++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578889999999999999986 45889999999653 23345678999999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 9999999988743 345889999999999999999999987 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=221.89 Aligned_cols=149 Identities=29% Similarity=0.351 Sum_probs=131.6
Q ss_pred cCCCcCCcccccCcccEEEEEeCC--CCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLPG--GEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
++|+..+.||+|+||.||+|.+.. +..||+|.+... .....+.+.+|+.++..++||||+++++++.+++..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468889999999999999998643 368999998643 233456788999999999999999999999999999999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 110 ~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999998843 345899999999999999999999988 99999999999999999999999999987653
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-27 Score=206.40 Aligned_cols=164 Identities=27% Similarity=0.399 Sum_probs=140.0
Q ss_pred HHHhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--------chhhHHHHHHHHHHHcCC-CCCceeceeEEE
Q 013737 265 EKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--------TTQWVDHFFNEVNLISGI-NHKNLVKLLGCS 334 (437)
Q Consensus 265 ~~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 334 (437)
...-+.|...+.||.|..+.|-++.+ ++|...|+|++... ...-.+.-.+|+.+|+++ .||+|+++.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 34456788899999999999999886 56889999988532 112245667899999998 499999999999
Q ss_pred eeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 013737 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIAD 414 (437)
Q Consensus 335 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~D 414 (437)
+++...++|+|.|+.|.|.++| ...-.+++....+|++|+.+|++|||..+ ||||||||+|||+|++.++||+|
T Consensus 93 es~sF~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred cCcchhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence 9999999999999999999999 44566899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCcceeeeecccC
Q 013737 415 FGLVRLFPEDITHISATLAGTL 436 (437)
Q Consensus 415 FG~a~~~~~~~~~~~~~~~Gt~ 436 (437)
||+|..+++... -..++|||
T Consensus 167 FGFa~~l~~Gek--LrelCGTP 186 (411)
T KOG0599|consen 167 FGFACQLEPGEK--LRELCGTP 186 (411)
T ss_pred cceeeccCCchh--HHHhcCCC
Confidence 999999876542 23467775
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=221.52 Aligned_cols=149 Identities=30% Similarity=0.375 Sum_probs=132.8
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc---hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++..++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999975 58999999997542 234567889999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
||+++++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999883 3346889999999999999999999988 99999999999999999999999999986643
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=224.56 Aligned_cols=167 Identities=22% Similarity=0.215 Sum_probs=139.3
Q ss_pred HHHHHhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC
Q 013737 263 TLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP 338 (437)
Q Consensus 263 ~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 338 (437)
.+....++|+..+.||+|+||.||++... +++.+|+|.+... .......+.+|+.+++.++||||+++++.+.+++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34445578999999999999999999975 5889999998642 2233456789999999999999999999999999
Q ss_pred eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCc
Q 013737 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (437)
Q Consensus 339 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a 418 (437)
..++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 99999999999999988732 34788889999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCcceeeeecccC
Q 013737 419 RLFPEDITHISATLAGTL 436 (437)
Q Consensus 419 ~~~~~~~~~~~~~~~Gt~ 436 (437)
+.+.........+..||+
T Consensus 190 ~~~~~~~~~~~~~~~gt~ 207 (371)
T cd05622 190 MKMNKEGMVRCDTAVGTP 207 (371)
T ss_pred eEcCcCCcccccCcccCc
Confidence 877543322222344553
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=218.42 Aligned_cols=149 Identities=23% Similarity=0.306 Sum_probs=132.6
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc---hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999975 68999999986432 234567889999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999998843 346899999999999999999999988 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-26 Score=219.77 Aligned_cols=151 Identities=22% Similarity=0.234 Sum_probs=132.7
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999974 5889999998642 2234556889999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999998843 2345889999999999999999999998 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-26 Score=219.54 Aligned_cols=152 Identities=23% Similarity=0.256 Sum_probs=134.2
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc---hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999964 68899999997542 234567889999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999988432 246899999999999999999999988 999999999999999999999999999877544
Q ss_pred C
Q 013737 425 I 425 (437)
Q Consensus 425 ~ 425 (437)
.
T Consensus 156 ~ 156 (330)
T cd05601 156 K 156 (330)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-26 Score=218.23 Aligned_cols=141 Identities=27% Similarity=0.284 Sum_probs=126.0
Q ss_pred CcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCC
Q 013737 275 NKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 350 (437)
+.||+|+||.||++.. .+++.+|+|.+... .......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999996 46899999998753 2334567889999999999999999999999999999999999999
Q ss_pred CccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 351 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 145 (323)
T cd05571 81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence 9988874 3346899999999999999999999998 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=225.97 Aligned_cols=151 Identities=22% Similarity=0.247 Sum_probs=132.3
Q ss_pred HhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
..++|+..++||+|+||.||+++.. +++.+|+|.+... .......+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3457889999999999999999974 5889999998643 22334567899999999999999999999999999999
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999988732 34788889999999999999999987 9999999999999999999999999998765
Q ss_pred CC
Q 013737 423 ED 424 (437)
Q Consensus 423 ~~ 424 (437)
..
T Consensus 194 ~~ 195 (370)
T cd05596 194 AN 195 (370)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-26 Score=219.53 Aligned_cols=163 Identities=23% Similarity=0.197 Sum_probs=137.0
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..+.||+|+||.||+++.. +++.+|+|.+... .......+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999974 5789999998642 2233456888999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..+
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999988432 345889999999999999999999987 999999999999999999999999999877554
Q ss_pred CcceeeeecccC
Q 013737 425 ITHISATLAGTL 436 (437)
Q Consensus 425 ~~~~~~~~~Gt~ 436 (437)
.........||+
T Consensus 156 ~~~~~~~~~gt~ 167 (331)
T cd05624 156 GTVQSSVAVGTP 167 (331)
T ss_pred CceeeccccCCc
Confidence 332222334543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=234.10 Aligned_cols=151 Identities=28% Similarity=0.426 Sum_probs=133.7
Q ss_pred hcCCCcCCcccccCcccEEEEEeCCC-CEEEEEEEeccchhhHHHHHHHHHHHcCCC-CCceeceeE-EEee------CC
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPGG-EAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLG-CSIT------GP 338 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-~~~~------~~ 338 (437)
..++++.+.|.+|||+.||.+.+..+ ..+|+|++...++...+.+.+|+++|++|+ |+|||.+++ .... .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 34567788999999999999998665 999999998888888999999999999997 999999999 3321 13
Q ss_pred eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCc
Q 013737 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (437)
Q Consensus 339 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a 418 (437)
+++|.||||++|+|.+++..+.... |++.++++|+.|+++|+.+||... +||||||||.+||||+.+++.||||||-|
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccc
Confidence 5789999999999999997655444 999999999999999999999984 78999999999999999999999999998
Q ss_pred cc
Q 013737 419 RL 420 (437)
Q Consensus 419 ~~ 420 (437)
.-
T Consensus 194 tt 195 (738)
T KOG1989|consen 194 TT 195 (738)
T ss_pred cc
Confidence 64
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-27 Score=214.73 Aligned_cols=150 Identities=28% Similarity=0.424 Sum_probs=123.4
Q ss_pred CCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCe-----eEEE
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE-----SLLV 343 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~lv 343 (437)
.|...+++|.|+||.||+|... +++.||||++..+... --+|+++|+.++|||||+|+-+|....+ ..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4667889999999999999974 5799999998765432 1369999999999999999988874432 3489
Q ss_pred EeccCCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC-CcEEEcccCCcccc
Q 013737 344 YEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLF 421 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~-~~~ki~DFG~a~~~ 421 (437)
||||+. +|.+.+... .....++...+.-+..||.+||.|||+.+ |+||||||.|+|+|.+ |.+||+|||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999974 787777431 12355788888899999999999999987 9999999999999966 89999999999998
Q ss_pred CCCCcc
Q 013737 422 PEDITH 427 (437)
Q Consensus 422 ~~~~~~ 427 (437)
...+..
T Consensus 177 ~~~epn 182 (364)
T KOG0658|consen 177 VKGEPN 182 (364)
T ss_pred ccCCCc
Confidence 766554
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.4e-26 Score=219.01 Aligned_cols=161 Identities=27% Similarity=0.328 Sum_probs=134.4
Q ss_pred CCCcCCcccccCcccEEEEEe----CCCCEEEEEEEecc----chhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCee
Q 013737 270 YFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYN----TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPES 340 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 340 (437)
+|+..+.||+|+||.||+++. .+++.+|+|.+... .....+.+.+|+.++..+ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999985 35789999998643 223346688999999999 499999999999999999
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999988843 345899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCcceeeeecccC
Q 013737 421 FPEDITHISATLAGTL 436 (437)
Q Consensus 421 ~~~~~~~~~~~~~Gt~ 436 (437)
+............||+
T Consensus 155 ~~~~~~~~~~~~~gt~ 170 (332)
T cd05614 155 FLSEEKERTYSFCGTI 170 (332)
T ss_pred ccccCCCccccccCCc
Confidence 6443332222344543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-26 Score=220.15 Aligned_cols=164 Identities=27% Similarity=0.357 Sum_probs=143.2
Q ss_pred HHHhcCCCcCCcccccCcccEEEEEeCC-CCEEEEEEEeccch---hhHHHHHHHHHHHcCCC-CCceeceeEEEeeCCe
Q 013737 265 EKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTT---QWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPE 339 (437)
Q Consensus 265 ~~~~~~~~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 339 (437)
......|...+.||+|.||.||++..+. |+.+|+|.+.+... ...+.+.+|+.+|+++. |||||.+++.+++...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 3445678888999999999999999765 99999999975432 34568999999999998 9999999999999999
Q ss_pred eEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC----CcEEEccc
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE----FTAKIADF 415 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~----~~~ki~DF 415 (437)
.++|||++.||.|.+.+... .+++..+..++.|++.++.|||+.+ |+||||||+|+|+... +.+|++||
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 99999999999999988654 2999999999999999999999988 9999999999999533 57999999
Q ss_pred CCccccCCCCcceeeeecccCC
Q 013737 416 GLVRLFPEDITHISATLAGTLF 437 (437)
Q Consensus 416 G~a~~~~~~~~~~~~~~~Gt~~ 437 (437)
|+|..... ......++||++
T Consensus 184 Gla~~~~~--~~~~~~~~Gtp~ 203 (382)
T KOG0032|consen 184 GLAKFIKP--GERLHTIVGTPE 203 (382)
T ss_pred CCceEccC--CceEeeecCCcc
Confidence 99998877 344557889874
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=211.51 Aligned_cols=151 Identities=27% Similarity=0.488 Sum_probs=132.8
Q ss_pred HHhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEe--ccchhhHHHHHHHHHHHcCCCCCceeceeEEEee-----C
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT-----G 337 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~ 337 (437)
.....|...+.||+|+||.|..+.. .+|+.||||++. .......++..+|+.+|+.++|+||+.+++.+.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 3445666688999999999999996 568999999997 4566678899999999999999999999998875 3
Q ss_pred CeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCC
Q 013737 338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417 (437)
Q Consensus 338 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~ 417 (437)
+.+|+|+|+| ..+|.+.+ +....++......++.|+++||.|+|+.+ |+||||||+|+|++.+..+||+|||+
T Consensus 99 ~DvYiV~elM-etDL~~ii---k~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQII---KSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred ceeEEehhHH-hhHHHHHH---HcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence 4689999999 57888888 33344899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCC
Q 013737 418 VRLFPE 423 (437)
Q Consensus 418 a~~~~~ 423 (437)
||....
T Consensus 172 AR~~~~ 177 (359)
T KOG0660|consen 172 ARYLDK 177 (359)
T ss_pred eeeccc
Confidence 998864
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-26 Score=223.38 Aligned_cols=147 Identities=23% Similarity=0.314 Sum_probs=130.3
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc---hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..+.||+|+||.||+++. .+++.+|||.+.... ......+.+|++++..++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3688899999999999999996 458999999986432 233566889999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|..+
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 99999999998843 345888999999999999999999988 999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-26 Score=224.02 Aligned_cols=146 Identities=24% Similarity=0.328 Sum_probs=130.2
Q ss_pred CCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc---hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
.|+..++||+|+||.||+++. .+++.+|+|.+.... ......+.+|++++++++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 578889999999999999996 458899999986532 3345678899999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 9999999998843 345889999999999999999999988 999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-26 Score=211.83 Aligned_cols=148 Identities=27% Similarity=0.277 Sum_probs=132.8
Q ss_pred CCCcCCcccccCcccEEEEEeCC-CCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 270 YFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
+|+..+.||.|.-|+||++++.+ +..+|+|++.+. ......+.+.|-+||+.++||.++.|++.++.+...+|+||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 35567899999999999999864 689999999754 33456678889999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
||+||+|..++ +++..+.+++..+..++..++.||+|||..| ||.|||||+||||.++|++.|+||.|+...
T Consensus 158 yCpGGdL~~Lr-qkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 158 YCPGGDLHSLR-QKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred cCCCccHHHHH-hhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence 99999998766 4456677999999999999999999999998 999999999999999999999999998765
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=192.74 Aligned_cols=150 Identities=29% Similarity=0.457 Sum_probs=130.5
Q ss_pred CCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
+|...++||+|.||+||+++. ++++.||+|++..+ ++.-.....+|+-+++.++|.|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 456678999999999999995 56899999998754 333456788999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~ 425 (437)
|. .+|.++.- .-.+.++......++.|+++||.|.|+++ +.||||||.|.||+.+|++|++|||+|+.++-..
T Consensus 83 cd-qdlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CD-QDLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hh-HHHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 94 57776652 23456899999999999999999999998 9999999999999999999999999999887654
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=221.45 Aligned_cols=164 Identities=22% Similarity=0.336 Sum_probs=142.8
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCe-eEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE-SLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 344 (437)
++|...+++|+|+||.++..+++ ++..+++|.+... .....+..++|+.++++++|||||.+.+.|..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46778899999999999999874 4778999998654 33344578899999999999999999999999888 99999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
+|++||+|.+.+...+ ...++++.+..++.|++.|+.|||++. |+|||||+.||+++.+..+||.|||+|+.+..+
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999885544 567999999999999999999999876 999999999999999999999999999999876
Q ss_pred CcceeeeecccCC
Q 013737 425 ITHISATLAGTLF 437 (437)
Q Consensus 425 ~~~~~~~~~Gt~~ 437 (437)
... ..+++||++
T Consensus 160 ~~~-a~tvvGTp~ 171 (426)
T KOG0589|consen 160 DSL-ASTVVGTPY 171 (426)
T ss_pred hhh-hheecCCCc
Confidence 532 346788875
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=216.33 Aligned_cols=142 Identities=28% Similarity=0.290 Sum_probs=126.3
Q ss_pred CcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCC
Q 013737 275 NKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 350 (437)
+.||+|+||.||++.. .+++.+|+|.+... .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999996 46899999999753 2344567889999999999999999999999999999999999999
Q ss_pred CccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 351 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
+|...+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence 99887732 346899999999999999999999988 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=217.17 Aligned_cols=163 Identities=23% Similarity=0.214 Sum_probs=136.1
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..++||+|+||.||+++.+ +++.+|+|.+... .......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999975 4788999998642 2223445888999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999988432 345899999999999999999999988 999999999999999999999999999866443
Q ss_pred CcceeeeecccC
Q 013737 425 ITHISATLAGTL 436 (437)
Q Consensus 425 ~~~~~~~~~Gt~ 436 (437)
.........||+
T Consensus 156 ~~~~~~~~~gt~ 167 (332)
T cd05623 156 GTVQSSVAVGTP 167 (332)
T ss_pred CcceecccccCc
Confidence 332222334553
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=216.38 Aligned_cols=141 Identities=28% Similarity=0.289 Sum_probs=125.6
Q ss_pred CcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCC
Q 013737 275 NKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 350 (437)
+.||+|+||.||++.. .+|..||+|.+... .......+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999996 46899999998754 2334567788999999999999999999999999999999999999
Q ss_pred CccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 351 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
+|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 145 (323)
T cd05595 81 ELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence 9988773 2346899999999999999999999987 999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=8e-26 Score=220.35 Aligned_cols=150 Identities=27% Similarity=0.358 Sum_probs=134.2
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|...+.||+|+||.||++... +++.||+|++... .......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888999999999999999975 6899999998753 2234567889999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999988433 56899999999999999999999987 999999999999999999999999999877544
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=212.54 Aligned_cols=148 Identities=29% Similarity=0.396 Sum_probs=128.9
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
++|...++||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888999999999999999974 68899999986542 23345678999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
+++ +|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 974 88887743 2345788999999999999999999988 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=214.09 Aligned_cols=140 Identities=24% Similarity=0.256 Sum_probs=125.3
Q ss_pred ccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCCCc
Q 013737 277 LGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL 352 (437)
Q Consensus 277 Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 352 (437)
||+|+||.||++... +++.||+|.+... .......+.+|+.++.+++||||+++++++..++..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999974 5889999998643 334456788999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 353 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~ 144 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNM 144 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCc
Confidence 988843 345899999999999999999999988 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=211.23 Aligned_cols=149 Identities=26% Similarity=0.307 Sum_probs=130.5
Q ss_pred CCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc---hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
|+..+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67788999999999999996 568999999986432 22334678999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
+++|+|.+.+... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 9999998776432 2345899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=212.47 Aligned_cols=150 Identities=25% Similarity=0.345 Sum_probs=130.3
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
++|+..+.||+|+||.||++++. +++.+|+|++... .....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888999999999999999975 5889999998654 23345678899999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
|++++.+..+. .....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+...
T Consensus 81 ~~~~~~l~~~~---~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLE---EMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 99987665433 22346899999999999999999999987 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=226.38 Aligned_cols=164 Identities=19% Similarity=0.292 Sum_probs=138.4
Q ss_pred CCCcCCcccccCcccEEEEEeC-C-CCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEecc
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-G-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (437)
.|...+.||+|+||.||++... + ++.||+|.+..........+.+|+.+++.++||||+++++++..++..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3788899999999999999853 3 6788899876666555667889999999999999999999999999999999999
Q ss_pred CCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCCc
Q 013737 348 PNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (437)
Q Consensus 348 ~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~~ 426 (437)
++|+|.+.+... ....++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999877532 23456899999999999999999999987 99999999999999999999999999997754322
Q ss_pred -ceeeeecccC
Q 013737 427 -HISATLAGTL 436 (437)
Q Consensus 427 -~~~~~~~Gt~ 436 (437)
....+..||+
T Consensus 225 ~~~~~~~~gt~ 235 (478)
T PTZ00267 225 LDVASSFCGTP 235 (478)
T ss_pred cccccccCCCc
Confidence 1223445654
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-25 Score=213.42 Aligned_cols=142 Identities=27% Similarity=0.278 Sum_probs=125.1
Q ss_pred CcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCC
Q 013737 275 NKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 350 (437)
+.||+|+||.||++.. .+++.+|+|.+... .......+.+|++++..++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999996 46899999999753 2334567788999999999999999999999999999999999999
Q ss_pred CccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE-ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 351 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
+|.+++. ....+++..+..++.||+.||.|||+ .+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~ 147 (325)
T cd05594 81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 147 (325)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence 9988773 23468999999999999999999997 56 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-26 Score=227.71 Aligned_cols=154 Identities=31% Similarity=0.497 Sum_probs=133.9
Q ss_pred CCcCCcccccCcccEEEEEe-CCC----CEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 271 FHESNKLGQGGSGSVYKGTL-PGG----EAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
.+..++||+|+||+||+|.| +.| .+||+|.+... ..+..+++.+|+-+|.+++|||+++|+|++.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34578999999999999996 434 47899988654 4555778999999999999999999999998766 88999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
+||+.|+|.++++. .+..+.....+.|..|||+||.|||++. ++||||.++|||+.+-..+||.|||+|+.+..+
T Consensus 777 q~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999999854 4456888999999999999999999886 999999999999999999999999999999877
Q ss_pred Ccceee
Q 013737 425 ITHISA 430 (437)
Q Consensus 425 ~~~~~~ 430 (437)
..+.++
T Consensus 852 ~~ey~~ 857 (1177)
T KOG1025|consen 852 EKEYSA 857 (1177)
T ss_pred cccccc
Confidence 655443
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-26 Score=217.46 Aligned_cols=162 Identities=29% Similarity=0.436 Sum_probs=144.7
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
..|+..+.||+|.||.||+|.+ .+++.||+|++..+ .....+.+++|+.++.+++++||.++++.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4577789999999999999996 56899999999765 445578899999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCCc
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~~ 426 (437)
+.+|++.+.| +....+++..+.-|+++++.||.|||.++ .+|||||+.|||+..+|.+||+|||.+-.+.....
T Consensus 93 ~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999988 33444588888899999999999999998 99999999999999999999999999999887665
Q ss_pred ceeeeecccCC
Q 013737 427 HISATLAGTLF 437 (437)
Q Consensus 427 ~~~~~~~Gt~~ 437 (437)
.. .+++||||
T Consensus 167 rr-~tfvGTPf 176 (467)
T KOG0201|consen 167 RR-KTFVGTPF 176 (467)
T ss_pred cc-cccccccc
Confidence 54 57899997
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-27 Score=211.43 Aligned_cols=159 Identities=32% Similarity=0.482 Sum_probs=141.6
Q ss_pred CCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCC
Q 013737 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN 349 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (437)
|.+..+||+|+||.||++.++ +|+.+|||++..+. ..+++..|+.+|.+++.|++|+++|.+.....+|+|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 566789999999999999974 69999999987553 467899999999999999999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCCccee
Q 013737 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429 (437)
Q Consensus 350 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~~~~~ 429 (437)
|+..+++.. +.+++++.++..+++..++||+|||... -||||||+.|||++.+|.+||+|||.|-.+.+-....
T Consensus 113 GSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR- 186 (502)
T KOG0574|consen 113 GSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR- 186 (502)
T ss_pred CcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHhh-
Confidence 999998854 4467999999999999999999999875 7999999999999999999999999999887654433
Q ss_pred eeecccCC
Q 013737 430 ATLAGTLF 437 (437)
Q Consensus 430 ~~~~Gt~~ 437 (437)
.++.||+|
T Consensus 187 NTVIGTPF 194 (502)
T KOG0574|consen 187 NTVIGTPF 194 (502)
T ss_pred CccccCcc
Confidence 36789987
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=218.46 Aligned_cols=148 Identities=27% Similarity=0.340 Sum_probs=131.9
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..+.||+|+||.||++... +++.+|+|.+... .......+.+|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999974 5899999998643 2334567889999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 99999999998843 345899999999999999999999988 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=220.53 Aligned_cols=155 Identities=31% Similarity=0.410 Sum_probs=132.8
Q ss_pred HHhcCCCcCCcccccCcccEEEEEe------CCCCEEEEEEEecc-chhhHHHHHHHHHHHcCC-CCCceeceeEEEeeC
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTL------PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG 337 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 337 (437)
...++|+..+.||+|+||.||+|.+ .++..||||+++.. .....+.+.+|+.++..+ +||||+++++++..+
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 3445788899999999999999974 23568999998644 234456789999999999 899999999999999
Q ss_pred CeeEEEEeccCCCCccccccccCC--------------------------------------------------------
Q 013737 338 PESLLVYEFVPNQSLLDNLFVRQD-------------------------------------------------------- 361 (437)
Q Consensus 338 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 361 (437)
+..++||||+++|+|.+++.....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 999999999999999888753211
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 362 ----------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 362 ----------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 125788999999999999999999987 99999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9e-27 Score=224.08 Aligned_cols=158 Identities=32% Similarity=0.492 Sum_probs=136.6
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccch---hhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTT---QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
..|...+.||.|+||.||.+.+ .+.+.||||++..... ...+++..|+.+|.+++|||+|.+.|++......||||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 3467788999999999999996 5688999999875433 33467889999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
|||- |+-.+++... .+++.+.++..|..+.+.||.|||+++ .||||||+.|||+++.|.+||+|||.|.+....
T Consensus 106 EYCl-GSAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 106 EYCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHHh-ccHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 9995 5777766433 357889999999999999999999998 999999999999999999999999999887654
Q ss_pred CcceeeeecccCC
Q 013737 425 ITHISATLAGTLF 437 (437)
Q Consensus 425 ~~~~~~~~~Gt~~ 437 (437)
. +++||||
T Consensus 180 n-----sFvGTPy 187 (948)
T KOG0577|consen 180 N-----SFVGTPY 187 (948)
T ss_pred h-----cccCCcc
Confidence 3 5788887
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=220.04 Aligned_cols=141 Identities=23% Similarity=0.250 Sum_probs=125.1
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEecc
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (437)
..|+..++||+|+||.||++.. .+++.||+|... ...+.+|++++++++||||+++++++......++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 5699999999999999999996 468899999753 235678999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
. ++|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 166 ~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 166 K-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred C-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 5 688777632 345889999999999999999999987 9999999999999999999999999997644
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=213.34 Aligned_cols=156 Identities=28% Similarity=0.393 Sum_probs=134.0
Q ss_pred CCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCC
Q 013737 274 SNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 350 (437)
.+.||.|.||+||-|++ ++|+.||||.+.+. ......++.+|+.+|.+++||.||.+.-.+++.+.+++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 47899999999999997 57999999998653 2334478999999999999999999999999999999999999 56
Q ss_pred CccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC---CcEEEcccCCccccCCCCcc
Q 013737 351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE---FTAKIADFGLVRLFPEDITH 427 (437)
Q Consensus 351 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~---~~~ki~DFG~a~~~~~~~~~ 427 (437)
+..+++.. .+.+.+++.....++.||+.||.|||.++ |+|+||||+|||+.+. -.+||+|||+||++++..-+
T Consensus 648 DMLEMILS-sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 648 DMLEMILS-SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred hHHHHHHH-hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 77777644 34567999999999999999999999998 9999999999999643 48999999999999987654
Q ss_pred eeeeecccC
Q 013737 428 ISATLAGTL 436 (437)
Q Consensus 428 ~~~~~~Gt~ 436 (437)
. .++||+
T Consensus 724 r--sVVGTP 730 (888)
T KOG4236|consen 724 R--SVVGTP 730 (888)
T ss_pred h--hhcCCc
Confidence 2 467775
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=218.28 Aligned_cols=161 Identities=27% Similarity=0.401 Sum_probs=139.1
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
...|.+.+.||+|.|++|.++.+ .++..||||.+.+. +......+.+|+++|+.|+|||||+++.+...+..+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 45688899999999999999996 56999999999754 4444566899999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||..+|.+.+++.. ...+.+..+..++.|+..+++|+|+++ |+|||||++||||+.++++||+|||++..+...
T Consensus 135 eya~~ge~~~yl~~---~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 135 EYASGGELFDYLVK---HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EeccCchhHHHHHh---cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc
Confidence 99999999999943 344666888899999999999999998 999999999999999999999999999988743
Q ss_pred CcceeeeecccC
Q 013737 425 ITHISATLAGTL 436 (437)
Q Consensus 425 ~~~~~~~~~Gt~ 436 (437)
. ...+.+|++
T Consensus 209 ~--~lqt~cgsp 218 (596)
T KOG0586|consen 209 L--MLQTFCGSP 218 (596)
T ss_pred c--cccccCCCC
Confidence 2 223445543
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=221.60 Aligned_cols=149 Identities=30% Similarity=0.487 Sum_probs=130.0
Q ss_pred CcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCCC
Q 013737 272 HESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQS 351 (437)
Q Consensus 272 ~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 351 (437)
...+-||.|+.|.||+|+++ ++.||||+++.-. +.+|..|++|+||||+.+.|+|....-++||||||..|-
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 45678999999999999998 6889999875322 357888999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCCcceeee
Q 013737 352 LLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431 (437)
Q Consensus 352 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~~~~~~~ 431 (437)
|.+.| +...+++....+.|..+||.||.|||.+. |||||||.-||||..+..+||+|||.++...+..+. -.
T Consensus 199 L~~VL---ka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STk--MS 270 (904)
T KOG4721|consen 199 LYEVL---KAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTK--MS 270 (904)
T ss_pred HHHHH---hccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhhh--hh
Confidence 99999 44556889999999999999999999987 999999999999999999999999999988765332 24
Q ss_pred ecccC
Q 013737 432 LAGTL 436 (437)
Q Consensus 432 ~~Gt~ 436 (437)
++||.
T Consensus 271 FaGTV 275 (904)
T KOG4721|consen 271 FAGTV 275 (904)
T ss_pred hhhhH
Confidence 66763
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=207.50 Aligned_cols=148 Identities=22% Similarity=0.327 Sum_probs=130.6
Q ss_pred cCCCcCCcccccCcccEEEEEeC----CCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP----GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
++|+..+.||+|+||.||+|.+. .+..||+|.++... ......+.+|+.++.+++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46788899999999999999853 35689999987653 33456789999999999999999999999999999999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
|||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+|++|||.+...
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 85 TEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 9999999999888432 346899999999999999999999987 999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=216.03 Aligned_cols=144 Identities=30% Similarity=0.455 Sum_probs=126.2
Q ss_pred CCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEecc
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (437)
+|+..++||+|+||.||++.+. +++.||||.+... .....+.+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3456788999999999999964 6899999998654 3344567899999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
++++|.+.. ..++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 155 ~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 155 DGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred CCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 999986532 2467778899999999999999988 99999999999999999999999999987653
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-25 Score=212.64 Aligned_cols=151 Identities=26% Similarity=0.378 Sum_probs=133.6
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
.++|+..+.||+|+||.||++... ++..+|+|.+... .....+++.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 467889999999999999999975 5889999998754 33445679999999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ .|+||||||+|||+++++.+||+|||+++.+..
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 9999999998843 345889999999999999999999853 399999999999999999999999999986643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-25 Score=211.05 Aligned_cols=149 Identities=30% Similarity=0.434 Sum_probs=129.5
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
.++|+..+.||+|+||.||+|+.. +++.+|+|.+.... ......+.+|+.+++.++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467899999999999999999975 68899999986542 2234467889999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
|++ ++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 995 677776633 2345889999999999999999999998 9999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=233.75 Aligned_cols=149 Identities=36% Similarity=0.523 Sum_probs=132.2
Q ss_pred hcCCCcCCcccccCcccEEEEEeCC--CC----EEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCee
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPG--GE----AVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES 340 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 340 (437)
....+..+.||+|.||.||+|...+ +. .||||.+... +.+...+|.+|..+|++++|||||+++|++.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3445667889999999999999643 33 4899998765 566788999999999999999999999999999999
Q ss_pred EEEEeccCCCCccccccccCC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccC
Q 013737 341 LLVYEFVPNQSLLDNLFVRQD----VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG 416 (437)
+|++|||++|+|..+|...+. ...++..+.+.++.|||+|+.||++++ +|||||.++|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999964421 346899999999999999999999987 9999999999999999999999999
Q ss_pred Ccc
Q 013737 417 LVR 419 (437)
Q Consensus 417 ~a~ 419 (437)
|||
T Consensus 848 lAr 850 (1025)
T KOG1095|consen 848 LAR 850 (1025)
T ss_pred hhH
Confidence 999
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-25 Score=212.02 Aligned_cols=144 Identities=31% Similarity=0.299 Sum_probs=126.5
Q ss_pred CcccccCcccEEEEEe----CCCCEEEEEEEeccc--hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccC
Q 013737 275 NKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (437)
+.||+|+||.||+++. .+++.+|+|++.... ......+.+|++++.+++||||+++++++..++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 357899999997542 2234567889999999999999999999999999999999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 349 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
+++|.+++. +...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 151 (318)
T cd05582 82 GGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 151 (318)
T ss_pred CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence 999988873 2345899999999999999999999988 999999999999999999999999999876443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-25 Score=211.64 Aligned_cols=142 Identities=27% Similarity=0.325 Sum_probs=122.1
Q ss_pred CcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcC-CCCCceeceeEEEeeCCeeEEEEeccCC
Q 013737 275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISG-INHKNLVKLLGCSITGPESLLVYEFVPN 349 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (437)
+.||+|+||.||++... +++.||+|.++.. .....+.+..|..++.. .+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999974 5889999998753 22334556667777664 4899999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 350 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENM 147 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence 999887732 345899999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-25 Score=212.65 Aligned_cols=141 Identities=28% Similarity=0.365 Sum_probs=124.3
Q ss_pred CcccccCcccEEEEEe----CCCCEEEEEEEecc----chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 275 NKLGQGGSGSVYKGTL----PGGEAVAVKRLFYN----TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
++||+|+||.||+++. .+++.+|+|.+... .......+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 35789999998743 223345678999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
+++++|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKES 150 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence 999999888732 345788889999999999999999988 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-25 Score=218.71 Aligned_cols=158 Identities=32% Similarity=0.438 Sum_probs=133.9
Q ss_pred HHHHhcCCCcCCcccccCcccEEEEEeC------CCCEEEEEEEecc-chhhHHHHHHHHHHHcCC-CCCceeceeEEEe
Q 013737 264 LEKATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSI 335 (437)
Q Consensus 264 ~~~~~~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 335 (437)
+....++|+..+.||+|+||.||++.+. ++..||+|.+... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 3444567889999999999999999842 2457999999754 333456788999999999 8999999999999
Q ss_pred eCCeeEEEEeccCCCCccccccccC-------------------------------------------------------
Q 013737 336 TGPESLLVYEFVPNQSLLDNLFVRQ------------------------------------------------------- 360 (437)
Q Consensus 336 ~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------- 360 (437)
..+..++||||+++|+|.+++....
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 9999999999999999998874321
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 361 ------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 361 ------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
...++++..+.+++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~ 265 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCC
Confidence 1134788999999999999999999987 999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-25 Score=218.88 Aligned_cols=158 Identities=26% Similarity=0.343 Sum_probs=134.3
Q ss_pred HHHHHhcCCCcCCcccccCcccEEEEEeC------CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCC-CCceeceeEEE
Q 013737 263 TLEKATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGIN-HKNLVKLLGCS 334 (437)
Q Consensus 263 ~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 334 (437)
.++...+.|.+.++||+|+||.||+|.+. .+..||||++... .....+.+.+|+++++++. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 34555678899999999999999999853 1347999999654 3344567999999999996 99999999999
Q ss_pred eeCCeeEEEEeccCCCCccccccccC------------------------------------------------------
Q 013737 335 ITGPESLLVYEFVPNQSLLDNLFVRQ------------------------------------------------------ 360 (437)
Q Consensus 335 ~~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------ 360 (437)
...+..+|||||+++|+|.+++....
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 99999999999999999988775321
Q ss_pred ---------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCC
Q 013737 361 ---------------------------------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSN 401 (437)
Q Consensus 361 ---------------------------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~N 401 (437)
....+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~N 267 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHh
Confidence 0124788889999999999999999987 9999999999
Q ss_pred eeeCCCCcEEEcccCCccccCC
Q 013737 402 ILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 402 Ill~~~~~~ki~DFG~a~~~~~ 423 (437)
||+++++.+||+|||+++.+..
T Consensus 268 ill~~~~~~kL~DfGla~~~~~ 289 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMH 289 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccc
Confidence 9999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.9e-25 Score=211.50 Aligned_cols=150 Identities=25% Similarity=0.389 Sum_probs=132.6
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
.++|+..++||+|+||.||++.+. ++..+|+|.+... .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 467899999999999999999975 5888999988754 33445679999999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+|||+++++.+||+|||+++.+.
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 9999999998843 345889999999999999999999752 39999999999999999999999999998664
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-25 Score=205.97 Aligned_cols=154 Identities=32% Similarity=0.475 Sum_probs=138.9
Q ss_pred HHhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
.+..+|+..++||+|+||.||+|...++..+++|.+..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34566888999999999999999988899999999987766567789999999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||++..+..
T Consensus 83 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 83 LMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred ecccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 99999999988543 3356899999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.2e-25 Score=211.02 Aligned_cols=141 Identities=28% Similarity=0.339 Sum_probs=124.3
Q ss_pred CcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCeeEEEEeccCC
Q 013737 275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPN 349 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (437)
+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999974 5789999998753 334456688899888776 799999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 350 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
++|..++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 99987763 2346899999999999999999999988 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.4e-25 Score=211.00 Aligned_cols=141 Identities=28% Similarity=0.342 Sum_probs=125.0
Q ss_pred CcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCeeEEEEeccCC
Q 013737 275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPN 349 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (437)
+.||+|+||.||++... +++.||+|.++.. .....+.+.+|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999974 5889999999753 233456688999999888 699999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 350 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
++|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 146 (329)
T cd05588 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccc
Confidence 99988773 2346899999999999999999999988 999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.8e-25 Score=203.38 Aligned_cols=148 Identities=28% Similarity=0.412 Sum_probs=131.3
Q ss_pred cCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccC
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (437)
++|+..+.||+|+||.||++.++++..+|+|.+.... ...+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4577788999999999999999888889999876432 234678899999999999999999999999999999999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 349 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
+++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL 151 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccC
Confidence 99999887432 235899999999999999999999987 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.8e-25 Score=215.23 Aligned_cols=147 Identities=28% Similarity=0.407 Sum_probs=127.8
Q ss_pred CCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC-----eeE
Q 013737 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP-----ESL 341 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 341 (437)
+|+..++||+|+||.||++.. .+++.||+|++... .....+++.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999996 46899999998643 3334567889999999999999999999998776 789
Q ss_pred EEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
+|+||+. ++|.+.+. ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 57777662 3346899999999999999999999988 999999999999999999999999999876
Q ss_pred CC
Q 013737 422 PE 423 (437)
Q Consensus 422 ~~ 423 (437)
..
T Consensus 154 ~~ 155 (372)
T cd07853 154 EP 155 (372)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.7e-25 Score=210.48 Aligned_cols=144 Identities=32% Similarity=0.413 Sum_probs=124.5
Q ss_pred CCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc---hhhHHHHHHHHHHH---cCCCCCceeceeEEEeeCCeeEEE
Q 013737 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLI---SGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
|+..+.||+|+||.||++.+. +++.||||.++... ....+.+.+|++++ ..++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567789999999999999964 68999999997532 23345666676554 677899999999999999999999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
|||+++++|...+. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 99999999987763 245899999999999999999999987 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.2e-25 Score=209.87 Aligned_cols=150 Identities=29% Similarity=0.504 Sum_probs=129.4
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCC----EEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGE----AVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
.+|+..+.||+|+||.||+|.+. +++ .||+|.+... .....+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46889999999999999999863 333 4899998654 334567899999999999999999999998764 5789
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
++||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999988432 345889999999999999999999987 9999999999999999999999999999875
Q ss_pred CC
Q 013737 423 ED 424 (437)
Q Consensus 423 ~~ 424 (437)
..
T Consensus 161 ~~ 162 (316)
T cd05108 161 AD 162 (316)
T ss_pred CC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=205.43 Aligned_cols=145 Identities=23% Similarity=0.307 Sum_probs=126.0
Q ss_pred ccccCcccEEEEEeC-CCCEEEEEEEeccc---hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCCCc
Q 013737 277 LGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL 352 (437)
Q Consensus 277 Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 352 (437)
||+|+||+||++... +++.+|+|.+.... ....+.+..|+++++.++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999964 68899999986432 22345678899999999999999999999999999999999999999
Q ss_pred ccccccc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 353 LDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 353 ~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
.+.+... .....+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDG 150 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence 8776432 23356899999999999999999999987 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=209.96 Aligned_cols=147 Identities=29% Similarity=0.300 Sum_probs=127.1
Q ss_pred CCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc---hhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCeeEEEE
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 344 (437)
+|+..+.||+|+||.||++... +++.+|+|.+.... ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999975 57899999987542 23345567788888777 5899999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
||+++|+|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 99999999887733 345889999999999999999999987 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=209.65 Aligned_cols=146 Identities=29% Similarity=0.315 Sum_probs=127.3
Q ss_pred CCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCC-ceeceeEEEeeCCeeEEEE
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHK-NLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 344 (437)
+|+..+.||+|+||.||+|... +++.||+|.+... .....+.+..|.+++..++|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999975 5789999998753 233456788899999999765 6888999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
||+++++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 81 EYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 9999999988773 2345889999999999999999999987 999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=210.00 Aligned_cols=142 Identities=29% Similarity=0.340 Sum_probs=124.1
Q ss_pred CcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCeeEEEEeccCC
Q 013737 275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPN 349 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (437)
++||+|+||.||+|+.. +++.||+|.+... .....+.+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999975 5789999998754 233455677888888765 799999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 350 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
++|...+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~ 147 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGI 147 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecc
Confidence 999887742 345889999999999999999999998 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.2e-25 Score=212.09 Aligned_cols=146 Identities=24% Similarity=0.392 Sum_probs=125.5
Q ss_pred CCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC-----eeE
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP-----ESL 341 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 341 (437)
+|+..++||+|+||.||++... +++.||||++... ......++.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999964 6899999998643 2334557889999999999999999999876433 479
Q ss_pred EEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
+||||++ ++|.+.+. ....+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 68888773 3345899999999999999999999998 999999999999999999999999999865
Q ss_pred C
Q 013737 422 P 422 (437)
Q Consensus 422 ~ 422 (437)
.
T Consensus 154 ~ 154 (338)
T cd07859 154 F 154 (338)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=203.35 Aligned_cols=151 Identities=32% Similarity=0.482 Sum_probs=134.4
Q ss_pred hcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEecc
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (437)
.++|+..++||+|+||.||+|...++..|++|.+..... ..+.+.+|+.++++++|+||+++++.+...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 356888999999999999999988888999998865432 3568899999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCC
Confidence 999999988543 3345888999999999999999999987 99999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=202.34 Aligned_cols=149 Identities=28% Similarity=0.418 Sum_probs=131.7
Q ss_pred cCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccC
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (437)
++|+..+.||+|+||.||++.+.++..+|+|.+.... ...+.+.+|+.++.+++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 3577788999999999999998777789999886443 234678999999999999999999999998889999999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 349 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
+++|.+++... ...+++..++.++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||+++....
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCC
Confidence 99999987432 236899999999999999999999987 99999999999999999999999999986644
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=204.51 Aligned_cols=151 Identities=32% Similarity=0.496 Sum_probs=132.3
Q ss_pred cCCCcCCcccccCcccEEEEEe-----CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeC--CeeE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-----PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PESL 341 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 341 (437)
++|+..+.||+|+||.||++.. .++..|++|.+........+.+.+|++++.+++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4678889999999999999974 35789999999876666677899999999999999999999987543 4678
Q ss_pred EEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
+|+||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999988432 345899999999999999999999987 999999999999999999999999999977
Q ss_pred CCC
Q 013737 422 PED 424 (437)
Q Consensus 422 ~~~ 424 (437)
...
T Consensus 159 ~~~ 161 (284)
T cd05081 159 PQD 161 (284)
T ss_pred cCC
Confidence 543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=205.94 Aligned_cols=150 Identities=27% Similarity=0.310 Sum_probs=130.9
Q ss_pred CCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc---hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
.|+..++||+|+||.||++.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 367789999999999999996 468899999986532 2223457889999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+++.+..
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99999998877432 2346899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=209.49 Aligned_cols=141 Identities=29% Similarity=0.334 Sum_probs=121.9
Q ss_pred CcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHH-HHcCCCCCceeceeEEEeeCCeeEEEEeccCC
Q 013737 275 NKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVN-LISGINHKNLVKLLGCSITGPESLLVYEFVPN 349 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (437)
+.||+|+||.||++.. .+|+.+|+|++... .......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999996 46899999998643 2233445566655 56789999999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 350 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
++|...+. ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 99988773 3456899999999999999999999988 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=209.09 Aligned_cols=141 Identities=29% Similarity=0.330 Sum_probs=121.6
Q ss_pred CcccccCcccEEEEEeC-CCCEEEEEEEeccc---hhhHHHHHHHHH-HHcCCCCCceeceeEEEeeCCeeEEEEeccCC
Q 013737 275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVN-LISGINHKNLVKLLGCSITGPESLLVYEFVPN 349 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (437)
+.||+|+||.||++... +++.||+|.+.... .....++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999974 68999999986432 223344555555 56789999999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 350 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 999887743 346889999999999999999999988 999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=208.72 Aligned_cols=141 Identities=29% Similarity=0.323 Sum_probs=121.1
Q ss_pred CcccccCcccEEEEEeC-CCCEEEEEEEeccc---hhhHHHHHHHHH-HHcCCCCCceeceeEEEeeCCeeEEEEeccCC
Q 013737 275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVN-LISGINHKNLVKLLGCSITGPESLLVYEFVPN 349 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (437)
++||+|+||.||+++.. +++.+|+|.+.... ......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999974 58899999986432 223345556654 67889999999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 350 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
++|...+. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 99987773 2345888999999999999999999987 999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=203.07 Aligned_cols=152 Identities=30% Similarity=0.416 Sum_probs=135.0
Q ss_pred HhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
..++|+..+.||+|++|.||++.+.+++.||+|.++... ...+++.+|+.++++++||||+++++++...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 345688899999999999999998778899999986543 2356789999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 99999999885432 346899999999999999999999987 99999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=218.51 Aligned_cols=159 Identities=23% Similarity=0.369 Sum_probs=134.1
Q ss_pred CCcCCcccccCcccEEEEEeC-CCCEEEEEEEec----cchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCe--eEEE
Q 013737 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFY----NTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE--SLLV 343 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv 343 (437)
.+...+||+|+|-+||+|.+. +|..||--.++. ..+...++|..|+.+|+.|+||||++++.+|.+... +.+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 345678999999999999974 577777544432 245567899999999999999999999999987765 7799
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC-CCcEEEcccCCccccC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFGLVRLFP 422 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~-~~~~ki~DFG~a~~~~ 422 (437)
+|.+..|+|..++. +.+.++...+..|++||++||.|||++. |||||||||.+||+|+. .|.+||+|+|||....
T Consensus 122 TEL~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 122 TELFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eecccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 99999999999884 3455888999999999999999999997 78999999999999985 4899999999999887
Q ss_pred CCCcceeeeecccC
Q 013737 423 EDITHISATLAGTL 436 (437)
Q Consensus 423 ~~~~~~~~~~~Gt~ 436 (437)
..... .+.|||
T Consensus 198 ~s~ak---svIGTP 208 (632)
T KOG0584|consen 198 KSHAK---SVIGTP 208 (632)
T ss_pred ccccc---eeccCc
Confidence 65543 367886
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=201.61 Aligned_cols=149 Identities=30% Similarity=0.410 Sum_probs=133.7
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
.++|+..+.||+|+||.||+|.. .+++.+|+|++..........+.+|+.++.+++||||+++++.+..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35688999999999999999996 56889999998765545556788999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
+++++|.+++.. ..++++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 999999988732 346899999999999999999999987 9999999999999999999999999998664
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=208.74 Aligned_cols=141 Identities=31% Similarity=0.389 Sum_probs=123.7
Q ss_pred CcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCeeEEEEeccCC
Q 013737 275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPN 349 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (437)
+.||+|+||.||+++.. +++.||+|.+... .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 5889999998753 223456677888888776 699999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 350 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 999887733 345899999999999999999999988 999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.5e-25 Score=221.50 Aligned_cols=160 Identities=22% Similarity=0.258 Sum_probs=136.0
Q ss_pred HHHHHHHhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeC
Q 013737 261 YETLEKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG 337 (437)
Q Consensus 261 ~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 337 (437)
..+.+...++|...+.||+|+||.||++.. .+++.||||.+... .......+.+|+.++..++|+||+++++.+...
T Consensus 24 ~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 24 EATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred cccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 344555667899999999999999999986 56899999998654 344566788999999999999999998876543
Q ss_pred C--------eeEEEEeccCCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC
Q 013737 338 P--------ESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408 (437)
Q Consensus 338 ~--------~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~ 408 (437)
+ ..++||||+++|+|.+++..+. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~ 180 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNG 180 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCC
Confidence 2 3679999999999999885432 2356899999999999999999999987 99999999999999999
Q ss_pred cEEEcccCCccccCC
Q 013737 409 TAKIADFGLVRLFPE 423 (437)
Q Consensus 409 ~~ki~DFG~a~~~~~ 423 (437)
.+||+|||+++.+..
T Consensus 181 ~vkL~DFGls~~~~~ 195 (496)
T PTZ00283 181 LVKLGDFGFSKMYAA 195 (496)
T ss_pred CEEEEecccCeeccc
Confidence 999999999987654
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=201.57 Aligned_cols=151 Identities=26% Similarity=0.421 Sum_probs=131.8
Q ss_pred cCCCcCCcccccCcccEEEEEeC-C---CCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-G---GEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
++|+..+.||+|+||.||+|.+. + +..+|+|.++... ....+.+.+|+.++.+++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46788899999999999999863 2 3378999886542 33456889999999999999999999999999999999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|||+++++|.+++... ...+++.++..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999988432 346899999999999999999999987 99999999999999999999999999987755
Q ss_pred C
Q 013737 424 D 424 (437)
Q Consensus 424 ~ 424 (437)
.
T Consensus 159 ~ 159 (267)
T cd05066 159 D 159 (267)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=207.99 Aligned_cols=141 Identities=26% Similarity=0.326 Sum_probs=124.6
Q ss_pred CcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCeeEEEEeccCC
Q 013737 275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPN 349 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (437)
++||+|+||.||++... +++.+|+|.+... .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999974 5789999999754 233456788999999888 699999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 350 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 99988773 2346899999999999999999999988 999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=217.08 Aligned_cols=160 Identities=33% Similarity=0.467 Sum_probs=142.3
Q ss_pred HHHHHHHhcCCCcCCcccccCcccEEEEEeCC-CCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCe
Q 013737 261 YETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE 339 (437)
Q Consensus 261 ~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 339 (437)
+++|+-...+.....+||-|.||.||.|.|+. .-.||||.++.+. ...++|+.|..+|+.++|||+|+|+|+|..+..
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 35566666677888999999999999999965 5689999997654 457899999999999999999999999999999
Q ss_pred eEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcc
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~ 419 (437)
.|||+|||..|+|.++|... +...++....+.++.||..||+||..++ +|||||.++|+|+.++..+||+|||++|
T Consensus 338 FYIiTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred eEEEEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhh
Confidence 99999999999999999544 3456788888999999999999999988 9999999999999999999999999999
Q ss_pred ccCCCC
Q 013737 420 LFPEDI 425 (437)
Q Consensus 420 ~~~~~~ 425 (437)
++..+.
T Consensus 414 lMtgDT 419 (1157)
T KOG4278|consen 414 LMTGDT 419 (1157)
T ss_pred hhcCCc
Confidence 997653
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=200.24 Aligned_cols=148 Identities=30% Similarity=0.429 Sum_probs=131.1
Q ss_pred CCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCC
Q 013737 270 YFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN 349 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (437)
+|+..+.||+|+||.||++.++++..+|+|.+..... ..+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4778899999999999999988777899998864332 245688999999999999999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 350 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++...+
T Consensus 84 ~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 84 GCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD 152 (256)
T ss_pred CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccc
Confidence 9999988433 236899999999999999999999988 99999999999999999999999999986643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=200.49 Aligned_cols=149 Identities=26% Similarity=0.421 Sum_probs=132.1
Q ss_pred cCCCcCCcccccCcccEEEEEeCC----CCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
++|+..+.||+|+||.||+|.+.. ...|+||.+... ......+|.+|+.++.+++||||+++++.+...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568889999999999999999742 457999988654 334456789999999999999999999999999999999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
|||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+|||+++++.+||+|||+++.+.
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999987432 346899999999999999999999987 9999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=206.50 Aligned_cols=148 Identities=28% Similarity=0.396 Sum_probs=128.2
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
+.|...++||+|+||.||++... +++.+|+|.+.... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888999999999999999975 57889999987542 22344678899999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
+++ +|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecC
Confidence 975 777766332 345788999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-25 Score=193.66 Aligned_cols=156 Identities=25% Similarity=0.324 Sum_probs=138.9
Q ss_pred HHhcCCCcCCcccccCcccEEEEE-eCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC-----e
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP-----E 339 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~ 339 (437)
...++|.+.++||+|||+.||+++ ..++..+|+|++.....+..+..++|++..++++|||+++++++...+. +
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 445789999999999999999999 5678999999998877778889999999999999999999998765443 4
Q ss_pred eEEEEeccCCCCccccccccCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCc
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a 418 (437)
.||+++|...|+|.+.+...+.. ..+++.+.+.|+.+|++||++||+.. +++.||||||.|||+.+.+.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 89999999999999988655443 46999999999999999999999986 57999999999999999999999999998
Q ss_pred cccC
Q 013737 419 RLFP 422 (437)
Q Consensus 419 ~~~~ 422 (437)
...+
T Consensus 177 ~~a~ 180 (302)
T KOG2345|consen 177 TQAP 180 (302)
T ss_pred cccc
Confidence 7654
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=207.77 Aligned_cols=147 Identities=28% Similarity=0.316 Sum_probs=127.3
Q ss_pred CCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCC-CCceeceeEEEeeCCeeEEEE
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 344 (437)
+|+..+.||+|+||.||++... +++.||+|.+... .....+.+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677889999999999999964 6889999998753 2233456788899888886 577888999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
||+++|+|.+++. ....+++.++..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 9999999988873 3346899999999999999999999987 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=206.64 Aligned_cols=142 Identities=27% Similarity=0.290 Sum_probs=120.3
Q ss_pred CcccccCcccEEEEEeC-CCCEEEEEEEeccc---hhhHHHHHHHHH-HHcCCCCCceeceeEEEeeCCeeEEEEeccCC
Q 013737 275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVN-LISGINHKNLVKLLGCSITGPESLLVYEFVPN 349 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (437)
+.||+|+||.||++... +++.+|+|.+.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999975 57889999986432 222334444544 56889999999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 350 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~ 147 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 147 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccc
Confidence 999888743 345788888999999999999999998 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-24 Score=202.59 Aligned_cols=151 Identities=28% Similarity=0.446 Sum_probs=130.7
Q ss_pred cCCCcCCcccccCcccEEEEEe-----CCCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-----PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
+.|+..+.||+|+||.||+|.+ .++..+++|.+... .......+.+|+++++.++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3577789999999999999984 24678999998743 33445678999999999999999999999999999999
Q ss_pred EEeccCCCCccccccccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC
Q 013737 343 VYEFVPNQSLLDNLFVRQD--------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~ 408 (437)
||||+++++|.+++..... ...+++.+++.++.|++.||.|||+.+ |+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999988743221 234789999999999999999999987 99999999999999999
Q ss_pred cEEEcccCCccccC
Q 013737 409 TAKIADFGLVRLFP 422 (437)
Q Consensus 409 ~~ki~DFG~a~~~~ 422 (437)
.+||+|||+++...
T Consensus 162 ~~kl~dfg~~~~~~ 175 (283)
T cd05090 162 HVKISDLGLSREIY 175 (283)
T ss_pred cEEecccccccccc
Confidence 99999999998654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=206.28 Aligned_cols=141 Identities=28% Similarity=0.330 Sum_probs=122.6
Q ss_pred CcccccCcccEEEEEeC-CCCEEEEEEEeccc---hhhHHHHHHHHHHHcC-CCCCceeceeEEEeeCCeeEEEEeccCC
Q 013737 275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISG-INHKNLVKLLGCSITGPESLLVYEFVPN 349 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (437)
+.||+|+||.||++++. +++.||+|.++... ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999975 58899999997542 2334566778887765 4899999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 350 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 999887733 345889999999999999999999988 999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-24 Score=205.64 Aligned_cols=141 Identities=28% Similarity=0.350 Sum_probs=122.7
Q ss_pred CcccccCcccEEEEEeC-CCCEEEEEEEeccc---hhhHHHHHHHHHHHcC-CCCCceeceeEEEeeCCeeEEEEeccCC
Q 013737 275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISG-INHKNLVKLLGCSITGPESLLVYEFVPN 349 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (437)
+.||+|+||.||+|... +++.||+|.++... ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 57899999997542 2334556778888775 5899999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 350 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 999988742 345889999999999999999999987 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-24 Score=203.29 Aligned_cols=150 Identities=29% Similarity=0.442 Sum_probs=122.9
Q ss_pred cCCCcCCcccccCcccEEEEEeC--CCCEEEEEEEeccc--hhhHHHHHHHHHHHcCC---CCCceeceeEEEe-----e
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP--GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGI---NHKNLVKLLGCSI-----T 336 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~ 336 (437)
++|+..+.||+|+||.||++... ++..||+|.+.... ......+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 46889999886432 22334566777766655 6999999999875 2
Q ss_pred CCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccC
Q 013737 337 GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (437)
Q Consensus 337 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG 416 (437)
....++||||++ ++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346899999996 6888877432 2345899999999999999999999988 9999999999999999999999999
Q ss_pred CccccCC
Q 013737 417 LVRLFPE 423 (437)
Q Consensus 417 ~a~~~~~ 423 (437)
+++....
T Consensus 156 ~~~~~~~ 162 (290)
T cd07862 156 LARIYSF 162 (290)
T ss_pred ceEeccC
Confidence 9987654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.9e-24 Score=197.82 Aligned_cols=143 Identities=28% Similarity=0.453 Sum_probs=126.8
Q ss_pred CcccccCcccEEEEEeC-CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCCCc
Q 013737 275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL 352 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 352 (437)
+.||+|+||.||++.+. +++.+|+|.+... .......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999974 6889999987644 334456799999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 353 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 145 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEE 145 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccc
Confidence 988743 2345899999999999999999999987 9999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4e-24 Score=202.14 Aligned_cols=143 Identities=21% Similarity=0.329 Sum_probs=124.6
Q ss_pred CCcccccCcccEEEEEeCCCCEEEEEEEeccch---hhHHHHHHHHHHHcCCCCCceeceeEEEee----CCeeEEEEec
Q 013737 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT---QWVDHFFNEVNLISGINHKNLVKLLGCSIT----GPESLLVYEF 346 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~ 346 (437)
...|++|+++.||+|.+ +|+.||||.+..... ...+.|.+|+.+|.+++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 46799999999999998 488999999865432 235778899999999999999999999877 3467899999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
+++|+|.+++.. ...+++.....++.|++.||.|||+. + ++||||||+|||+++++.+||+|||+++.+..
T Consensus 104 ~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 104 CTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred CCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 999999998843 34688999999999999999999984 5 78999999999999999999999999986543
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=202.02 Aligned_cols=153 Identities=30% Similarity=0.461 Sum_probs=131.2
Q ss_pred HhcCCCcCCcccccCcccEEEEEeC------CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCe
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE 339 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 339 (437)
..++|+..+.||+|+||.||++.+. .+..+|+|.+... ......++.+|+.+++.++||||+++++++..+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999999753 2467999988643 23345678999999999999999999999999999
Q ss_pred eEEEEeccCCCCccccccccCC-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQD-------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI 412 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki 412 (437)
.++||||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999988754221 234678889999999999999999987 999999999999999999999
Q ss_pred cccCCccccC
Q 013737 413 ADFGLVRLFP 422 (437)
Q Consensus 413 ~DFG~a~~~~ 422 (437)
+|||+++.+.
T Consensus 161 ~dfg~~~~~~ 170 (277)
T cd05062 161 GDFGMTRDIY 170 (277)
T ss_pred CCCCCccccC
Confidence 9999997653
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=224.95 Aligned_cols=150 Identities=22% Similarity=0.307 Sum_probs=131.6
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..++||+|+||.||+|... +++.||+|++... .....+++.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888999999999999999974 5899999998643 2334567999999999999999999999999999999999
Q ss_pred eccCCCCccccccccC--------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccC
Q 013737 345 EFVPNQSLLDNLFVRQ--------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG 416 (437)
||+++++|.+++.... ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999998874321 1234667888999999999999999987 9999999999999999999999999
Q ss_pred Ccccc
Q 013737 417 LVRLF 421 (437)
Q Consensus 417 ~a~~~ 421 (437)
+++..
T Consensus 159 LAk~i 163 (932)
T PRK13184 159 AAIFK 163 (932)
T ss_pred cceec
Confidence 99876
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=203.88 Aligned_cols=149 Identities=26% Similarity=0.365 Sum_probs=131.2
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
++|+..+.||+|+||.||++.+. ++..+++|.+... ......++.+|++++.+++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999964 5788999988654 334456788999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
+++++|.+++.. ...+++..+..++.|+++||.|||+.. +++|+||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 999999998843 356899999999999999999999741 39999999999999999999999999987654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-24 Score=212.58 Aligned_cols=156 Identities=28% Similarity=0.394 Sum_probs=132.9
Q ss_pred HHHHhcCCCcCCcccccCcccEEEEEeC------CCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCC-CCceeceeEEEe
Q 013737 264 LEKATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGIN-HKNLVKLLGCSI 335 (437)
Q Consensus 264 ~~~~~~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 335 (437)
++...++|...++||+|+||.||+|.+. .+..||+|++.... ....+.+.+|+.+|.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4555567888899999999999999863 24689999997542 333457889999999997 999999999999
Q ss_pred eCCeeEEEEeccCCCCccccccccCC------------------------------------------------------
Q 013737 336 TGPESLLVYEFVPNQSLLDNLFVRQD------------------------------------------------------ 361 (437)
Q Consensus 336 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------ 361 (437)
..+..++||||+++|+|.+++.....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999988854211
Q ss_pred -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCC
Q 013737 362 -----------------------------------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLS 400 (437)
Q Consensus 362 -----------------------------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~ 400 (437)
...+++..++.++.|++.||.|||+.+ |+||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence 124678888999999999999999987 999999999
Q ss_pred CeeeCCCCcEEEcccCCccccC
Q 013737 401 NILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 401 NIll~~~~~~ki~DFG~a~~~~ 422 (437)
|||+++++.+||+|||+++.+.
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~ 290 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIM 290 (401)
T ss_pred eEEEeCCCEEEEEecCcceecc
Confidence 9999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-24 Score=200.38 Aligned_cols=144 Identities=31% Similarity=0.412 Sum_probs=122.9
Q ss_pred CcccccCcccEEEEEeCC---CCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCC
Q 013737 275 NKLGQGGSGSVYKGTLPG---GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 350 (437)
+.||+|+||.||+|...+ ...+++|.+... .......+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 346888877544 3344567889999999999999999999999999999999999999
Q ss_pred CccccccccCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 351 SLLDNLFVRQD--VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 351 ~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
+|.+++..... ....++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 150 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQ 150 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecccccccc
Confidence 99998854332 233567888999999999999999987 999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-24 Score=201.35 Aligned_cols=150 Identities=26% Similarity=0.365 Sum_probs=135.5
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
.++|+..+.||+|+||.||++.+. ++..+|+|.+........+.+.+|++++++++||||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 456888899999999999999974 5889999999877666778899999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++....
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 9999999887432 346899999999999999999999998 9999999999999999999999999987654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-24 Score=224.79 Aligned_cols=149 Identities=26% Similarity=0.328 Sum_probs=132.8
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|.+.++||+|+||.||+|.+. +++.||||++... .......+.+|+.++..++||||+++++++...+..+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56888999999999999999975 6899999998643 2334567889999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
||+++++|.+++.. ...+++..++.|+.||+.||.|||..+ |+||||||+||||+.++.+||+|||+++....
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~~~~ 156 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCccccC
Confidence 99999999998843 345888999999999999999999987 99999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-24 Score=204.92 Aligned_cols=141 Identities=31% Similarity=0.371 Sum_probs=124.1
Q ss_pred CcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCeeEEEEeccCC
Q 013737 275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPN 349 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (437)
+.||+|+||.||++... +++.+|+|.+... .....+.+.+|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 5789999999754 233456678899988877 699999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 350 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
++|...+. ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 81 GDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 99988773 2346899999999999999999999987 999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-24 Score=200.92 Aligned_cols=145 Identities=38% Similarity=0.586 Sum_probs=126.1
Q ss_pred cCCcccccCcccEEEEEeC-----CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 273 ESNKLGQGGSGSVYKGTLP-----GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 273 ~~~~Lg~G~~g~V~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
..+.||.|.||.||+|.+. .+..|+||.+... .....+.|.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999976 2568999999654 344578899999999999999999999999988889999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
+++|+|.++|... ....+++..+..|+.||++||.|||+.+ ++|+||+++||++++++.+||+|||+++..
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPI 153 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 9999999998654 2456899999999999999999999987 999999999999999999999999999877
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.91 E-value=4e-24 Score=202.66 Aligned_cols=154 Identities=29% Similarity=0.456 Sum_probs=131.2
Q ss_pred HHhcCCCcCCcccccCcccEEEEEeC------CCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGP 338 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 338 (437)
...++|++.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 34677899999999999999999753 24579999876443 233456889999999999999999999999999
Q ss_pred eeEEEEeccCCCCccccccccCC-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 013737 339 ESLLVYEFVPNQSLLDNLFVRQD-------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAK 411 (437)
Q Consensus 339 ~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~k 411 (437)
..++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 99999999999999999854221 234577888999999999999999987 99999999999999999999
Q ss_pred EcccCCccccC
Q 013737 412 IADFGLVRLFP 422 (437)
Q Consensus 412 i~DFG~a~~~~ 422 (437)
|+|||+++.+.
T Consensus 160 L~Dfg~~~~~~ 170 (288)
T cd05061 160 IGDFGMTRDIY 170 (288)
T ss_pred ECcCCcccccc
Confidence 99999998653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-25 Score=228.35 Aligned_cols=168 Identities=26% Similarity=0.216 Sum_probs=148.8
Q ss_pred HHHHHhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC
Q 013737 263 TLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP 338 (437)
Q Consensus 263 ~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 338 (437)
+++-..++|.+.++||+|+||.|..++++ +++.+|+|++.+- ......-|..|-.+|..-+.+-|++++-.|+++.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 44455678999999999999999999985 5889999998652 2334567889999999999999999999999999
Q ss_pred eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCc
Q 013737 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (437)
Q Consensus 339 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a 418 (437)
++|+|||||+||+|..++. +..++++..+..++..|..||.-||+.| +|||||||+|||||..|++||+|||.+
T Consensus 149 ~LYlVMdY~pGGDlltLlS---k~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLS---KFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred ceEEEEecccCchHHHHHh---hcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhH
Confidence 9999999999999999883 3337999999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCcceeeeecccC
Q 013737 419 RLFPEDITHISATLAGTL 436 (437)
Q Consensus 419 ~~~~~~~~~~~~~~~Gt~ 436 (437)
-.+..+.+..+...+|||
T Consensus 223 lkm~~dG~V~s~~aVGTP 240 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTP 240 (1317)
T ss_pred HhcCCCCcEEeccccCCC
Confidence 999988877777889997
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.9e-25 Score=205.26 Aligned_cols=165 Identities=30% Similarity=0.348 Sum_probs=136.2
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc-------hhhHHHHHHHHHHHcCCCCCceeceeEEEe-eCCe
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT-------TQWVDHFFNEVNLISGINHKNLVKLLGCSI-TGPE 339 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~ 339 (437)
++|-...+||+|+|++||++.+ ...+.||||+-..+. ....+...+|.++.+.|+||.||++++++. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 4566778999999999999985 557889999764331 122345678999999999999999999886 4556
Q ss_pred eEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC---CCcEEEcccC
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---EFTAKIADFG 416 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~---~~~~ki~DFG 416 (437)
.+-|+||++|.+|.-+|. ....+++.++..|+.||..||.||.+. ++||||-||||.|||+.+ -|.+||+|||
T Consensus 543 FCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 789999999999988883 445689999999999999999999998 478999999999999954 4799999999
Q ss_pred CccccCCCCcc------eeeeecccCC
Q 013737 417 LVRLFPEDITH------ISATLAGTLF 437 (437)
Q Consensus 417 ~a~~~~~~~~~------~~~~~~Gt~~ 437 (437)
++++++++... .+...+||+|
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYW 645 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYW 645 (775)
T ss_pred hhhhccCCccCcccceeeecccCceee
Confidence 99999765432 3446789987
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=214.34 Aligned_cols=144 Identities=25% Similarity=0.346 Sum_probs=126.5
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
...|...+.||+|+||.||++.+. .++.||||... ...+.+|+++|++++|+||+++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 456889999999999999999975 47889999643 23456899999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
+. ++|.+++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARG 312 (461)
T ss_pred cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence 95 688877643 2346899999999999999999999988 99999999999999999999999999987654
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.9e-24 Score=200.02 Aligned_cols=149 Identities=28% Similarity=0.460 Sum_probs=130.6
Q ss_pred CCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
+|+..+.||+|++|.||+|... +++.||+|.+... .....+.+.+|+.++..++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999974 6899999998643 233356788999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
++ ++|.+++........+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+++...
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence 97 688877754444467899999999999999999999987 9999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=195.14 Aligned_cols=143 Identities=34% Similarity=0.496 Sum_probs=127.2
Q ss_pred CcccccCcccEEEEEeCCCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCCCcc
Q 013737 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLL 353 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 353 (437)
++||+|+||.||++...++..+|+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 4799999999999998888999999986553 334457899999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 354 DNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 354 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
+++... ...+++..+..++.|++.+|.|||+.+ ++|+||||+||++++++.+||+|||+++...
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 144 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQED 144 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecc
Confidence 887432 345889999999999999999999987 9999999999999999999999999997644
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.4e-24 Score=199.70 Aligned_cols=147 Identities=29% Similarity=0.410 Sum_probs=131.3
Q ss_pred CCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCC
Q 013737 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN 349 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (437)
|+..+.||+|+||.||++... ++..+++|.+........+.+.+|+++++.++||||+++++.+..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 566788999999999999975 4778899998766666677899999999999999999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 350 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
++|..++.. ...++++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT 154 (282)
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccc
Confidence 999887643 2346899999999999999999999987 9999999999999999999999999987654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.9e-24 Score=198.26 Aligned_cols=150 Identities=33% Similarity=0.501 Sum_probs=132.2
Q ss_pred HhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
..+.|+..++||+|+||.||++..++++.+|+|.+..... ...++.+|+.++++++||||+++++++ ..+..+++|||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEc
Confidence 4567888999999999999999988889999999875433 346789999999999999999999986 45678999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
+++++|.+++... ....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++...
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 82 MENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred CCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 9999999987443 3356899999999999999999999987 9999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.4e-24 Score=197.98 Aligned_cols=150 Identities=32% Similarity=0.466 Sum_probs=130.0
Q ss_pred hcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEecc
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (437)
.++|+..++||+|+||.||++.+.+...||+|.+..... ..+++.+|++++.+++||||+++++.+. .+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 356889999999999999999987777899999875332 3457899999999999999999999874 45679999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.+..
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 999999988532 2345789999999999999999999987 99999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.3e-24 Score=196.74 Aligned_cols=149 Identities=32% Similarity=0.541 Sum_probs=133.5
Q ss_pred hcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEecc
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (437)
.++|+..+.||+|+||.||++... ++.|++|.+..... ..+++.+|+.++..++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 356788899999999999999876 78899999976544 5678999999999999999999999999889999999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++...
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccc
Confidence 9999999874332 236899999999999999999999988 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.6e-24 Score=200.70 Aligned_cols=151 Identities=26% Similarity=0.419 Sum_probs=132.8
Q ss_pred cCCCcCCcccccCcccEEEEEeC------CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++.+++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 56888999999999999999852 245689998876666667789999999999999999999999999999999
Q ss_pred EEeccCCCCccccccccC----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 013737 343 VYEFVPNQSLLDNLFVRQ----------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI 412 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki 412 (437)
||||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999998875322 2235899999999999999999999987 999999999999999999999
Q ss_pred cccCCccccC
Q 013737 413 ADFGLVRLFP 422 (437)
Q Consensus 413 ~DFG~a~~~~ 422 (437)
+|||+++...
T Consensus 162 ~dfg~~~~~~ 171 (288)
T cd05093 162 GDFGMSRDVY 171 (288)
T ss_pred ccCCcccccc
Confidence 9999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.7e-24 Score=198.02 Aligned_cols=150 Identities=28% Similarity=0.477 Sum_probs=125.4
Q ss_pred CCcCCcccccCcccEEEEEeCC-CC--EEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeC------Ce
Q 013737 271 FHESNKLGQGGSGSVYKGTLPG-GE--AVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG------PE 339 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 339 (437)
|...++||+|+||.||+|.+.. +. .+|+|.++.. .....+.+.+|+++++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467899999999999999754 33 6899988643 344567899999999999999999999987532 24
Q ss_pred eEEEEeccCCCCcccccccc---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccC
Q 013737 340 SLLVYEFVPNQSLLDNLFVR---QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG 416 (437)
.+++|||+++++|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999998876322 12345899999999999999999999987 9999999999999999999999999
Q ss_pred CccccCC
Q 013737 417 LVRLFPE 423 (437)
Q Consensus 417 ~a~~~~~ 423 (437)
+++.+..
T Consensus 158 ~~~~~~~ 164 (272)
T cd05075 158 LSKKIYN 164 (272)
T ss_pred cccccCc
Confidence 9987653
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=199.37 Aligned_cols=148 Identities=30% Similarity=0.403 Sum_probs=132.7
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEecc
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (437)
++|+..++||+|+||.||++.. .+++.+|+|.++.........+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4577788999999999999986 458899999987665555667889999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
++++|.+++. ....+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+.
T Consensus 89 ~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 89 GGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQIT 157 (267)
T ss_pred CCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence 9999999873 2346899999999999999999999998 9999999999999999999999999987654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-24 Score=199.12 Aligned_cols=150 Identities=33% Similarity=0.489 Sum_probs=132.4
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEecc
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (437)
.+|...+.||+|+||.||++.+. .+..+++|.+..+. ...+++.+|++++..++||||+++++++...+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45777889999999999999974 58899999986543 34567899999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
++++|.+++... ....+++..++.++.|+++||.|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 999999987432 2345899999999999999999999987 99999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=199.30 Aligned_cols=149 Identities=28% Similarity=0.384 Sum_probs=134.0
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
.+.|+..++||+|+||.||+++.. +++.+++|.+........+.+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 466888999999999999999975 4889999999877766778899999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
+++++|..++.. ....+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 91 ~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 91 CPGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceec
Confidence 999999876632 2345899999999999999999999987 999999999999999999999999998754
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.5e-24 Score=201.36 Aligned_cols=150 Identities=27% Similarity=0.421 Sum_probs=134.7
Q ss_pred HhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
...+|+..+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 346788999999999999999996 5689999999976655556778999999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|+++++|.+++. ...+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 97 ~~~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 97 YLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred ccCCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 999999998873 234789999999999999999999987 99999999999999999999999999986644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.4e-24 Score=199.37 Aligned_cols=141 Identities=26% Similarity=0.352 Sum_probs=120.4
Q ss_pred cccccCcccEEEEEeCC-------------------------CCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceece
Q 013737 276 KLGQGGSGSVYKGTLPG-------------------------GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330 (437)
Q Consensus 276 ~Lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 330 (437)
.||+|+||.||+|.+.. ...|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13588898876555556678899999999999999999
Q ss_pred eEEEeeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC--
Q 013737 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-- 408 (437)
Q Consensus 331 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~-- 408 (437)
++++......++||||+++++|..++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999887743 2346889999999999999999999987 99999999999997643
Q ss_pred -----cEEEcccCCcccc
Q 013737 409 -----TAKIADFGLVRLF 421 (437)
Q Consensus 409 -----~~ki~DFG~a~~~ 421 (437)
.+|++|||++...
T Consensus 157 ~~~~~~~kl~d~g~~~~~ 174 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTA 174 (274)
T ss_pred cCccceeeecCCcccccc
Confidence 4899999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.8e-24 Score=200.86 Aligned_cols=150 Identities=30% Similarity=0.383 Sum_probs=133.4
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..+.||+|+||.||++.+. +++.+|+|.+... .....+.+.+|++++++++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36788899999999999999974 5899999998643 2334567899999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999988743 356899999999999999999999987 999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-24 Score=204.97 Aligned_cols=140 Identities=26% Similarity=0.269 Sum_probs=119.8
Q ss_pred ccccCcccEEEEEeC-CCCEEEEEEEeccc---hhhHHHHHHHHHHHcCC---CCCceeceeEEEeeCCeeEEEEeccCC
Q 013737 277 LGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGI---NHKNLVKLLGCSITGPESLLVYEFVPN 349 (437)
Q Consensus 277 Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (437)
||+|+||.||+++.. +++.||+|++.... ......+..|..++..+ +||||+++++.+...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999974 58999999986432 22334455666666655 699999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 350 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
++|.+.+. ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~ 147 (330)
T cd05586 81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANL 147 (330)
T ss_pred ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCC
Confidence 99988773 3345899999999999999999999998 9999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9e-24 Score=197.71 Aligned_cols=152 Identities=24% Similarity=0.382 Sum_probs=132.8
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..+.||+|+||.||++... +++.+|||.+... .......+.+|+++++.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888999999999999999964 6899999987542 3344567899999999999999999999999999999999
Q ss_pred eccCCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 345 EFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999988774322 2345889999999999999999999987 99999999999999999999999999887654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.7e-24 Score=199.54 Aligned_cols=150 Identities=27% Similarity=0.457 Sum_probs=130.4
Q ss_pred cCCCcCCcccccCcccEEEEEe-----CCCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeC--Cee
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-----PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PES 340 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 340 (437)
+.|+..+.||+|+||.||++.. .++..||+|.+... .......+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467889999999999999984 34788999998654 344567899999999999999999999988775 568
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999987432 235899999999999999999999987 99999999999999999999999999987
Q ss_pred cCC
Q 013737 421 FPE 423 (437)
Q Consensus 421 ~~~ 423 (437)
+..
T Consensus 159 ~~~ 161 (284)
T cd05079 159 IET 161 (284)
T ss_pred ccc
Confidence 654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-25 Score=199.13 Aligned_cols=152 Identities=25% Similarity=0.428 Sum_probs=127.7
Q ss_pred cCCCcCCcccccCcccEEEEEeC---C--CCEEEEEEEeccch--hhHHHHHHHHHHHcCCCCCceeceeEEEee-CCee
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP---G--GEAVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLVKLLGCSIT-GPES 340 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 340 (437)
..|+....||+|.||.||++.-. + ...+|+|+++.... .......+|+.+++.++||||+.|..++.+ +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 45888899999999999999642 2 23789999875422 233457799999999999999999999887 7789
Q ss_pred EEEEeccCCCCcccccccc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC----CcEEEcc
Q 013737 341 LLVYEFVPNQSLLDNLFVR--QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE----FTAKIAD 414 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~----~~~ki~D 414 (437)
++++||.+. +|.++++.+ .+...++...+..|+.||+.|+.|||++- |+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999975 787777533 23456899999999999999999999998 9999999999999876 8999999
Q ss_pred cCCccccCCC
Q 013737 415 FGLVRLFPED 424 (437)
Q Consensus 415 FG~a~~~~~~ 424 (437)
||++|++...
T Consensus 180 lGlaR~~~~p 189 (438)
T KOG0666|consen 180 LGLARLFNNP 189 (438)
T ss_pred ccHHHHhhcc
Confidence 9999988654
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-24 Score=207.26 Aligned_cols=153 Identities=28% Similarity=0.380 Sum_probs=128.7
Q ss_pred HhcCCCcCCcccccCcccEEEEEe------CCCCEEEEEEEeccc-hhhHHHHHHHHHHHcCC-CCCceeceeEEEeeC-
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTL------PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG- 337 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 337 (437)
+.++|+..+.||+|+||.||+|.+ .+++.||||+++... ......+.+|+.++.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 346789999999999999999974 346789999997543 33456788999999999 689999999987654
Q ss_pred CeeEEEEeccCCCCccccccccCC--------------------------------------------------------
Q 013737 338 PESLLVYEFVPNQSLLDNLFVRQD-------------------------------------------------------- 361 (437)
Q Consensus 338 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 361 (437)
...+++|||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 467899999999999888743210
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 362 --------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 362 --------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~ 230 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIY 230 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccc
Confidence 124688889999999999999999987 9999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=196.59 Aligned_cols=149 Identities=30% Similarity=0.469 Sum_probs=131.4
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc-----hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT-----TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
++|...+.||+|++|.||++.. .+++.+++|.+.... ....+.+.+|++++++++||||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688899999999999999986 468999999886432 2234578899999999999999999999999999999
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
|+||+++++|.+.+.. ...+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.++|+|||+++.+.
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999888743 345889999999999999999999988 9999999999999999999999999998654
Q ss_pred C
Q 013737 423 E 423 (437)
Q Consensus 423 ~ 423 (437)
.
T Consensus 156 ~ 156 (263)
T cd06625 156 T 156 (263)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-24 Score=207.01 Aligned_cols=155 Identities=28% Similarity=0.405 Sum_probs=129.9
Q ss_pred HHhcCCCcCCcccccCcccEEEEEeC------CCCEEEEEEEeccc-hhhHHHHHHHHHHHcCC-CCCceeceeEEEeeC
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG 337 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 337 (437)
.+.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++.++ +|+||+++++++...
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 34567889999999999999999642 35789999986442 33456788999999999 799999999987654
Q ss_pred -CeeEEEEeccCCCCccccccccCC-------------------------------------------------------
Q 013737 338 -PESLLVYEFVPNQSLLDNLFVRQD------------------------------------------------------- 361 (437)
Q Consensus 338 -~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------- 361 (437)
...+++|||+++++|.+++.....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 567899999999999888743211
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 362 ---VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 362 ---~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
..++++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~ 225 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 225 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhccc
Confidence 136899999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=198.53 Aligned_cols=149 Identities=29% Similarity=0.437 Sum_probs=126.0
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCC----EEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGE----AVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
++|+..+.||+|+||.||+|.+. +++ .+++|.+.... .....++..|+..+++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 45778899999999999999963 344 47777775432 334567888999999999999999999875 455789
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
++||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999998843 2346899999999999999999999987 9999999999999999999999999998764
Q ss_pred C
Q 013737 423 E 423 (437)
Q Consensus 423 ~ 423 (437)
.
T Consensus 161 ~ 161 (279)
T cd05111 161 P 161 (279)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-24 Score=197.77 Aligned_cols=150 Identities=33% Similarity=0.489 Sum_probs=131.1
Q ss_pred hcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEecc
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (437)
.++|+..++||+|+||.||++..+++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 456788899999999999999988888899999875433 3457899999999999999999999875 45689999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 999999987432 2345899999999999999999999987 99999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=196.61 Aligned_cols=145 Identities=30% Similarity=0.368 Sum_probs=124.3
Q ss_pred CcccccCcccEEEEEeCC---CCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCC
Q 013737 275 NKLGQGGSGSVYKGTLPG---GEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 350 (437)
+.||+|+||.||+|.+.+ +..+++|.+.... ......+.+|+.++++++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 469999999999998643 4579999886543 334457889999999999999999999999999999999999999
Q ss_pred CccccccccCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 351 SLLDNLFVRQD--VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 351 ~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
+|.+++..... ....++..+..++.|++.||.|||+.+ ++||||||+||++++++++||+|||+++...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCcccccccc
Confidence 99998854322 234677888899999999999999987 9999999999999999999999999997543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=8e-24 Score=201.29 Aligned_cols=152 Identities=28% Similarity=0.445 Sum_probs=130.2
Q ss_pred hcCCCcCCcccccCcccEEEEEeCC---------------CCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceecee
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPG---------------GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLL 331 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~ 331 (437)
.++|+..+.||+|+||.||++.... ...||+|.+... .....+.|.+|++++++++||||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3568889999999999999987532 235899998754 334456799999999999999999999
Q ss_pred EEEeeCCeeEEEEeccCCCCccccccccC---------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCe
Q 013737 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQ---------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNI 402 (437)
Q Consensus 332 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NI 402 (437)
+++...+..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999998874321 1124788999999999999999999987 99999999999
Q ss_pred eeCCCCcEEEcccCCccccC
Q 013737 403 LLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 403 ll~~~~~~ki~DFG~a~~~~ 422 (437)
++++++.+||+|||+++.+.
T Consensus 161 ll~~~~~~kl~dfg~~~~~~ 180 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLY 180 (295)
T ss_pred EEcCCCcEEecccccccccc
Confidence 99999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=194.98 Aligned_cols=143 Identities=26% Similarity=0.421 Sum_probs=123.2
Q ss_pred cccccCcccEEEEEeC---CCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCCC
Q 013737 276 KLGQGGSGSVYKGTLP---GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQS 351 (437)
Q Consensus 276 ~Lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 351 (437)
.||+|+||.||+|.+. .+..||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999863 35579999986553 334567999999999999999999999875 457899999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 352 LLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 352 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+..+
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 148 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGAD 148 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCC
Confidence 9988743 2346899999999999999999999987 999999999999999999999999999866543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.5e-24 Score=199.29 Aligned_cols=151 Identities=28% Similarity=0.446 Sum_probs=132.1
Q ss_pred cCCCcCCcccccCcccEEEEEeCC------CCEEEEEEEeccchh-hHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (437)
++|...+.||+|+||.||+|...+ +..||+|.+...... ..+.+.+|++++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457788999999999999998632 478999998755433 4578999999999999999999999999999999
Q ss_pred EEEeccCCCCccccccccC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 013737 342 LVYEFVPNQSLLDNLFVRQ-----------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ 410 (437)
+||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999885432 2245889999999999999999999987 9999999999999999999
Q ss_pred EEcccCCccccC
Q 013737 411 KIADFGLVRLFP 422 (437)
Q Consensus 411 ki~DFG~a~~~~ 422 (437)
||+|||+++.+.
T Consensus 162 kl~d~g~~~~~~ 173 (280)
T cd05049 162 KIGDFGMSRDVY 173 (280)
T ss_pred EECCcccceecc
Confidence 999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=199.45 Aligned_cols=148 Identities=27% Similarity=0.307 Sum_probs=129.4
Q ss_pred CCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc---hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
|+..+.||+|+||+||++.+ .+++.+|+|.+.... ......+.+|++++..++|+||+++.+.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 56678999999999999997 468899999986542 22344578899999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
+++++|.+.+... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++....
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIP 153 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence 9999998877432 2346899999999999999999999987 9999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-24 Score=200.59 Aligned_cols=151 Identities=25% Similarity=0.368 Sum_probs=132.5
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
++|+..+.||+|+||.||++... ++..+|+|.+... .......+.+|++++.+++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35778899999999999999975 6899999988654 334456899999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
+++++|..++........+++..+..++.|++.||.|||+. + |+|+||||+||+++.++.+||+|||++..+.
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999988775433334689999999999999999999974 5 9999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.3e-24 Score=201.22 Aligned_cols=157 Identities=31% Similarity=0.437 Sum_probs=134.4
Q ss_pred HHHHhcCCCcCCcccccCcccEEEEEeCC------CCEEEEEEEecc-chhhHHHHHHHHHHHcCC-CCCceeceeEEEe
Q 013737 264 LEKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSI 335 (437)
Q Consensus 264 ~~~~~~~~~~~~~Lg~G~~g~V~~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 335 (437)
++...++|+..+.||+|+||.||++.... ...+|+|.+... ......++.+|++++.++ +||||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 33445678888999999999999998632 357999998754 334456788999999999 7999999999999
Q ss_pred eCCeeEEEEeccCCCCcccccccc-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCe
Q 013737 336 TGPESLLVYEFVPNQSLLDNLFVR-------------QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNI 402 (437)
Q Consensus 336 ~~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NI 402 (437)
.++..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+.+ |+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeE
Confidence 999999999999999999887532 22356899999999999999999999987 99999999999
Q ss_pred eeCCCCcEEEcccCCccccCC
Q 013737 403 LLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 403 ll~~~~~~ki~DFG~a~~~~~ 423 (437)
|+++++.+||+|||+++.+..
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~ 184 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHH 184 (293)
T ss_pred EEcCCCeEEeCcccccccccc
Confidence 999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=197.71 Aligned_cols=143 Identities=23% Similarity=0.288 Sum_probs=123.8
Q ss_pred ccccCcccEEEEEeC-CCCEEEEEEEeccc---hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCCCc
Q 013737 277 LGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL 352 (437)
Q Consensus 277 Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 352 (437)
||+|+||.||++..+ +|+.+|+|.+.... ......+..|++++.+++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999974 58999999986432 12234556799999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 353 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
.+.+... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++..+..
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 147 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKD 147 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence 8877432 3345889999999999999999999987 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=196.60 Aligned_cols=152 Identities=34% Similarity=0.497 Sum_probs=135.2
Q ss_pred HhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
..++|...++||+|+||.||++..+++..++||.+..... ..+++.+|+.++++++||||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 4567889999999999999999988788999999875432 356789999999999999999999999988999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccc
Confidence 9999999988542 2345899999999999999999999987 99999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=196.96 Aligned_cols=156 Identities=28% Similarity=0.337 Sum_probs=134.4
Q ss_pred HHHHhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 264 LEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 264 ~~~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
++.+++++.....||+|+||.||++.+. ++..|++|.+........+.+.+|+.+++.++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3455677777789999999999999964 578899999877666667789999999999999999999999999999999
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC-CCcEEEcccCCcccc
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFGLVRLF 421 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~-~~~~ki~DFG~a~~~ 421 (437)
|+||+++++|.+++.........++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||++..+
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 9999999999998854322112278888999999999999999987 999999999999976 679999999998765
Q ss_pred C
Q 013737 422 P 422 (437)
Q Consensus 422 ~ 422 (437)
.
T Consensus 160 ~ 160 (268)
T cd06624 160 A 160 (268)
T ss_pred c
Confidence 4
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=195.18 Aligned_cols=152 Identities=25% Similarity=0.393 Sum_probs=134.2
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..+.||+|+||.||++... +++.+++|.++.. .....+.+.+|++++++++|+||+++++.+...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999975 7899999988632 3334678999999999999999999999999999999999
Q ss_pred eccCCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 345 EFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 345 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
||+++++|.+++... .....+++..+..++.+++.||.|||+.+ |+|+||+|+||++++++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999887432 22345899999999999999999999987 99999999999999999999999999886654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=197.40 Aligned_cols=149 Identities=27% Similarity=0.438 Sum_probs=131.0
Q ss_pred CCCcCCcccccCcccEEEEEeCC-C---CEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 270 YFHESNKLGQGGSGSVYKGTLPG-G---EAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
.|+..+.||+|+||.||+|.+.. + ..|+||.+... ......+|..|+.++++++||||+++++++..++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778999999999999999743 3 36999998754 3445678999999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
||+++++|.+++... ...+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999887432 346899999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=196.21 Aligned_cols=151 Identities=26% Similarity=0.459 Sum_probs=132.0
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CC---CEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GG---EAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
.++|+..+.||+|+||.||++.+. ++ ..+++|.+... .....+.+.+|++++.+++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 346788899999999999999974 23 37899988654 34446779999999999999999999999999999999
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999988743 2356899999999999999999999987 9999999999999999999999999998765
Q ss_pred C
Q 013737 423 E 423 (437)
Q Consensus 423 ~ 423 (437)
.
T Consensus 159 ~ 159 (268)
T cd05063 159 D 159 (268)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=196.51 Aligned_cols=149 Identities=29% Similarity=0.484 Sum_probs=127.9
Q ss_pred CCcCCcccccCcccEEEEEeCC----CCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCe-----
Q 013737 271 FHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE----- 339 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 339 (437)
|++.+.||+|+||.||+|.+.. +..+|+|.++.. .....+.+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998632 467999998754 33446789999999999999999999998876554
Q ss_pred -eEEEEeccCCCCccccccccC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 013737 340 -SLLVYEFVPNQSLLDNLFVRQ---DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415 (437)
Q Consensus 340 -~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DF 415 (437)
.++++||+++++|..++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999988874432 2346899999999999999999999987 999999999999999999999999
Q ss_pred CCccccC
Q 013737 416 GLVRLFP 422 (437)
Q Consensus 416 G~a~~~~ 422 (437)
|+++.+.
T Consensus 158 g~~~~~~ 164 (273)
T cd05035 158 GLSKKIY 164 (273)
T ss_pred cceeecc
Confidence 9998764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=198.27 Aligned_cols=150 Identities=24% Similarity=0.363 Sum_probs=131.4
Q ss_pred cCCCcCCcccccCcccEEEEEeC------CCCEEEEEEEeccchh-hHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (437)
++|+..+.||+|+||.||+++.+ +.+.+++|.+...... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888999999999999999963 2467899988654433 5678999999999999999999999999989999
Q ss_pred EEEeccCCCCccccccccCCC------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 013737 342 LVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DF 415 (437)
+||||+++++|.+++...... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999988544322 26899999999999999999999988 999999999999999999999999
Q ss_pred CCcccc
Q 013737 416 GLVRLF 421 (437)
Q Consensus 416 G~a~~~ 421 (437)
|+++..
T Consensus 162 ~~~~~~ 167 (275)
T cd05046 162 SLSKDV 167 (275)
T ss_pred cccccc
Confidence 998754
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=200.82 Aligned_cols=148 Identities=28% Similarity=0.408 Sum_probs=129.1
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
+.|...++||+|+||.||++... +++.||+|.+.... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888899999999999999874 58899999986542 33345678899999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
++ ++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+|||+++++.+||+|||+++...
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 97 5888777432 345889999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=198.48 Aligned_cols=150 Identities=31% Similarity=0.414 Sum_probs=129.0
Q ss_pred CCCcCCcccccCcccEEEEEeC------CCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
+|+..+.||+|+||.||+|... ....+++|.+.... .....++.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677899999999999999852 23578888886543 3445789999999999999999999999999999999
Q ss_pred EEeccCCCCccccccccC---------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCC
Q 013737 343 VYEFVPNQSLLDNLFVRQ---------------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSN 401 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~N 401 (437)
++||+++++|.+++.... ...++++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999998764321 1235889999999999999999999987 9999999999
Q ss_pred eeeCCCCcEEEcccCCccccC
Q 013737 402 ILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 402 Ill~~~~~~ki~DFG~a~~~~ 422 (437)
||+++++.+||+|||+++...
T Consensus 158 ill~~~~~~kl~dfg~~~~~~ 178 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVY 178 (290)
T ss_pred EEEcCCCcEEecccccccccc
Confidence 999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=200.16 Aligned_cols=149 Identities=27% Similarity=0.423 Sum_probs=133.6
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
..+|+..+.||+|+||.||++.. .+++.+++|.+........+.+.+|+.+++.++||||+++++.+..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35788889999999999999986 46889999999766555567889999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
+++++|.+++. ...+++.++..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 99 ~~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 99 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred cCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 99999999873 234789999999999999999999987 99999999999999999999999999886543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=198.56 Aligned_cols=152 Identities=29% Similarity=0.435 Sum_probs=132.0
Q ss_pred hcCCCcCCcccccCcccEEEEEeCC-----------------CCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceec
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPG-----------------GEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVK 329 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 329 (437)
.++|+..+.||+|+||.||++.... +..||+|.+.... ....+.+.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578899999999999999998642 2468999987543 345678999999999999999999
Q ss_pred eeEEEeeCCeeEEEEeccCCCCccccccccC--------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCC
Q 013737 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQ--------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSN 401 (437)
Q Consensus 330 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~N 401 (437)
+++++..++..+++|||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999998885432 1236899999999999999999999987 9999999999
Q ss_pred eeeCCCCcEEEcccCCccccC
Q 013737 402 ILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 402 Ill~~~~~~ki~DFG~a~~~~ 422 (437)
|++++++.++|+|||+++...
T Consensus 161 ili~~~~~~~l~dfg~~~~~~ 181 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLY 181 (296)
T ss_pred eeecCCCceEEccccceeecc
Confidence 999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=197.82 Aligned_cols=151 Identities=32% Similarity=0.502 Sum_probs=130.8
Q ss_pred cCCCcCCcccccCcccEEEEEeCC------CCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (437)
++|+..+.||+|+||.||+|.... ...|++|.+... .......|.+|+.++.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 357888999999999999998643 257999988654 3344567899999999999999999999999999999
Q ss_pred EEEeccCCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC
Q 013737 342 LVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~ 408 (437)
++|||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999988854321 145889999999999999999999987 99999999999999999
Q ss_pred cEEEcccCCccccC
Q 013737 409 TAKIADFGLVRLFP 422 (437)
Q Consensus 409 ~~ki~DFG~a~~~~ 422 (437)
.+||+|||+++...
T Consensus 162 ~~~L~dfg~~~~~~ 175 (283)
T cd05048 162 TVKISDFGLSRDIY 175 (283)
T ss_pred cEEECCCcceeecc
Confidence 99999999998653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=199.79 Aligned_cols=152 Identities=28% Similarity=0.402 Sum_probs=130.8
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-----------------CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceec
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-----------------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVK 329 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 329 (437)
.++|+..++||+|+||.||++... ++..+|+|.+... .....+++.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 456889999999999999998632 2346899998754 3445678999999999999999999
Q ss_pred eeEEEeeCCeeEEEEeccCCCCccccccccCC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCC
Q 013737 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQD--------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSN 401 (437)
Q Consensus 330 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~N 401 (437)
+++++...+..++||||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999988754321 134778899999999999999999988 9999999999
Q ss_pred eeeCCCCcEEEcccCCccccC
Q 013737 402 ILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 402 Ill~~~~~~ki~DFG~a~~~~ 422 (437)
||+++++.+||+|||+++.+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~ 181 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLY 181 (296)
T ss_pred EEEcCCCCEEeccCccccccc
Confidence 999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=198.29 Aligned_cols=149 Identities=27% Similarity=0.319 Sum_probs=129.8
Q ss_pred CCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc---hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
|+..+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++++++|+||+++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999974 68899999986532 22335677899999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.....
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 9999998877432 2345899999999999999999999987 99999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=195.87 Aligned_cols=145 Identities=24% Similarity=0.370 Sum_probs=128.0
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
++|+..++||+|+||.||++.+ .+++.+|+|.+..+ .....+++.+|++++.+++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3577788999999999999986 56889999998654 334456789999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
+++++|..+ ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++..+..
T Consensus 81 ~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 81 MDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred CCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 999988543 23678889999999999999999987 99999999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.1e-26 Score=196.27 Aligned_cols=161 Identities=26% Similarity=0.364 Sum_probs=135.0
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++.|+..+.||+|.|+.|+++.. ++|+.+|+|.+... +....+++.+|+++...|+||||++|++...+....|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 45677888999999999999985 67999999987533 4446788999999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC---CCcEEEcccCCcccc
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---EFTAKIADFGLVRLF 421 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~---~~~~ki~DFG~a~~~ 421 (437)
|+|.|++|..-+-.+ ..+++..+-..+.||+++|.|.|.++ |||||+||+|+|+.. .--+||+|||+|..+
T Consensus 90 e~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999999997655333 44788888899999999999999998 999999999999953 346999999999988
Q ss_pred CCCCcceeeeecccC
Q 013737 422 PEDITHISATLAGTL 436 (437)
Q Consensus 422 ~~~~~~~~~~~~Gt~ 436 (437)
.+. ..-...+|||
T Consensus 164 ~~g--~~~~G~~GtP 176 (355)
T KOG0033|consen 164 NDG--EAWHGFAGTP 176 (355)
T ss_pred CCc--cccccccCCC
Confidence 732 2223456765
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=195.09 Aligned_cols=143 Identities=26% Similarity=0.372 Sum_probs=122.4
Q ss_pred CcccccCcccEEEEEeCC-------------CCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeE
Q 013737 275 NKLGQGGSGSVYKGTLPG-------------GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (437)
+.||+|+||.||+|.+.+ ...|++|.+..........+.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2258888876655555668899999999999999999999999999999
Q ss_pred EEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCc-------EEEcc
Q 013737 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT-------AKIAD 414 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~-------~ki~D 414 (437)
+||||+++++|..++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999877632 2346899999999999999999999987 999999999999987654 89999
Q ss_pred cCCccccC
Q 013737 415 FGLVRLFP 422 (437)
Q Consensus 415 FG~a~~~~ 422 (437)
||++..+.
T Consensus 156 ~g~~~~~~ 163 (262)
T cd05077 156 PGIPITVL 163 (262)
T ss_pred CCCCcccc
Confidence 99987654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=200.75 Aligned_cols=149 Identities=32% Similarity=0.483 Sum_probs=128.1
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCC--EEEEEEEecc-chhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCeeEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGE--AVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 343 (437)
++|+..+.||+|+||.||+|.+. ++. .+++|.+... .......+.+|++++.++ +||||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46788899999999999999974 344 4577776543 334456788999999999 899999999999999999999
Q ss_pred EeccCCCCccccccccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 013737 344 YEFVPNQSLLDNLFVRQ-------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ 410 (437)
|||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999885432 1235889999999999999999999987 9999999999999999999
Q ss_pred EEcccCCccc
Q 013737 411 KIADFGLVRL 420 (437)
Q Consensus 411 ki~DFG~a~~ 420 (437)
||+|||+++.
T Consensus 164 kl~dfg~~~~ 173 (303)
T cd05088 164 KIADFGLSRG 173 (303)
T ss_pred EeCccccCcc
Confidence 9999999864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=204.40 Aligned_cols=150 Identities=29% Similarity=0.402 Sum_probs=127.7
Q ss_pred HHhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc--hhhHHHHHHHHHHHcCCCCCceeceeEEEeeC-----
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITG----- 337 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 337 (437)
...++|...+.||+|+||.||++.. .+++.||||.+.... ....+.+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457799999999999999999996 468899999986532 23345688999999999999999999987543
Q ss_pred -CeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccC
Q 013737 338 -PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (437)
Q Consensus 338 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG 416 (437)
...++++|++ +++|.+++. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3468999988 778877662 345899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCC
Q 013737 417 LVRLFPE 423 (437)
Q Consensus 417 ~a~~~~~ 423 (437)
+++....
T Consensus 164 ~~~~~~~ 170 (343)
T cd07878 164 LARQADD 170 (343)
T ss_pred cceecCC
Confidence 9987654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=193.65 Aligned_cols=148 Identities=32% Similarity=0.457 Sum_probs=131.3
Q ss_pred CCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc-----hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEE
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-----TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
+|+..+.||+|+||.||+|... +++.|++|.+.... ....+.+.+|+.+++.++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3677889999999999999975 68999999886432 23457799999999999999999999999999999999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
+||+++++|.+++.. ..++++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999988732 345889999999999999999999987 99999999999999999999999999886543
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=200.21 Aligned_cols=155 Identities=28% Similarity=0.406 Sum_probs=132.5
Q ss_pred HHhcCCCcCCcccccCcccEEEEEeC--------CCCEEEEEEEecc-chhhHHHHHHHHHHHcCC-CCCceeceeEEEe
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTLP--------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSI 335 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 335 (437)
...++|...+.||+|+||.||++... ++..+|+|.+... ......++.+|+.++..+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 33466788899999999999999741 2457999988644 334467799999999999 7999999999999
Q ss_pred eCCeeEEEEeccCCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCe
Q 013737 336 TGPESLLVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNI 402 (437)
Q Consensus 336 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NI 402 (437)
.....++||||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 99999999999999999998854321 235788999999999999999999987 99999999999
Q ss_pred eeCCCCcEEEcccCCccccCC
Q 013737 403 LLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 403 ll~~~~~~ki~DFG~a~~~~~ 423 (437)
|+++++.+||+|||+++.+..
T Consensus 169 li~~~~~~kl~D~g~~~~~~~ 189 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNN 189 (304)
T ss_pred EEcCCCcEEECCCccceeccc
Confidence 999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=195.50 Aligned_cols=149 Identities=34% Similarity=0.499 Sum_probs=129.3
Q ss_pred cCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccC
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (437)
+.|...++||+|++|.||++.+.++..+++|.+.... ...+.+.+|+.++++++|||++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4578889999999999999998777789999876443 23467889999999999999999999875 456899999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 349 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 99999988542 2345899999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=194.55 Aligned_cols=151 Identities=32% Similarity=0.430 Sum_probs=135.4
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
.++|+..+.||+|+||.||++... +++.+++|.+........+.+.+|++++++++||||+++++.+...+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 467888999999999999999974 5788999999876655678899999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||++..+..
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 9999999877432 256899999999999999999999987 99999999999999999999999999886643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.1e-24 Score=209.18 Aligned_cols=148 Identities=28% Similarity=0.373 Sum_probs=129.5
Q ss_pred CCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCC-C-----CceeceeEEEeeCCeeEE
Q 013737 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-H-----KNLVKLLGCSITGPESLL 342 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 342 (437)
+|.+.+.||+|.||.|.+|.+ .+++.||||+++.. .....+-..|+.+|..|+ | -|+|+++++|...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 678899999999999999996 56999999999654 445667788999999987 4 489999999999999999
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC--CcEEEcccCCccc
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE--FTAKIADFGLVRL 420 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~--~~~ki~DFG~a~~ 420 (437)
|+|.+ ..+|.+++.. .+...++...+..|+.||+.||.+||+.+ |||+||||+||||.+- ..+||+|||.|..
T Consensus 266 VfELL-~~NLYellK~-n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELL-STNLYELLKN-NKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhh-hhhHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 99999 5799999854 34456999999999999999999999987 9999999999999754 3899999999987
Q ss_pred cCC
Q 013737 421 FPE 423 (437)
Q Consensus 421 ~~~ 423 (437)
...
T Consensus 341 ~~q 343 (586)
T KOG0667|consen 341 ESQ 343 (586)
T ss_pred cCC
Confidence 654
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=195.08 Aligned_cols=142 Identities=28% Similarity=0.383 Sum_probs=121.9
Q ss_pred CcccccCcccEEEEEeCC-C----------CEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEE
Q 013737 275 NKLGQGGSGSVYKGTLPG-G----------EAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
+.||+|+||.||++.+.+ + ..+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 469999999999999754 3 24777876544333 6788999999999999999999999888 778999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC-------cEEEcccC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-------TAKIADFG 416 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~-------~~ki~DFG 416 (437)
|||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999885432 26899999999999999999999987 99999999999999887 79999999
Q ss_pred CccccCC
Q 013737 417 LVRLFPE 423 (437)
Q Consensus 417 ~a~~~~~ 423 (437)
+++....
T Consensus 154 ~a~~~~~ 160 (259)
T cd05037 154 IPITVLS 160 (259)
T ss_pred ccccccc
Confidence 9987543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=196.66 Aligned_cols=149 Identities=31% Similarity=0.520 Sum_probs=128.4
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCC----EEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGE----AVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
++|+..++||+|+||.||+|.+ .+++ .||+|.+... .......+.+|+.++..++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 5678889999999999999985 3444 4899998654 33445678999999999999999999998875 45789
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
++||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 ~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 86 VTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 9999999999998743 2345899999999999999999999987 9999999999999999999999999998775
Q ss_pred C
Q 013737 423 E 423 (437)
Q Consensus 423 ~ 423 (437)
.
T Consensus 161 ~ 161 (279)
T cd05109 161 I 161 (279)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=195.27 Aligned_cols=146 Identities=32% Similarity=0.507 Sum_probs=130.2
Q ss_pred CCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccc------hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEE
Q 013737 270 YFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT------TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
+|+..+.||+|+||.||++...+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 467889999999999999998889999999886432 22345688999999999999999999999999999999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
+||+++++|.+++.. ..++++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||+++..
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 999999999998843 245889999999999999999999987 999999999999999999999999998865
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=193.09 Aligned_cols=151 Identities=21% Similarity=0.332 Sum_probs=133.6
Q ss_pred CCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
+|+..+.||+|+||.||.++. .+++.+++|.+... .....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478889999999999999986 45889999988643 344567789999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
+++++|.+++.... ...+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 99999999885432 356899999999999999999999987 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=196.28 Aligned_cols=152 Identities=24% Similarity=0.383 Sum_probs=133.1
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..+.||+|+||.||++.. .+++.++||.+... ......++.+|+.+++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4577889999999999999996 57899999987642 3334568899999999999999999999999999999999
Q ss_pred eccCCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 345 EFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 345 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
||+++++|.+++... .....+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999887432 22356899999999999999999999988 99999999999999999999999999887654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=197.84 Aligned_cols=152 Identities=26% Similarity=0.378 Sum_probs=132.6
Q ss_pred cCCCcCCcccccCcccEEEEEeC------CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
++|...+.||+|+||.||++... ++..+++|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45777889999999999999852 345688999876666666789999999999999999999999999999999
Q ss_pred EEeccCCCCccccccccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCc
Q 013737 343 VYEFVPNQSLLDNLFVRQ-------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT 409 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~ 409 (437)
||||+++++|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||+++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999885422 1235899999999999999999999998 999999999999999999
Q ss_pred EEEcccCCccccCC
Q 013737 410 AKIADFGLVRLFPE 423 (437)
Q Consensus 410 ~ki~DFG~a~~~~~ 423 (437)
+||+|||+++....
T Consensus 162 ~~l~dfg~a~~~~~ 175 (291)
T cd05094 162 VKIGDFGMSRDVYS 175 (291)
T ss_pred EEECCCCcccccCC
Confidence 99999999986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-24 Score=198.46 Aligned_cols=145 Identities=37% Similarity=0.518 Sum_probs=128.1
Q ss_pred CCcCCcccccCcccEEEEEeCC-CCEEEEEEEeccchhhH--HHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEecc
Q 013737 271 FHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWV--DHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (437)
|+..+.||+|+||.||++.... ++.+|+|.+........ ....+|+.++.+++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4567899999999999999754 66899999986644332 23456999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
++++|.+++. ....+++..+..++.|+++||.+||+.+ |+|+||||+||++++++.++|+|||.+...
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 9999999885 3455899999999999999999999997 999999999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=196.40 Aligned_cols=150 Identities=25% Similarity=0.412 Sum_probs=130.9
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc--hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
++|+..+.||+|+||.||++... +++.+|+|++.... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36788899999999999999975 58999999886432 2334568899999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
|++++.|..++. ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++..+...
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999888876652 2345899999999999999999999987 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=193.17 Aligned_cols=142 Identities=28% Similarity=0.437 Sum_probs=123.5
Q ss_pred cccccCcccEEEEEe---CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCC
Q 013737 276 KLGQGGSGSVYKGTL---PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350 (437)
Q Consensus 276 ~Lg~G~~g~V~~~~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 350 (437)
+||+|+||.||+|.+ .++..+|+|++... .....+++.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999975 35788999998644 3345678999999999999999999999875 45678999999999
Q ss_pred CccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 351 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 99988832 345899999999999999999999987 999999999999999999999999999877544
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=192.58 Aligned_cols=151 Identities=25% Similarity=0.397 Sum_probs=133.7
Q ss_pred CCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
+|+..+.||+|++|.||++... +++.+++|.+... .....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999974 5889999998643 344567899999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 9999999988543 2356899999999999999999999987 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=210.84 Aligned_cols=149 Identities=26% Similarity=0.369 Sum_probs=122.1
Q ss_pred HhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeC--------
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITG-------- 337 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 337 (437)
..++|+..+.||+|+||.||+|.. .+++.||||++..... ...+|+.+|+.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ----YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 346799999999999999999997 4688999998854322 245799999999999999999876432
Q ss_pred CeeEEEEeccCCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC-cEEEccc
Q 013737 338 PESLLVYEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADF 415 (437)
Q Consensus 338 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~-~~ki~DF 415 (437)
...++||||+++ +|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 236689999975 666555321 23456899999999999999999999998 99999999999998664 7999999
Q ss_pred CCccccCC
Q 013737 416 GLVRLFPE 423 (437)
Q Consensus 416 G~a~~~~~ 423 (437)
|+|+.+..
T Consensus 216 Gla~~~~~ 223 (440)
T PTZ00036 216 GSAKNLLA 223 (440)
T ss_pred ccchhccC
Confidence 99987654
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=195.22 Aligned_cols=151 Identities=30% Similarity=0.461 Sum_probs=132.5
Q ss_pred HhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
..+.|+..++||+|+||.||++.+.++..+++|.+.... ...+.+.+|++++++++|+||+++++.+.. ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 456788999999999999999998777889999886543 335678999999999999999999999877 778999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+..
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 82 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred CCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 9999999988543 3345788999999999999999999987 99999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=198.44 Aligned_cols=148 Identities=30% Similarity=0.436 Sum_probs=130.1
Q ss_pred CCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccch-----hhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEE
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT-----QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
+|+..+.||+|+||.||+|... +++.|++|.+..... .....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3677889999999999999974 589999999875432 2345677899999999999999999999999999999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|||+ +++|.+++.... ..+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999884322 36899999999999999999999998 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-23 Score=191.88 Aligned_cols=150 Identities=21% Similarity=0.327 Sum_probs=132.3
Q ss_pred CCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEecc
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (437)
+|+..++||+|+||.||++... +++.+++|.+... .....+.+.+|+.+++.++||||+++++.+.+++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677899999999999999974 5889999998643 3445677889999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
++++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+++.+..
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 152 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence 999998877432 3345889999999999999999999987 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=196.94 Aligned_cols=146 Identities=36% Similarity=0.506 Sum_probs=126.7
Q ss_pred CCcCCcccccCcccEEEEEe-----CCCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeC--CeeEE
Q 013737 271 FHESNKLGQGGSGSVYKGTL-----PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PESLL 342 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 342 (437)
|+..+.||+|+||.||++.. .++..||+|.+.... ......+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 47889999999999988653 357789999987543 33456788999999999999999999987654 35789
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
+|||+++++|.+++.. ..+++.++..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999988732 34899999999999999999999987 9999999999999999999999999998765
Q ss_pred C
Q 013737 423 E 423 (437)
Q Consensus 423 ~ 423 (437)
.
T Consensus 159 ~ 159 (283)
T cd05080 159 E 159 (283)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=197.64 Aligned_cols=152 Identities=31% Similarity=0.488 Sum_probs=131.7
Q ss_pred hcCCCcCCcccccCcccEEEEEeCC------CCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCee
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES 340 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 340 (437)
.++|...+.||+|+||.||++.... +..+++|.+.... ......+.+|+.++..++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4578889999999999999998642 3689999986543 34456788999999999999999999999999999
Q ss_pred EEEEeccCCCCccccccccCC-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQD-------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIA 413 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~ 413 (437)
++||||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999998854321 234788999999999999999999987 9999999999999999999999
Q ss_pred ccCCccccC
Q 013737 414 DFGLVRLFP 422 (437)
Q Consensus 414 DFG~a~~~~ 422 (437)
|||+++.+.
T Consensus 162 dfg~~~~~~ 170 (277)
T cd05032 162 DFGMTRDIY 170 (277)
T ss_pred Ccccchhhc
Confidence 999998654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=196.37 Aligned_cols=153 Identities=27% Similarity=0.386 Sum_probs=132.4
Q ss_pred hcCCCcCCcccccCcccEEEEEeCC-----CCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEee-CCee
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPG-----GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT-GPES 340 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 340 (437)
.++|...+.||+|+||.||+|.+.. +..|++|.+... .....+.+.+|+.++++++||||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4578888999999999999999754 678999988654 34456778999999999999999999998766 4678
Q ss_pred EEEEeccCCCCccccccccCCC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDV-----EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DF 415 (437)
++++||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999988543322 46899999999999999999999987 999999999999999999999999
Q ss_pred CCccccCC
Q 013737 416 GLVRLFPE 423 (437)
Q Consensus 416 G~a~~~~~ 423 (437)
|+++.+..
T Consensus 162 g~~~~~~~ 169 (280)
T cd05043 162 ALSRDLFP 169 (280)
T ss_pred CCcccccC
Confidence 99987643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=201.09 Aligned_cols=152 Identities=30% Similarity=0.421 Sum_probs=131.6
Q ss_pred hcCCCcCCcccccCcccEEEEEeC--------CCCEEEEEEEecc-chhhHHHHHHHHHHHcCC-CCCceeceeEEEeeC
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP--------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG 337 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 337 (437)
.++|...+.||+|+||.||++... +...+|+|.+... ......++.+|++++.++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 456889999999999999999852 2346999998754 234456788999999999 799999999999999
Q ss_pred CeeEEEEeccCCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee
Q 013737 338 PESLLVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL 404 (437)
Q Consensus 338 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll 404 (437)
+..++||||+++++|.+++..... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999998854321 135899999999999999999999987 9999999999999
Q ss_pred CCCCcEEEcccCCccccC
Q 013737 405 DEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 405 ~~~~~~ki~DFG~a~~~~ 422 (437)
++++.+||+|||+++.+.
T Consensus 174 ~~~~~~kL~dfg~a~~~~ 191 (307)
T cd05098 174 TEDNVMKIADFGLARDIH 191 (307)
T ss_pred cCCCcEEECCCccccccc
Confidence 999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=200.20 Aligned_cols=145 Identities=26% Similarity=0.427 Sum_probs=119.0
Q ss_pred CCcccccCcccEEEEEeC---CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEee--CCeeEEEEeccC
Q 013737 274 SNKLGQGGSGSVYKGTLP---GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT--GPESLLVYEFVP 348 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 348 (437)
.++||+|+||.||+|... +++.+|+|.+.... ....+.+|+.++++++||||+++++++.. +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 568999999999999864 46789999986442 23457789999999999999999998864 456789999986
Q ss_pred CCCcccccccc------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee----CCCCcEEEcccCCc
Q 013737 349 NQSLLDNLFVR------QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLV 418 (437)
Q Consensus 349 ~g~L~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll----~~~~~~ki~DFG~a 418 (437)
++|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5776665321 12235899999999999999999999998 9999999999999 45679999999999
Q ss_pred cccCCC
Q 013737 419 RLFPED 424 (437)
Q Consensus 419 ~~~~~~ 424 (437)
+.+...
T Consensus 160 ~~~~~~ 165 (317)
T cd07868 160 RLFNSP 165 (317)
T ss_pred eccCCC
Confidence 877543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=198.07 Aligned_cols=150 Identities=28% Similarity=0.427 Sum_probs=128.6
Q ss_pred cCCCcCCcccccCcccEEEEEeCC-CC--EEEEEEEecc-chhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCeeEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLPG-GE--AVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 343 (437)
++|+..+.||+|+||.||+|.... +. .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468889999999999999998743 33 4788887643 334456789999999999 799999999999999999999
Q ss_pred EeccCCCCccccccccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 013737 344 YEFVPNQSLLDNLFVRQ-------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ 410 (437)
+||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999998885322 1135889999999999999999999987 9999999999999999999
Q ss_pred EEcccCCcccc
Q 013737 411 KIADFGLVRLF 421 (437)
Q Consensus 411 ki~DFG~a~~~ 421 (437)
||+|||++...
T Consensus 159 kl~dfg~~~~~ 169 (297)
T cd05089 159 KIADFGLSRGE 169 (297)
T ss_pred EECCcCCCccc
Confidence 99999998643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=200.26 Aligned_cols=153 Identities=31% Similarity=0.421 Sum_probs=131.3
Q ss_pred HhcCCCcCCcccccCcccEEEEEeC--------CCCEEEEEEEecc-chhhHHHHHHHHHHHcCC-CCCceeceeEEEee
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLP--------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSIT 336 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 336 (437)
..++|...++||+|+||.||++... ....+|+|.+... .......+.+|+.++.++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3456888999999999999999742 2457899988754 334466789999999999 69999999999999
Q ss_pred CCeeEEEEeccCCCCccccccccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCee
Q 013737 337 GPESLLVYEFVPNQSLLDNLFVRQ-------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNIL 403 (437)
Q Consensus 337 ~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIl 403 (437)
.+..+++|||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence 999999999999999999885432 1245899999999999999999999987 999999999999
Q ss_pred eCCCCcEEEcccCCccccC
Q 013737 404 LDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 404 l~~~~~~ki~DFG~a~~~~ 422 (437)
+++++.+||+|||+++...
T Consensus 167 l~~~~~~kL~Dfg~~~~~~ 185 (314)
T cd05099 167 VTEDNVMKIADFGLARGVH 185 (314)
T ss_pred EcCCCcEEEcccccccccc
Confidence 9999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=197.97 Aligned_cols=150 Identities=27% Similarity=0.406 Sum_probs=128.9
Q ss_pred CCCcCCcccccCcccEEEEEeC------CCCEEEEEEEeccch-hhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
+|+..++||+|+||.||+|.+. .++.||+|.+..... ...+.+.+|+.++..++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3566789999999999999863 247899999875433 335678899999999999999999999999999999
Q ss_pred EEeccCCCCccccccccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCc
Q 013737 343 VYEFVPNQSLLDNLFVRQ-------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT 409 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~ 409 (437)
++||+++++|.+++..+. ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999988874221 1235888999999999999999999987 999999999999999999
Q ss_pred EEEcccCCccccC
Q 013737 410 AKIADFGLVRLFP 422 (437)
Q Consensus 410 ~ki~DFG~a~~~~ 422 (437)
+||+|||+++...
T Consensus 163 ~kl~Dfg~~~~~~ 175 (283)
T cd05091 163 VKISDLGLFREVY 175 (283)
T ss_pred eEecccccccccc
Confidence 9999999988664
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=207.91 Aligned_cols=145 Identities=27% Similarity=0.345 Sum_probs=126.3
Q ss_pred hcCCCcCCcccccCcccEEEEEeC---CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP---GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
..+|...+.||+|+||.||++... .+..|++|.+... ....+|++++++++||||+++++++......+++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 356899999999999999999753 3578999987543 23468999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
|++. ++|.+++ .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 166 e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9995 6787777 23456899999999999999999999988 999999999999999999999999999876543
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=193.12 Aligned_cols=144 Identities=35% Similarity=0.552 Sum_probs=127.6
Q ss_pred CcccccCcccEEEEEeCC--C--CEEEEEEEeccch-hhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCC
Q 013737 275 NKLGQGGSGSVYKGTLPG--G--EAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN 349 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (437)
++||+|++|.||++.+.+ + ..+|+|.+..... ...+.+.+|+.++++++||||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999743 3 3689999976655 567789999999999999999999999888 889999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 350 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
++|.+.+..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccc
Confidence 999998854332 56899999999999999999999987 99999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=196.07 Aligned_cols=153 Identities=29% Similarity=0.392 Sum_probs=131.4
Q ss_pred HHhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCC-CCCceeceeEEEeeC------
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG------ 337 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------ 337 (437)
.+++.|+..+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.++.++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45677888999999999999999974 58899999986543 3345788999999998 699999999998753
Q ss_pred CeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCC
Q 013737 338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417 (437)
Q Consensus 338 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~ 417 (437)
...+++|||+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 4578999999999999987532 2346899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCC
Q 013737 418 VRLFPE 423 (437)
Q Consensus 418 a~~~~~ 423 (437)
++....
T Consensus 158 ~~~~~~ 163 (272)
T cd06637 158 SAQLDR 163 (272)
T ss_pred ceeccc
Confidence 986643
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=195.88 Aligned_cols=151 Identities=26% Similarity=0.369 Sum_probs=132.2
Q ss_pred cCCCcCCcccccCcccEEEEEeC------CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
++|...++||+|+||.||++... ++..+++|.+........+.+.+|+++++.++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45777899999999999999742 356789998876666667789999999999999999999999999999999
Q ss_pred EEeccCCCCccccccccCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 013737 343 VYEFVPNQSLLDNLFVRQD------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ 410 (437)
+|||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999988754321 134889999999999999999999987 9999999999999999999
Q ss_pred EEcccCCccccC
Q 013737 411 KIADFGLVRLFP 422 (437)
Q Consensus 411 ki~DFG~a~~~~ 422 (437)
||+|||+++.+.
T Consensus 162 kL~dfg~~~~~~ 173 (280)
T cd05092 162 KIGDFGMSRDIY 173 (280)
T ss_pred EECCCCceeEcC
Confidence 999999997653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=199.75 Aligned_cols=143 Identities=22% Similarity=0.226 Sum_probs=115.6
Q ss_pred HHHhcCCCcCCcccccCcccEEEEEeC--CCCEEEEEEEecc-----chhhHHHHHHHHHHHcCCCCCceec-eeEEEee
Q 013737 265 EKATNYFHESNKLGQGGSGSVYKGTLP--GGEAVAVKRLFYN-----TTQWVDHFFNEVNLISGINHKNLVK-LLGCSIT 336 (437)
Q Consensus 265 ~~~~~~~~~~~~Lg~G~~g~V~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~ 336 (437)
....+.|...+.||+|+||+||+|.+. +++.+|||++... .....+.|.+|+++|++++|+|++. +++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---- 89 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---- 89 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----
Confidence 344577999999999999999999864 5778899987532 2233567999999999999999985 443
Q ss_pred CCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCC-CCCCeeeCCCCcEEEccc
Q 013737 337 GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDI-KLSNILLDEEFTAKIADF 415 (437)
Q Consensus 337 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDl-k~~NIll~~~~~~ki~DF 415 (437)
.+..+|||||+++++|.. + .. .. ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+||
T Consensus 90 ~~~~~LVmE~~~G~~L~~-~---~~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 90 TGKDGLVRGWTEGVPLHL-A---RP---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred cCCcEEEEEccCCCCHHH-h---Cc---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEEC
Confidence 246799999999998862 2 11 11 1467889999999999987 999999 999999999999999999
Q ss_pred CCccccCCC
Q 013737 416 GLVRLFPED 424 (437)
Q Consensus 416 G~a~~~~~~ 424 (437)
|+|+.+...
T Consensus 157 GlA~~~~~~ 165 (365)
T PRK09188 157 QLASVFRRR 165 (365)
T ss_pred ccceecccC
Confidence 999977543
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=198.43 Aligned_cols=146 Identities=23% Similarity=0.325 Sum_probs=130.1
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc---hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..+.||+|+||.||++... +++.|++|.+.... ....+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888899999999999999975 47899999986543 234567889999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 99999999998833 346899999999999999999999987 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=197.07 Aligned_cols=152 Identities=34% Similarity=0.490 Sum_probs=132.1
Q ss_pred hcCCCcCCcccccCcccEEEEEeC------CCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCee
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES 340 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 340 (437)
.++|+..+.||+|+||.||++..+ ++..+|+|.+.... ....+++.+|+.++++++||||+++++++..++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467888999999999999999863 36789999987543 34456799999999999999999999999999999
Q ss_pred EEEEeccCCCCccccccccC-------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCC
Q 013737 341 LLVYEFVPNQSLLDNLFVRQ-------------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSN 401 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~N 401 (437)
++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999998885321 1134788999999999999999999987 9999999999
Q ss_pred eeeCCCCcEEEcccCCccccC
Q 013737 402 ILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 402 Ill~~~~~~ki~DFG~a~~~~ 422 (437)
|++++++.+||+|||+++.+.
T Consensus 161 il~~~~~~~~l~dfg~~~~~~ 181 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIY 181 (288)
T ss_pred eEecCCCceEECccccceecc
Confidence 999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=195.92 Aligned_cols=149 Identities=31% Similarity=0.488 Sum_probs=132.4
Q ss_pred CCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc--hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
+|+..+.||+|+||.||+|.+. +++.|++|.+.... ....+.+.+|+.++++++||||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999974 68999999987543 33456799999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
+ +++|.+++... ..++++.++..++.||+.||.|||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 99999887432 256899999999999999999999987 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=196.94 Aligned_cols=147 Identities=30% Similarity=0.422 Sum_probs=128.3
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccch-hhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
++|+..+.||+|++|.||++..+ +++.||+|.+..... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56888899999999999999975 588999999865432 2234577899999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
+++ +|.+++... ...+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAK 153 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccccc
Confidence 974 888877432 236899999999999999999999987 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=194.67 Aligned_cols=143 Identities=23% Similarity=0.345 Sum_probs=121.3
Q ss_pred CcccccCcccEEEEEeCCC---CEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCC
Q 013737 275 NKLGQGGSGSVYKGTLPGG---EAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 350 (437)
++||+|+||.||++...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999985433 346677765443 345678999999999999999999999999999999999999999
Q ss_pred CccccccccCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 351 SLLDNLFVRQD-VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 351 ~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
+|.+++..... ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccc
Confidence 99998854322 234677788899999999999999987 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-23 Score=194.63 Aligned_cols=149 Identities=29% Similarity=0.510 Sum_probs=129.4
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCC----EEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGE----AVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
.+|+..+.||+|+||.||+|.++ ++. .+++|.+.... .....++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 45778899999999999999864 233 68999886553 3445788999999999999999999999887 78899
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
||||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999998843 2345899999999999999999999987 9999999999999999999999999998765
Q ss_pred C
Q 013737 423 E 423 (437)
Q Consensus 423 ~ 423 (437)
.
T Consensus 161 ~ 161 (279)
T cd05057 161 V 161 (279)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.6e-23 Score=226.00 Aligned_cols=145 Identities=25% Similarity=0.407 Sum_probs=123.4
Q ss_pred HHHhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEE
Q 013737 265 EKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 265 ~~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
+.....++..+.||+|+||.||+|.. .++..||||++...... ...|++.+++++|||||++++++.+++..++|
T Consensus 686 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv 761 (968)
T PLN00113 686 NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI 761 (968)
T ss_pred HHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence 33445678889999999999999997 56899999998643322 23468899999999999999999999999999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
|||+++|+|.+++. .++|..+.+|+.|+++||+|||....++|+||||||+||+++.++.+++. ||....
T Consensus 762 ~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~ 831 (968)
T PLN00113 762 HEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL 831 (968)
T ss_pred EeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence 99999999999883 38999999999999999999996655569999999999999999888875 666544
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=196.67 Aligned_cols=148 Identities=29% Similarity=0.311 Sum_probs=129.5
Q ss_pred CCCcCCcccccCcccEEEEEe----CCCCEEEEEEEeccc----hhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCee
Q 013737 270 YFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNT----TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPES 340 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 340 (437)
+|+..+.||+|+||.||++.. .+|..+|+|.+.... ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467789999999999999986 368899999986532 23346788999999999 599999999999999999
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+|||+++++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999998843 345889999999999999999999987 99999999999999999999999999987
Q ss_pred cCC
Q 013737 421 FPE 423 (437)
Q Consensus 421 ~~~ 423 (437)
+..
T Consensus 155 ~~~ 157 (290)
T cd05613 155 FHE 157 (290)
T ss_pred ccc
Confidence 654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=198.31 Aligned_cols=146 Identities=32% Similarity=0.479 Sum_probs=129.6
Q ss_pred CCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCC
Q 013737 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN 349 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (437)
|.....||+|+||.||++.. .++..+|||.+........+.+.+|+.+++.++||||+++++.+..++..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 34456799999999999986 45889999998766555667899999999999999999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 350 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
++|.+++. ...+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||++..+..
T Consensus 104 ~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (292)
T cd06658 104 GALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK 170 (292)
T ss_pred CcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence 99988762 235889999999999999999999987 99999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=201.28 Aligned_cols=154 Identities=29% Similarity=0.412 Sum_probs=131.3
Q ss_pred HhcCCCcCCcccccCcccEEEEEeC--------CCCEEEEEEEecc-chhhHHHHHHHHHHHcCC-CCCceeceeEEEee
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLP--------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSIT 336 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 336 (437)
...+|++.+.||+|+||.||++... ....+|+|.+... .....+++.+|++++.++ +||||+++++++..
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 3456888999999999999999742 1236899988654 334467899999999999 79999999999999
Q ss_pred CCeeEEEEeccCCCCccccccccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCee
Q 013737 337 GPESLLVYEFVPNQSLLDNLFVRQ-------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNIL 403 (437)
Q Consensus 337 ~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIl 403 (437)
.+..++++||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEE
Confidence 999999999999999999885432 1235889999999999999999999987 999999999999
Q ss_pred eCCCCcEEEcccCCccccCC
Q 013737 404 LDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 404 l~~~~~~ki~DFG~a~~~~~ 423 (437)
+++++.+||+|||+++.+..
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~ 186 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHN 186 (334)
T ss_pred EcCCCcEEECCcccceeccc
Confidence 99999999999999986643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=203.46 Aligned_cols=142 Identities=25% Similarity=0.375 Sum_probs=124.3
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
...|+..+.||+|+||.||+|... +++.||+|..... ....|+.++++++||||+++++++...+..++|+|+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 356999999999999999999975 4778999975332 234689999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
+. ++|.+++.. ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 139 ~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 139 YS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred cC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 95 688777643 3456899999999999999999999987 999999999999999999999999999754
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=193.63 Aligned_cols=148 Identities=31% Similarity=0.454 Sum_probs=128.1
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc-----chhhHHHHHHHHHHHcCCCCCceeceeEEEeeC--Cee
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-----TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PES 340 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 340 (437)
.+|+..+.||+|+||.||++... ++..|++|.+... .....+.+.+|+.++.+++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999974 5899999988532 123456788999999999999999999988764 457
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
+++|||+++++|.+++.. ...+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999988742 245788999999999999999999987 99999999999999999999999999986
Q ss_pred cC
Q 013737 421 FP 422 (437)
Q Consensus 421 ~~ 422 (437)
..
T Consensus 156 ~~ 157 (265)
T cd06652 156 LQ 157 (265)
T ss_pred cc
Confidence 53
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=197.59 Aligned_cols=154 Identities=31% Similarity=0.419 Sum_probs=132.5
Q ss_pred HhcCCCcCCcccccCcccEEEEEeC------CCCEEEEEEEecc-chhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCC
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGP 338 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 338 (437)
..++|...+.||+|+||.||++... .+..+|+|.++.. .....+.+.+|+.+++++ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3456888999999999999999741 2457999988654 234456789999999999 7999999999999999
Q ss_pred eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCc
Q 013737 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (437)
Q Consensus 339 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a 418 (437)
..++||||+++++|.+++.... ...+++.++..++.|++.||.|||+.+ |+|+||||+|||+++++.+||+|||++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 9999999999999999884322 234899999999999999999999987 999999999999999999999999999
Q ss_pred cccCCC
Q 013737 419 RLFPED 424 (437)
Q Consensus 419 ~~~~~~ 424 (437)
+.+...
T Consensus 189 ~~~~~~ 194 (302)
T cd05055 189 RDIMND 194 (302)
T ss_pred ccccCC
Confidence 876543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-23 Score=194.18 Aligned_cols=152 Identities=32% Similarity=0.385 Sum_probs=130.4
Q ss_pred hcCCCcCCcccccCcccEEEEEeC------CCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCee
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES 340 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 340 (437)
.++|+..+.||+|+||.||+|.+. .+..|++|.+.... ......|.+|+.+++.++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 466888999999999999999974 35678999876443 33445789999999999999999999999999999
Q ss_pred EEEEeccCCCCccccccccCC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC---cEEEc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQD----VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF---TAKIA 413 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~---~~ki~ 413 (437)
++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999998754321 235899999999999999999999987 99999999999998654 69999
Q ss_pred ccCCccccC
Q 013737 414 DFGLVRLFP 422 (437)
Q Consensus 414 DFG~a~~~~ 422 (437)
|||+++.+.
T Consensus 162 dfg~~~~~~ 170 (277)
T cd05036 162 DFGMARDIY 170 (277)
T ss_pred cCccccccC
Confidence 999998763
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-23 Score=196.97 Aligned_cols=148 Identities=26% Similarity=0.444 Sum_probs=133.4
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEecc
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (437)
.+|+..+.||.|+||.||++.. .+++.|++|.+........+.+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4588889999999999999986 568999999987665555678899999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
++++|.+++. ...+++.++..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++....
T Consensus 99 ~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 99 AGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred CCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 9999998773 235899999999999999999999987 99999999999999999999999999886543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.6e-23 Score=191.20 Aligned_cols=147 Identities=35% Similarity=0.555 Sum_probs=130.4
Q ss_pred CcccccCcccEEEEEeCC----CCEEEEEEEeccchh-hHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCC
Q 013737 275 NKLGQGGSGSVYKGTLPG----GEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN 349 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (437)
+.||+|+||.||++.... +..+++|.+...... ..+.+.+|++++..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999999753 788999998765433 367899999999999999999999999999999999999999
Q ss_pred CCccccccccCC------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 350 QSLLDNLFVRQD------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 350 g~L~~~l~~~~~------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
++|.+++..... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999998854321 366899999999999999999999987 99999999999999999999999999987765
Q ss_pred C
Q 013737 424 D 424 (437)
Q Consensus 424 ~ 424 (437)
.
T Consensus 158 ~ 158 (262)
T cd00192 158 D 158 (262)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-24 Score=192.42 Aligned_cols=151 Identities=28% Similarity=0.361 Sum_probs=132.3
Q ss_pred HHHHHHHhcCCCcCCcccccCcccEEEEE-eCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCC-CCceeceeEEEeeCC
Q 013737 261 YETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGP 338 (437)
Q Consensus 261 ~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 338 (437)
++++-+.+ .+.||+|+|+.|--+. +.+|..+|||++.+.......+..+|++++.+.+ |+||++|+++|+++.
T Consensus 75 F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 44444444 3689999999999988 6889999999998877777889999999999986 999999999999999
Q ss_pred eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC---cEEEccc
Q 013737 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF---TAKIADF 415 (437)
Q Consensus 339 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~---~~ki~DF 415 (437)
..|||||-|.||+|...+.. ...+++.++.+++++|+.||.|||.++ |.||||||+|||-.+.. -+||+||
T Consensus 150 ~FYLVfEKm~GGplLshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQK---RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred eEEEEEecccCchHHHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecc
Confidence 99999999999999998843 455899999999999999999999998 99999999999986543 5899999
Q ss_pred CCccccC
Q 013737 416 GLVRLFP 422 (437)
Q Consensus 416 G~a~~~~ 422 (437)
.+..-+.
T Consensus 224 DLgSg~k 230 (463)
T KOG0607|consen 224 DLGSGIK 230 (463)
T ss_pred ccccccc
Confidence 9987553
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=202.58 Aligned_cols=147 Identities=30% Similarity=0.412 Sum_probs=125.2
Q ss_pred HhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC-----
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP----- 338 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 338 (437)
..++|+..+.||+|+||.||++.. .+++.+|+|.+... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 347799999999999999999997 45899999998643 3344567889999999999999999999886543
Q ss_pred -eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCC
Q 013737 339 -ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417 (437)
Q Consensus 339 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~ 417 (437)
..++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 46999999975 5555442 23788899999999999999999998 99999999999999999999999999
Q ss_pred ccccC
Q 013737 418 VRLFP 422 (437)
Q Consensus 418 a~~~~ 422 (437)
++...
T Consensus 170 a~~~~ 174 (359)
T cd07876 170 ARTAC 174 (359)
T ss_pred ccccc
Confidence 98654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=196.36 Aligned_cols=161 Identities=27% Similarity=0.351 Sum_probs=135.5
Q ss_pred cCHHHHHHHhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCC-CCCceeceeEEEe-
Q 013737 259 FSYETLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSI- 335 (437)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~- 335 (437)
+.++.+..+.++|+..+.||+|+||.||++... +++.+++|.+.... .....+.+|+.++..+ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445667778899999999999999999999874 57899999875432 2235688899999999 6999999999874
Q ss_pred ----eCCeeEEEEeccCCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 013737 336 ----TGPESLLVYEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410 (437)
Q Consensus 336 ----~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ 410 (437)
.++..++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 345689999999999998876432 23346889999999999999999999987 9999999999999999999
Q ss_pred EEcccCCccccCC
Q 013737 411 KIADFGLVRLFPE 423 (437)
Q Consensus 411 ki~DFG~a~~~~~ 423 (437)
||+|||+++.+..
T Consensus 164 kl~dfg~~~~~~~ 176 (286)
T cd06638 164 KLVDFGVSAQLTS 176 (286)
T ss_pred EEccCCceeeccc
Confidence 9999999986643
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-23 Score=192.78 Aligned_cols=146 Identities=32% Similarity=0.521 Sum_probs=128.8
Q ss_pred CCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccch---------hhHHHHHHHHHHHcCCCCCceeceeEEEeeCCee
Q 013737 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT---------QWVDHFFNEVNLISGINHKNLVKLLGCSITGPES 340 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 340 (437)
|...+.||+|+||.||+|... +++.+|+|.+..... ...+.+.+|+.++++++||||+++++++...+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 667789999999999999864 578999998864321 1235688999999999999999999999999999
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
+++|||+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++.
T Consensus 82 ~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 82 NIFLEYVPGGSVAALLN---NYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEEEecCCCCHHHHHH---hccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999998883 2356889999999999999999999987 99999999999999999999999999987
Q ss_pred cC
Q 013737 421 FP 422 (437)
Q Consensus 421 ~~ 422 (437)
+.
T Consensus 156 ~~ 157 (267)
T cd06628 156 LE 157 (267)
T ss_pred cc
Confidence 75
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=193.45 Aligned_cols=148 Identities=28% Similarity=0.440 Sum_probs=130.3
Q ss_pred CCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc------hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT------TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
+|+..+.||+|++|.||++.. .+++.+|+|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999986 568999999986432 1235688999999999999999999999999999999
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC-cEEEcccCCcccc
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRLF 421 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~-~~ki~DFG~a~~~ 421 (437)
|+||+++++|.+++.. ..++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++..+
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999998743 346889999999999999999999998 99999999999998775 6999999999876
Q ss_pred CC
Q 013737 422 PE 423 (437)
Q Consensus 422 ~~ 423 (437)
..
T Consensus 155 ~~ 156 (268)
T cd06630 155 AA 156 (268)
T ss_pred cc
Confidence 54
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.3e-23 Score=190.44 Aligned_cols=147 Identities=30% Similarity=0.483 Sum_probs=127.5
Q ss_pred cCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEe-eCCeeEEEEecc
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI-TGPESLLVYEFV 347 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~ 347 (437)
++|+..+.||+|+||.||++... +..+++|.+.... ..+.+.+|+.++++++|+|++++++++. .++..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46788899999999999999876 7789999886433 3467899999999999999999999765 456789999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~ 153 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 153 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecc
Confidence 999999987543 2345889999999999999999999987 9999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.5e-23 Score=193.98 Aligned_cols=149 Identities=30% Similarity=0.464 Sum_probs=130.7
Q ss_pred cCCCcCCcccccCcccEEEEEeC-----CCCEEEEEEEeccchh-hHHHHHHHHHHHcCCCCCceeceeEEEee--CCee
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-----GGEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSIT--GPES 340 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 340 (437)
+.|+..+.||+|+||.||++.+. ++..+|||.+...... ..+.|.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45677889999999999999853 3678999998765443 56789999999999999999999999877 5578
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
+++|||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999988432 235899999999999999999999987 99999999999999999999999999988
Q ss_pred cC
Q 013737 421 FP 422 (437)
Q Consensus 421 ~~ 422 (437)
..
T Consensus 159 ~~ 160 (284)
T cd05038 159 LP 160 (284)
T ss_pred cc
Confidence 76
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.8e-24 Score=191.65 Aligned_cols=161 Identities=27% Similarity=0.278 Sum_probs=138.5
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|...++||+|.||+|.+++- .+++.+|+|+++++ .......-..|-++|...+||.+..|.-.|+..+.+++||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 5677889999999999999986 46899999999765 3344556678999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||..||.|.-+|. ....+++.....+...|..||.|||+.+ ||.||||.+|.|+|.+|++||+|||+++.-...
T Consensus 248 eyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 248 EYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccc
Confidence 9999999988873 3445888888899999999999999988 999999999999999999999999999865443
Q ss_pred CcceeeeecccC
Q 013737 425 ITHISATLAGTL 436 (437)
Q Consensus 425 ~~~~~~~~~Gt~ 436 (437)
.. .+.+++|||
T Consensus 322 g~-t~kTFCGTP 332 (516)
T KOG0690|consen 322 GD-TTKTFCGTP 332 (516)
T ss_pred cc-eeccccCCh
Confidence 32 334788886
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.7e-23 Score=189.23 Aligned_cols=143 Identities=34% Similarity=0.538 Sum_probs=127.9
Q ss_pred CcccccCcccEEEEEeCCCCEEEEEEEeccch-hhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCCCcc
Q 013737 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLL 353 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 353 (437)
++||+|+||.||++.+.+++.|++|.+..... .....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 47999999999999987699999999875533 35678999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 354 DNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 354 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
+++... ...+++..+..++.+++.+|.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 144 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEE 144 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeecccccccc
Confidence 887432 345789999999999999999999987 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-23 Score=218.79 Aligned_cols=159 Identities=26% Similarity=0.336 Sum_probs=131.4
Q ss_pred HHHhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeC--Ce
Q 013737 265 EKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PE 339 (437)
Q Consensus 265 ~~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 339 (437)
+...++|.+.++||+|+||.||++.+. ++..+|+|.+... .......|..|+.++.+|+||||+++++++... ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 344567999999999999999999974 4778999988643 334467789999999999999999999988643 46
Q ss_pred eEEEEeccCCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCC----CCeeeCCCCCCCeeeCC--------
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESK----LRIIHRDIKLSNILLDE-------- 406 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~----~~iiHrDlk~~NIll~~-------- 406 (437)
.+|||||+++++|.++|.... ....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999885422 23569999999999999999999998531 34999999999999964
Q ss_pred ---------CCcEEEcccCCccccCC
Q 013737 407 ---------EFTAKIADFGLVRLFPE 423 (437)
Q Consensus 407 ---------~~~~ki~DFG~a~~~~~ 423 (437)
...+||+|||+++.+..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~ 194 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGI 194 (1021)
T ss_pred cccccccCCCCceEEccCCccccccc
Confidence 23589999999987653
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-23 Score=193.09 Aligned_cols=149 Identities=28% Similarity=0.402 Sum_probs=128.7
Q ss_pred cCCCcCCcccccCcccEEEEEeCC----CCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
++|...++||+|+||.||+|.+.+ ...+++|...... ....+.+.+|+.++++++||||+++++++.. +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457788999999999999998643 2468999886554 4556789999999999999999999998865 567899
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 9999999999988432 335899999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.2e-23 Score=189.47 Aligned_cols=150 Identities=33% Similarity=0.496 Sum_probs=134.4
Q ss_pred hcCCCcCCcccccCcccEEEEEeCC-CCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
.++|+..+.||+|+||.||++.+.. ++.+++|.+..... .+++.+|++++++++||||+++++.+......++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 4678899999999999999999764 78999999865433 67899999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++..+...
T Consensus 80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 999999998743 2356899999999999999999999987 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.9e-23 Score=190.83 Aligned_cols=149 Identities=31% Similarity=0.451 Sum_probs=132.9
Q ss_pred CCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccch--hhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
+|+..+.||+|+||.||++... +++.+++|.+..... ...+.+.+|+++++.++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777899999999999999964 688999999876543 3677899999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 999999998743 334788999999999999999999988 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.4e-23 Score=193.74 Aligned_cols=150 Identities=29% Similarity=0.471 Sum_probs=131.2
Q ss_pred CCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEecc
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (437)
+|+..++||+|++|.||+|+.. +++.||||.+.... ....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999975 58899999987543 233466788999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
++ +|.+++........+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~ 152 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGI 152 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence 85 88887754444456899999999999999999999987 99999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.3e-23 Score=192.14 Aligned_cols=147 Identities=30% Similarity=0.447 Sum_probs=128.6
Q ss_pred CCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccch----------hhHHHHHHHHHHHcCCCCCceeceeEEEeeCC
Q 013737 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTT----------QWVDHFFNEVNLISGINHKNLVKLLGCSITGP 338 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 338 (437)
+|...+.||+|+||.||+|.. .+++.+|+|.+..... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 466788999999999999986 4588999998753211 12346888999999999999999999999999
Q ss_pred eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCc
Q 013737 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (437)
Q Consensus 339 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a 418 (437)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 99999999999999998843 256899999999999999999999987 999999999999999999999999999
Q ss_pred cccC
Q 013737 419 RLFP 422 (437)
Q Consensus 419 ~~~~ 422 (437)
+...
T Consensus 156 ~~~~ 159 (272)
T cd06629 156 KKSD 159 (272)
T ss_pred cccc
Confidence 8654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-24 Score=210.87 Aligned_cols=162 Identities=23% Similarity=0.326 Sum_probs=137.2
Q ss_pred CCCcCCcccccCcccEEEEEeCC-CCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccC
Q 013737 270 YFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (437)
.|.+...||.|+||.||++..+. +-..|.|.+...+....+.+.-|+++|+.++||+||+|++.+...+.+||+.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 34556789999999999999764 44567788877778888999999999999999999999999999999999999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCCcce
Q 013737 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428 (437)
Q Consensus 349 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~~~~ 428 (437)
||-...++.. -...|++.++.-++.|++.||.|||++. |||||||+.|||++-+|.++|+|||.+..........
T Consensus 113 GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 113 GGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred CchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence 9988776632 2356899999999999999999999997 9999999999999999999999999986543322211
Q ss_pred eeeecccCC
Q 013737 429 SATLAGTLF 437 (437)
Q Consensus 429 ~~~~~Gt~~ 437 (437)
.++.||||
T Consensus 188 -DsFIGTPY 195 (1187)
T KOG0579|consen 188 -DSFIGTPY 195 (1187)
T ss_pred -ccccCCcc
Confidence 25678876
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.6e-23 Score=196.47 Aligned_cols=150 Identities=29% Similarity=0.319 Sum_probs=133.0
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccch---hhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT---QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..+.||+|+||.||++... +++.+|+|.+..... ...+.+.+|++++..++||||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999975 489999999875432 34567899999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
||+++++|.+++.. .....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 99999999998743 23456899999999999999999999987 9999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=190.96 Aligned_cols=143 Identities=32% Similarity=0.503 Sum_probs=123.0
Q ss_pred CcccccCcccEEEEEeCC-CC--EEEEEEEecc-chhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCeeEEEEeccCC
Q 013737 275 NKLGQGGSGSVYKGTLPG-GE--AVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPN 349 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (437)
+.||+|+||.||++.+.+ +. .+++|.+... .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999753 43 4688887643 344556889999999999 799999999999999999999999999
Q ss_pred CCccccccccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccC
Q 013737 350 QSLLDNLFVRQ-------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (437)
Q Consensus 350 g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG 416 (437)
++|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99998875322 1234789999999999999999999987 9999999999999999999999999
Q ss_pred Cccc
Q 013737 417 LVRL 420 (437)
Q Consensus 417 ~a~~ 420 (437)
+++.
T Consensus 158 l~~~ 161 (270)
T cd05047 158 LSRG 161 (270)
T ss_pred Cccc
Confidence 9863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.4e-23 Score=194.79 Aligned_cols=150 Identities=28% Similarity=0.438 Sum_probs=129.6
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc--hhhHHHHHHHHHHHcCCCCCceeceeEEEeeC--CeeEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PESLLV 343 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 343 (437)
++|+..+.||+|+||.||+|..+ +++.+++|.++... ......+.+|+.++.+++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999975 58899999987542 23344677899999999999999999998877 889999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|||++ ++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 85 ~e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 4888877432 236899999999999999999999987 99999999999999999999999999987654
Q ss_pred C
Q 013737 424 D 424 (437)
Q Consensus 424 ~ 424 (437)
.
T Consensus 159 ~ 159 (293)
T cd07843 159 P 159 (293)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.8e-23 Score=197.07 Aligned_cols=144 Identities=23% Similarity=0.277 Sum_probs=125.3
Q ss_pred cCCccccc--CcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEecc
Q 013737 273 ESNKLGQG--GSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (437)
Q Consensus 273 ~~~~Lg~G--~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (437)
..++||+| +|++||++.. .+|+.||+|.+... .....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 6789999986 56899999998654 2334566788999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++++||+.+..
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~ 150 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLS 150 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhc
Confidence 9999999874332 235899999999999999999999988 99999999999999999999999986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.2e-23 Score=194.43 Aligned_cols=146 Identities=31% Similarity=0.495 Sum_probs=129.5
Q ss_pred CCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccC
Q 013737 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (437)
|+..+.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 556678999999999999864 57899999886442 3445679999999999999999999999999999999999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 349 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
+++|.+++. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+..
T Consensus 86 ~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 86 GGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccC
Confidence 999988773 245889999999999999999999987 99999999999999999999999999987654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=7e-23 Score=194.31 Aligned_cols=150 Identities=30% Similarity=0.408 Sum_probs=128.4
Q ss_pred HhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++++|...+.||+|+||.||+|.. .+++.+++|.+.... ......+.+|+.+++.++|+||+++++++..++..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 346788999999999999999986 458899999986543 223346788999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
||+. ++|.+.+.. ....+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++...
T Consensus 83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 9996 677666532 2345788889999999999999999987 9999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.4e-23 Score=196.45 Aligned_cols=147 Identities=31% Similarity=0.457 Sum_probs=129.6
Q ss_pred CCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCC
Q 013737 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN 349 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (437)
|.....||+|+||.||++... +++.+|+|.+........+.+.+|+.++..++||||+++++++..++..++|+||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 334557999999999999864 6899999998765555567788999999999999999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 350 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
++|.+++. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+..+
T Consensus 103 ~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~ 170 (297)
T cd06659 103 GALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD 170 (297)
T ss_pred CCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccc
Confidence 99988662 245899999999999999999999987 999999999999999999999999999866543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=189.36 Aligned_cols=153 Identities=33% Similarity=0.452 Sum_probs=135.1
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
++|+..+.||.|+||.||++... ++..+++|.+.... ....+.+.+|+++++.++|+||+++++.+...+..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999964 57899999986542 33567899999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
+++++|.+++........+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 999999998854333356899999999999999999999987 999999999999999999999999998876543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.7e-23 Score=193.08 Aligned_cols=151 Identities=25% Similarity=0.358 Sum_probs=126.4
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc-hhhHHHHHHHHHH-HcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNL-ISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
++|+..+.||+|+||.||++.+. +|+.||+|.+.... .....++..|+.+ ++.++||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999975 58999999987542 2233456666665 666789999999999999999999999
Q ss_pred ccCCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 346 FVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 346 ~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|++ ++|.+++... .....+++..+..++.||+.||.|||++ + ++||||||+||++++++.+||+|||+++.+..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6777766432 2335689999999999999999999986 5 99999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-23 Score=183.00 Aligned_cols=142 Identities=17% Similarity=0.156 Sum_probs=109.9
Q ss_pred CCcccccCcccEEEEEeCCCCEEEEEEEeccchh--h-------H-----------------HHHHHHHHHHcCCCCCce
Q 013737 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQ--W-------V-----------------DHFFNEVNLISGINHKNL 327 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~ni 327 (437)
...||+|+||.||+|..++|++||||+++..... . . ....+|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999998654211 0 1 122459999999988777
Q ss_pred eceeEEEeeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCCeeeCCCCCCCeeeCC
Q 013737 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL-HEESKLRIIHRDIKLSNILLDE 406 (437)
Q Consensus 328 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yL-H~~~~~~iiHrDlk~~NIll~~ 406 (437)
.....+.. ...+|||||++++++..... ...++++..+..++.|++.+|.+| |+.+ |+||||||+|||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~~ 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYHD 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEEC
Confidence 54443322 23489999999877654321 234688999999999999999999 6877 999999999999984
Q ss_pred CCcEEEcccCCccccCCC
Q 013737 407 EFTAKIADFGLVRLFPED 424 (437)
Q Consensus 407 ~~~~ki~DFG~a~~~~~~ 424 (437)
+.++|+|||+|.....+
T Consensus 154 -~~v~LiDFG~a~~~~~~ 170 (190)
T cd05147 154 -GKLYIIDVSQSVEHDHP 170 (190)
T ss_pred -CcEEEEEccccccCCCc
Confidence 78999999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-23 Score=196.41 Aligned_cols=149 Identities=28% Similarity=0.405 Sum_probs=130.1
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc--hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
++|+..++||+|+||.||++.++ +++.+|+|.+.... ....+.+.+|+++++.++||||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 35788899999999999999975 58999999875432 2235678899999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|+++++|.++.. ....+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 999988877552 2234899999999999999999999987 99999999999999999999999999886643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=190.84 Aligned_cols=148 Identities=28% Similarity=0.468 Sum_probs=131.6
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
..|+..++||+|+||.||+|.+. ++..+|+|.+.... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 34677889999999999999975 58899999987543 44567899999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
+++++|.+++. ..++++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+..
T Consensus 84 ~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 84 LGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 99999998873 245889999999999999999999987 99999999999999999999999999977643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.9e-23 Score=194.81 Aligned_cols=151 Identities=28% Similarity=0.361 Sum_probs=131.1
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
++|+..+.||+|+||.||++.++ +++.|++|.+... .....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 35888899999999999999975 5889999988643 33345788999999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~ 425 (437)
|++++.+..+. .....+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++..+....
T Consensus 81 ~~~~~~l~~~~---~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLE---ASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 99986665544 22345899999999999999999999987 9999999999999999999999999998776543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=189.84 Aligned_cols=148 Identities=30% Similarity=0.467 Sum_probs=128.2
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc-----chhhHHHHHHHHHHHcCCCCCceeceeEEEeeC--Cee
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-----TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PES 340 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 340 (437)
.+|+..+.||+|+||.||++... ++..+++|.+... .......+.+|+.++++++||||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999874 5889999988643 123456788999999999999999999988753 567
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
++++||+++++|.+.+.. ...+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999988743 345889999999999999999999987 99999999999999999999999999986
Q ss_pred cC
Q 013737 421 FP 422 (437)
Q Consensus 421 ~~ 422 (437)
+.
T Consensus 156 ~~ 157 (266)
T cd06651 156 LQ 157 (266)
T ss_pred cc
Confidence 54
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.4e-23 Score=189.55 Aligned_cols=149 Identities=28% Similarity=0.452 Sum_probs=131.0
Q ss_pred cCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccC
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (437)
.+|+..+.||+|+||.||++.+.++..+++|.+..... ....+.+|++++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 35777899999999999999987788999998864432 24578899999999999999999999999999999999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 349 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
+++|.+++.. ....+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 83 ~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 83 HGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeeccc
Confidence 9999888743 2345889999999999999999999987 99999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.7e-24 Score=207.50 Aligned_cols=152 Identities=31% Similarity=0.486 Sum_probs=133.8
Q ss_pred CCcCCcccccCcccEEEEEeC--CCC--EEEEEEEeccchh-hHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 271 FHESNKLGQGGSGSVYKGTLP--GGE--AVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
....++||+|.||.|++|.|. +|+ .||||.+..+... ....|++|+.+|.+|+|||+++|||+..+ ....+|+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 345679999999999999984 344 6899999876443 78899999999999999999999999987 67889999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~ 425 (437)
+++.|+|.+.|.+ .....|.......++.|||.||.||.++. +|||||..+|+|+-....+||+||||.|.++.+.
T Consensus 191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999999966 34556888888999999999999999987 9999999999999999999999999999988765
Q ss_pred cc
Q 013737 426 TH 427 (437)
Q Consensus 426 ~~ 427 (437)
..
T Consensus 267 d~ 268 (1039)
T KOG0199|consen 267 DM 268 (1039)
T ss_pred cc
Confidence 54
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=4e-23 Score=192.35 Aligned_cols=149 Identities=29% Similarity=0.302 Sum_probs=132.8
Q ss_pred CCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc---hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
+|+..+.||+|+||.||++... +++.+++|.+.... ....+.+.+|++++++++||||+++++.+..++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999975 58999999986532 2456789999999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
|+++++|.+++.. ..++++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999988733 246899999999999999999999987 999999999999999999999999998876543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=188.94 Aligned_cols=150 Identities=36% Similarity=0.582 Sum_probs=131.0
Q ss_pred CCcCCcccccCcccEEEEEeCC-----CCEEEEEEEeccchh-hHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 271 FHESNKLGQGGSGSVYKGTLPG-----GEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
|+..+.||+|+||.||++.+.. +..+|+|.+...... ..+.+..|++++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999999753 388999999755433 5678999999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999998743221 22899999999999999999999987 999999999999999999999999999876543
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-23 Score=202.79 Aligned_cols=151 Identities=30% Similarity=0.481 Sum_probs=130.7
Q ss_pred cCCCcCCcccccCcccEEEEEeC---CC--CEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP---GG--EAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~---~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
+.....++||+|.||.||+|... .| -.||||.-+.+ .+...+.|..|..+|++++|||||+|+|+|.+ ...||
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 33456788999999999999852 23 35888987764 56668899999999999999999999999865 56899
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
|||.++-|.|.++|..+ ...++......++.||+.+|.|||+.. .|||||..+|||+...--+||+|||++|.+.
T Consensus 468 vmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred EEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 99999999999999543 455888899999999999999999986 9999999999999999999999999999887
Q ss_pred CCC
Q 013737 423 EDI 425 (437)
Q Consensus 423 ~~~ 425 (437)
++.
T Consensus 543 d~~ 545 (974)
T KOG4257|consen 543 DDA 545 (974)
T ss_pred ccc
Confidence 653
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-23 Score=211.49 Aligned_cols=165 Identities=21% Similarity=0.287 Sum_probs=124.4
Q ss_pred hcCCCcCCcccccCcccEEEEEeCC--CCEEEEEE--------------Ee---ccchhhHHHHHHHHHHHcCCCCCcee
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPG--GEAVAVKR--------------LF---YNTTQWVDHFFNEVNLISGINHKNLV 328 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~--~~~vavK~--------------~~---~~~~~~~~~~~~E~~~l~~l~h~niv 328 (437)
.++|+..++||+|+||+||++.++. +...++|. +. .........+.+|+.+|.+++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4679999999999999999987532 22222221 10 11223345688999999999999999
Q ss_pred ceeEEEeeCCeeEEEEeccCCCCccccccccCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC
Q 013737 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQD--VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE 406 (437)
Q Consensus 329 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~ 406 (437)
++++++...+..++|+|++. ++|.+++..... ........+..|+.||+.||.|||+++ |+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECC
Confidence 99999999999999999985 567666533211 122345667889999999999999988 999999999999999
Q ss_pred CCcEEEcccCCccccCCCCcceeeeecccC
Q 013737 407 EFTAKIADFGLVRLFPEDITHISATLAGTL 436 (437)
Q Consensus 407 ~~~~ki~DFG~a~~~~~~~~~~~~~~~Gt~ 436 (437)
++.+||+|||+++.+............||+
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~ 332 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTV 332 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCc
Confidence 999999999999987654333222344553
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=188.48 Aligned_cols=143 Identities=32% Similarity=0.483 Sum_probs=123.7
Q ss_pred CcccccCcccEEEEEeCC----CCEEEEEEEeccch-hhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCC
Q 013737 275 NKLGQGGSGSVYKGTLPG----GEAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN 349 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (437)
++||+|+||.||+|.+.. +..+|+|.+..... ...+++.+|+.+++.++||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999998532 36899999875543 34567899999999999999999999875 4568999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 350 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||+++.+...
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAG 148 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecC
Confidence 9999988432 36899999999999999999999987 999999999999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.8e-23 Score=201.20 Aligned_cols=148 Identities=28% Similarity=0.402 Sum_probs=125.8
Q ss_pred HhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC-----
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP----- 338 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 338 (437)
..++|+..+.||+|+||.||++... .++.+|||.+... .......+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4467999999999999999999864 5889999998643 3344567889999999999999999999886433
Q ss_pred -eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCC
Q 013737 339 -ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417 (437)
Q Consensus 339 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~ 417 (437)
..++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 46999999965 5655552 24788999999999999999999988 99999999999999999999999999
Q ss_pred ccccCC
Q 013737 418 VRLFPE 423 (437)
Q Consensus 418 a~~~~~ 423 (437)
++....
T Consensus 166 ~~~~~~ 171 (355)
T cd07874 166 ARTAGT 171 (355)
T ss_pred cccCCC
Confidence 987643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=195.14 Aligned_cols=145 Identities=26% Similarity=0.428 Sum_probs=118.6
Q ss_pred CCcccccCcccEEEEEeC---CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEee--CCeeEEEEeccC
Q 013737 274 SNKLGQGGSGSVYKGTLP---GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT--GPESLLVYEFVP 348 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 348 (437)
..+||+|+||.||+|... ++..+|+|.+.... ....+.+|++++++++||||+++++++.. +...++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 468999999999999964 35789999886442 23457889999999999999999998854 456789999986
Q ss_pred CCCcccccccc------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee----CCCCcEEEcccCCc
Q 013737 349 NQSLLDNLFVR------QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLV 418 (437)
Q Consensus 349 ~g~L~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll----~~~~~~ki~DFG~a 418 (437)
+ +|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ ++++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 4 666655321 12235889999999999999999999987 9999999999999 56679999999999
Q ss_pred cccCCC
Q 013737 419 RLFPED 424 (437)
Q Consensus 419 ~~~~~~ 424 (437)
+.+...
T Consensus 160 ~~~~~~ 165 (317)
T cd07867 160 RLFNSP 165 (317)
T ss_pred eccCCC
Confidence 877543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=190.06 Aligned_cols=147 Identities=30% Similarity=0.462 Sum_probs=130.2
Q ss_pred CCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEecc
Q 013737 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (437)
-|+..+.||+|+||.||++.. .++..+|+|.+.... ....+.+.+|+.++.+++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 467788999999999999986 468899999886432 344567889999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
++++|.+++. ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||+++.+..
T Consensus 85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 9999998873 245899999999999999999999987 99999999999999999999999999876643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-23 Score=197.60 Aligned_cols=161 Identities=26% Similarity=0.362 Sum_probs=137.5
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
.-|...+.||+|.|..|-++++ -+|+.||||++.+. +.-....+.+|++.|+.++|||||+||++..++..+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4577788999999999999985 57999999999754 33345678899999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC-CCCcEEEcccCCccccCCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~-~~~~~ki~DFG~a~~~~~~ 424 (437)
+=.+|+|.+++.++. ..+.+..+.+++.||+.|+.|.|+.. +|||||||+|+.+- .-|.+||.|||++-.+...
T Consensus 98 LGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 999999999986543 45899999999999999999999987 99999999999875 5589999999999888654
Q ss_pred CcceeeeecccC
Q 013737 425 ITHISATLAGTL 436 (437)
Q Consensus 425 ~~~~~~~~~Gt~ 436 (437)
.. -++.+|++
T Consensus 173 ~k--L~TsCGSL 182 (864)
T KOG4717|consen 173 KK--LTTSCGSL 182 (864)
T ss_pred ch--hhcccchh
Confidence 42 23455553
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=190.50 Aligned_cols=149 Identities=31% Similarity=0.420 Sum_probs=133.1
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
++|+..+.||.|++|.||++... +++.+++|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 35778899999999999999974 58899999986543 44456789999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
+++++|.+++.. .++++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.+...
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 999999988743 26899999999999999999999987 999999999999999999999999999877643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.8e-23 Score=194.62 Aligned_cols=148 Identities=28% Similarity=0.455 Sum_probs=128.0
Q ss_pred CCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc--hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
+|+..+.||+|+||.||++... +|+.+++|.+.... ......+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 3677889999999999999974 68999999986432 22345678899999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
++ ++|.+++.. ....+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 81 CD-QDLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGI 151 (284)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence 97 577776632 2345899999999999999999999987 99999999999999999999999999986643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=192.67 Aligned_cols=149 Identities=32% Similarity=0.469 Sum_probs=121.9
Q ss_pred CCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc--hhhHHHHHHHHHHHcCC---CCCceeceeEEEeeC-----C
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGI---NHKNLVKLLGCSITG-----P 338 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~ 338 (437)
+|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999974 68899999986432 22233456677766655 799999999987642 3
Q ss_pred eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCc
Q 013737 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (437)
Q Consensus 339 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a 418 (437)
..+++|||++ ++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 5789999997 4787776432 2345899999999999999999999998 999999999999999999999999999
Q ss_pred cccCC
Q 013737 419 RLFPE 423 (437)
Q Consensus 419 ~~~~~ 423 (437)
+.+..
T Consensus 156 ~~~~~ 160 (288)
T cd07863 156 RIYSC 160 (288)
T ss_pred ccccC
Confidence 87653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=188.98 Aligned_cols=146 Identities=32% Similarity=0.517 Sum_probs=126.8
Q ss_pred cCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccC
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (437)
++|+..+.||+|+||.||++.. +++.+|+|.+.... ..+.+.+|+.++.+++||||+++++++... ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4578889999999999999975 57789999986543 245788999999999999999999988654 5799999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 349 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
+++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGS 151 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecc
Confidence 99999988543 2345889999999999999999999987 9999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-23 Score=204.12 Aligned_cols=155 Identities=32% Similarity=0.400 Sum_probs=134.7
Q ss_pred cccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCCCccc
Q 013737 276 KLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354 (437)
Q Consensus 276 ~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 354 (437)
+||+|.||+||-|++. +...+|||-+...+.+..+-+..|+.+.++|+|.|||+++|.+.+++..-|.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999974 466799999988877788889999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC-CCCcEEEcccCCccccCCCCcceeee
Q 013737 355 NLFVRQDVEPL--SWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRLFPEDITHISAT 431 (437)
Q Consensus 355 ~l~~~~~~~~l--~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~-~~~~~ki~DFG~a~~~~~~~~~~~~~ 431 (437)
+|. .+.+++ .+...-.+.+||++||.|||++. |||||||-+|+||+ -.|.+||+|||.++.+..-.. .+.+
T Consensus 662 LLr--skWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~TET 735 (1226)
T KOG4279|consen 662 LLR--SKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CTET 735 (1226)
T ss_pred HHH--hccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCc-cccc
Confidence 884 455666 78888899999999999999987 99999999999996 568999999999998753322 2235
Q ss_pred ecccC
Q 013737 432 LAGTL 436 (437)
Q Consensus 432 ~~Gt~ 436 (437)
+.||+
T Consensus 736 FTGTL 740 (1226)
T KOG4279|consen 736 FTGTL 740 (1226)
T ss_pred cccch
Confidence 66775
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=194.96 Aligned_cols=151 Identities=25% Similarity=0.424 Sum_probs=127.9
Q ss_pred CCCcCCcccccCcccEEEEEeC---CCCEEEEEEEeccc---hhhHHHHHHHHHHHcCCCCCceeceeEEEeeC--CeeE
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP---GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PESL 341 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 341 (437)
.|+..++||+|+||.||+|... +++.+|+|.+.... ....+.+.+|+.++.+++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3677889999999999999974 47899999987632 34456788999999999999999999999988 7899
Q ss_pred EEEeccCCCCccccccccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC----CCcEEEccc
Q 013737 342 LVYEFVPNQSLLDNLFVRQ--DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE----EFTAKIADF 415 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~----~~~~ki~DF 415 (437)
+||||+++ +|.+.+.... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 6666553222 2236899999999999999999999987 999999999999999 899999999
Q ss_pred CCccccCCC
Q 013737 416 GLVRLFPED 424 (437)
Q Consensus 416 G~a~~~~~~ 424 (437)
|+++.+...
T Consensus 157 g~~~~~~~~ 165 (316)
T cd07842 157 GLARLFNAP 165 (316)
T ss_pred ccccccCCC
Confidence 999876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.7e-23 Score=193.37 Aligned_cols=148 Identities=28% Similarity=0.375 Sum_probs=130.0
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
++|+..+.||+|+||.||++... +++.+|+|.+... .....+.+.+|++++..++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45777889999999999999964 5889999988654 344567899999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
+++++|.+++.. ..++++.....++.+++.+|.|||+.. +++||||||+||++++++.++|+|||++...
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~ 154 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGEL 154 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence 999999887732 346899999999999999999999742 3999999999999999999999999998765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=188.54 Aligned_cols=150 Identities=31% Similarity=0.437 Sum_probs=135.0
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccch-hhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
++|+..+.||+|++|.||++... +++.+++|++..... ...+.+.+|+..+.+++|+||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999976 489999999876543 4567899999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE-ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
+++++|.+++... ..+++..+..++.|+++||.|||+ .+ ++|+||+|+||+++.++.++|+|||++..+...
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999988432 568999999999999999999999 87 999999999999999999999999999877543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=192.95 Aligned_cols=150 Identities=27% Similarity=0.409 Sum_probs=127.2
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc--hhhHHHHHHHHHHHcCCC-CCceeceeEEEeeCCe-----
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPE----- 339 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 339 (437)
++|+..+.||+|+||.||++.+. +++.||+|.+.... ......+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888999999999999999974 58999999876442 223467889999999995 6999999999887665
Q ss_pred eEEEEeccCCCCccccccccCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC-CCcEEEcccC
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQD--VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFG 416 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~-~~~~ki~DFG 416 (437)
.++||||+++ +|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 78877644322 346899999999999999999999987 999999999999998 8899999999
Q ss_pred CccccC
Q 013737 417 LVRLFP 422 (437)
Q Consensus 417 ~a~~~~ 422 (437)
+++.+.
T Consensus 157 ~~~~~~ 162 (295)
T cd07837 157 LGRAFS 162 (295)
T ss_pred cceecC
Confidence 998654
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=188.40 Aligned_cols=143 Identities=31% Similarity=0.461 Sum_probs=121.3
Q ss_pred CcccccCcccEEEEEeC----CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEe-eCCeeEEEEeccC
Q 013737 275 NKLGQGGSGSVYKGTLP----GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSI-TGPESLLVYEFVP 348 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~ 348 (437)
+.||+|+||.||+|.+. ....+|+|.+... .....+.+.+|+.+++.++||||+++++++. .++..+++|||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2357999988543 3445678899999999999999999999776 4556789999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 349 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
+++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999988432 234678888999999999999999987 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=192.80 Aligned_cols=149 Identities=28% Similarity=0.435 Sum_probs=132.7
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
.++|...+.||+|+||.||++.. .++..+++|.+........+.+.+|+.++++++||||+++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 36788899999999999999986 46789999998655555567789999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+..
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 999999988732 34789999999999999999999987 99999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.2e-23 Score=191.74 Aligned_cols=143 Identities=26% Similarity=0.367 Sum_probs=123.0
Q ss_pred CcccccCcccEEEEEeCC--------CCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 275 NKLGQGGSGSVYKGTLPG--------GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
+.||+|+||.||+|.... ...+++|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998632 234888887655555667889999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCc--------EEEcccCCc
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT--------AKIADFGLV 418 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~--------~ki~DFG~a 418 (437)
+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999988433 235899999999999999999999987 999999999999987764 699999998
Q ss_pred cccC
Q 013737 419 RLFP 422 (437)
Q Consensus 419 ~~~~ 422 (437)
....
T Consensus 156 ~~~~ 159 (258)
T cd05078 156 ITVL 159 (258)
T ss_pred cccC
Confidence 7554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=199.64 Aligned_cols=148 Identities=28% Similarity=0.395 Sum_probs=125.8
Q ss_pred HhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeC------
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG------ 337 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 337 (437)
..++|+..+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3567999999999999999999964 5889999998643 334456788999999999999999999987543
Q ss_pred CeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCC
Q 013737 338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417 (437)
Q Consensus 338 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~ 417 (437)
...++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999965 6666552 24788999999999999999999987 99999999999999999999999999
Q ss_pred ccccCC
Q 013737 418 VRLFPE 423 (437)
Q Consensus 418 a~~~~~ 423 (437)
++....
T Consensus 173 a~~~~~ 178 (364)
T cd07875 173 ARTAGT 178 (364)
T ss_pred ccccCC
Confidence 987644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=193.36 Aligned_cols=149 Identities=32% Similarity=0.534 Sum_probs=126.2
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCC----EEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGE----AVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
++|+..+.||+|+||.||++.+. ++. .+|+|.+.... .....++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45778899999999999999863 344 47888876543 23345788999999999999999999988754 4679
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
++||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 99999999999987432 335889999999999999999999987 9999999999999999999999999998765
Q ss_pred C
Q 013737 423 E 423 (437)
Q Consensus 423 ~ 423 (437)
.
T Consensus 161 ~ 161 (303)
T cd05110 161 G 161 (303)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=188.84 Aligned_cols=148 Identities=29% Similarity=0.460 Sum_probs=128.6
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc-----chhhHHHHHHHHHHHcCCCCCceeceeEEEeeC--Cee
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN-----TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PES 340 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 340 (437)
.+|+..+.||+|+||.||++.. .+++.+++|.+... .......+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999996 45899999987532 233456789999999999999999999988764 457
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
++++||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999988732 345789999999999999999999987 99999999999999999999999999986
Q ss_pred cC
Q 013737 421 FP 422 (437)
Q Consensus 421 ~~ 422 (437)
..
T Consensus 156 ~~ 157 (264)
T cd06653 156 IQ 157 (264)
T ss_pred cc
Confidence 53
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=189.57 Aligned_cols=148 Identities=29% Similarity=0.506 Sum_probs=131.1
Q ss_pred CCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc-chhhHHHHHHHHHHHcCCC---CCceeceeEEEeeCCeeEEEE
Q 013737 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGIN---HKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 344 (437)
.|+..+.||+|+||.||+|.+ .+++.+++|.+... .....+++.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999996 56899999998654 3345667889999999886 999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999987732 36899999999999999999999988 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=187.07 Aligned_cols=150 Identities=21% Similarity=0.331 Sum_probs=131.9
Q ss_pred CCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
+|+..+.||+|+||.+|++.. .+++.+++|.+... .....+++.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 477889999999999999986 46889999998643 334456889999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
+++++|.+.+... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+..
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 9999998877432 2345789999999999999999999987 99999999999999999999999999986644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=192.89 Aligned_cols=159 Identities=30% Similarity=0.356 Sum_probs=135.0
Q ss_pred CHHHHHHHhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCC-CCCceeceeEEEeeC
Q 013737 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG 337 (437)
Q Consensus 260 ~~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 337 (437)
....+..++++|+..+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.++.++ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 3455667788999999999999999999997 468899999986432 2345678899999998 799999999998754
Q ss_pred C-----eeEEEEeccCCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 013737 338 P-----ESLLVYEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAK 411 (437)
Q Consensus 338 ~-----~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~k 411 (437)
+ ..++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence 3 579999999999998877432 23356899999999999999999999987 99999999999999999999
Q ss_pred EcccCCccccC
Q 013737 412 IADFGLVRLFP 422 (437)
Q Consensus 412 i~DFG~a~~~~ 422 (437)
|+|||+++.+.
T Consensus 169 l~dfg~~~~~~ 179 (291)
T cd06639 169 LVDFGVSAQLT 179 (291)
T ss_pred Eeecccchhcc
Confidence 99999988654
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-22 Score=187.57 Aligned_cols=149 Identities=28% Similarity=0.486 Sum_probs=125.5
Q ss_pred CCcCCcccccCcccEEEEEeC----CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC------
Q 013737 271 FHESNKLGQGGSGSVYKGTLP----GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP------ 338 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 338 (437)
|+..+.||+|+||.||+|.+. +++.+|||.+..+ .....+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999853 3688999998654 3445677899999999999999999999876542
Q ss_pred eeEEEEeccCCCCccccccccC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 013737 339 ESLLVYEFVPNQSLLDNLFVRQ---DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415 (437)
Q Consensus 339 ~~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DF 415 (437)
..++++||+++++|.+++.... +...+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999987764321 2235789999999999999999999987 999999999999999999999999
Q ss_pred CCccccC
Q 013737 416 GLVRLFP 422 (437)
Q Consensus 416 G~a~~~~ 422 (437)
|+++...
T Consensus 158 g~~~~~~ 164 (273)
T cd05074 158 GLSKKIY 164 (273)
T ss_pred ccccccc
Confidence 9998764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-23 Score=193.71 Aligned_cols=161 Identities=25% Similarity=0.287 Sum_probs=139.3
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
+.|+.-++||+|+||.|+-++. .+|+.+|.|++.+. ........++|-.+|.+++.+.||.+--.+++.+.++||+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 5688889999999999999986 56999999988543 2223345678999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
..|.||+|.-+++.... ..+++..++.++.+|+.||++||+.. ||.|||||+|||+|+.|+++|+|+|+|..+++.
T Consensus 265 tlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999988865543 46999999999999999999999987 999999999999999999999999999999877
Q ss_pred Ccceeeeeccc
Q 013737 425 ITHISATLAGT 435 (437)
Q Consensus 425 ~~~~~~~~~Gt 435 (437)
..... -+||
T Consensus 341 ~~~~~--rvGT 349 (591)
T KOG0986|consen 341 KPIRG--RVGT 349 (591)
T ss_pred Ccccc--ccCc
Confidence 65433 2555
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=191.56 Aligned_cols=148 Identities=33% Similarity=0.530 Sum_probs=129.1
Q ss_pred CCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc--hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
+|+..+.||+|++|.||+++.. +++.++||.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999974 68899999886442 22345788999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
+. ++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+.
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG 151 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence 96 6787776432 3356899999999999999999999987 9999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-22 Score=185.72 Aligned_cols=150 Identities=23% Similarity=0.310 Sum_probs=129.3
Q ss_pred CCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEee-CCeeEEEEe
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT-GPESLLVYE 345 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 345 (437)
.|+..+.||+|++|.||++... +++.+++|.+... .....+.+.+|++++++++|+|++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 3778899999999999999964 4789999998654 23445678899999999999999999998764 446789999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|+++++|.+++... ....+++.++..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+++.+..
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 99999999888542 2345899999999999999999999988 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=188.94 Aligned_cols=142 Identities=24% Similarity=0.290 Sum_probs=124.5
Q ss_pred ccccCcccEEEEEeC-CCCEEEEEEEeccc---hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCCCc
Q 013737 277 LGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL 352 (437)
Q Consensus 277 Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 352 (437)
||+|+||+||++... +++.+++|.+.... ......+.+|+++++.++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999864 58899999986432 22345677899999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 353 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~ 146 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELK 146 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhc
Confidence 98875433 246899999999999999999999987 9999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-22 Score=191.65 Aligned_cols=152 Identities=31% Similarity=0.496 Sum_probs=129.6
Q ss_pred HHhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc--hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC----
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGP---- 338 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 338 (437)
...++|+..+.||+|+||.||+|..+ +++.||+|.+.... ......+.+|+++++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 44577899999999999999999975 58899999986542 233456788999999999999999999887654
Q ss_pred ------eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 013737 339 ------ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI 412 (437)
Q Consensus 339 ------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki 412 (437)
..++|+||+++ ++...+.. ....+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999976 66665532 2346899999999999999999999987 999999999999999999999
Q ss_pred cccCCccccCC
Q 013737 413 ADFGLVRLFPE 423 (437)
Q Consensus 413 ~DFG~a~~~~~ 423 (437)
+|||+++.+..
T Consensus 158 ~dfg~~~~~~~ 168 (302)
T cd07864 158 ADFGLARLYNS 168 (302)
T ss_pred CcccccccccC
Confidence 99999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=184.73 Aligned_cols=149 Identities=30% Similarity=0.512 Sum_probs=133.3
Q ss_pred CCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccch--hhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
+|+..+.||+|++|.||++... +++.+++|.+..... ...+.+.+|++++.+++|||++++++++..++..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677899999999999999875 578999999876543 4567899999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
+++++|.+++.. ...+++..+..++.|++.+|.|||+.+ |+||||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 999999988743 256899999999999999999999987 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=190.85 Aligned_cols=149 Identities=34% Similarity=0.499 Sum_probs=128.8
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
.+.|+..+.||+|+||.||++... +++.|++|.+... .....+++.+|+++++.++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 355888899999999999999974 5889999988643 233446788999999999999999999999999999999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
+||++ |+|.+.+.. ....+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||+++...
T Consensus 94 ~e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 94 MEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HHhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 99997 566665532 2345899999999999999999999987 9999999999999999999999999997654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=177.47 Aligned_cols=143 Identities=18% Similarity=0.172 Sum_probs=113.5
Q ss_pred CCcccccCcccEEEEEeCCCCEEEEEEEeccchh--------------------------hHHHHHHHHHHHcCCCCCce
Q 013737 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQ--------------------------WVDHFFNEVNLISGINHKNL 327 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni 327 (437)
...||+|+||.||+|...+|+.||||.+...... ....+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998754211 01234678999999999988
Q ss_pred eceeEEEeeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeeeCCCCCCCeeeCC
Q 013737 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE-ESKLRIIHRDIKLSNILLDE 406 (437)
Q Consensus 328 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiHrDlk~~NIll~~ 406 (437)
.....+... ..+|||||++++++..... ...+++......++.|++.+|.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 655544333 3489999999875543321 22457788899999999999999999 87 99999999999999
Q ss_pred CCcEEEcccCCccccCCCC
Q 013737 407 EFTAKIADFGLVRLFPEDI 425 (437)
Q Consensus 407 ~~~~ki~DFG~a~~~~~~~ 425 (437)
++.++|+|||+++.++.+.
T Consensus 153 ~~~~~liDFG~a~~~~~~~ 171 (190)
T cd05145 153 DGKPYIIDVSQAVELDHPN 171 (190)
T ss_pred CCCEEEEEcccceecCCCC
Confidence 7899999999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=186.61 Aligned_cols=152 Identities=24% Similarity=0.407 Sum_probs=128.5
Q ss_pred CCCcCCcccccCcccEEEEEeCC--CCEEEEEEEecc----------chhhHHHHHHHHHHHcC-CCCCceeceeEEEee
Q 013737 270 YFHESNKLGQGGSGSVYKGTLPG--GEAVAVKRLFYN----------TTQWVDHFFNEVNLISG-INHKNLVKLLGCSIT 336 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 336 (437)
+|+..+.||+|+||.||++.+.. ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788899999999999999754 688999987532 22334567889888865 799999999999999
Q ss_pred CCeeEEEEeccCCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 013737 337 GPESLLVYEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHE-ESKLRIIHRDIKLSNILLDEEFTAKIAD 414 (437)
Q Consensus 337 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiHrDlk~~NIll~~~~~~ki~D 414 (437)
.+..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+ .+ ++|+||+|+||++++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999998876432 234568999999999999999999996 44 99999999999999999999999
Q ss_pred cCCccccCCC
Q 013737 415 FGLVRLFPED 424 (437)
Q Consensus 415 FG~a~~~~~~ 424 (437)
||++......
T Consensus 158 fg~~~~~~~~ 167 (269)
T cd08528 158 FGLAKQKQPE 167 (269)
T ss_pred ccceeecccc
Confidence 9999876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-22 Score=190.36 Aligned_cols=149 Identities=30% Similarity=0.347 Sum_probs=128.8
Q ss_pred CCCcCCcccccCcccEEEEEe----CCCCEEEEEEEeccc----hhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCee
Q 013737 270 YFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNT----TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPES 340 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 340 (437)
+|+..+.||+|+||.||++.. .+++.+|||.+.... ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367788999999999999985 346889999986432 23346788999999999 599999999999999999
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
++||||+++++|.+.+.. ...+++..+..++.|++++|.|||+.+ ++||||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999888743 345889999999999999999999987 99999999999999999999999999987
Q ss_pred cCCC
Q 013737 421 FPED 424 (437)
Q Consensus 421 ~~~~ 424 (437)
+...
T Consensus 155 ~~~~ 158 (288)
T cd05583 155 FLAE 158 (288)
T ss_pred cccc
Confidence 6443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=188.35 Aligned_cols=153 Identities=32% Similarity=0.408 Sum_probs=132.5
Q ss_pred HHhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCC-----
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGP----- 338 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~----- 338 (437)
.++++|+..+.||+|++|.||++... +++.+++|.+..... ..+.+.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45688999999999999999999975 578999998875543 346789999999999 6999999999987654
Q ss_pred -eeEEEEeccCCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccC
Q 013737 339 -ESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (437)
Q Consensus 339 -~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG 416 (437)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999988874322 2456899999999999999999999987 9999999999999999999999999
Q ss_pred CccccC
Q 013737 417 LVRLFP 422 (437)
Q Consensus 417 ~a~~~~ 422 (437)
++....
T Consensus 159 ~~~~~~ 164 (275)
T cd06608 159 VSAQLD 164 (275)
T ss_pred cceecc
Confidence 987654
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=187.86 Aligned_cols=148 Identities=28% Similarity=0.381 Sum_probs=131.6
Q ss_pred CCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEecc
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (437)
+|+..+.||+|+||.||++.+. +++.+++|.+.... ....+++.+|++++++++||||+++++.+...+..++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5777889999999999999975 58899999987653 345567899999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE-ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
++++|.+++.... .++++..+..++.|++.||.|||+ .+ ++|+||||+||++++++.+||+|||++..+.
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 9999999884332 568999999999999999999999 76 9999999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=8e-22 Score=182.17 Aligned_cols=150 Identities=33% Similarity=0.507 Sum_probs=134.9
Q ss_pred CCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccC
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (437)
+|+..+.||+|++|.||++... +++.+++|++........+.+.+|++++++++||||+++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677889999999999999975 688999999977655567789999999999999999999999999999999999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 349 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
+++|.+++.... ..+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 999998874322 46899999999999999999999987 999999999999999999999999999877654
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9e-23 Score=198.05 Aligned_cols=156 Identities=24% Similarity=0.342 Sum_probs=133.7
Q ss_pred HHHHHHHh---cCCCcCCcccccCcccEEEEE-eCCCCEEEEEEEeccc---hhhHHHHHHHHHHHcCCCCCceeceeEE
Q 013737 261 YETLEKAT---NYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGC 333 (437)
Q Consensus 261 ~~~~~~~~---~~~~~~~~Lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~ 333 (437)
|-.++++. .-|...+.||-|+||+|.++. .++...+|+|.+.+.+ .......+.|-.||+..+.+-||+|+-.
T Consensus 618 YiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS 697 (1034)
T KOG0608|consen 618 YIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS 697 (1034)
T ss_pred HHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence 44444443 447888999999999999987 4567789999986543 2344567889999999999999999999
Q ss_pred EeeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 013737 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIA 413 (437)
Q Consensus 334 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~ 413 (437)
|.+.+.+|+||||++||++..+|. +.+.+++..+..++..+..|+++.|..| +|||||||+|||||.+|++||+
T Consensus 698 FQDkdnLYFVMdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLT 771 (1034)
T KOG0608|consen 698 FQDKDNLYFVMDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLT 771 (1034)
T ss_pred eccCCceEEEEeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeee
Confidence 999999999999999999999884 3455888999999999999999999988 9999999999999999999999
Q ss_pred ccCCccccC
Q 013737 414 DFGLVRLFP 422 (437)
Q Consensus 414 DFG~a~~~~ 422 (437)
||||+.-+.
T Consensus 772 DFGLCTGfR 780 (1034)
T KOG0608|consen 772 DFGLCTGFR 780 (1034)
T ss_pred eccccccce
Confidence 999987554
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-22 Score=188.38 Aligned_cols=148 Identities=30% Similarity=0.461 Sum_probs=129.1
Q ss_pred CCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc--hhhHHHHHHHHHHHcCCCCCceeceeEEEeeC--CeeEEEEe
Q 013737 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PESLLVYE 345 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 345 (437)
|+..++||+|+||.||++... +++.+++|.+.... ......+.+|+++++.++|||++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999975 48899999997652 34456788999999999999999999999888 78999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
|+++ +|.+++... ...+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9974 887776432 246899999999999999999999987 999999999999999999999999999877544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-22 Score=188.12 Aligned_cols=140 Identities=29% Similarity=0.382 Sum_probs=125.4
Q ss_pred ccccCcccEEEEEeC-CCCEEEEEEEeccch---hhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCCCc
Q 013737 277 LGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT---QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL 352 (437)
Q Consensus 277 Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 352 (437)
||+|+||.||++... +++.+++|.+..... ...+.+.+|++++.+++||||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999986 489999999865432 4567789999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 353 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~ 144 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGL 144 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcc
Confidence 9888432 36899999999999999999999987 9999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.2e-22 Score=185.10 Aligned_cols=153 Identities=24% Similarity=0.399 Sum_probs=130.5
Q ss_pred CCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEee--CCeeEEEE
Q 013737 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT--GPESLLVY 344 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 344 (437)
+|+..+.||.|+||.||++.. .++..+++|.+... .....+++.+|++++++++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477789999999999999986 46889999998643 34445678899999999999999999997764 44678999
Q ss_pred eccCCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHhh-----cCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCc
Q 013737 345 EFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLH-----EESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (437)
Q Consensus 345 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH-----~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a 418 (437)
||+++++|.+++... ....++++..++.++.|++.||.||| +.+ ++|+||+|+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999888543 22456899999999999999999999 555 999999999999999999999999999
Q ss_pred cccCCCC
Q 013737 419 RLFPEDI 425 (437)
Q Consensus 419 ~~~~~~~ 425 (437)
.......
T Consensus 158 ~~~~~~~ 164 (265)
T cd08217 158 KILGHDS 164 (265)
T ss_pred ccccCCc
Confidence 9775443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.4e-22 Score=187.23 Aligned_cols=151 Identities=30% Similarity=0.477 Sum_probs=134.9
Q ss_pred HHhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
..++.|+..+.||+|++|.||++.++ ++..+++|.+..... ..+.+.+|+++++.++|+||+++++.+...+..++++
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 45566888899999999999999976 688999999976544 4667889999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++....
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 9999999999885432 36899999999999999999999987 9999999999999999999999999887554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.8e-22 Score=187.10 Aligned_cols=147 Identities=31% Similarity=0.488 Sum_probs=130.9
Q ss_pred CCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccC
Q 013737 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (437)
.|...+.||+|++|.||++.. .+++.+++|.+........+.+.+|+.++..++||||+++++++..++..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 355567999999999999996 4688999999876555556778999999999999999999999999999999999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 349 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
+++|.+++.. .++++..+..++.|++.||.|||+.+ |+||||+|+||++++++.++|+|||++.....
T Consensus 100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~ 167 (285)
T cd06648 100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK 167 (285)
T ss_pred CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence 9999988743 45889999999999999999999988 99999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.5e-22 Score=184.26 Aligned_cols=151 Identities=23% Similarity=0.346 Sum_probs=131.2
Q ss_pred CCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
+|+..+.||+|+||.||++.. .+++.+++|.+... .....+.+.+|+++++.++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477889999999999999986 46889999998653 334467899999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC-CcEEEcccCCccccCCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFPED 424 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~-~~~ki~DFG~a~~~~~~ 424 (437)
+++++|.+++... ....+++..+..++.+++.+|.|||+++ ++|+||+|+||+++++ +.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999988543 2345899999999999999999999987 9999999999999855 46899999999876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.4e-22 Score=187.18 Aligned_cols=141 Identities=26% Similarity=0.249 Sum_probs=117.6
Q ss_pred cccccCcccEEEEEe-CCCCEEEEEEEeccc---hhhHHHHHHHHH---HHcCCCCCceeceeEEEeeCCeeEEEEeccC
Q 013737 276 KLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT---TQWVDHFFNEVN---LISGINHKNLVKLLGCSITGPESLLVYEFVP 348 (437)
Q Consensus 276 ~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (437)
.||+|+||.||++.. .+++.+|+|.+.... ......+.+|.. ++...+||||+.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999997 458899999886432 122223444443 3344579999999999999999999999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 349 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
+++|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++....
T Consensus 81 ~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 81 GGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (279)
T ss_pred CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence 999988774 2346899999999999999999999988 9999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-22 Score=188.30 Aligned_cols=158 Identities=28% Similarity=0.387 Sum_probs=134.1
Q ss_pred CHHHHHHHhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCC-CCCceeceeEEEee-
Q 013737 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSIT- 336 (437)
Q Consensus 260 ~~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 336 (437)
++..+..+.+.|+..+.||+|+||.||++.. .+++.+|+|.+.... ....++..|+.++.++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 4555666778899999999999999999997 458899999886543 2345688999999988 69999999998853
Q ss_pred -----CCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 013737 337 -----GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAK 411 (437)
Q Consensus 337 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~k 411 (437)
....+++|||+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 45679999999999999887432 2345888889999999999999999987 99999999999999999999
Q ss_pred EcccCCccccC
Q 013737 412 IADFGLVRLFP 422 (437)
Q Consensus 412 i~DFG~a~~~~ 422 (437)
|+|||+++...
T Consensus 162 l~dfg~~~~~~ 172 (282)
T cd06636 162 LVDFGVSAQLD 172 (282)
T ss_pred EeeCcchhhhh
Confidence 99999987654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.8e-22 Score=184.95 Aligned_cols=142 Identities=26% Similarity=0.305 Sum_probs=126.3
Q ss_pred ccccCcccEEEEEeC-CCCEEEEEEEeccc---hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCCCc
Q 013737 277 LGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL 352 (437)
Q Consensus 277 Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 352 (437)
||.|++|.||++... +++.+++|.+.... ....+.+.+|+.+++.++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 48899999986532 23456799999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 353 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++.....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence 998843 345889999999999999999999987 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=190.55 Aligned_cols=150 Identities=34% Similarity=0.487 Sum_probs=128.0
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc--hhhHHHHHHHHHHHcCCCCCceeceeEEEeeC--CeeEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PESLL 342 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 342 (437)
.++|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.+++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467899999999999999999974 58999999986442 22234567899999999999999999998755 46899
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
||||++ ++|.+++... ...+++.++..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999996 4787776432 256899999999999999999999998 9999999999999999999999999998765
Q ss_pred C
Q 013737 423 E 423 (437)
Q Consensus 423 ~ 423 (437)
.
T Consensus 160 ~ 160 (309)
T cd07845 160 L 160 (309)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.9e-22 Score=187.78 Aligned_cols=149 Identities=26% Similarity=0.437 Sum_probs=126.4
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc--hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
++|+..+.||+|++|.||++... +++.+++|.+.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999975 68899999886432 2334678899999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC-CCcEEEcccCCccccC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFGLVRLFP 422 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~-~~~~ki~DFG~a~~~~ 422 (437)
|++ ++|.+.+... ....+++..+..++.||+.||+|||+.+ ++|+||+|+||++++ ++.+||+|||+++...
T Consensus 82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 996 5777766332 2334678888899999999999999987 999999999999985 5679999999998654
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-22 Score=189.06 Aligned_cols=143 Identities=31% Similarity=0.477 Sum_probs=128.1
Q ss_pred CCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCCCc
Q 013737 274 SNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL 352 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 352 (437)
..+||+|+||.||++.. .+++.+|+|.+..........+.+|+.+++.++|+||+++++.+..++..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 46799999999999987 46899999998665555567799999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 353 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
.+++. ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++..+..
T Consensus 105 ~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 105 TDIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence 88762 235789999999999999999999987 99999999999999999999999999876654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.3e-22 Score=187.96 Aligned_cols=151 Identities=29% Similarity=0.364 Sum_probs=129.5
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeC--CeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 344 (437)
++|...+.||.|++|.||++... +++.+|+|.+.... .....++.+|++++++++||||+++++++... +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35778899999999999999974 58899999987542 34467799999999999999999999988654 3689999
Q ss_pred eccCCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 345 EFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 345 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999998876432 23455889999999999999999999987 9999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=193.82 Aligned_cols=148 Identities=26% Similarity=0.459 Sum_probs=126.7
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC-----ee
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP-----ES 340 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 340 (437)
.++|+..++||+|+||.||++.. .+++.||+|.+... .......+.+|+.++++++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46799999999999999999986 46899999998643 3344567889999999999999999998866443 57
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
++|+||++ ++|.+.+ ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~----~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELME-TDLYKLI----KTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcc-cCHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 99999996 4776665 2345899999999999999999999988 99999999999999999999999999987
Q ss_pred cCC
Q 013737 421 FPE 423 (437)
Q Consensus 421 ~~~ 423 (437)
...
T Consensus 156 ~~~ 158 (336)
T cd07849 156 ADP 158 (336)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=5e-22 Score=193.07 Aligned_cols=151 Identities=27% Similarity=0.448 Sum_probs=128.9
Q ss_pred HHHhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC---
Q 013737 265 EKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP--- 338 (437)
Q Consensus 265 ~~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 338 (437)
....++|+..+.||+|+||.||++.. .++..||||++... .......+.+|+.++++++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 34567899999999999999999985 46899999998543 2333457889999999999999999999887554
Q ss_pred ---eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 013737 339 ---ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415 (437)
Q Consensus 339 ---~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DF 415 (437)
..++||||+ +++|.+++. ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 358999999 678877662 245899999999999999999999987 999999999999999999999999
Q ss_pred CCccccCC
Q 013737 416 GLVRLFPE 423 (437)
Q Consensus 416 G~a~~~~~ 423 (437)
|+++....
T Consensus 163 g~~~~~~~ 170 (343)
T cd07880 163 GLARQTDS 170 (343)
T ss_pred cccccccc
Confidence 99987654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.8e-22 Score=199.88 Aligned_cols=153 Identities=25% Similarity=0.353 Sum_probs=120.2
Q ss_pred HhcCCCcCCcccccCcccEEEEEe-----------------CCCCEEEEEEEeccchhhHHHH--------------HHH
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTL-----------------PGGEAVAVKRLFYNTTQWVDHF--------------FNE 315 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E 315 (437)
..++|++.++||+|+||.||+|.+ ..++.||||++........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 2356799999875443333333 346
Q ss_pred HHHHcCCCCCce-----eceeEEEee--------CCeeEEEEeccCCCCccccccccCC---------------------
Q 013737 316 VNLISGINHKNL-----VKLLGCSIT--------GPESLLVYEFVPNQSLLDNLFVRQD--------------------- 361 (437)
Q Consensus 316 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~--------------------- 361 (437)
+.++.+++|.++ +++++++.. .+..+|||||+++++|.+++.....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 667777766554 677777653 3568999999999999988753211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 362 VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 362 ~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
...+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~ 360 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMC 360 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccc
Confidence 123567888999999999999999987 9999999999999999999999999997654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-22 Score=195.37 Aligned_cols=149 Identities=25% Similarity=0.347 Sum_probs=127.0
Q ss_pred CCCcCCcccccCcccEEEEEeCC-CCEEEEEEEeccc---hhhH-----HHHHHHHHHHcCCC---CCceeceeEEEeeC
Q 013737 270 YFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNT---TQWV-----DHFFNEVNLISGIN---HKNLVKLLGCSITG 337 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~-----~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 337 (437)
+|...+.||+|+||.|+.|.++. ...|+||.+.+.. ..|. -..-.|+.+|..++ |+||++++++|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 47888999999999999999854 6689999886542 1222 23557999999997 99999999999999
Q ss_pred CeeEEEEecc-CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccC
Q 013737 338 PESLLVYEFV-PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (437)
Q Consensus 338 ~~~~lv~e~~-~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG 416 (437)
+..||+||-. ++.+|.+++. ....+++.++..|++||+.|+++||+++ |||||||-+|++++.+|-+||+|||
T Consensus 642 d~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeecc
Confidence 9999999976 4568888873 3345899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCC
Q 013737 417 LVRLFPED 424 (437)
Q Consensus 417 ~a~~~~~~ 424 (437)
.|......
T Consensus 716 saa~~ksg 723 (772)
T KOG1152|consen 716 SAAYTKSG 723 (772)
T ss_pred chhhhcCC
Confidence 99866543
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=181.72 Aligned_cols=152 Identities=24% Similarity=0.393 Sum_probs=134.7
Q ss_pred CCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc--hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
+|+..+.||.|+||.||++... ++..+++|.+.... ....+.+.+|+++++.++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777889999999999999975 58899999987543 35567889999999999999999999999999999999999
Q ss_pred cCCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 347 VPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 347 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
+++++|.+.+.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999998885432 2367899999999999999999999987 999999999999999999999999999876554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=187.78 Aligned_cols=148 Identities=34% Similarity=0.504 Sum_probs=127.7
Q ss_pred CCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
.|+..+.||+|+||.||++.. .++..+|+|.+... .......+.+|++++++++|||++++++++..+...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 366788999999999999996 45889999998643 22345678899999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|++ |+|.+.+.. ...++++.++..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++.....
T Consensus 106 ~~~-g~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 106 YCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred CCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 997 477666533 2345899999999999999999999987 99999999999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=8e-22 Score=186.20 Aligned_cols=147 Identities=32% Similarity=0.514 Sum_probs=128.1
Q ss_pred CCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc--hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEecc
Q 013737 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (437)
|+..++||.|++|.||++... +|..|++|++.... ....+.+.+|+++++.++|||++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999974 68999999986543 233457889999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
+ ++|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||+++.+.
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~ 150 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFG 150 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence 5 68888774322 246899999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.6e-23 Score=211.78 Aligned_cols=150 Identities=31% Similarity=0.482 Sum_probs=120.4
Q ss_pred HHhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeC------
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG------ 337 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 337 (437)
+-..+|++.+.||+|+||.||+++.+ +|+.+|||++... .......+.+|+.++++|+|||||+++..|.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34467888999999999999999975 6999999999765 334456789999999999999999998754210
Q ss_pred --------------------------------------------------------------------------------
Q 013737 338 -------------------------------------------------------------------------------- 337 (437)
Q Consensus 338 -------------------------------------------------------------------------------- 337 (437)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHh
Q 013737 338 ---------------------------------PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384 (437)
Q Consensus 338 ---------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yL 384 (437)
-.+||-||||+...|.+++.... .. -.....++++++|++||.|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~-~~-~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH-FN-SQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc-cc-hhhHHHHHHHHHHHHHHHHH
Confidence 11356677777666655552211 11 14677889999999999999
Q ss_pred hcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 385 H~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
|+++ ||||||||.||+++++..+||+|||+|..
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATD 746 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchh
Confidence 9998 99999999999999999999999999987
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.1e-22 Score=186.66 Aligned_cols=145 Identities=36% Similarity=0.491 Sum_probs=124.5
Q ss_pred CcccccCcccEEEEEeCC-------CCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 275 NKLGQGGSGSVYKGTLPG-------GEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
+.||+|+||.||+++..+ ++.+++|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999998642 2578999876543 34466889999999999999999999999999999999999
Q ss_pred cCCCCccccccccC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC-----cEEEcccCC
Q 013737 347 VPNQSLLDNLFVRQ----DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-----TAKIADFGL 417 (437)
Q Consensus 347 ~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~-----~~ki~DFG~ 417 (437)
+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++++. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999885432 2234789999999999999999999987 99999999999999877 899999999
Q ss_pred ccccC
Q 013737 418 VRLFP 422 (437)
Q Consensus 418 a~~~~ 422 (437)
++.+.
T Consensus 158 ~~~~~ 162 (269)
T cd05044 158 ARDIY 162 (269)
T ss_pred ccccc
Confidence 97653
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.7e-22 Score=193.33 Aligned_cols=149 Identities=23% Similarity=0.419 Sum_probs=127.8
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEee----CCee
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT----GPES 340 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 340 (437)
.++|+..+.||+|+||.||++... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367888999999999999999964 5899999998654 22345678899999999999999999988763 3467
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
++||||+. ++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999995 68888773 2345899999999999999999999987 99999999999999999999999999986
Q ss_pred cCC
Q 013737 421 FPE 423 (437)
Q Consensus 421 ~~~ 423 (437)
...
T Consensus 157 ~~~ 159 (334)
T cd07855 157 LSS 159 (334)
T ss_pred ecc
Confidence 643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.9e-22 Score=200.55 Aligned_cols=174 Identities=29% Similarity=0.399 Sum_probs=147.1
Q ss_pred ccCHHHHHHHhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCC-CCCceeceeEEEe
Q 013737 258 NFSYETLEKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSI 335 (437)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 335 (437)
...++.+..+++.|.+.+.||+|.+|.||+++. ++++..|+|++..... ..++++.|.++++.. .|||++.++|++.
T Consensus 8 ~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 8 DIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred ccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence 445666777888899999999999999999995 6688999998865543 245677888888877 5999999999887
Q ss_pred e-----CCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 013737 336 T-----GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410 (437)
Q Consensus 336 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ 410 (437)
. ++++|||||||.+|+..+++.... ...+.|..+..|++.++.||.+||... ++|||||-.|||++.++.+
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcE
Confidence 3 568999999999999999886544 677999999999999999999999986 9999999999999999999
Q ss_pred EEcccCCccccCCCCcceeeeecccCC
Q 013737 411 KIADFGLVRLFPEDITHISATLAGTLF 437 (437)
Q Consensus 411 ki~DFG~a~~~~~~~~~~~~~~~Gt~~ 437 (437)
||.|||++..++.-..+.. +..||+|
T Consensus 163 KLvDFGvSaQldsT~grRn-T~iGtP~ 188 (953)
T KOG0587|consen 163 KLVDFGVSAQLDSTVGRRN-TFIGTPY 188 (953)
T ss_pred EEeeeeeeeeeeccccccc-CcCCCcc
Confidence 9999999998865443332 5678876
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.6e-22 Score=187.92 Aligned_cols=149 Identities=27% Similarity=0.359 Sum_probs=132.4
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCC-CCceeceeEEEeeCCeeEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 343 (437)
++|...+.||+|+||.||++... +++.+++|.+... .....+.+.+|.+++.+++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888899999999999999974 6899999998642 2333567889999999998 99999999999999999999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999998843 346999999999999999999999988 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.7e-22 Score=188.70 Aligned_cols=150 Identities=29% Similarity=0.459 Sum_probs=126.2
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc--hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC------
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGP------ 338 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 338 (437)
-++|+..++||+|+||.||++... +++.||||.+.... ......+.+|++++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 346889999999999999999974 58999999886432 223445678999999999999999999887654
Q ss_pred --eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccC
Q 013737 339 --ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (437)
Q Consensus 339 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG 416 (437)
..++||||+. ++|.+.+.. ....+++.++..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 3499999996 477776632 2346899999999999999999999987 9999999999999999999999999
Q ss_pred CccccCC
Q 013737 417 LVRLFPE 423 (437)
Q Consensus 417 ~a~~~~~ 423 (437)
++..+..
T Consensus 165 ~~~~~~~ 171 (310)
T cd07865 165 LARAFSL 171 (310)
T ss_pred CcccccC
Confidence 9987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.6e-22 Score=192.30 Aligned_cols=149 Identities=32% Similarity=0.489 Sum_probs=127.0
Q ss_pred HhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCC-CCCceeceeEEEeeC--Cee
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG--PES 340 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~ 340 (437)
..++|+..+.||+|+||.||+|.+. +++.+|+|++... .......+.+|+.++.++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467888899999999999999975 5889999988542 333455678899999999 999999999988654 367
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
++||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 588777632 26889999999999999999999987 99999999999999999999999999987
Q ss_pred cCC
Q 013737 421 FPE 423 (437)
Q Consensus 421 ~~~ 423 (437)
+..
T Consensus 157 ~~~ 159 (337)
T cd07852 157 LSE 159 (337)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=181.60 Aligned_cols=150 Identities=32% Similarity=0.417 Sum_probs=133.7
Q ss_pred CCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc--hhhHHHHHHHHHHHcCCCCCceeceeEEEeeC--CeeEEEE
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PESLLVY 344 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 344 (437)
+|+..+.||+|++|.||+|... ++..+++|.+.... ....+.+.+|+.++++++||||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999976 68899999986553 34567899999999999999999999999988 8899999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||+++++|.+++... ..+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999988432 37899999999999999999999987 999999999999999999999999999877654
Q ss_pred C
Q 013737 425 I 425 (437)
Q Consensus 425 ~ 425 (437)
.
T Consensus 155 ~ 155 (260)
T cd06606 155 E 155 (260)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.4e-22 Score=183.49 Aligned_cols=151 Identities=23% Similarity=0.375 Sum_probs=130.8
Q ss_pred CCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
+|+..+.||+|+||.||++... ++..+|+|.+... .....+.+.+|+++++.++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999975 5889999998653 223456788999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC-cEEEcccCCccccCCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRLFPED 424 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~-~~ki~DFG~a~~~~~~ 424 (437)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++ .+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999987432 2345799999999999999999999987 99999999999999875 5799999999876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.9e-22 Score=201.13 Aligned_cols=151 Identities=24% Similarity=0.275 Sum_probs=119.9
Q ss_pred HHHHHhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCC------CCceeceeEEEe
Q 013737 263 TLEKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN------HKNLVKLLGCSI 335 (437)
Q Consensus 263 ~~~~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~ 335 (437)
++....++|++.++||+|+||.||++.+ .+++.||||+++... .....+..|+.++..++ |++++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 3444567899999999999999999997 457899999986432 22344556666666654 456889998887
Q ss_pred eC-CeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeeeCCCCCCCeeeCCCC-----
Q 013737 336 TG-PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEF----- 408 (437)
Q Consensus 336 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiHrDlk~~NIll~~~~----- 408 (437)
.. ...++|||++ +++|.+++.. ...+++..+..|+.||+.||.|||++ + ||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence 65 4678999988 6788887743 34689999999999999999999974 6 99999999999998765
Q ss_pred -----------cEEEcccCCcccc
Q 013737 409 -----------TAKIADFGLVRLF 421 (437)
Q Consensus 409 -----------~~ki~DFG~a~~~ 421 (437)
.+||+|||++...
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~ 298 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDE 298 (467)
T ss_pred ccccccCCCCceEEECCCCccccC
Confidence 4999999988643
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=183.36 Aligned_cols=141 Identities=26% Similarity=0.251 Sum_probs=117.8
Q ss_pred cccccCcccEEEEEe-CCCCEEEEEEEeccch---hhHHHHHHHH---HHHcCCCCCceeceeEEEeeCCeeEEEEeccC
Q 013737 276 KLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTT---QWVDHFFNEV---NLISGINHKNLVKLLGCSITGPESLLVYEFVP 348 (437)
Q Consensus 276 ~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (437)
.||+|+||.||++.. .+++.||+|.+..... .....+..|. .++....||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999986 4588999998864321 1122233443 34555689999999999999999999999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 349 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
+++|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence 999988773 3356899999999999999999999987 9999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.8e-22 Score=191.29 Aligned_cols=149 Identities=26% Similarity=0.415 Sum_probs=127.5
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeC-----Ce
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG-----PE 339 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 339 (437)
.++|...+.||+|+||.||++.. .+++.||||.+... .......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45688899999999999999996 46899999998643 233455678899999999999999999987654 34
Q ss_pred eEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcc
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~ 419 (437)
.++|+||+. ++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 67877763 3356899999999999999999999987 9999999999999999999999999998
Q ss_pred ccCC
Q 013737 420 LFPE 423 (437)
Q Consensus 420 ~~~~ 423 (437)
....
T Consensus 157 ~~~~ 160 (337)
T cd07858 157 TTSE 160 (337)
T ss_pred ccCC
Confidence 7654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.9e-24 Score=185.95 Aligned_cols=148 Identities=29% Similarity=0.486 Sum_probs=123.0
Q ss_pred CCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeC--------C
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG--------P 338 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~ 338 (437)
.|....+||+|.||+||+++.+ +|+.||+|++..+ .........+|+.+|..++|+|++.+++.|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 3555678999999999999974 5788898876432 233445678999999999999999999887532 3
Q ss_pred eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCc
Q 013737 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (437)
Q Consensus 339 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a 418 (437)
..|+|+++|+ .+|.-+|.. ....++..++.+++.++..||.|+|... |+|||+||+|+||+.++.+||+|||++
T Consensus 98 t~ylVf~~ce-hDLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 98 TFYLVFDFCE-HDLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeeHHHhh-hhHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence 4799999997 478777732 3356899999999999999999999987 999999999999999999999999999
Q ss_pred cccCC
Q 013737 419 RLFPE 423 (437)
Q Consensus 419 ~~~~~ 423 (437)
|.+..
T Consensus 172 r~fs~ 176 (376)
T KOG0669|consen 172 RAFST 176 (376)
T ss_pred cceec
Confidence 88753
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=190.92 Aligned_cols=148 Identities=29% Similarity=0.422 Sum_probs=126.4
Q ss_pred HhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeC------
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG------ 337 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 337 (437)
..++|+..+.||+|+||.||++.. .+++.||+|.+... .....+++.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457799999999999999999996 46899999998642 334456788999999999999999999987644
Q ss_pred CeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCC
Q 013737 338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417 (437)
Q Consensus 338 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~ 417 (437)
...++||||+. ++|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 34699999996 577776621 2788999999999999999999987 99999999999999999999999999
Q ss_pred ccccCC
Q 013737 418 VRLFPE 423 (437)
Q Consensus 418 a~~~~~ 423 (437)
++....
T Consensus 165 ~~~~~~ 170 (353)
T cd07850 165 ARTAGT 170 (353)
T ss_pred ceeCCC
Confidence 987654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=189.55 Aligned_cols=154 Identities=28% Similarity=0.416 Sum_probs=129.8
Q ss_pred HHHHHHhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeC-
Q 013737 262 ETLEKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG- 337 (437)
Q Consensus 262 ~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 337 (437)
.++...+++|...+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+.++.+++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 44566778999999999999999999986 56889999998653 223356788999999999999999999987643
Q ss_pred -----CeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 013737 338 -----PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI 412 (437)
Q Consensus 338 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki 412 (437)
...++++|++ +++|.+++. ...+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence 3467888877 778877662 235899999999999999999999987 999999999999999999999
Q ss_pred cccCCccccCC
Q 013737 413 ADFGLVRLFPE 423 (437)
Q Consensus 413 ~DFG~a~~~~~ 423 (437)
+|||+++....
T Consensus 162 ~dfg~~~~~~~ 172 (345)
T cd07877 162 LDFGLARHTDD 172 (345)
T ss_pred ecccccccccc
Confidence 99999986543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=180.96 Aligned_cols=142 Identities=26% Similarity=0.284 Sum_probs=119.8
Q ss_pred CcccccCcccEEEEEeC-CCCEEEEEEEeccc---hhhHHHHHHHHHH-HcCCCCCceeceeEEEeeCCeeEEEEeccCC
Q 013737 275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNL-ISGINHKNLVKLLGCSITGPESLLVYEFVPN 349 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (437)
+.||+|+||.||+|... +++.||+|.+.... ......+..|..+ ....+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999974 58899999986432 1222344555554 4456899999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 350 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
++|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++...
T Consensus 82 ~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 82 GDCASLIK---TLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 99999873 2346889999999999999999999987 9999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.8e-22 Score=190.28 Aligned_cols=148 Identities=28% Similarity=0.422 Sum_probs=129.5
Q ss_pred CCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc--hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC-----eeE
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGP-----ESL 341 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 341 (437)
+|+..+.||+|++|.||++... +++.+++|++.... ....+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999975 48999999987543 445678999999999999999999999988775 789
Q ss_pred EEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
++|||++ ++|.+.+. ...++++..+..++.|++.||.|||+.+ |+|+||||+|||+++++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIK---SPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 57877773 2337899999999999999999999988 999999999999999999999999999877
Q ss_pred CCC
Q 013737 422 PED 424 (437)
Q Consensus 422 ~~~ 424 (437)
...
T Consensus 154 ~~~ 156 (330)
T cd07834 154 DPD 156 (330)
T ss_pred ccc
Confidence 544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=188.81 Aligned_cols=147 Identities=27% Similarity=0.358 Sum_probs=125.6
Q ss_pred cCCC-cCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhh--------------HHHHHHHHHHHcCCCCCceeceeE
Q 013737 269 NYFH-ESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQW--------------VDHFFNEVNLISGINHKNLVKLLG 332 (437)
Q Consensus 269 ~~~~-~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~ 332 (437)
++|. ..+.||+|+||.||++... +++.||||.+....... ...+.+|++++..++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3444 4577999999999999964 68999999886432211 125778999999999999999999
Q ss_pred EEeeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 013737 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI 412 (437)
Q Consensus 333 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki 412 (437)
++..++..++||||++ ++|.+++. ....+++.....++.|++.||.|||+.+ |+|+||+|+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999996 68888773 2345899999999999999999999987 999999999999999999999
Q ss_pred cccCCccccC
Q 013737 413 ADFGLVRLFP 422 (437)
Q Consensus 413 ~DFG~a~~~~ 422 (437)
+|||+++...
T Consensus 161 ~dfg~~~~~~ 170 (335)
T PTZ00024 161 ADFGLARRYG 170 (335)
T ss_pred CCccceeecc
Confidence 9999998765
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=182.34 Aligned_cols=146 Identities=25% Similarity=0.337 Sum_probs=123.0
Q ss_pred CCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCC-CCceeceeEEEeeC--CeeEEEEe
Q 013737 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGIN-HKNLVKLLGCSITG--PESLLVYE 345 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 345 (437)
|+..++||+|+||.||++.. .+++.+|+|.++... ........+|+.++.++. |+||+++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56678999999999999996 458899999986532 222234457888898885 99999999999987 88999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|++ ++|.+.+... ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++ +.+||+|||+++.+..
T Consensus 81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 997 5777776332 246899999999999999999999987 999999999999999 9999999999987643
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=187.69 Aligned_cols=150 Identities=29% Similarity=0.457 Sum_probs=128.5
Q ss_pred HHHhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEee-CCee
Q 013737 265 EKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT-GPES 340 (437)
Q Consensus 265 ~~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 340 (437)
...+++|+..+.||+|+||.||++... +++.+|+|++... .....+.+.+|++++..++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999864 6899999988543 23345678899999999999999999998875 4578
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
++++||+ +++|.+++. ..++++..+..++.|+++||.|||+.+ |+||||+|+||++++++.+||+|||+++.
T Consensus 86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 8999998 568877662 245788888999999999999999987 99999999999999999999999999986
Q ss_pred cC
Q 013737 421 FP 422 (437)
Q Consensus 421 ~~ 422 (437)
..
T Consensus 158 ~~ 159 (328)
T cd07856 158 QD 159 (328)
T ss_pred cC
Confidence 54
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=181.26 Aligned_cols=152 Identities=28% Similarity=0.446 Sum_probs=132.7
Q ss_pred CCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
+|+..+.||+|+||.||++... +++.+++|.+... ......++.+|++++++++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999864 6889999998653 334456788999999999999999999999999999999999
Q ss_pred cCCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 347 VPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 347 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 99999998875422 2356899999999999999999999988 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.1e-23 Score=212.26 Aligned_cols=153 Identities=31% Similarity=0.407 Sum_probs=132.5
Q ss_pred HHhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
..+-++.....||.|.||.||-+.. .+|+..|+|-++.. .....+.+.+|..++..|+|||+|+++|+-.+.+..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 3445677788999999999999985 67999999987533 34445678899999999999999999999999999999
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
.||||++|+|.+.+. ...-.++.....+..|++.|+.|||++| ||||||||.||+++.+|.+|++|||.|..+.
T Consensus 1312 FMEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEec
Confidence 999999999999883 2333566667778899999999999998 9999999999999999999999999999876
Q ss_pred CC
Q 013737 423 ED 424 (437)
Q Consensus 423 ~~ 424 (437)
.+
T Consensus 1386 ~~ 1387 (1509)
T KOG4645|consen 1386 NN 1387 (1509)
T ss_pred Cc
Confidence 54
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.4e-21 Score=179.16 Aligned_cols=146 Identities=26% Similarity=0.270 Sum_probs=119.5
Q ss_pred HhcCCCcCCcc--cccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcC-CCCCceeceeEEEeeCCeeEE
Q 013737 267 ATNYFHESNKL--GQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISG-INHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 267 ~~~~~~~~~~L--g~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~l 342 (437)
..++|+..+.+ |+|+||.||++.. .++..+|+|.+........ |+..... .+||||+++++.+...+..++
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 34556666665 9999999999996 4578899998864322111 2222221 279999999999999999999
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC-cEEEcccCCcccc
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRLF 421 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~-~~ki~DFG~a~~~ 421 (437)
||||+++++|.+++.. ...+++.++..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||+++..
T Consensus 87 v~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 87 IMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred EEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 9999999999998843 237899999999999999999999988 99999999999999988 9999999998866
Q ss_pred CC
Q 013737 422 PE 423 (437)
Q Consensus 422 ~~ 423 (437)
..
T Consensus 161 ~~ 162 (267)
T PHA03390 161 GT 162 (267)
T ss_pred CC
Confidence 53
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=182.96 Aligned_cols=148 Identities=32% Similarity=0.427 Sum_probs=127.3
Q ss_pred CCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccch-hhHHHHHHHHHHHcCCC-CCceeceeEEEeeCCeeEEEEecc
Q 013737 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT-QWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVYEFV 347 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 347 (437)
|+..+.||+|++|.||+|... +++.++||++..... .......+|+..+.+++ ||||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999975 478999999865422 22234567999999999 999999999999999999999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
+++|.+.+.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||+++....
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRS 151 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence 789988774332 346899999999999999999999987 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-21 Score=186.51 Aligned_cols=141 Identities=26% Similarity=0.315 Sum_probs=122.6
Q ss_pred Cccccc--CcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCC
Q 013737 275 NKLGQG--GSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN 349 (437)
Q Consensus 275 ~~Lg~G--~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (437)
..||+| +||+||++.+ .+++.||+|.+... .....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456766 8999999997 46899999998643 333457889999999999999999999999999999999999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcc
Q 013737 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (437)
Q Consensus 350 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~ 419 (437)
++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++||+.+.
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~ 149 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLY 149 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHh
Confidence 99998874432 345899999999999999999999987 9999999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.6e-23 Score=181.79 Aligned_cols=149 Identities=27% Similarity=0.426 Sum_probs=126.3
Q ss_pred CCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC-----eeEE
Q 013737 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP-----ESLL 342 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l 342 (437)
.+..+.||-|+||.||.+.+ ++|+.|++|++..- +-...+++.+|+.+|..++|.|++..++...-.. ++|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 45578999999999999997 56999999988532 3334678999999999999999999998766443 4678
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
++|.|. .+|.+++ -....++...+.-++.||++||+|||+.+ |.||||||.|.|++.+..+||+|||+||..+
T Consensus 135 ~TELmQ-SDLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 135 LTELMQ-SDLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHH-hhhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence 999984 5787777 34566888999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCc
Q 013737 423 EDIT 426 (437)
Q Consensus 423 ~~~~ 426 (437)
.+..
T Consensus 208 ~d~~ 211 (449)
T KOG0664|consen 208 QRDR 211 (449)
T ss_pred hhhh
Confidence 5544
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-21 Score=182.43 Aligned_cols=148 Identities=36% Similarity=0.531 Sum_probs=129.6
Q ss_pred CCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc--hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEecc
Q 013737 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (437)
|+..+.||+|++|.||+|+.. +++.+++|.+.... ....+.+.+|+.++++++|+||+++++++...+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456788999999999999975 58999999987642 334567889999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
+ ++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~ 151 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIP 151 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCC
Confidence 7 58988884322 46899999999999999999999987 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.9e-22 Score=168.27 Aligned_cols=158 Identities=26% Similarity=0.363 Sum_probs=130.1
Q ss_pred HHHHhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc-chhhHHHHHHHHHHHcC-CCCCceeceeEEEeeCCee
Q 013737 264 LEKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISG-INHKNLVKLLGCSITGPES 340 (437)
Q Consensus 264 ~~~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~ 340 (437)
++...+.......||+|++|.|-+-++ .+|...|+|++... ..+..++.++|+.+..+ ...|.+|+++|........
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 444455556677899999999988886 67999999999754 44556778899987554 5799999999999999999
Q ss_pred EEEEeccCCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcc
Q 013737 341 LLVYEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~ 419 (437)
++.||.|. .+|..+...- .....+++..+-+|+..+..||.|||++ ..+||||+||+||||+.+|++||+|||++-
T Consensus 121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999994 6776654221 3456689999999999999999999996 469999999999999999999999999988
Q ss_pred ccCCC
Q 013737 420 LFPED 424 (437)
Q Consensus 420 ~~~~~ 424 (437)
.+.+.
T Consensus 198 ~L~dS 202 (282)
T KOG0984|consen 198 YLVDS 202 (282)
T ss_pred eehhh
Confidence 76543
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-21 Score=182.89 Aligned_cols=150 Identities=27% Similarity=0.408 Sum_probs=125.4
Q ss_pred hcCCCcCCcccccCcccEEEEEeCC-CCEEEEEEEeccc-hhhHHHHHHHHHHHcCCC-CCceeceeEEEeeCCeeEEEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNT-TQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 344 (437)
.++|+..+.||+|+||.||++.++. ++.+|||.+.... .....++..|+.++.+.. ||||+++++++.+....+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3567888999999999999999864 8899999987542 334456777887776665 999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
||++ ++|.+++.. ....+++..+..++.|++.||.|||+. + |+||||+|+||++++++.+||+|||++..+..
T Consensus 94 e~~~-~~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMS-TCLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccC-cCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9985 466665532 224689999999999999999999974 5 99999999999999999999999999986643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.4e-21 Score=184.76 Aligned_cols=143 Identities=20% Similarity=0.168 Sum_probs=120.2
Q ss_pred CcccccCcccEEEEEeCCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCCCc
Q 013737 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL 352 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 352 (437)
+.+|.|+++.|+++.. +++.+|||++... .....+.+.+|+++++.++||||+++++++...+..+++|||+++++|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3444444444444443 5899999998754 345567899999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 353 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||.+..+.
T Consensus 87 ~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~ 152 (314)
T cd08216 87 EDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMI 152 (314)
T ss_pred HHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeec
Confidence 99885432 245889999999999999999999987 9999999999999999999999999887553
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.5e-22 Score=172.11 Aligned_cols=156 Identities=22% Similarity=0.355 Sum_probs=129.5
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCC-CCceeceeEEEeeCC--eeEEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGP--ESLLV 343 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~lv 343 (437)
.++|++.+++|+|.|++||.|.. .+.+.++||.+++-. .+.+.+|+.+|..|. ||||++|++...++. ...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 46688889999999999999984 668899999997543 457889999999997 999999999988765 45799
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC-CcEEEcccCCccccC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFP 422 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~-~~~ki~DFG~a~~~~ 422 (437)
+||+.+.+...+. ..++...+..++.+++.||.|.|+.| |+|||+||.|++||.. ..++|+|+|+|.++.
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999988776554 34677788899999999999999998 9999999999999955 589999999999987
Q ss_pred CCCcceeeeecccC
Q 013737 423 EDITHISATLAGTL 436 (437)
Q Consensus 423 ~~~~~~~~~~~Gt~ 436 (437)
.... -+.+++..+
T Consensus 185 p~~e-YnVRVASRy 197 (338)
T KOG0668|consen 185 PGKE-YNVRVASRY 197 (338)
T ss_pred CCce-eeeeeehhh
Confidence 6543 233444443
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.7e-21 Score=182.38 Aligned_cols=148 Identities=32% Similarity=0.495 Sum_probs=129.2
Q ss_pred CCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccch--hhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEecc
Q 013737 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (437)
|+..+.||+|++|.||++... +++.+++|.+..... .....+.+|++++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 556789999999999999974 688999999865432 34567889999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
++ +|.+.+... ..++++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||.+......
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence 75 887776432 256899999999999999999999988 999999999999999999999999999877554
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=3e-21 Score=182.75 Aligned_cols=150 Identities=27% Similarity=0.371 Sum_probs=124.2
Q ss_pred CCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCC-CCceeceeEEEeeCCeeEEEEec
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
+|...+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. ||||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556678999999999999974 58999999986542 344567889999999996 99999999999999999999999
Q ss_pred cCCCCccccccc--cCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 347 VPNQSLLDNLFV--RQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 347 ~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
+. +++.++... ......+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++.+..
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 86 455443211 12235689999999999999999999975 5 99999999999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.4e-21 Score=183.04 Aligned_cols=148 Identities=31% Similarity=0.502 Sum_probs=127.0
Q ss_pred CCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
.|+..+.||+|+||.||++... +++.+++|.+... .....+++.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666788999999999999974 5789999988642 23345678899999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|+. ++|.+.+... ..++++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++.....
T Consensus 96 ~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 96 YCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred ccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 996 5777665332 345889999999999999999999987 99999999999999999999999999886543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-21 Score=187.25 Aligned_cols=162 Identities=23% Similarity=0.351 Sum_probs=137.8
Q ss_pred hcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEec--cchhhHHHHHHHHHHHcCCC-CCceeceeEEEeeCCeeEEEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFY--NTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 344 (437)
...|++.++||.||.+.||++...+.+.+|+|++.. .+.+...-|.+|+..|.+|+ |.+||+|++|-..++.+|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 456888999999999999999988888888887753 36667889999999999996 999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||= ..+|.++|..+.. ....| .+..+..|++.++.++|+++ |||-||||.|+|+-. |.+||+|||+|..+..+
T Consensus 440 E~G-d~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD 512 (677)
T ss_pred ecc-cccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence 976 5789988854332 22334 67889999999999999998 999999999999976 49999999999999988
Q ss_pred Ccceee-eecccC
Q 013737 425 ITHISA-TLAGTL 436 (437)
Q Consensus 425 ~~~~~~-~~~Gt~ 436 (437)
.+.... ..+||+
T Consensus 513 TTsI~kdsQvGT~ 525 (677)
T KOG0596|consen 513 TTSIVKDSQVGTV 525 (677)
T ss_pred ccceeeccccCcc
Confidence 776544 678875
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=180.75 Aligned_cols=145 Identities=36% Similarity=0.503 Sum_probs=125.4
Q ss_pred CCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
|...+.||+|+||.||+|+. .+++.+++|.+... .......+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55667899999999999997 45889999998643 223446788999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
+. ++|.+.+.. ...++++.++..++.|++.+|.|||+.+ ++|+||+|+||++++++.+||+|||++...
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS 171 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCccc
Confidence 96 577666632 2346899999999999999999999987 999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=5e-21 Score=170.90 Aligned_cols=139 Identities=17% Similarity=0.247 Sum_probs=108.1
Q ss_pred CCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCC-----CCCceeceeEEEeeCC---eeE-
Q 013737 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-----NHKNLVKLLGCSITGP---ESL- 341 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~- 341 (437)
+...++||+|+||.||. ++.....+||++........+.+.+|+.+++.+ +||||++++|++.++. ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 45678999999999996 433333479988765455567899999999999 5799999999998874 333
Q ss_pred EEEec--cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHH-HHhhcCCCCCeeeCCCCCCCeeeCC----CCcEEEcc
Q 013737 342 LVYEF--VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGL-AYLHEESKLRIIHRDIKLSNILLDE----EFTAKIAD 414 (437)
Q Consensus 342 lv~e~--~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l-~yLH~~~~~~iiHrDlk~~NIll~~----~~~~ki~D 414 (437)
+|+|| +++++|.+++.. ..+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 78999 557999999833 235555 35678888887 9999998 999999999999974 34899999
Q ss_pred -cCCccc
Q 013737 415 -FGLVRL 420 (437)
Q Consensus 415 -FG~a~~ 420 (437)
||....
T Consensus 153 g~G~~~~ 159 (210)
T PRK10345 153 NIGESTF 159 (210)
T ss_pred CCCCcce
Confidence 554444
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=5e-21 Score=185.23 Aligned_cols=147 Identities=29% Similarity=0.419 Sum_probs=122.8
Q ss_pred CCCcCCcccccCcccEEEEEeC-C--CCEEEEEEEecc--chhhHHHHHHHHHHHcCC-CCCceeceeEEEeeC----Ce
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-G--GEAVAVKRLFYN--TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG----PE 339 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 339 (437)
+|+..+.||+|+||.||++... . +..+|+|.+... .....+.+.+|++++.++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 3677889999999999999964 3 778999998643 223356788999999999 599999999875432 45
Q ss_pred eEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcc
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~ 419 (437)
.++++||+. ++|.+.+. ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 788899885 68887773 3456899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCC
Q 013737 420 LFPE 423 (437)
Q Consensus 420 ~~~~ 423 (437)
.+..
T Consensus 154 ~~~~ 157 (332)
T cd07857 154 GFSE 157 (332)
T ss_pred eccc
Confidence 6643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.6e-21 Score=176.34 Aligned_cols=141 Identities=34% Similarity=0.396 Sum_probs=125.5
Q ss_pred ccccCcccEEEEEeC-CCCEEEEEEEeccc---hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCCCc
Q 013737 277 LGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL 352 (437)
Q Consensus 277 Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 352 (437)
||+|+||.||++... +++.+++|.+.... ....+.+.+|+.++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999975 48899999986542 23456889999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 353 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 145 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSS 145 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence 988843 235899999999999999999999987 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.1e-21 Score=180.98 Aligned_cols=149 Identities=21% Similarity=0.281 Sum_probs=111.0
Q ss_pred hcCCCcCCcccccCcccEEEEEeCC----CCEEEEEEEeccchhhH-----------HHHHHHHHHHcCCCCCceeceeE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYNTTQWV-----------DHFFNEVNLISGINHKNLVKLLG 332 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~ 332 (437)
.+.|++.++||+|+||.||+|.+.+ +..+++|.......... .....+...+..++|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3678999999999999999999754 34566665432221110 11223444567789999999999
Q ss_pred EEeeCC----eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC
Q 013737 333 CSITGP----ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408 (437)
Q Consensus 333 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~ 408 (437)
++.... ..++++|++. .++.+.+. .....++..+..++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFK---RIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHH---hhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 766544 3467888764 35544442 2233578888999999999999999987 99999999999999999
Q ss_pred cEEEcccCCccccCC
Q 013737 409 TAKIADFGLVRLFPE 423 (437)
Q Consensus 409 ~~ki~DFG~a~~~~~ 423 (437)
.+||+|||+|+.+..
T Consensus 164 ~~~l~DFGla~~~~~ 178 (294)
T PHA02882 164 RGYIIDYGIASHFII 178 (294)
T ss_pred cEEEEEcCCceeecc
Confidence 999999999987643
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.1e-21 Score=187.46 Aligned_cols=147 Identities=29% Similarity=0.500 Sum_probs=126.1
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeC---------
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITG--------- 337 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------- 337 (437)
..+|...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 36788899999999999999997 46899999998766656667889999999999999999999876543
Q ss_pred -----CeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC-CCCcEE
Q 013737 338 -----PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD-EEFTAK 411 (437)
Q Consensus 338 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~-~~~~~k 411 (437)
...++||||++ ++|.+++. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++ +++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 58877662 235889999999999999999999988 99999999999997 456899
Q ss_pred EcccCCccccC
Q 013737 412 IADFGLVRLFP 422 (437)
Q Consensus 412 i~DFG~a~~~~ 422 (437)
|+|||+++.+.
T Consensus 156 l~dfg~~~~~~ 166 (342)
T cd07854 156 IGDFGLARIVD 166 (342)
T ss_pred ECCcccceecC
Confidence 99999998653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.1e-21 Score=179.12 Aligned_cols=149 Identities=31% Similarity=0.449 Sum_probs=123.9
Q ss_pred CCcCCcccccCcccEEEEEeCC-CCEEEEEEEeccc--hhhHHHHHHHHHHHcCC---CCCceeceeEEEeeCCe-----
Q 013737 271 FHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNT--TQWVDHFFNEVNLISGI---NHKNLVKLLGCSITGPE----- 339 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 339 (437)
|+..+.||+|+||.||+++++. ++.+|+|.+.... ......+.+|+.++.++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5677899999999999999864 8999999986432 22234566787766555 69999999999988776
Q ss_pred eEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcc
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~ 419 (437)
.+++|||+. ++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999997 4788776432 2235899999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCC
Q 013737 420 LFPED 424 (437)
Q Consensus 420 ~~~~~ 424 (437)
.+...
T Consensus 156 ~~~~~ 160 (287)
T cd07838 156 IYSFE 160 (287)
T ss_pred eccCC
Confidence 76543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.9e-21 Score=183.88 Aligned_cols=150 Identities=31% Similarity=0.485 Sum_probs=125.5
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc--hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC------
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGP------ 338 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 338 (437)
.++|+..++||+|+||.||++... +++.+++|.+.... ......+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467899999999999999999974 58899999986432 222346778999999999999999999875433
Q ss_pred --eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccC
Q 013737 339 --ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (437)
Q Consensus 339 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG 416 (437)
..++|+||+.+ +|...+.. ....+++..+..++.|+++||.|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999964 66665532 2346899999999999999999999988 9999999999999999999999999
Q ss_pred CccccCC
Q 013737 417 LVRLFPE 423 (437)
Q Consensus 417 ~a~~~~~ 423 (437)
+++....
T Consensus 161 ~~~~~~~ 167 (311)
T cd07866 161 LARPYDG 167 (311)
T ss_pred cchhccC
Confidence 9986643
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.5e-22 Score=177.22 Aligned_cols=148 Identities=25% Similarity=0.305 Sum_probs=121.5
Q ss_pred HhcCCCcC-CcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCC-CCCceeceeEEEee----CCe
Q 013737 267 ATNYFHES-NKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSIT----GPE 339 (437)
Q Consensus 267 ~~~~~~~~-~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~ 339 (437)
.+++|++. ++||-|-.|.|..+.. .+++.+|+|++... ....+|+++.-.. .|||||++++++.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 34556543 6799999999999987 46899999988532 3456788865444 69999999998763 345
Q ss_pred eEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC---CCcEEEcccC
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---EFTAKIADFG 416 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~---~~~~ki~DFG 416 (437)
+.+|||.|+||.|.+.+..+ ....+++.++..|++||+.|+.|||+.+ |.||||||+|+|... +..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 68999999999999988543 4466999999999999999999999998 999999999999964 4579999999
Q ss_pred CccccCC
Q 013737 417 LVRLFPE 423 (437)
Q Consensus 417 ~a~~~~~ 423 (437)
+|+.-.+
T Consensus 210 FAK~t~~ 216 (400)
T KOG0604|consen 210 FAKETQE 216 (400)
T ss_pred cccccCC
Confidence 9997654
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.7e-21 Score=184.70 Aligned_cols=147 Identities=29% Similarity=0.466 Sum_probs=124.1
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC------
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP------ 338 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 338 (437)
.++|...+.||+|+||.||+|.. .+++.||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 36788899999999999999996 46899999998643 2233456889999999999999999999887543
Q ss_pred eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCc
Q 013737 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (437)
Q Consensus 339 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a 418 (437)
..++|+||+. .+|...+ ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEecccc-cCHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 4589999996 3565443 235889999999999999999999987 999999999999999999999999999
Q ss_pred cccCC
Q 013737 419 RLFPE 423 (437)
Q Consensus 419 ~~~~~ 423 (437)
+....
T Consensus 165 ~~~~~ 169 (342)
T cd07879 165 RHADA 169 (342)
T ss_pred cCCCC
Confidence 86543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.5e-21 Score=198.48 Aligned_cols=159 Identities=28% Similarity=0.403 Sum_probs=136.8
Q ss_pred HHHHHhcCCCcCCcccccCcccEEEEEeC----C----CCEEEEEEEecc-chhhHHHHHHHHHHHcCCC-CCceeceeE
Q 013737 263 TLEKATNYFHESNKLGQGGSGSVYKGTLP----G----GEAVAVKRLFYN-TTQWVDHFFNEVNLISGIN-HKNLVKLLG 332 (437)
Q Consensus 263 ~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~----~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~ 332 (437)
.++...++....+.||+|.||.|++|... . ...||||.++.. .....+.+..|+++|..+. |+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 56666677777789999999999999852 1 347999999754 3456788999999999985 999999999
Q ss_pred EEeeCCeeEEEEeccCCCCccccccccC-----C------C--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCC
Q 013737 333 CSITGPESLLVYEFVPNQSLLDNLFVRQ-----D------V--EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKL 399 (437)
Q Consensus 333 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----~------~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~ 399 (437)
++...+..++|+||++.|+|.++|...+ . . ..++..+.+.++.|||.||+||++.. +|||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999996554 0 0 23889999999999999999999986 99999999
Q ss_pred CCeeeCCCCcEEEcccCCccccCCC
Q 013737 400 SNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 400 ~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
+|||+.++..+||+|||+||....+
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~ 471 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNK 471 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCC
Confidence 9999999999999999999965443
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-21 Score=172.26 Aligned_cols=150 Identities=25% Similarity=0.385 Sum_probs=126.1
Q ss_pred CcCCcccccCcccEEEEEeC-CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCC-CCceeceeEEEeeCCeeEEEEeccC
Q 013737 272 HESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVYEFVP 348 (437)
Q Consensus 272 ~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 348 (437)
+....||.|..|.|+++... +|..+|||.+... +....++++..+.++.+-+ .|.||+.+|+|..+...++-||.|.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 34567999999999999975 5899999999754 5666788888998877664 8999999999999999999999984
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCCc
Q 013737 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (437)
Q Consensus 349 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~~ 426 (437)
.-+.+++.+ ..+++++..+-++...+..||.||.++. .|||||+||+|||+|+.|++|++|||++-.+-+...
T Consensus 175 -~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 175 -TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred -HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 445555432 3456899888899999999999998875 599999999999999999999999999987765443
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.9e-22 Score=183.85 Aligned_cols=161 Identities=31% Similarity=0.339 Sum_probs=132.6
Q ss_pred cCCCcCCcccccCcccEEEEEeCC-CCEEEEEEEeccc---hhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCeeEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNT---TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 343 (437)
.+|....+||+|+||+|.++..++ .+.+|||+++++. ....+--..|-++|+.. +-|.+++++.++++-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 468888999999999999998754 6789999987652 22333445677777766 478999999999999999999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|||+.||+|.-.+ +.-+.+.+..++.++..|+-||-|||+++ ||.||||..|||+|.+|++||+|||+++.---
T Consensus 429 MEyvnGGDLMyhi---QQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHI---QQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEecCchhhhHH---HHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc
Confidence 9999999998777 34455788889999999999999999998 99999999999999999999999999985432
Q ss_pred CCcceeeeecccC
Q 013737 424 DITHISATLAGTL 436 (437)
Q Consensus 424 ~~~~~~~~~~Gt~ 436 (437)
+. ..+.+++||+
T Consensus 503 ~~-~TTkTFCGTP 514 (683)
T KOG0696|consen 503 DG-VTTKTFCGTP 514 (683)
T ss_pred CC-cceeeecCCC
Confidence 22 1233789986
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-21 Score=175.00 Aligned_cols=162 Identities=27% Similarity=0.304 Sum_probs=138.1
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCeeEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 342 (437)
.++|...++||+|+|.+|..+++ ++.+.+|+|+++++ +....+..+.|-.+..+. +||.+|-|+.+++++..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 46789999999999999999997 45788999988653 445566677777777665 69999999999999999999
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
|.||++||+|.-.+ +....++++.+..+...|..||.|||+.| ||.||||..|+|+|..|++||+|+|+++.--
T Consensus 329 vieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999997666 34456999999999999999999999998 9999999999999999999999999998644
Q ss_pred CCCcceeeeecccC
Q 013737 423 EDITHISATLAGTL 436 (437)
Q Consensus 423 ~~~~~~~~~~~Gt~ 436 (437)
.+. ..+.+++|||
T Consensus 403 ~~g-d~tstfcgtp 415 (593)
T KOG0695|consen 403 GPG-DTTSTFCGTP 415 (593)
T ss_pred CCC-cccccccCCC
Confidence 332 2445788986
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.1e-21 Score=177.41 Aligned_cols=150 Identities=25% Similarity=0.307 Sum_probs=124.2
Q ss_pred CCCcCCcccccCcccEEEEEeCC-CCEEEEEEEecc-----chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEE
Q 013737 270 YFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYN-----TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
+|...++||+|+||.||++.+.. +..+++|.++.. ......++.+|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999998643 445555555421 223345677899999999999999999999999999999
Q ss_pred EeccCCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 344 YEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
+||+++++|.+.+... .....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999998877432 23356899999999999999999999987 999999999999976 479999999998764
Q ss_pred C
Q 013737 423 E 423 (437)
Q Consensus 423 ~ 423 (437)
.
T Consensus 157 ~ 157 (260)
T cd08222 157 G 157 (260)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.7e-21 Score=185.68 Aligned_cols=149 Identities=28% Similarity=0.435 Sum_probs=128.5
Q ss_pred HhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCe----
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE---- 339 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 339 (437)
..++|+..+.||+|++|.||++... +++.+|+|.+... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4567889999999999999999975 5789999988643 23345668889999999999999999998776554
Q ss_pred --eEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCC
Q 013737 340 --SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417 (437)
Q Consensus 340 --~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~ 417 (437)
.++|+||+ +++|.+++. ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVK----CQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 568888773 246899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCC
Q 013737 418 VRLFPE 423 (437)
Q Consensus 418 a~~~~~ 423 (437)
+.....
T Consensus 165 ~~~~~~ 170 (343)
T cd07851 165 ARHTDD 170 (343)
T ss_pred cccccc
Confidence 987643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4e-22 Score=189.28 Aligned_cols=159 Identities=25% Similarity=0.289 Sum_probs=136.9
Q ss_pred CCCcCCcccccCcccEEEEEeCCCC-EEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 270 YFHESNKLGQGGSGSVYKGTLPGGE-AVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
+++....||-|+||.|=++..++.. .+|+|.+++. +....+....|-.+|...+.|.||+|+..|.+...+|++||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 4455678999999999998876433 4788877543 44456678899999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~ 425 (437)
-|-||.|...|. +.+.++......++..+.+|++|||+++ ||.|||||+|.|++.+|-+||.|||+|+.+....
T Consensus 501 aClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 501 ACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 999999999994 4456888889999999999999999998 9999999999999999999999999999997654
Q ss_pred cceeeeecccC
Q 013737 426 THISATLAGTL 436 (437)
Q Consensus 426 ~~~~~~~~Gt~ 436 (437)
. +-+++||+
T Consensus 575 K--TwTFcGTp 583 (732)
T KOG0614|consen 575 K--TWTFCGTP 583 (732)
T ss_pred c--eeeecCCc
Confidence 3 33789986
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.7e-22 Score=192.19 Aligned_cols=165 Identities=29% Similarity=0.407 Sum_probs=144.0
Q ss_pred HHhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
.+.++|.....+|.|.||.|||+++ .+++..|+|.++........-+++|+-+++..+|||||.++|.+...+..|+.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 4557788999999999999999996 568999999999887777788889999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||+.+|+|.+..+ ...++++.++....+..++||.|||+.+ -+|||||-.|||+++.+.+|++|||.+..+..-
T Consensus 92 EycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 92 EYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh
Confidence 9999999999773 4567999999999999999999999998 799999999999999999999999998876533
Q ss_pred CcceeeeecccCC
Q 013737 425 ITHISATLAGTLF 437 (437)
Q Consensus 425 ~~~~~~~~~Gt~~ 437 (437)
..+.. .+.||+|
T Consensus 166 i~Krk-sfiGtpy 177 (829)
T KOG0576|consen 166 IAKRK-SFIGTPY 177 (829)
T ss_pred hhhhh-cccCCcc
Confidence 22111 3566665
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.2e-20 Score=171.83 Aligned_cols=132 Identities=20% Similarity=0.150 Sum_probs=114.0
Q ss_pred cCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCCCccccccc
Q 013737 280 GGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV 358 (437)
Q Consensus 280 G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 358 (437)
|.+|.||++.+ .+++.+|+|.+.... .+.+|...+....||||+++++++...+..++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999997 468899999986543 233455555666799999999999999999999999999999988743
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 359 RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 359 ~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++++|||++..+.
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~ 136 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVE 136 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccc
Confidence 235899999999999999999999987 9999999999999999999999999876554
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.2e-22 Score=173.40 Aligned_cols=149 Identities=30% Similarity=0.424 Sum_probs=121.5
Q ss_pred CcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc-hhhHHHHHHHHHHH-cCCCCCceeceeEEEeeCCeeEEEEeccC
Q 013737 272 HESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT-TQWVDHFFNEVNLI-SGINHKNLVKLLGCSITGPESLLVYEFVP 348 (437)
Q Consensus 272 ~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (437)
+....||.|+||+|+|-.+ +.|+.+|||++.... ....++++.|.+.. +.-+.||||+++|....++..|+-||.|.
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 3456899999999999987 569999999998653 45677899998865 44579999999999999999999999994
Q ss_pred CCCccccccc--cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 349 NQSLLDNLFV--RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 349 ~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
.+|..+... ......+++...-.|......||.||-+.- .|||||+||+|||++..|.+||+|||++-.+.+
T Consensus 147 -~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 147 -ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred -hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 566544311 112345888888888888999999998753 599999999999999999999999999876543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.5e-20 Score=165.38 Aligned_cols=149 Identities=37% Similarity=0.517 Sum_probs=132.1
Q ss_pred CCcCCcccccCcccEEEEEeCC-CCEEEEEEEeccchh-hHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccC
Q 013737 271 FHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (437)
|+..+.||+|++|.||++.... ++.+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999999865 889999999766544 67789999999999999999999999999899999999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 349 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
+++|.+++..... .+++..+..++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++..+...
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence 9999988743221 1789999999999999999999987 999999999999999999999999999887654
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.3e-20 Score=191.42 Aligned_cols=150 Identities=23% Similarity=0.263 Sum_probs=106.1
Q ss_pred HhcCCCcCCcccccCcccEEEEEeC-C----CCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEE------Ee
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLP-G----GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC------SI 335 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~ 335 (437)
..++|...++||+|+||.||+|.+. + +..||+|++...... +.+..| .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4568999999999999999999974 4 689999987543221 111111 1122222222222211 24
Q ss_pred eCCeeEEEEeccCCCCccccccccCCC-----------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCC
Q 013737 336 TGPESLLVYEFVPNQSLLDNLFVRQDV-----------------EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIK 398 (437)
Q Consensus 336 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk 398 (437)
.....+||+||+++++|.+++...... ....+..+..++.||+.||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 556789999999999998887432210 01123445679999999999999987 9999999
Q ss_pred CCCeeeCC-CCcEEEcccCCccccCC
Q 013737 399 LSNILLDE-EFTAKIADFGLVRLFPE 423 (437)
Q Consensus 399 ~~NIll~~-~~~~ki~DFG~a~~~~~ 423 (437)
|+|||+++ ++.+||+|||+|+.+..
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~ 308 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRV 308 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccc
Confidence 99999985 57999999999986643
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.82 E-value=3e-20 Score=147.90 Aligned_cols=99 Identities=35% Similarity=0.668 Sum_probs=73.5
Q ss_pred eeec---CCccCCCchhhhHHHHHHHHHHHHHhhcC--CceeeeeecccCCCceEEEeeeccCCCChhhHHHHHHHHHhh
Q 013737 91 TVCG---SKDFGGNNTVFGANAIELVRNLSVQAVKN--DGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSR 165 (437)
Q Consensus 91 ~~~~---~~~~~~~~~~f~~~~~~ll~~l~~~a~~~--~~~~~~~~~~~~~~~~vygl~QC~~dl~~~~C~~Cl~~~~~~ 165 (437)
..|+ ..+...+++.|+.+++.||..|+..|+.. .+|++++.+ .++++||||+||++||++.+|..||+.++.+
T Consensus 2 ~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~~--~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~ 79 (106)
T PF01657_consen 2 HFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSSSKGFATGSAG--SGPDTVYGLAQCRGDLSPSDCRACLADAVAN 79 (106)
T ss_dssp --E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE----ST---EEEEEEE-TTS-HHHHHHHHHHHHCC
T ss_pred CcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhccccCcEEeecC--CCCCeEEEEEEcCCCCChhhhHHHHHHHHHH
Confidence 4576 22232345569999999999999998854 579998863 5778999999999999999999999999999
Q ss_pred hhc-ccCCCCceecCCccccccccccc
Q 013737 166 IAS-CTQKEEGRVLNAGCYLRYSTQRF 191 (437)
Q Consensus 166 ~~~-c~~~~~g~v~~~~C~~ry~~~~f 191 (437)
+.. |....+|+++.++|++||+.++|
T Consensus 80 ~~~~C~~~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 80 ISSCCPGSRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp HHHHTTSBSSEEEEESSEEEEEESS--
T ss_pred HHHhCCCCceEEEECCCEEEEEECCCC
Confidence 998 67789999999999999999987
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-20 Score=149.99 Aligned_cols=76 Identities=39% Similarity=0.888 Sum_probs=60.9
Q ss_pred CCccchhhcc---ccEEEeecCCCCcEEEEEEcCCCCChhhhHHHHHHHHHHHHhhCCCCCCcccEEEEccceEEEEecc
Q 013737 2 DIVTPLIARQ---RYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFYDGCYLRYDDY 78 (437)
Q Consensus 2 ~~l~~~~~~~---~~~~~~~g~~~~~vyg~~~C~~d~~~~~C~~Cl~~~~~~~~~~c~~~~~~~~~~~~~~~C~~ry~~~ 78 (437)
..|+.+++.. +|+++..|.++++||||+||++|+++++|..||+.++..++.+|+++ +||+||+++|+||||++
T Consensus 28 ~~l~~~a~~~~~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~~~~C~~~---~g~~v~~~~C~lRY~~~ 104 (106)
T PF01657_consen 28 SSLVSNAASSSSKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVANISSCCPGS---RGGRVWYDSCFLRYENY 104 (106)
T ss_dssp HHHHHHGGGTT-TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHHHCCHHHHTTSB---SSEEEEESSEEEEEESS
T ss_pred HHHHHHHhhccccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHHHHhCCCC---ceEEEECCCEEEEEECC
Confidence 4566665543 89999888899999999999999999999999999999999999986 99999999999999999
Q ss_pred Cc
Q 013737 79 DF 80 (437)
Q Consensus 79 ~f 80 (437)
+|
T Consensus 105 ~F 106 (106)
T PF01657_consen 105 PF 106 (106)
T ss_dssp --
T ss_pred CC
Confidence 98
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.6e-19 Score=163.74 Aligned_cols=148 Identities=18% Similarity=0.143 Sum_probs=114.1
Q ss_pred hcCCCcCCcccccCcccEEEEE--eCCCCEEEEEEEeccchh------------------------hHHHHHHHHHHHcC
Q 013737 268 TNYFHESNKLGQGGSGSVYKGT--LPGGEAVAVKRLFYNTTQ------------------------WVDHFFNEVNLISG 321 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~ 321 (437)
...|.+.+.||+|+||.||+|. ..+|+.||+|.+...... ....+.+|+..+.+
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3457788999999999999998 567999999998643210 11236789999999
Q ss_pred CCCC--ceeceeEEEeeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCC
Q 013737 322 INHK--NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKL 399 (437)
Q Consensus 322 l~h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~ 399 (437)
+.+. .++++++. ...++||||+++.+|..... ...++.......++.|++.+|.+||+.+ +|+||||||
T Consensus 107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp 177 (237)
T smart00090 107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSE 177 (237)
T ss_pred HHhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCCh
Confidence 9753 33444442 23589999999988866542 1234566667899999999999999875 499999999
Q ss_pred CCeeeCCCCcEEEcccCCccccCCCC
Q 013737 400 SNILLDEEFTAKIADFGLVRLFPEDI 425 (437)
Q Consensus 400 ~NIll~~~~~~ki~DFG~a~~~~~~~ 425 (437)
+||+++ ++.++|+|||.+.....+.
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~~~~ 202 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELDHPM 202 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccCCcc
Confidence 999999 7899999999998766544
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.3e-20 Score=185.16 Aligned_cols=151 Identities=32% Similarity=0.447 Sum_probs=120.6
Q ss_pred CCcCCcccccCcc-cEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCC-CCceeceeEEEeeCCeeEEEEeccC
Q 013737 271 FHESNKLGQGGSG-SVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVYEFVP 348 (437)
Q Consensus 271 ~~~~~~Lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 348 (437)
|...+.+|.|+-| .||+|... |++||||++..+. .+-..+|+..|..-+ |||||++++.-.+....||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 5566789999988 57999987 7899999985432 335678999988874 999999999999999999999999
Q ss_pred CCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC---C--CcEEEcccCCccccC
Q 013737 349 NQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---E--FTAKIADFGLVRLFP 422 (437)
Q Consensus 349 ~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~---~--~~~ki~DFG~a~~~~ 422 (437)
..+|.+++... ...........+.++.|++.||+|||+.+ ||||||||.||||+. + ..++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 47999988553 11111111445778999999999999987 999999999999975 3 579999999999998
Q ss_pred CCCccee
Q 013737 423 EDITHIS 429 (437)
Q Consensus 423 ~~~~~~~ 429 (437)
.+.+...
T Consensus 663 ~~~sS~~ 669 (903)
T KOG1027|consen 663 GGKSSFS 669 (903)
T ss_pred CCcchhh
Confidence 7765543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.4e-19 Score=156.45 Aligned_cols=143 Identities=38% Similarity=0.588 Sum_probs=126.6
Q ss_pred ccccCcccEEEEEeCC-CCEEEEEEEeccchh-hHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCCCccc
Q 013737 277 LGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354 (437)
Q Consensus 277 Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 354 (437)
||+|.+|.||++...+ ++.+++|.+...... ..+.+.+|+..+..++|++|+++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 899999998765432 45679999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC-CCcEEEcccCCccccCCC
Q 013737 355 NLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFGLVRLFPED 424 (437)
Q Consensus 355 ~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~-~~~~ki~DFG~a~~~~~~ 424 (437)
++.... ..+++..+..++.+++++|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 874321 45899999999999999999999987 999999999999999 899999999999876543
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-19 Score=161.83 Aligned_cols=142 Identities=11% Similarity=0.111 Sum_probs=115.3
Q ss_pred HhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccch---hhHHH------HHHHHHHHcCCCCCceeceeEEEeeC
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT---QWVDH------FFNEVNLISGINHKNLVKLLGCSITG 337 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~ 337 (437)
...+|+..++||+|+||.||+... ++..+|||.+..... ..... +.+|+..+.+++||+|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 357899999999999999999766 567899999965422 22223 68999999999999999999886643
Q ss_pred --------CeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCc
Q 013737 338 --------PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT 409 (437)
Q Consensus 338 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~ 409 (437)
+..+|+|||++|.+|.+.. .++. ....+++.+|..+|+.+ ++|||++|+||++++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP-------EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh-------hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 3578999999999997753 1222 24568999999999998 99999999999999988
Q ss_pred EEEcccCCccccCCC
Q 013737 410 AKIADFGLVRLFPED 424 (437)
Q Consensus 410 ~ki~DFG~a~~~~~~ 424 (437)
++|+|||..+...++
T Consensus 173 i~liDfg~~~~~~e~ 187 (232)
T PRK10359 173 LRIIDLSGKRCTAQR 187 (232)
T ss_pred EEEEECCCcccccch
Confidence 999999998877543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.5e-19 Score=159.58 Aligned_cols=147 Identities=20% Similarity=0.342 Sum_probs=121.1
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCC-CCCceeceeEE-EeeCCeeEEEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGC-SITGPESLLVY 344 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~ 344 (437)
.+.|.+.+.||+|.||.+.+++++ +...+++|.+... .....+|.+|..---.| .|.||+.-+++ |++.+...+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 356888999999999999999985 4678899987543 23356799998765555 48999988774 66777888999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC--CCCcEEEcccCCccccC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD--EEFTAKIADFGLVRLFP 422 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~--~~~~~ki~DFG~a~~~~ 422 (437)
||++.|+|.+-+. ...+-+....+++.|++.|+.|+|+++ +||||||.+||||- +..++||+|||+.+..+
T Consensus 102 E~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999988762 244777888999999999999999998 99999999999993 44589999999988654
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=7e-19 Score=157.23 Aligned_cols=146 Identities=21% Similarity=0.180 Sum_probs=113.0
Q ss_pred HHHHhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchh----------------------hHHHHHHHHHHHcC
Q 013737 264 LEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQ----------------------WVDHFFNEVNLISG 321 (437)
Q Consensus 264 ~~~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~ 321 (437)
+......|...+.||+|+||.||++..++|+.||||++...... ....+.+|+.++..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 33333447778999999999999999888999999987543210 11236778888988
Q ss_pred CCCCc--eeceeEEEeeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCC
Q 013737 322 INHKN--LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKL 399 (437)
Q Consensus 322 l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~ 399 (437)
+.|++ +++.++ ....++||||+++++|.+... ......++.+++.++.++|+.+ |+||||||
T Consensus 90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p 153 (198)
T cd05144 90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSE 153 (198)
T ss_pred HHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence 88774 444443 345689999999998876531 0234578899999999999987 99999999
Q ss_pred CCeeeCCCCcEEEcccCCccccCCCC
Q 013737 400 SNILLDEEFTAKIADFGLVRLFPEDI 425 (437)
Q Consensus 400 ~NIll~~~~~~ki~DFG~a~~~~~~~ 425 (437)
+||++++++.++|+|||++.....+.
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~~~~ 179 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTDHPN 179 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCCCcc
Confidence 99999999999999999997766543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.3e-19 Score=159.14 Aligned_cols=136 Identities=18% Similarity=0.236 Sum_probs=113.9
Q ss_pred CcccccCcccEEEEEeCCCCEEEEEEEeccch--------hhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT--------QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
+.||+|++|.||+|.+ .+..+++|+...... ....++.+|++++..+.|++|+....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 567889997653221 1124678899999999999998888887778888999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
++|++|.+.+... .+ ....++.+++.+|.+||+.+ ++|+|++|+|||++ ++.++|+|||+++...
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 9999998877321 12 77889999999999999987 99999999999999 7899999999998643
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=153.23 Aligned_cols=134 Identities=15% Similarity=0.062 Sum_probs=105.7
Q ss_pred CcCCcccccCcccEEEEEeCCCCEEEEEEEeccchh----hHHHHHHHHHHHcCCC-CCceeceeEEEeeCCeeEEEEec
Q 013737 272 HESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQ----WVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 272 ~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
.....|++|+||+|+.+.. .+.+++.+.+.....- ....+.+|+++|++|+ |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999997766 5777777776543221 1225889999999995 5889999886 456999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCC-CCCCeeeCCCCcEEEcccCCccccCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDI-KLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDl-k~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
++|.+|.+.+. . ....++.|++++|.++|+.+ |+|||| ||+|||+++++.++|+|||+|.....
T Consensus 80 I~G~~L~~~~~---------~-~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 80 LAGAAMYQRPP---------R-GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred ecCccHHhhhh---------h-hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 99988864321 0 12357789999999999998 999999 79999999999999999999986554
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.9e-19 Score=155.32 Aligned_cols=150 Identities=21% Similarity=0.306 Sum_probs=124.6
Q ss_pred hcCCCcCCcccccCcccEEEEE-eCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCC-CceeceeEEEeeCCeeEEEEe
Q 013737 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH-KNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 345 (437)
..+|...++||.|+||.+|.|. ..+|+.||||.-..... ..++.-|..+...|+| ..|+.+..+..+...-.+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 3578899999999999999998 47799999998654322 2356778888888874 678888888888888999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC---CcEEEcccCCccccC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE---FTAKIADFGLVRLFP 422 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~---~~~ki~DFG~a~~~~ 422 (437)
.+ |.+|.+++.... ..++...++.++-|++.-++|+|.++ +|||||||+|+|..-+ ..+.++|||+|+.+.
T Consensus 92 LL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 98 789988774332 34788899999999999999999998 9999999999998633 479999999999886
Q ss_pred CCC
Q 013737 423 EDI 425 (437)
Q Consensus 423 ~~~ 425 (437)
+..
T Consensus 166 d~~ 168 (341)
T KOG1163|consen 166 DIR 168 (341)
T ss_pred ccc
Confidence 544
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.7e-19 Score=180.13 Aligned_cols=143 Identities=20% Similarity=0.279 Sum_probs=115.1
Q ss_pred HHHhcCCCcCCcccccCcccEEEEEeCCCCEEEEEE-Eecc-------chhhHHHHHHHHHHHcCCCCCceeceeEEEee
Q 013737 265 EKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKR-LFYN-------TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT 336 (437)
Q Consensus 265 ~~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~-~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 336 (437)
......|...++||+|+||.||++.+.+.. +++|+ +... .....+++.+|++++..++|++++....+...
T Consensus 329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 329 EEVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred cccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 333445677899999999999999876543 33343 2211 11224568899999999999999988888887
Q ss_pred CCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccC
Q 013737 337 GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (437)
Q Consensus 337 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG 416 (437)
....++||||+++++|.+++. ....++.+++++|.+||+.+ ++||||||+|||+ +++.++|+|||
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFG 472 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFG 472 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCc
Confidence 788899999999999988762 35678999999999999988 9999999999999 57799999999
Q ss_pred CccccCC
Q 013737 417 LVRLFPE 423 (437)
Q Consensus 417 ~a~~~~~ 423 (437)
+++....
T Consensus 473 la~~~~~ 479 (535)
T PRK09605 473 LGKYSDL 479 (535)
T ss_pred ccccCCc
Confidence 9987643
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=159.29 Aligned_cols=137 Identities=32% Similarity=0.437 Sum_probs=122.4
Q ss_pred CcccEEEEEeC-CCCEEEEEEEeccchhh-HHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCCCccccccc
Q 013737 281 GSGSVYKGTLP-GGEAVAVKRLFYNTTQW-VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV 358 (437)
Q Consensus 281 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 358 (437)
+||.||++... +++.+++|.+....... .+.+.+|++.+++++|+||+++++.+......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999986 48999999997654433 67899999999999999999999999999999999999999999988743
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 359 RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 359 ~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
. ..+++..+..++.+++.++.|||+.+ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 ~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~ 139 (244)
T smart00220 81 R---GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDP 139 (244)
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecc
Confidence 2 23889999999999999999999987 99999999999999999999999999987755
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-18 Score=155.05 Aligned_cols=132 Identities=19% Similarity=0.291 Sum_probs=107.6
Q ss_pred cccccCcccEEEEEeCCCCEEEEEEEeccc---h-----hhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEecc
Q 013737 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNT---T-----QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (437)
Q Consensus 276 ~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (437)
.||+|+||.||++.+. +..+++|...... . ....++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 4899999999999954 6789999864321 1 12356789999999999887766666666777789999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
+|++|.+.+... . ..++.+++.+|.+||+.+ ++|+|++|+||+++ ++.++++|||+++...
T Consensus 80 ~g~~l~~~~~~~---~-------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEG---N-------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhc---H-------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 999998876221 0 078999999999999987 99999999999999 7899999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-18 Score=158.03 Aligned_cols=151 Identities=23% Similarity=0.308 Sum_probs=125.7
Q ss_pred cCCCcCCcccccCcccEEEEE-eCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCC-CCceeceeEEEeeCCeeEEEEec
Q 013737 269 NYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
-+|++.++||+|+||.++.|+ +-++++||||.-...+ ..-++..|.+..+.|. .++|...+-+..++..-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 468999999999999999998 5679999999754332 2345777888877775 68999999888888888999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC-----CcEEEcccCCcccc
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-----FTAKIADFGLVRLF 421 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~-----~~~ki~DFG~a~~~ 421 (437)
+ |.+|.+++-. -...++...+..++.|++.-++|+|++. +|.|||||+|+||... ..+.|+|||+|+.+
T Consensus 106 L-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8 7888887632 2345899999999999999999999998 9999999999999633 46999999999998
Q ss_pred CCCCcc
Q 013737 422 PEDITH 427 (437)
Q Consensus 422 ~~~~~~ 427 (437)
.+..+.
T Consensus 180 rDp~Tk 185 (449)
T KOG1165|consen 180 RDPKTK 185 (449)
T ss_pred cCcccc
Confidence 766543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.3e-18 Score=159.07 Aligned_cols=155 Identities=23% Similarity=0.273 Sum_probs=128.8
Q ss_pred HhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCC--C----ceeceeEEEeeCCe
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH--K----NLVKLLGCSITGPE 339 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~l~~~~~~~~~ 339 (437)
.+.+|.+..++|+|.||.|-++.+. .+..||||+++.- ....+..+-|++++.++.+ | -+|++.+++.-.++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 3678999999999999999999864 4789999998643 2345567789999999842 2 47888899999999
Q ss_pred eEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC-------------
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE------------- 406 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~------------- 406 (437)
.+||+|.+ |-|+.++|.. ++-.+++..++..|+.|++++++|||+.. ++|-||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred eEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 99999998 6689998843 45567999999999999999999999987 999999999999832
Q ss_pred -------CCcEEEcccCCccccCCCCcc
Q 013737 407 -------EFTAKIADFGLVRLFPEDITH 427 (437)
Q Consensus 407 -------~~~~ki~DFG~a~~~~~~~~~ 427 (437)
+..+||+|||-|....+..+.
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~hs~ 268 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHHST 268 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCcce
Confidence 235999999999988776644
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.3e-19 Score=171.99 Aligned_cols=146 Identities=25% Similarity=0.328 Sum_probs=121.8
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCeeEEEEe
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 345 (437)
++.|.....+|.|+|+.|-++.+ .+++..+||++..... +..+|+.++... +||||+++.+.+.++.+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 56678888899999999999986 5688899999865522 234577655554 69999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee-CCCCcEEEcccCCccccCCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL-DEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll-~~~~~~ki~DFG~a~~~~~~ 424 (437)
.+.++-+.+.+... +....++..|+.+|+.++.|||+++ ||||||||+|||+ ++.++++|+|||.++....+
T Consensus 397 ~l~g~ell~ri~~~----~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSK----PEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHhc----chhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 99999887766322 2233778889999999999999998 9999999999999 58899999999999987655
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=6e-18 Score=162.69 Aligned_cols=145 Identities=25% Similarity=0.308 Sum_probs=120.4
Q ss_pred CCCcCCcccccCcccEEEEEeCCC--CEEEEEEEeccchhhHHHHHHHHHHHcCCCC----CceeceeEEE-eeCCeeEE
Q 013737 270 YFHESNKLGQGGSGSVYKGTLPGG--EAVAVKRLFYNTTQWVDHFFNEVNLISGINH----KNLVKLLGCS-ITGPESLL 342 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 342 (437)
.|.+.++||+|+||.||++..... ..+|+|............+..|..++..+.+ +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 789999999999999999997553 4788887765433222267788888888863 6888999888 47778899
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC-----CcEEEcccCC
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-----FTAKIADFGL 417 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~-----~~~ki~DFG~ 417 (437)
||+.+ |.+|.++..... ...++...++.|+.|++.+|++||+.| ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 789988663333 567999999999999999999999998 9999999999999754 4699999999
Q ss_pred cc
Q 013737 418 VR 419 (437)
Q Consensus 418 a~ 419 (437)
++
T Consensus 174 ar 175 (322)
T KOG1164|consen 174 AR 175 (322)
T ss_pred Cc
Confidence 99
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.2e-18 Score=161.20 Aligned_cols=148 Identities=28% Similarity=0.431 Sum_probs=127.0
Q ss_pred HHHHhcCCCcCCcccccCcccEEEEEeC----CCCEEEEEEEeccchhhHHHHHHHHHHHcCCC-CCceeceeEEEeeCC
Q 013737 264 LEKATNYFHESNKLGQGGSGSVYKGTLP----GGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGP 338 (437)
Q Consensus 264 ~~~~~~~~~~~~~Lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 338 (437)
+....+.|...++||+|.|+.||++.+. ..+.||+|.+...+. ..++.+|+++|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4445567889999999999999999863 467899999865432 456889999999995 899999999999999
Q ss_pred eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC-CcEEEcccCC
Q 013737 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGL 417 (437)
Q Consensus 339 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~-~~~ki~DFG~ 417 (437)
...+|+||+++....+++. .++..++..+++.+..||.++|.+| ||||||||+|+|.+.. +.-.|.|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 9999999999988877762 3668889999999999999999998 9999999999999854 6789999999
Q ss_pred ccccC
Q 013737 418 VRLFP 422 (437)
Q Consensus 418 a~~~~ 422 (437)
|...+
T Consensus 180 A~~~d 184 (418)
T KOG1167|consen 180 AQRYD 184 (418)
T ss_pred HHHHH
Confidence 98543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.9e-18 Score=156.12 Aligned_cols=155 Identities=24% Similarity=0.311 Sum_probs=130.2
Q ss_pred HHHHhcCCCcCCcccccCcccEEEEEeCC------CCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEee
Q 013737 264 LEKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT 336 (437)
Q Consensus 264 ~~~~~~~~~~~~~Lg~G~~g~V~~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 336 (437)
+.....+++...++.+|.||.||+|.|.+ .+.|-+|.++.. ++-....+..|.-++..+.|||+.++.+++.+
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 33344567888899999999999997642 346777877654 44456789999999999999999999998875
Q ss_pred C-CeeEEEEeccCCCCcccccc-----ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 013737 337 G-PESLLVYEFVPNQSLLDNLF-----VRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410 (437)
Q Consensus 337 ~-~~~~lv~e~~~~g~L~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ 410 (437)
. ...+.++.++.-|+|..+|. +......++..+.+.++.|++.||+|||.++ |||.||.++|.+||+..++
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqV 435 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQV 435 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeE
Confidence 4 46788999999999999987 3344456888999999999999999999998 9999999999999999999
Q ss_pred EEcccCCcccc
Q 013737 411 KIADFGLVRLF 421 (437)
Q Consensus 411 ki~DFG~a~~~ 421 (437)
||+|=.++|-+
T Consensus 436 kltDsaLSRDL 446 (563)
T KOG1024|consen 436 KLTDSALSRDL 446 (563)
T ss_pred Eeccchhcccc
Confidence 99999999853
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.8e-17 Score=144.58 Aligned_cols=139 Identities=21% Similarity=0.187 Sum_probs=99.4
Q ss_pred CCcccccCcccEEEEEeCCCCEEEEEEEeccchh--hHHH----------------------HHHHHHHHcCCCCC--ce
Q 013737 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQ--WVDH----------------------FFNEVNLISGINHK--NL 327 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~--ni 327 (437)
.+.||+|+||.||++...++++||||.+...... .... ...|.+.+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999988653211 1111 13455555555433 24
Q ss_pred eceeEEEeeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeeeCCCCCCCeeeCC
Q 013737 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE-ESKLRIIHRDIKLSNILLDE 406 (437)
Q Consensus 328 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiHrDlk~~NIll~~ 406 (437)
.+.++. ...++||||++++.+......... .. .....++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444443 245899999998654322111100 11 5678899999999999999 76 99999999999999
Q ss_pred CCcEEEcccCCccccCCC
Q 013737 407 EFTAKIADFGLVRLFPED 424 (437)
Q Consensus 407 ~~~~ki~DFG~a~~~~~~ 424 (437)
++.++|+|||.+.....+
T Consensus 150 ~~~~~liDfg~a~~~~~~ 167 (187)
T cd05119 150 DGKVYIIDVPQAVEIDHP 167 (187)
T ss_pred CCcEEEEECcccccccCc
Confidence 889999999999876553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.9e-17 Score=136.43 Aligned_cols=137 Identities=24% Similarity=0.191 Sum_probs=115.4
Q ss_pred cCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCC--CceeceeEEEeeCCeeEEEEeccCCC
Q 013737 273 ESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH--KNLVKLLGCSITGPESLLVYEFVPNQ 350 (437)
Q Consensus 273 ~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 350 (437)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.++..++| +++++++++...++..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999865 7899998865433 4578899999999976 58999999888888899999999887
Q ss_pred CccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 351 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
.+..+ +......++.+++++|.+||.....+++|+||+|+||++++.+.++++|||.++..+
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 77543 556677889999999999998644459999999999999998999999999998654
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.7e-18 Score=153.07 Aligned_cols=146 Identities=31% Similarity=0.435 Sum_probs=118.6
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC------e
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP------E 339 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 339 (437)
.+|...+.+|.|.- .|-.+.+ -.+++||+|++... .....++..+|..++..++|+||++++.++.-.. +
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666778888877 4554543 34889999987532 3344567889999999999999999999987443 5
Q ss_pred eEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcc
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~ 419 (437)
.|+|||+|. .+|...+. ..++-..+..|..|++.|++|||+.+ |+||||||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 799999994 67877663 34677888999999999999999998 9999999999999999999999999998
Q ss_pred ccCCC
Q 013737 420 LFPED 424 (437)
Q Consensus 420 ~~~~~ 424 (437)
.-..+
T Consensus 167 ~e~~~ 171 (369)
T KOG0665|consen 167 TEDTD 171 (369)
T ss_pred ccCcc
Confidence 66544
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.8e-17 Score=156.10 Aligned_cols=134 Identities=27% Similarity=0.386 Sum_probs=112.1
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCC-----C---CceeceeEEEee---
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-----H---KNLVKLLGCSIT--- 336 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~--- 336 (437)
.+|...++||-|.|++||++.+ .+.+.||+|+.+. .....+..+.||.+|++++ | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 5688899999999999999986 5678899998863 3445677889999999884 2 479999999874
Q ss_pred -CCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC
Q 013737 337 -GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE 407 (437)
Q Consensus 337 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~ 407 (437)
+.++++|+|++ |-+|..++.. .....++...+..|++||+.||.|||.+. +|||-||||+|||+..+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~-s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKY-SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHH-hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 44789999999 6788887743 34456899999999999999999999976 79999999999999544
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.3e-16 Score=143.55 Aligned_cols=137 Identities=20% Similarity=0.261 Sum_probs=105.9
Q ss_pred CCccc-ccCcccEEEEEeCCCCEEEEEEEeccc-------------hhhHHHHHHHHHHHcCCCCCce--eceeEEEeeC
Q 013737 274 SNKLG-QGGSGSVYKGTLPGGEAVAVKRLFYNT-------------TQWVDHFFNEVNLISGINHKNL--VKLLGCSITG 337 (437)
Q Consensus 274 ~~~Lg-~G~~g~V~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 337 (437)
...|| .|+.|+||++... +..++||.+.... .....++.+|++++.+|+|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45787 8999999999876 6788888774211 1223568899999999998875 6777764433
Q ss_pred Ce----eEEEEeccCC-CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 013737 338 PE----SLLVYEFVPN-QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI 412 (437)
Q Consensus 338 ~~----~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki 412 (437)
.. .++|||++++ .+|.+++.. .+++.. .+.+|+.+|.+||+.+ |+||||||+|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 22 2599999997 688777632 234543 3568999999999998 999999999999999889999
Q ss_pred cccCCccccC
Q 013737 413 ADFGLVRLFP 422 (437)
Q Consensus 413 ~DFG~a~~~~ 422 (437)
+|||.++...
T Consensus 184 IDfg~~~~~~ 193 (239)
T PRK01723 184 IDFDRGELRT 193 (239)
T ss_pred EECCCcccCC
Confidence 9999998764
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1e-16 Score=153.26 Aligned_cols=157 Identities=21% Similarity=0.217 Sum_probs=131.6
Q ss_pred HHHHhcCCCcCCcccccCcccEEEEEeCC-CCEEEEEEEeccchhhHHHHHHHHHHHcCCC------CCceeceeEEEee
Q 013737 264 LEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGIN------HKNLVKLLGCSIT 336 (437)
Q Consensus 264 ~~~~~~~~~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~ 336 (437)
-+.....|......|+|-|+.|.+|.+.. |+.||||++..+.. ..+.=+.|+++|++|+ --|+++|+-.|..
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 34445567777788999999999999754 78999999976533 2344568999999995 3589999999999
Q ss_pred CCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC-CcEEEccc
Q 013737 337 GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADF 415 (437)
Q Consensus 337 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~-~~~ki~DF 415 (437)
.++++||+|-+ .-+|.+.|........|....+..++.|+..||..|-..+ |+|.||||.|||+++. ..+||+||
T Consensus 506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccC
Confidence 99999999988 5789999877666677888999999999999999999877 9999999999999876 47899999
Q ss_pred CCccccCCCC
Q 013737 416 GLVRLFPEDI 425 (437)
Q Consensus 416 G~a~~~~~~~ 425 (437)
|.|....++.
T Consensus 582 GSA~~~~ene 591 (752)
T KOG0670|consen 582 GSASFASENE 591 (752)
T ss_pred cccccccccc
Confidence 9998876653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.8e-15 Score=143.16 Aligned_cols=150 Identities=37% Similarity=0.498 Sum_probs=126.8
Q ss_pred CCcCCcccccCcccEEEEEeCCCCEEEEEEEeccch---hhHHHHHHHHHHHcCCCCC-ceeceeEEEeeCCeeEEEEec
Q 013737 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT---QWVDHFFNEVNLISGINHK-NLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 346 (437)
|...+.||.|+|+.||++... ..+++|.+..... .....+.+|+.++..+.|+ +|+++.+.+......++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999987 7889998865422 2467899999999999988 799999999777778999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC-cEEEcccCCccccCCCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRLFPEDI 425 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~-~~ki~DFG~a~~~~~~~ 425 (437)
+.++++.+++........++......++.|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999865522111126889999999999999999999998 99999999999999988 79999999998665443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.5e-15 Score=159.06 Aligned_cols=145 Identities=25% Similarity=0.305 Sum_probs=113.4
Q ss_pred HHhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCC---CCceeceeEEEeeCCeeEE
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN---HKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l 342 (437)
.-.+.|.+.+.||+|+||.||+|...+|+.||+|.-+....- +|.-=.+++.+|+ -+-|..+...+.-.+..+|
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 334568888999999999999999888999999987654322 1111122333333 2345555555666778899
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC-------CCCcEEEccc
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD-------EEFTAKIADF 415 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~-------~~~~~ki~DF 415 (437)
|+||.+.|+|.+++. ..+.++|.....++.|++.-+++||..+ |||+||||+|.||. +..-++|+||
T Consensus 772 v~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEec
Confidence 999999999999984 5566999999999999999999999998 99999999999993 2346999999
Q ss_pred CCcc
Q 013737 416 GLVR 419 (437)
Q Consensus 416 G~a~ 419 (437)
|-+-
T Consensus 846 G~si 849 (974)
T KOG1166|consen 846 GRSI 849 (974)
T ss_pred ccce
Confidence 9875
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.2e-14 Score=144.59 Aligned_cols=143 Identities=20% Similarity=0.203 Sum_probs=99.3
Q ss_pred CCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHH----------------------------------------HHH
Q 013737 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVD----------------------------------------HFF 313 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~----------------------------------------~~~ 313 (437)
.+.||.|++|.||+|++++|+.||||+.+++...... .|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 4679999999999999999999999998654211100 134
Q ss_pred HHHHHHcCC----C-CCceeceeEEEeeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHH-HHHHhhcC
Q 013737 314 NEVNLISGI----N-HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE-GLAYLHEE 387 (437)
Q Consensus 314 ~E~~~l~~l----~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~-~l~yLH~~ 387 (437)
+|...+.++ + ++++.-..-+.......+|||||++|++|.+....... ..+ ...++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CCC---HHHHHHHHHHHHHHHHHhC
Confidence 455444444 2 33332222222223457899999999999886532111 122 3445666655 46788988
Q ss_pred CCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 388 ~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
+ ++|+|++|.||+++++++++++|||++..+++.
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~ 310 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE 310 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence 7 999999999999999999999999999887643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.1e-13 Score=139.39 Aligned_cols=145 Identities=17% Similarity=0.187 Sum_probs=93.0
Q ss_pred cCCCcCCcccccCcccEEEEEeCC-CCEEEEEEEeccchh----------------------------------hHHH--
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQ----------------------------------WVDH-- 311 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~~-- 311 (437)
..|+. +.||.|++|.||+|++++ |+.||||+++++... ..+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 44665 789999999999999977 999999999754211 1112
Q ss_pred ----HHHHHHHHcCC----CCCceeceeEEEee-CCeeEEEEeccCCCCccccccccCCC---CCCCHHHHHHHHHHHHH
Q 013737 312 ----FFNEVNLISGI----NHKNLVKLLGCSIT-GPESLLVYEFVPNQSLLDNLFVRQDV---EPLSWEVRYKIILSTAE 379 (437)
Q Consensus 312 ----~~~E~~~l~~l----~h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~---~~l~~~~~~~i~~~i~~ 379 (437)
+.+|+..+.++ .+.+.+.+-.++.+ ....+|||||++|+++.+.-...... ..+....+..++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 23333333333 23333333333322 34567999999999997642111111 112233333333333
Q ss_pred HHHHhhcCCCCCeeeCCCCCCCeeeCCCC----cEEEcccCCccccCCC
Q 013737 380 GLAYLHEESKLRIIHRDIKLSNILLDEEF----TAKIADFGLVRLFPED 424 (437)
Q Consensus 380 ~l~yLH~~~~~~iiHrDlk~~NIll~~~~----~~ki~DFG~a~~~~~~ 424 (437)
+..| ++|+|+||.||+++.++ ++++.|||++..+++.
T Consensus 277 -----f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 277 -----FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred -----HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 3456 99999999999999888 9999999999887654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.43 E-value=6.1e-13 Score=115.57 Aligned_cols=132 Identities=20% Similarity=0.159 Sum_probs=97.4
Q ss_pred CCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCce-eceeEEEeeCCeeEEEEeccCCCCc
Q 013737 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL-VKLLGCSITGPESLLVYEFVPNQSL 352 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L 352 (437)
.+.|+.|.++.||+++.. +..+++|....... ....+.+|+.++..+.+.++ ++++.+. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 357899999999999876 67899998754432 12346788888888865544 4455443 3345899999999887
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--CCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES--KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 353 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
.+.. . ....+..+++++|..||..+ +..++|+|++|.||+++ ++.++++|||.+..-
T Consensus 79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 5420 1 11245678999999999986 23369999999999999 568999999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=4.7e-13 Score=137.44 Aligned_cols=146 Identities=24% Similarity=0.285 Sum_probs=111.9
Q ss_pred CcCCcccccCcccEEEEEeC-CCCEEEEEEEe-----ccchhh-HHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 272 HESNKLGQGGSGSVYKGTLP-GGEAVAVKRLF-----YNTTQW-VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 272 ~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~-----~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
.....+|.|++|.|+..... ..+..+.|... ...... ...+..|+.+-..+.|||++..+....+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678999999977777642 22323333221 112111 222667888888999999988887777766666669
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||+++ +|..++.. ...+...++-.++.|++.|+.|||+.| |.|||||++|+++..++.+||+|||.+..+.-+
T Consensus 401 E~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 99988733 235788889999999999999999998 999999999999999999999999999876533
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.34 E-value=6.4e-13 Score=143.04 Aligned_cols=95 Identities=17% Similarity=0.202 Sum_probs=74.3
Q ss_pred cCCCC-CceeceeEEE-------eeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 013737 320 SGINH-KNLVKLLGCS-------ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391 (437)
Q Consensus 320 ~~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ 391 (437)
+.++| +||.++++++ ......++++|++ +++|.+++.. ....+++.+++.++.||++||.|||+++
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 34456 5888888877 2334567888987 5699998843 2355899999999999999999999988
Q ss_pred eeeCCCCCCCeeeCC-------------------CCcEEEcccCCccc
Q 013737 392 IIHRDIKLSNILLDE-------------------EFTAKIADFGLVRL 420 (437)
Q Consensus 392 iiHrDlk~~NIll~~-------------------~~~~ki~DFG~a~~ 420 (437)
|+||||||+||||+. ++.+||+|||+++.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~ 148 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRR 148 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccc
Confidence 999999999999954 44566777777764
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.6e-11 Score=107.88 Aligned_cols=138 Identities=12% Similarity=0.065 Sum_probs=99.3
Q ss_pred CcccccCcccEEEEEeCC-------CCEEEEEEEecc-------------c---------hhhHHHH----HHHHHHHcC
Q 013737 275 NKLGQGGSGSVYKGTLPG-------GEAVAVKRLFYN-------------T---------TQWVDHF----FNEVNLISG 321 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~~-------~~~vavK~~~~~-------------~---------~~~~~~~----~~E~~~l~~ 321 (437)
..||.|.-+.||.|...+ +..+|||..+.. + ....+.+ ++|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 478999976321 0 1112233 389999988
Q ss_pred CC--CCceeceeEEEeeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCCeeeCCCC
Q 013737 322 IN--HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL-HEESKLRIIHRDIK 398 (437)
Q Consensus 322 l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yL-H~~~~~~iiHrDlk 398 (437)
+. .-++++++++ ...+|||||+.+..+..... +...++..+...+..+++.+|..| |..+ |+|+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 85 3566677764 45689999997654422111 112345556677889999999998 7777 9999999
Q ss_pred CCCeeeCCCCcEEEcccCCccccCC
Q 013737 399 LSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 399 ~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
+.|||+++ +.+.|+|||.+-....
T Consensus 153 ~~NIL~~~-~~v~iIDF~qav~~~h 176 (197)
T cd05146 153 EYNMLWHD-GKVWFIDVSQSVEPTH 176 (197)
T ss_pred HHHEEEEC-CcEEEEECCCceeCCC
Confidence 99999974 5899999999876653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.8e-11 Score=109.76 Aligned_cols=144 Identities=24% Similarity=0.269 Sum_probs=111.4
Q ss_pred CCcccccCcccEEEEEeCCCCEEEEEEEeccch-hhHHHHHHHHHHHcCCCC--CceeceeEEEeeCC---eeEEEEecc
Q 013737 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT-QWVDHFFNEVNLISGINH--KNLVKLLGCSITGP---ESLLVYEFV 347 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~ 347 (437)
.+.|+.|..+.+|++...+|..+++|....... .....+.+|.+++..+.+ .++++++.+..... ..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 357899999999999987678899998754322 234578899999999875 44677777766542 568999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC---------------------------------------
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES--------------------------------------- 388 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--------------------------------------- 388 (437)
++.++.+.+.. ..++..+...++.++++.|..||+..
T Consensus 83 ~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 83 DGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99888775521 34677778888888999888888531
Q ss_pred --------------CCCeeeCCCCCCCeeeCC--CCcEEEcccCCcccc
Q 013737 389 --------------KLRIIHRDIKLSNILLDE--EFTAKIADFGLVRLF 421 (437)
Q Consensus 389 --------------~~~iiHrDlk~~NIll~~--~~~~ki~DFG~a~~~ 421 (437)
+..++|+|+.|.|||+++ ++.+.|+||+.+..-
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 244799999999999998 667899999988753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.3e-13 Score=119.05 Aligned_cols=138 Identities=23% Similarity=0.395 Sum_probs=114.6
Q ss_pred cCCcccccCcccEEEEEeCCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCC
Q 013737 273 ESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350 (437)
Q Consensus 273 ~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 350 (437)
...+|.+...|+.|+|+|+ |..+++|++... .......|..|.-.|+-+.||||..++|.|..+.+..++..||+.|
T Consensus 194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 3457888999999999998 456677776533 3444567999999999999999999999999999999999999999
Q ss_pred CccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 013737 351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIA 413 (437)
Q Consensus 351 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~ 413 (437)
+|+..|+.. ..-..+..++++++.++++||.|||+..+ -|..--|.+..++||++.+++|+
T Consensus 273 slynvlhe~-t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 273 SLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred HHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhhee
Confidence 999998543 23447888999999999999999999863 24445689999999999988775
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=5.1e-13 Score=131.66 Aligned_cols=142 Identities=28% Similarity=0.227 Sum_probs=116.5
Q ss_pred cccccCcccEEEEEe----CCCCEEEEEEEeccch--hhHHHHHHHHHHHcCCC-CCceeceeEEEeeCCeeEEEEeccC
Q 013737 276 KLGQGGSGSVYKGTL----PGGEAVAVKRLFYNTT--QWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVYEFVP 348 (437)
Q Consensus 276 ~Lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 348 (437)
.+|+|.||.|+++.- ..+..+|+|.+++... ........|..++..++ ||.++++.-.++.+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998752 3467788887754321 11124566788888887 9999999999999999999999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 349 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
+|+|...+. +...+++.....+...++.+++++|+.+ |+|||+|++||+++.+|++|+.|||+++..-+
T Consensus 81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~ 149 (612)
T KOG0603|consen 81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK 149 (612)
T ss_pred cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHh
Confidence 999988773 3344677777778888999999999988 99999999999999999999999999997644
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=5.1e-11 Score=101.26 Aligned_cols=134 Identities=21% Similarity=0.288 Sum_probs=101.2
Q ss_pred CcccccCcccEEEEEeCCCCEEEEEE-Eecc--ch-----hhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 275 NKLGQGGSGSVYKGTLPGGEAVAVKR-LFYN--TT-----QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~~~~~vavK~-~~~~--~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
..+++|+-+.++.+.+. |.++++|. +++. .+ -...+..+|+.++.+++--.|....=+..+++...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46789999999999775 44466664 2221 11 1234678899999988766666666667788888999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
++|..|.+.+... ...++..+-.-+.-||..+ |+|+||.++||++..+. +.++||||+..-.+
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~ 143 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSDE 143 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccccc
Confidence 9998888777322 2456677777788899998 99999999999998874 99999999986543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.6e-10 Score=97.72 Aligned_cols=144 Identities=23% Similarity=0.238 Sum_probs=106.0
Q ss_pred cCCcccccCcccEEEEEeCCCCEEEEEEE-ecc-------chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 273 ESNKLGQGGSGSVYKGTLPGGEAVAVKRL-FYN-------TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 273 ~~~~Lg~G~~g~V~~~~~~~~~~vavK~~-~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
....|-||+-+.|+++.+. |+...||.= .+. ..-...+..+|++++.++.--.|....-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5678899999999999987 666666642 211 1223467889999999887656655555677777788999
Q ss_pred eccCC-CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC---cEEEcccCCccc
Q 013737 345 EFVPN-QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF---TAKIADFGLVRL 420 (437)
Q Consensus 345 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~---~~ki~DFG~a~~ 420 (437)
||+++ .++.+++...-... ........++..|-+.+.-||..+ |||+||..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 36666664433222 222333678888999999999998 99999999999997654 468999999875
Q ss_pred c
Q 013737 421 F 421 (437)
Q Consensus 421 ~ 421 (437)
-
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 4
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.08 E-value=3.6e-10 Score=104.75 Aligned_cols=150 Identities=23% Similarity=0.291 Sum_probs=95.4
Q ss_pred CCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCC----------CceeceeEEEe
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINH----------KNLVKLLGCSI 335 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~ 335 (437)
.+...+.||.|+++.||.+++. +++++|||..... .....+++++|.-....+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3455778999999999999985 5899999987532 23346677777755554432 12222222221
Q ss_pred ---------eCC--------eeEEEEeccCCCCcccccc---ccCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeee
Q 013737 336 ---------TGP--------ESLLVYEFVPNQSLLDNLF---VRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394 (437)
Q Consensus 336 ---------~~~--------~~~lv~e~~~~g~L~~~l~---~~~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH 394 (437)
... +.+++|+-+ .++|.+++. ..... ..+....++.+..|+++.+++||+.+ ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 111 235677777 467776642 22221 12334445667789999999999998 999
Q ss_pred CCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 395 RDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 395 rDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
+||+|+|++++++|.++|+||+.....++
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~ 197 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGT 197 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTE
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCc
Confidence 99999999999999999999998766543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.8e-10 Score=107.85 Aligned_cols=89 Identities=31% Similarity=0.446 Sum_probs=70.8
Q ss_pred CCCceeceeEEEee---------------------------CCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHH
Q 013737 323 NHKNLVKLLGCSIT---------------------------GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIIL 375 (437)
Q Consensus 323 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~ 375 (437)
+|||||++.+.|.+ +...|+||..++ .+|.+++..+ ..+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC----CCchHHHHHHHH
Confidence 59999999988753 234688888774 5788877433 245666778899
Q ss_pred HHHHHHHHhhcCCCCCeeeCCCCCCCeee--CCCC--cEEEcccCCcc
Q 013737 376 STAEGLAYLHEESKLRIIHRDIKLSNILL--DEEF--TAKIADFGLVR 419 (437)
Q Consensus 376 ~i~~~l~yLH~~~~~~iiHrDlk~~NIll--~~~~--~~ki~DFG~a~ 419 (437)
|+++|+.|||.++ |.|||||++|||| |+|. .+.|+|||.+-
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceee
Confidence 9999999999998 9999999999998 4444 68899999864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.1e-09 Score=95.79 Aligned_cols=127 Identities=24% Similarity=0.265 Sum_probs=83.3
Q ss_pred cEEEEEeCCCCEEEEEEEeccc-------------h---------h----hHHHHHHHHHHHcCCCCC--ceeceeEEEe
Q 013737 284 SVYKGTLPGGEAVAVKRLFYNT-------------T---------Q----WVDHFFNEVNLISGINHK--NLVKLLGCSI 335 (437)
Q Consensus 284 ~V~~~~~~~~~~vavK~~~~~~-------------~---------~----~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 335 (437)
.||.|...+|..+|||..+... . . ......+|.+.|.++..- ++++++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899999889999999764210 0 0 123567899999999755 567777553
Q ss_pred eCCeeEEEEeccC--CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHH-hhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 013737 336 TGPESLLVYEFVP--NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY-LHEESKLRIIHRDIKLSNILLDEEFTAKI 412 (437)
Q Consensus 336 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~y-LH~~~~~~iiHrDlk~~NIll~~~~~~ki 412 (437)
...|||||++ |..+..+. ... ++......++.+++..+.. +|..+ |+|+||.+.|||++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~-~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLK-DVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHH-HCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHH-hcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 3479999998 54444322 111 1133455677777776655 56777 9999999999999988 9999
Q ss_pred cccCCccccCC
Q 013737 413 ADFGLVRLFPE 423 (437)
Q Consensus 413 ~DFG~a~~~~~ 423 (437)
+|||.+.....
T Consensus 148 IDf~qav~~~~ 158 (188)
T PF01163_consen 148 IDFGQAVDSSH 158 (188)
T ss_dssp --GTTEEETTS
T ss_pred EecCcceecCC
Confidence 99999876654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=5.4e-11 Score=123.74 Aligned_cols=143 Identities=22% Similarity=0.191 Sum_probs=113.3
Q ss_pred CCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccc-hhhHHHHHHHHHH--HcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 270 YFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT-TQWVDHFFNEVNL--ISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
++...+.||.+.|=+|.+++++.|. |+||++.+.. .-..+.|.++++- ...++|||.+.+.-+-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5677889999999999999998887 8999875443 3334444444332 4556899999988877777778888899
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
.. .+|.+.+. -+.-+...+..-|+.|++.||.-.|..+ |.|+|||.+||||+.=.=+.|+||.--|.
T Consensus 103 vk-hnLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKP 169 (1431)
T KOG1240|consen 103 VK-HNLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKP 169 (1431)
T ss_pred Hh-hhhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCC
Confidence 85 57888772 2233677788889999999999999998 99999999999999887889999976553
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.9e-09 Score=97.96 Aligned_cols=141 Identities=15% Similarity=0.088 Sum_probs=98.7
Q ss_pred CcccccCcccEEEEEeCCCCEEEEEEEeccchh-hH----------HHHHHHHHHHcCCCCCc--eeceeEEEee-----
Q 013737 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQ-WV----------DHFFNEVNLISGINHKN--LVKLLGCSIT----- 336 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~E~~~l~~l~h~n--iv~l~~~~~~----- 336 (437)
+.+-+.....|++..+. |+.+.||+....... .. ..+.+|...+.++...+ .+.++++...
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 34444444457776664 678999976432211 11 14778988888775333 3455555543
Q ss_pred CCeeEEEEeccCCC-CccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC-------CC
Q 013737 337 GPESLLVYEFVPNQ-SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-------EF 408 (437)
Q Consensus 337 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~-------~~ 408 (437)
....+||||++++. +|.+++.... ..+.+......++.+++..+.-||..| |+|+||+++|||++. +.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence 23468999999876 7877763211 234556677889999999999999998 999999999999975 46
Q ss_pred cEEEcccCCccc
Q 013737 409 TAKIADFGLVRL 420 (437)
Q Consensus 409 ~~ki~DFG~a~~ 420 (437)
.+.++||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 899999998864
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=9.2e-10 Score=108.59 Aligned_cols=100 Identities=35% Similarity=0.599 Sum_probs=90.3
Q ss_pred HcCCCCCceeceeEEEeeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCC
Q 013737 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIK 398 (437)
Q Consensus 319 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk 398 (437)
|+.+.|.|+.+++|.+.++...++|.+|++.|+|.+.+.. ....++|.-...++++|+.||.|||... . ..|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP-I-GYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeeec
Confidence 4678999999999999999999999999999999999854 3456899999999999999999999863 2 3999999
Q ss_pred CCCeeeCCCCcEEEcccCCccccC
Q 013737 399 LSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 399 ~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
+.|.++|....+||+|||+..+..
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~ 100 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLE 100 (484)
T ss_pred cccceeeeeEEEEechhhhccccc
Confidence 999999999999999999988774
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.9e-10 Score=116.99 Aligned_cols=152 Identities=28% Similarity=0.372 Sum_probs=122.1
Q ss_pred hcCCCcCCcccccCcccEEEEEeCC--CCEEEEEEEecc--chhhHHHHHHHHHHHcCCC-CCceeceeEEEeeCCeeEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPG--GEAVAVKRLFYN--TTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 342 (437)
...|...+.||+|+|+.|-...... ...+|+|.+... .....+....|..+-..+. |+|++++++.....+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 4567778889999999998887533 445666665433 2334455566777777777 9999999999999999999
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCCCeeeCCCCCCCeeeCCCC-cEEEcccCCccc
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH-EESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRL 420 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH-~~~~~~iiHrDlk~~NIll~~~~-~~ki~DFG~a~~ 420 (437)
++||..++++.+.+. .......+....-.++.|+..++.|+| ..+ +.||||||+|.+++..+ .+|++|||+|..
T Consensus 99 ~~~~s~g~~~f~~i~-~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKIS-HPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCcccccccccccc-cCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999988763 122224566677789999999999999 776 99999999999999999 999999999998
Q ss_pred cCC
Q 013737 421 FPE 423 (437)
Q Consensus 421 ~~~ 423 (437)
+..
T Consensus 175 ~~~ 177 (601)
T KOG0590|consen 175 YRN 177 (601)
T ss_pred ccc
Confidence 876
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.2e-08 Score=92.06 Aligned_cols=138 Identities=21% Similarity=0.187 Sum_probs=98.3
Q ss_pred CCcCCcccccCcccEEEEEeCCCCEEEEEEEeccch------------------h----hHHHHHHHHHHHcCCCCC--c
Q 013737 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT------------------Q----WVDHFFNEVNLISGINHK--N 326 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~----~~~~~~~E~~~l~~l~h~--n 326 (437)
..+.++||.|.-+.||.|..+.|.++|||.=+.... . .....++|.+.|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 456789999999999999999999999995421110 1 123467899999998754 7
Q ss_pred eeceeEEEeeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC
Q 013737 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE 406 (437)
Q Consensus 327 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~ 406 (437)
+++.+++ +...+|||+++|-.|...- ++....-.++..|++-+.-+-..| |||+|+.+-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 7777764 4568999999987665422 112223333444444444333445 999999999999999
Q ss_pred CCcEEEcccCCccccCC
Q 013737 407 EFTAKIADFGLVRLFPE 423 (437)
Q Consensus 407 ~~~~ki~DFG~a~~~~~ 423 (437)
+|.+.++||--+-....
T Consensus 238 dg~~~vIDwPQ~v~~~h 254 (304)
T COG0478 238 DGDIVVIDWPQAVPISH 254 (304)
T ss_pred CCCEEEEeCcccccCCC
Confidence 99999999987765443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.7e-08 Score=98.15 Aligned_cols=140 Identities=24% Similarity=0.335 Sum_probs=112.8
Q ss_pred ccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEee----CCeeEEEEeccCC-CCccccc
Q 013737 283 GSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT----GPESLLVYEFVPN-QSLLDNL 356 (437)
Q Consensus 283 g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-g~L~~~l 356 (437)
.+.|++.. .+|..+++|+++.+..+.......-+++++++.|+|+|++.+++.. ...+++|++|+++ ++|.++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 57899985 5799999999965544444444556889999999999999998873 3467899999985 4666654
Q ss_pred cccC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 357 FVRQ------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 357 ~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
+... .....++..++.++.|+..||.++|+.| +.-+-|.|++||++.+.+++|+.-|+...+.++
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 4321 1234788999999999999999999998 888999999999999999999999998887766
Q ss_pred C
Q 013737 425 I 425 (437)
Q Consensus 425 ~ 425 (437)
.
T Consensus 447 ~ 447 (655)
T KOG3741|consen 447 P 447 (655)
T ss_pred C
Confidence 5
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=9.7e-09 Score=102.73 Aligned_cols=121 Identities=18% Similarity=0.194 Sum_probs=100.0
Q ss_pred CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCCCccccccccCCCCCCCHHHH
Q 013737 291 PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVR 370 (437)
Q Consensus 291 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~ 370 (437)
.++.+|.|...+...........+-++.|+.++||||++++......+..|||+|.+. .|..++.. +.....
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~v 106 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEEV 106 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHHH
Confidence 4578888888876655556667888899999999999999999999999999999884 45555521 335566
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 371 ~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
.-.+.||+.||.|||+.+ .++|++|.-..|++++.|+.||.+|-++...
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~ 155 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKA 155 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence 677899999999999765 5999999999999999999999999887543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.72 E-value=9.7e-08 Score=96.02 Aligned_cols=144 Identities=17% Similarity=0.205 Sum_probs=94.7
Q ss_pred CcccccCcccEEEEEeCCCCEEEEEEEeccchhhH------------------------------H----------HHHH
Q 013737 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWV------------------------------D----------HFFN 314 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~------------------------------~----------~~~~ 314 (437)
+.|+.++-|.||+|++++|+.||||+.+++-.... + .+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67999999999999999999999998765422110 1 1233
Q ss_pred HHHHHcCC----C-CCceeceeEEEeeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 013737 315 EVNLISGI----N-HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389 (437)
Q Consensus 315 E~~~l~~l----~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~ 389 (437)
|..-+.++ + .|++.-..=++.-.....|+|||++|..+.+....+. ..++...+.....++. +..+-..+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia~~~~~~f--~~q~~~dg- 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKELAELLVRAF--LRQLLRDG- 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHHHHHHHHHHH--HHHHHhcC-
Confidence 43333333 2 3433322223334566789999999999888753322 3355444333333322 22222345
Q ss_pred CCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCC
Q 013737 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (437)
Q Consensus 390 ~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~ 425 (437)
++|.|..|.||+++.++++.+.|||+...+++..
T Consensus 286 --ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~~ 319 (517)
T COG0661 286 --FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPKF 319 (517)
T ss_pred --ccccCCCccceEEecCCcEEEEcCcceecCCHHH
Confidence 9999999999999999999999999998876543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.71 E-value=5.3e-08 Score=87.31 Aligned_cols=108 Identities=23% Similarity=0.237 Sum_probs=83.3
Q ss_pred HHHHHHHHHHHcCCC--CCceeceeEEEeeCC----eeEEEEeccCCC-CccccccccCCCCCCCHHHHHHHHHHHHHHH
Q 013737 309 VDHFFNEVNLISGIN--HKNLVKLLGCSITGP----ESLLVYEFVPNQ-SLLDNLFVRQDVEPLSWEVRYKIILSTAEGL 381 (437)
Q Consensus 309 ~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l 381 (437)
..+..+|...+..|. .-..++.+++..... ..+||+|++++. +|.+++.... ..+......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHH
Confidence 346778888777765 334556667665532 358999999874 7887773311 255667788999999999
Q ss_pred HHhhcCCCCCeeeCCCCCCCeeeCCCC---cEEEcccCCccccC
Q 013737 382 AYLHEESKLRIIHRDIKLSNILLDEEF---TAKIADFGLVRLFP 422 (437)
Q Consensus 382 ~yLH~~~~~~iiHrDlk~~NIll~~~~---~~ki~DFG~a~~~~ 422 (437)
.-||+.+ |+|+|+++.|||++.+. .+.++||+-++...
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999998 99999999999999886 89999999887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.1e-08 Score=104.74 Aligned_cols=111 Identities=24% Similarity=0.356 Sum_probs=76.6
Q ss_pred hcCCCcCCcccccCcccEEEEEeCC-CCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
..+|...++|..|+||.||..+++. .+.+|+|+-+.+. +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l------ilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL------ILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccch------hhhc--cccccCCccee------------------
Confidence 3578889999999999999999764 6778884322110 0000 22333334333
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
|+-...+ +..++++... +.+++|||+.+ |+|||+||+|.+|+.-|++|+.|||+++..
T Consensus 136 ---gDc~tll---k~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 ---GDCATLL---KNIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred ---chhhhhc---ccCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhh
Confidence 3333333 2223344322 67899999988 999999999999999999999999998854
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.59 E-value=3.4e-08 Score=97.83 Aligned_cols=151 Identities=23% Similarity=0.275 Sum_probs=118.8
Q ss_pred cCCCcCCcccc--cCcccEEEEEe---CCCCEEEEEEEe--ccchhhHHHHHHHHHHHcCCC-CCceeceeEEEeeCCee
Q 013737 269 NYFHESNKLGQ--GGSGSVYKGTL---PGGEAVAVKRLF--YNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPES 340 (437)
Q Consensus 269 ~~~~~~~~Lg~--G~~g~V~~~~~---~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 340 (437)
+.|...+.+|. |.+|.+|.+.. .++..+|+|+-+ ...+.....=.+|+....+++ |+|.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34667788999 99999999987 357889999743 222333334456777777775 99999999999999999
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHH----HHHHhhcCCCCCeeeCCCCCCCeeeCCC-CcEEEccc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE----GLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADF 415 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~----~l~yLH~~~~~~iiHrDlk~~NIll~~~-~~~ki~DF 415 (437)
++-+|++. .+|..+... ...-++....+.+..+... ||.++|+.. ++|-|+||.||++..+ ...+++||
T Consensus 194 fiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999984 677665532 2233667777888888888 999999987 9999999999999999 89999999
Q ss_pred CCccccCCCC
Q 013737 416 GLVRLFPEDI 425 (437)
Q Consensus 416 G~a~~~~~~~ 425 (437)
|+...+.+..
T Consensus 268 ~~v~~i~~~~ 277 (524)
T KOG0601|consen 268 GLVSKISDGN 277 (524)
T ss_pred ceeEEccCCc
Confidence 9998876543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.58 E-value=6.2e-07 Score=79.19 Aligned_cols=139 Identities=22% Similarity=0.159 Sum_probs=99.8
Q ss_pred ccccCcccEEEEEeCCCCEEEEEEEecc------chhhHHHHHHHHHHHcCCCC--CceeceeEEEeeCC----eeEEEE
Q 013737 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYN------TTQWVDHFFNEVNLISGINH--KNLVKLLGCSITGP----ESLLVY 344 (437)
Q Consensus 277 Lg~G~~g~V~~~~~~~~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~----~~~lv~ 344 (437)
-|+||.+-|++-...+ ..+-+|+-... -+.....|.+|+..+.+|.. -.++++........ .-+||+
T Consensus 26 ~~rgG~SgV~r~~~~g-~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERNG-KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeCC-cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 4678899999987764 46888876411 12345679999999888853 23455552222211 357999
Q ss_pred eccCC-CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCc--EEEcccCCccc
Q 013737 345 EFVPN-QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT--AKIADFGLVRL 420 (437)
Q Consensus 345 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~--~ki~DFG~a~~ 420 (437)
|-+++ .+|.+++.. ....+.+......++.+++..+.-||+.+ +.|+|+.+.||+++.++. ++++||--++.
T Consensus 105 e~L~g~~~L~~~l~~-~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQ-HAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhc-CCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97754 467666632 22335677778899999999999999998 999999999999986666 99999987664
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.55 E-value=8.8e-07 Score=80.51 Aligned_cols=140 Identities=15% Similarity=0.167 Sum_probs=84.4
Q ss_pred CcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCc--eeceeEEEeeCCeeEEEEeccCCCC-
Q 013737 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN--LVKLLGCSITGPESLLVYEFVPNQS- 351 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~- 351 (437)
.+||+|..+.||+.. +..+++|...... ......+|.+++..+..-. +++.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~~---~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTHK---TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEec---CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 578999999999842 4567788775432 2345688999998876433 4677777777777889999999863
Q ss_pred ccccccc-------------------cC-CCCCCCHHHHH-HHHH----------HHHH-HHHHhhcC-CCCCeeeCCCC
Q 013737 352 LLDNLFV-------------------RQ-DVEPLSWEVRY-KIIL----------STAE-GLAYLHEE-SKLRIIHRDIK 398 (437)
Q Consensus 352 L~~~l~~-------------------~~-~~~~l~~~~~~-~i~~----------~i~~-~l~yLH~~-~~~~iiHrDlk 398 (437)
+.+.+.. +. ........... .+-. .+.. ...+|... ....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 2111100 00 00011111000 0000 0001 11222211 23457899999
Q ss_pred CCCeeeCCCCcEEEcccCCccc
Q 013737 399 LSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 399 ~~NIll~~~~~~ki~DFG~a~~ 420 (437)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.5e-08 Score=98.73 Aligned_cols=93 Identities=30% Similarity=0.392 Sum_probs=77.9
Q ss_pred eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCc
Q 013737 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (437)
Q Consensus 339 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a 418 (437)
..+|.|+++...+|.+++..+......++...+.++.|++.|++| ++ .+|||+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999777667778999999999999999999 55 899999999999999999999999998
Q ss_pred cccCCCC-----cceeeeecccCC
Q 013737 419 RLFPEDI-----THISATLAGTLF 437 (437)
Q Consensus 419 ~~~~~~~-----~~~~~~~~Gt~~ 437 (437)
....... ....+...||.+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~ 427 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLL 427 (516)
T ss_pred eecccCCcccchhhhhhhcccccc
Confidence 8776555 222344556653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.53 E-value=3.4e-08 Score=97.83 Aligned_cols=148 Identities=23% Similarity=0.256 Sum_probs=115.6
Q ss_pred HhcCCCcCCcccccCcccEEEEEe--CCCCEEEEEEEeccchhhHHH--HHHHHHHHcCC-CCCceeceeEEEeeCCeeE
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTL--PGGEAVAVKRLFYNTTQWVDH--FFNEVNLISGI-NHKNLVKLLGCSITGPESL 341 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 341 (437)
...+|.....||.|.|+.|++... .++..+++|.+.........+ -..|+.+...+ .|.+++.....+......+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 445788899999999999999874 457788999876543332222 23455555555 4888999888888888888
Q ss_pred EEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC-CcEEEcccCCccc
Q 013737 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRL 420 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~-~~~ki~DFG~a~~ 420 (437)
+-.||++++++.... .-...+++..++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||....
T Consensus 343 ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 999999999886654 22234677888999999999999999877 9999999999999886 7889999998863
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.1e-07 Score=80.99 Aligned_cols=62 Identities=34% Similarity=0.319 Sum_probs=52.6
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 350 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
|+|.+++..+ ..++++.++..|+.|++.||.|||+.+ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~ 62 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE 62 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc
Confidence 5787877432 346999999999999999999999864 999999999999999 9999876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=7.2e-08 Score=88.62 Aligned_cols=97 Identities=22% Similarity=0.249 Sum_probs=81.2
Q ss_pred HHHHcCCCCCceeceeEEEeeCC-----eeEEEEeccCCCCccccccccCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 013737 316 VNLISGINHKNLVKLLGCSITGP-----ESLLVYEFVPNQSLLDNLFVRQD-VEPLSWEVRYKIILSTAEGLAYLHEESK 389 (437)
Q Consensus 316 ~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~ 389 (437)
+.-|.++.|.|||+++.++.+.. ...+++|||+.|++..+|.+.+. ...+......+|+-||+.||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 34455667999999999887543 46899999999999999865433 345778888899999999999999986
Q ss_pred CCeeeCCCCCCCeeeCCCCcEEEc
Q 013737 390 LRIIHRDIKLSNILLDEEFTAKIA 413 (437)
Q Consensus 390 ~~iiHrDlk~~NIll~~~~~~ki~ 413 (437)
++|+|+++..+-|++..++-+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred CccccCCcchhheeecCCceEEec
Confidence 789999999999999999988874
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.5e-06 Score=76.47 Aligned_cols=155 Identities=21% Similarity=0.209 Sum_probs=100.1
Q ss_pred cCHHHHHHHhcCCCcCCcc---cccCcccEEEEEeCCCCEEEEEEEeccchhhH------------------------HH
Q 013737 259 FSYETLEKATNYFHESNKL---GQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWV------------------------DH 311 (437)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~L---g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~------------------------~~ 311 (437)
.+.+.+....+...+.... ..|.-+.||+|...++..+|||+.+....... ..
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 4455566665555555554 45666789999988899999998854322111 11
Q ss_pred HHHHHHHHcCCC--CCceeceeEEEeeCCeeEEEEeccCCCCc-cccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 013737 312 FFNEVNLISGIN--HKNLVKLLGCSITGPESLLVYEFVPNQSL-LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388 (437)
Q Consensus 312 ~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~ 388 (437)
..+|+.-|.++. +-.+++.+++. .-.|||||+..... .-.| +..++...+...+..++++.+.-|-...
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence 245555555553 34455555443 34799999964311 1111 1122333356777788888888776632
Q ss_pred CCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 389 ~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
++||+||+.=|||+. ++.+.|+|||-|-....+
T Consensus 187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred --CcccccchhhheEEE-CCeEEEEECccccccCCC
Confidence 399999999999999 779999999998766543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.37 E-value=6.5e-06 Score=73.06 Aligned_cols=137 Identities=15% Similarity=0.119 Sum_probs=86.6
Q ss_pred hcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHH---------HHHHHHHHcCCC---CCceeceeEEEe
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDH---------FFNEVNLISGIN---HKNLVKLLGCSI 335 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~---h~niv~l~~~~~ 335 (437)
..+|...+.+-......|.+-..+ |..+++|..........+. ..+++..+.+++ -.....++.+..
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 456777777777766666666555 6788888775443222111 123333333332 122222222222
Q ss_pred -----eCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 013737 336 -----TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410 (437)
Q Consensus 336 -----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ 410 (437)
-....+|+|||++|..|.+.. .+++ .+...+.+.+.-||..| +.|+|..|.|++++++ .+
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~-------~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i 173 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIE-------DIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GI 173 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccch-------hcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cE
Confidence 223456899999998886643 1222 24455677899999998 9999999999999966 59
Q ss_pred EEcccCCccc
Q 013737 411 KIADFGLVRL 420 (437)
Q Consensus 411 ki~DFG~a~~ 420 (437)
+++||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 9999988764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.33 E-value=4.5e-06 Score=76.95 Aligned_cols=142 Identities=18% Similarity=0.142 Sum_probs=85.7
Q ss_pred cccccCc-ccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCC-CCceeceeEEEeeCCeeEEEEeccCCCCcc
Q 013737 276 KLGQGGS-GSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVYEFVPNQSLL 353 (437)
Q Consensus 276 ~Lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 353 (437)
.|..|.. ..||+.... +..+.||...... ...+.+|++++..+. +--+++++++....+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3555555 688998765 4678888875432 335667888887774 344667787777666789999999988776
Q ss_pred cccc-------------------ccCC-CCCCCHH--HHHHHHH--------------------HHHHHHHHhhc----C
Q 013737 354 DNLF-------------------VRQD-VEPLSWE--VRYKIIL--------------------STAEGLAYLHE----E 387 (437)
Q Consensus 354 ~~l~-------------------~~~~-~~~l~~~--~~~~i~~--------------------~i~~~l~yLH~----~ 387 (437)
.... .... ..++... ....... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4321 0000 0011100 0000000 01111122211 1
Q ss_pred CCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 388 ~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
.++.++|+|+.|.|||++++....|+||+.+..-
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g 194 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVA 194 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccccc
Confidence 2345899999999999999877899999988643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.32 E-value=3e-06 Score=77.15 Aligned_cols=145 Identities=20% Similarity=0.184 Sum_probs=84.2
Q ss_pred CCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCC--ceeceeEEEee---CCeeEEEEeccC
Q 013737 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHK--NLVKLLGCSIT---GPESLLVYEFVP 348 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~e~~~ 348 (437)
.+.|+.|..+.||+....+ ..+++|..... .....+.+|..++..+... .+++++..... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3578999999999999887 68999987544 4456777888888777532 35667764432 334689999999
Q ss_pred CCCcccc----------------c---ccc-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHhhc
Q 013737 349 NQSLLDN----------------L---FVR-QDVEPLSWEV---------RYKI------------ILSTAE-GLAYLHE 386 (437)
Q Consensus 349 ~g~L~~~----------------l---~~~-~~~~~l~~~~---------~~~i------------~~~i~~-~l~yLH~ 386 (437)
+..+... + +.. ....+..+.. .... ...+.+ .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 8877660 0 000 0111111100 0000 011122 2333332
Q ss_pred ----CCCCCeeeCCCCCCCeeeC-CCCcEEEcccCCcccc
Q 013737 387 ----ESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRLF 421 (437)
Q Consensus 387 ----~~~~~iiHrDlk~~NIll~-~~~~~ki~DFG~a~~~ 421 (437)
..+..++|+|+.|.|||++ +++.+-|+||+.+...
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 1335599999999999999 6666789999987643
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.28 E-value=3.6e-06 Score=74.00 Aligned_cols=105 Identities=25% Similarity=0.198 Sum_probs=82.5
Q ss_pred HHHHHHHcCCCC-CceeceeEEEeeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 013737 313 FNEVNLISGINH-KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391 (437)
Q Consensus 313 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ 391 (437)
..|.-+|..+++ +++++++|+| ..++|.||...+++......-...-..+|..+.+|+.++++.+++|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357888888876 6999999998 34789999987766432100012224689999999999999999999864445
Q ss_pred eeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 392 iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
+.-.|++|+|+-+++++++|++|...+-..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999876544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.2e-05 Score=86.89 Aligned_cols=80 Identities=11% Similarity=0.241 Sum_probs=57.9
Q ss_pred CCcccccCcccEEEEEeCCC---CEEEEEEEeccc-hhhHHHHHHHHHHHcCCC-CCce--eceeEEEeeC---CeeEEE
Q 013737 274 SNKLGQGGSGSVYKGTLPGG---EAVAVKRLFYNT-TQWVDHFFNEVNLISGIN-HKNL--VKLLGCSITG---PESLLV 343 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv 343 (437)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|.++|+.+. |+++ ++++.++.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999887653 367777764332 123456889999999985 6665 7778777654 457899
Q ss_pred EeccCCCCcc
Q 013737 344 YEFVPNQSLL 353 (437)
Q Consensus 344 ~e~~~~g~L~ 353 (437)
|||++|..+.
T Consensus 123 ME~v~G~~~~ 132 (822)
T PLN02876 123 MEYLEGRIFV 132 (822)
T ss_pred EEecCCcccC
Confidence 9999876543
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.25 E-value=7.5e-06 Score=82.29 Aligned_cols=142 Identities=17% Similarity=0.180 Sum_probs=92.8
Q ss_pred CCcccccCcccEEEEEeCCCCEEEEEEEeccchhh-------------------------------HH------HHHHHH
Q 013737 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQW-------------------------------VD------HFFNEV 316 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------------------------------~~------~~~~E~ 316 (437)
.+.||.-+.|.||+|++++|+.||||+-++.-... .+ +|.+|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 46799999999999999999999999765432111 01 133333
Q ss_pred HHH----cCCCCCc------eeceeEEEeeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 013737 317 NLI----SGINHKN------LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386 (437)
Q Consensus 317 ~~l----~~l~h~n------iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~ 386 (437)
+-. ..+.|-+ |++++- .-.....|+||||+|..+.+.-...+ ..++...+..-+.+...-+-+-|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~i~~~l~~~~~~qIf~~- 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDK--RGISPHDILNKLVEAYLEQIFKT- 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHH--cCCCHHHHHHHHHHHHHHHHHhc-
Confidence 322 2233444 333332 22346789999999998877643322 23565555555444433333333
Q ss_pred CCCCCeeeCCCCCCCeeeCC----CCcEEEcccCCccccCCC
Q 013737 387 ESKLRIIHRDIKLSNILLDE----EFTAKIADFGLVRLFPED 424 (437)
Q Consensus 387 ~~~~~iiHrDlk~~NIll~~----~~~~ki~DFG~a~~~~~~ 424 (437)
| ++|.|=.|.||++.. ++++.+-|||+...+...
T Consensus 321 -G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 321 -G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred -C---CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 4 899999999999983 678999999998876543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.21 E-value=2e-05 Score=69.71 Aligned_cols=137 Identities=21% Similarity=0.266 Sum_probs=92.4
Q ss_pred CcCCcccccCcccEEEEEeCCCCEEEEEEEeccc----------------hhhHHHHHHHHHHHcCCC------CCceec
Q 013737 272 HESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT----------------TQWVDHFFNEVNLISGIN------HKNLVK 329 (437)
Q Consensus 272 ~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~ 329 (437)
+....||+|+.-.||. +++....+||+..... ....++..+|+.-...+. +.+|.+
T Consensus 4 ~~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 4 SESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CCCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 4567899999988886 4555667888886554 122455666766554444 889999
Q ss_pred eeEEEeeCCeeEEEEeccCC--C----CccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCee
Q 013737 330 LLGCSITGPESLLVYEFVPN--Q----SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNIL 403 (437)
Q Consensus 330 l~~~~~~~~~~~lv~e~~~~--g----~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIl 403 (437)
++|+.+++...-+|+|.+.+ | +|.+++ ....++. .....+. +-..||-+.. |+.+||+|.||+
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l----~~~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv 150 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYL----KEGGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIV 150 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHH----HcCCccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEE
Confidence 99999999999999998753 2 344444 2233554 3333333 3345666665 999999999999
Q ss_pred eCCC---C-cEEEcc-cCCcccc
Q 013737 404 LDEE---F-TAKIAD-FGLVRLF 421 (437)
Q Consensus 404 l~~~---~-~~ki~D-FG~a~~~ 421 (437)
+... . .+.|+| ||-...+
T Consensus 151 ~~~~~~~~~~lvlIDG~G~~~~i 173 (199)
T PF10707_consen 151 VQRRDSGEFRLVLIDGLGEKELI 173 (199)
T ss_pred EEecCCCceEEEEEeCCCCcccc
Confidence 9532 2 577777 5655543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.09 E-value=6.6e-05 Score=71.25 Aligned_cols=78 Identities=9% Similarity=-0.036 Sum_probs=56.5
Q ss_pred CcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCC---CceeceeEEEee---CCeeEEEEe
Q 013737 272 HESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH---KNLVKLLGCSIT---GPESLLVYE 345 (437)
Q Consensus 272 ~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~---~~~~~lv~e 345 (437)
...+.||.|..+.||+....+++ +.+|..+... ....+..|.+.|+.|.- ..++++++++.. .+..+||||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGN-PMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCCC-EEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 44678999999999999876554 5666643211 23478889998887752 467888887754 356899999
Q ss_pred ccCCCCc
Q 013737 346 FVPNQSL 352 (437)
Q Consensus 346 ~~~~g~L 352 (437)
++++.++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998765
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.06 E-value=3.3e-05 Score=70.79 Aligned_cols=75 Identities=13% Similarity=0.259 Sum_probs=46.2
Q ss_pred CcccccCcc-cEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCC---ceeceeEEEeeCC---eeEEEEecc
Q 013737 275 NKLGQGGSG-SVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHK---NLVKLLGCSITGP---ESLLVYEFV 347 (437)
Q Consensus 275 ~~Lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~---~~~lv~e~~ 347 (437)
+.|+.|+.. .||+. +..+++|..... .....+.+|.+++..+... .+.++++.....+ ..+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457777666 58875 234667764432 2245788899988777532 3444554433322 348899999
Q ss_pred CCCCcccc
Q 013737 348 PNQSLLDN 355 (437)
Q Consensus 348 ~~g~L~~~ 355 (437)
+|.++.+.
T Consensus 77 ~G~~l~~~ 84 (235)
T cd05155 77 EGETATAA 84 (235)
T ss_pred cCCCCCcc
Confidence 99877543
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.0001 Score=64.70 Aligned_cols=125 Identities=27% Similarity=0.402 Sum_probs=88.5
Q ss_pred cCCCcCCcccccCc-ccEEEEEeCCCCEEEEEEEec---cch------------------hhHHHHHHHHHHHcCCC---
Q 013737 269 NYFHESNKLGQGGS-GSVYKGTLPGGEAVAVKRLFY---NTT------------------QWVDHFFNEVNLISGIN--- 323 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~-g~V~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~l~--- 323 (437)
.+++..+.||.|.. |.||+++.. |+.+|+|.... ... ....-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888899999999 999999987 67999999321 100 12345888998877775
Q ss_pred CCce--eceeEEEeeCC------------------eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHH
Q 013737 324 HKNL--VKLLGCSITGP------------------ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383 (437)
Q Consensus 324 h~ni--v~l~~~~~~~~------------------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~y 383 (437)
+.++ |+.+|+..-.. ...||.||++... .+.... +.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~~----~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIRD----IPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchhH----HHHHHHHHHH
Confidence 4556 89999874221 1246777665422 123333 4556667888
Q ss_pred hhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCc
Q 013737 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (437)
Q Consensus 384 LH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a 418 (437)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99887 999999999987 5689999865
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.86 E-value=9.4e-05 Score=67.68 Aligned_cols=141 Identities=20% Similarity=0.207 Sum_probs=80.5
Q ss_pred CcccccCcccEEEEEeCC--CCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCc-eeceeEEEeeCCeeEEEEeccCCCC
Q 013737 275 NKLGQGGSGSVYKGTLPG--GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN-LVKLLGCSITGPESLLVYEFVPNQS 351 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g~ 351 (437)
+.|..|-...+|+....+ +..+++|........ .....+|+.++..+...+ .+++++... ..++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 467778888999998764 678888876543222 122346888887774333 344444332 248999999876
Q ss_pred ccccc-----------------cccCCC--------CCC-CHHHHHHHH-------------------------HHHHHH
Q 013737 352 LLDNL-----------------FVRQDV--------EPL-SWEVRYKII-------------------------LSTAEG 380 (437)
Q Consensus 352 L~~~l-----------------~~~~~~--------~~l-~~~~~~~i~-------------------------~~i~~~ 380 (437)
+.... +..... ... .+..+..+. .+.+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 63220 000000 011 111211111 111111
Q ss_pred HH-HhhcC-CCCCeeeCCCCCCCeeeCC-CCcEEEcccCCccc
Q 013737 381 LA-YLHEE-SKLRIIHRDIKLSNILLDE-EFTAKIADFGLVRL 420 (437)
Q Consensus 381 l~-yLH~~-~~~~iiHrDlk~~NIll~~-~~~~ki~DFG~a~~ 420 (437)
|. .+-.. .+..++|+|+.+.|||+++ +..+.|+||..|..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 11 11111 2345999999999999998 57899999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00012 Score=62.27 Aligned_cols=130 Identities=16% Similarity=0.171 Sum_probs=86.1
Q ss_pred CcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCcee-ceeEEEeeCCeeEEEEeccCCC
Q 013737 272 HESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV-KLLGCSITGPESLLVYEFVPNQ 350 (437)
Q Consensus 272 ~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g 350 (437)
...+.|++|.+|.||++.+. |..+|+|.-..+++ ...++.|.++|..+...++. +++.+. ..++.|||+.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence 34578999999999999998 45888887655443 45788999999988766554 344443 335669999988
Q ss_pred CccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCC-CCCeeeCCCCcEEEcccCCcccc
Q 013737 351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIK-LSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 351 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk-~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
+|.+.... .+..++.. +++.---|-..| |-|..|. |..++|-++..+.|+||.-|+.-
T Consensus 98 ~L~~~~~~------~~rk~l~~----vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 98 PLGKLEIG------GDRKHLLR----VLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred chhhhhhc------ccHHHHHH----HHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 88664411 12333333 333322233334 8888875 44455555559999999998844
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00012 Score=68.02 Aligned_cols=139 Identities=14% Similarity=0.104 Sum_probs=78.1
Q ss_pred cccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCce-eceeEEEeeCCeeEEEEeccCCCCccc
Q 013737 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL-VKLLGCSITGPESLLVYEFVPNQSLLD 354 (437)
Q Consensus 276 ~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L~~ 354 (437)
.+..|-.+.+|+... ++..+++|..........-...+|.++++.+....+ ++++.... .++||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 355677889998874 466788887543322211134678888888754333 44444332 369999999876643
Q ss_pred c-----------------ccccC-CCCCCCHHHH-HHHHHHH---------HHHHHHhhcC-----CCCCeeeCCCCCCC
Q 013737 355 N-----------------LFVRQ-DVEPLSWEVR-YKIILST---------AEGLAYLHEE-----SKLRIIHRDIKLSN 401 (437)
Q Consensus 355 ~-----------------l~~~~-~~~~l~~~~~-~~i~~~i---------~~~l~yLH~~-----~~~~iiHrDlk~~N 401 (437)
. ++... ...+++.... ..+..++ ..-+..+-.. .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 2 00000 0111222111 1111111 1112222111 12358999999999
Q ss_pred eeeCCCCcEEEcccCCccc
Q 013737 402 ILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 402 Ill~~~~~~ki~DFG~a~~ 420 (437)
|++++++ +.|+||..|..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00034 Score=68.64 Aligned_cols=76 Identities=16% Similarity=0.156 Sum_probs=54.9
Q ss_pred CCcccccCcccEEEEEeCCC-CEEEEEEEecc-----c--hhhHHHHHHHHHHHcCCC---CCceeceeEEEeeCCeeEE
Q 013737 274 SNKLGQGGSGSVYKGTLPGG-EAVAVKRLFYN-----T--TQWVDHFFNEVNLISGIN---HKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l 342 (437)
.+.||.|.+..||++...+| +.++||.-... . +...+++..|.+.|..+. ..++++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 45799999999999998776 58999985311 1 224567778888877753 3467778776 4456789
Q ss_pred EEeccCCCC
Q 013737 343 VYEFVPNQS 351 (437)
Q Consensus 343 v~e~~~~g~ 351 (437)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.002 Score=61.88 Aligned_cols=143 Identities=14% Similarity=0.146 Sum_probs=75.9
Q ss_pred CCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCC--CCceeceeE------EEeeCCeeEEEEe
Q 013737 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN--HKNLVKLLG------CSITGPESLLVYE 345 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~------~~~~~~~~~lv~e 345 (437)
.+.|+.|....+|+....+| .+++|+..... .+....|..++..|. .-.+++.+. +....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 35567777789999887655 67888775212 223334444444442 112333332 1223456789999
Q ss_pred ccCCCCcccc--------------ccccCC--------CCCCCH-HHHHH------------HHHH-HHHHHHHhhcC--
Q 013737 346 FVPNQSLLDN--------------LFVRQD--------VEPLSW-EVRYK------------IILS-TAEGLAYLHEE-- 387 (437)
Q Consensus 346 ~~~~g~L~~~--------------l~~~~~--------~~~l~~-~~~~~------------i~~~-i~~~l~yLH~~-- 387 (437)
|++|..+... ++.... ...+.| ..... .+.+ +...++.+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 9998754321 000000 001111 11111 1111 11122333211
Q ss_pred --CCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 388 --SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 388 --~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
-+..++|+|+.|.|||++++...-|+||+.+..
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 134599999999999999775568999998753
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.001 Score=63.09 Aligned_cols=143 Identities=15% Similarity=0.160 Sum_probs=84.2
Q ss_pred CCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCC--ceeceeEE------EeeCCeeEEEEe
Q 013737 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHK--NLVKLLGC------SITGPESLLVYE 345 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~------~~~~~~~~lv~e 345 (437)
.+.|..|....+|+....++ .+++|.... .....+..|++++..+.+. .+++++.. ....+..++|+|
T Consensus 19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSG-RYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCCC-cEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 45677787789999876544 688887754 2234566777777776432 24444431 223455689999
Q ss_pred ccCCCCcccc----c----------ccc----CC----CCCCCHHHHH----------HHHHHHHHHHHHhhc----CCC
Q 013737 346 FVPNQSLLDN----L----------FVR----QD----VEPLSWEVRY----------KIILSTAEGLAYLHE----ESK 389 (437)
Q Consensus 346 ~~~~g~L~~~----l----------~~~----~~----~~~l~~~~~~----------~i~~~i~~~l~yLH~----~~~ 389 (437)
+++|..+... . +.. .. .....|.... .....+...+.++.. .-+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 9998776431 0 000 00 0011221110 011112334444443 112
Q ss_pred CCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 390 ~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
..++|+|+.|.|||++++..+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3599999999999999987789999988763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00085 Score=63.90 Aligned_cols=142 Identities=23% Similarity=0.264 Sum_probs=82.2
Q ss_pred CcccccCcccEEEEEeCC-------CCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCc-eeceeEEEeeCCeeEEEEec
Q 013737 275 NKLGQGGSGSVYKGTLPG-------GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN-LVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~ 346 (437)
+.|..|-...+|+....+ ++.+++|....... ......+|.+++..+.... .+++++.+.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 455666677899988654 57888998654432 2234567877777765322 3455555432 368999
Q ss_pred cCCCCcccc-c----------------cccCCCC------CCC--HHHHHH--------------------------HHH
Q 013737 347 VPNQSLLDN-L----------------FVRQDVE------PLS--WEVRYK--------------------------IIL 375 (437)
Q Consensus 347 ~~~g~L~~~-l----------------~~~~~~~------~l~--~~~~~~--------------------------i~~ 375 (437)
++|..+... + +...... ..+ +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998776431 1 0000000 010 111111 111
Q ss_pred HHHHHHHHhhc------CCCCCeeeCCCCCCCeeeCCC----CcEEEcccCCcccc
Q 013737 376 STAEGLAYLHE------ESKLRIIHRDIKLSNILLDEE----FTAKIADFGLVRLF 421 (437)
Q Consensus 376 ~i~~~l~yLH~------~~~~~iiHrDlk~~NIll~~~----~~~ki~DFG~a~~~ 421 (437)
.+..-+.+|.. ..+..++|+|+.|.|||++++ +.++++||..|..-
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~ 214 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN 214 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence 12222334432 234568999999999999984 78999999988743
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0022 Score=60.74 Aligned_cols=137 Identities=16% Similarity=0.213 Sum_probs=79.2
Q ss_pred cccccCcccEEEEEeCCCCEEEEEEEe-ccchhhHHHHHHHHHHHcCCCCC--ceeceeEEEeeCC--eeEEEEeccCCC
Q 013737 276 KLGQGGSGSVYKGTLPGGEAVAVKRLF-YNTTQWVDHFFNEVNLISGINHK--NLVKLLGCSITGP--ESLLVYEFVPNQ 350 (437)
Q Consensus 276 ~Lg~G~~g~V~~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~--~~~lv~e~~~~g 350 (437)
.+..|-.-.+|..... ++.+++.+-. ...........+|.++|+.+.-- -+...++.+.++. ..+.||+|++|.
T Consensus 32 ~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe 110 (321)
T COG3173 32 EISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGE 110 (321)
T ss_pred eccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecce
Confidence 3333333345555444 6777777221 12223345566788888776532 2344555555554 569999999885
Q ss_pred CccccccccCCCCCCCHHHHHHHH-HHHHHHH------------------------------------------------
Q 013737 351 SLLDNLFVRQDVEPLSWEVRYKII-LSTAEGL------------------------------------------------ 381 (437)
Q Consensus 351 ~L~~~l~~~~~~~~l~~~~~~~i~-~~i~~~l------------------------------------------------ 381 (437)
.+.+.+.... .. ..++ ..+++.|
T Consensus 111 ~~~~~~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~ 182 (321)
T COG3173 111 VVWSALPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR 182 (321)
T ss_pred eccCcCCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence 4433321100 00 0011 1223333
Q ss_pred --HHhhcC-----CCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 382 --AYLHEE-----SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 382 --~yLH~~-----~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
.||+.+ +++.++|+|+.+.||+++++..+=|.||+++..-
T Consensus 183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 333333 3356999999999999999888999999998753
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0064 Score=58.06 Aligned_cols=143 Identities=16% Similarity=0.172 Sum_probs=80.2
Q ss_pred CCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCC--CceeceeEE------EeeCCeeEEEEe
Q 013737 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH--KNLVKLLGC------SITGPESLLVYE 345 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~------~~~~~~~~lv~e 345 (437)
.+.++.|....+|+....++ .+++|+...... .+....|.+++..|.. -.+++++.. ....+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677777789999886555 567787654321 2344456666655532 123444431 112355789999
Q ss_pred ccCCCCcccc--------------ccccCCC------C---CCCHHHHHH------------HHHHHHHHHHHhhc----
Q 013737 346 FVPNQSLLDN--------------LFVRQDV------E---PLSWEVRYK------------IILSTAEGLAYLHE---- 386 (437)
Q Consensus 346 ~~~~g~L~~~--------------l~~~~~~------~---~l~~~~~~~------------i~~~i~~~l~yLH~---- 386 (437)
|++|..+... ++..... . .-.|..... ....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9998654321 0000000 0 011111100 01112334555532
Q ss_pred CCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcc
Q 013737 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (437)
Q Consensus 387 ~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~ 419 (437)
.-+..++|+|+.+.||++++++...|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 123569999999999999988777899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0027 Score=59.59 Aligned_cols=32 Identities=22% Similarity=0.414 Sum_probs=26.4
Q ss_pred CCeeeCCCCCCCeeeCCCCc-EEEcccCCcccc
Q 013737 390 LRIIHRDIKLSNILLDEEFT-AKIADFGLVRLF 421 (437)
Q Consensus 390 ~~iiHrDlk~~NIll~~~~~-~ki~DFG~a~~~ 421 (437)
+.++|+|+.|.|||+++++. .-|+||+.+..-
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 34899999999999997555 569999988753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.00028 Score=65.83 Aligned_cols=132 Identities=17% Similarity=0.211 Sum_probs=90.5
Q ss_pred CCcCCcccccCcccEEEEEeCCCCEEEEEEEecc------------------chhhH----HHHHHHHHHHcCCCC--Cc
Q 013737 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN------------------TTQWV----DHFFNEVNLISGINH--KN 326 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~------------------~~~~~----~~~~~E~~~l~~l~h--~n 326 (437)
+...++||-|.-+.||.+-...|.+.++|.-... ...|. -...+|+..|+.|.- --
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 5778999999999999999999999998843211 11121 234678888887752 23
Q ss_pred eeceeEEEeeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC
Q 013737 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE 406 (437)
Q Consensus 327 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~ 406 (437)
+++.++ .+..++|||++.+-.|...-. ..+...+..-+. .-+.-|..+| +||+|..-=||++++
T Consensus 174 VPkpiD----~~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm---~~Iv~la~~G---lIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 174 VPKPID----HNRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLM---GLIVRLANHG---LIHGDFNEFNIMVKD 237 (465)
T ss_pred CCCccc----ccceeeHHHhhcccceeeeee------cCChHHHHHHHH---HHHHHHHHcC---ceecccchheeEEec
Confidence 445554 345689999998887765321 123333333332 2334455666 999999999999999
Q ss_pred CCcEEEcccCCc
Q 013737 407 EFTAKIADFGLV 418 (437)
Q Consensus 407 ~~~~ki~DFG~a 418 (437)
+..++++||--.
T Consensus 238 d~~i~vIDFPQm 249 (465)
T KOG2268|consen 238 DDKIVVIDFPQM 249 (465)
T ss_pred CCCEEEeechHh
Confidence 999999999643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.16 E-value=6.7e-05 Score=79.25 Aligned_cols=148 Identities=19% Similarity=0.179 Sum_probs=100.6
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
.+.+.+.+-+-.|.++.++.+.-. .|...+.|..... .....+....+-.++-...||-++...--+......+|+
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 345666778888999998887643 2433333332211 111122233333344444567666655545566788999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
++|+.+++|...|+. ....+..-....+..+.++++|||... ++|+|++|.|+|+..++..+++|||.....
T Consensus 883 ~~~~~~~~~~Skl~~---~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHN---SGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hHHhccCCchhhhhc---CCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 999999999888743 234455555566677888999999875 899999999999999999999999965543
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0029 Score=61.41 Aligned_cols=142 Identities=19% Similarity=0.291 Sum_probs=80.9
Q ss_pred CcccccCcccEEEEEeCC-----CCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCce-eceeEEEeeCCeeEEEEeccC
Q 013737 275 NKLGQGGSGSVYKGTLPG-----GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL-VKLLGCSITGPESLLVYEFVP 348 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~ 348 (437)
+.|-.|-...+|+....+ ++.+++|..........++ .+|..++..+...++ +++++.+..+ .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 455557778899987542 3678888776544333333 678888877753333 3555655322 5899998
Q ss_pred CCCcccc-----------------ccccC-C--CCCCCHHHHHHHHHHH-----------------HHHHHH----hhc-
Q 013737 349 NQSLLDN-----------------LFVRQ-D--VEPLSWEVRYKIILST-----------------AEGLAY----LHE- 386 (437)
Q Consensus 349 ~g~L~~~-----------------l~~~~-~--~~~l~~~~~~~i~~~i-----------------~~~l~y----LH~- 386 (437)
+.+|... ++... . .....+..+..+..++ ..-+.. +..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7666421 01100 0 0011223222322111 111111 221
Q ss_pred CCCCCeeeCCCCCCCeeeCC-CCcEEEcccCCcccc
Q 013737 387 ESKLRIIHRDIKLSNILLDE-EFTAKIADFGLVRLF 421 (437)
Q Consensus 387 ~~~~~iiHrDlk~~NIll~~-~~~~ki~DFG~a~~~ 421 (437)
..+..++|+|+++.|||+++ ++.+.++||..|..-
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 12345899999999999986 468999999988743
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0043 Score=58.39 Aligned_cols=75 Identities=17% Similarity=0.193 Sum_probs=47.4
Q ss_pred CcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCC---CCCceeceeEEEeeCCeeEEEEeccC
Q 013737 272 HESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI---NHKNLVKLLGCSITGPESLLVYEFVP 348 (437)
Q Consensus 272 ~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (437)
+..+.++.|....+|+.. .+++.+.||.-... ....|..|.+-|+.| .--.+++++++....+..+|||||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 345678889999999987 55778999987622 234567777766666 45678899998888888899999998
Q ss_pred CC
Q 013737 349 NQ 350 (437)
Q Consensus 349 ~g 350 (437)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 66
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.018 Score=55.10 Aligned_cols=142 Identities=16% Similarity=0.153 Sum_probs=95.3
Q ss_pred cCCcccccCcccEEEEEeCCCCEEEEEEEecc------------------------chhh--HHHHHHHHHHHcCCCCCc
Q 013737 273 ESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN------------------------TTQW--VDHFFNEVNLISGINHKN 326 (437)
Q Consensus 273 ~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~------------------------~~~~--~~~~~~E~~~l~~l~h~n 326 (437)
+...|..|.-+-||.+.-.+|..+|||+.+.. ++.. .-..+.|++-|.+|+...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 34568888889999999988999999976421 0111 112456777777776555
Q ss_pred eeceeEEEeeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC
Q 013737 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE 406 (437)
Q Consensus 327 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~ 406 (437)
|+..--... ....|||+|+..-.. -.-+.+...++...+..+-.+++.-|.-|-..+ ++||.||.-=|+|+.+
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd 300 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD 300 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC
Confidence 443222221 134699999953221 111123345777778888888888888887765 6999999999999876
Q ss_pred CCcEEEcccCCccccC
Q 013737 407 EFTAKIADFGLVRLFP 422 (437)
Q Consensus 407 ~~~~ki~DFG~a~~~~ 422 (437)
+ .+.|+|-+-+-...
T Consensus 301 G-~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 301 G-KLYIIDVSQSVEHD 315 (520)
T ss_pred C-EEEEEEccccccCC
Confidence 4 89999988765443
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0079 Score=57.93 Aligned_cols=72 Identities=15% Similarity=0.106 Sum_probs=48.2
Q ss_pred cccccCcccEEEEEeCCC-CEEEEEEEec-------cchhhHHHHHHHHHHHcCCC--CC-ceeceeEEEeeCCeeEEEE
Q 013737 276 KLGQGGSGSVYKGTLPGG-EAVAVKRLFY-------NTTQWVDHFFNEVNLISGIN--HK-NLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 276 ~Lg~G~~g~V~~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~ 344 (437)
.||.|....||++..++| +.|+||.-.. .-+-..++...|.+.|.... -| .+++++.+ +++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999998654 6899997531 11233455666777776543 23 45566543 555667999
Q ss_pred eccCC
Q 013737 345 EFVPN 349 (437)
Q Consensus 345 e~~~~ 349 (437)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99964
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.019 Score=56.31 Aligned_cols=73 Identities=10% Similarity=0.128 Sum_probs=49.8
Q ss_pred CCcccccCcccEEEEEeCCCCEEEEEEEecc----ch---hhHHHHHHHHHHHcCCC---CCceeceeEEEeeCCeeEEE
Q 013737 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN----TT---QWVDHFFNEVNLISGIN---HKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~----~~---~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 343 (437)
.+.||.|....||+.... +..++||+-... .. ....+-..|.+.|..+. ..++++++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 567899999999998875 456889975411 11 13344455566665543 357888888776 456889
Q ss_pred EeccCC
Q 013737 344 YEFVPN 349 (437)
Q Consensus 344 ~e~~~~ 349 (437)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.00038 Score=70.21 Aligned_cols=148 Identities=18% Similarity=0.081 Sum_probs=99.3
Q ss_pred HHHHHHhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCc-eeceeEEEeeCCee
Q 013737 262 ETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN-LVKLLGCSITGPES 340 (437)
Q Consensus 262 ~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~ 340 (437)
..+++.+..+...+-++++++++++|.+....+....+.+... ....-++++|.+++||| .+..++-+..+...
T Consensus 235 p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~ 309 (829)
T KOG0576|consen 235 PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYL 309 (829)
T ss_pred CcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCccccc
Confidence 3444555555556678899999999987433333345554322 34556889999999999 77777777777788
Q ss_pred EEEEeccCCC-CccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcc
Q 013737 341 LLVYEFVPNQ-SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (437)
Q Consensus 341 ~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~ 419 (437)
+++++++..+ +...... .....+...+...+.+.-.+++++||+.. =+|+| ||+..+ ...|..||+...
T Consensus 310 ~i~~~i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~ 379 (829)
T KOG0576|consen 310 WIPMRICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPP 379 (829)
T ss_pred chhhhhhcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCc
Confidence 9999999876 2221110 11112333444556666678999999863 48998 787776 588999999988
Q ss_pred ccCCC
Q 013737 420 LFPED 424 (437)
Q Consensus 420 ~~~~~ 424 (437)
.+...
T Consensus 380 ~L~~~ 384 (829)
T KOG0576|consen 380 QLTRT 384 (829)
T ss_pred ccCcc
Confidence 77654
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.058 Score=51.55 Aligned_cols=32 Identities=22% Similarity=0.385 Sum_probs=28.4
Q ss_pred CCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 389 ~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
+..++|+|+.+.|||+++++.+.|+||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34599999999999999999999999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.036 Score=53.50 Aligned_cols=141 Identities=20% Similarity=0.251 Sum_probs=77.5
Q ss_pred CcccccCcccEEEEEeCC----CCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCce-eceeEEEeeCCeeEEEEeccCC
Q 013737 275 NKLGQGGSGSVYKGTLPG----GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL-VKLLGCSITGPESLLVYEFVPN 349 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~ 349 (437)
+.|..|=...+|+....+ +..+++|.......... .-.+|..+++.+...++ +++++++. .+ +|.||+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVI-DRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEe-chHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 345556677899887543 23788887755433222 23568888877764444 35565552 22 58999977
Q ss_pred CCcccc-----------------ccccC---CCCCCCHHHHHHHHHHH-------------------------HHHHH-H
Q 013737 350 QSLLDN-----------------LFVRQ---DVEPLSWEVRYKIILST-------------------------AEGLA-Y 383 (437)
Q Consensus 350 g~L~~~-----------------l~~~~---~~~~l~~~~~~~i~~~i-------------------------~~~l~-y 383 (437)
..|... ++... ...+-.|..+..+..++ +..+. .
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 655321 01100 00011222222222111 11111 1
Q ss_pred hhc-CCCCCeeeCCCCCCCeeeCC-CCcEEEcccCCccc
Q 013737 384 LHE-ESKLRIIHRDIKLSNILLDE-EFTAKIADFGLVRL 420 (437)
Q Consensus 384 LH~-~~~~~iiHrDlk~~NIll~~-~~~~ki~DFG~a~~ 420 (437)
+.. ..+....|.||.+.|||+++ ++.++++||..|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 211 12234799999999999974 57899999998764
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.039 Score=52.60 Aligned_cols=29 Identities=28% Similarity=0.407 Sum_probs=25.4
Q ss_pred CCeeeCCCCCCCeeeCCCCcEEEcccCCcc
Q 013737 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (437)
Q Consensus 390 ~~iiHrDlk~~NIll~~~~~~ki~DFG~a~ 419 (437)
..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 45899999999999988 578999999664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.014 Score=56.96 Aligned_cols=74 Identities=14% Similarity=0.033 Sum_probs=50.0
Q ss_pred CCcccccCcccEEEEEeCC-CCEEEEEEEec------cchhhHHHHHHHHHHHcCCC--CC-ceeceeEEEeeCCeeEEE
Q 013737 274 SNKLGQGGSGSVYKGTLPG-GEAVAVKRLFY------NTTQWVDHFFNEVNLISGIN--HK-NLVKLLGCSITGPESLLV 343 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv 343 (437)
.+.||.|.-..||++..++ +..|+||.-.. .-+-..++..-|.+.|+... -| .+++++.+ +++...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4678999999999999753 56899997421 11233566677777776553 23 56667654 45566789
Q ss_pred EeccCC
Q 013737 344 YEFVPN 349 (437)
Q Consensus 344 ~e~~~~ 349 (437)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998864
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.1 Score=50.12 Aligned_cols=140 Identities=20% Similarity=0.285 Sum_probs=79.3
Q ss_pred cccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCc------eeceeEE----EeeCCeeEEEEe
Q 013737 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN------LVKLLGC----SITGPESLLVYE 345 (437)
Q Consensus 276 ~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~----~~~~~~~~lv~e 345 (437)
.|.+ .-..+|+....+|+. ++|..... ....++..|+..|..|.-.. +..+=|- ...+...+-+++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 456789998887777 88887665 23445566666666553111 2222221 111236678999
Q ss_pred ccCCCCccc-ccc------------------c----cCC-CCCCCHHH----H---------HHHHHHHHHHHHHhhcCC
Q 013737 346 FVPNQSLLD-NLF------------------V----RQD-VEPLSWEV----R---------YKIILSTAEGLAYLHEES 388 (437)
Q Consensus 346 ~~~~g~L~~-~l~------------------~----~~~-~~~l~~~~----~---------~~i~~~i~~~l~yLH~~~ 388 (437)
|++|..+.. ... . +.. .....|.. . .....++...+..+.+.-
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999888873 110 0 000 01223320 0 011223333444444331
Q ss_pred ----CC-C--eeeCCCCCCCeeeCCCCc-EEEcccCCcc
Q 013737 389 ----KL-R--IIHRDIKLSNILLDEEFT-AKIADFGLVR 419 (437)
Q Consensus 389 ----~~-~--iiHrDlk~~NIll~~~~~-~ki~DFG~a~ 419 (437)
+. + +||+|+.|.||+++.+.. +.++||+-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 11 2 899999999999998875 8999999775
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.34 Score=46.63 Aligned_cols=96 Identities=10% Similarity=-0.031 Sum_probs=53.9
Q ss_pred ccccCHHHHHHHhcCCCcC---C-cccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCC--Cceec
Q 013737 256 KLNFSYETLEKATNYFHES---N-KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH--KNLVK 329 (437)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~---~-~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~ 329 (437)
...++.+.+..+...+-.. + ..-.+.-..||+....++..+++|...... ....++..|.+.+..|.. -.++.
T Consensus 8 ~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~ 86 (325)
T PRK11768 8 FQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVA 86 (325)
T ss_pred CCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCC
Confidence 3455666666665554221 1 111234467999988878889999875332 234456667776655531 11222
Q ss_pred ee---E--EEeeCCeeEEEEeccCCCCc
Q 013737 330 LL---G--CSITGPESLLVYEFVPNQSL 352 (437)
Q Consensus 330 l~---~--~~~~~~~~~lv~e~~~~g~L 352 (437)
.. | ....++..+.++++++|...
T Consensus 87 p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 87 PLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred CccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 11 1 12234567789999987654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.069 Score=51.90 Aligned_cols=136 Identities=15% Similarity=0.190 Sum_probs=85.3
Q ss_pred CcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCC-CCCceeceeEE------EeeCC-eeEEE
Q 013737 272 HESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGC------SITGP-ESLLV 343 (437)
Q Consensus 272 ~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~------~~~~~-~~~lv 343 (437)
...+.||+|+-+.+|-.--- ..-+.|+.+........ +.+..|.+. .||-+-.=+.+ .-... ..-++
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecchh--hchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 45778999999999864321 12244665543332222 123333333 46643321111 01122 24567
Q ss_pred EeccCCCCcccccc----ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 013737 344 YEFVPNQSLLDNLF----VRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415 (437)
Q Consensus 344 ~e~~~~g~L~~~l~----~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DF 415 (437)
|..+++..-...++ +++......|...++.++.++.+..-||+.| .+-+|+.++|+|+++++.+.|.|=
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcc
Confidence 77776543222222 2334456899999999999999999999998 888999999999999988888773
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.68 E-value=0.037 Score=52.86 Aligned_cols=71 Identities=25% Similarity=0.275 Sum_probs=53.0
Q ss_pred eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCc
Q 013737 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (437)
Q Consensus 339 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a 418 (437)
..|++|++- |+++... .--.+.+.+.++.+.+.-+.-+..+ .+.-||||...||||+ +|++-|+||-++
T Consensus 300 y~yl~~kdh-gt~is~i-------k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 300 YLYLHFKDH-GTPISII-------KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred EEEEEEecC-Cceeeee-------ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeee
Confidence 456777766 4555322 1246788888988876655555443 5689999999999999 899999999999
Q ss_pred cc
Q 013737 419 RL 420 (437)
Q Consensus 419 ~~ 420 (437)
|+
T Consensus 369 Rl 370 (488)
T COG5072 369 RL 370 (488)
T ss_pred ec
Confidence 94
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.24 Score=44.53 Aligned_cols=76 Identities=18% Similarity=0.262 Sum_probs=50.8
Q ss_pred CCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCC---CCCceeceeEEEeeCCeeEEEEeccCCC
Q 013737 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI---NHKNLVKLLGCSITGPESLLVYEFVPNQ 350 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~g 350 (437)
.+.+.-|.--..|...+ +..++-||.- .......|..|+.-|..+ +--++.+++.+..+.+..|+||||++-+
T Consensus 21 r~~v~gG~inea~~v~d-g~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~ 96 (286)
T COG3001 21 REEVSGGDINEAWRLRD-GTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG 96 (286)
T ss_pred ccccCCccccceeEeec-CCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence 34555555445555443 2457777763 333445677777655444 4567888898888999999999999987
Q ss_pred Ccc
Q 013737 351 SLL 353 (437)
Q Consensus 351 ~L~ 353 (437)
.+.
T Consensus 97 ~~d 99 (286)
T COG3001 97 PLD 99 (286)
T ss_pred CCC
Confidence 665
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.18 Score=56.20 Aligned_cols=141 Identities=17% Similarity=0.231 Sum_probs=75.8
Q ss_pred CcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCC-------CCCceecee-E----EEee-CC--e
Q 013737 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-------NHKNLVKLL-G----CSIT-GP--E 339 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~l~-~----~~~~-~~--~ 339 (437)
+.|+ |..-.+|+....+|..+++|+....... .....|...|..| .-|.+++-. | .... .+ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~--~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPR--VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccch--hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 3454 3457889998888888999998754322 2333344444333 233333322 1 1111 22 3
Q ss_pred eEEEEeccCCCCcccccc-----------------------ccC-CCCCCCHHH-----------------HHHHHHHHH
Q 013737 340 SLLVYEFVPNQSLLDNLF-----------------------VRQ-DVEPLSWEV-----------------RYKIILSTA 378 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~-----------------------~~~-~~~~l~~~~-----------------~~~i~~~i~ 378 (437)
.+-+++|++|..+.+... ... ....+.|.. ...++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 567899999877754110 000 001122211 112222332
Q ss_pred HHHH-----HhhcCCCCCeeeCCCCCCCeeeCCCC--cEE-EcccCCcc
Q 013737 379 EGLA-----YLHEESKLRIIHRDIKLSNILLDEEF--TAK-IADFGLVR 419 (437)
Q Consensus 379 ~~l~-----yLH~~~~~~iiHrDlk~~NIll~~~~--~~k-i~DFG~a~ 419 (437)
+... .|... +..+||.|+.+.|||++.+. ++. |+|||-+.
T Consensus 188 ~~~~~~v~p~l~~L-p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 188 ARFERNVAPRLAAL-PAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHHhcC-CcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 2221 12222 23499999999999999875 555 99999765
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.15 E-value=0.095 Score=50.93 Aligned_cols=59 Identities=17% Similarity=0.174 Sum_probs=37.5
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD 405 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~ 405 (437)
.|+-+|++|.++..++.. ...++....+++.-...|+.-+-.-. ..+|.|+.|.||++-
T Consensus 321 vl~E~~~~Gl~v~~~v~~----~~~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 321 VLVETYERGLSVLRFVKW----KSQPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIR 379 (565)
T ss_pred eeeeeccccccHHhhhhc----ccChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEE
Confidence 466678888888777732 22344455555555555554332221 299999999999994
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.12 E-value=0.092 Score=46.79 Aligned_cols=102 Identities=16% Similarity=0.134 Sum_probs=65.0
Q ss_pred EEEEEEEeccchh-hHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHH
Q 013737 295 AVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI 373 (437)
Q Consensus 295 ~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i 373 (437)
+..+|++....-. ...-|..+.++++++. .|+++..= ..-..-+++|+|-.... . ...+
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------~----~~N~ 146 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------N----FSNF 146 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------c----hhHH
Confidence 3455665433222 3345678888888875 46776621 22234588888832111 1 1122
Q ss_pred HHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCC
Q 013737 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417 (437)
Q Consensus 374 ~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~ 417 (437)
+.--+..|.-.|+.. ...+|+|-.|+||+-|..|.+||.|=+.
T Consensus 147 i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 147 ITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence 332246778889654 4699999999999999999999999653
|
The function of this family is unknown. |
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=94.57 E-value=0.22 Score=45.92 Aligned_cols=76 Identities=20% Similarity=0.160 Sum_probs=54.6
Q ss_pred CCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHH---HHHcCCCCCceeceeEEEeeCCeeEEEEecc-CC
Q 013737 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEV---NLISGINHKNLVKLLGCSITGPESLLVYEFV-PN 349 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~-~~ 349 (437)
...+..|..+.|+.+...+|.+.++|....... +..|. ..|+..+-...|++++.- ...-.|++|.+ ++
T Consensus 7 ~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~-----~~~E~~g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g 79 (253)
T PF04655_consen 7 DGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAE-----AEHEARGEAALRWWNGRGAVRLLAAD--PERGALLLERLDPG 79 (253)
T ss_pred CCCCCCCcceEEEEEEcCCCCeEEEEecCCccc-----chhhhhHHhHhheeCCCCceeeeccc--cccchhhhhhccCC
Confidence 345667889999999999999999998764332 11233 457777888889999854 33557888998 55
Q ss_pred CCccccc
Q 013737 350 QSLLDNL 356 (437)
Q Consensus 350 g~L~~~l 356 (437)
.+|.+..
T Consensus 80 ~~L~~~~ 86 (253)
T PF04655_consen 80 RSLASLP 86 (253)
T ss_pred Cchhhcc
Confidence 5776554
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.64 E-value=0.43 Score=46.97 Aligned_cols=74 Identities=20% Similarity=0.291 Sum_probs=43.5
Q ss_pred CcccccCcccEEEEEeCCC--CE-----EEEEEEeccchhhHHHHHHHHHHHcCCCCCce-eceeEEEeeCCeeEEEEec
Q 013737 275 NKLGQGGSGSVYKGTLPGG--EA-----VAVKRLFYNTTQWVDHFFNEVNLISGINHKNL-VKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~ 346 (437)
+.|..|-...+|++...++ .. |.++.......... .-.+|+++++.+...++ +++++.+. -+++.||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEe-ccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEE
Confidence 4555677889999976433 22 33333211111111 23568888888864444 45666553 2699999
Q ss_pred cCCCCcc
Q 013737 347 VPNQSLL 353 (437)
Q Consensus 347 ~~~g~L~ 353 (437)
++|..|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9987764
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=92.92 E-value=0.063 Score=55.13 Aligned_cols=46 Identities=26% Similarity=0.452 Sum_probs=39.6
Q ss_pred HHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 375 ~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
.+++.||.|+|... .+||++|.|++|.++.++..||+.|+++-...
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~ 151 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNAN 151 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccC
Confidence 34558999999864 69999999999999999999999999876443
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.52 E-value=0.1 Score=45.60 Aligned_cols=29 Identities=14% Similarity=0.227 Sum_probs=25.6
Q ss_pred CeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 391 ~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
..+|+|+.|.||++++++ ++|+||+.|..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 469999999999998887 89999998764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 437 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-33 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-33 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-30 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-30 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-30 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-28 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-22 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-22 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-17 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-17 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-17 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-17 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-17 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-17 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-08 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-08 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-08 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-07 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-07 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-07 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-07 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-07 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-07 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-07 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-07 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-07 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-07 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-07 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-07 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-07 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-07 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-07 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-07 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-07 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-07 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-07 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-07 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-07 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-07 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-07 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-07 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-07 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-07 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-06 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-06 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-06 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-06 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-06 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-06 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-06 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-06 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-06 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 7e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 8e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-05 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-05 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-05 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-05 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-05 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-05 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-05 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-05 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-05 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-05 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-05 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-05 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-05 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-05 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 5e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-05 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 5e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-05 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-04 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-04 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-04 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-04 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-04 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 275 bits (705), Expect = 5e-90
Identities = 81/180 (45%), Positives = 107/180 (59%), Gaps = 2/180 (1%)
Query: 259 FSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDH-FFNEVN 317
FS L+ A++ F N LG+GG G VYKG L G VAVKRL TQ + F EV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSWEVRYKIILS 376
+IS H+NL++L G +T E LLVY ++ N S+ L + PL W R +I L
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
+A GLAYLH+ +IIHRD+K +NILLDEEF A + DFGL +L TH++ + GT+
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 199
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 252 bits (647), Expect = 1e-81
Identities = 81/188 (43%), Positives = 107/188 (56%), Gaps = 15/188 (7%)
Query: 259 FSYETLEKATNYFHE------SNKLGQGGSGSVYKGTLPGGEAVAVKRL----FYNTTQW 308
FS+ L+ TN F E NK+G+GG G VYKG + VAVK+L T +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT-VAVKKLAAMVDITTEEL 73
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWE 368
F E+ +++ H+NLV+LLG S G + LVY ++PN SLLD L PLSW
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE-DITH 427
+R KI A G+ +LHE IHRDIK +NILLDE FTAKI+DFGL R + T
Sbjct: 134 MRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 428 ISATLAGT 435
+++ + GT
Sbjct: 191 MTSRIVGT 198
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 3e-79
Identities = 71/187 (37%), Positives = 99/187 (52%), Gaps = 5/187 (2%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVD 310
V LE+ATN F +G G G VYKG L G VA+KR ++Q ++
Sbjct: 21 LVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIE 80
Query: 311 HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSWEV 369
F E+ +S H +LV L+G E +L+Y+++ N +L +L+ +SWE
Sbjct: 81 EFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ 140
Query: 370 RYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE-DITHI 428
R +I + A GL YLH + IIHRD+K NILLDE F KI DFG+ + E D TH+
Sbjct: 141 RLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197
Query: 429 SATLAGT 435
S + GT
Sbjct: 198 STVVKGT 204
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 2e-57
Identities = 59/194 (30%), Positives = 78/194 (40%), Gaps = 20/194 (10%)
Query: 255 SKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQ-WVDHFF 313
S ++ E L + +G G V+K E VAVK Q W
Sbjct: 10 SGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSW--QNE 66
Query: 314 NEVNLISGINHKNLVKLLGCSITGP----ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEV 369
EV + G+ H+N+++ +G G + L+ F SL D L +SW
Sbjct: 67 YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNE 122
Query: 370 RYKIILSTAEGLAYLHEE-------SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422
I + A GLAYLHE+ K I HRDIK N+LL TA IADFGL F
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 423 EDITHISAT-LAGT 435
+ GT
Sbjct: 183 AGKSAGDTHGQVGT 196
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 4e-49
Identities = 52/199 (26%), Positives = 79/199 (39%), Gaps = 28/199 (14%)
Query: 257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEV 316
+ + + +G+G G+VYKG+L VAVK + +F NE
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEK 56
Query: 317 N--LISGINHKNLVKLLGCSITGPES-----LLVYEFVPNQSLLDNLFVRQDVEPLSWEV 369
N + + H N+ + + LLV E+ PN SL L + W
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVS 112
Query: 370 RYKIILSTAEGLAYLHEE------SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-- 421
++ S GLAYLH E K I HRD+ N+L+ + T I+DFGL
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 422 -----PEDITHISATLAGT 435
P + + + + GT
Sbjct: 173 NRLVRPGEEDNAAISEVGT 191
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-44
Identities = 53/165 (32%), Positives = 82/165 (49%), Gaps = 7/165 (4%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLG 332
K+G G G+V++ G VAVK L + V+ F EV ++ + H N+V +G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
P +V E++ SL L E L R + A+G+ YLH I
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPI 160
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT-LAGTL 436
+HR++K N+L+D+++T K+ DFGL RL + T +S+ AGT
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTP 203
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-40
Identities = 54/175 (30%), Positives = 80/175 (45%), Gaps = 22/175 (12%)
Query: 275 NKLGQGGSGSVYKGTLPG-GEAVAVKRLFY-------NTTQWVDHFFNEVNLISGINHKN 326
++G+GG G V+KG L VA+K L + F EV ++S +NH N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
+VKL G P +V EFVP L L P+ W V+ +++L A G+ Y+
Sbjct: 85 IVKLYGLMHNPP--RMVMEFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 387 ESKLRIIHRDIKLSNILLDE-----EFTAKIADFGLVRLFPEDITHISATLAGTL 436
+ I+HRD++ NI L AK+ADFGL + ++ L G
Sbjct: 141 Q-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS----GLLGNF 190
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 6e-40
Identities = 48/167 (28%), Positives = 71/167 (42%), Gaps = 10/167 (5%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
+G+G G V K + VA+K++ + F E+ +S +NH N+VKL
Sbjct: 10 IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVKL 66
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
G P L V E+ SL + L + + + L ++G+AYLH
Sbjct: 67 YGAC-LNPVCL-VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 391 RIIHRDIKLSNILLDEEFT-AKIADFGLVRLFPEDITHISATLAGTL 436
+IHRD+K N+LL T KI DFG DI G+
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSA 167
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-39
Identities = 49/175 (28%), Positives = 76/175 (43%), Gaps = 22/175 (12%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNE--VNLISGINHKNLVKLLG 332
+G+G G V++G+ GE VAVK ++ +F E + + H+N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 333 CSITGPES----LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE- 387
+T S L+ + SL D L + L +I+LS A GLA+LH E
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 388 ----SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA---TLAGT 435
K I HRD+K NIL+ + IAD GL + + + GT
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-39
Identities = 53/176 (30%), Positives = 78/176 (44%), Gaps = 22/176 (12%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNE--VNLISGINHKNLVKLLG 332
++G+G G V+ G GE VAVK F T +F E + + H+N++ +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFF---TTEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 333 CSITGPES----LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE- 387
I G S L+ ++ N SL D +++ L + K+ S+ GL +LH E
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYD--YLKS--TTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 388 ----SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI---SATLAGTL 436
K I HRD+K NIL+ + T IAD GL F D + T GT
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-39
Identities = 43/158 (27%), Positives = 66/158 (41%), Gaps = 6/158 (3%)
Query: 275 NKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
LG+G G K T GE + +K L + F EV ++ + H N++K +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
+ E++ +L ++ W R A G+AYLH + II
Sbjct: 76 LYKDKRLNFITEYIKGGTLRG--IIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNII 130
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
HRD+ N L+ E +ADFGL RL ++ T
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-39
Identities = 37/151 (24%), Positives = 65/151 (43%), Gaps = 7/151 (4%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLG 332
KL + SG ++KG G + VK L +T+ F E + +H N++ +LG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 333 CSITGPESLL--VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
+ P + ++P SL + L + K L A G+A+LH L
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMARGMAFLHTLEPL 133
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
I + ++++DE+ TA+I+ + F
Sbjct: 134 -IPRHALNSRSVMIDEDMTARISMADVKFSF 163
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 8e-39
Identities = 50/174 (28%), Positives = 79/174 (45%), Gaps = 20/174 (11%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRL----FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
+G GG G VY+ G+ VAVK + +Q +++ E L + + H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
G + P LV EF L L ++ + ++ + A G+ YLH+E+ +
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 391 RIIHRDIKLSNILLDEEF--------TAKIADFGLVRLFPEDITHISATLAGTL 436
IIHRD+K SNIL+ ++ KI DFGL R + + AG
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAY 178
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-38
Identities = 52/176 (29%), Positives = 78/176 (44%), Gaps = 22/176 (12%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNE--VNLISGINHKNLVKLLG 332
+G+G G V++G GE VAVK ++ +F E + + H+N++ +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIA 103
Query: 333 CSI----TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE- 387
T + LV ++ + SL D L + ++ E K+ LSTA GLA+LH E
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 388 ----SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDITHISATLAGTL 436
K I HRD+K NIL+ + T IAD GL + I GT
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-35
Identities = 55/165 (33%), Positives = 78/165 (47%), Gaps = 11/165 (6%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
++G G G+VYKG G VAVK L T Q + F NEV ++ H N++ +G
Sbjct: 30 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
S T P+ +V ++ SL + + I TA G+ YLH +S I
Sbjct: 88 YS-TAPQLAIVTQWCEGSSLYH--HLHASETKFEMKKLIDIARQTARGMDYLHAKS---I 141
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT-LAGTL 436
IHRD+K +NI L E+ T KI DFGL L+G++
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-34
Identities = 37/148 (25%), Positives = 62/148 (41%), Gaps = 10/148 (6%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
+G+G G VY G G VA++ + + + F EV H+N+V +G
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
++ P ++ ++L VR L +I +G+ YLH + I
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYS--VVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---I 151
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRL 420
+H+D+K N+ D I DFGL +
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSI 178
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 51/167 (30%), Positives = 79/167 (47%), Gaps = 12/167 (7%)
Query: 275 NKLGQGGSGSVYKGTLPG-----GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
++LG+G GSV G VAVK+L ++ F E+ ++ ++ +VK
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 330 LLG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
G G +SL LV E++P+ L D F+++ L +G+ YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRD--FLQRHRARLDASRLLLYSSQICKGMEYL--G 144
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG 434
S+ R +HRD+ NIL++ E KIADFGL +L P D + G
Sbjct: 145 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG 190
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-31
Identities = 53/167 (31%), Positives = 84/167 (50%), Gaps = 12/167 (7%)
Query: 275 NKLGQGGSGSVYKGTLPG-----GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+LG+G GSV GE VAVK+L ++T + + F E+ ++ + H N+VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 330 LLG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
G C G +L L+ E++P SL D ++++ E + + +G+ YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYL--G 131
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG 434
+K R IHRD+ NIL++ E KI DFGL ++ P+D G
Sbjct: 132 TK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPG 177
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-31
Identities = 53/167 (31%), Positives = 85/167 (50%), Gaps = 12/167 (7%)
Query: 275 NKLGQGGSGSVYKGTLPG-----GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+LG+G GSV GE VAVK+L ++T + + F E+ ++ + H N+VK
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 330 LLG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
G C G +L L+ E++P SL D ++++ E + + +G+ YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYL--G 162
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG 434
+K R IHRD+ NIL++ E KI DFGL ++ P+D + G
Sbjct: 163 TK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPG 208
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 4e-31
Identities = 43/153 (28%), Positives = 70/153 (45%), Gaps = 9/153 (5%)
Query: 276 KLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLG- 332
++G+G G V+ G L VAVK F E ++ +H N+V+L+G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
C+ P +V E V L F+R + L + +++ A G+ YL +
Sbjct: 181 CTQKQP-IYIVMELVQGGDFLT--FLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CC 234
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425
IHRD+ N L+ E+ KI+DFG+ R + +
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 45/175 (25%), Positives = 80/175 (45%), Gaps = 15/175 (8%)
Query: 269 NYFHESNKLGQGGSGSVYKGTLPG-----GEAVAVKRL--FYNTTQWVDHFFNEVNLISG 321
+ LG+G G V GE VAVK L D E+ ++
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD-LKKEIEILRN 79
Query: 322 INHKNLVKLLG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
+ H+N+VK G C+ G + L+ EF+P+ SL + ++ ++ ++ + + K + +
Sbjct: 80 LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE--YLPKNKNKINLKQQLKYAVQICK 137
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG 434
G+ YL S+ + +HRD+ N+L++ E KI DFGL + D + +
Sbjct: 138 GMDYL--GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDR 189
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-30
Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 12/156 (7%)
Query: 275 NKLGQGGSGSVYKGTL--PGGEA---VAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLV 328
LG G G+VYKG G + VA+K L T+ +E +++ +++ ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
+LLG L+ + +P LLD +VR+ + + + + A+G+ YL E
Sbjct: 81 RLLGI-CLTSTVQLITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL--ED 135
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
+ R++HRD+ N+L+ KI DFGL +L +
Sbjct: 136 R-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 5e-30
Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 8/152 (5%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG-C 333
+LG G G V G G VA+K + + D F E ++ ++H+ LV+L G C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
+ P ++ E++ N LL+ ++R+ + ++ E + YL ESK + +
Sbjct: 89 TKQRP-IFIITEYMANGCLLN--YLREMRHRFQTQQLLEMCKDVCEAMEYL--ESK-QFL 142
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425
HRD+ N L++++ K++DFGL R +D
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-30
Identities = 49/150 (32%), Positives = 74/150 (49%), Gaps = 8/150 (5%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG-CS 334
+LG G G V G G VAVK + + D FF E + ++H LVK G CS
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
P +V E++ N LL+ ++R + L ++ EG+A+L ES + IH
Sbjct: 74 KEYP-IYIVTEYISNGCLLN--YLRSHGKGLEPSQLLEMCYDVCEGMAFL--ESH-QFIH 127
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPED 424
RD+ N L+D + K++DFG+ R +D
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 9e-30
Identities = 45/152 (29%), Positives = 71/152 (46%), Gaps = 8/152 (5%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG-C 333
++G G G V+ G + VA+K + + F E ++ ++H LV+L G C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
P LV EF+ + L D ++R + E + L EG+AYL E +I
Sbjct: 73 LEQAP-ICLVTEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYL--EEA-CVI 126
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425
HRD+ N L+ E K++DFG+ R +D
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 52/158 (32%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 275 NKLGQGGSGSVYKGTLPG-----GEAVAVKRL-FYNTTQWVDHFFNEVNLISGINHKNLV 328
LG+G G V GE VAVK L Q + E++++ + H++++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 329 KLLG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
K G C G SL LV E+VP SL D ++ + L+ + + EG+AYLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRD--YLPRHSIGLAQLLLF--AQQICEGMAYLHA 152
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
IHRD+ N+LLD + KI DFGL + PE
Sbjct: 153 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-29
Identities = 50/167 (29%), Positives = 74/167 (44%), Gaps = 14/167 (8%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
LG+G G VY G L +A+K + +++ E+ L + HKN+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 336 TGPESLLVYEFVPNQSLLDNLFVR----QDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
+ E VP SL L + +D E + EGL YLH+ +
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT---IG-FYTKQILEGLKYLHDN---Q 142
Query: 392 IIHRDIKLSNILLDEEF-TAKIADFGLVRLFPEDITHISATLAGTLF 437
I+HRDIK N+L++ KI+DFG + I + T GTL
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQ 188
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-29
Identities = 47/159 (29%), Positives = 72/159 (45%), Gaps = 11/159 (6%)
Query: 272 HESNKLGQGGSGSVYKGTLPGGE----AVAVKRLFYNTT-QWVDHFFNEVNLISGINHKN 326
H +G+G G VY G A+K L T Q V+ F E L+ G+NH N
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
++ L+G ++ ++ + LL F+R + + L A G+ YL
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQ--FIRSPQRNPTVKDLISFGLQVARGMEYL- 140
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
+ + +HRD+ N +LDE FT K+ADFGL R +
Sbjct: 141 -AEQ-KFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-29
Identities = 38/180 (21%), Positives = 71/180 (39%), Gaps = 11/180 (6%)
Query: 254 KSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHF 312
+ L F + ++ KLG+GG V L G A+KR+ + Q +
Sbjct: 14 RENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEA 73
Query: 313 FNEVNLISGINHKNLVKLLGCSITGPES----LLVYEFVPNQSLLDNLFVR-QDVEPLS- 366
E ++ NH N+++L+ + + L+ F +L + + L+
Sbjct: 74 QREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTE 133
Query: 367 WEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426
++ ++L GL +H HRD+K +NILL +E + D G + +
Sbjct: 134 DQIL-WLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVE 189
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-29
Identities = 50/152 (32%), Positives = 79/152 (51%), Gaps = 8/152 (5%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+LG G G V+ G G VAVK L + D F E NL+ + H+ LV+L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV- 76
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
+T ++ E++ N SL+D F++ L+ + AEG+A++ E + I
Sbjct: 77 VTQEPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFI--EER-NYI 131
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425
HRD++ +NIL+ + + KIADFGL RL ++
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNE 163
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 12/156 (7%)
Query: 275 NKLGQGGSGSVYKGTL--PGGEA---VAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLV 328
LG G G+VYKG G + VA+K L T+ +E +++ +++ ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
+LLG L+ + +P LLD +VR+ + + + + A+G+ YL E
Sbjct: 81 RLLGI-CLTSTVQLITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL--ED 135
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
+ R++HRD+ N+L+ KI DFGL +L +
Sbjct: 136 R-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 54/153 (35%), Positives = 78/153 (50%), Gaps = 8/153 (5%)
Query: 275 NKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
+KLG G G VY+G VAVK L +T + V+ F E ++ I H NLV+LLG
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
P ++ EF+ +LLD ++R+ + + +S V + + + YL E K
Sbjct: 78 CTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYL--EKK-NF 132
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425
IHRD+ N L+ E K+ADFGL RL D
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 53/153 (34%), Positives = 78/153 (50%), Gaps = 8/153 (5%)
Query: 275 NKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
+KLG G G VY+G VAVK L +T + V+ F E ++ I H NLV+LLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
P ++ EF+ +LLD ++R+ + + +S V + + + YL E K
Sbjct: 285 CTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYL--EKK-NF 339
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425
IHR++ N L+ E K+ADFGL RL D
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 46/156 (29%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 275 NKLGQGGSGSVYKGTL--PGGEA---VAVKRL-FYNTTQWVDHFFNEVNLISGINHKNLV 328
LG G G+V+KG G V +K + + Q + + I ++H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
+LLG G LV +++P SLLD VRQ L ++ + A+G+ YL E
Sbjct: 79 RLLGL-CPGSSLQLVTQYLPLGSLLD--HVRQHRGALGPQLLLNWGVQIAKGMYYL--EE 133
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
++HR++ N+LL ++ADFG+ L P D
Sbjct: 134 H-GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-28
Identities = 43/165 (26%), Positives = 74/165 (44%), Gaps = 14/165 (8%)
Query: 276 KLGQGGSGSVYKGTLPGGEA---VAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLVKL 330
+LG G G+V KG + VAVK L D E N++ +++ +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 331 LG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
+G C +LV E L +++Q+ + + +++ + G+ YL E
Sbjct: 84 IGIC--EAESWMLVMEMAELGPLNK--YLQQN-RHVKDKNIIELVHQVSMGMKYL--EES 136
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG 434
+HRD+ N+LL + AKI+DFGL + D + A G
Sbjct: 137 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 180
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-28
Identities = 44/163 (26%), Positives = 73/163 (44%), Gaps = 10/163 (6%)
Query: 276 KLGQGGSGSVYKGTLPGGE---AVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLL 331
+LG G GSV +G + VA+K L T + E ++ +++ +V+L+
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
G +LV E L F+ E + +++ + G+ YL E K
Sbjct: 77 GV-CQAEALMLVMEMAGGGPLHK--FLVGKREEIPVSNVAELLHQVSMGMKYL--EEK-N 130
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG 434
+HRD+ N+LL AKI+DFGL + D ++ +A AG
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 173
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 1e-27
Identities = 45/147 (30%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG-C 333
+G+G G V G G + VAVK + + T F E ++++ + H NLV+LLG
Sbjct: 27 QTIGKGEFGDVMLGDYRGNK-VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
+V E++ SL+D ++R L + K L E + YL E
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGN-NF 138
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVR 419
+HRD+ N+L+ E+ AK++DFGL +
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 48/152 (31%), Positives = 76/152 (50%), Gaps = 13/152 (8%)
Query: 275 NKLGQGGSGSVYKGTLPGGE----AVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLV 328
+G+G G VY GTL + AVK L + + F E ++ +H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNVL 89
Query: 329 KLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
LLG C + L+V ++ + L + F+R + + + L A+G+ YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL--A 145
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
SK + +HRD+ N +LDE+FT K+ADFGL R
Sbjct: 146 SK-KFVHRDLAARNCMLDEKFTVKVADFGLAR 176
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 42/155 (27%), Positives = 70/155 (45%), Gaps = 13/155 (8%)
Query: 276 KLGQGGSGSVYKGTLPGGEA----VAVKRLFYNTTQW-VDHFFNEVNLISGINHKNLVKL 330
LG+G G VY+G + VAVK + T + F +E ++ ++H ++VKL
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 331 LG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
+G + ++ E P L ++ ++ L L + +AYL ES
Sbjct: 79 IGII--EEEPTWIIMELYPYGELGH--YLERNKNSLKVLTLVLYSLQICKAMAYL--ESI 132
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
+HRDI + NIL+ K+ DFGL R ++
Sbjct: 133 -NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 48/151 (31%), Positives = 71/151 (47%), Gaps = 6/151 (3%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
KLG G G V+ T VAVK + + V+ F E N++ + H LVKL
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV- 251
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
+T ++ EF+ SLLD L + AEG+A++ E + IH
Sbjct: 252 VTKEPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFI--EQR-NYIH 307
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425
RD++ +NIL+ KIADFGL R+ ++
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNE 338
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 49/152 (32%), Positives = 76/152 (50%), Gaps = 8/152 (5%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
KLGQG G V+ GT G VA+K L T + F E ++ + H+ LV+L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV- 330
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
++ +V E++ SLLD F++ + L + A G+AY+ E +
Sbjct: 331 VSEEPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYV--ERM-NYV 385
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425
HRD++ +NIL+ E K+ADFGL RL ++
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNE 417
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 57/157 (36%), Positives = 79/157 (50%), Gaps = 15/157 (9%)
Query: 276 KLGQGGSGSVYKGTL--PGGEA--VAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLV 328
KLG G G V +G P G+ VAVK L + + +D F EVN + ++H+NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 329 KLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
+L G P +V E P SLLD +R+ + + AEG+ YL E
Sbjct: 85 RLYGVV--LTPPMKMVTELAPLGSLLD--RLRKHQGHFLLGTLSRYAVQVAEGMGYL--E 138
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
SK R IHRD+ N+LL KI DFGL+R P++
Sbjct: 139 SK-RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 45/147 (30%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG-C 333
+G+G G V G G + VAVK + + T F E ++++ + H NLV+LLG
Sbjct: 199 QTIGKGEFGDVMLGDYRGNK-VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
+V E++ SL+D ++R L + K L E + YL E
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGN-NF 310
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVR 419
+HRD+ N+L+ E+ AK++DFGL +
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 49/152 (32%), Positives = 76/152 (50%), Gaps = 8/152 (5%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
KLGQG G V+ GT G VA+K L T + F E ++ + H+ LV+L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV- 247
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
++ +V E++ SLLD F++ + L + A G+AY+ E +
Sbjct: 248 VSEEPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYV--ERM-NYV 302
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425
HRD++ +NIL+ E K+ADFGL RL ++
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNE 334
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-27
Identities = 39/176 (22%), Positives = 70/176 (39%), Gaps = 15/176 (8%)
Query: 270 YFHESNKLGQGGSGSVYKGT-LPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKN 326
+ ++G+G +VYKG VA + T F E ++ G+ H N
Sbjct: 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 86
Query: 327 LVKLLGC---SITGPESLLVY-EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
+V+ ++ G + +++ E + + +L + + + +V +GL
Sbjct: 87 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKT---YLKRFKVMKIKVLRSWCRQILKGLQ 143
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRLFPEDITHISATLAGTLF 437
+LH + IIHRD+K NI + + KI D GL L + GT
Sbjct: 144 FLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPE 195
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-27
Identities = 44/154 (28%), Positives = 66/154 (42%), Gaps = 11/154 (7%)
Query: 276 KLGQGGSGSVYKGTL--PGGE--AVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKL 330
+G+G G V++G P AVA+K T+ + F E + +H ++VKL
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
+G IT ++ E L F++ L + LAYL ESK
Sbjct: 82 IGV-ITENPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYL--ESK- 135
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
R +HRDI N+L+ K+ DFGL R +
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 43/207 (20%), Positives = 77/207 (37%), Gaps = 17/207 (8%)
Query: 237 QKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEA 295
+ +R + + + KL + ++ ++G+G G V++ G
Sbjct: 26 KLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQ 85
Query: 296 VAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDN 355
AVK++ + E+ +G++ +V L G GP + E + SL
Sbjct: 86 CAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQL 140
Query: 356 LFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIAD 414
+ + + L + + EGL YLH RI+H D+K N+LL + A + D
Sbjct: 141 I---KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCD 194
Query: 415 FG----LVRLFPEDITHISATLAGTLF 437
FG L + GT
Sbjct: 195 FGHALCLQPDGLGKSLLTGDYIPGTET 221
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 42/162 (25%), Positives = 71/162 (43%), Gaps = 22/162 (13%)
Query: 275 NKLGQGGSGSVYKGTLPGGE----AVAVKRLFYNTTQWVDH--FFNEVNLISGINHKNLV 328
LG+G GSV + L + VAVK L + D F E + +H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 329 KLLG-CSITGPES-----LLVYEFVPNQSLLDNLFVR-----QDVEPLSWEVRYKIILST 377
KL+G + + +++ F+ + L F+ ++ L + + ++
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHA--FLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
A G+ YL S+ IHRD+ N +L E+ T +ADFGL R
Sbjct: 147 ACGMEYL--SSR-NFIHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 47/157 (29%), Positives = 77/157 (49%), Gaps = 13/157 (8%)
Query: 275 NKLGQGGSGSVYKGTLPGGE----AVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLV 328
+G+G G VY GTL + AVK L + + F E ++ +H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNVL 153
Query: 329 KLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
LLG C + L+V ++ + L + F+R + + + L A+G+ +L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFL--A 209
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
SK + +HRD+ N +LDE+FT K+ADFGL R +
Sbjct: 210 SK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 43/163 (26%), Positives = 73/163 (44%), Gaps = 10/163 (6%)
Query: 276 KLGQGGSGSVYKGTLPGGEA---VAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLL 331
+LG G GSV +G + VA+K L T + E ++ +++ +V+L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
G +LV E L F+ E + +++ + G+ YL E K
Sbjct: 403 GV-CQAEALMLVMEMAGGGPLHK--FLVGKREEIPVSNVAELLHQVSMGMKYL--EEK-N 456
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG 434
+HR++ N+LL AKI+DFGL + D ++ +A AG
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 499
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-27
Identities = 38/162 (23%), Positives = 73/162 (45%), Gaps = 23/162 (14%)
Query: 275 NKLGQGGSGSVYKGTLPGGE----AVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNL 327
LG+G GSV +G L + VAVK + + + + F +E + +H N+
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEE-FLSEAACMKDFSHPNV 98
Query: 328 VKLLG-CSITGPES----LLVYEFVPNQSLLDNLFVRQ-----DVEPLSWEVRYKIILST 377
++LLG C + +++ F+ L ++ + + + K ++
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHT--YLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
A G+ YL ++ +HRD+ N +L ++ T +ADFGL +
Sbjct: 157 ALGMEYL--SNR-NFLHRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-27
Identities = 46/156 (29%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 275 NKLGQGGSGSVYKGTL--PGGE--AVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLV 328
+G G SG V G L PG VA+K L T Q D F +E +++ +H N++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEASIMGQFDHPNII 113
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
+L G G +++V E++ N SL F+R + ++ G+ YL
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQFTIMQLVGMLRGVGAGMRYL--SD 169
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
+HRD+ N+L+D K++DFGL R+ +D
Sbjct: 170 L-GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 15/157 (9%)
Query: 276 KLGQGGSGSVYKGTL--PGGEA---VAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLV 328
+G G G VYKG L G+ VA+K L T Q VD F E ++ +H N++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQFSHHNII 109
Query: 329 KLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
+L G S P +++ E++ N +L F+R+ S ++ A G+ YL
Sbjct: 110 RLEGVISKYKP-MMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRGIAAGMKYL--A 164
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
+ +HRD+ NIL++ K++DFGL R+ +D
Sbjct: 165 NM-NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 57/187 (30%), Positives = 86/187 (45%), Gaps = 20/187 (10%)
Query: 232 RRKLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-L 290
+ + R+QL L + ++ LEK LG+G GSVYK
Sbjct: 2 LETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEK----------LGEGSYGSVYKAIHK 51
Query: 291 PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350
G+ VA+K++ + E++++ + ++VK G + +V E+
Sbjct: 52 ETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAG 109
Query: 351 SLLDNLFVRQDVEPLSWEVRYKIIL-STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT 409
S+ D + +R L+ E IL ST +GL YLH R IHRDIK NILL+ E
Sbjct: 110 SVSDIIRLRNK--TLT-EDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGH 163
Query: 410 AKIADFG 416
AK+ADFG
Sbjct: 164 AKLADFG 170
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 21/161 (13%)
Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRLFYNTTQW-VDHFFNEVNLISGINHKNL 327
+LGQG G VY+G G VA+K + + F NE +++ N ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQ---------DVEPLSWEVRYKIILSTA 378
V+LLG G +L++ E + L ++R + P S ++ A
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKS--YLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
+G+AYL + + +HRD+ N ++ E+FT KI DFG+ R
Sbjct: 149 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-26
Identities = 40/165 (24%), Positives = 72/165 (43%), Gaps = 21/165 (12%)
Query: 276 KLGQGGSGSVYKGTL--PGGEA------VAVKRLFYNTTQWVDHFFNEVNLISGINHKNL 327
LGQG ++KG G V +K L + + FF +++S ++HK+L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
V G + G E++LV EFV SL +++++ ++ + ++ A + +L E
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDT--YLKKNKNCINILWKLEVAKQLAAAMHFL--E 130
Query: 388 SKLRIIHRDIKLSNILLDEEFT--------AKIADFGLVRLFPED 424
+IH ++ NILL E K++D G+
Sbjct: 131 EN-TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 40/194 (20%), Positives = 80/194 (41%), Gaps = 15/194 (7%)
Query: 249 QVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKR--LFYNTT 306
V+ N ++++ + ++G GGS V++ + A+K L
Sbjct: 8 SSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN 67
Query: 307 QWVDHFFNEVNLISGINHKNL--VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP 364
Q +D + NE+ ++ + + ++L IT +V E N L L + +
Sbjct: 68 QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKS 123
Query: 365 LS-WEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
+ WE + + E + +H+ I+H D+K +N L+ + K+ DFG+
Sbjct: 124 IDPWERKS-YWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQP 178
Query: 424 DITHISA-TLAGTL 436
D T + + GT+
Sbjct: 179 DTTSVVKDSQVGTV 192
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-26
Identities = 39/165 (23%), Positives = 64/165 (38%), Gaps = 24/165 (14%)
Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV 328
+LG+G G V+ VAVK L T F E L++ + H+++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 329 KLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST---------- 377
K G C P ++V+E++ + L L + + + +
Sbjct: 81 KFYGVCGDGDP-LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 378 ---AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
A G+ YL + +HRD+ N L+ KI DFG+ R
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-26
Identities = 46/173 (26%), Positives = 70/173 (40%), Gaps = 31/173 (17%)
Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRLFYNTTQW-VDHFFNEVNLISGINHKNL 327
LG+G G V K T + VAVK L N + + +E N++ +NH ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST---------- 377
+KL G LL+ E+ SL L + V P S+
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 378 -----------AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
++G+ YL +++HRD+ NIL+ E KI+DFGL R
Sbjct: 149 MGDLISFAWQISQGMQYL--AEM-KLVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 37/174 (21%), Positives = 72/174 (41%), Gaps = 19/174 (10%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKR--LFYNTTQWVDHFFNEVNLISGINHKNL- 327
+ ++G GGS V++ + A+K L Q +D + NE+ ++ + +
Sbjct: 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 328 -VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLS-WEVRYKI--ILSTAEGLAY 383
++L IT +V E N L L + + + WE + +L +
Sbjct: 118 IIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKNMLE---AVHT 170
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA-TLAGTL 436
+H+ I+H D+K +N L+ + K+ DFG+ D T + + G +
Sbjct: 171 IHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAV 220
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 40/168 (23%), Positives = 69/168 (41%), Gaps = 17/168 (10%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQW-VDHFFNEVNLISGINHKNLV 328
F LG+GG G V++ A+KR+ + + EV ++ + H +V
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 329 KLLGCSITGPE---------SLLVY---EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS 376
+ + + +Y + ++L D + R +E V I L
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
AE + +LH + ++HRD+K SNI + K+ DFGLV +D
Sbjct: 127 IAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 171
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 43/150 (28%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN 326
K+G+G +G V G VAVK + Q + FNEV ++ H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
+V++ + G E ++ EF+ +L D + + E ++ + + + LAYLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEE---QIAT-VCEAVLQALAYLHA 159
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFG 416
+ +IHRDIK +ILL + K++DFG
Sbjct: 160 Q---GVIHRDIKSDSILLTLDGRVKLSDFG 186
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 49/191 (25%), Positives = 80/191 (41%), Gaps = 23/191 (12%)
Query: 253 NKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLF-YNTTQWVD 310
++S N + + LGQG + +V++G G+ A+K + + VD
Sbjct: 3 SQSTSNHLWLLSDI----------LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVD 52
Query: 311 HFFNEVNLISGINHKNLVKLLGC--SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWE 368
E ++ +NHKN+VKL T +L+ EF P SL L + L
Sbjct: 53 VQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES 112
Query: 369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLVRLFPED 424
++ G+ +L + I+HR+IK NI+ D + K+ DFG R +D
Sbjct: 113 EFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169
Query: 425 ITHISATLAGT 435
+L GT
Sbjct: 170 --EQFVSLYGT 178
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 48/164 (29%), Positives = 74/164 (45%), Gaps = 23/164 (14%)
Query: 275 NKLGQGGSGSVYKGTLPGGEA---VAVKRL--FYNTTQWVDHFFNEVNLISGI-NHKNLV 328
+ +G+G G V K + A+KR+ + + D F E+ ++ + +H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNII 89
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST----------- 377
LLG L E+ P+ +LLD L + +E ST
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 378 --AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
A G+ YL S+ + IHRD+ NIL+ E + AKIADFGL R
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-26
Identities = 40/148 (27%), Positives = 73/148 (49%), Gaps = 8/148 (5%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+ +LG G G VYK G A K + + + ++ + E+ +++ +H +VK
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIIL-STAEGLAYLHEES 388
LLG + ++ EF P ++ + + L+ E + +++ E L +LH +
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDA--IMLELDRGLT-EPQIQVVCRQMLEALNFLHSK- 136
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFG 416
RIIHRD+K N+L+ E ++ADFG
Sbjct: 137 --RIIHRDLKAGNVLMTLEGDIRLADFG 162
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-26
Identities = 38/172 (22%), Positives = 73/172 (42%), Gaps = 15/172 (8%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKR--LFYNTTQWVDHFFNEVNLISGINHKNL- 327
+ ++G GGS V++ + A+K L Q +D + NE+ ++ + +
Sbjct: 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 328 -VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLS-WEVRYKIILSTAEGLAYLH 385
++L IT +V E N L L + + + WE + + E + +H
Sbjct: 71 IIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKS-YWKNMLEAVHTIH 125
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA-TLAGTL 436
+ I+H D+K +N L+ + K+ DFG+ D T + + GT+
Sbjct: 126 QH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTV 173
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-26
Identities = 41/150 (27%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN 326
+ K+GQG SG+VY + G+ VA++++ + NE+ ++ + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
+V L + G E +V E++ SL D + E ++ + + L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG---QIAA-VCRECLQALEFLHS 134
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFG 416
++IHRDIK NILL + + K+ DFG
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFG 161
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 45/156 (28%), Positives = 75/156 (48%), Gaps = 12/156 (7%)
Query: 275 NKLGQGGSGSVYKGTL--PGGE--AVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLV 328
+G G G V G L P + +VA+K L T Q D F E +++ +H N++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNII 109
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
+L G ++V E++ N SL F+R+ + ++ A G+ YL S
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---S 164
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
+ +HRD+ NIL++ K++DFGL R+ +D
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 36/188 (19%), Positives = 75/188 (39%), Gaps = 12/188 (6%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYN--TTQ 307
V+ N ++++EK + K+G+G G G +K + + +++
Sbjct: 10 GVDLGTENLYFQSMEK----YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK 65
Query: 308 WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSW 367
+ EV +++ + H N+V+ +V ++ L Q
Sbjct: 66 EREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDL-FKRINAQKGVLFQE 124
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
+ + L ++H+ +I+HRDIK NI L ++ T ++ DFG+ R+
Sbjct: 125 DQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-VE 180
Query: 428 ISATLAGT 435
++ GT
Sbjct: 181 LARACIGT 188
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 41/169 (24%), Positives = 66/169 (39%), Gaps = 23/169 (13%)
Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV 328
+LG+G G V+ VAVK L + F E L++ + H+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 329 KLLG-CSITGPESLLVYEFVPNQSLLDNL------------FVRQDVEPLSWEVRYKIIL 375
+ G C+ P L+V+E++ + L L PL +
Sbjct: 107 RFFGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 376 STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
A G+ YL + L +HRD+ N L+ + KI DFG+ R
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 211
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 44/155 (28%), Positives = 65/155 (41%), Gaps = 13/155 (8%)
Query: 276 KLGQGGSGSVYKGTL--PGGEA--VAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLVK 329
+G+G G V++G P A VA+K T+ F E + +H ++VK
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVK 455
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
L+G IT ++ E L F++ L + LAYL ESK
Sbjct: 456 LIGV-ITENPVWIIMELCTLGELRS--FLQVRKFSLDLASLILYAYQLSTALAYL--ESK 510
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
R +HRDI N+L+ K+ DFGL R +
Sbjct: 511 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 46/167 (27%), Positives = 71/167 (42%), Gaps = 25/167 (14%)
Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKN 326
LG+G G V + G + VAVK L T +E+ ++ I +H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST-------- 377
+V LLG C+ G +++ EF +L L +++ +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 378 -----AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
A+G+ +L S+ + IHRD+ NILL E+ KI DFGL R
Sbjct: 153 YSFQVAKGMEFL--ASR-KCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 52/165 (31%), Positives = 73/165 (44%), Gaps = 24/165 (14%)
Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKN 326
LG G G V + T G VAVK L + +E+ ++S + H+N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNL-FVRQDVEPLSWEVRYKIILST------- 377
+V LLG C+ GP L++ E+ LL+ L + +E ST
Sbjct: 112 IVNLLGACTHGGP-VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 378 ---AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
A+G+A+L SK IHRD+ N+LL AKI DFGL R
Sbjct: 171 SQVAQGMAFL--ASK-NCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 50/191 (26%), Positives = 80/191 (41%), Gaps = 23/191 (12%)
Query: 253 NKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLF-YNTTQWVD 310
++S N + + LGQG + +V++G G+ A+K + + VD
Sbjct: 3 SQSTSNHLWLLSDI----------LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVD 52
Query: 311 HFFNEVNLISGINHKNLVKLLGC--SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWE 368
E ++ +NHKN+VKL T +L+ EF P SL L + L
Sbjct: 53 VQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES 112
Query: 369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLVRLFPED 424
++ G+ +L E I+HR+IK NI+ D + K+ DFG R +D
Sbjct: 113 EFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169
Query: 425 ITHISATLAGT 435
+L GT
Sbjct: 170 --EQFVSLYGT 178
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 26/168 (15%)
Query: 275 NKLGQGGSGSVYKGTLPGGE--------AVAVKRLFYNTTQW-VDHFFNEVNLISGI-NH 324
LG+G G V G + VAVK L + T+ + +E+ ++ I H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNL-------------FVRQDVEPLSWEVRY 371
KN++ LLG ++ E+ +L + L R E ++++
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
A G+ YL S+ + IHRD+ N+L+ E KIADFGL R
Sbjct: 161 SCTYQLARGMEYL--ASQ-KCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 49/163 (30%), Positives = 67/163 (41%), Gaps = 25/163 (15%)
Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRL--FYNTTQWVDHFFNEVNLISGINHKN 326
LG G G VY+G + G VAVK L + +D F E +IS NH+N
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQN 94
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQ------DVEPLSWEVRYKIILSTAE 379
+V+ +G + P ++ E + L F+R+ L+ + A
Sbjct: 95 IVRCIGVSLQSLP-RFILMELMAGGDLKS--FLRETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVR 419
G YL E IHRDI N LL AKI DFG+ R
Sbjct: 152 GCQYL--EEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 43/166 (25%), Positives = 72/166 (43%), Gaps = 25/166 (15%)
Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNL 327
+LG+ G VYKG L G AVA+K L + F +E L + + H N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 328 VKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST--------- 377
V LLG + P +++ + + L + L +R + + + S
Sbjct: 75 VCLLGVVTKDQP-LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 378 ----AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
A G+ YL S ++H+D+ N+L+ ++ KI+D GL R
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 45/168 (26%), Positives = 76/168 (45%), Gaps = 20/168 (11%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLV 328
F + K+G+G G V+KG + VA+K + + ++ E+ ++S + +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
K G + + ++ E++ S LD L E ++ I+ +GL YLH E
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDET---QIAT-ILREILKGLDYLHSE- 138
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
+ IHRDIK +N+LL E K+ADFG ++ L T
Sbjct: 139 --KKIHRDIKAANVLLSEHGEVKLADFG-----------VAGQLTDTQ 173
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-25
Identities = 42/146 (28%), Positives = 67/146 (45%), Gaps = 12/146 (8%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLF---YNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
LG+GG ++ + E A K + + E+++ + H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLR 391
+V E +SLL+ R+ + EP E RY + G YLH + R
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEP---EARY-YLRQIVLGCQYLH---RNR 161
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGL 417
+IHRD+KL N+ L+E+ KI DFGL
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGL 187
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 46/168 (27%), Positives = 73/168 (43%), Gaps = 26/168 (15%)
Query: 275 NKLGQGGSGSVYKGTLPGGE--------AVAVKRLFYNTTQW-VDHFFNEVNLISGI-NH 324
LG+G G V G + VAVK L + T+ + +E+ ++ I H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNL---------FVRQDVEPLSWEVRYKIIL 375
KN++ LLG ++ E+ +L + L + ++ K ++
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 376 S----TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
S A G+ YL SK + IHRD+ N+L+ E+ KIADFGL R
Sbjct: 195 SCAYQVARGMEYL--ASK-KCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-25
Identities = 54/169 (31%), Positives = 75/169 (44%), Gaps = 28/169 (16%)
Query: 275 NKLGQGGSGSVYKGTLPGGEA------VAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKN 326
LG G G V + T G VAVK L + + +E+ ++S + NH N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNL------FVRQDVEPLSWEVRYKIILST-- 377
+V LLG C+I GP +L++ E+ LL+ L F+ P E +
Sbjct: 89 IVNLLGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 378 -------AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
A+G+A+L SK IHRD+ NILL KI DFGL R
Sbjct: 148 LSFSYQVAKGMAFL--ASK-NCIHRDLAARNILLTHGRITKICDFGLAR 193
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 50/172 (29%), Positives = 70/172 (40%), Gaps = 16/172 (9%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRL-FYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
+G G + V P E VA+KR+ +D E+ +S +H N+V
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 334 SITGPESLLVYEFVPNQSLLD-----NLFVRQDVEPLSWEVRYKIIL-STAEGLAYLHEE 387
+ E LV + + S+LD L E IL EGL YLH+
Sbjct: 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD-ESTIATILREVLEGLEYLHKN 140
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFG----LVRLFPEDITHISATLAGT 435
+ IHRD+K NILL E+ + +IADFG L + T GT
Sbjct: 141 GQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 26/168 (15%)
Query: 275 NKLGQGGSGSVYKGTLPGGE--------AVAVKRLFYNTTQW-VDHFFNEVNLISGI-NH 324
LG+G G V G + VAVK L + T+ + +E+ ++ I H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNL-------------FVRQDVEPLSWEVRY 371
KN++ LLG ++ E+ +L + L R E ++++
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
A G+ YL S+ + IHRD+ N+L+ E KIADFGL R
Sbjct: 207 SCTYQLARGMEYL--ASQ-KCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 48/163 (29%), Positives = 67/163 (41%), Gaps = 25/163 (15%)
Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRL--FYNTTQWVDHFFNEVNLISGINHKN 326
LG G G VY+G + G VAVK L + +D F E +IS NH+N
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQN 135
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQ------DVEPLSWEVRYKIILSTAE 379
+V+ +G + P ++ E + L F+R+ L+ + A
Sbjct: 136 IVRCIGVSLQSLP-RFILLELMAGGDLKS--FLRETRPRPSQPSSLAMLDLLHVARDIAC 192
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVR 419
G YL + IHRDI N LL AKI DFG+ R
Sbjct: 193 GCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 35/148 (23%), Positives = 61/148 (41%), Gaps = 11/148 (7%)
Query: 275 NKLGQGGS--GSVYKGT-LPGGEAVAVKR--LFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+G+G +V P GE V V+R L + + V E+++ NH N+V
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIIL-STAEGLAYLHEES 388
I E +V F+ S D L ++ ++ E+ IL + L Y+H
Sbjct: 91 YRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMN-ELAIAYILQGVLKALDYIHHMG 148
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFG 416
+HR +K S+IL+ + ++
Sbjct: 149 Y---VHRSVKASHILISVDGKVYLSGLR 173
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 42/147 (28%), Positives = 69/147 (46%), Gaps = 14/147 (9%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLF---YNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
LG+GG ++ + E A K + + E+++ + H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 333 CSITGPESL-LVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKL 390
+ + +V E +SLL+ R+ + EP E RY + G YLH +
Sbjct: 83 F-FEDNDFVFVVLELCRRRSLLELHKRRKALTEP---EARY-YLRQIVLGCQYLH---RN 134
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGL 417
R+IHRD+KL N+ L+E+ KI DFGL
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGL 161
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 12/151 (7%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFF---NEVNLISGINHKN 326
F + ++G G G+VY + E VA+K++ Y+ Q + + EV + + H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIIL-STAEGLAYLH 385
++ GC + + LV E+ S D L V + +PL EV + +GLAYLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHK--KPLQ-EVEIAAVTHGALQGLAYLH 171
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFG 416
+IHRD+K NILL E K+ DFG
Sbjct: 172 SH---NMIHRDVKAGNILLSEPGLVKLGDFG 199
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 50/184 (27%), Positives = 79/184 (42%), Gaps = 12/184 (6%)
Query: 246 GALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYN 304
G+L A + + +F +T+E L +GG VY+ + G A+KRL N
Sbjct: 5 GSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN 64
Query: 305 TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPES-------LLVYEFVPNQSLLDNL 356
+ EV + + H N+V+ + G E L+ + L++ L
Sbjct: 65 EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL 124
Query: 357 FVRQDVEPLS-WEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415
+ PLS V KI T + ++H K IIHRD+K+ N+LL + T K+ DF
Sbjct: 125 KKMESRGPLSCDTVL-KIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDF 182
Query: 416 GLVR 419
G
Sbjct: 183 GSAT 186
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 52/222 (23%), Positives = 84/222 (37%), Gaps = 39/222 (17%)
Query: 234 KLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHE--------SNKLGQGGSGSV 285
K ++ R QL +QV + F + E + E LG G G V
Sbjct: 2 KYKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKV 61
Query: 286 YKGTLPGGEA------VAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKNLVKLLGCSITG 337
T G VAVK L + +E+ +++ + +H+N+V LLG
Sbjct: 62 MNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121
Query: 338 PESLLVYEFVPNQSLLDNL----------FVRQDVEPLSWEVRYKIILST---------- 377
L++E+ LL+ L + + + E +L+
Sbjct: 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 181
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
A+G+ +L E K +HRD+ N+L+ KI DFGL R
Sbjct: 182 AKGMEFL--EFK-SCVHRDLAARNVLVTHGKVVKICDFGLAR 220
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 47/187 (25%), Positives = 80/187 (42%), Gaps = 33/187 (17%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
F E +G GG G V+K G+ +KR+ YN + EV ++ ++H N+V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVH 68
Query: 330 LLGC-------------SITGPESLLVY---EFVPNQSLLDNLFVRQDV---EPLSWEVR 370
GC + + ++ ++ EF +L + R+ + L+
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL--- 125
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA 430
++ +G+ Y+H + ++I+RD+K SNI L + KI DFGLV D
Sbjct: 126 -ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--T 179
Query: 431 TLAGTLF 437
GTL
Sbjct: 180 RSKGTLR 186
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 47/174 (27%), Positives = 69/174 (39%), Gaps = 33/174 (18%)
Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRL--FYNTTQWVDHFFNEVNLISGINHKN 326
+G+G G V++ PG VAVK L + D F E L++ ++ N
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMAEFDNPN 111
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST--------- 377
+VKLLG G L++E++ L + L S +
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 378 ------------AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
A G+AYL S+ + +HRD+ N L+ E KIADFGL R
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 99.5 bits (249), Expect = 7e-24
Identities = 51/166 (30%), Positives = 71/166 (42%), Gaps = 14/166 (8%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLG 332
LG+G VY+ + G VA+K + V NEV + + H ++++L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLS-WEVRYKIILSTAEGLAYLHEESKLR 391
LV E N + L R +P S E R+ + G+ YLH
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRV--KPFSENEARH-FMHQIITGMLYLH---SHG 132
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTL 436
I+HRD+ LSN+LL KIADFGL +L H TL GT
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH--YTLCGTP 176
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 44/171 (25%), Positives = 74/171 (43%), Gaps = 26/171 (15%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
F E LGQG G V K A+K++ + + + +EV L++ +NH+ +V+
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVR 66
Query: 330 LLGC----------SITGPESLLVY---EFVPNQSLLDNLFVRQDV---EPLSWEVRYKI 373
+ ++ E+ N +L D L +++ W + +I
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYD-LIHSENLNQQRDEYWRLFRQI 125
Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
+ E L+Y+H + IIHRD+K NI +DE KI DFGL +
Sbjct: 126 L----EALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-23
Identities = 48/158 (30%), Positives = 75/158 (47%), Gaps = 21/158 (13%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRL-------FYNTTQWVDHFFNEVNLISGINHKN 326
KLG G +VYKG G VA+K + +T E++L+ + H+N
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA------IREISLMKELKHEN 64
Query: 327 LVKLLGCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
+V+L I L LV+EF+ N + +D+ V L + +GLA+
Sbjct: 65 IVRLYDV-IHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
HE +I+HRD+K N+L+++ K+ DFGL R F
Sbjct: 124 CHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF 158
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 5e-23
Identities = 45/183 (24%), Positives = 75/183 (40%), Gaps = 13/183 (7%)
Query: 258 NFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYN---TTQWVDHFF 313
+ Y TL F K+G+G VY+ L G VA+K++ +
Sbjct: 25 DMGYNTLAN----FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCI 80
Query: 314 NEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVEPLSWEVRYK 372
E++L+ +NH N++K I E +V E L + ++ + +K
Sbjct: 81 KEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWK 140
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
+ L ++H R++HRDIK +N+ + K+ D GL R F T +L
Sbjct: 141 YFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH-SL 196
Query: 433 AGT 435
GT
Sbjct: 197 VGT 199
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 47/173 (27%), Positives = 70/173 (40%), Gaps = 15/173 (8%)
Query: 253 NKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDH 311
+S L F +G G G VYKG + G+ A+K + + +
Sbjct: 8 ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE- 66
Query: 312 FFNEVNLISGI-NHKNLVKLLGCSITGPESL------LVYEFVPNQSLLDNLFVRQDVEP 364
E+N++ +H+N+ G I LV EF S+ D L
Sbjct: 67 IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNT 125
Query: 365 LS-WEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416
L + Y I GL++LH+ ++IHRDIK N+LL E K+ DFG
Sbjct: 126 LKEEWIAY-ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 174
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 46/207 (22%), Positives = 80/207 (38%), Gaps = 30/207 (14%)
Query: 253 NKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLF---------- 302
N LN + +K N + L QG + + A+K+
Sbjct: 15 NLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDF 73
Query: 303 -------YNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLD 354
+ D F NE+ +I+ I ++ + G IT + + ++YE++ N S+L
Sbjct: 74 TKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG-IITNYDEVYIIYEYMENDSILK 132
Query: 355 NL-----FVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT 409
+ + +V II S +Y+H ++ I HRD+K SNIL+D+
Sbjct: 133 FDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGR 190
Query: 410 AKIADFGLVRLFPEDITHISATLAGTL 436
K++DFG + GT
Sbjct: 191 VKLSDFGESEYMVDKKIK---GSRGTY 214
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 3e-22
Identities = 48/180 (26%), Positives = 73/180 (40%), Gaps = 25/180 (13%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFN-----EVNL---ISG 321
+ ++G G G+VYK G VA+K + EV L +
Sbjct: 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 322 INHKNLVKLL----GCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKII 374
H N+V+L+ + LV+E V ++ LD L E ++
Sbjct: 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA----PPPGLPAETIKDLM 126
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF--PEDITHISATL 432
GL +LH I+HRD+K NIL+ T K+ADFGL R++ +T + TL
Sbjct: 127 RQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTL 183
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 3e-22
Identities = 47/170 (27%), Positives = 80/170 (47%), Gaps = 21/170 (12%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFN-----EVNLISGINHKNLV 328
+ LG+G +VYK + VA+K++ N E+ L+ ++H N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 329 KLLGCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
LL ++ LV++F+ + ++ + + L+ +L T +GL YLH
Sbjct: 76 GLLDA-FGHKSNISLVFDFMETDLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLH 129
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDITHISATL 432
+ I+HRD+K +N+LLDE K+ADFGL + F TH T
Sbjct: 130 QH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR 176
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-22
Identities = 48/166 (28%), Positives = 66/166 (39%), Gaps = 13/166 (7%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKL 330
LG+G G+VY +A+K LF EV + S + H N+++L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
G L+ E+ P ++ L Q + + I A L+Y H
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCH---SK 128
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
R+IHRDIK N+LL KIADFG P L GTL
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---DLCGTL 171
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 4e-22
Identities = 51/172 (29%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRL--------FYNTTQWVDHFFNEVNLISGINHKN 326
K+G+G G VYK G VA+KR+ +T E++L+ ++H N
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA------IREISLLKELHHPN 80
Query: 327 LVKLLGCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
+V L+ I L LV+EF+ + +LD L + G+A+
Sbjct: 81 IVSLIDV-IHSERCLTLVFEFMEKDLKKVLDENKT-----GLQDSQIKIYLYQLLRGVAH 134
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDITHISATL 432
H+ RI+HRD+K N+L++ + K+ADFGL R F TH TL
Sbjct: 135 CHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTL 183
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 97.4 bits (242), Expect = 6e-22
Identities = 44/172 (25%), Positives = 69/172 (40%), Gaps = 16/172 (9%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRL-FYNTTQWVDHFFNEVNLISGINHKNLVKLL-- 331
+LG GG G V + GE VA+K+ + + + + E+ ++ +NH N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 332 ----GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
LL E+ L L ++ L ++ + L YLHE
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE- 139
Query: 388 SKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITHISATLAGTL 436
RIIHRD+K NI+L + KI D G + + + GTL
Sbjct: 140 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--ELCTEFVGTL 187
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 6e-22
Identities = 45/181 (24%), Positives = 82/181 (45%), Gaps = 7/181 (3%)
Query: 238 KRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTL-PGGEAV 296
K+ E +L Q ++ L + E + F + ++LG G G V+K + P G +
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVM 61
Query: 297 AVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDN 355
A K + + + E+ ++ N +V G + E + E + SL
Sbjct: 62 ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ- 120
Query: 356 LFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415
V + + ++ K+ ++ +GL YL E+ +I+HRD+K SNIL++ K+ DF
Sbjct: 121 --VLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDF 176
Query: 416 G 416
G
Sbjct: 177 G 177
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 8e-22
Identities = 53/169 (31%), Positives = 77/169 (45%), Gaps = 23/169 (13%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFN-----EVNLISGINHKNLVK 329
K+G+G G VYK GE A+K++ D E++++ + H N+VK
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKE---DEGIPSTTIREISILKELKHSNIVK 64
Query: 330 LLGCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
L I + L LV+E + + LLD L +L G+AY H+
Sbjct: 65 LYDV-IHTKKRLVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHD 118
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDITHISATL 432
R++HRD+K N+L++ E KIADFGL R F TH TL
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL 164
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 40/204 (19%), Positives = 70/204 (34%), Gaps = 15/204 (7%)
Query: 239 RRERKQLGALQVAVNKSKLNFSYETLEKATNY---FHESNKLGQGGSGSVYKGT-LPGGE 294
+ + + + + +++ + Y+ + + F ++LG G G V+K G
Sbjct: 24 HQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGR 83
Query: 295 AVAVK--RLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPNQS 351
AVK + + EV + H V+L G L E S
Sbjct: 84 LYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPS 142
Query: 352 LLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAK 411
L + L + + T LA+LH + ++H D+K +NI L K
Sbjct: 143 LQQHC--EAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCK 197
Query: 412 IADFGLVRLFPEDITHISATLAGT 435
+ DFGL+ G
Sbjct: 198 LGDFGLLVEL--GTAGAGEVQEGD 219
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 2e-21
Identities = 50/189 (26%), Positives = 75/189 (39%), Gaps = 30/189 (15%)
Query: 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVN-LISGINHKNL 327
N LG G SG+V G VAVKR+ + D E+ L +H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM---LIDFCDIALMEIKLLTESDDHPNV 71
Query: 328 VKLLGCSITGPESL-LVYEFVPNQSLLD----NLFVRQDVEPLSWEVRYKIILSTAEGLA 382
++ CS T L + E N +L D ++++ ++ A G+A
Sbjct: 72 IRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 383 YLHEESKLRIIHRDIKLSNILLD-------------EEFTAKIADFGLVRLFPEDITHIS 429
+LH L+IIHRD+K NIL+ E I+DFGL + +
Sbjct: 130 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 430 ATL---AGT 435
L +GT
Sbjct: 187 TNLNNPSGT 195
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-21
Identities = 43/168 (25%), Positives = 70/168 (41%), Gaps = 9/168 (5%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLG 332
+G G G K G+ + K L Y T +EVNL+ + H N+V+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 333 CSITGPESLL--VYEFVPNQSLLDNL-FVRQDVEPLSWEVRYKIILSTAEGLAYLHE--E 387
I + L V E+ L + ++ + L E +++ L H +
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
++HRD+K +N+ LD + K+ DFGL R+ D T + T GT
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKTFVGT 179
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 48/190 (25%), Positives = 80/190 (42%), Gaps = 20/190 (10%)
Query: 253 NKSKLNFSYE-TLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWV 309
+ KL S E + + ++G+G GSV K P G+ +AVKR+ +
Sbjct: 5 SSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ 64
Query: 310 DHFFNEVN-LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL--FVRQDVEPLS 366
+++ ++ + +V+ G + + E + + S + +
Sbjct: 65 KQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIP 123
Query: 367 WEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426
E+ KI L+T + L +L L+IIHRDIK SNILLD K+ DFG
Sbjct: 124 EEILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFG---------- 171
Query: 427 HISATLAGTL 436
IS L ++
Sbjct: 172 -ISGQLVDSI 180
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 3e-21
Identities = 46/174 (26%), Positives = 74/174 (42%), Gaps = 19/174 (10%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVK 329
F + LG G G++ + VAVKR+ + D EV L+ + H N+++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVIR 82
Query: 330 LLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
C+ + + E + L ++D L E ++ T GLA+LH
Sbjct: 83 YF-CTEKDRQFQYIAIELCA--ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLHS-- 136
Query: 389 KLRIIHRDIKLSNILLDE-----EFTAKIADFGLVRLFPEDITHIS--ATLAGT 435
L I+HRD+K NIL+ + A I+DFGL + S + + GT
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 48/176 (27%), Positives = 79/176 (44%), Gaps = 29/176 (16%)
Query: 271 FHESNKLGQGGSGSVYKGTLPG-GEAVAVKRL-------FYNTTQWVDHFFNEVNLISGI 322
+ + +KLG+G +VYKG VA+K + T EV+L+ +
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA------IREVSLLKDL 57
Query: 323 NHKNLVKLLGCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
H N+V L I +SL LV+E++ + LD+ ++ +
Sbjct: 58 KHANIVTLHDI-IHTEKSLTLVFEYLDKDLKQYLDDCGN-----IINMHNVKLFLFQLLR 111
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDITHISATL 432
GLAY H + +++HRD+K N+L++E K+ADFGL R + + TL
Sbjct: 112 GLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTL 164
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 3e-21
Identities = 42/159 (26%), Positives = 72/159 (45%), Gaps = 27/159 (16%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRL--------FYNTTQWVDHFFNEVNLISGINHK 325
K+G+G G+V+K E VA+KR+ ++ E+ L+ + HK
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA------LREICLLKELKHK 61
Query: 326 NLVKLLGCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
N+V+L + + L LV+EF + D+ L E+ + +GL
Sbjct: 62 NIVRLHDV-LHSDKKLTLVFEFCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLG 115
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
+ H ++HRD+K N+L++ K+A+FGL R F
Sbjct: 116 FCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF 151
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 3e-21
Identities = 53/173 (30%), Positives = 81/173 (46%), Gaps = 29/173 (16%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRL--------FYNTTQWVDHFFNEVNLISGINHK 325
K+G+G G VYK GE VA+K++ +T E++L+ +NH
Sbjct: 9 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA------IREISLLKELNHP 62
Query: 326 NLVKLLGCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
N+VKLL I L LV+EF+ + +D + + + + +GLA
Sbjct: 63 NIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALT----GIPLPLIKSYLFQLLQGLA 117
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDITHISATL 432
+ H R++HRD+K N+L++ E K+ADFGL R F TH TL
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL 167
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 6e-21
Identities = 44/178 (24%), Positives = 78/178 (43%), Gaps = 18/178 (10%)
Query: 263 TLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHFFNEVN-LI 319
++E + +LG+G G V K +P G+ +AVKR+ +Q +++ +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVEPLSWEVRYKIILSTA 378
++ V G + + E + + SL V + + ++ KI +S
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
+ L +LH SKL +IHRD+K SN+L++ K+ DFG IS L +
Sbjct: 120 KALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFG-----------ISGYLVDDV 164
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 9e-21
Identities = 48/184 (26%), Positives = 76/184 (41%), Gaps = 35/184 (19%)
Query: 271 FHESNKLGQGGSGSVYKG--TLPGGEAVAVKRL--------FYNTTQWVDHFFNEVNL-- 318
+ ++G+G G V+K GG VA+KR+ +T EV +
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST------IREVAVLR 66
Query: 319 -ISGINHKNLVKLL----GCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVR 370
+ H N+V+L L LV+E V + LD + + E
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV----PEPGVPTETI 122
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF--PEDITHI 428
++ GL +LH R++HRD+K NIL+ K+ADFGL R++ +T +
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV 179
Query: 429 SATL 432
TL
Sbjct: 180 VVTL 183
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 9e-21
Identities = 35/219 (15%), Positives = 64/219 (29%), Gaps = 26/219 (11%)
Query: 231 VRRKLLQKRRER-KQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT 289
+ KLL + K + + + + LG+G VY+ T
Sbjct: 26 LIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEAT 85
Query: 290 LPG------GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343
+ +K + + +K + S+LV
Sbjct: 86 QGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLV 145
Query: 344 YEFVPNQSLLD--NLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSN 401
E +LL+ NL+ + + + + + +H IIH DIK N
Sbjct: 146 GELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDN 202
Query: 402 ILL-----------DEEFTAKIADFGL---VRLFPEDIT 426
+L D + D G ++LFP+
Sbjct: 203 FILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTI 241
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 1e-20
Identities = 45/167 (26%), Positives = 68/167 (40%), Gaps = 19/167 (11%)
Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVK 329
LG+G G+VY K +A+K LF + E+ + S + H N+++
Sbjct: 22 LGKGKFGNVYLAREKQN---KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILR 78
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
+ L+ EF P L L Q + + A+ L Y H +
Sbjct: 79 MYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYCH---E 132
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
++IHRDIK N+L+ + KIADFG P T+ GTL
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR---TMCGTL 176
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-20
Identities = 40/173 (23%), Positives = 61/173 (35%), Gaps = 27/173 (15%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKR--LFYNTTQWVDHFFNEVNLISGI-NHKN 326
FHE K+G G GSV+K G A+KR + + EV + + H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
+V+ L+ E+ SL D + + + ++L GL Y+H
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 386 EESKLRIIHRDIKLSNILLDEE-------------------FTAKIADFGLVR 419
++H DIK SNI + KI D G V
Sbjct: 133 SM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 4e-20
Identities = 47/182 (25%), Positives = 75/182 (41%), Gaps = 30/182 (16%)
Query: 261 YETLEKATNYFHESNKLGQGGSGSVYKG----TLPGGEAVAVKRL-FYNTTQWVDHF-FN 314
YE + K +G+G G V+K T G+ VA+K+ +
Sbjct: 5 YEKIGK----------IGEGSYGVVFKCRNRDT---GQIVAIKKFLESEDDPVIKKIALR 51
Query: 315 EVNLISGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI 373
E+ ++ + H NLV LL L LV+E+ + ++L + + + + I
Sbjct: 52 EIRMLKQLKHPNLVNLLEV-FRRKRRLHLVFEYC-DHTVLH--ELDRYQRGVPEHLVKSI 107
Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF--PEDI-THISA 430
T + + + H K IHRD+K NIL+ + K+ DFG RL P D A
Sbjct: 108 TWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA 164
Query: 431 TL 432
T
Sbjct: 165 TR 166
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 4e-20
Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 276 KLGQGGSGSVYKGT---LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVK 329
KLG GG +VY L VA+K + + + F EV+ S ++H+N+V
Sbjct: 18 KLGGGGMSTVYLAEDTIL--NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
++ LV E++ +L + + + PLS + +G+ + H+
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAHDM-- 130
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED-ITHISATLAGT 435
RI+HRDIK NIL+D T KI DFG+ + E +T + L GT
Sbjct: 131 -RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-GT 175
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 4e-20
Identities = 50/178 (28%), Positives = 73/178 (41%), Gaps = 36/178 (20%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRL--------FYNTTQWVDHFFNEVNLISGINHK 325
KLG+G G VYK E VA+KR+ T EV+L+ + H+
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA------IREVSLLKELQHR 93
Query: 326 NLVKLLGCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
N+++L I L L++E+ N + +D +S V + G+
Sbjct: 94 NIIELKSV-IHHNHRLHLIFEYAENDLKKYMDKN------PDVSMRVIKSFLYQLINGVN 146
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTA-----KIADFGLVRLF---PEDITHISATL 432
+ H R +HRD+K N+LL + KI DFGL R F TH TL
Sbjct: 147 FCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITL 201
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 4e-20
Identities = 49/186 (26%), Positives = 68/186 (36%), Gaps = 38/186 (20%)
Query: 261 YETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL--------FYNTTQWVDH 311
YE L +G+G G V K G VA+K+
Sbjct: 27 YENLGL----------VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA----- 71
Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEV 369
E+ L+ + H+NLV LL LV+EFV + L+ L ++V
Sbjct: 72 -MREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPN-----GLDYQV 125
Query: 370 RYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDIT 426
K + G+ + H IIHRDIK NIL+ + K+ DFG R E
Sbjct: 126 VQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD 182
Query: 427 HISATL 432
AT
Sbjct: 183 DEVATR 188
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 6e-20
Identities = 42/195 (21%), Positives = 78/195 (40%), Gaps = 20/195 (10%)
Query: 246 GALQVAVNKS-KLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFY 303
G+ + ++ L + + N ++G G G V+K G +AVK++
Sbjct: 1 GSSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR 60
Query: 304 NTT-QWVDHFFNEVN-LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQD 361
+ + +++ ++ + +V+ G IT + + E + ++
Sbjct: 61 SGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEK--LKKRM 117
Query: 362 VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
P+ + K+ ++ + L YL K +IHRD+K SNILLDE K+ DFG
Sbjct: 118 QGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFG----- 170
Query: 422 PEDITHISATLAGTL 436
IS L
Sbjct: 171 ------ISGRLVDDK 179
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 6e-20
Identities = 49/188 (26%), Positives = 83/188 (44%), Gaps = 40/188 (21%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL--------FYNTTQWVDHFFNEVNLISG 321
+ + K+GQG G V+K G+ VA+K++ F T E+ ++
Sbjct: 19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA------LREIKILQL 72
Query: 322 INHKNLVKLLG-------CSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRY 371
+ H+N+V L+ S+ LV++F + LL N+ V +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-----KFTLSEIK 127
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-------PED 424
+++ GL Y+H +I+HRD+K +N+L+ + K+ADFGL R F P
Sbjct: 128 RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 425 ITHISATL 432
T+ TL
Sbjct: 185 YTNRVVTL 192
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 25/177 (14%), Positives = 54/177 (30%), Gaps = 37/177 (20%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFY----------------------------NTTQ 307
LGQ + + T GE+ V ++ +
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 308 WVDHFFNEVNLISGINHKNLVKLLGC--SITGPESLLVYEFV--PNQSLLDNLFVRQDV- 362
F +L+ K ++++ + +Y + Q+ + L
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 363 EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
+ L R ++ L LA LH ++H ++ +I+LD+ + F +
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 42/188 (22%), Positives = 80/188 (42%), Gaps = 29/188 (15%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFN---- 314
+ E K + F GQG G+V G G +VA+K++ + F N
Sbjct: 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-----FRNRELQ 68
Query: 315 EVNLISGINHKNLVKLLGCSITGPES-------LLVYEFVP---NQSLLDNLFVRQDVEP 364
+ ++ ++H N+V+L T E +V E+VP ++ + + P
Sbjct: 69 IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPP 128
Query: 365 LSWEVRYKI--ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLF 421
+ ++ + ++ + LH S + + HRDIK N+L++E T K+ DFG +
Sbjct: 129 I--LIKVFLFQLI---RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182
Query: 422 PEDITHIS 429
+++
Sbjct: 183 SPSEPNVA 190
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 5e-19
Identities = 41/166 (24%), Positives = 69/166 (41%), Gaps = 18/166 (10%)
Query: 276 KLGQGGSGSVYKGT---LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVK 329
LG GG V+ VAVK L + F E + +NH +V
Sbjct: 19 ILGFGGMSEVHLARDLRD--HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 330 LL--GCSITGPESL--LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
+ G + T L +V E+V +L D + P++ + ++I + L + H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH 133
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
+ IIHRD+K +NI++ K+ DFG+ R + ++ T
Sbjct: 134 Q---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 6e-19
Identities = 44/166 (26%), Positives = 73/166 (43%), Gaps = 23/166 (13%)
Query: 276 KLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFN-EVNLISGINHKNLVKLLGC 333
+G G G VY+ L GE VA+K++ + F N E+ ++ ++H N+V+L
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYF 115
Query: 334 SITGPESL------LVYEFVP---NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
+ E LV ++VP + +Q + + V+ + LAY+
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI--YVKL-YMYQLFRSLAYI 172
Query: 385 HEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFPEDITHIS 429
H I HRDIK N+LLD + K+ DFG + ++S
Sbjct: 173 H---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 215
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 86.6 bits (214), Expect = 8e-19
Identities = 18/196 (9%), Positives = 44/196 (22%), Gaps = 44/196 (22%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLF---YNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
L G V+ + E A+K N+ ++ + + ++ +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 333 C--------------------------SITGPESLLVYEFV-----PNQSLLDNLFVRQD 361
LL+ S LD ++V +
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR- 188
Query: 362 VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
+ + A L ++H N+ + + + D +
Sbjct: 189 -GDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 422 PEDITHISATLAGTLF 437
+ +
Sbjct: 245 GT----RGPASSVPVT 256
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 25/193 (12%), Positives = 54/193 (27%), Gaps = 37/193 (19%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFY----------------------------NTTQ 307
LGQ + + T GE+ V ++ +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 308 WVDHFFNEVNLISGINHKNLVKLLGC--SITGPESLLVYEFV--PNQSLLDNLFVRQDV- 362
F +L+ K ++++ + +Y + Q+ + L
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 363 EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422
+ L R ++ L LA LH ++H ++ +I+LD+ + F +
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 423 EDITHISATLAGT 435
Sbjct: 263 ASAVSPIGRGFAP 275
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 43/186 (23%), Positives = 77/186 (41%), Gaps = 29/186 (15%)
Query: 254 KSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKG---TLPGGEAVAVKRL----FYNTT 306
K KL+ E +E Y E K+G+G G VYK + A+K++ +
Sbjct: 8 KVKLSSERERVEDLFEY--EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA 65
Query: 307 QWVDHFFNEVNLISGINHKNLVKLLG-CSITGPESL-LVYEFVPN--QSLLDNLFVRQDV 362
E+ L+ + H N++ L + L++++ + ++ +
Sbjct: 66 C------REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN 119
Query: 363 E---PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA----KIADF 415
+ L + ++ +G+ YLH ++HRD+K +NIL+ E KIAD
Sbjct: 120 KKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 176
Query: 416 GLVRLF 421
G RLF
Sbjct: 177 GFARLF 182
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 51/231 (22%), Positives = 73/231 (31%), Gaps = 51/231 (22%)
Query: 253 NKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVK-----RLFYNTT 306
+ L F +L + +H +GQG G V A+K ++
Sbjct: 10 GRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINP 69
Query: 307 QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLS 366
+ V+ EV L+ ++H N+ +L LV E LLD L V D
Sbjct: 70 KDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGK 129
Query: 367 WEVRY-------------------------------------KIILSTAEGLAYLHEESK 389
+ I+ L YLH
Sbjct: 130 CAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---N 186
Query: 390 LRIIHRDIKLSNILL--DEEFTAKIADFGLVRLFP---EDITHISATLAGT 435
I HRDIK N L ++ F K+ DFGL + F + T AGT
Sbjct: 187 QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 2e-18
Identities = 38/168 (22%), Positives = 63/168 (37%), Gaps = 22/168 (13%)
Query: 276 KLGQGGSGSVYKG--TLPGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLL- 331
+ GG G +Y G V +K L ++ + E ++ + H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 332 ----GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
P +V E+V QSL + + L +L L+YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKR---SKG--QKLPVAEAIAYLLEILPALSYLHSI 201
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
+++ D+K NI+L EE K+ D G V I GT
Sbjct: 202 ---GLVYNDLKPENIMLTEE-QLKLIDLGAVSR----INSFGYLY-GT 240
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 43/181 (23%), Positives = 75/181 (41%), Gaps = 23/181 (12%)
Query: 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVK-----RLFYNTTQWVDH---FFNEVNL 318
+ + S LG G G V + VA++ + + + D E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILST 377
+ +NH ++K+ + +V E + L D + + + E Y+++
Sbjct: 194 LKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML--- 249
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAG 434
+ YLHE IIHRD+K N+LL +E+ KI DFG ++ E + TL G
Sbjct: 250 -LAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCG 303
Query: 435 T 435
T
Sbjct: 304 T 304
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 43/180 (23%), Positives = 77/180 (42%), Gaps = 24/180 (13%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFN--EVNLI 319
+T E+ + +G G G V++ L + VA+K++ D F E+ ++
Sbjct: 33 KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVL------QDKRFKNRELQIM 86
Query: 320 SGINHKNLVKLLGCSITGPESL------LVYEFVP---NQSLLDNLFVRQDVEPLSWEVR 370
+ H N+V L + + LV E+VP ++ ++Q + L ++
Sbjct: 87 RIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPML--LIK 144
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFPEDITHIS 429
+ LAY+H + I HRDIK N+LLD K+ DFG ++ ++S
Sbjct: 145 L-YMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS 200
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 46/154 (29%), Positives = 67/154 (43%), Gaps = 15/154 (9%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGC 333
+G+G V + G VA+K + + F EV ++ +NH N+VKL
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKI--ILSTAEGLAYLHEESKL 390
T L+ E+ + D L + E E R K I+S + Y H +
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEK---EARSKFRQIVS---AVQYCH---QK 133
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
RI+HRD+K N+LLD + KIADFG F
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 42/178 (23%), Positives = 67/178 (37%), Gaps = 33/178 (18%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVK-----RLFYNTTQWVDH---FFNEVNLISGINHKN 326
LG G G V + VA+K + + + D E+ ++ +NH
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KIILSTAEG 380
++K+ + +V E + L D + + R
Sbjct: 77 IIKIKN-FFDAEDYYIVLELMEGGELFDKVVGNK---------RLKEATCKLYFYQMLLA 126
Query: 381 LAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGT 435
+ YLHE IIHRD+K N+LL +E+ KI DFG ++ E + TL GT
Sbjct: 127 VQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCGT 179
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 46/207 (22%), Positives = 73/207 (35%), Gaps = 14/207 (6%)
Query: 237 QKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEA 295
++ Q + + F + + KLG G G V
Sbjct: 5 HHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVE 64
Query: 296 VAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLL 353
A+K + +T EV ++ ++H N++KL LV E L
Sbjct: 65 RAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELF 124
Query: 354 DNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTA 410
D + R + II G+ YLH+ I+HRD+K N+LL +++
Sbjct: 125 DEIIHR---MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALI 178
Query: 411 KIADFGLVRLFPEDITHISATLAGTLF 437
KI DFGL +F GT +
Sbjct: 179 KIVDFGLSAVFENQ--KKMKERLGTAY 203
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 37/170 (21%), Positives = 64/170 (37%), Gaps = 14/170 (8%)
Query: 276 KLGQGGSGSVYKGTLPG-GEAVAVK-----RLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+G+G V + G+ AVK + + + E ++ + H ++V+
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEES 388
LL + +V+EF+ L + R S V + E L Y H+
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-- 148
Query: 389 KLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGT 435
IIHRD+K +LL + K+ FG+ E ++ GT
Sbjct: 149 -NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES-GLVAGGRVGT 196
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 4e-17
Identities = 42/177 (23%), Positives = 70/177 (39%), Gaps = 31/177 (17%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVK----RLFYNTTQWV-----DHFFNEVNLISGIN-H 324
LG+G S V + P + AVK + + + EV+++ ++ H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KIILSTA 378
N+++L T LV++ + L D L + KI+ +
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---------TLSEKETRKIMRALL 134
Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
E + LH+ L I+HRD+K NILLD++ K+ DFG + GT
Sbjct: 135 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGT 186
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-17
Identities = 34/168 (20%), Positives = 61/168 (36%), Gaps = 16/168 (9%)
Query: 276 KLGQGGSGSVYKGT---LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVK 329
+G+GG G VY+ VA+K + + + E + ++V
Sbjct: 41 LVGRGGMGDVYEAEDTVR--ERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
+ + + + L L + PL+ I+ L H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAHAA-- 153
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED-ITHISATLAGTL 436
HRD+K NIL+ + A + DFG+ ++ +T + T+ GTL
Sbjct: 154 -GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTL 199
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 9e-17
Identities = 46/199 (23%), Positives = 78/199 (39%), Gaps = 15/199 (7%)
Query: 246 GALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL--- 301
G++ ++ + F + ++ + LG+G G V G+ AVK +
Sbjct: 3 GSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR 62
Query: 302 FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQD 361
+ EV L+ ++H N++KL LV E L D + R
Sbjct: 63 QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR-- 120
Query: 362 VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLV 418
+ S +II G+ Y+H+ +I+HRD+K N+LL ++ +I DFGL
Sbjct: 121 -KRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176
Query: 419 RLFPEDITHISATLAGTLF 437
F GT +
Sbjct: 177 THFEAS--KKMKDKIGTAY 193
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 9e-17
Identities = 45/172 (26%), Positives = 69/172 (40%), Gaps = 26/172 (15%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
LG+G G V K + AVK + + EV L+ ++H N++KL
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KIILSTAEGLAYLHE 386
+V E L D + R+ R+ +II G+ Y+H+
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRK---------RFSEHDAARIIKQVFSGITYMHK 139
Query: 387 ESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGT 435
I+HRD+K NILL +++ KI DFGL F ++ GT
Sbjct: 140 ---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGT 186
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 39/205 (19%), Positives = 67/205 (32%), Gaps = 25/205 (12%)
Query: 227 VAFFVRRKLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVY 286
V F + K+ A+ + +L EK KL G +
Sbjct: 21 VVFEAKNKVDDC----------NYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYF 70
Query: 287 KGTLPGGEAVAVKRLFYNTTQWVDH------------FFNEVNLISGINHKNLVKLLGCS 334
L + + + ++ + + KN V L S
Sbjct: 71 NAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPS 130
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
+ + ++L D + R +E V I + AE + +LH + ++H
Sbjct: 131 SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMH 187
Query: 395 RDIKLSNILLDEEFTAKIADFGLVR 419
RD+K SNI + K+ DFGLV
Sbjct: 188 RDLKPSNIFFTMDDVVKVGDFGLVT 212
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 46/195 (23%), Positives = 76/195 (38%), Gaps = 28/195 (14%)
Query: 253 NKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL--FYNTTQWV 309
+ + N ++ ++ LG+G G V K + AVK + +
Sbjct: 8 SSGRENLYFQ--GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT 65
Query: 310 DHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEV 369
EV L+ ++H N++KL +V E L D + R+
Sbjct: 66 STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--------- 116
Query: 370 RY------KIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRL 420
R+ +II G+ Y+H+ I+HRD+K NILL +++ KI DFGL
Sbjct: 117 RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173
Query: 421 FPEDITHISATLAGT 435
F ++ GT
Sbjct: 174 FQQN--TKMKDRIGT 186
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 1e-16
Identities = 42/179 (23%), Positives = 69/179 (38%), Gaps = 21/179 (11%)
Query: 268 TNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQW-VDHFFNEVNLISGINHK 325
+ F KLG G G V+ G +K + + +Q ++ E+ ++ ++H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KIILSTAE 379
N++K+ +V E LL+ + V + +++
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERI-----VSAQARGKALSEGYVAELMKQMMN 135
Query: 380 GLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGT 435
LAY H ++H+D+K NIL KI DFGL LF D S AGT
Sbjct: 136 ALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--EHSTNAAGT 189
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 38/176 (21%), Positives = 67/176 (38%), Gaps = 30/176 (17%)
Query: 276 KLGQGGSGSVYKGTLPG-GEAVAVKRL--------FYNTTQWVDHFFNEVNLISGI-NHK 325
+G+G S V + G AVK + + + E +++ + H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KIILSTAE 379
+++ L+ + LV++ + L D L + V I+ S E
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK---------VALSEKETRSIMRSLLE 211
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
+++LH I+HRD+K NILLD+ +++DFG L GT
Sbjct: 212 AVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKLRELCGT 262
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 45/191 (23%), Positives = 79/191 (41%), Gaps = 22/191 (11%)
Query: 250 VAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQW 308
V + +N Y ++ LG G G V+K G +A K + +
Sbjct: 78 VTAKQGAVNSFYT--------VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD 129
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWE 368
+ NE+++++ ++H NL++L + + +LV E+V L D + + +
Sbjct: 130 KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDR-IIDESYNLTELD 188
Query: 369 VRY--KIILSTAEGLAYLHEESKLRIIHRDIKLSNILL--DEEFTAKIADFGLVRLFPED 424
K I EG+ ++H ++ I+H D+K NIL + KI DFGL R +
Sbjct: 189 TILFMKQIC---EGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242
Query: 425 ITHISATLAGT 435
GT
Sbjct: 243 --EKLKVNFGT 251
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 49/206 (23%), Positives = 79/206 (38%), Gaps = 37/206 (17%)
Query: 255 SKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL------------ 301
+ + + K + + KLG G G V G A+K +
Sbjct: 22 NPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSD 81
Query: 302 -FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQ 360
N ++ + +NE++L+ ++H N++KL LV EF L + + R
Sbjct: 82 DNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH 141
Query: 361 DVEPLSWEVRY------KIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAK 411
++ I+ G+ YLH+ I+HRDIK NILL + K
Sbjct: 142 ---------KFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIK 189
Query: 412 IADFGLVRLFPEDITHISATLAGTLF 437
I DFGL F +D + GT +
Sbjct: 190 IVDFGLSSFFSKD--YKLRDRLGTAY 213
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 43/170 (25%), Positives = 64/170 (37%), Gaps = 25/170 (14%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
LG G V+ G+ A+K + + NE+ ++ I H+N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KIILSTAEGLAYLHEES 388
+ LV + V L D + R Y +I + YLHE
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERG---------VYTEKDASLVIQQVLSAVKYLHE-- 124
Query: 389 KLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGT 435
I+HRD+K N+L +E I DFGL ++ I T GT
Sbjct: 125 -NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS---TACGT 170
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 3e-16
Identities = 37/170 (21%), Positives = 65/170 (38%), Gaps = 24/170 (14%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+G+G G V A K++ + VD F E+ ++ ++H N+++L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KIILSTAEGLAYLHEES 388
+ LV E L + + ++ + +I+ +AY H+
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKR---------VFRESDAARIMKDVLSAVAYCHK-- 124
Query: 389 KLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGT 435
L + HRD+K N L + K+ DFGL F + T GT
Sbjct: 125 -LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKVGT 171
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 3e-16
Identities = 48/154 (31%), Positives = 67/154 (43%), Gaps = 14/154 (9%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVK---RLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
LG G G V G G VAVK R + V E+ + H +++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI--ILSTAEGLAYLHEESKL 390
T + +V E+V L D + VE + E R ILS + Y H +
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEM--EARRLFQQILS---AVDYCH---RH 130
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
++HRD+K N+LLD AKIADFGL + +
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 47/154 (30%), Positives = 67/154 (43%), Gaps = 14/154 (9%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVK---RLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
LG G G V G G VAVK R + V E+ + H +++KL
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI--ILSTAEGLAYLHEESKL 390
T + +V E+V L D + ++ E R ILS G+ Y H +
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGRLDEK--ESRRLFQQILS---GVDYCH---RH 135
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
++HRD+K N+LLD AKIADFGL + +
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 8e-16
Identities = 40/161 (24%), Positives = 60/161 (37%), Gaps = 22/161 (13%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVK--------RLFYNTTQWVDHFFNEVNLISGINHKNL 327
LG G G V+ + V VK + + E+ ++S + H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 328 VKLLGCSITGPESLLVYEF-VPNQSLLDNLFVRQDV-EPLSWEVRYKI--ILSTAEGLAY 383
+K+L LV E L + + EP Y ++S + Y
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP---LASYIFRQLVS---AVGY 145
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
L IIHRDIK NI++ E+FT K+ DFG
Sbjct: 146 LR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 8e-16
Identities = 38/161 (23%), Positives = 65/161 (40%), Gaps = 26/161 (16%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVK----RLFYNTTQWVDHFFNEVNLISGINHKNLVKLL 331
LG+G G V + AVK + + E+ L+ + HKN+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 332 GCSITGPES----LLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYK---IILSTAEGLA 382
+ E +V E+ Q +LD++ ++ + +I +GL
Sbjct: 73 --DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPV---CQAHGYFCQLI----DGLE 123
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
YLH I+H+DIK N+LL T KI+ G+
Sbjct: 124 YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 1e-15
Identities = 41/169 (24%), Positives = 64/169 (37%), Gaps = 20/169 (11%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVK-----RLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+LG+G V + G A K +L + + E + + H N+V+
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---SARDFQKLEREARICRKLQHPNIVR 69
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
L LV++ V L +++ R E S I E +AY H
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHS--- 123
Query: 390 LRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGT 435
I+HR++K N+LL + K+ADFGL + AGT
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGT 170
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-15
Identities = 19/150 (12%), Positives = 42/150 (28%), Gaps = 16/150 (10%)
Query: 276 KLGQGGSGSVYKGT---LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVK 329
G ++ L VA+ + + + +S I+ + +
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
+L T L+V E++ SL + S + + S A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAHRAG- 149
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
+ S + + + +A +
Sbjct: 150 --VALSIDHPSRVRVSIDGDVVLAYPATMP 177
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 45/176 (25%), Positives = 71/176 (40%), Gaps = 14/176 (7%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDH--FFNEVNLISG 321
+Y+ +LG G G V++ G K F NT +D NE+++++
Sbjct: 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAK--FINTPYPLDKYTVKNEISIMNQ 104
Query: 322 INHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGL 381
++H L+ L E +L+ EF+ L D + +S + EGL
Sbjct: 105 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGL 162
Query: 382 AYLHEESKLRIIHRDIKLSNILL--DEEFTAKIADFGLVRLFPEDITHISATLAGT 435
++HE I+H DIK NI+ + + KI DFGL D I T
Sbjct: 163 KHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTAT 213
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 37/174 (21%), Positives = 67/174 (38%), Gaps = 10/174 (5%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN 323
+ +++ +LG G G V++ T G A K + + E+ +S +
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR 212
Query: 324 HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
H LV L E +++YEF+ L + + + +S + + + +GL +
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCH 270
Query: 384 LHEESKLRIIHRDIKLSNILL--DEEFTAKIADFGLVRLFPEDITHISATLAGT 435
+HE +H D+K NI+ K+ DFGL GT
Sbjct: 271 MHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTTGT 319
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 39/162 (24%), Positives = 72/162 (44%), Gaps = 25/162 (15%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD--HFFNEVNLISGINHKNLVKLLG 332
+G G G V + VA+K++ +D E+ +++ +NH ++VK+L
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVL- 118
Query: 333 CSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWE-VRYKI--ILSTAEGLA 382
I P+ + +V E S LF L+ ++ + +L G+
Sbjct: 119 -DIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTPV--YLTELHIKTLLYNLLV---GVK 170
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
Y+H I+HRD+K +N L++++ + K+ DFGL R
Sbjct: 171 YVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 46/170 (27%), Positives = 71/170 (41%), Gaps = 26/170 (15%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+LG+G + VY+ + A+K L T E+ ++ ++H N++KL
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KIILSTAEGLAYLHEES 388
T E LV E V L D + + Y + E +AYLHE
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKG---------YYSERDAADAVKQILEAVAYLHE-- 166
Query: 389 KLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGT 435
I+HRD+K N+L + KIADFGL ++ + T+ GT
Sbjct: 167 -NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VLMKTVCGT 213
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 35/166 (21%), Positives = 65/166 (39%), Gaps = 13/166 (7%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
+LG+G V + + G+ A + + + E + + H N+V+L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
L+++ V L +++ R E S I E + + H+ + +
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQ---MGV 131
Query: 393 IHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGT 435
+HR++K N+LL + K+ADFGL + AGT
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFGFAGT 176
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-15
Identities = 42/162 (25%), Positives = 65/162 (40%), Gaps = 25/162 (15%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRL------FYNTTQWVDHFFNEVNLISGINHK--NL 327
LG GG GSVY G + VA+K + + EV L+ ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 328 VKLLGCSITGPESLLVYEFV-PNQSLLDNLFVRQDV-EPLSWEVRYK---IILSTAEGLA 382
++LL +L+ E P Q L D + R + E R ++ E +
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE---LARSFFWQVL----EAVR 163
Query: 383 YLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFPE 423
+ H ++HRDIK NIL+D K+ DFG L +
Sbjct: 164 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 202
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 43/192 (22%), Positives = 73/192 (38%), Gaps = 38/192 (19%)
Query: 260 SYETLEKATNYFHESNK------LGQGGSGSVYKGTLPGGEAVAVKRLF--YNTTQWVDH 311
+ + + G G+V G G VA+KR+F + + V+
Sbjct: 7 EAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNI 66
Query: 312 FFN---------EVNLISGINHKNLVKLLGCSITGPESL-------LVYEFVPNQSLLDN 355
+ E+ L++ +H N++ L I LV E + ++ L
Sbjct: 67 LSDSFLCKRVLREIRLLNHFHHPNILGLR--DIFVHFEEPAMHKLYLVTELM--RTDLAQ 122
Query: 356 LFVRQDVEPLSWE-VRYKI--ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI 412
+ + +S + ++Y + IL GL LHE ++HRD+ NILL + I
Sbjct: 123 V-IHDQRIVISPQHIQYFMYHILL---GLHVLHEAG---VVHRDLHPGNILLADNNDITI 175
Query: 413 ADFGLVRLFPED 424
DF L R D
Sbjct: 176 CDFNLAREDTAD 187
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 6e-15
Identities = 48/152 (31%), Positives = 70/152 (46%), Gaps = 18/152 (11%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFN---EVNLISGINHKNLVKLLG 332
LG+G G V EAVAVK + + + VD N E+ + +NH+N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLS-WEVRYKI--ILSTAEGLAYLHEESK 389
G L E+ L D + + + + +++ G+ YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMA---GVVYLH---G 123
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
+ I HRDIK N+LLDE KI+DFGL +F
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVF 155
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 6e-15
Identities = 46/193 (23%), Positives = 77/193 (39%), Gaps = 47/193 (24%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVK-----RLFYNTTQW---------------------V 309
+G+G G V A+K +L +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 310 DHFFNEVNLISGINHKNLVKLLGCSITGPESL---LVYEFVPNQSLLDNLFVRQDVEPLS 366
+ + E+ ++ ++H N+VKL+ + P +V+E V +++ PLS
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPVME--VPTLK--PLS 135
Query: 367 WEV--RY--KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422
+ Y +I G+ YLH +IIHRDIK SN+L+ E+ KIADFG+ F
Sbjct: 136 EDQARFYFQDLIK----GIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF- 187
Query: 423 EDITHISATLAGT 435
+ + + GT
Sbjct: 188 KGSDALLSNTVGT 200
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 7e-15
Identities = 41/166 (24%), Positives = 62/166 (37%), Gaps = 14/166 (8%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDH--FFNEVNLISGINHKNLVKLLG 332
+LG+G V + G A K + D E + + H N+V+L
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
LV++ V L +++ R E S I E +AY H I
Sbjct: 96 SIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHS---NGI 149
Query: 393 IHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGT 435
+HR++K N+LL + K+ADFGL + AGT
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGT 193
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 8e-15
Identities = 48/152 (31%), Positives = 70/152 (46%), Gaps = 18/152 (11%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFN---EVNLISGINHKNLVKLLG 332
LG+G G V EAVAVK + + + VD N E+ + +NH+N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLS-WEVRYKI--ILSTAEGLAYLHEESK 389
G L E+ L D + + + + +++ G+ YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMA---GVVYLH---G 123
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
+ I HRDIK N+LLDE KI+DFGL +F
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVF 155
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 40/154 (25%), Positives = 70/154 (45%), Gaps = 15/154 (9%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVK---RLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
LG+G G V T + VA+K R + E++ + + H +++KL
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI--ILSTAEGLAYLHEESKL 390
T + ++V E+ + L D + ++ + E R I+ + Y H +
Sbjct: 77 VITTPTDIVMVIEYAGGE-LFDYIVEKKRMTE--DEGRRFFQQIIC---AIEYCH---RH 127
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
+I+HRD+K N+LLD+ KIADFGL + +
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 47/169 (27%), Positives = 77/169 (45%), Gaps = 27/169 (15%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
+G G G+V G VA+K+L F + + E+ L+ + H+N++ LL
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF-AKRAYRELRLLKHMRHENVIGLLD 91
Query: 333 CSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWE-VRYKI--ILSTAEGLA 382
T E+L LV F+ + L L + L + +++ + +L GL
Sbjct: 92 V-FTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE---KLGEDRIQFLVYQMLK---GLR 142
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
Y+H IIHRD+K N+ ++E+ KI DFGL R ++T T
Sbjct: 143 YIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVT 188
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 49/178 (27%), Positives = 79/178 (44%), Gaps = 28/178 (15%)
Query: 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGIN 323
+ +G G GSV GE VA+K+L F + + E+ L+ +
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIF-AKRAYRELLLLKHMQ 81
Query: 324 HKNLVKLLGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWE-VRYKI-- 373
H+N++ LL T SL LV F+ Q+ L + + S E ++Y +
Sbjct: 82 HENVIGLLDV-FTPASSLRNFYDFYLVMPFM--QTDLQKI-MGL---KFSEEKIQYLVYQ 134
Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
+L GL Y+H ++HRD+K N+ ++E+ KI DFGL R ++T T
Sbjct: 135 MLK---GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVT 186
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 46/185 (24%), Positives = 71/185 (38%), Gaps = 25/185 (13%)
Query: 265 EKATNYFHESNKLGQGGSGSVY----KGTLPGGEAVAVK----RLFYNTTQWVDH--FFN 314
+K +++ +LG G V K T G A K R + + V
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKST---GLEYAAKFIKKRQSRASRRGVSREEIER 64
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
EV+++ + H N++ L + +L+ E V L D L + E LS E I
Sbjct: 65 EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK---ESLSEEEATSFI 121
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLVRLFPEDITHISA 430
+G+ YLH +I H D+K NI+L K+ DFGL +
Sbjct: 122 KQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFK 176
Query: 431 TLAGT 435
+ GT
Sbjct: 177 NIFGT 181
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-14
Identities = 39/178 (21%), Positives = 64/178 (35%), Gaps = 29/178 (16%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCS 334
LG+G V L + AVK + F EV ++ H+N+++L+
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KIILSTAEGLAYLHEES 388
LV+E + S+L ++ R+ + ++ A L +LH
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIHKRR---------HFNELEASVVVQDVASALDFLHN-- 129
Query: 389 KLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISA------TLAGTLF 437
I HRD+K NIL ++ KI DF L + T G+
Sbjct: 130 -KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 43/173 (24%), Positives = 76/173 (43%), Gaps = 27/173 (15%)
Query: 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL--FYNTTQWVDHFFNEVNLISGINH 324
+ + +G+G G V VA+K++ F + T E+ ++ H
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY-CQRTLREIKILLRFRH 84
Query: 325 KNLVKLLGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWE-VRYKI--I 374
+N++ + I ++ +V + + ++ L L Q LS + + Y + I
Sbjct: 85 ENIIGIN--DIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKTQ---HLSNDHICYFLYQI 137
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
L GL Y+H + ++HRD+K SN+LL+ KI DFGL R+ D H
Sbjct: 138 LR---GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 5e-14
Identities = 42/199 (21%), Positives = 67/199 (33%), Gaps = 27/199 (13%)
Query: 237 QKRRERKQLGALQVAVNK-SKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE 294
LG + N Y K +LG+G V + G+
Sbjct: 5 HHHSSGVDLGTENLYFQSMENFNNFYILTSK---------ELGRGKFAVVRQCISKSTGQ 55
Query: 295 AVAVK--RLFYNTTQWVDHFFNEVNLISGINH-KNLVKLLGCSITGPESLLVYEFVPNQS 351
A K + +E+ ++ ++ L E +L+ E+
Sbjct: 56 EYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGE 115
Query: 352 LLDNLFVRQDVEPLS-WEVRY--KIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---D 405
+ + + E +S +V K IL EG+ YLH+ I+H D+K NILL
Sbjct: 116 IFSLC-LPELAEMVSENDVIRLIKQIL---EGVYYLHQ---NNIVHLDLKPQNILLSSIY 168
Query: 406 EEFTAKIADFGLVRLFPED 424
KI DFG+ R
Sbjct: 169 PLGDIKIVDFGMSRKIGHA 187
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 6e-14
Identities = 38/180 (21%), Positives = 69/180 (38%), Gaps = 27/180 (15%)
Query: 269 NYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKN 326
+ + LG+G K +A AVK + + + + E+ + H N
Sbjct: 11 DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKII---SKRMEANTQKEITALKLCEGHPN 67
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KIILSTAEG 380
+VKL + LV E + L + + ++ + I+
Sbjct: 68 IVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK---------HFSETEASYIMRKLVSA 118
Query: 381 LAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGTLF 437
++++H+ + ++HRD+K N+L ++ KI DFG RL P D T TL
Sbjct: 119 VSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPLKTPCFTLH 174
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 37/212 (17%), Positives = 79/212 (37%), Gaps = 59/212 (27%)
Query: 264 LEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFN-EVNLISG 321
LE ++ + LG G G V + + G+ A+K++ + + N E++++
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKV 56
Query: 322 INHKNLVKLLGCSITGPESL--------------------------------------LV 343
++H N++KL+ T + ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 344 YEFVP---NQSLLDNLFVRQDVEPLSWEVRYKI--ILSTAEGLAYLHEESKLRIIHRDIK 398
E+VP ++ L + + + + I + + ++H L I HRDIK
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMN--LISIYIYQLF---RAVGFIH---SLGICHRDIK 168
Query: 399 LSNILLDEE-FTAKIADFGLVRLFPEDITHIS 429
N+L++ + T K+ DFG + ++
Sbjct: 169 PQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVA 200
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 7e-14
Identities = 51/189 (26%), Positives = 87/189 (46%), Gaps = 28/189 (14%)
Query: 253 NKSKLNFSYETLEKATNYFHESNK------LGQGGSGSVYKGT-LPGGEAVAVKRL---F 302
+KSK++ + ++E + F + +G G G V VA+K+L F
Sbjct: 40 SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 99
Query: 303 YNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-------LVYEFVPNQSLLDN 355
N T + E+ L+ +NHKN++ LL T ++L LV E + + L
Sbjct: 100 QNQTH-AKRAYRELVLMKCVNHKNIISLLNV-FTPQKTLEEFQDVYLVMELM--DANLCQ 155
Query: 356 LFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415
+ ++ +++ + Y ++ G+ +LH IIHRD+K SNI++ + T KI DF
Sbjct: 156 V-IQMELDHE--RMSY-LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF 208
Query: 416 GLVRLFPED 424
GL R
Sbjct: 209 GLARTAGTS 217
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 41/165 (24%), Positives = 74/165 (44%), Gaps = 31/165 (18%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVD--HFFNEVNLISGINHKNLVK 329
+G+G G VY + VA+K++ F + D E+ +++ + +++
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI---DCKRILREITILNRLKSDYIIR 89
Query: 330 LLGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWE-VRYKI--ILSTAE 379
L + P+ L +V E S L LF L+ E ++ + +L
Sbjct: 90 LY--DLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTPI--FLTEEHIKTILYNLLL--- 140
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
G ++HE IIHRD+K +N LL+++ + K+ DFGL R +
Sbjct: 141 GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 8e-14
Identities = 41/160 (25%), Positives = 64/160 (40%), Gaps = 17/160 (10%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVK----RLFYNTTQWVDH--FFNEVNLISGINHKNLV 328
+LG G V K G+ A K R ++ + V EVN++ I H N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
L + +L+ E V L D L + E L+ + + + +G+ YLH
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHS-- 126
Query: 389 KLRIIHRDIKLSNILL----DEEFTAKIADFGLVRLFPED 424
RI H D+K NI+L K+ DFG+
Sbjct: 127 -KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG 165
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 9e-14
Identities = 43/182 (23%), Positives = 67/182 (36%), Gaps = 19/182 (10%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVK------RLFYNTTQWVDHFFNEVN 317
+K +++ +LG G V K G A K + EV+
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST 377
++ + H N++ L + +L+ E V L D L + E LS E I
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQI 124
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLVRLFPEDITHISATLA 433
+G+ YLH +I H D+K NI+L K+ DFGL + +
Sbjct: 125 LDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIF 179
Query: 434 GT 435
GT
Sbjct: 180 GT 181
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 9e-14
Identities = 30/170 (17%), Positives = 60/170 (35%), Gaps = 23/170 (13%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQW-VDHFFNEVNLISGI 322
++ + + LG+G G V++ + K F E+++++
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAK--FVKVKGTDQVLVKKEISILNIA 58
Query: 323 NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KIILS 376
H+N++ L + E ++++EF+ + + + +
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINTS--------AFELNEREIVSYVHQ 110
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILL--DEEFTAKIADFGLVRLFPED 424
E L +LH I H DI+ NI+ T KI +FG R
Sbjct: 111 VCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 47/176 (26%), Positives = 85/176 (48%), Gaps = 24/176 (13%)
Query: 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN 326
+ + + LG GG+G V+ + VA+K++ Q V H E+ +I ++H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV-----------EPLSWE-VRYKI- 373
+VK+ I GP + + V + + L+++++ Q+ PL E R +
Sbjct: 70 IVKVF--EILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMY 127
Query: 374 -ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRLFPEDITH 427
+L GL Y+H + ++HRD+K +N+ ++ E KI DFGL R+ +H
Sbjct: 128 QLLR---GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 46/194 (23%), Positives = 80/194 (41%), Gaps = 26/194 (13%)
Query: 256 KLNFSYETLEKAT-NYFHESNKLGQGGSGSVY----KGTLPGGEAVAVKRL---FYNTTQ 307
L + + + ++F + LG+GG G V+ K T G+ A K+L +
Sbjct: 171 FLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKAT---GKLYACKKLNKKRLKKRK 227
Query: 308 WVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLS 366
E +++ ++ + +V L T L LV + + +++ + P
Sbjct: 228 GYQGAMVEKKILAKVHSRFIVSLAYAFET-KTDLCLVMTIMNGGDIRYHIYNVDEDNPGF 286
Query: 367 WEVRYK-----IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
E R I+ GL +LH+ II+RD+K N+LLD++ +I+D GL
Sbjct: 287 QEPRAIFYTAQIVS----GLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339
Query: 422 PEDITHISATLAGT 435
T AGT
Sbjct: 340 KAGQTKTK-GYAGT 352
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 35/200 (17%), Positives = 68/200 (34%), Gaps = 26/200 (13%)
Query: 252 VNKSKLNFSYETLEKATNYFHE-----SNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT 305
+ S L ++ E + LG G +G V + G+ A+K L
Sbjct: 7 HHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL---- 62
Query: 306 TQWVDHFFNEVN-LISGINHKNLVKLLG----CSITGPESLLVYEFVPNQSLLDNLFVRQ 360
EV+ ++V +L L++ E + L + +
Sbjct: 63 -YDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRI-QER 120
Query: 361 DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGL 417
+ + +I+ + +LH I HRD+K N+L +++ K+ DFG
Sbjct: 121 GDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177
Query: 418 VRLFPEDITHISATLAGTLF 437
+ ++ T T +
Sbjct: 178 AKETTQNALQ---TPCYTPY 194
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 47/189 (24%), Positives = 81/189 (42%), Gaps = 27/189 (14%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL--FYNTTQWVDHFFNEVNL 318
+ ++ F + LG+G G V T P GE VA+K++ F E+ +
Sbjct: 4 RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF-ALRTLREIKI 62
Query: 319 ISGINHKNLVKLLGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWE-VR 370
+ H+N++ + +I P+S ++ E + Q+ L + Q LS + ++
Sbjct: 63 LKHFKHENIITIF--NIQRPDSFENFNEVYIIQELM--QTDLHRVISTQ---MLSDDHIQ 115
Query: 371 YKI--ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428
Y I L + LH + +IHRD+K SN+L++ K+ DFGL R+ E
Sbjct: 116 YFIYQTLR---AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169
Query: 429 SATLAGTLF 437
S
Sbjct: 170 SEPTGQQSG 178
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 47/176 (26%), Positives = 72/176 (40%), Gaps = 30/176 (17%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYN-TTQWVD-----HFFNEVN----LISGINHK 325
LG+GG G+V+ G L VA+K + N W EV + +G H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 326 NLVKLLGCSITGPESLLVYEF-VPNQSLLDNLFVRQDV-EPLSWEVRYK---IILSTAEG 380
+++LL T +LV E +P Q L D + + + E R ++
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEG---PSRCFFGQVV----AA 151
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFPEDITHISATLAGT 435
+ + H ++HRDIK NIL+D AK+ DFG L ++ GT
Sbjct: 152 IQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT---DFDGT 201
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 53/199 (26%), Positives = 85/199 (42%), Gaps = 36/199 (18%)
Query: 240 RERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAV 298
R ++ V + S + L++ + +G G G V VA+
Sbjct: 4 RSKRDNNFYSVEIGDST----FTVLKR----YQNLKPIGSGAQGIVCAAYDAILERNVAI 55
Query: 299 KRL---FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-------LVYEFVP 348
K+L F N T + E+ L+ +NHKN++ LL T +SL +V E +
Sbjct: 56 KKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIGLLNV-FTPQKSLEEFQDVYIVMELM- 112
Query: 349 NQSLLDNLFVRQDVEPLSWE-VRYKI--ILSTAEGLAYLHEESKLRIIHRDIKLSNILLD 405
+ L + ++ L E + Y + +L G+ +LH IIHRD+K SNI++
Sbjct: 113 -DANLCQV-IQM---ELDHERMSYLLYQMLC---GIKHLHSAG---IIHRDLKPSNIVVK 161
Query: 406 EEFTAKIADFGLVRLFPED 424
+ T KI DFGL R
Sbjct: 162 SDCTLKILDFGLARTAGTS 180
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 6e-13
Identities = 46/195 (23%), Positives = 67/195 (34%), Gaps = 45/195 (23%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL------FYNTTQWVDHFFNEVN 317
E +Y+ +LG G V K G A K + + EV+
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL-------------FVRQDVEP 364
++ I H N++ L + +L+ E V L D L F++Q
Sbjct: 67 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ---- 122
Query: 365 LSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLVRL 420
IL G+ YLH L+I H D+K NI+L + KI DFGL
Sbjct: 123 ---------IL---NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 421 FPEDITHISATLAGT 435
+ GT
Sbjct: 168 IDFGNEF--KNIFGT 180
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 33/199 (16%)
Query: 253 NKSKLNFSYETLEKATNYFHESNK------LGQGGSGSVYKGT-LPGGEAVAVKRL---F 302
+ S+ ++ E + + +G G GSV G VAVK+L F
Sbjct: 7 HHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF 66
Query: 303 YNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-------LVYEFVPNQSLLDN 355
+ + E+ L+ + H+N++ LL T SL LV + + L+N
Sbjct: 67 QSIIH-AKRTYRELRLLKHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM--GADLNN 122
Query: 356 LFVRQDVEPLSWE-VRYKI--ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI 412
+ Q L+ + V++ I IL GL Y+H IIHRD+K SN+ ++E+ KI
Sbjct: 123 IVKCQ---KLTDDHVQFLIYQILR---GLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 173
Query: 413 ADFGLVRLFPEDITHISAT 431
DFGL R +++T AT
Sbjct: 174 LDFGLARHTADEMTGYVAT 192
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 42/134 (31%), Positives = 60/134 (44%), Gaps = 22/134 (16%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDV---EP 364
V + F E+ ++ G+ H LV L E + +V + + L +L +Q+V E
Sbjct: 59 VRNVFKELQIMQGLEHPFLVNLWYSFQD-EEDMFMVVDLLLGGDLRYHL--QQNVHFKEE 115
Query: 365 LSWEVRYKIILSTAE---GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
V+ I E L YL RIIHRD+K NILLDE I DF + +
Sbjct: 116 ---TVKLFI----CELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165
Query: 422 PEDITHISATLAGT 435
P + T+AGT
Sbjct: 166 PRETQI--TTMAGT 177
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 7e-13
Identities = 39/178 (21%), Positives = 65/178 (36%), Gaps = 20/178 (11%)
Query: 269 NYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVN-LISGINHKN 326
+Y S LG G +G V + E A+K L Q EV +
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPH 116
Query: 327 LVKLLGC---SITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
+V+++ G + L +V E + L + + + + +I+ S E +
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 383 YLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGTLF 437
YLH + I HRD+K N+L K+ DFG + + T T +
Sbjct: 176 YLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTTPCYTPY 228
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 8e-13
Identities = 44/170 (25%), Positives = 66/170 (38%), Gaps = 23/170 (13%)
Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVK 329
+G+G G V K + A+K L F E +++ + K +
Sbjct: 82 IGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT 138
Query: 330 LLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYLH 385
L + +L LV ++ LL L +D P Y AE + +H
Sbjct: 139 LH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY-----LAEMVIAIDSVH 192
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
+L +HRDIK NIL+D ++ADFG ED T S+ GT
Sbjct: 193 ---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGT 239
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 9e-13
Identities = 39/155 (25%), Positives = 61/155 (39%), Gaps = 18/155 (11%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVKLLGCS 334
+G G G E VAVK + +D + E+ + H N+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVK--YIERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKI--ILSTAEGLAYLHEESKLR 391
+T ++ E+ L + + E E R+ +LS G++Y H ++
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSED---EARFFFQQLLS---GVSYCH---SMQ 136
Query: 392 IIHRDIKLSNILLDEEFTA--KIADFGLVRLFPED 424
I HRD+KL N LLD KI DFG +
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 67.6 bits (164), Expect = 1e-12
Identities = 31/202 (15%), Positives = 53/202 (26%), Gaps = 54/202 (26%)
Query: 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVD--------HFFNEVNL 318
T K+G+G G V++ VA+K + V+ E+ +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIADHTP-VAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 319 ---------ISGINHKNLVKLLGCSI---TGPESL------------------------- 341
+ + L + P L
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 342 --LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKL 399
+V EF L+ + + S I+ LA LR HRD+
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK----LSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHW 190
Query: 400 SNILLDEEFTAKIADFGLVRLF 421
N+LL + K+ +
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSS 212
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 35/202 (17%), Positives = 71/202 (35%), Gaps = 33/202 (16%)
Query: 252 VNKSKLNFSYETLEKATNYFHE----SNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTT 306
+ ++ + L + + F + +G G + AVK + + +
Sbjct: 1 MQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII--DKS 58
Query: 307 QWVDHFFNEVN-LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPL 365
+ E+ L+ H N++ L G +V E + LLD + ++
Sbjct: 59 K--RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK----- 111
Query: 366 SWEVRY------KIILSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADF 415
+ ++ + + + YLH ++HRD+K SNIL + +I DF
Sbjct: 112 ----FFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDF 164
Query: 416 GLVRLFPEDITHISATLAGTLF 437
G + + + T T
Sbjct: 165 GFAKQLRAE-NGLLMTPCYTAN 185
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 47/174 (27%), Positives = 69/174 (39%), Gaps = 31/174 (17%)
Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL----FYNTTQWVDHFFNEVNLISGINHKNLV 328
LG+G +V T A+K L + V + E +++S ++H V
Sbjct: 38 LGEGSFSTVVLARELAT---SREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHPFFV 93
Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEV-R-YKIILSTAE---GLA 382
KL E L + N LL + + + R Y TAE L
Sbjct: 94 KLYFTFQD-DEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFY-----TAEIVSALE 144
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA-TLAGT 435
YLH IIHRD+K NILL+E+ +I DFG ++ + A + GT
Sbjct: 145 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 53/192 (27%), Positives = 79/192 (41%), Gaps = 25/192 (13%)
Query: 256 KLNFSYETLEKAT-NYFHESNKLGQGGSGSVY----KGTLPGGEAVAVKRL---FYNTTQ 307
L + + + T N F + LG+GG G V + T G+ A K+L +
Sbjct: 170 FLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRK 226
Query: 308 WVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLS 366
NE ++ +N + +V L T ++L LV + L ++ +
Sbjct: 227 GEAMALNEKQILEKVNSRFVVSLAYAYET-KDALCLVLTLMNGGDLKFHI--YHMGQAGF 283
Query: 367 WEVRYKIILSTAE---GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
E R AE GL LH E RI++RD+K NILLD+ +I+D GL PE
Sbjct: 284 PEARAVFY--AAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338
Query: 424 DITHISATLAGT 435
T GT
Sbjct: 339 GQT--IKGRVGT 348
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 37/158 (23%), Positives = 60/158 (37%), Gaps = 18/158 (11%)
Query: 269 NYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVN-LISGINHKN 326
+Y S LG G +G V + E A+K L Q EV +
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPH 72
Query: 327 LVKLLGC---SITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
+V+++ G + L +V E + L + + + + +I+ S E +
Sbjct: 73 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 383 YLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGL 417
YLH + I HRD+K N+L K+ DFG
Sbjct: 132 YLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 50/164 (30%), Positives = 84/164 (51%), Gaps = 30/164 (18%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVD--HFFNEVNLISGIN-HKNL 327
KLG+G G V+K GE VAVK++ F N+T D F E+ +++ ++ H+N+
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNST---DAQRTFREIMILTELSGHENI 71
Query: 328 VKLLGCSITGPESL----LVYEFVPNQSLLDNLFVRQDVEPLSWE-VRYKI--ILSTAEG 380
V LL ++ ++ LV++++ ++ L + L +Y + ++
Sbjct: 72 VNLL--NVLRADNDRDVYLVFDYM--ETDLHAVIRAN---ILEPVHKQYVVYQLIK---V 121
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
+ YLH ++HRD+K SNILL+ E K+ADFGL R F
Sbjct: 122 IKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 3e-12
Identities = 41/156 (26%), Positives = 71/156 (45%), Gaps = 29/156 (18%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDH--FFNEVNLISGI-NHKNLVKL 330
KLG+G V++ + E V VK L + V E+ ++ + N++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGGPNIITL 96
Query: 331 LGCSITGPES---LLVYEFVPNQSLLDNLFVRQDVEPLS-WEVRYKI--ILSTAEGLAYL 384
+ P S LV+E V N +Q + L+ +++R+ + IL + L Y
Sbjct: 97 ADI-VKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMYEIL---KALDYC 146
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTA-KIADFGLVR 419
H S I+HRD+K N+++D E ++ D+GL
Sbjct: 147 H--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 45/173 (26%), Positives = 73/173 (42%), Gaps = 30/173 (17%)
Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKN--- 326
+G+GG G VY T G+ A+K L Q NE ++S ++ +
Sbjct: 197 IGRGGFGEVYGCRKADT---GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 327 LVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLA 382
+V + T P+ L + + + L +L + V + Y AE GL
Sbjct: 254 IVCMSYAFHT-PDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFY-----AAEIILGLE 306
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
++H +++RD+K +NILLDE +I+D GL F + H GT
Sbjct: 307 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGT 353
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 5e-12
Identities = 44/170 (25%), Positives = 65/170 (38%), Gaps = 23/170 (13%)
Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVK 329
+G+G V K T G+ A+K + V F E +++ + + + +
Sbjct: 69 IGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125
Query: 330 LLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYLH 385
L + L LV E+ LL L + P Y AE + +H
Sbjct: 126 LH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY-----LAEIVMAIDSVH 179
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
+L +HRDIK NILLD ++ADFG D T S GT
Sbjct: 180 ---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGT 226
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 49/175 (28%), Positives = 68/175 (38%), Gaps = 34/175 (19%)
Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVK 329
LG+G G V K T G A+K L V H E ++ H L
Sbjct: 156 LGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 330 LLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS---TAE---GLA 382
L T + L V E+ LF LS E + + AE L
Sbjct: 213 LKYSFQT-HDRLCFVMEYANG----GELFFH-----LSRERVFSEDRARFYGAEIVSALD 262
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGT 435
YLH S+ +++RD+KL N++LD++ KI DFGL + + T GT
Sbjct: 263 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK---TFCGT 312
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 48/171 (28%), Positives = 72/171 (42%), Gaps = 27/171 (15%)
Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL----FYNTTQWVDHFFNEVNLISGINHKNLV 328
+G+G G V K T + A+K L + F+ E ++++ N +V
Sbjct: 77 IGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSD-SAFFWEERDIMAFANSPWVV 132
Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYL 384
+L L +V E++P L+ NL DV P W Y TAE L +
Sbjct: 133 QLFYAFQD-DRYLYMVMEYMPGGDLV-NLMSNYDV-PEKWARFY-----TAEVVLALDAI 184
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
H + IHRD+K N+LLD+ K+ADFG ++ T GT
Sbjct: 185 H---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 232
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 46/171 (26%), Positives = 73/171 (42%), Gaps = 30/171 (17%)
Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL----FYNTTQWVDHFFNEVNLISGINHKNLV 328
LG G G V K + G A+K L Q ++H NE ++ +N LV
Sbjct: 49 LGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFPFLV 104
Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYL 384
KL +L +V E+V + +L + + S E + A+ YL
Sbjct: 105 KLEFSFKD-NSNLYMVMEYVAGGEMFSHL---RRIGRFS-EPHARFY--AAQIVLTFEYL 157
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
H L +I+RD+K N+L+D++ ++ DFG + + T TL GT
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW---TLCGT 201
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 62.5 bits (153), Expect = 4e-11
Identities = 48/174 (27%), Positives = 76/174 (43%), Gaps = 36/174 (20%)
Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL----FYNTTQWVDHFFNEVNLISGINHKNLV 328
LG G G V+ + G A+K L Q V+H +E ++S + H ++
Sbjct: 14 LGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIVTHPFII 69
Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS---TAE---GL 381
++ G + + ++ +++ L F L R+ ++ AE L
Sbjct: 70 RMWGTFQD-AQQIFMIMDYIEGGEL----FSL-----LRKSQRFPNPVAKFYAAEVCLAL 119
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
YLH II+RD+K NILLD+ KI DFG + P D+T+ TL GT
Sbjct: 120 EYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-DVTY---TLCGT 166
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 9e-11
Identities = 49/175 (28%), Positives = 66/175 (37%), Gaps = 35/175 (20%)
Query: 277 LGQGGSGSV----YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVK 329
LG+G G V K T G A+K L V H E ++ H L
Sbjct: 13 LGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 330 LLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS---TAE---GLA 382
L T + L V E+ LF LS E + + AE L
Sbjct: 70 LKYAFQT-HDRLCFVMEYANG----GELFFH-----LSRERVFTEERARFYGAEIVSALE 119
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGT 435
YLH +++RDIKL N++LD++ KI DFGL + + T GT
Sbjct: 120 YLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK---TFCGT 168
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 52/173 (30%), Positives = 70/173 (40%), Gaps = 30/173 (17%)
Query: 277 LGQGGSGSV----YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVN-LISGINHKNLV 328
LG+G G V KGT E AVK L V+ E L L
Sbjct: 349 LGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYL 384
+L C T + L V E+V L+ ++ + V Y AE GL +L
Sbjct: 406 QLHSCFQT-MDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFY-----AAEIAIGLFFL 458
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGT 435
II+RD+KL N++LD E KIADFG+ + ++ T T GT
Sbjct: 459 QS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK---TFCGT 505
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 6e-10
Identities = 53/173 (30%), Positives = 73/173 (42%), Gaps = 30/173 (17%)
Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVN-LISGINHKNLV 328
+G+G V K T A++ + N + +D E + NH LV
Sbjct: 60 IGRGSYAKVLLVRLKKT---DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116
Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYL 384
L C T L V E+V L+ ++ RQ P Y +AE L YL
Sbjct: 117 GLHSCFQT-ESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFY-----SAEISLALNYL 169
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGT 435
HE II+RD+KL N+LLD E K+ D+G+ + L P D T T GT
Sbjct: 170 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS---TFCGT 216
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 6e-10
Identities = 54/173 (31%), Positives = 73/173 (42%), Gaps = 30/173 (17%)
Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVN-LISGINHKNLV 328
+G+G V K T A+K + N + +D E + NH LV
Sbjct: 17 IGRGSYAKVLLVRLKKT---DRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73
Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYL 384
L C T L V E+V L+ ++ RQ P Y +AE L YL
Sbjct: 74 GLHSCFQT-ESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFY-----SAEISLALNYL 126
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGT 435
HE II+RD+KL N+LLD E K+ D+G+ + L P D T T GT
Sbjct: 127 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS---TFCGT 173
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 7e-10
Identities = 50/173 (28%), Positives = 73/173 (42%), Gaps = 30/173 (17%)
Query: 277 LGQGGSGSV----YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVN-LISGINHKNLV 328
LG+G G V +K T + A+K L V+ E L H L
Sbjct: 25 LGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYL 384
+ T E+L V E++ L+ ++ LS Y AE GL +L
Sbjct: 82 HMFCTFQT-KENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFY-----AAEIILGLQFL 134
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGT 435
H I++RD+KL NILLD++ KIADFG+ + + + T+ T GT
Sbjct: 135 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN---TFCGT 181
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 8e-10
Identities = 52/173 (30%), Positives = 70/173 (40%), Gaps = 30/173 (17%)
Query: 277 LGQGGSGSV----YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVN-LISGINHKNLV 328
LG+G G V KGT E AVK L V+ E L L
Sbjct: 28 LGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYL 384
+L C T + L V E+V L+ ++ + V Y AE GL +L
Sbjct: 85 QLHSCFQT-MDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFY-----AAEIAIGLFFL 137
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGT 435
II+RD+KL N++LD E KIADFG+ + ++ T T GT
Sbjct: 138 QS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK---TFCGT 184
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 26/62 (41%), Positives = 32/62 (51%), Gaps = 6/62 (9%)
Query: 377 TAE---GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA 433
E L +LH+ L II+RDIKL NILLD + DFGL + F D T +
Sbjct: 165 VGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 221
Query: 434 GT 435
GT
Sbjct: 222 GT 223
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 56/173 (32%), Positives = 73/173 (42%), Gaps = 30/173 (17%)
Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVN-LISGINHKNLV 328
LG+G G V K T G+ AVK L V+ E L NH L
Sbjct: 31 LGKGSFGKVMLARVKET---GDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 87
Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYL 384
+L C T P+ L V EFV L+ ++ Q E R + AE L +L
Sbjct: 88 QLFCCFQT-PDRLFFVMEFVNGGDLMFHI---QKSRRFD-EARARFY--AAEIISALMFL 140
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGL--VRLFPEDITHISATLAGT 435
H+ II+RD+KL N+LLD E K+ADFG+ + T T GT
Sbjct: 141 HD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA---TFCGT 187
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 57.9 bits (141), Expect = 2e-09
Identities = 48/180 (26%), Positives = 75/180 (41%), Gaps = 41/180 (22%)
Query: 277 LGQGGSGSVY-------KGTLPGGEAVAVK-----RLFYNTTQWVDHFFNEVNLISGINH 324
LG+GG G V+ T G+ A+K + N H E N++ + H
Sbjct: 25 LGKGGYGKVFQVRKVTGANT---GKIFAMKVLKKAMIVRNAKD-TAHTKAERNILEEVKH 80
Query: 325 KNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS---TAE- 379
+V L+ T L L+ E++ LF++ L E + + AE
Sbjct: 81 PFIVDLIYAFQT-GGKLYLILEYLSG----GELFMQ-----LEREGIFMEDTACFYLAEI 130
Query: 380 --GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL--VRLFPEDITHISATLAGT 435
L +LH+ II+RD+K NI+L+ + K+ DFGL + +TH T GT
Sbjct: 131 SMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH---TFCGT 184
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 3e-09
Identities = 26/64 (40%), Positives = 33/64 (51%), Gaps = 11/64 (17%)
Query: 377 TAE---GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL--VRLFPEDITHISAT 431
AE L +LH L II+RD+K NILLDEE K+ DFGL + E + +
Sbjct: 132 LAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---S 185
Query: 432 LAGT 435
GT
Sbjct: 186 FCGT 189
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 40/163 (24%), Positives = 69/163 (42%), Gaps = 27/163 (16%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN----------- 323
KLG G +V+ + VA+K + + + +E+ L+ +N
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 324 HKNLVKLLGC-SITGPESL---LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
+++KLL + GP + +V+E V ++LL L + + + +I
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLA-LIKKYEHRGIPLIYVKQISKQLLL 142
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEE------FTAKIADFG 416
GL Y+H + IIH DIK N+L++ KIAD G
Sbjct: 143 GLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG 183
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 48/175 (27%), Positives = 67/175 (38%), Gaps = 34/175 (19%)
Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVN-LISGINHKNLV 328
+G+G G V K AVK L + H +E N L+ + H LV
Sbjct: 46 IGKGSFGKVLLARHKAE---EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYK-----IILSTAEGLA 382
L T + L V +++ L +L Q E R + I L
Sbjct: 103 GLHFSFQT-ADKLYFVLDYINGGELFYHL---QRERCFL-EPRARFYAAEIAS----ALG 153
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGT 435
YLH L I++RD+K NILLD + + DFGL + + T T GT
Sbjct: 154 YLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTS---TFCGT 202
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 32/152 (21%), Positives = 56/152 (36%), Gaps = 19/152 (12%)
Query: 275 NKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKN 326
LG+G G V + G VAVK L T +E+ ++ I +H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
+V LLG C+ G +++ EF +L L R + + +G +
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFRQ 137
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417
+ + I D+K + ++ + F
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 5e-08
Identities = 20/42 (47%), Positives = 27/42 (64%), Gaps = 3/42 (7%)
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
A+G+ +L S+ + IHRD+ NILL E+ KI DFGL R
Sbjct: 203 AKGMEFL--ASR-KCIHRDLAARNILLSEKNVVKICDFGLAR 241
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 9e-08
Identities = 43/142 (30%), Positives = 68/142 (47%), Gaps = 18/142 (12%)
Query: 276 KLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI--------NHKN 326
KLG G +V+ + G + VA+K + + + + +E+ L+ + N +
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102
Query: 327 LVKLLGC-SITGPESL---LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
+V+LL I+G +V+E V LL ++ + + L KII +GL
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFE-VLGHHLLK-WIIKSNYQGLPLPCVKKIIQQVLQGLD 160
Query: 383 YLHEESKLRIIHRDIKLSNILL 404
YLH +K RIIH DIK NILL
Sbjct: 161 YLH--TKCRIIHTDIKPENILL 180
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 25/181 (13%), Positives = 55/181 (30%), Gaps = 37/181 (20%)
Query: 275 NKLGQGGSGSVYKGT---------LPGGEAVAVK-----------RLFYNTTQWVDHFFN 314
+ + G +Y+ P + ++K + F+
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 315 EVNLISGINHKNLVKLLGCSITGPE-SLLVYEFV-PNQSLLDNLFVRQDVEPLSWEVRYK 372
L + +G + + LV + + L + LS +
Sbjct: 108 WKKL-YSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRS---LQSALDVSPKHVLSERSVLQ 163
Query: 373 I---ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI--ADFGLVRLFPEDITH 427
+ +L E +LHE +H ++ NI +D E +++ A +G + H
Sbjct: 164 VACRLLDALE---FLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKH 217
Query: 428 I 428
+
Sbjct: 218 V 218
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.2 bits (124), Expect = 3e-07
Identities = 65/422 (15%), Positives = 125/422 (29%), Gaps = 121/422 (28%)
Query: 76 DDYDFFNESLSSQDRTVCGSKD--------FGGNNTVFGA---NAIELVRNLSVQAVKND 124
+Y F + ++ R +N VF + ++ L QA+
Sbjct: 89 INYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLR-QALLEL 147
Query: 125 GFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRV--LNAGC 182
NV + G+ G + + V K + ++ LN
Sbjct: 148 R--------PAKNVLIDGVLGS-----G---KTWVALDVCLSYKVQCKMDFKIFWLNLKN 191
Query: 183 YLRYST-----QRFYNNSGPD-----------PVPGNGGDNKLAVILATSA-VALLLVFS 225
T Q+ P+ + + +L +L + LLV
Sbjct: 192 CNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLL 251
Query: 226 LV-------AFFVRRKLLQKRRERK---QLGAL---QVAVNKSKLNFSYETLEKATNYFH 272
V AF + K+L R ++ L A ++++ + T ++ +
Sbjct: 252 NVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTL---TPDEVKSLL- 307
Query: 273 ESNKLGQGGSGSVYKGTLPGGEAV-----------AVKRLFYNTTQWVDHFFNEVNLISG 321
L LP E + R T H
Sbjct: 308 -LKYLDCR------PQDLP-REVLTTNPRRLSIIAESIRDGLATWDNWKH---------- 349
Query: 322 INHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV-RQDVE-P---LS--WE--VRYK 372
+N L ++ S+ L E+ + + D L V P LS W ++
Sbjct: 350 VNCDKLTTIIESSL---NVLEPAEY---RKMFDRLSVFPPSAHIPTILLSLIWFDVIKSD 403
Query: 373 IILSTAE----GLAYLH-EESKLRI--IHRDIKLSNILLDEEFT--AKIAD-FGLVRLFP 422
+++ + L +ES + I I+ ++K+ L+ E+ I D + + + F
Sbjct: 404 VMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVK---LENEYALHRSIVDHYNIPKTFD 460
Query: 423 ED 424
D
Sbjct: 461 SD 462
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 42/171 (24%), Positives = 65/171 (38%), Gaps = 33/171 (19%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISG 321
EK + + + +G+G G V K E VA+K + N +++ EV L+
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK---NKKAFLNQAQIEVRLLEL 106
Query: 322 INH------KNLVKLLG--------CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSW 367
+N +V L C + S +Y+ L + F +S
Sbjct: 107 MNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDL-----LRNTNFR-----GVSL 156
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA--KIADFG 416
+ K L +L +L IIH D+K NILL + KI DFG
Sbjct: 157 NLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG 206
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 43/179 (24%), Positives = 70/179 (39%), Gaps = 45/179 (25%)
Query: 257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVK--RLFYNTTQWVDHFF 313
+ + YE L+ +G+G G V K + VA+K R N ++
Sbjct: 95 VAYRYEVLKV----------IGKGSFGQVVKAYDHKVHQHVALKMVR---NEKRFHRQAA 141
Query: 314 NEVNLISGINHK------NLVKLLG--------CSITGPESLLVYEFVPNQSLLDNLFVR 359
E+ ++ + + N++ +L C S+ +YE + N F
Sbjct: 142 EEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYEL-----IKKNKFQ- 195
Query: 360 QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA--KIADFG 416
S + K S + L LH K RIIH D+K NILL ++ + K+ DFG
Sbjct: 196 ----GFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFG 247
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 41/182 (22%), Positives = 66/182 (36%), Gaps = 39/182 (21%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGC 333
K+G G G + G L E VA+K E + + + ++
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIK--LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYF 73
Query: 334 SITGPESLLVYEFV-PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA--------YL 384
G + +V E + P+ L++LF D L T +A Y+
Sbjct: 74 GPCGKYNAMVLELLGPS---LEDLFDLCD---------RTFSLKTVLMIAIQLISRMEYV 121
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAK-----IADFGLVRLF--PEDITHI----SATLA 433
H ++ +I+RD+K N L+ I DF L + + PE HI +L
Sbjct: 122 HSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLT 178
Query: 434 GT 435
GT
Sbjct: 179 GT 180
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 30/173 (17%), Positives = 56/173 (32%), Gaps = 23/173 (13%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDH--FFNEVN----LISGINHKNLVK 329
+GQGG G +Y + E+V + D+ F E+ + ++
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQ----DVEPLSWEVRYKIILSTAEGLA--- 382
G + D++ + + T L+
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRI 161
Query: 383 -----YLHEESKLRIIHRDIKLSNILLDEEFTAKI--ADFGLVRLFPEDITHI 428
Y+HE +H DIK SN+LL+ + ++ D+GL + + H
Sbjct: 162 LDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 38/178 (21%), Positives = 73/178 (41%), Gaps = 31/178 (17%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGC 333
++G+G G +++GT L + VA+K + +E + + +
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 334 SITGPESLLVYEFV-PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE----GLAYLHEES 388
G ++LV + + P+ L++L S K + A+ + +HE+S
Sbjct: 75 GQEGLHNVLVIDLLGPS---LEDLLDLCG-RKFS----VKTVAMAAKQMLARVQSIHEKS 126
Query: 389 KLRIIHRDIKLSNILLDEEFTAK-----IADFGLVRLF--PEDITHI----SATLAGT 435
+++RDIK N L+ + + DFG+V+ + P HI L+GT
Sbjct: 127 ---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 40/163 (24%), Positives = 67/163 (41%), Gaps = 21/163 (12%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNL---ISGINHKNLVKLL 331
K+G G G +Y GT + GE VA+K T E + + G + +
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG--IPTIR 71
Query: 332 GCSITGPESLLVYEFV-PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
C G +++V E + P+ L++LF + S + + + Y+H ++
Sbjct: 72 WCGAEGDYNVMVMELLGPS---LEDLFNFCSRK-FSLKTVLLLADQMISRIEYIHSKN-- 125
Query: 391 RIIHRDIKLSNILL---DEEFTAKIADFGLVRLF--PEDITHI 428
IHRD+K N L+ + I DFGL + + HI
Sbjct: 126 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 167
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 42/172 (24%), Positives = 69/172 (40%), Gaps = 21/172 (12%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV-KLLGC 333
K+G G G +Y GT + E VA+K T E + + + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWF 71
Query: 334 SITGPESLLVYEFV-PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
+ G ++LV + + P+ L++LF LS + + + ++H +S
Sbjct: 72 GVEGDYNVLVMDLLGPS---LEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKS---F 124
Query: 393 IHRDIKLSNILLDEEFTAK---IADFGLVRLF--PEDITHI----SATLAGT 435
+HRDIK N L+ A I DFGL + + HI + L GT
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 16/50 (32%), Positives = 26/50 (52%), Gaps = 5/50 (10%)
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKI--ADFGLVRLFPEDITHI 428
L Y+HE +H DIK +N+LL + ++ AD+GL + + H
Sbjct: 164 LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 35/147 (23%), Positives = 54/147 (36%), Gaps = 32/147 (21%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINH-----KNL 327
K+G G G V + + AVK R N ++ E +++ I + N+
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVR---NIKKYTRSAKIEADILKKIQNDDINNNNI 98
Query: 328 VKLLG--------CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
VK G C I P +YE + N + E + +
Sbjct: 99 VKYHGKFMYYDHMCLIFEPLGPSLYEI-----ITRNNYN-----GFHIEDIKLYCIEILK 148
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDE 406
L YL K+ + H D+K NILLD+
Sbjct: 149 ALNYLR---KMSLTHTDLKPENILLDD 172
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 36/178 (20%), Positives = 56/178 (31%), Gaps = 53/178 (29%)
Query: 276 KLGQGGSGSVYKG--TLPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHK------ 325
LG+G G V + G VA+K R N ++ + E+N++ I K
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIR---NVGKYREAARLEINVLKKIKEKDKENKF 82
Query: 326 NLVKLLG--------CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST 377
V + C +EF L +N F P +
Sbjct: 83 LCVLMSDWFNFHGHMCIAFELLGKNTFEF-----LKENNFQ-----PYPLPHVRHMAYQL 132
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA-------------------KIADFG 416
L +LH + ++ H D+K NIL ++ADFG
Sbjct: 133 CHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 437 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.98 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.97 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.97 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.97 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.96 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.96 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.96 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.96 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.96 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.96 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.96 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.96 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.96 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.96 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.96 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.96 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.96 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.95 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.95 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.95 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.95 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.95 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.95 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.95 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.95 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.95 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.95 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.95 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.95 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.95 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.95 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.95 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.95 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.95 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.95 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.95 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.95 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.95 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.95 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.95 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.95 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.95 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.95 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.95 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.95 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.95 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.95 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.94 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.94 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.94 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.94 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.94 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.94 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.94 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.94 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.94 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.94 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.94 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.94 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.94 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.94 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.94 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.94 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.94 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.94 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.94 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.94 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.94 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.94 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.94 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.94 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.94 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.94 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.94 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.94 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.94 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.94 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.94 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.94 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.94 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.94 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.94 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.94 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.94 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.94 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.94 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.94 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.94 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.94 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.94 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.94 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.94 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.94 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.94 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.94 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.94 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.94 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.94 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.94 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.94 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.94 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.94 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.94 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.94 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.94 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.94 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.94 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.94 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.94 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.94 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.94 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.94 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.94 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.94 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.94 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.94 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.94 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.93 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.93 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.93 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.93 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.93 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.93 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.93 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.93 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.93 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.93 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.93 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.93 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.93 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.93 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.93 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.93 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.93 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.93 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.93 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.93 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.93 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.93 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.93 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.93 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.93 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.93 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.93 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.93 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.93 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.93 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.93 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.93 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.93 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.93 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.93 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.93 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.93 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.93 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.93 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.93 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.93 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.93 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.93 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.93 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.93 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.93 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.93 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.93 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.93 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.93 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.93 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.93 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.93 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.93 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.93 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.93 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.93 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.93 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.93 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.93 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.93 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.93 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.93 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.93 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.93 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.93 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.93 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.92 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.92 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.92 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.92 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.92 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.92 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.92 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.92 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.92 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.92 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.92 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.92 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.92 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.92 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.92 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.92 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.92 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.92 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.92 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.92 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.92 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.92 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.92 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.92 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.92 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.92 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.91 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.91 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.91 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.91 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.91 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.91 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.91 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.91 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.91 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.91 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.91 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.91 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.91 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.91 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.9 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.9 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.9 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.9 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.9 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.89 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.89 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.89 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.85 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.85 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.84 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.84 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.75 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.44 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.19 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.81 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.73 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.63 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.62 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.53 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.51 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.47 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.18 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.08 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.92 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.91 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.78 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.52 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.51 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.49 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.43 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.43 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.39 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.37 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.07 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.97 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.56 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.94 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.82 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 90.07 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 90.02 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.01 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 88.26 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 84.49 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=291.05 Aligned_cols=165 Identities=24% Similarity=0.371 Sum_probs=140.6
Q ss_pred cCCCcCCcccccCcccEEEEEeC------CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
++|...++||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++|++.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46778899999999999999864 367899999987777778899999999999999999999999999999999
Q ss_pred EEeccCCCCcccccccc----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 013737 343 VYEFVPNQSLLDNLFVR----------QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI 412 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~----------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki 412 (437)
||||+++|+|.++|... .....++|.+++.|+.||+.||.|||+++ ||||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 99999999999998643 23456999999999999999999999987 999999999999999999999
Q ss_pred cccCCccccCCCCcc-eeeeecccC
Q 013737 413 ADFGLVRLFPEDITH-ISATLAGTL 436 (437)
Q Consensus 413 ~DFG~a~~~~~~~~~-~~~~~~Gt~ 436 (437)
+|||+|+........ ......||+
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~ 194 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPI 194 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECG
T ss_pred CCcccceecCCCCceeecCceecCh
Confidence 999999976543322 222345664
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=291.82 Aligned_cols=165 Identities=24% Similarity=0.342 Sum_probs=135.0
Q ss_pred cCCCcCCcccccCcccEEEEEeC------CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
++|...++||+|+||.||+|+++ +++.||||+++.......++|.+|+++|++++|||||+++|++.+++..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45667789999999999999864 477899999987777778899999999999999999999999999999999
Q ss_pred EEeccCCCCccccccccCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 013737 343 VYEFVPNQSLLDNLFVRQD------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ 410 (437)
||||+++|+|.+++..... ..+++|.+++.|+.||+.||.|||+++ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999865321 246999999999999999999999987 9999999999999999999
Q ss_pred EEcccCCccccCCCCc-ceeeeecccC
Q 013737 411 KIADFGLVRLFPEDIT-HISATLAGTL 436 (437)
Q Consensus 411 ki~DFG~a~~~~~~~~-~~~~~~~Gt~ 436 (437)
||+|||+|+.+..... ...++..||+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~ 224 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPI 224 (329)
T ss_dssp EECCCC----------------CCCCG
T ss_pred EEcccccceeccCCCcceecCcccccc
Confidence 9999999997754332 2334566775
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=289.13 Aligned_cols=163 Identities=24% Similarity=0.314 Sum_probs=144.0
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..++||+|+||+||+|+. .+++.||||++... .....+.+.+|+++|++++|||||++++++.+++..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4699999999999999999997 56999999999753 2344678999999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||+++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999843 346999999999999999999999998 999999999999999999999999999988654
Q ss_pred Ccc-eeeeecccCC
Q 013737 425 ITH-ISATLAGTLF 437 (437)
Q Consensus 425 ~~~-~~~~~~Gt~~ 437 (437)
... ...+++||+.
T Consensus 186 ~~~~~~~~~~GTp~ 199 (311)
T 4aw0_A 186 SKQARANSFVGTAQ 199 (311)
T ss_dssp TTCCCBCCCCSCGG
T ss_pred CCcccccCcccCcc
Confidence 332 3346789873
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=292.95 Aligned_cols=162 Identities=30% Similarity=0.492 Sum_probs=144.0
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
.+.|+..++||+|+||.||+|.+. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..||||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 356888999999999999999974 6999999999766555566789999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCCc
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~~ 426 (437)
+++|+|.+++.. ..+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+..+..
T Consensus 153 ~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 153 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 999999998843 35899999999999999999999998 99999999999999999999999999998865443
Q ss_pred ceeeeecccCC
Q 013737 427 HISATLAGTLF 437 (437)
Q Consensus 427 ~~~~~~~Gt~~ 437 (437)
. .++.+||++
T Consensus 226 ~-~~~~~GTp~ 235 (346)
T 4fih_A 226 R-RKSLVGTPY 235 (346)
T ss_dssp C-BCCCCSCGG
T ss_pred c-ccccccCcC
Confidence 2 345788874
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=292.34 Aligned_cols=164 Identities=19% Similarity=0.332 Sum_probs=137.7
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
++|+..++||+|+||+||+|++ .+|+.||||++... .....+.+.+|+++|++|+|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5789999999999999999997 56999999999754 34456789999999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~ 425 (437)
|+++|+|.+++..+ +...+++.++..|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999998543 3456899999999999999999999998 9999999999999999999999999999875432
Q ss_pred cceeeeecccCC
Q 013737 426 THISATLAGTLF 437 (437)
Q Consensus 426 ~~~~~~~~Gt~~ 437 (437)
. ..++.+||++
T Consensus 180 ~-~~~~~~GT~~ 190 (350)
T 4b9d_A 180 E-LARACIGTPY 190 (350)
T ss_dssp H-HHHHHHSCCT
T ss_pred c-cccccCCCcc
Confidence 2 2335678864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=284.61 Aligned_cols=163 Identities=32% Similarity=0.450 Sum_probs=134.6
Q ss_pred HHhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEE
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
...+++...++||+|+||+||+|++++ .||||+++.. .....++|.+|+.+|++++|||||+++|++.+ +..+||
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 345678889999999999999999763 6999998643 44557889999999999999999999998754 568999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|||+++|+|.++|... ..+++|.+++.|+.||+.||.|||+++ ||||||||+||||++++++||+|||+|+....
T Consensus 110 mEy~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EECCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 9999999999988533 356999999999999999999999987 99999999999999999999999999998764
Q ss_pred CCc-ceeeeecccC
Q 013737 424 DIT-HISATLAGTL 436 (437)
Q Consensus 424 ~~~-~~~~~~~Gt~ 436 (437)
... ...++.+||+
T Consensus 185 ~~~~~~~~~~~GT~ 198 (307)
T 3omv_A 185 WSGSQQVEQPTGSV 198 (307)
T ss_dssp ---------CCCCT
T ss_pred CCcceeecccccCC
Confidence 332 2334667886
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=294.20 Aligned_cols=162 Identities=30% Similarity=0.495 Sum_probs=144.5
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
.+.|+..++||+|+||.||+|.+ .+|+.||||++........+.+.+|+.+|++++|||||++++++.+++.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 46799999999999999999997 46999999999876555567789999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCCc
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~~ 426 (437)
|++|+|.+++.. ..+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999998842 35899999999999999999999998 99999999999999999999999999998865443
Q ss_pred ceeeeecccCC
Q 013737 427 HISATLAGTLF 437 (437)
Q Consensus 427 ~~~~~~~Gt~~ 437 (437)
. .++++||++
T Consensus 303 ~-~~~~~GTp~ 312 (423)
T 4fie_A 303 R-RKSLVGTPY 312 (423)
T ss_dssp C-BCCCEECTT
T ss_pred c-ccccccCcC
Confidence 2 345788874
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=285.59 Aligned_cols=164 Identities=24% Similarity=0.358 Sum_probs=137.5
Q ss_pred CCCcCCcccccCcccEEEEEeC------CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
+++..++||+|+||+||+|.+. +++.||||+++.. .....++|.+|+.+|++++|||||+++|++.+++..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3556788999999999999863 4678999999754 33456789999999999999999999999999999999
Q ss_pred EEeccCCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCc
Q 013737 343 VYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT 409 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~ 409 (437)
|||||++|+|.++|..+.. ...++|.+++.|+.||+.||.|||+++ ||||||||+||||+++++
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 9999999999999864321 246899999999999999999999987 999999999999999999
Q ss_pred EEEcccCCccccCCCC-cceeeeecccC
Q 013737 410 AKIADFGLVRLFPEDI-THISATLAGTL 436 (437)
Q Consensus 410 ~ki~DFG~a~~~~~~~-~~~~~~~~Gt~ 436 (437)
+||+|||+|+.+.... ....++..||+
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~ 211 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPI 211 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCG
T ss_pred EEECCcccceeccCCCceeEecccccCC
Confidence 9999999999765432 22233456664
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=279.35 Aligned_cols=153 Identities=25% Similarity=0.402 Sum_probs=128.2
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC--------
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP-------- 338 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 338 (437)
++|+..+.||+|+||.||+|++ .+|+.||||++... .....+++.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 3588899999999999999997 46899999999754 3445678999999999999999999999987654
Q ss_pred ----eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 013737 339 ----ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIAD 414 (437)
Q Consensus 339 ----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~D 414 (437)
..|+||||+++|+|.+++..+....+.++..++.|+.||++||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999865544455677888999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCC
Q 013737 415 FGLVRLFPED 424 (437)
Q Consensus 415 FG~a~~~~~~ 424 (437)
||+|+.+..+
T Consensus 162 FGla~~~~~~ 171 (299)
T 4g31_A 162 FGLVTAMDQD 171 (299)
T ss_dssp CCCC------
T ss_pred CccceecCCC
Confidence 9999987654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=276.87 Aligned_cols=159 Identities=26% Similarity=0.333 Sum_probs=135.4
Q ss_pred CcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEee----CCeeEEEE
Q 013737 272 HESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT----GPESLLVY 344 (437)
Q Consensus 272 ~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 344 (437)
+..++||+|+||.||+|.+. ++..||+|.+... .....++|.+|+++|++++|||||++++++.+ ++..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 55678999999999999974 5899999999643 34456789999999999999999999999875 34579999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC-CCCcEEEcccCCccccCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~-~~~~~ki~DFG~a~~~~~ 423 (437)
||+++|+|.+++.. ...+++..+..|+.||+.||.|||+++ ++||||||||+||||+ +++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999999853 346899999999999999999999985 4699999999999998 478999999999987544
Q ss_pred CCcceeeeecccCC
Q 013737 424 DITHISATLAGTLF 437 (437)
Q Consensus 424 ~~~~~~~~~~Gt~~ 437 (437)
. ...+++||+.
T Consensus 185 ~---~~~~~~GTp~ 195 (290)
T 3fpq_A 185 S---FAKAVIGTPE 195 (290)
T ss_dssp T---SBEESCSSCC
T ss_pred C---ccCCcccCcc
Confidence 3 2346789874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=273.21 Aligned_cols=160 Identities=25% Similarity=0.407 Sum_probs=127.0
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..+.||+|+||+||+|.. .+|+.||||.+... .....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999997 46999999999654 2334567999999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||+ +|+|.+++.. ..++++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+...+.
T Consensus 93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 6799988843 346999999999999999999999998 999999999999999999999999999977543
Q ss_pred CcceeeeecccCC
Q 013737 425 ITHISATLAGTLF 437 (437)
Q Consensus 425 ~~~~~~~~~Gt~~ 437 (437)
. ..++.+||+.
T Consensus 166 ~--~~~~~~GT~~ 176 (275)
T 3hyh_A 166 N--FLKTSCGSPN 176 (275)
T ss_dssp -----------CT
T ss_pred C--ccCCeeECcc
Confidence 3 2235678863
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=280.95 Aligned_cols=161 Identities=28% Similarity=0.261 Sum_probs=131.9
Q ss_pred cCCCcCCcccccCcccEEEEEe----CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~----~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
++|+..+.||+|+||+||+|+. .+++.||||.+... ......++.+|+++|++++|||||++++++.+++..||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5699999999999999999986 24789999998643 22234468899999999999999999999999999999
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
||||+++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999843 346999999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCcceeeeecccC
Q 013737 423 EDITHISATLAGTL 436 (437)
Q Consensus 423 ~~~~~~~~~~~Gt~ 436 (437)
.... ...+.+||+
T Consensus 178 ~~~~-~~~~~~GT~ 190 (304)
T 3ubd_A 178 DHEK-KAYSFCGTV 190 (304)
T ss_dssp ---C-CCCSCCCCG
T ss_pred CCCc-cccccccCc
Confidence 4332 233567886
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=280.32 Aligned_cols=157 Identities=25% Similarity=0.333 Sum_probs=133.3
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEecc
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (437)
+.|...++||+|+||.||+|++ .+|+.||||+++.... ..+|+.+|++++|||||++++++.+++..||||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 4577788999999999999997 4699999999975432 247999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC-cEEEcccCCccccCCCCc
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRLFPEDIT 426 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~-~~ki~DFG~a~~~~~~~~ 426 (437)
++|+|.+++.. ...+++.++..++.||+.||+|||+++ ||||||||+||||+.++ ++||+|||+|+.+..+..
T Consensus 133 ~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 99999999853 346999999999999999999999998 99999999999999887 699999999998865432
Q ss_pred c----eeeeecccC
Q 013737 427 H----ISATLAGTL 436 (437)
Q Consensus 427 ~----~~~~~~Gt~ 436 (437)
. ....++||+
T Consensus 207 ~~~~~~~~~~~GT~ 220 (336)
T 4g3f_A 207 GKSLLTGDYIPGTE 220 (336)
T ss_dssp -------CCCCCCG
T ss_pred ccceecCCccccCc
Confidence 2 122467886
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-35 Score=280.30 Aligned_cols=177 Identities=27% Similarity=0.352 Sum_probs=148.4
Q ss_pred cccCHHHHHHHhcCCCcCCcccccCcccEEEEEeCC------CCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCC-Ccee
Q 013737 257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNT-TQWVDHFFNEVNLISGINH-KNLV 328 (437)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv 328 (437)
+.++...|+...++|+..++||+|+||+||+|.+.. ++.||||.+.... ....+.|.+|+++|.+++| ||||
T Consensus 52 lp~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV 131 (353)
T 4ase_A 52 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131 (353)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEE
Confidence 445667788888999999999999999999998642 3579999997653 3456789999999999975 8999
Q ss_pred ceeEEEeeC-CeeEEEEeccCCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeee
Q 013737 329 KLLGCSITG-PESLLVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394 (437)
Q Consensus 329 ~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH 394 (437)
+++|+|.+. +..+||||||++|+|.++|..... ...+++.+++.++.||+.||+|||+++ |||
T Consensus 132 ~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiH 208 (353)
T 4ase_A 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIH 208 (353)
T ss_dssp CEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred EEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eec
Confidence 999998765 568999999999999999864321 345899999999999999999999998 999
Q ss_pred CCCCCCCeeeCCCCcEEEcccCCccccCCCCcce-eeeecccC
Q 013737 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI-SATLAGTL 436 (437)
Q Consensus 395 rDlk~~NIll~~~~~~ki~DFG~a~~~~~~~~~~-~~~~~Gt~ 436 (437)
|||||+|||+++++.+||+|||+|+.+..+.... .++..||+
T Consensus 209 RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~ 251 (353)
T 4ase_A 209 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 251 (353)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECG
T ss_pred CccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccc
Confidence 9999999999999999999999999876554432 23566775
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=273.15 Aligned_cols=162 Identities=31% Similarity=0.351 Sum_probs=130.2
Q ss_pred cCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC----eeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP----ESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 344 (437)
++|...++||+|+||+||+|++. |+.||||++...... ...++.|+..+.+++|||||++++++.+++ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 45667889999999999999985 889999999654322 223445666778899999999999998654 579999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCCeeeCCCCCCCeeeCCCCcEEEcccCCcc
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES-----KLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-----~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~ 419 (437)
||+++|+|.+++.. .+++|..+.+++.|++.||.|||++. .++||||||||+||||++++++||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999843 35899999999999999999999861 2359999999999999999999999999999
Q ss_pred ccCCCCcce---eeeecccC
Q 013737 420 LFPEDITHI---SATLAGTL 436 (437)
Q Consensus 420 ~~~~~~~~~---~~~~~Gt~ 436 (437)
......... ..+.+||+
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~ 176 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTK 176 (303)
T ss_dssp EEETTTTEESCC-----CCG
T ss_pred cccCCCCceeeecccccccc
Confidence 876544322 22457876
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=270.28 Aligned_cols=162 Identities=22% Similarity=0.372 Sum_probs=136.9
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEee------CCe
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT------GPE 339 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 339 (437)
++|+..+.||+|+||.||+|.+ .+|+.||||++... .....+.+.+|+++|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999997 56999999999643 33456788999999999999999999998764 357
Q ss_pred eEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcc
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~ 419 (437)
+||||||++ |+|.+++. ...++++.++..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 899999996 68988883 3457999999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCC---cceeeeecccCC
Q 013737 420 LFPEDI---THISATLAGTLF 437 (437)
Q Consensus 420 ~~~~~~---~~~~~~~~Gt~~ 437 (437)
.+.... ....++.+||++
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~ 227 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRW 227 (398)
T ss_dssp CC-------CCCCCSSCCCCT
T ss_pred ecccCccccccccccceeChH
Confidence 875432 122346788874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-32 Score=261.48 Aligned_cols=148 Identities=25% Similarity=0.384 Sum_probs=131.3
Q ss_pred HHHhcCCCcCCcccccCcccEEEEEeC----CCCEEEEEEEeccchhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCe
Q 013737 265 EKATNYFHESNKLGQGGSGSVYKGTLP----GGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPE 339 (437)
Q Consensus 265 ~~~~~~~~~~~~Lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 339 (437)
....+.|+..++||+|+||.||+|+.+ +++.||||.+.... ...++.+|+++|..+ +||||+++++++.+.+.
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 345678999999999999999999853 46789999986543 345688999999988 69999999999999999
Q ss_pred eEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC-CcEEEcccCCc
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLV 418 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~-~~~ki~DFG~a 418 (437)
.+|||||+++|+|.+++ ..+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|
T Consensus 95 ~~lvmE~~~g~~L~~~~------~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDIL------NSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEEECCCCCCHHHHH------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEeCCCcccHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 99999999999999987 24899999999999999999999998 9999999999999876 79999999999
Q ss_pred cccCC
Q 013737 419 RLFPE 423 (437)
Q Consensus 419 ~~~~~ 423 (437)
+...+
T Consensus 166 ~~~~~ 170 (361)
T 4f9c_A 166 QGTHD 170 (361)
T ss_dssp EECTT
T ss_pred cccCC
Confidence 87654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-32 Score=275.60 Aligned_cols=159 Identities=25% Similarity=0.217 Sum_probs=136.5
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc---hh---hHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT---TQ---WVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (437)
++|+..++||+|+||.||+|+. .+|+.||||++.+.. .. .......++.+++.++|||||++++++.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 5688999999999999999997 469999999996431 11 1223344577888999999999999999999999
Q ss_pred EEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
|||||++||+|.+++.. ...+++..+..++.||+.||+|||+++ ||||||||+||||+.+|++||+|||+|+.+
T Consensus 269 lVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999853 346999999999999999999999998 999999999999999999999999999987
Q ss_pred CCCCcceeeeecccC
Q 013737 422 PEDITHISATLAGTL 436 (437)
Q Consensus 422 ~~~~~~~~~~~~Gt~ 436 (437)
..... .+.+||+
T Consensus 343 ~~~~~---~t~~GTp 354 (689)
T 3v5w_A 343 SKKKP---HASVGTH 354 (689)
T ss_dssp SSCCC---CSCCSCG
T ss_pred CCCCC---CCccCCc
Confidence 65443 3567886
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=272.28 Aligned_cols=161 Identities=23% Similarity=0.342 Sum_probs=143.4
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEecc
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (437)
++|++.+.||+|+||.||+|.. .+|+.||+|.+........+.+.+|+.+|+.++|||||++++++.+.+..+||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 5789999999999999999997 469999999998776666788999999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC--CcEEEcccCCccccCCCC
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE--FTAKIADFGLVRLFPEDI 425 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~--~~~ki~DFG~a~~~~~~~ 425 (437)
++|+|.+++.. ....+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 237 ~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 237 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred CCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999998843 3356999999999999999999999998 9999999999999854 899999999999886543
Q ss_pred cceeeeecccC
Q 013737 426 THISATLAGTL 436 (437)
Q Consensus 426 ~~~~~~~~Gt~ 436 (437)
...+.+||+
T Consensus 312 --~~~~~~GT~ 320 (573)
T 3uto_A 312 --SVKVTTGTA 320 (573)
T ss_dssp --EEEEECSSG
T ss_pred --ceeeeEECc
Confidence 234567886
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-30 Score=257.54 Aligned_cols=173 Identities=23% Similarity=0.198 Sum_probs=147.6
Q ss_pred cCHHHHHHHhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc---hhhHHHHHHHHHHHcCCCCCceeceeEEE
Q 013737 259 FSYETLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCS 334 (437)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 334 (437)
..+.+++...++|+..++||+|+||.||++++. +++.||+|++.... ......+.+|..++..++||||+++++++
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 345556666789999999999999999999975 47899999996432 12233488999999999999999999999
Q ss_pred eeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 013737 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIAD 414 (437)
Q Consensus 335 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~D 414 (437)
.+.+..+|||||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcc
Confidence 999999999999999999998843 2356999999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCcceeeeecccC
Q 013737 415 FGLVRLFPEDITHISATLAGTL 436 (437)
Q Consensus 415 FG~a~~~~~~~~~~~~~~~Gt~ 436 (437)
||+|+.+..+.....+..+||+
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~ 240 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTP 240 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCG
T ss_pred hhhhhhcccCCCcccccccCCc
Confidence 9999887765554444566775
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-29 Score=240.95 Aligned_cols=163 Identities=39% Similarity=0.610 Sum_probs=145.1
Q ss_pred ccCHHHHHHHhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeC
Q 013737 258 NFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITG 337 (437)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 337 (437)
.+...+++..+++|+..+.||+|+||.||+|.+++++.||||++........+.+.+|+.+++.++||||+++++++...
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 34444556678899999999999999999999888999999998777666778899999999999999999999999999
Q ss_pred CeeEEEEeccCCCCccccccccCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccC
Q 013737 338 PESLLVYEFVPNQSLLDNLFVRQD-VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (437)
Q Consensus 338 ~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG 416 (437)
+..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999998854432 235899999999999999999999988 9999999999999999999999999
Q ss_pred CccccCC
Q 013737 417 LVRLFPE 423 (437)
Q Consensus 417 ~a~~~~~ 423 (437)
+++....
T Consensus 185 ~~~~~~~ 191 (321)
T 2qkw_B 185 ISKKGTE 191 (321)
T ss_dssp TCEECSS
T ss_pred ccccccc
Confidence 9987643
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=241.62 Aligned_cols=182 Identities=45% Similarity=0.681 Sum_probs=154.3
Q ss_pred cccccCHHHHHHHhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccch-hhHHHHHHHHHHHcCCCCCceeceeEE
Q 013737 255 SKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLGC 333 (437)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~ 333 (437)
....+++.+++...++|+..+.||+|+||.||++...+++.||||++..... .....+.+|+++++.++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 3456889999999999999999999999999999988899999999875432 223368999999999999999999999
Q ss_pred EeeCCeeEEEEeccCCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 013737 334 SITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI 412 (437)
Q Consensus 334 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki 412 (437)
+...+..++||||+++++|.+++.... ...++++..+..++.|++.||.|||+...++|+||||||+|||+++++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 999999999999999999999886543 2345999999999999999999999982223999999999999999999999
Q ss_pred cccCCccccCCCCcceeeeecccC
Q 013737 413 ADFGLVRLFPEDITHISATLAGTL 436 (437)
Q Consensus 413 ~DFG~a~~~~~~~~~~~~~~~Gt~ 436 (437)
+|||+++.+............||+
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~ 199 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTI 199 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCG
T ss_pred ccCccccccCcccccccccccCCc
Confidence 999999987655544444445654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.5e-29 Score=235.69 Aligned_cols=151 Identities=28% Similarity=0.447 Sum_probs=137.3
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEecc
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (437)
++|...++||+|+||.||++.+. +++.||+|.+........+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 56788899999999999999974 58999999997777777889999999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
++++|.+++... ...+++.++..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 90 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 90 KGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp TTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred CCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 999999988542 356899999999999999999999998 999999999999999999999999999877543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.96 E-value=6.5e-29 Score=238.47 Aligned_cols=151 Identities=26% Similarity=0.407 Sum_probs=136.7
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
.++|+..+.||+|+||.||+|.+ .+|+.||||++... .....+++.+|+++++.++||||+++++++.+.+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45789999999999999999997 57999999999654 4455678999999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 94 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 999999999988543 45899999999999999999999998 999999999999999999999999999877543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-29 Score=247.05 Aligned_cols=173 Identities=23% Similarity=0.190 Sum_probs=146.7
Q ss_pred cCHHHHHHHhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc---hhhHHHHHHHHHHHcCCCCCceeceeEEE
Q 013737 259 FSYETLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCS 334 (437)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 334 (437)
+.+++++...++|+..+.||+|+||.||+++.. +++.||||++.... ....+.+.+|..++..++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 344455556788999999999999999999974 68999999996532 22334588999999999999999999999
Q ss_pred eeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 013737 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIAD 414 (437)
Q Consensus 335 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~D 414 (437)
.+.+..+|||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEee
Confidence 9999999999999999999998543 236899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCcceeeeecccC
Q 013737 415 FGLVRLFPEDITHISATLAGTL 436 (437)
Q Consensus 415 FG~a~~~~~~~~~~~~~~~Gt~ 436 (437)
||+++.+..+........+||+
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~ 227 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTP 227 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCG
T ss_pred chhheeccCCCccccceecccc
Confidence 9999987665443333456664
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-28 Score=231.00 Aligned_cols=166 Identities=47% Similarity=0.720 Sum_probs=148.8
Q ss_pred cccccCHHHHHHHhcCCCcC------CcccccCcccEEEEEeCCCCEEEEEEEecc----chhhHHHHHHHHHHHcCCCC
Q 013737 255 SKLNFSYETLEKATNYFHES------NKLGQGGSGSVYKGTLPGGEAVAVKRLFYN----TTQWVDHFFNEVNLISGINH 324 (437)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~------~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h 324 (437)
....+++.+++.++++|... +.||+|+||.||+|.. +++.||||++... .....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 44678999999999999887 8999999999999997 4789999998643 23446789999999999999
Q ss_pred CceeceeEEEeeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee
Q 013737 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL 404 (437)
Q Consensus 325 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll 404 (437)
|||+++++++.+.+..++||||+++++|.+++.......++++..+..++.|++.||.|||+.+ |+||||||+|||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999998865555567999999999999999999999998 9999999999999
Q ss_pred CCCCcEEEcccCCccccCCC
Q 013737 405 DEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 405 ~~~~~~ki~DFG~a~~~~~~ 424 (437)
++++.+||+|||+++.....
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKF 186 (307)
T ss_dssp CTTCCEEECCCTTCEECCSC
T ss_pred cCCCcEEEeecccccccccc
Confidence 99999999999999877543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-28 Score=233.65 Aligned_cols=162 Identities=29% Similarity=0.409 Sum_probs=143.3
Q ss_pred cccCHHHHHHHhcC----------CCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCC
Q 013737 257 LNFSYETLEKATNY----------FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHK 325 (437)
Q Consensus 257 ~~~~~~~~~~~~~~----------~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 325 (437)
..+++++++.+++. |+..+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45677777776654 566778999999999999975 6999999999876666678899999999999999
Q ss_pred ceeceeEEEeeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC
Q 013737 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD 405 (437)
Q Consensus 326 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~ 405 (437)
||+++++++...+..++||||+++++|.+++. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 99999999999999999999999999999873 245899999999999999999999988 99999999999999
Q ss_pred CCCcEEEcccCCccccCCCC
Q 013737 406 EEFTAKIADFGLVRLFPEDI 425 (437)
Q Consensus 406 ~~~~~ki~DFG~a~~~~~~~ 425 (437)
.++.+||+|||+++.+....
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~ 195 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDV 195 (321)
T ss_dssp TTCCEEECCCTTCEECCSSS
T ss_pred CCCcEEEeeeeeeeecccCc
Confidence 99999999999998876543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-28 Score=232.52 Aligned_cols=152 Identities=26% Similarity=0.417 Sum_probs=138.1
Q ss_pred HhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
..++|+..+.||+|+||.||++.. .+++.||||.+........+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 346799999999999999999996 5689999999976665667789999999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~ 425 (437)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999998843 24899999999999999999999998 9999999999999999999999999998776544
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=248.63 Aligned_cols=168 Identities=21% Similarity=0.214 Sum_probs=143.1
Q ss_pred HHHHHHhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc---hhhHHHHHHHHHHHcCCCCCceeceeEEEeeC
Q 013737 262 ETLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITG 337 (437)
Q Consensus 262 ~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 337 (437)
..++...++|+..++||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++..++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344555678999999999999999999975 58899999986421 12234578999999999999999999999999
Q ss_pred CeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCC
Q 013737 338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417 (437)
Q Consensus 338 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~ 417 (437)
+..++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 999999999999999998843 34899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCcceeeeecccC
Q 013737 418 VRLFPEDITHISATLAGTL 436 (437)
Q Consensus 418 a~~~~~~~~~~~~~~~Gt~ 436 (437)
++.+.........+.+||+
T Consensus 215 a~~~~~~~~~~~~~~~gt~ 233 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTP 233 (410)
T ss_dssp CEECCTTSEEECCSCCSCG
T ss_pred eEeeccCCcccccCCcCCc
Confidence 9987665433333556764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-28 Score=235.55 Aligned_cols=154 Identities=25% Similarity=0.417 Sum_probs=135.1
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCe------
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE------ 339 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 339 (437)
.++|+..+.||+|+||.||+|++. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 356888999999999999999985 7999999999754 33456789999999999999999999999866542
Q ss_pred ---------------------------------------------------eEEEEeccCCCCccccccccCCCCCCCHH
Q 013737 340 ---------------------------------------------------SLLVYEFVPNQSLLDNLFVRQDVEPLSWE 368 (437)
Q Consensus 340 ---------------------------------------------------~~lv~e~~~~g~L~~~l~~~~~~~~l~~~ 368 (437)
.++||||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 79999999999999998766555667888
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 369 ~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
.++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 217 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence 89999999999999999998 999999999999999999999999999987654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=233.01 Aligned_cols=163 Identities=28% Similarity=0.422 Sum_probs=135.3
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
.++|+..+.||+|+||.||++.+ .+++.||+|.+... .....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 45788999999999999999996 46899999998543 344567899999999999999999999999999999999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|||+++++|.+++... .++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999988433 46899999999999999999999998 99999999999999999999999999998765
Q ss_pred CCcceeeeecccC
Q 013737 424 DITHISATLAGTL 436 (437)
Q Consensus 424 ~~~~~~~~~~Gt~ 436 (437)
..........||+
T Consensus 164 ~~~~~~~~~~gt~ 176 (294)
T 4eqm_A 164 TSLTQTNHVLGTV 176 (294)
T ss_dssp -----------CC
T ss_pred ccccccCccccCc
Confidence 4433333445554
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=238.37 Aligned_cols=152 Identities=26% Similarity=0.425 Sum_probs=128.2
Q ss_pred cCCCcCCcccccCcccEEEEEeC----CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP----GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
++|+..+.||+|+||.||+|++. ++..||||.++.. .....++|.+|+.++++++||||+++++++.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57889999999999999999864 4778999999754 344567899999999999999999999999999999999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 125 ~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 125 TEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 999999999998843 3346899999999999999999999998 99999999999999999999999999998765
Q ss_pred CC
Q 013737 424 DI 425 (437)
Q Consensus 424 ~~ 425 (437)
..
T Consensus 200 ~~ 201 (373)
T 2qol_A 200 DP 201 (373)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=237.24 Aligned_cols=162 Identities=30% Similarity=0.357 Sum_probs=135.3
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCeeEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 342 (437)
.++|+..+.||+|+||.||+++.. +++.||||++... .....+.+.+|..++..+ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 467999999999999999999974 5899999999754 233456788999999988 69999999999999999999
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 102 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 99999999999888443 45899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCcceeeeecccC
Q 013737 423 EDITHISATLAGTL 436 (437)
Q Consensus 423 ~~~~~~~~~~~Gt~ 436 (437)
.... ...+.+||+
T Consensus 176 ~~~~-~~~~~~gt~ 188 (353)
T 3txo_A 176 CNGV-TTATFCGTP 188 (353)
T ss_dssp C----------CCG
T ss_pred cCCc-cccccCCCc
Confidence 3322 223456664
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=233.50 Aligned_cols=150 Identities=30% Similarity=0.395 Sum_probs=132.1
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
.++|+..+.||+|+||.||++.+. +++.||||.+.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 357889999999999999999975 68999999986543 2334678899999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|+++++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 999999999883 3345899999999999999999999998 99999999999999999999999999987653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.5e-28 Score=232.44 Aligned_cols=152 Identities=28% Similarity=0.464 Sum_probs=133.6
Q ss_pred cCCCcCCcccccCcccEEEEEeC----CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP----GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
++|+..+.||+|+||.||+|.+. .+..||||.+... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 45777899999999999999974 3456999999765 445567899999999999999999999999999999999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 129 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 129 TEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred eeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 999999999998843 3346999999999999999999999998 99999999999999999999999999998765
Q ss_pred CC
Q 013737 424 DI 425 (437)
Q Consensus 424 ~~ 425 (437)
..
T Consensus 204 ~~ 205 (325)
T 3kul_A 204 DP 205 (325)
T ss_dssp --
T ss_pred Cc
Confidence 43
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-28 Score=234.25 Aligned_cols=161 Identities=28% Similarity=0.272 Sum_probs=138.4
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..+.||+|+||.||+++.. +++.||+|.+... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 56888999999999999999975 6899999999754 2334667899999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999999988843 245899999999999999999999998 999999999999999999999999999875433
Q ss_pred CcceeeeecccC
Q 013737 425 ITHISATLAGTL 436 (437)
Q Consensus 425 ~~~~~~~~~Gt~ 436 (437)
... ..+..||+
T Consensus 159 ~~~-~~~~~gt~ 169 (337)
T 1o6l_A 159 GAT-MKTFCGTP 169 (337)
T ss_dssp TCC-BCCCEECG
T ss_pred CCc-ccccccCh
Confidence 221 22345554
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.4e-28 Score=233.61 Aligned_cols=152 Identities=26% Similarity=0.365 Sum_probs=135.4
Q ss_pred HhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccch------hhHHHHHHHHHHHcCCCCCceeceeEEEeeCCe
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT------QWVDHFFNEVNLISGINHKNLVKLLGCSITGPE 339 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 339 (437)
..+.|...+.||+|+||.||++... +|+.||+|.+..... ...+.+.+|+.++.+++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3467889999999999999999975 589999999975422 135789999999999999999999999999999
Q ss_pred eEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC----cEEEccc
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF----TAKIADF 415 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~----~~ki~DF 415 (437)
.++||||+++++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999883 3456999999999999999999999998 99999999999998776 7999999
Q ss_pred CCccccCCC
Q 013737 416 GLVRLFPED 424 (437)
Q Consensus 416 G~a~~~~~~ 424 (437)
|+++.+...
T Consensus 164 G~a~~~~~~ 172 (361)
T 2yab_A 164 GLAHEIEDG 172 (361)
T ss_dssp SSCEECCTT
T ss_pred CCceEcCCC
Confidence 999987653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-28 Score=237.40 Aligned_cols=160 Identities=27% Similarity=0.357 Sum_probs=138.9
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.+|..++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56888999999999999999974 5889999998643 2334578899999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999988843 346999999999999999999999998 999999999999999999999999999987543
Q ss_pred CcceeeeecccC
Q 013737 425 ITHISATLAGTL 436 (437)
Q Consensus 425 ~~~~~~~~~Gt~ 436 (437)
.. .....||+
T Consensus 169 ~~--~~~~~gt~ 178 (384)
T 4fr4_A 169 TQ--ITTMAGTK 178 (384)
T ss_dssp CC--BCCCCSCG
T ss_pred Cc--eeccCCCc
Confidence 32 22345553
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=4.6e-28 Score=231.53 Aligned_cols=149 Identities=26% Similarity=0.362 Sum_probs=134.2
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..+.||+|+||.||+++.. +|+.||+|.+... .....+.+.+|..+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56888999999999999999974 6899999999754 2234567889999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999998843 345899999999999999999999988 99999999999999999999999999987654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.2e-28 Score=236.79 Aligned_cols=153 Identities=28% Similarity=0.419 Sum_probs=134.9
Q ss_pred hcCCCcCCcccccCcccEEEEEeC--------CCCEEEEEEEecc-chhhHHHHHHHHHHHcCC-CCCceeceeEEEeeC
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP--------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG 337 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 337 (437)
.++|...+.||+|+||.||+|.+. ++..||||.+... .....+++.+|+.+++.+ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467888999999999999999852 3457999999755 344567899999999999 899999999999999
Q ss_pred CeeEEEEeccCCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee
Q 013737 338 PESLLVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL 404 (437)
Q Consensus 338 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll 404 (437)
+..++||||+++|+|.+++..... ...+++.+++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999865431 245899999999999999999999998 9999999999999
Q ss_pred CCCCcEEEcccCCccccCC
Q 013737 405 DEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 405 ~~~~~~ki~DFG~a~~~~~ 423 (437)
+.++.+||+|||+++.+..
T Consensus 237 ~~~~~~kl~DFG~a~~~~~ 255 (370)
T 2psq_A 237 TENNVMKIADFGLARDINN 255 (370)
T ss_dssp CTTCCEEECCCSSCEETTC
T ss_pred CCCCCEEEccccCCcccCc
Confidence 9999999999999987654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=233.88 Aligned_cols=159 Identities=30% Similarity=0.505 Sum_probs=132.7
Q ss_pred HHHHhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeE
Q 013737 264 LEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (437)
Q Consensus 264 ~~~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (437)
+....++|+..+.||+|+||.||++++. ++.||||++... .....+++.+|++++++++||||+++++++...+..+
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence 3344567889999999999999999874 788999998654 3445678999999999999999999999999999999
Q ss_pred EEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
+||||+++++|.+++........+++..++.++.|++.||.|||+.+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999999999998854333334899999999999999999999985 35999999999999999999999999999865
Q ss_pred CCC
Q 013737 422 PED 424 (437)
Q Consensus 422 ~~~ 424 (437)
...
T Consensus 190 ~~~ 192 (309)
T 3p86_A 190 AST 192 (309)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-28 Score=226.42 Aligned_cols=150 Identities=28% Similarity=0.443 Sum_probs=135.1
Q ss_pred hcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEecc
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (437)
.++|+..+.||+|+||.||++.+.+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 356888899999999999999998888999999975432 3467999999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 88 ~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 88 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccc
Confidence 99999998843 3346899999999999999999999998 99999999999999999999999999987654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.7e-28 Score=228.66 Aligned_cols=152 Identities=28% Similarity=0.412 Sum_probs=132.9
Q ss_pred HhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
..++|+..++||+|+||.||++.+.+++.||+|++... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 34678999999999999999999988999999998654 2334567899999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||+++ +|.+.+.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 99 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 99 EFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp ECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred cCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 99984 77777643 3345899999999999999999999998 999999999999999999999999999877543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-27 Score=225.61 Aligned_cols=149 Identities=28% Similarity=0.428 Sum_probs=128.0
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccch--------------------------hhHHHHHHHHHHHcC
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTT--------------------------QWVDHFFNEVNLISG 321 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~ 321 (437)
++|+..+.||+|+||.||+|.. .+++.||||.+..... ...+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 5788999999999999999997 4588999999865421 123568999999999
Q ss_pred CCCCceeceeEEEee--CCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCC
Q 013737 322 INHKNLVKLLGCSIT--GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKL 399 (437)
Q Consensus 322 l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~ 399 (437)
++||||+++++++.+ .+..++||||+++++|.+++ ...++++..+..++.||+.||.|||+++ |+||||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp 165 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKP 165 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCH
Confidence 999999999999986 56789999999999998865 2346999999999999999999999998 99999999
Q ss_pred CCeeeCCCCcEEEcccCCccccCCC
Q 013737 400 SNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 400 ~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
+|||++.++.+||+|||+++.+...
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~ 190 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGS 190 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSS
T ss_pred HHEEECCCCCEEEecCCCccccccc
Confidence 9999999999999999999877644
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=6.7e-28 Score=233.44 Aligned_cols=150 Identities=24% Similarity=0.305 Sum_probs=135.1
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..+.||+|+||.||+++.. +++.||+|.+... .....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 56888999999999999999975 6899999999654 2234677899999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 999999999988543 45899999999999999999999998 999999999999999999999999999977543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-28 Score=238.88 Aligned_cols=162 Identities=27% Similarity=0.311 Sum_probs=135.9
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCeeEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 342 (437)
.++|+..++||+|+||.||+++.. +++.+|+|+++.. .....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 357889999999999999999975 5789999999754 223345678899998876 89999999999999999999
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 99999999999888532 45899999999999999999999998 9999999999999999999999999998643
Q ss_pred CCCcceeeeecccC
Q 013737 423 EDITHISATLAGTL 436 (437)
Q Consensus 423 ~~~~~~~~~~~Gt~ 436 (437)
.... ...+.+||+
T Consensus 205 ~~~~-~~~~~~gt~ 217 (396)
T 4dc2_A 205 RPGD-TTSTFCGTP 217 (396)
T ss_dssp CTTC-CBCCCCBCG
T ss_pred cCCC-ccccccCCc
Confidence 3222 223456664
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.7e-28 Score=233.94 Aligned_cols=164 Identities=25% Similarity=0.308 Sum_probs=138.2
Q ss_pred HHhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc---hhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCee
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPES 340 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 340 (437)
...++|...+.||+|+||.||+++.. +++.||||.+.... ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999975 58899999997542 33456788899998876 899999999999999999
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 9999999999999988432 45899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCcceeeeecccC
Q 013737 421 FPEDITHISATLAGTL 436 (437)
Q Consensus 421 ~~~~~~~~~~~~~Gt~ 436 (437)
....... ..+.+||+
T Consensus 168 ~~~~~~~-~~~~~gt~ 182 (345)
T 1xjd_A 168 NMLGDAK-TNTFCGTP 182 (345)
T ss_dssp CCCTTCC-BCCCCSCG
T ss_pred cccCCCc-ccCCCCCc
Confidence 5432221 23455664
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-28 Score=232.88 Aligned_cols=161 Identities=27% Similarity=0.316 Sum_probs=137.6
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCeeEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 343 (437)
++|+..+.||+|+||.||+++.. +++.||+|++... .....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56888999999999999999975 5889999999754 334466788999999887 899999999999999999999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 9999999999888432 45899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCcceeeeecccC
Q 013737 424 DITHISATLAGTL 436 (437)
Q Consensus 424 ~~~~~~~~~~Gt~ 436 (437)
... ...+..||+
T Consensus 163 ~~~-~~~~~~gt~ 174 (345)
T 3a8x_A 163 PGD-TTSTFCGTP 174 (345)
T ss_dssp TTC-CBCCCCSCG
T ss_pred CCC-cccccCCCc
Confidence 222 122445654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-27 Score=226.61 Aligned_cols=161 Identities=19% Similarity=0.237 Sum_probs=138.7
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
.++|+..+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 467889999999999999999975 58899999987543 3456788999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC--CCcEEEcccCCccccCCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE--EFTAKIADFGLVRLFPED 424 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~--~~~~ki~DFG~a~~~~~~ 424 (437)
+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999998843 2346899999999999999999999998 999999999999987 789999999999987654
Q ss_pred CcceeeeecccC
Q 013737 425 ITHISATLAGTL 436 (437)
Q Consensus 425 ~~~~~~~~~Gt~ 436 (437)
.. .....||+
T Consensus 158 ~~--~~~~~gt~ 167 (321)
T 1tki_A 158 DN--FRLLFTAP 167 (321)
T ss_dssp CE--EEEEESCG
T ss_pred Cc--cccccCCh
Confidence 32 22344554
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=236.70 Aligned_cols=166 Identities=28% Similarity=0.385 Sum_probs=142.9
Q ss_pred ccccCHHHHHHHhcCCCcCCcccccCcccEEEEEe------CCCCEEEEEEEecc-chhhHHHHHHHHHHHcCC-CCCce
Q 013737 256 KLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTL------PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNL 327 (437)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni 327 (437)
...++...++...++|+..+.||+|+||.||+|.+ .+++.||||++... .....+.+.+|++++.++ +||||
T Consensus 9 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpni 88 (359)
T 3vhe_A 9 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88 (359)
T ss_dssp GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred hCCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcce
Confidence 44567777888889999999999999999999984 24678999999764 344567899999999999 79999
Q ss_pred eceeEEEeeCCe-eEEEEeccCCCCccccccccCC---------------------------------------------
Q 013737 328 VKLLGCSITGPE-SLLVYEFVPNQSLLDNLFVRQD--------------------------------------------- 361 (437)
Q Consensus 328 v~l~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------- 361 (437)
+++++++.+.+. .++||||+++|+|.+++.....
T Consensus 89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (359)
T 3vhe_A 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168 (359)
T ss_dssp CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence 999999887654 8999999999999998865432
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 362 ------------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 362 ------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 245 (359)
T 3vhe_A 169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYK 245 (359)
T ss_dssp ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence 122899999999999999999999998 99999999999999999999999999997754
Q ss_pred C
Q 013737 424 D 424 (437)
Q Consensus 424 ~ 424 (437)
.
T Consensus 246 ~ 246 (359)
T 3vhe_A 246 D 246 (359)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-27 Score=231.30 Aligned_cols=152 Identities=24% Similarity=0.348 Sum_probs=134.7
Q ss_pred HhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEE
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
..++|+..+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3467899999999999999999974 5899999999754 334567899999999999999999999999999999999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC---CcEEEcccCCccc
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE---FTAKIADFGLVRL 420 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~---~~~ki~DFG~a~~ 420 (437)
|||+++++|.+.+. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||+++.
T Consensus 107 ~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999998884 3356899999999999999999999998 9999999999999865 4599999999988
Q ss_pred cCCC
Q 013737 421 FPED 424 (437)
Q Consensus 421 ~~~~ 424 (437)
....
T Consensus 181 ~~~~ 184 (362)
T 2bdw_A 181 VNDS 184 (362)
T ss_dssp CTTC
T ss_pred ecCC
Confidence 7643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.1e-28 Score=223.91 Aligned_cols=152 Identities=29% Similarity=0.430 Sum_probs=136.4
Q ss_pred hcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEecc
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (437)
.++|+..+.||+|+||.||++.+.++..||+|.+..... ..+++.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 467888999999999999999998888999999975432 3467899999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCC
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~ 425 (437)
++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 999999988543 235899999999999999999999998 9999999999999999999999999998776544
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-27 Score=224.07 Aligned_cols=150 Identities=27% Similarity=0.436 Sum_probs=131.5
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
++|+..++||+|+||.||+|.+. +++.||||++... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888999999999999999974 5899999999754 33445788999999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
|+++ +|.+.+.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9975 55555532 2356999999999999999999999998 999999999999999999999999999877543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=4.2e-27 Score=230.73 Aligned_cols=153 Identities=26% Similarity=0.351 Sum_probs=136.6
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
.+.|+..+.||+|+||.||+|... +++.+|+|.+..........+.+|+.+|..++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 457899999999999999999974 6899999999876655667899999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC--CCcEEEcccCCccccCCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE--EFTAKIADFGLVRLFPED 424 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~--~~~~ki~DFG~a~~~~~~ 424 (437)
+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999998843 2346899999999999999999999998 999999999999974 468999999999987654
Q ss_pred C
Q 013737 425 I 425 (437)
Q Consensus 425 ~ 425 (437)
.
T Consensus 205 ~ 205 (387)
T 1kob_A 205 E 205 (387)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-27 Score=227.04 Aligned_cols=151 Identities=28% Similarity=0.360 Sum_probs=134.4
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccch------hhHHHHHHHHHHHcCCCCCceeceeEEEeeCCee
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT------QWVDHFFNEVNLISGINHKNLVKLLGCSITGPES 340 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 340 (437)
.+.|...+.||+|+||.||++... +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 355888999999999999999975 589999999865422 1367899999999999999999999999999999
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC----cEEEcccC
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF----TAKIADFG 416 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~----~~ki~DFG 416 (437)
++||||+++++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999883 3456999999999999999999999998 99999999999999887 89999999
Q ss_pred CccccCCC
Q 013737 417 LVRLFPED 424 (437)
Q Consensus 417 ~a~~~~~~ 424 (437)
+++.+...
T Consensus 164 ~a~~~~~~ 171 (326)
T 2y0a_A 164 LAHKIDFG 171 (326)
T ss_dssp TCEECCTT
T ss_pred CCeECCCC
Confidence 99887543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.4e-28 Score=230.21 Aligned_cols=149 Identities=35% Similarity=0.461 Sum_probs=130.5
Q ss_pred hcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC----eeEEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP----ESLLV 343 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv 343 (437)
.++|+..++||+|+||.||+|++. ++.||||++..... ....+.+|+.++.+++||||+++++++.... ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 457889999999999999999976 78999999965433 3445677999999999999999999998754 36999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcC----------CCCCeeeCCCCCCCeeeCCCCcEEEc
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE----------SKLRIIHRDIKLSNILLDEEFTAKIA 413 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~----------~~~~iiHrDlk~~NIll~~~~~~ki~ 413 (437)
|||+++|+|.+++.. ..+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+
T Consensus 101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence 999999999998843 3489999999999999999999998 6 9999999999999999999999
Q ss_pred ccCCccccCCCC
Q 013737 414 DFGLVRLFPEDI 425 (437)
Q Consensus 414 DFG~a~~~~~~~ 425 (437)
|||+++.+....
T Consensus 174 DFg~a~~~~~~~ 185 (322)
T 3soc_A 174 DFGLALKFEAGK 185 (322)
T ss_dssp CCTTCEEECTTS
T ss_pred cCCccccccccc
Confidence 999998776543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-28 Score=236.85 Aligned_cols=154 Identities=26% Similarity=0.401 Sum_probs=136.3
Q ss_pred HHHhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 265 EKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 265 ~~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
+...++|...+.||+|+||.||+|.+. +++.||||.+... .....++|.+|+++|++++||||+++++++...+..++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 334567888999999999999999985 6899999998754 33445678999999999999999999999999999999
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
||||+++|+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 190 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp EEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 99999999999988532 235899999999999999999999998 9999999999999999999999999998754
Q ss_pred C
Q 013737 423 E 423 (437)
Q Consensus 423 ~ 423 (437)
+
T Consensus 265 ~ 265 (377)
T 3cbl_A 265 D 265 (377)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=231.91 Aligned_cols=163 Identities=28% Similarity=0.264 Sum_probs=138.4
Q ss_pred HhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCeeE
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESL 341 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 341 (437)
..++|+..+.||+|+||.||+++.. +++.||||.+... .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3467899999999999999999985 4789999999754 223456788999999988 7999999999999999999
Q ss_pred EEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 999999999999988532 35899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCcceeeeecccC
Q 013737 422 PEDITHISATLAGTL 436 (437)
Q Consensus 422 ~~~~~~~~~~~~Gt~ 436 (437)
..... ...+.+||+
T Consensus 172 ~~~~~-~~~~~~gt~ 185 (353)
T 2i0e_A 172 IWDGV-TTKTFCGTP 185 (353)
T ss_dssp CCTTC-CBCCCCSCG
T ss_pred ccCCc-ccccccCCc
Confidence 43322 122445664
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-27 Score=227.04 Aligned_cols=155 Identities=29% Similarity=0.419 Sum_probs=136.1
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC--eeEEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGP--ESLLV 343 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 343 (437)
.++|...++||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 356888999999999999999975 48999999997543 344677889999999999999999999988765 67999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee----CCCCcEEEcccCCcc
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLVR 419 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll----~~~~~~ki~DFG~a~ 419 (437)
|||+++++|.+++........+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999866555555999999999999999999999998 9999999999999 788889999999999
Q ss_pred ccCCCC
Q 013737 420 LFPEDI 425 (437)
Q Consensus 420 ~~~~~~ 425 (437)
.+....
T Consensus 165 ~~~~~~ 170 (319)
T 4euu_A 165 ELEDDE 170 (319)
T ss_dssp ECCTTC
T ss_pred ecCCCC
Confidence 876543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=237.27 Aligned_cols=148 Identities=20% Similarity=0.286 Sum_probs=123.6
Q ss_pred hcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccc--------hhhHHHHHHHHHHHcCCC---------CCceece
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT--------TQWVDHFFNEVNLISGIN---------HKNLVKL 330 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l 330 (437)
.++|+..++||+|+||.||+|++ +++.||||++.... ....+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35678889999999999999998 58999999997542 233477889999888875 6666666
Q ss_pred eEEE-----------------ee-------------CCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHH
Q 013737 331 LGCS-----------------IT-------------GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEG 380 (437)
Q Consensus 331 ~~~~-----------------~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~ 380 (437)
.+.+ .+ .+..+|||||+++|++.+.+.. ..+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 6653 32 6789999999999987777622 458999999999999999
Q ss_pred HHHhh-cCCCCCeeeCCCCCCCeeeCCCC--------------------cEEEcccCCccccCC
Q 013737 381 LAYLH-EESKLRIIHRDIKLSNILLDEEF--------------------TAKIADFGLVRLFPE 423 (437)
Q Consensus 381 l~yLH-~~~~~~iiHrDlk~~NIll~~~~--------------------~~ki~DFG~a~~~~~ 423 (437)
|.||| +.+ |+||||||+|||++.++ .+||+|||+|+....
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~ 234 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD 234 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC
Confidence 99999 887 99999999999999887 999999999997754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.95 E-value=8.7e-28 Score=225.52 Aligned_cols=152 Identities=24% Similarity=0.389 Sum_probs=133.4
Q ss_pred HHhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
...++|+..+.||+|+||.||++.+.++..||+|++..... ..+++.+|++++.+++||||+++++++.+.+..++|||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 34567888999999999999999999888999999975432 34678999999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|+++++|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 100 YMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred ccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999988432 345899999999999999999999998 99999999999999999999999999987644
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-27 Score=237.37 Aligned_cols=150 Identities=29% Similarity=0.439 Sum_probs=135.3
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc---hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|...+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56888999999999999999975 69999999996542 234567999999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||+++++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 9999999999884 3456999999999999999999999998 999999999999999999999999999987653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=242.79 Aligned_cols=155 Identities=34% Similarity=0.491 Sum_probs=137.8
Q ss_pred HHHhcCCCcCCcccccCcccEEEEEeCC-CCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEE
Q 013737 265 EKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 265 ~~~~~~~~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
+...++|+..++||+|+||.||+|.+.. +..||||.+.... ...++|.+|+.+|++++||||+++++++...+..+||
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 3345668888999999999999999864 8899999997543 3467899999999999999999999999999999999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|||+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 295 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 295 TEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp EECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 9999999999998543 3356899999999999999999999998 99999999999999999999999999998754
Q ss_pred C
Q 013737 424 D 424 (437)
Q Consensus 424 ~ 424 (437)
+
T Consensus 371 ~ 371 (495)
T 1opk_A 371 D 371 (495)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-27 Score=238.97 Aligned_cols=149 Identities=23% Similarity=0.373 Sum_probs=122.4
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeC-----Ce
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG-----PE 339 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 339 (437)
.++|+..+.||+|+||.||+|.+. +++.||||++... .....+++.+|+.+|+.++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367999999999999999999964 6899999998653 344567899999999999999999999998543 56
Q ss_pred eEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcc
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~ 419 (437)
.++||||+ +++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+
T Consensus 132 ~~lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 89999998 578888773 3356999999999999999999999998 9999999999999999999999999999
Q ss_pred ccCC
Q 013737 420 LFPE 423 (437)
Q Consensus 420 ~~~~ 423 (437)
.+..
T Consensus 205 ~~~~ 208 (458)
T 3rp9_A 205 TVDY 208 (458)
T ss_dssp CTTS
T ss_pred hccC
Confidence 8753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=233.36 Aligned_cols=165 Identities=18% Similarity=0.185 Sum_probs=135.8
Q ss_pred HHhcCCCcCCcccccCcccEEEEE------eCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCC---CCceeceeEEEee
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGT------LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN---HKNLVKLLGCSIT 336 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 336 (437)
...++|...++||+|+||.||+|. ..+++.||||++.... ..++.+|++++..++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345678889999999999999994 3568899999997554 346777777777776 9999999999999
Q ss_pred CCeeEEEEeccCCCCccccccccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC--------
Q 013737 337 GPESLLVYEFVPNQSLLDNLFVRQ--DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-------- 406 (437)
Q Consensus 337 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~-------- 406 (437)
.+..++||||+++|+|.+++.... ....+++..+..|+.||+.||+|||+.+ |+||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 999999999999999999985432 3456999999999999999999999988 999999999999998
Q ss_pred ---CCcEEEcccCCccccCCCC-cceeeeecccC
Q 013737 407 ---EFTAKIADFGLVRLFPEDI-THISATLAGTL 436 (437)
Q Consensus 407 ---~~~~ki~DFG~a~~~~~~~-~~~~~~~~Gt~ 436 (437)
++.+||+|||+|+.+.... ....+...||+
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~ 249 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETS 249 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTT
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCC
Confidence 8999999999997654221 22233455664
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=6.5e-28 Score=227.85 Aligned_cols=152 Identities=32% Similarity=0.493 Sum_probs=132.3
Q ss_pred hcCCCcCCcccccCcccEEEEEe-----CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeC--Cee
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-----PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PES 340 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 340 (437)
.++|+..++||+|+||.||++++ .+++.||||++........+.+.+|++++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46788899999999999999984 35889999999877777778899999999999999999999998654 458
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999988543 235899999999999999999999988 99999999999999999999999999998
Q ss_pred cCCC
Q 013737 421 FPED 424 (437)
Q Consensus 421 ~~~~ 424 (437)
+...
T Consensus 164 ~~~~ 167 (295)
T 3ugc_A 164 LPQD 167 (295)
T ss_dssp ----
T ss_pred ccCC
Confidence 7544
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-27 Score=224.78 Aligned_cols=149 Identities=32% Similarity=0.472 Sum_probs=132.4
Q ss_pred cCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccc--hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
++|+..+.||+|+||.||++...+++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 4688899999999999999999889999999986543 22346788999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
+++ +|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence 975 88887743 2356899999999999999999999998 99999999999999999999999999987654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-28 Score=244.49 Aligned_cols=156 Identities=30% Similarity=0.450 Sum_probs=137.6
Q ss_pred HHHHHHhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeE
Q 013737 262 ETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (437)
Q Consensus 262 ~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (437)
..++...++|+..+.||+|+||.||+|.++++..||||.++... ...+.|.+|+.+|++++||||+++++++. .+..+
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 34555667888999999999999999999888899999997644 34678999999999999999999999986 66789
Q ss_pred EEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
+||||+++|+|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 259 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EEECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 9999999999999985321 235789999999999999999999998 999999999999999999999999999977
Q ss_pred CC
Q 013737 422 PE 423 (437)
Q Consensus 422 ~~ 423 (437)
..
T Consensus 335 ~~ 336 (454)
T 1qcf_A 335 ED 336 (454)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=9.2e-28 Score=231.66 Aligned_cols=156 Identities=33% Similarity=0.467 Sum_probs=137.5
Q ss_pred HHHHhcCCCcCCcccccCcccEEEEEeC------CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEee
Q 013737 264 LEKATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT 336 (437)
Q Consensus 264 ~~~~~~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 336 (437)
+....++|+..+.||+|+||.||++.+. +++.||||.+... .....+.+.+|+.++++++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3445678999999999999999999974 3478999999765 34456789999999999999999999999999
Q ss_pred CCeeEEEEeccCCCCccccccccCC---------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeC
Q 013737 337 GPESLLVYEFVPNQSLLDNLFVRQD---------------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHR 395 (437)
Q Consensus 337 ~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHr 395 (437)
.+..++||||+++++|.+++..... ...+++.+++.++.||+.||.|||+++ |+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 9999999999999999998865321 256899999999999999999999998 9999
Q ss_pred CCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 396 DIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 396 Dlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
||||+|||+++++.+||+|||+++.+.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 225 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIY 225 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccc
Confidence 999999999999999999999998764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-27 Score=236.79 Aligned_cols=164 Identities=21% Similarity=0.274 Sum_probs=138.1
Q ss_pred HHhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc--hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
...++|+..+.||+|+||.||++.. .+|+.+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 3456789999999999999999986 468999999987543 3445679999999999999999999999999999999
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC---CCCcEEEcccCCcc
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVR 419 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~---~~~~~ki~DFG~a~ 419 (437)
||||+++|+|.+.+.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ +++.+||+|||+++
T Consensus 88 v~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 9999999999988854 345899999999999999999999998 99999999999998 46789999999998
Q ss_pred ccCCCCcceeeeecccC
Q 013737 420 LFPEDITHISATLAGTL 436 (437)
Q Consensus 420 ~~~~~~~~~~~~~~Gt~ 436 (437)
.+...... .....||+
T Consensus 162 ~~~~~~~~-~~~~~gt~ 177 (444)
T 3soa_A 162 EVEGEQQA-WFGFAGTP 177 (444)
T ss_dssp CCCTTCCB-CCCSCSCG
T ss_pred EecCCCce-eecccCCc
Confidence 87654332 22345554
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=229.86 Aligned_cols=150 Identities=26% Similarity=0.335 Sum_probs=124.9
Q ss_pred hcCCCcCCcccccCcccEEEEEe----CCCCEEEEEEEeccc----hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCe
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNT----TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE 339 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 339 (437)
.++|+..+.||+|+||.||+++. .+++.||+|++.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35788999999999999999997 468999999997542 2345568899999999999999999999999999
Q ss_pred eEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcc
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~ 419 (437)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999988843 245889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCC
Q 013737 420 LFPE 423 (437)
Q Consensus 420 ~~~~ 423 (437)
....
T Consensus 170 ~~~~ 173 (327)
T 3a62_A 170 ESIH 173 (327)
T ss_dssp ----
T ss_pred cccc
Confidence 6543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.8e-28 Score=229.65 Aligned_cols=151 Identities=25% Similarity=0.398 Sum_probs=129.5
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCe----
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE---- 339 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 339 (437)
.++|+..+.||+|+||.||++.+ .+++.||||++... .......+.+|+.++.+++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46788999999999999999996 56889999999754 33445689999999999999999999999876554
Q ss_pred eEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcc
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~ 419 (437)
.++||||+++++|.+++... .++++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 39999999999999988533 45899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCC
Q 013737 420 LFPED 424 (437)
Q Consensus 420 ~~~~~ 424 (437)
.+...
T Consensus 165 ~~~~~ 169 (311)
T 3ork_A 165 AIADS 169 (311)
T ss_dssp -----
T ss_pred ccccc
Confidence 77544
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-27 Score=229.60 Aligned_cols=149 Identities=24% Similarity=0.408 Sum_probs=132.6
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|...+.||+|+||.||+|.+ .+++.||||.+... .......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5788999999999999999997 56899999998643 2223457899999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||+ +|+|.+++... ..+++.++..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 89 E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred ECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999 68888887443 45899999999999999999999998 999999999999999999999999999877543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-27 Score=240.65 Aligned_cols=163 Identities=27% Similarity=0.308 Sum_probs=140.4
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
.++|+..+.||+|+||.||++... +|+.||+|++... .......+.+|+.+|..++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 356888999999999999999974 6999999999653 223456788999999999999999999999999999999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|||+++|+|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 263 mEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999888543 2345899999999999999999999998 99999999999999999999999999998765
Q ss_pred CCcceeeeecccC
Q 013737 424 DITHISATLAGTL 436 (437)
Q Consensus 424 ~~~~~~~~~~Gt~ 436 (437)
... ....+||+
T Consensus 339 ~~~--~~~~~GT~ 349 (576)
T 2acx_A 339 GQT--IKGRVGTV 349 (576)
T ss_dssp TCC--EECCCSCG
T ss_pred Ccc--ccccCCCc
Confidence 432 22345664
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-27 Score=224.85 Aligned_cols=155 Identities=30% Similarity=0.414 Sum_probs=136.3
Q ss_pred HhcCCCcCCcccccCcccEEEEEe------CCCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCe
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTL------PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE 339 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 339 (437)
..++|...+.||+|+||.||++.+ .++..||||.+... .....+.+.+|++++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 356788899999999999999986 23578999999754 34556789999999999999999999999999999
Q ss_pred eEEEEeccCCCCccccccccCC---------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCC
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQD---------------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIK 398 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk 398 (437)
.++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999865432 134899999999999999999999998 9999999
Q ss_pred CCCeeeCCCCcEEEcccCCccccCCC
Q 013737 399 LSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 399 ~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
|+|||+++++.+||+|||+++.....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~ 203 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEE 203 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTT
T ss_pred hheEEEcCCCCEEEcccccccccccc
Confidence 99999999999999999999877544
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-27 Score=230.16 Aligned_cols=154 Identities=23% Similarity=0.286 Sum_probs=133.7
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc-----hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT-----TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
+.|+..+.||+|+||.||++.. .+++.||||.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 5688899999999999999997 468999999986431 1246789999999999999999999999999999999
Q ss_pred EEeccCCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCc---EEEcccCCc
Q 013737 343 VYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT---AKIADFGLV 418 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~---~ki~DFG~a 418 (437)
||||+++++|.+.+.... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999988775432 2345899999999999999999999998 999999999999986654 999999999
Q ss_pred cccCCCC
Q 013737 419 RLFPEDI 425 (437)
Q Consensus 419 ~~~~~~~ 425 (437)
+.+....
T Consensus 181 ~~~~~~~ 187 (351)
T 3c0i_A 181 IQLGESG 187 (351)
T ss_dssp EECCTTS
T ss_pred eEecCCC
Confidence 8876543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.6e-28 Score=240.17 Aligned_cols=161 Identities=27% Similarity=0.274 Sum_probs=127.5
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..++||+|+||.||++.. .+++.||||++... .......+.+|+.++..++||||+++++++...+..++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 5688899999999999999996 46899999999753 3344567889999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE-ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
||+++++|.+++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+||||+.++.+||+|||+|+....
T Consensus 228 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 228 EYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp CCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred eeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 99999999988843 2458999999999999999999998 77 99999999999999999999999999987544
Q ss_pred CCcceeeeecccC
Q 013737 424 DITHISATLAGTL 436 (437)
Q Consensus 424 ~~~~~~~~~~Gt~ 436 (437)
.... .....||+
T Consensus 302 ~~~~-~~~~~gt~ 313 (446)
T 4ejn_A 302 DGAT-MKTFCGTP 313 (446)
T ss_dssp ------CCSSSCG
T ss_pred CCcc-cccccCCc
Confidence 3322 22345554
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.6e-27 Score=229.61 Aligned_cols=147 Identities=27% Similarity=0.365 Sum_probs=127.1
Q ss_pred cCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCCC
Q 013737 273 ESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQS 351 (437)
Q Consensus 273 ~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 351 (437)
..+.||+|+||.||+|.. .+++.||+|++........+.+.+|++++.+++||||+++++++...+..+|||||+++++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 356899999999999997 4689999999987766667889999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee--CCCCcEEEcccCCccccCCC
Q 013737 352 LLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL--DEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 352 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll--~~~~~~ki~DFG~a~~~~~~ 424 (437)
|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||+ ++++.+||+|||+++.+...
T Consensus 173 L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 173 LFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp EHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred HHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 9888743 2345899999999999999999999998 9999999999999 56789999999999987654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.2e-27 Score=223.20 Aligned_cols=152 Identities=30% Similarity=0.462 Sum_probs=120.2
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
.++|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457889999999999999999974 58999999997543 3344678899999999999999999999999999999999
Q ss_pred ccCCCCccccccccC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 346 FVPNQSLLDNLFVRQ---DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
|++ ++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 58988775432 2245899999999999999999999998 9999999999999999999999999998775
Q ss_pred C
Q 013737 423 E 423 (437)
Q Consensus 423 ~ 423 (437)
.
T Consensus 160 ~ 160 (317)
T 2pmi_A 160 I 160 (317)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.94 E-value=4.9e-27 Score=238.75 Aligned_cols=164 Identities=23% Similarity=0.321 Sum_probs=141.1
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc---hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|...+.||+|+||.||+++.. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56888899999999999999974 69999999996542 234567899999999999999999999999999999999
Q ss_pred eccCCCCccccccccCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 345 EFVPNQSLLDNLFVRQD-VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
||+++|+|.+++..... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999988854332 346999999999999999999999998 99999999999999999999999999998765
Q ss_pred CCcceeeeecccC
Q 013737 424 DITHISATLAGTL 436 (437)
Q Consensus 424 ~~~~~~~~~~Gt~ 436 (437)
.... .....||+
T Consensus 342 ~~~~-~~~~~GT~ 353 (543)
T 3c4z_A 342 GQTK-TKGYAGTP 353 (543)
T ss_dssp TCCC-BCCCCSCT
T ss_pred CCcc-cccccCCc
Confidence 4332 22346765
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=231.94 Aligned_cols=162 Identities=27% Similarity=0.288 Sum_probs=128.7
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc---hhhHHHHHHHHHH-HcCCCCCceeceeEEEeeCCeeEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNL-ISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
.++|+..+.||+|+||.||+++.. +++.+|||++.... ......+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 356889999999999999999975 58899999997542 2334566777776 577899999999999999999999
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999998843 245889999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCcceeeeecccC
Q 013737 423 EDITHISATLAGTL 436 (437)
Q Consensus 423 ~~~~~~~~~~~Gt~ 436 (437)
.... ...+.+||+
T Consensus 191 ~~~~-~~~~~~gt~ 203 (373)
T 2r5t_A 191 EHNS-TTSTFCGTP 203 (373)
T ss_dssp CCCC-CCCSBSCCC
T ss_pred cCCC-ccccccCCc
Confidence 3322 223455664
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.8e-27 Score=231.09 Aligned_cols=155 Identities=29% Similarity=0.400 Sum_probs=136.0
Q ss_pred HHhcCCCcCCcccccCcccEEEEEeC--------CCCEEEEEEEecc-chhhHHHHHHHHHHHcCC-CCCceeceeEEEe
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTLP--------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSI 335 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 335 (437)
...++|...++||+|+||.||+|.+. .+..||||++... .....+++.+|+++++++ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 34567888999999999999999852 2357999999755 344567899999999999 8999999999999
Q ss_pred eCCeeEEEEeccCCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCe
Q 013737 336 TGPESLLVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNI 402 (437)
Q Consensus 336 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NI 402 (437)
..+..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceE
Confidence 99999999999999999998865431 245999999999999999999999998 99999999999
Q ss_pred eeCCCCcEEEcccCCccccCC
Q 013737 403 LLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 403 ll~~~~~~ki~DFG~a~~~~~ 423 (437)
|+++++.+||+|||+++.+..
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~ 243 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHH 243 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSC
T ss_pred EEcCCCcEEEcccCccccccc
Confidence 999999999999999987754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.1e-27 Score=220.24 Aligned_cols=152 Identities=23% Similarity=0.377 Sum_probs=136.6
Q ss_pred HhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
..++|+..+.||+|+||.||++... ++..+|+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3466889999999999999999975 478999999987655667889999999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee---CCCCcEEEcccCCccccC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll---~~~~~~ki~DFG~a~~~~ 422 (437)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 87 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999998887442 45899999999999999999999998 9999999999999 788899999999998775
Q ss_pred CC
Q 013737 423 ED 424 (437)
Q Consensus 423 ~~ 424 (437)
..
T Consensus 161 ~~ 162 (277)
T 3f3z_A 161 PG 162 (277)
T ss_dssp TT
T ss_pred Cc
Confidence 43
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=7.3e-28 Score=241.35 Aligned_cols=156 Identities=31% Similarity=0.464 Sum_probs=133.8
Q ss_pred HHHHHhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 263 TLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 263 ~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
.++...++|+..++||+|+||.||+|.+.++..||||.++... ...+.|.+|+.+|++++||||+++++++.+ +..++
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i 255 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 255 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence 3445567788899999999999999999888889999997543 235689999999999999999999999876 67899
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
||||+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 256 v~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp EECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred EehhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 99999999999998532 2245899999999999999999999998 9999999999999999999999999999775
Q ss_pred CC
Q 013737 423 ED 424 (437)
Q Consensus 423 ~~ 424 (437)
..
T Consensus 332 ~~ 333 (452)
T 1fmk_A 332 DN 333 (452)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=228.10 Aligned_cols=157 Identities=27% Similarity=0.425 Sum_probs=123.3
Q ss_pred HHHhcCCCcCCcccccCcccEEEEEeCC-C---CEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC
Q 013737 265 EKATNYFHESNKLGQGGSGSVYKGTLPG-G---EAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP 338 (437)
Q Consensus 265 ~~~~~~~~~~~~Lg~G~~g~V~~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 338 (437)
....++|+..+.||+|+||.||+|.+.. + ..||||.+... .....+++.+|++++++++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 3445679999999999999999999754 3 27999998754 4455678999999999999999999999998776
Q ss_pred ee------EEEEeccCCCCccccccccC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCc
Q 013737 339 ES------LLVYEFVPNQSLLDNLFVRQ---DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT 409 (437)
Q Consensus 339 ~~------~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~ 409 (437)
.. ++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCC
Confidence 55 99999999999999885432 2235899999999999999999999998 999999999999999999
Q ss_pred EEEcccCCccccCCC
Q 013737 410 AKIADFGLVRLFPED 424 (437)
Q Consensus 410 ~ki~DFG~a~~~~~~ 424 (437)
+||+|||+++.+...
T Consensus 176 ~kl~Dfg~a~~~~~~ 190 (323)
T 3qup_A 176 VCVADFGLSRKIYSG 190 (323)
T ss_dssp EEECCCCC-------
T ss_pred EEEeecccccccccc
Confidence 999999999876543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.6e-27 Score=234.23 Aligned_cols=150 Identities=24% Similarity=0.364 Sum_probs=131.2
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeC-----Ce
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG-----PE 339 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 339 (437)
.++|...+.||+|+||.||+|.+. +++.||||++... .....+++.+|+.+|++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 467899999999999999999974 5889999999653 344567899999999999999999999998776 56
Q ss_pred eEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcc
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~ 419 (437)
.++||||++ ++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 105 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999996 59988873 3356899999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCC
Q 013737 420 LFPED 424 (437)
Q Consensus 420 ~~~~~ 424 (437)
.....
T Consensus 178 ~~~~~ 182 (432)
T 3n9x_A 178 TINSE 182 (432)
T ss_dssp EC---
T ss_pred ccccc
Confidence 87543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-27 Score=227.74 Aligned_cols=159 Identities=27% Similarity=0.396 Sum_probs=134.9
Q ss_pred HHHHhcCCCcCCcccccCcccEEEEEe------CCCCEEEEEEEecc-chhhHHHHHHHHHHHcCC-CCCceeceeEEEe
Q 013737 264 LEKATNYFHESNKLGQGGSGSVYKGTL------PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSI 335 (437)
Q Consensus 264 ~~~~~~~~~~~~~Lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 335 (437)
++...++|...+.||+|+||.||+|.+ .++..||||.+... .....+.+.+|+.++.++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 344567889999999999999999996 23568999999754 334457899999999999 8999999999999
Q ss_pred eCCeeEEEEeccCCCCccccccccCCC--------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeC
Q 013737 336 TGPESLLVYEFVPNQSLLDNLFVRQDV--------------------EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHR 395 (437)
Q Consensus 336 ~~~~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHr 395 (437)
..+..++||||+++++|.+++...... ..+++..++.++.||+.||.|||+.+ |+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 999999999999999999988654321 34899999999999999999999998 9999
Q ss_pred CCCCCCeeeCCCCcEEEcccCCccccCCCC
Q 013737 396 DIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (437)
Q Consensus 396 Dlk~~NIll~~~~~~ki~DFG~a~~~~~~~ 425 (437)
||||+|||++.++.+||+|||+++.+....
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~ 226 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDS 226 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCT
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCc
Confidence 999999999999999999999998775443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=224.31 Aligned_cols=157 Identities=34% Similarity=0.481 Sum_probs=139.0
Q ss_pred HHHHhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 264 LEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 264 ~~~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
++...++|+..+.||+|+||.||++.+. ++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 3345677889999999999999999975 48899999997543 346789999999999999999999999999999999
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 87 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EEECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 99999999999988543 3456899999999999999999999998 9999999999999999999999999999876
Q ss_pred CCC
Q 013737 423 EDI 425 (437)
Q Consensus 423 ~~~ 425 (437)
.+.
T Consensus 163 ~~~ 165 (288)
T 3kfa_A 163 GDT 165 (288)
T ss_dssp SSS
T ss_pred CCc
Confidence 544
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.94 E-value=5e-27 Score=228.42 Aligned_cols=148 Identities=23% Similarity=0.293 Sum_probs=129.6
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
.++|...+.||+|+||.||+++.. +++.||||.+..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467899999999999999999975 689999999975432 235688999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCc--EEEcccCCccccC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT--AKIADFGLVRLFP 422 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~--~ki~DFG~a~~~~ 422 (437)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||+++...
T Consensus 98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 999999998843 235899999999999999999999998 999999999999987765 9999999998543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=8.6e-28 Score=233.32 Aligned_cols=162 Identities=28% Similarity=0.324 Sum_probs=137.9
Q ss_pred cCCCcCCcccccCcccEEEEEe----CCCCEEEEEEEecc----chhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCe
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYN----TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPE 339 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 339 (437)
++|+..+.||+|+||.||+++. .+++.||||++... .....+.+.+|++++.++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5788999999999999999997 36899999998643 123345677899999999 69999999999999999
Q ss_pred eEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcc
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~ 419 (437)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 99999999999999988543 35899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCcceeeeecccC
Q 013737 420 LFPEDITHISATLAGTL 436 (437)
Q Consensus 420 ~~~~~~~~~~~~~~Gt~ 436 (437)
.+............||+
T Consensus 208 ~~~~~~~~~~~~~~gt~ 224 (355)
T 1vzo_A 208 EFVADETERAYDFCGTI 224 (355)
T ss_dssp ECCGGGGGGGCGGGSCC
T ss_pred ecccCCCCcccCcccCc
Confidence 77544333333445554
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=230.30 Aligned_cols=152 Identities=24% Similarity=0.341 Sum_probs=128.4
Q ss_pred HHhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc--------hhhHHHHHHHHHHHcCCCCCceeceeEEEee
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT--------TQWVDHFFNEVNLISGINHKNLVKLLGCSIT 336 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 336 (437)
...++|...+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.+|++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 4467899999999999999999997 458999999986432 112235889999999999999999999875
Q ss_pred CCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC---CcEEEc
Q 013737 337 GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE---FTAKIA 413 (437)
Q Consensus 337 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~---~~~ki~ 413 (437)
.+..++||||+++++|.+++. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.+ ..+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 556899999999999998874 3456899999999999999999999998 9999999999999754 459999
Q ss_pred ccCCccccCCC
Q 013737 414 DFGLVRLFPED 424 (437)
Q Consensus 414 DFG~a~~~~~~ 424 (437)
|||+++.+...
T Consensus 285 DFG~a~~~~~~ 295 (419)
T 3i6u_A 285 DFGHSKILGET 295 (419)
T ss_dssp CSSTTTSCC--
T ss_pred ecccceecCCC
Confidence 99999987643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=215.98 Aligned_cols=149 Identities=30% Similarity=0.405 Sum_probs=134.3
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
.++|+..+.||+|+||.||++... +++.||||.+... .....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 356888999999999999999975 6899999998754 33456789999999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
|+++++|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 156 (276)
T 2yex_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (276)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence 999999999883 3346899999999999999999999998 9999999999999999999999999998764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=228.03 Aligned_cols=151 Identities=20% Similarity=0.250 Sum_probs=135.4
Q ss_pred HhcCCCcCCccccc--CcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeE
Q 013737 267 ATNYFHESNKLGQG--GSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G--~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (437)
..++|+..++||+| +||.||+++.. +++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 34678999999999 99999999975 6999999999754 3445677889999999999999999999999999999
Q ss_pred EEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
+||||+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999988543 2345899999999999999999999998 999999999999999999999999998754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.3e-27 Score=227.23 Aligned_cols=157 Identities=28% Similarity=0.320 Sum_probs=133.6
Q ss_pred HHHHhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc-----chhhHHHHHHHHHHHcCCCCCceeceeEEEeeC
Q 013737 264 LEKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN-----TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG 337 (437)
Q Consensus 264 ~~~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 337 (437)
+....++|+..+.||+|+||.||++.. .+++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 456667899999999999999999997 45889999998643 334567899999999999999999999999999
Q ss_pred CeeEEEEeccCCCCccccccccC-------------------------------------CCCCCCHHHHHHHHHHHHHH
Q 013737 338 PESLLVYEFVPNQSLLDNLFVRQ-------------------------------------DVEPLSWEVRYKIILSTAEG 380 (437)
Q Consensus 338 ~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~i~~~ 380 (437)
+..++||||+++++|.+++.... ....+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999998874210 01124677788999999999
Q ss_pred HHHhhcCCCCCeeeCCCCCCCeeeCCCC--cEEEcccCCccccCC
Q 013737 381 LAYLHEESKLRIIHRDIKLSNILLDEEF--TAKIADFGLVRLFPE 423 (437)
Q Consensus 381 l~yLH~~~~~~iiHrDlk~~NIll~~~~--~~ki~DFG~a~~~~~ 423 (437)
|.|||+.+ |+||||||+|||++.++ .+||+|||+++.+..
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~ 222 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYK 222 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGG
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccc
Confidence 99999998 99999999999998776 899999999987643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-27 Score=219.40 Aligned_cols=150 Identities=28% Similarity=0.429 Sum_probs=135.0
Q ss_pred hcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEecc
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (437)
.++|+..+.||+|+||.||++.+.+++.||+|.+..... ..+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 356888899999999999999998888999999976533 3467899999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccc
Confidence 999999988542 346899999999999999999999998 99999999999999999999999999987643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.2e-27 Score=221.73 Aligned_cols=152 Identities=28% Similarity=0.458 Sum_probs=131.4
Q ss_pred cCCCcCCcccccCcccEEEEEe-----CCCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeC--Cee
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-----PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PES 340 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 340 (437)
+.|+..+.||+|+||.||++.+ .+++.||+|.+... .....+.+.+|++++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4578889999999999999983 35889999999754 334567899999999999999999999999876 568
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 9999999999999988443 245899999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCC
Q 013737 421 FPEDI 425 (437)
Q Consensus 421 ~~~~~ 425 (437)
+....
T Consensus 176 ~~~~~ 180 (302)
T 4e5w_A 176 IETDK 180 (302)
T ss_dssp CCTTC
T ss_pred ccCCC
Confidence 76543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.9e-27 Score=220.33 Aligned_cols=152 Identities=26% Similarity=0.361 Sum_probs=124.2
Q ss_pred HhcCCCcCCcccccCcccEEEEEeCC----CCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeE
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (437)
..++|+..+.||+|+||.||+|.+.. +..||+|.+... .....+.+.+|+.++++++||||+++++++ ..+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccE
Confidence 34678889999999999999998742 457999998654 344567899999999999999999999987 456789
Q ss_pred EEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 999999999999988532 345899999999999999999999998 999999999999999999999999999887
Q ss_pred CCC
Q 013737 422 PED 424 (437)
Q Consensus 422 ~~~ 424 (437)
...
T Consensus 167 ~~~ 169 (281)
T 1mp8_A 167 EDS 169 (281)
T ss_dssp ---
T ss_pred Ccc
Confidence 544
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=219.92 Aligned_cols=147 Identities=31% Similarity=0.462 Sum_probs=125.3
Q ss_pred hcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcC--CCCCceeceeEEEeeC----CeeE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISG--INHKNLVKLLGCSITG----PESL 341 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~ 341 (437)
.++|+..+.||+|+||.||+|++ +++.||||++.... ...+.+|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46789999999999999999998 58899999986442 3445566666555 8999999999986543 4578
Q ss_pred EEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 013737 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH--------EESKLRIIHRDIKLSNILLDEEFTAKIA 413 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH--------~~~~~~iiHrDlk~~NIll~~~~~~ki~ 413 (437)
+||||+++|+|.+++. ...+++..++.++.|++.||.||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 9999999999999883 346899999999999999999999 766 9999999999999999999999
Q ss_pred ccCCccccCCCC
Q 013737 414 DFGLVRLFPEDI 425 (437)
Q Consensus 414 DFG~a~~~~~~~ 425 (437)
|||+++......
T Consensus 156 Dfg~a~~~~~~~ 167 (301)
T 3q4u_A 156 DLGLAVMHSQST 167 (301)
T ss_dssp CCTTCEEEETTT
T ss_pred eCCCeeeccccc
Confidence 999998765543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.5e-27 Score=225.75 Aligned_cols=149 Identities=29% Similarity=0.413 Sum_probs=121.6
Q ss_pred HhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
..+.|+..+.||+|+||.||+|.+. +++.||||.+.... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4567889999999999999999985 58899999997543 34568899999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC---CCcEEEcccCCccccC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---EFTAKIADFGLVRLFP 422 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~---~~~~ki~DFG~a~~~~ 422 (437)
|+++++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 999999999884 3345899999999999999999999998 999999999999975 8899999999998765
Q ss_pred C
Q 013737 423 E 423 (437)
Q Consensus 423 ~ 423 (437)
.
T Consensus 203 ~ 203 (349)
T 2w4o_A 203 H 203 (349)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.94 E-value=9e-27 Score=233.30 Aligned_cols=149 Identities=30% Similarity=0.476 Sum_probs=132.3
Q ss_pred HhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC-eeEEEEe
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP-ESLLVYE 345 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e 345 (437)
..++|+..+.||+|+||.||+|.+. ++.||||.++... ..+.|.+|+.+|++++||||+++++++...+ ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 3467888899999999999999986 6799999997543 4567999999999999999999999987665 7899999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
|+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 268 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 268 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp CCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 99999999998643 2334799999999999999999999998 9999999999999999999999999998654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=220.93 Aligned_cols=150 Identities=25% Similarity=0.396 Sum_probs=132.6
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
++|+..++||+|+||.||++.+. +++.||+|++... .....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 56888999999999999999975 5899999998654 23345678899999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
|+++++|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 83 ~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999998888763 2345899999999999999999999998 999999999999999999999999999877543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.7e-27 Score=229.98 Aligned_cols=154 Identities=29% Similarity=0.427 Sum_probs=135.2
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC--eeEEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGP--ESLLV 343 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 343 (437)
.++|...++||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 356888999999999999999975 58999999997543 344677889999999999999999999988765 67999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee----CCCCcEEEcccCCcc
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLVR 419 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll----~~~~~~ki~DFG~a~ 419 (437)
|||+++++|.+++........+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999865544455999999999999999999999998 9999999999999 777889999999998
Q ss_pred ccCCC
Q 013737 420 LFPED 424 (437)
Q Consensus 420 ~~~~~ 424 (437)
.+...
T Consensus 165 ~~~~~ 169 (396)
T 4eut_A 165 ELEDD 169 (396)
T ss_dssp ECCCG
T ss_pred EccCC
Confidence 87554
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.8e-27 Score=225.65 Aligned_cols=153 Identities=25% Similarity=0.301 Sum_probs=133.8
Q ss_pred HhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccch--------hhHHHHHHHHHHHcCCCCCceeceeEEEeeC
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTT--------QWVDHFFNEVNLISGINHKNLVKLLGCSITG 337 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 337 (437)
..++|+..+.||+|+||.||++.+ .+++.||||.+..... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 356799999999999999999996 5688999999875421 1334677899999999999999999999999
Q ss_pred CeeEEEEeccCCC-CccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccC
Q 013737 338 PESLLVYEFVPNQ-SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (437)
Q Consensus 338 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG 416 (437)
+..++||||+.+| +|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999776 8888773 3346999999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCC
Q 013737 417 LVRLFPEDI 425 (437)
Q Consensus 417 ~a~~~~~~~ 425 (437)
+++.+....
T Consensus 176 ~a~~~~~~~ 184 (335)
T 3dls_A 176 SAAYLERGK 184 (335)
T ss_dssp TCEECCTTC
T ss_pred cceECCCCC
Confidence 999876543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.3e-27 Score=222.32 Aligned_cols=158 Identities=32% Similarity=0.428 Sum_probs=137.9
Q ss_pred HHHhcCCCcCCcccccCcccEEEEEe------CCCCEEEEEEEeccc-hhhHHHHHHHHHHHcCC-CCCceeceeEEEee
Q 013737 265 EKATNYFHESNKLGQGGSGSVYKGTL------PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLVKLLGCSIT 336 (437)
Q Consensus 265 ~~~~~~~~~~~~Lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 336 (437)
+...++|+..+.||+|+||.||++.+ .+++.||||.+.... ....+.+.+|+.++.++ +||||+++++++..
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 34456788999999999999999985 346789999997553 34567899999999999 89999999999999
Q ss_pred CCeeEEEEeccCCCCccccccccCC---------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCC
Q 013737 337 GPESLLVYEFVPNQSLLDNLFVRQD---------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSN 401 (437)
Q Consensus 337 ~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~N 401 (437)
++..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccce
Confidence 9999999999999999998865432 225899999999999999999999998 9999999999
Q ss_pred eeeCCCCcEEEcccCCccccCCCC
Q 013737 402 ILLDEEFTAKIADFGLVRLFPEDI 425 (437)
Q Consensus 402 Ill~~~~~~ki~DFG~a~~~~~~~ 425 (437)
||++.++.+||+|||+++......
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~ 199 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDS 199 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCT
T ss_pred EEEcCCCCEEEccccccccccccc
Confidence 999999999999999999876544
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.6e-27 Score=220.12 Aligned_cols=151 Identities=27% Similarity=0.370 Sum_probs=134.2
Q ss_pred hcCCCcCCcccccCcccEEEEEeCC-C-------CEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCe
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPG-G-------EAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE 339 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 339 (437)
.++|...+.||+|+||.||++.+.. + ..||+|.+........+.+.+|+.++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3568889999999999999998643 3 4799999977766777889999999999999999999999999999
Q ss_pred eEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCc--------EE
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT--------AK 411 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~--------~k 411 (437)
.++||||+++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999988542 234899999999999999999999998 999999999999998876 99
Q ss_pred EcccCCccccCC
Q 013737 412 IADFGLVRLFPE 423 (437)
Q Consensus 412 i~DFG~a~~~~~ 423 (437)
|+|||+++....
T Consensus 162 l~Dfg~~~~~~~ 173 (289)
T 4fvq_A 162 LSDPGISITVLP 173 (289)
T ss_dssp ECCCCSCTTTSC
T ss_pred eccCcccccccC
Confidence 999999976543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=222.75 Aligned_cols=156 Identities=28% Similarity=0.402 Sum_probs=135.4
Q ss_pred HHhcCCCcCCcccccCcccEEEEEeC--------CCCEEEEEEEecc-chhhHHHHHHHHHHHcCC-CCCceeceeEEEe
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTLP--------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSI 335 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 335 (437)
...++|...+.||+|+||.||+|.+. ++..||||.+... .....+.+.+|+++++++ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 34577889999999999999999863 4678999999754 344567899999999999 8999999999999
Q ss_pred eCCeeEEEEeccCCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCe
Q 013737 336 TGPESLLVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNI 402 (437)
Q Consensus 336 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NI 402 (437)
..+..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceE
Confidence 99999999999999999998864332 234899999999999999999999998 99999999999
Q ss_pred eeCCCCcEEEcccCCccccCCC
Q 013737 403 LLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 403 ll~~~~~~ki~DFG~a~~~~~~ 424 (437)
|++.++.+||+|||+++.....
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~ 210 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNI 210 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTT
T ss_pred EEcCCCCEEEcccccccccccc
Confidence 9999999999999999877643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-26 Score=216.02 Aligned_cols=151 Identities=28% Similarity=0.342 Sum_probs=133.4
Q ss_pred CCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccC
Q 013737 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (437)
.|.....||+|+||.||+|.+ .+++.||||.+........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 355667999999999999996 5688999999987666667889999999999999999999999999999999999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC-CCcEEEcccCCccccCC
Q 013737 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFGLVRLFPE 423 (437)
Q Consensus 349 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~-~~~~ki~DFG~a~~~~~ 423 (437)
+++|.+++........+++..+..++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||+++.+..
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999999865544556789999999999999999999998 999999999999987 89999999999987654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.8e-27 Score=225.91 Aligned_cols=161 Identities=22% Similarity=0.327 Sum_probs=133.1
Q ss_pred hcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCC--CceeceeEEEeeCCeeEEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINH--KNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv 343 (437)
.+.|+..+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++| |||+++++++..++..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4568899999999999999999988999999998754 34456789999999999986 9999999999999999999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|| +.+++|.+++.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 88 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 557899998853 346899999999999999999999998 99999999999997 56899999999998765
Q ss_pred CCcc-eeeeecccC
Q 013737 424 DITH-ISATLAGTL 436 (437)
Q Consensus 424 ~~~~-~~~~~~Gt~ 436 (437)
.... ......||+
T Consensus 160 ~~~~~~~~~~~gt~ 173 (343)
T 3dbq_A 160 DTTSVVKDSQVGTV 173 (343)
T ss_dssp ----------CCCC
T ss_pred ccccccCCCCcCCc
Confidence 4332 122445664
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=4.9e-27 Score=219.94 Aligned_cols=154 Identities=32% Similarity=0.508 Sum_probs=134.5
Q ss_pred HHHhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 265 EKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 265 ~~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
+...++|+..+.||+|+||.||+|...++..||+|.+.... ...+.+.+|++++++++||||+++++++. .+..++||
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 86 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIIT 86 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEE
Confidence 33456788899999999999999999888899999997543 23578999999999999999999999876 45689999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 87 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 87 EYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp ECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred ecCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 999999999988432 1125899999999999999999999998 999999999999999999999999999887644
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=218.31 Aligned_cols=153 Identities=25% Similarity=0.381 Sum_probs=132.3
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
+.|...++||+|+||.||++.. .++..+|+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 5688899999999999999997 458899999987553 34567899999999999999999999999999999999999
Q ss_pred cCCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee---CCCCcEEEcccCCccccC
Q 013737 347 VPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 347 ~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll---~~~~~~ki~DFG~a~~~~ 422 (437)
+++++|.+.+... .....+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999887543 12356899999999999999999999998 9999999999999 456789999999998765
Q ss_pred CC
Q 013737 423 ED 424 (437)
Q Consensus 423 ~~ 424 (437)
..
T Consensus 179 ~~ 180 (285)
T 3is5_A 179 SD 180 (285)
T ss_dssp --
T ss_pred Cc
Confidence 43
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=228.12 Aligned_cols=148 Identities=31% Similarity=0.505 Sum_probs=123.0
Q ss_pred HhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCC-CCceeceeEEEeeCC--ee
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGP--ES 340 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~ 340 (437)
..++|+..+.||+|+||.||+|.+ .+++.||||++... .....+++.+|+.++..+. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 457899999999999999999996 56899999998543 4455677889999999997 999999999997654 68
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
++||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999997 588887743 35899999999999999999999998 99999999999999999999999999987
Q ss_pred cC
Q 013737 421 FP 422 (437)
Q Consensus 421 ~~ 422 (437)
+.
T Consensus 159 ~~ 160 (388)
T 3oz6_A 159 FV 160 (388)
T ss_dssp SS
T ss_pred cc
Confidence 64
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=223.33 Aligned_cols=150 Identities=21% Similarity=0.268 Sum_probs=131.9
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCeeEEEEe
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 345 (437)
.++|+..+.||+|+||.||+|.. .+++.||||.+..... .+.+.+|+++++++ +||||+++++++..++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 35788999999999999999996 5689999999865432 23588999999999 89999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCc-----EEEcccCCccc
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT-----AKIADFGLVRL 420 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~-----~ki~DFG~a~~ 420 (437)
|+ +++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999988543 356999999999999999999999998 999999999999998887 99999999998
Q ss_pred cCCCC
Q 013737 421 FPEDI 425 (437)
Q Consensus 421 ~~~~~ 425 (437)
+....
T Consensus 160 ~~~~~ 164 (330)
T 2izr_A 160 YIDPE 164 (330)
T ss_dssp SBCTT
T ss_pred eecCC
Confidence 75443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.1e-27 Score=223.75 Aligned_cols=152 Identities=30% Similarity=0.403 Sum_probs=135.3
Q ss_pred cCCCcCCcccccCcccEEEEEe-----CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEe--eCCeeE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-----PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI--TGPESL 341 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~ 341 (437)
++|+..+.||+|+||.||++.+ .+++.||||++........+.+.+|++++++++||||+++++++. .....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5688899999999999999984 357899999998777777788999999999999999999999887 455689
Q ss_pred EEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
+||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 999999999999988542 235899999999999999999999998 999999999999999999999999999987
Q ss_pred CCCC
Q 013737 422 PEDI 425 (437)
Q Consensus 422 ~~~~ 425 (437)
....
T Consensus 178 ~~~~ 181 (327)
T 3lxl_A 178 PLDK 181 (327)
T ss_dssp CTTC
T ss_pred ccCC
Confidence 6543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=243.14 Aligned_cols=163 Identities=28% Similarity=0.264 Sum_probs=139.1
Q ss_pred HhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCeeE
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESL 341 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 341 (437)
..++|+..++||+|+||.||+++.. +++.||||++... .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3467899999999999999999975 5889999999753 233456788999999988 6999999999999999999
Q ss_pred EEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
|||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+|+..
T Consensus 419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999988543 45899999999999999999999998 999999999999999999999999999965
Q ss_pred CCCCcceeeeecccC
Q 013737 422 PEDITHISATLAGTL 436 (437)
Q Consensus 422 ~~~~~~~~~~~~Gt~ 436 (437)
..+.. ...+..||+
T Consensus 493 ~~~~~-~~~~~~GT~ 506 (674)
T 3pfq_A 493 IWDGV-TTKTFCGTP 506 (674)
T ss_dssp CCTTC-CBCCCCSCS
T ss_pred ccCCc-ccccccCCC
Confidence 43322 233556775
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=227.30 Aligned_cols=161 Identities=30% Similarity=0.446 Sum_probs=139.4
Q ss_pred CHHHHHHHhcCCCcCCcccccCcccEEEEEeC------CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeE
Q 013737 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLG 332 (437)
Q Consensus 260 ~~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~ 332 (437)
..++++...++|+..+.||+|+||.||+|.+. +++.||||.+... .......+.+|+.++++++||||+++++
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 34455566788999999999999999999864 3678999998754 3345567999999999999999999999
Q ss_pred EEeeCCeeEEEEeccCCCCccccccccC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC
Q 013737 333 CSITGPESLLVYEFVPNQSLLDNLFVRQ-------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD 405 (437)
Q Consensus 333 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~ 405 (437)
++.+.+..++||||+++++|.+++.... ...++++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~ 172 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVA 172 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEEC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEc
Confidence 9999999999999999999999885422 1245799999999999999999999998 99999999999999
Q ss_pred CCCcEEEcccCCccccCC
Q 013737 406 EEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 406 ~~~~~ki~DFG~a~~~~~ 423 (437)
.++.+||+|||+++....
T Consensus 173 ~~~~~kl~Dfg~~~~~~~ 190 (322)
T 1p4o_A 173 EDFTVKIGDFGMTRDIYE 190 (322)
T ss_dssp TTCCEEECCTTCCCGGGG
T ss_pred CCCeEEECcCcccccccc
Confidence 999999999999987643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.4e-27 Score=222.15 Aligned_cols=150 Identities=26% Similarity=0.284 Sum_probs=127.5
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..++||+|+||+||+|.+. +++.||||++... ......++..|+..+.++ +||||+++++++.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 56888999999999999999975 6899999998643 233344555666655554 8999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||+ +++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 67888877543 346999999999999999999999997 999999999999999999999999999877543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-26 Score=215.69 Aligned_cols=150 Identities=30% Similarity=0.429 Sum_probs=134.0
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc---hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..+.||+|+||.||++.. .+++.||||.+.... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5688899999999999999997 568999999996432 233578999999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
||+++++|.+++.. ...++++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 91 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 91 EMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp ECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999998843 3356899999999999999999999998 99999999999999999999999999987653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.5e-27 Score=228.13 Aligned_cols=151 Identities=31% Similarity=0.386 Sum_probs=131.9
Q ss_pred hcCCCcCCcccccCcccEEEEEeC------CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCee
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES 340 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 340 (437)
.++|+..+.||+|+||.||+|.+. +++.||||++... ......++.+|+.++++++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 466888999999999999999953 4668999998654 445566799999999999999999999999999999
Q ss_pred EEEEeccCCCCccccccccC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC---cEEEc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQ----DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF---TAKIA 413 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~---~~ki~ 413 (437)
++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999886543 2245899999999999999999999998 99999999999999554 59999
Q ss_pred ccCCcccc
Q 013737 414 DFGLVRLF 421 (437)
Q Consensus 414 DFG~a~~~ 421 (437)
|||+++.+
T Consensus 227 DFG~a~~~ 234 (367)
T 3l9p_A 227 DFGMARDI 234 (367)
T ss_dssp CCHHHHHH
T ss_pred CCcccccc
Confidence 99999854
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=7e-27 Score=222.76 Aligned_cols=167 Identities=28% Similarity=0.378 Sum_probs=141.9
Q ss_pred ccccCHHHHHHHhcCCCcCCcccccCcccEEEEEe------CCCCEEEEEEEecc-chhhHHHHHHHHHHHcCC-CCCce
Q 013737 256 KLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTL------PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNL 327 (437)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni 327 (437)
.+.+....++...++|+..+.||+|+||.||++.+ .+++.||||.+... .....+.+.+|+.++.++ +||||
T Consensus 14 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i 93 (316)
T 2xir_A 14 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93 (316)
T ss_dssp GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred hccccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCe
Confidence 34556667777788999999999999999999984 34678999999764 334456899999999999 69999
Q ss_pred eceeEEEeeCC-eeEEEEeccCCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCee
Q 013737 328 VKLLGCSITGP-ESLLVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393 (437)
Q Consensus 328 v~l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ii 393 (437)
+++++++...+ ..++||||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ |+
T Consensus 94 v~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~ 170 (316)
T 2xir_A 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CI 170 (316)
T ss_dssp CCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred eeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 99999988765 48999999999999998854332 123889999999999999999999998 99
Q ss_pred eCCCCCCCeeeCCCCcEEEcccCCccccCCCC
Q 013737 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (437)
Q Consensus 394 HrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~ 425 (437)
||||||+|||++.++.+||+|||+++.+....
T Consensus 171 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 202 (316)
T 2xir_A 171 HRDLAARNILLSEKNVVKICDFGLARDIYKDP 202 (316)
T ss_dssp CSCCSGGGEEECGGGCEEECCCGGGSCTTTCT
T ss_pred cccCccceEEECCCCCEEECCCccccccccCc
Confidence 99999999999999999999999998775543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-27 Score=242.08 Aligned_cols=156 Identities=31% Similarity=0.466 Sum_probs=136.8
Q ss_pred HHHHHHhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeE
Q 013737 262 ETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (437)
Q Consensus 262 ~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (437)
..++...++|+..++||+|+||.||+|.+.++..||||+++.... ..++|.+|+++|++++||||+++++++.+ +..+
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 334455677888999999999999999998888899999976542 35689999999999999999999999876 6789
Q ss_pred EEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
|||||+++|+|.+++... ....+++.+++.|+.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.+
T Consensus 338 lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp EEECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred EeeehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 999999999999998532 2245899999999999999999999998 999999999999999999999999999877
Q ss_pred CC
Q 013737 422 PE 423 (437)
Q Consensus 422 ~~ 423 (437)
..
T Consensus 414 ~~ 415 (535)
T 2h8h_A 414 ED 415 (535)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=220.74 Aligned_cols=151 Identities=19% Similarity=0.259 Sum_probs=130.5
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
.++|+..+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++.+++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 467999999999999999999975 6889999998654 233457899999999999999999999999999999999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|||+++++|.+++... .++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 113 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 9999999999988532 45899999999999999999999998 99999999999999999999999999987654
Q ss_pred C
Q 013737 424 D 424 (437)
Q Consensus 424 ~ 424 (437)
.
T Consensus 187 ~ 187 (309)
T 2h34_A 187 E 187 (309)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-26 Score=219.20 Aligned_cols=148 Identities=24% Similarity=0.331 Sum_probs=130.1
Q ss_pred cCCCcC-CcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCeeEEEEe
Q 013737 269 NYFHES-NKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 269 ~~~~~~-~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 345 (437)
+.|... +.||+|+||.||++.. .+++.||||++........+.+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 456664 7899999999999996 46899999999776656677899999999885 79999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCc---EEEcccCCccccC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT---AKIADFGLVRLFP 422 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~---~ki~DFG~a~~~~ 422 (437)
|+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++.+.
T Consensus 92 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999988543 45899999999999999999999998 999999999999998765 9999999998764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-26 Score=221.39 Aligned_cols=150 Identities=25% Similarity=0.343 Sum_probs=134.7
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
.++|...+.||+|+||.||++.+. +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 456888999999999999999975 5889999998654 334567899999999999999999999999999999999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|||+++++|.+++... ..+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 120 ~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 9999999999887432 45899999999999999999999998 99999999999999999999999999987753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=216.98 Aligned_cols=150 Identities=29% Similarity=0.387 Sum_probs=132.1
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc---hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
.++|+..+.||+|+||.||++... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 456888999999999999999974 57899999986432 23356789999999999999999999999999999999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|||+++++|.+.+... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 9999999999888433 45899999999999999999999987 99999999999999999999999999876544
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=215.54 Aligned_cols=152 Identities=32% Similarity=0.465 Sum_probs=124.7
Q ss_pred hcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccc----hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT----TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
.++|+..+.||+|+||.||++.+. ++.+|||.+.... ....+.+.+|+++++.++||||+++++++..++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357888999999999999999976 7899999986542 23357899999999999999999999999999999999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC--------CCcEEEccc
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE--------EFTAKIADF 415 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~--------~~~~ki~DF 415 (437)
|||+++++|.+++. ...+++..+..++.|++.||.|||+++..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999998873 346899999999999999999999987556999999999999986 678999999
Q ss_pred CCccccCCC
Q 013737 416 GLVRLFPED 424 (437)
Q Consensus 416 G~a~~~~~~ 424 (437)
|+++.+...
T Consensus 161 g~~~~~~~~ 169 (271)
T 3dtc_A 161 GLAREWHRT 169 (271)
T ss_dssp CC-------
T ss_pred Ccccccccc
Confidence 999876543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=216.62 Aligned_cols=155 Identities=27% Similarity=0.350 Sum_probs=134.4
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCeeEEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 343 (437)
.++|+..+.||+|+||.||++... +++.||+|.+... ......++.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 456888999999999999999975 6899999998754 334466788999999998 899999999999999999999
Q ss_pred EeccCCCCccccccccCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC----------------
Q 013737 344 YEFVPNQSLLDNLFVRQD-VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---------------- 406 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~---------------- 406 (437)
|||+++++|.+++..... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999998854321 256899999999999999999999998 999999999999984
Q ss_pred ---CCcEEEcccCCccccCCCC
Q 013737 407 ---EFTAKIADFGLVRLFPEDI 425 (437)
Q Consensus 407 ---~~~~ki~DFG~a~~~~~~~ 425 (437)
...+||+|||+++......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~ 188 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ 188 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC
T ss_pred cCCceEEEEcccccccccCCcc
Confidence 4479999999998876543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-26 Score=218.62 Aligned_cols=149 Identities=34% Similarity=0.510 Sum_probs=131.7
Q ss_pred CCCcCCcccccCcccEEEEEeC-----CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeC--CeeE
Q 013737 270 YFHESNKLGQGGSGSVYKGTLP-----GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PESL 341 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 341 (437)
.|+..++||+|+||.||++.+. +++.||||++... .....+.+.+|++++++++||||+++++++.+. ...+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 3488899999999999998652 5789999999765 345567899999999999999999999999874 5789
Q ss_pred EEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
+||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 112 lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccc
Confidence 99999999999998843 24899999999999999999999998 999999999999999999999999999987
Q ss_pred CCCC
Q 013737 422 PEDI 425 (437)
Q Consensus 422 ~~~~ 425 (437)
....
T Consensus 185 ~~~~ 188 (318)
T 3lxp_A 185 PEGH 188 (318)
T ss_dssp CTTC
T ss_pred cccc
Confidence 6543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-26 Score=216.51 Aligned_cols=150 Identities=24% Similarity=0.329 Sum_probs=134.4
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
.++|...+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 356888999999999999999975 5889999998654 334567889999999999999999999999999999999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999987743 245899999999999999999999998 99999999999999999999999999987653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=224.69 Aligned_cols=149 Identities=31% Similarity=0.502 Sum_probs=131.6
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
+.|+..+.||+|+||.||+|.. .+++.||||++... .....+.+.+|++++++++||||+++++++..++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588889999999999999996 56899999999754 2334567899999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
||++ |+|.+.+... ..++++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 6777776432 346899999999999999999999998 99999999999999999999999999987654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-26 Score=219.16 Aligned_cols=142 Identities=26% Similarity=0.347 Sum_probs=125.3
Q ss_pred CCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCC-CCceeceeEEEeeCCeeEEEEeccCCCC
Q 013737 274 SNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVYEFVPNQS 351 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~ 351 (437)
.++||+|+||.||++.+. +++.||||++... ....+.+|+.++..+. ||||+++++++.+....++||||+++++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 578999999999999974 6899999998643 3456789999999997 9999999999999999999999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC---cEEEcccCCccccCCC
Q 013737 352 LLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF---TAKIADFGLVRLFPED 424 (437)
Q Consensus 352 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~---~~ki~DFG~a~~~~~~ 424 (437)
|.+++.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 9998843 346899999999999999999999998 99999999999997665 8999999999876544
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=6.8e-27 Score=224.39 Aligned_cols=151 Identities=27% Similarity=0.489 Sum_probs=126.5
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCC----EEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGE----AVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
++|+..++||+|+||.||+|.+. +++ .||+|.+... .....+++.+|+.++++++||||+++++++..+. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 56888999999999999999963 344 3588877543 3345678999999999999999999999998754 789
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
|+||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 94 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 99999999999988543 346899999999999999999999998 9999999999999999999999999999876
Q ss_pred CCC
Q 013737 423 EDI 425 (437)
Q Consensus 423 ~~~ 425 (437)
...
T Consensus 169 ~~~ 171 (327)
T 3poz_A 169 AEE 171 (327)
T ss_dssp TTC
T ss_pred CCc
Confidence 543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-27 Score=228.53 Aligned_cols=159 Identities=31% Similarity=0.431 Sum_probs=137.2
Q ss_pred HHHHHhcCCCcCCcccccCcccEEEEEeCC-C-----CEEEEEEEecc-chhhHHHHHHHHHHHcCC-CCCceeceeEEE
Q 013737 263 TLEKATNYFHESNKLGQGGSGSVYKGTLPG-G-----EAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCS 334 (437)
Q Consensus 263 ~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 334 (437)
.++...++|+..+.||+|+||.||+|.+.. + ..||+|.+... .....+.+.+|+.++.++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345556789999999999999999999642 2 47999999754 334567899999999999 899999999999
Q ss_pred eeCCeeEEEEeccCCCCccccccccC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCee
Q 013737 335 ITGPESLLVYEFVPNQSLLDNLFVRQ-----------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNIL 403 (437)
Q Consensus 335 ~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIl 403 (437)
...+..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 99999999999999999999885432 1345899999999999999999999998 999999999999
Q ss_pred eCCCCcEEEcccCCccccCCC
Q 013737 404 LDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 404 l~~~~~~ki~DFG~a~~~~~~ 424 (437)
+++++.+||+|||+++.+...
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~ 217 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMND 217 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGC
T ss_pred ECCCCeEEECccccccccccc
Confidence 999999999999999876543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.3e-27 Score=223.54 Aligned_cols=151 Identities=29% Similarity=0.449 Sum_probs=128.5
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCE----EEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEA----VAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
++|+..++||+|+||.||+|.+. +++. |++|.+... .....+.+.+|+.++.+++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 46788899999999999999964 4443 778877543 2333456788999999999999999999886 466899
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 99999999999988432 346889999999999999999999998 9999999999999999999999999999876
Q ss_pred CCC
Q 013737 423 EDI 425 (437)
Q Consensus 423 ~~~ 425 (437)
...
T Consensus 167 ~~~ 169 (325)
T 3kex_A 167 PDD 169 (325)
T ss_dssp CCT
T ss_pred ccc
Confidence 544
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-26 Score=231.82 Aligned_cols=158 Identities=27% Similarity=0.373 Sum_probs=127.4
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC------
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP------ 338 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 338 (437)
.++|+..++||+|+||.||+|.+ .+++.||||++... .....+++.+|+.+|+.++||||+++++++...+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46789999999999999999986 45889999999754 4455678999999999999999999999987553
Q ss_pred eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCc
Q 013737 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (437)
Q Consensus 339 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a 418 (437)
..++||||+++ +|.+.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 141 ~~~lv~E~~~~-~l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCC-CHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 56999999975 4555552 23899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCcceeeeecccC
Q 013737 419 RLFPEDITHISATLAGTL 436 (437)
Q Consensus 419 ~~~~~~~~~~~~~~~Gt~ 436 (437)
+...... ..+...||+
T Consensus 212 ~~~~~~~--~~~~~~gt~ 227 (464)
T 3ttj_A 212 RTAGTSF--MMTPYVVTR 227 (464)
T ss_dssp -----CC--CC----CCC
T ss_pred eecCCCc--ccCCCcccc
Confidence 9775432 223445664
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=227.79 Aligned_cols=160 Identities=22% Similarity=0.334 Sum_probs=132.9
Q ss_pred cCCCcCCcccccCcccEEEEEeCCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCC--CCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGIN--HKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~ 344 (437)
+.|+..+.||+|+||.||++...+++.||||++... .....+.+.+|+.+|.+++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458899999999999999999888999999998654 3455678999999999996 599999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
| +.+++|.+++... ..+++.++..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+...
T Consensus 136 E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 5688999988542 36899999999999999999999988 99999999999996 579999999999987654
Q ss_pred Ccce-eeeecccC
Q 013737 425 ITHI-SATLAGTL 436 (437)
Q Consensus 425 ~~~~-~~~~~Gt~ 436 (437)
.... .....||+
T Consensus 208 ~~~~~~~~~~gt~ 220 (390)
T 2zmd_A 208 TTSVVKDSQVGAV 220 (390)
T ss_dssp ------CCSCCCG
T ss_pred CccccCCCCCcCC
Confidence 3321 22445654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-26 Score=219.48 Aligned_cols=151 Identities=26% Similarity=0.357 Sum_probs=134.5
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccch------hhHHHHHHHHHHHcCCCCCceeceeEEEeeCCee
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT------QWVDHFFNEVNLISGINHKNLVKLLGCSITGPES 340 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 340 (437)
.+.|+..+.||+|+||.||++... +++.||+|.+..... ...+.+.+|+.++.+++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 356888999999999999999975 589999999865422 1367899999999999999999999999999999
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC----cEEEcccC
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF----TAKIADFG 416 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~----~~ki~DFG 416 (437)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999998843 346899999999999999999999998 99999999999999887 79999999
Q ss_pred CccccCCC
Q 013737 417 LVRLFPED 424 (437)
Q Consensus 417 ~a~~~~~~ 424 (437)
+++.+...
T Consensus 165 ~~~~~~~~ 172 (321)
T 2a2a_A 165 LAHEIEDG 172 (321)
T ss_dssp TCEECCTT
T ss_pred cceecCcc
Confidence 99877653
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.7e-26 Score=220.92 Aligned_cols=151 Identities=26% Similarity=0.344 Sum_probs=134.2
Q ss_pred hcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchh-----------------hHHHHHHHHHHHcCCCCCceece
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQ-----------------WVDHFFNEVNLISGINHKNLVKL 330 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~h~niv~l 330 (437)
.++|...+.||+|+||.||++.. +++.||||.+...... ..+.+.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46789999999999999999999 8999999998643211 12789999999999999999999
Q ss_pred eEEEeeCCeeEEEEeccCCCCcccc------ccccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeeeCCCCCCCee
Q 013737 331 LGCSITGPESLLVYEFVPNQSLLDN------LFVRQDVEPLSWEVRYKIILSTAEGLAYLHE-ESKLRIIHRDIKLSNIL 403 (437)
Q Consensus 331 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiHrDlk~~NIl 403 (437)
++++.+.+..++||||+++++|.++ +.. .....+++..+..++.|++.||.|||+ .+ |+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999998 422 224679999999999999999999998 77 999999999999
Q ss_pred eCCCCcEEEcccCCccccCC
Q 013737 404 LDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 404 l~~~~~~ki~DFG~a~~~~~ 423 (437)
++.++.+||+|||+++....
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~ 204 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVD 204 (348)
T ss_dssp ECTTSCEEECCCTTCEECBT
T ss_pred EcCCCcEEEecccccccccc
Confidence 99999999999999987654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-26 Score=220.04 Aligned_cols=150 Identities=29% Similarity=0.450 Sum_probs=129.2
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
++|+..+.||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 56888899999999999999975 5899999998654 33345678899999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
|+++++|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 105 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 105 FVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp CCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 999988887653 2345899999999999999999999998 999999999999999999999999999876543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-26 Score=238.84 Aligned_cols=144 Identities=26% Similarity=0.402 Sum_probs=126.4
Q ss_pred cccccCcccEEEEEeC---CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCCC
Q 013737 276 KLGQGGSGSVYKGTLP---GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQS 351 (437)
Q Consensus 276 ~Lg~G~~g~V~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 351 (437)
.||+|+||.||+|.+. ++..||||.++.. .....++|.+|+++|++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999863 4567999999764 33457889999999999999999999999876 56899999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCC
Q 013737 352 LLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (437)
Q Consensus 352 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~ 425 (437)
|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+||||++++.+||+|||+++.+..+.
T Consensus 422 L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 422 LHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp HHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred HHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 9998843 3456899999999999999999999998 9999999999999999999999999999876443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-26 Score=223.27 Aligned_cols=164 Identities=24% Similarity=0.279 Sum_probs=140.7
Q ss_pred cccccCHHHHHHHhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCC-----CCcee
Q 013737 255 SKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-----HKNLV 328 (437)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv 328 (437)
+...+++.......++|...++||+|+||.||+|.+ .+++.||||++... ....+.+..|++++..++ ||||+
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 344556666666778999999999999999999997 56899999998643 344566788999998886 99999
Q ss_pred ceeEEEeeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC--
Q 013737 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-- 406 (437)
Q Consensus 329 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~-- 406 (437)
++++++...+..++||||+ +++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~ 174 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPY 174 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTT
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccc
Confidence 9999999999999999999 89999988543 3345899999999999999999999998 999999999999975
Q ss_pred -----------------------CCcEEEcccCCccccCCC
Q 013737 407 -----------------------EFTAKIADFGLVRLFPED 424 (437)
Q Consensus 407 -----------------------~~~~ki~DFG~a~~~~~~ 424 (437)
++.+||+|||+++.....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~ 215 (360)
T 3llt_A 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY 215 (360)
T ss_dssp CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC
T ss_pred ccccccchhcccccccccccccCCCCEEEEeccCceecCCC
Confidence 789999999999876543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-26 Score=218.27 Aligned_cols=153 Identities=24% Similarity=0.300 Sum_probs=133.8
Q ss_pred HhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEee----CCeeE
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT----GPESL 341 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 341 (437)
..++|+..+.||+|+||.||++.. .+++.||||.+........+.+.+|+++++.++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 346789999999999999999997 5689999999977766777889999999999999999999999873 34678
Q ss_pred EEEeccCCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 342 LVYEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
+||||+++++|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999888542 23456999999999999999999999998 99999999999999999999999999876
Q ss_pred cC
Q 013737 421 FP 422 (437)
Q Consensus 421 ~~ 422 (437)
..
T Consensus 184 ~~ 185 (317)
T 2buj_A 184 AC 185 (317)
T ss_dssp SC
T ss_pred cc
Confidence 53
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=2.9e-26 Score=215.99 Aligned_cols=150 Identities=36% Similarity=0.535 Sum_probs=124.4
Q ss_pred HHhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEE
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
...++|+..++||+|+||.||++++.. .+|+|.+... .....+.+.+|+.++++++||||++++++. ..+..++|
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 345679999999999999999998753 5999998654 345567899999999999999999999965 55678999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 98 TQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EEecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence 999999999988843 3356899999999999999999999998 99999999999999999999999999986653
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-26 Score=219.97 Aligned_cols=153 Identities=31% Similarity=0.484 Sum_probs=134.8
Q ss_pred hcCCCcCCcccccCcccEEEEEe-----CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC--ee
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-----PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP--ES 340 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~ 340 (437)
.++|+..+.||+|+||.||++.+ .+++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35688889999999999999984 358899999998776677788999999999999999999999887654 68
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999988543 345899999999999999999999988 99999999999999999999999999998
Q ss_pred cCCCC
Q 013737 421 FPEDI 425 (437)
Q Consensus 421 ~~~~~ 425 (437)
.....
T Consensus 195 ~~~~~ 199 (326)
T 2w1i_A 195 LPQDK 199 (326)
T ss_dssp CCSSC
T ss_pred ccccc
Confidence 76543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-26 Score=222.84 Aligned_cols=157 Identities=23% Similarity=0.371 Sum_probs=137.7
Q ss_pred HHHHHHhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc--------hhhHHHHHHHHHHHcCC-CCCceecee
Q 013737 262 ETLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--------TQWVDHFFNEVNLISGI-NHKNLVKLL 331 (437)
Q Consensus 262 ~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~ 331 (437)
.......++|...+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.++.++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 334455677999999999999999999985 69999999986543 12245788999999999 799999999
Q ss_pred EEEeeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 013737 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAK 411 (437)
Q Consensus 332 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~k 411 (437)
+++...+..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+|
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence 999999999999999999999998853 245899999999999999999999998 99999999999999999999
Q ss_pred EcccCCccccCCC
Q 013737 412 IADFGLVRLFPED 424 (437)
Q Consensus 412 i~DFG~a~~~~~~ 424 (437)
|+|||++..+...
T Consensus 241 l~DfG~~~~~~~~ 253 (365)
T 2y7j_A 241 LSDFGFSCHLEPG 253 (365)
T ss_dssp ECCCTTCEECCTT
T ss_pred EEecCcccccCCC
Confidence 9999999877644
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.2e-26 Score=231.79 Aligned_cols=152 Identities=30% Similarity=0.484 Sum_probs=132.1
Q ss_pred HhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccch-------------hhHHHHHHHHHHHcCCCCCceeceeE
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT-------------QWVDHFFNEVNLISGINHKNLVKLLG 332 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~ 332 (437)
..+.|...++||+|+||.||+|... +++.+|+|.+..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4577999999999999999999974 588999999865321 33567899999999999999999999
Q ss_pred EEeeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC---c
Q 013737 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF---T 409 (437)
Q Consensus 333 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~---~ 409 (437)
++.+....++||||+++|+|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999999999888443 45899999999999999999999998 99999999999998775 6
Q ss_pred EEEcccCCccccCCC
Q 013737 410 AKIADFGLVRLFPED 424 (437)
Q Consensus 410 ~ki~DFG~a~~~~~~ 424 (437)
+||+|||+++.+...
T Consensus 188 ~kl~Dfg~a~~~~~~ 202 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKD 202 (504)
T ss_dssp EEECCCTTCEECCTT
T ss_pred EEEEECCCCEEcCCC
Confidence 999999999987654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-26 Score=223.09 Aligned_cols=158 Identities=24% Similarity=0.320 Sum_probs=132.7
Q ss_pred CHHHHHHHhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccc-----------hhhHHHHHHHHHHHcCCCCCcee
Q 013737 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT-----------TQWVDHFFNEVNLISGINHKNLV 328 (437)
Q Consensus 260 ~~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~E~~~l~~l~h~niv 328 (437)
...++....++|...+.||+|+||.||++...+++.||||++.... ....+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 3566788889999999999999999999998889999999985421 22347899999999999999999
Q ss_pred ceeEEEeeC-----CeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCee
Q 013737 329 KLLGCSITG-----PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNIL 403 (437)
Q Consensus 329 ~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIl 403 (437)
++++++... ...++||||++ ++|.+.+.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 999998543 35799999997 688777743 3446899999999999999999999998 999999999999
Q ss_pred eCCCCcEEEcccCCccccCC
Q 013737 404 LDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 404 l~~~~~~ki~DFG~a~~~~~ 423 (437)
++.++.+||+|||+++....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~ 186 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTA 186 (362)
T ss_dssp ECTTCCEEECCTTC------
T ss_pred EcCCCCEEEEecCccccccc
Confidence 99999999999999986544
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-26 Score=220.63 Aligned_cols=151 Identities=27% Similarity=0.436 Sum_probs=127.9
Q ss_pred cCCCcCCcccccCcccEEEEEeCC-----CCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLPG-----GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
++|+..+.||+|+||.||+|.+.. +..||||.+... .......+.+|+.++.+++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456677899999999999998642 236999999754 34456679999999999999999999999999999999
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 124 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999998853 2356899999999999999999999998 9999999999999999999999999999876
Q ss_pred CC
Q 013737 423 ED 424 (437)
Q Consensus 423 ~~ 424 (437)
..
T Consensus 199 ~~ 200 (333)
T 1mqb_A 199 DD 200 (333)
T ss_dssp --
T ss_pred cc
Confidence 44
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-26 Score=213.79 Aligned_cols=151 Identities=25% Similarity=0.370 Sum_probs=133.9
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
.++|+..+.||+|+||.||++.+. +++.||+|.+... .....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467899999999999999999974 5899999998654 3445678899999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCc---EEEcccCCcccc
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT---AKIADFGLVRLF 421 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~---~ki~DFG~a~~~ 421 (437)
||+++++|.+.+... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 999999998887443 45899999999999999999999998 999999999999986654 999999999876
Q ss_pred CCC
Q 013737 422 PED 424 (437)
Q Consensus 422 ~~~ 424 (437)
...
T Consensus 159 ~~~ 161 (284)
T 3kk8_A 159 NDS 161 (284)
T ss_dssp CSS
T ss_pred ccC
Confidence 544
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.3e-26 Score=212.82 Aligned_cols=151 Identities=35% Similarity=0.600 Sum_probs=129.0
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchh-------hHHHHHHHHHHHcCCCCCceeceeEEEeeCCe
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQ-------WVDHFFNEVNLISGINHKNLVKLLGCSITGPE 339 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 339 (437)
.++|+..+.||+|+||.||++.+ .+++.||+|.+...... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 36788899999999999999997 46899999998643221 1267899999999999999999999986654
Q ss_pred eEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCc-----EEEcc
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT-----AKIAD 414 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~-----~ki~D 414 (437)
++||||+++++|.+.+.. ....+++..+..++.|++.||.|||+++ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 799999999999887743 3456999999999999999999999985 35999999999999988776 99999
Q ss_pred cCCccccCC
Q 013737 415 FGLVRLFPE 423 (437)
Q Consensus 415 FG~a~~~~~ 423 (437)
||+++....
T Consensus 173 fg~~~~~~~ 181 (287)
T 4f0f_A 173 FGLSQQSVH 181 (287)
T ss_dssp CTTCBCCSS
T ss_pred CCccccccc
Confidence 999986544
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-26 Score=232.49 Aligned_cols=161 Identities=27% Similarity=0.378 Sum_probs=133.1
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc--hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
.+.|+..++||+|+||.||+|... ++..+|+|.+.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456889999999999999999975 68899999987542 334567899999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC---CcEEEcccCCcccc
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE---FTAKIADFGLVRLF 421 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~---~~~ki~DFG~a~~~ 421 (437)
||+++|+|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.. +.+||+|||+++.+
T Consensus 116 e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999998887433 45899999999999999999999998 9999999999999764 45999999999887
Q ss_pred CCCCcceeeeecccC
Q 013737 422 PEDITHISATLAGTL 436 (437)
Q Consensus 422 ~~~~~~~~~~~~Gt~ 436 (437)
..... .....||+
T Consensus 190 ~~~~~--~~~~~gt~ 202 (494)
T 3lij_A 190 ENQKK--MKERLGTA 202 (494)
T ss_dssp BTTBC--BCCCCSCT
T ss_pred CCCcc--ccccCCCc
Confidence 65432 22344554
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.2e-26 Score=214.26 Aligned_cols=150 Identities=29% Similarity=0.454 Sum_probs=135.3
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
.+.|+..+.||+|+||.||+|.. .+++.||||.+.... ....+.+.+|+.++..++||||+++++++...+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 45688899999999999999986 468999999997543 4456789999999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
|+++++|.+++. ..++++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+...
T Consensus 101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 999999999873 246899999999999999999999998 999999999999999999999999999877543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-26 Score=215.42 Aligned_cols=151 Identities=30% Similarity=0.442 Sum_probs=130.0
Q ss_pred cCCCcCCcccccCcccEEEEEeCC----CCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEe-eCCeeEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSI-TGPESLL 342 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~l 342 (437)
..|+..+.||+|+||.||+|.+.+ ...+|+|.+... .....+.+.+|+.++++++||||+++++++. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457788999999999999998642 236899988653 4455678999999999999999999999864 4567899
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 105 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence 9999999999998843 3456899999999999999999999998 9999999999999999999999999998775
Q ss_pred CC
Q 013737 423 ED 424 (437)
Q Consensus 423 ~~ 424 (437)
..
T Consensus 180 ~~ 181 (298)
T 3f66_A 180 DK 181 (298)
T ss_dssp CG
T ss_pred cc
Confidence 43
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-26 Score=222.45 Aligned_cols=154 Identities=27% Similarity=0.417 Sum_probs=127.0
Q ss_pred HHHHhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc--hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCee
Q 013737 264 LEKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES 340 (437)
Q Consensus 264 ~~~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 340 (437)
.....++|+..++||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL 108 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence 344557899999999999999999996 468899999986543 23356788999999999999999999999999999
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee-----CCCCcEEEccc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL-----DEEFTAKIADF 415 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll-----~~~~~~ki~DF 415 (437)
++||||++ ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ ++++.+||+||
T Consensus 109 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 109 HLIFEYAE-NDLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp EEEEECCS-EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred EEEEecCC-CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcC
Confidence 99999997 589888743 345899999999999999999999998 9999999999999 45556999999
Q ss_pred CCccccCCC
Q 013737 416 GLVRLFPED 424 (437)
Q Consensus 416 G~a~~~~~~ 424 (437)
|+++.+...
T Consensus 182 g~a~~~~~~ 190 (329)
T 3gbz_A 182 GLARAFGIP 190 (329)
T ss_dssp THHHHHC--
T ss_pred CCccccCCc
Confidence 999876543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-26 Score=224.62 Aligned_cols=149 Identities=27% Similarity=0.458 Sum_probs=125.2
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC------
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP------ 338 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 338 (437)
.+.|+..+.||+|+||.||+|.+ .+|+.||||++... .....+++.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46788999999999999999997 56899999998543 3445678999999999999999999999988663
Q ss_pred eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCc
Q 013737 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (437)
Q Consensus 339 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a 418 (437)
..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 7899888743 45899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCC
Q 013737 419 RLFPED 424 (437)
Q Consensus 419 ~~~~~~ 424 (437)
+.....
T Consensus 176 ~~~~~~ 181 (367)
T 1cm8_A 176 RQADSE 181 (367)
T ss_dssp EECCSS
T ss_pred cccccc
Confidence 976543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=5.9e-26 Score=218.32 Aligned_cols=157 Identities=31% Similarity=0.466 Sum_probs=128.9
Q ss_pred HHHHHHHhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcC--CCCCceeceeEEEeeC-
Q 013737 261 YETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISG--INHKNLVKLLGCSITG- 337 (437)
Q Consensus 261 ~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~- 337 (437)
........++|+..++||+|+||.||+|++. ++.||||++.... ...+.+|.+++.. ++||||+++++++...
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 3344455678999999999999999999986 8899999986443 2344555555554 4899999999999887
Q ss_pred ---CeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCCeeeCCCCCCCeeeCCCCc
Q 013737 338 ---PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES-----KLRIIHRDIKLSNILLDEEFT 409 (437)
Q Consensus 338 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-----~~~iiHrDlk~~NIll~~~~~ 409 (437)
...++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.. +++|+||||||+|||++.++.
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCCCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence 678999999999999999843 35899999999999999999999880 113999999999999999999
Q ss_pred EEEcccCCccccCCCC
Q 013737 410 AKIADFGLVRLFPEDI 425 (437)
Q Consensus 410 ~ki~DFG~a~~~~~~~ 425 (437)
+||+|||+++.+....
T Consensus 181 ~kl~Dfg~a~~~~~~~ 196 (337)
T 3mdy_A 181 CCIADLGLAVKFISDT 196 (337)
T ss_dssp EEECCCTTCEECC---
T ss_pred EEEEeCCCceeecccc
Confidence 9999999998775443
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.4e-26 Score=210.60 Aligned_cols=152 Identities=24% Similarity=0.346 Sum_probs=133.2
Q ss_pred cCCCcCCcccccCcccEEEEEeCCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeC--CeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 344 (437)
++|+..+.||+|+||.||+|++. ++.+|||.+... .....+.+.+|+.++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 56888999999999999999986 888999999754 344567899999999999999999999999887 7789999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
||+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||||+|||+++++.++|+|||++.....
T Consensus 89 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp ECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred cccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 999999999998542 3336899999999999999999999875 4599999999999999999999999988765443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-26 Score=219.46 Aligned_cols=161 Identities=25% Similarity=0.448 Sum_probs=128.5
Q ss_pred HHHHHHHhcCCCcCCcccccCcccEEEEEeC----CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEE
Q 013737 261 YETLEKATNYFHESNKLGQGGSGSVYKGTLP----GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCS 334 (437)
Q Consensus 261 ~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 334 (437)
...+....++|...+.||+|+||.||+|.+. ++..||+|.+... .....+.+.+|+.++++++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 3444445677888999999999999999863 3458999998654 344567899999999999999999999998
Q ss_pred eeCCe-----eEEEEeccCCCCcccccccc---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC
Q 013737 335 ITGPE-----SLLVYEFVPNQSLLDNLFVR---QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE 406 (437)
Q Consensus 335 ~~~~~-----~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~ 406 (437)
...+. .++||||+++++|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+|||+++
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~ 182 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRD 182 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcC
Confidence 87653 49999999999999987432 23456999999999999999999999987 999999999999999
Q ss_pred CCcEEEcccCCccccCCC
Q 013737 407 EFTAKIADFGLVRLFPED 424 (437)
Q Consensus 407 ~~~~ki~DFG~a~~~~~~ 424 (437)
++.+||+|||+++.+...
T Consensus 183 ~~~~kl~Dfg~~~~~~~~ 200 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSG 200 (313)
T ss_dssp TSCEEECSCSCC------
T ss_pred CCcEEEeecCcceecccc
Confidence 999999999999876543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-26 Score=232.33 Aligned_cols=151 Identities=28% Similarity=0.437 Sum_probs=133.7
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
.++|+..++||+|+||.||++... +++.||||++... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 456889999999999999999974 6899999998643 2334678999999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC---CCCcEEEcccCCcccc
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLF 421 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~---~~~~~ki~DFG~a~~~ 421 (437)
||+++++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.+
T Consensus 101 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 999999998887443 45899999999999999999999998 99999999999995 4568999999999877
Q ss_pred CCC
Q 013737 422 PED 424 (437)
Q Consensus 422 ~~~ 424 (437)
...
T Consensus 175 ~~~ 177 (486)
T 3mwu_A 175 QQN 177 (486)
T ss_dssp CCC
T ss_pred CCC
Confidence 544
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-26 Score=221.92 Aligned_cols=153 Identities=29% Similarity=0.416 Sum_probs=126.6
Q ss_pred HHhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchh-----hHHHHHHHHHHHcCCCCCceeceeEEEeeCCe
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQ-----WVDHFFNEVNLISGINHKNLVKLLGCSITGPE 339 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 339 (437)
...++|+..+.||+|+||.||++.+. +++.||||.+...... ..+.+.+|+.++..++||||+++++++...+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34567999999999999999999974 5899999998643211 12468899999999999999999999999999
Q ss_pred eEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcc
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~ 419 (437)
.++||||+++ +|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999985 78777633 3346888999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCC
Q 013737 420 LFPED 424 (437)
Q Consensus 420 ~~~~~ 424 (437)
.+...
T Consensus 161 ~~~~~ 165 (346)
T 1ua2_A 161 SFGSP 165 (346)
T ss_dssp TTTSC
T ss_pred eccCC
Confidence 87543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.3e-26 Score=214.79 Aligned_cols=153 Identities=32% Similarity=0.443 Sum_probs=126.7
Q ss_pred HhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc-----hhhHHHHHHHHHHHcCC---CCCceeceeEEEeeC
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT-----TQWVDHFFNEVNLISGI---NHKNLVKLLGCSITG 337 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~ 337 (437)
..++|+..++||+|+||.||+|.+ .+++.||||.+.... ......+.+|+.+++.+ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357899999999999999999996 568999999986432 11234566777777666 499999999999876
Q ss_pred C-----eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 013737 338 P-----ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI 412 (437)
Q Consensus 338 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki 412 (437)
. ..++||||+. ++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4789999997 6998887543 2344899999999999999999999998 999999999999999999999
Q ss_pred cccCCccccCCC
Q 013737 413 ADFGLVRLFPED 424 (437)
Q Consensus 413 ~DFG~a~~~~~~ 424 (437)
+|||+++.+...
T Consensus 162 ~Dfg~a~~~~~~ 173 (308)
T 3g33_A 162 ADFGLARIYSYQ 173 (308)
T ss_dssp CSCSCTTTSTTC
T ss_pred eeCccccccCCC
Confidence 999999877543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=7.6e-26 Score=212.82 Aligned_cols=151 Identities=26% Similarity=0.396 Sum_probs=131.4
Q ss_pred cCCCcCC-cccccCcccEEEEEeC---CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEE
Q 013737 269 NYFHESN-KLGQGGSGSVYKGTLP---GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 269 ~~~~~~~-~Lg~G~~g~V~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
++|...+ .||+|+||.||+|.+. ++..||||.+... .....+++.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3455555 8999999999999853 5778999999764 345577899999999999999999999998 55678999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999998843 3456899999999999999999999998 99999999999999999999999999998754
Q ss_pred CC
Q 013737 424 DI 425 (437)
Q Consensus 424 ~~ 425 (437)
..
T Consensus 163 ~~ 164 (287)
T 1u59_A 163 DD 164 (287)
T ss_dssp CS
T ss_pred Cc
Confidence 43
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-26 Score=224.07 Aligned_cols=148 Identities=30% Similarity=0.465 Sum_probs=121.7
Q ss_pred CCcCCcccccCcccEEEEEeC--CC--CEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEee-CCeeEEEE
Q 013737 271 FHESNKLGQGGSGSVYKGTLP--GG--EAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT-GPESLLVY 344 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~~--~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ 344 (437)
|+..+.||+|+||.||+|.+. ++ ..||||.+... .....+++.+|+.++++++||||+++++++.. .+..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 556789999999999999863 22 36899988643 44556789999999999999999999998754 45789999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
||+++++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 171 e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 171 PYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp ECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred ECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 99999999998843 3345889999999999999999999998 99999999999999999999999999987644
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.93 E-value=9.9e-26 Score=212.30 Aligned_cols=152 Identities=26% Similarity=0.342 Sum_probs=130.9
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEee----CCeeE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT----GPESL 341 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 341 (437)
+.|...+.||+|+||.||+|.+ .++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 3467778999999999999997 45889999998754 34556789999999999999999999998875 34589
Q ss_pred EEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC-CCCcEEEcccCCccc
Q 013737 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRL 420 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~-~~~~~ki~DFG~a~~ 420 (437)
+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ .+|+||||||+|||++ +++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999988432 45899999999999999999999975 3599999999999998 788999999999986
Q ss_pred cCCC
Q 013737 421 FPED 424 (437)
Q Consensus 421 ~~~~ 424 (437)
....
T Consensus 182 ~~~~ 185 (290)
T 1t4h_A 182 KRAS 185 (290)
T ss_dssp CCTT
T ss_pred cccc
Confidence 6543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=4.3e-26 Score=214.15 Aligned_cols=149 Identities=28% Similarity=0.384 Sum_probs=132.8
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc---hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56888999999999999999975 57899999986432 233567899999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999988543 35899999999999999999999988 99999999999999999999999999976654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.93 E-value=5.4e-26 Score=214.93 Aligned_cols=150 Identities=27% Similarity=0.434 Sum_probs=131.7
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEee----------
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT---------- 336 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 336 (437)
.++|+..+.||+|+||.||+|.. .+++.||||.+... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 45688899999999999999997 46899999998643 3446789999999999999999999998865
Q ss_pred ---CCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 013737 337 ---GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIA 413 (437)
Q Consensus 337 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~ 413 (437)
.+..++||||+++++|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 34678999999999999988532 345788999999999999999999998 9999999999999999999999
Q ss_pred ccCCccccCC
Q 013737 414 DFGLVRLFPE 423 (437)
Q Consensus 414 DFG~a~~~~~ 423 (437)
|||+++....
T Consensus 159 dfg~~~~~~~ 168 (303)
T 1zy4_A 159 DFGLAKNVHR 168 (303)
T ss_dssp CCCCCSCTTC
T ss_pred eCcchhhccc
Confidence 9999987653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-26 Score=212.89 Aligned_cols=150 Identities=27% Similarity=0.413 Sum_probs=134.5
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|...+.||+|+||.||++.+. +++.||||.+... .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57888999999999999999975 6899999998654 2234568899999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.....
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 91 EYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp ECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 999999999988543 35899999999999999999999998 999999999999999999999999999877543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.1e-26 Score=215.56 Aligned_cols=148 Identities=28% Similarity=0.494 Sum_probs=125.3
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEe-----------
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI----------- 335 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----------- 335 (437)
.++|...+.||+|+||.||++... +++.||+|.+........+++.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 367888999999999999999975 48999999998777777788999999999999999999999873
Q ss_pred ---eCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC-CCCcEE
Q 013737 336 ---TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD-EEFTAK 411 (437)
Q Consensus 336 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~-~~~~~k 411 (437)
+....++||||++ ++|.+++. ..++++..+..++.|++.||.|||+.+ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3467899999997 68988873 346899999999999999999999998 99999999999997 567999
Q ss_pred EcccCCccccCC
Q 013737 412 IADFGLVRLFPE 423 (437)
Q Consensus 412 i~DFG~a~~~~~ 423 (437)
|+|||+++....
T Consensus 162 l~Dfg~~~~~~~ 173 (320)
T 2i6l_A 162 IGDFGLARIMDP 173 (320)
T ss_dssp ECCCTTCBCC--
T ss_pred EccCccccccCC
Confidence 999999997754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-26 Score=221.48 Aligned_cols=148 Identities=26% Similarity=0.395 Sum_probs=133.7
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
.++|+..+.||+|+||.||++.+. +++.||+|.+... .....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 356888999999999999999975 6899999999765 44456789999999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
|+++++|.+++... ..+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++.+
T Consensus 112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 99999999988443 3589999999999999999999985 6 999999999999999999999999999755
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.93 E-value=5.7e-26 Score=213.03 Aligned_cols=149 Identities=26% Similarity=0.352 Sum_probs=132.6
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccch------hhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT------QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (437)
++|+..+.||+|+||.||++... +++.||+|.+..... ...+.+.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 45888999999999999999975 689999999865421 23678999999999999999999999999999999
Q ss_pred EEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC----cEEEcccCC
Q 013737 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF----TAKIADFGL 417 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~----~~ki~DFG~ 417 (437)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999998843 345899999999999999999999998 99999999999998877 899999999
Q ss_pred ccccCC
Q 013737 418 VRLFPE 423 (437)
Q Consensus 418 a~~~~~ 423 (437)
++....
T Consensus 159 ~~~~~~ 164 (283)
T 3bhy_A 159 AHKIEA 164 (283)
T ss_dssp CEECC-
T ss_pred ceeccC
Confidence 987654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-26 Score=221.03 Aligned_cols=150 Identities=29% Similarity=0.404 Sum_probs=127.4
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchh-hHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
++|...+.||+|+||.||+|... +++.||+|.+...... ....+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888999999999999999975 6899999998654322 122456899999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
++ ++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 97 5888877432 346899999999999999999999998 999999999999999999999999999876543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=214.18 Aligned_cols=153 Identities=24% Similarity=0.376 Sum_probs=127.6
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..+.||+|+||.||++.. .+++.||||++... .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 5688999999999999999996 56899999999753 3445678999999999999999999999999999999999
Q ss_pred eccCCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 345 EFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 345 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
||+++++|.+++... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999987532 23456899999999999999999999998 99999999999999999999999999987654
Q ss_pred C
Q 013737 424 D 424 (437)
Q Consensus 424 ~ 424 (437)
.
T Consensus 189 ~ 189 (310)
T 2wqm_A 189 K 189 (310)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-25 Score=212.19 Aligned_cols=151 Identities=23% Similarity=0.275 Sum_probs=128.7
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc----hhhHHHHHHHHHHHcCCCCCceeceeEEEe--eCCee
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT----TQWVDHFFNEVNLISGINHKNLVKLLGCSI--TGPES 340 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 340 (437)
.++|...+.||+|+||.||++.. .+++.+|+|.+.... ....+.+.+|+.++++++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 46799999999999999999997 468899999996542 234678999999999999999999999984 45578
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
++||||++++ |.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999876 66655432 3456899999999999999999999998 99999999999999999999999999987
Q ss_pred cCC
Q 013737 421 FPE 423 (437)
Q Consensus 421 ~~~ 423 (437)
...
T Consensus 159 ~~~ 161 (305)
T 2wtk_C 159 LHP 161 (305)
T ss_dssp CCT
T ss_pred cCc
Confidence 653
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.9e-26 Score=229.60 Aligned_cols=152 Identities=27% Similarity=0.394 Sum_probs=135.1
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
.++|+..++||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 356888999999999999999975 6899999998643 234567899999999999999999999999999999999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee---CCCCcEEEcccCCccc
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRL 420 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll---~~~~~~ki~DFG~a~~ 420 (437)
|||+++++|.+.+.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999988743 346899999999999999999999998 9999999999999 5678999999999987
Q ss_pred cCCCC
Q 013737 421 FPEDI 425 (437)
Q Consensus 421 ~~~~~ 425 (437)
+....
T Consensus 179 ~~~~~ 183 (484)
T 3nyv_A 179 FEASK 183 (484)
T ss_dssp BCCCC
T ss_pred ccccc
Confidence 76543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=227.38 Aligned_cols=152 Identities=18% Similarity=0.224 Sum_probs=125.9
Q ss_pred HhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHH---HHHcCCCCCceecee-------E
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEV---NLISGINHKNLVKLL-------G 332 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~ 332 (437)
..++|...+.||+|+||.||+|.+ .+|+.||||++... .....+.+.+|+ .++++++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 356788899999999999999996 56999999999743 444567899999 566677899999998 6
Q ss_pred EEeeCCe-----------------eEEEEeccCCCCccccccccCC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 013737 333 CSITGPE-----------------SLLVYEFVPNQSLLDNLFVRQD----VEPLSWEVRYKIILSTAEGLAYLHEESKLR 391 (437)
Q Consensus 333 ~~~~~~~-----------------~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ 391 (437)
++...+. .++||||+ +|+|.+++..... ...+++..++.|+.||+.||.|||+++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 6655532 78999999 6899998854321 122446888899999999999999998
Q ss_pred eeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 392 iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
|+||||||+|||++.++.+||+|||+|+...
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~ 257 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecC
Confidence 9999999999999999999999999998644
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-26 Score=216.65 Aligned_cols=149 Identities=26% Similarity=0.398 Sum_probs=131.4
Q ss_pred HhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
..+.|+..+.||+|+||.||++.+. +++.+|+|.+........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4567889999999999999999985 589999999977666667889999999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
|+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAK 166 (302)
T ss_dssp CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence 99999998877432 345899999999999999999999998 99999999999999999999999999754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=6.1e-26 Score=221.18 Aligned_cols=148 Identities=28% Similarity=0.427 Sum_probs=116.3
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeC------C
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG------P 338 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 338 (437)
.++|+..+.||+|+||.||+|.+ .+|+.||||++... .....+++.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 46789999999999999999996 56899999998643 344567889999999999999999999998754 5
Q ss_pred eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCc
Q 013737 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (437)
Q Consensus 339 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a 418 (437)
..++|+|++ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 6899887732 46999999999999999999999998 999999999999999999999999999
Q ss_pred cccCC
Q 013737 419 RLFPE 423 (437)
Q Consensus 419 ~~~~~ 423 (437)
+....
T Consensus 180 ~~~~~ 184 (367)
T 2fst_X 180 RHTAD 184 (367)
T ss_dssp -----
T ss_pred ccccc
Confidence 87654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=7.5e-26 Score=213.78 Aligned_cols=148 Identities=30% Similarity=0.454 Sum_probs=128.8
Q ss_pred CCcCCcccccCcccEEEEEeC-CC---CEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCee-EEEE
Q 013737 271 FHESNKLGQGGSGSVYKGTLP-GG---EAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES-LLVY 344 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv~ 344 (437)
|...++||+|+||.||+|.+. ++ ..+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+.. ++||
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 556689999999999999853 22 37999998754 345567899999999999999999999999877665 9999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
||+.+++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 103 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 103 PYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp CCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred ecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 99999999998843 3456899999999999999999999998 99999999999999999999999999986644
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.93 E-value=5.4e-26 Score=219.40 Aligned_cols=149 Identities=22% Similarity=0.336 Sum_probs=128.3
Q ss_pred HhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCeeEEEE
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 344 (437)
..++|+..+.||+|+||.||++... +++.||||.+...... ..+|++++.++ +||||+++++++.+++..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3466889999999999999999975 5889999999755332 34688888777 7999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC----CcEEEcccCCccc
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE----FTAKIADFGLVRL 420 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~----~~~ki~DFG~a~~ 420 (437)
||+++|+|.+.+.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+.++ +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999998843 346899999999999999999999998 9999999999998543 3599999999998
Q ss_pred cCCCC
Q 013737 421 FPEDI 425 (437)
Q Consensus 421 ~~~~~ 425 (437)
+....
T Consensus 170 ~~~~~ 174 (342)
T 2qr7_A 170 LRAEN 174 (342)
T ss_dssp CBCTT
T ss_pred CcCCC
Confidence 76543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.93 E-value=6.9e-26 Score=223.33 Aligned_cols=146 Identities=24% Similarity=0.296 Sum_probs=122.6
Q ss_pred cCCCcC-CcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHH-cCCCCCceeceeEEEee----CCeeE
Q 013737 269 NYFHES-NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLI-SGINHKNLVKLLGCSIT----GPESL 341 (437)
Q Consensus 269 ~~~~~~-~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~ 341 (437)
++|... +.||+|+||.||++.+. +++.||||++... ..+.+|++++ +..+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 345554 68999999999999974 6899999998632 3567788876 45589999999998875 55789
Q ss_pred EEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC---CCcEEEcccCCc
Q 013737 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---EFTAKIADFGLV 418 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~---~~~~ki~DFG~a 418 (437)
|||||+++|+|.+++... ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999988542 2346999999999999999999999988 999999999999997 789999999999
Q ss_pred cccCC
Q 013737 419 RLFPE 423 (437)
Q Consensus 419 ~~~~~ 423 (437)
+....
T Consensus 212 ~~~~~ 216 (400)
T 1nxk_A 212 KETTS 216 (400)
T ss_dssp EECC-
T ss_pred cccCC
Confidence 87654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.93 E-value=4.8e-26 Score=216.05 Aligned_cols=150 Identities=26% Similarity=0.364 Sum_probs=131.1
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
.++|...+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 456888999999999999999974 6899999999866554556789999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee---CCCCcEEEcccCCccccCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll---~~~~~~ki~DFG~a~~~~~ 423 (437)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||++ ++++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 9999999887432 45899999999999999999999998 9999999999999 7888999999999986543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-26 Score=215.84 Aligned_cols=151 Identities=26% Similarity=0.395 Sum_probs=130.1
Q ss_pred hcCCCcCC-cccccCcccEEEEEe---CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeE
Q 013737 268 TNYFHESN-KLGQGGSGSVYKGTL---PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (437)
Q Consensus 268 ~~~~~~~~-~Lg~G~~g~V~~~~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (437)
.++|...+ .||+|+||.||++.+ .+++.||||.+... .....+++.+|+.+++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45677777 999999999999964 34678999998754 233467899999999999999999999998 667789
Q ss_pred EEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 99999999999998843 345899999999999999999999998 999999999999999999999999999887
Q ss_pred CCCC
Q 013737 422 PEDI 425 (437)
Q Consensus 422 ~~~~ 425 (437)
....
T Consensus 168 ~~~~ 171 (291)
T 1xbb_A 168 RADE 171 (291)
T ss_dssp CTTC
T ss_pred ccCC
Confidence 6543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.8e-26 Score=219.08 Aligned_cols=148 Identities=28% Similarity=0.485 Sum_probs=128.2
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc--hhhHHHHHHHHHHHcCCCCCceeceeEEEee--------C
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSIT--------G 337 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 337 (437)
++|+..++||+|+||.||+|.. .+++.||||++.... ......+.+|+.+++.++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5788999999999999999997 568999999986442 2334578899999999999999999999887 3
Q ss_pred CeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCC
Q 013737 338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417 (437)
Q Consensus 338 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~ 417 (437)
+..++||||+++ +|.+.+.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 468999999975 67666633 3345899999999999999999999998 99999999999999999999999999
Q ss_pred ccccC
Q 013737 418 VRLFP 422 (437)
Q Consensus 418 a~~~~ 422 (437)
++.+.
T Consensus 171 a~~~~ 175 (351)
T 3mi9_A 171 ARAFS 175 (351)
T ss_dssp CEECC
T ss_pred ccccc
Confidence 98765
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=5e-26 Score=213.35 Aligned_cols=149 Identities=30% Similarity=0.465 Sum_probs=131.0
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEee----------
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT---------- 336 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 336 (437)
.++|+..+.||+|+||.||++.+. +++.||+|.+..... .+.+|++++.+++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG----GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH----HHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 456888999999999999999985 689999999976543 46789999999999999999998864
Q ss_pred ------CCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 013737 337 ------GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410 (437)
Q Consensus 337 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ 410 (437)
....++||||+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 34579999999999999988543 2346899999999999999999999998 9999999999999999999
Q ss_pred EEcccCCccccCCC
Q 013737 411 KIADFGLVRLFPED 424 (437)
Q Consensus 411 ki~DFG~a~~~~~~ 424 (437)
||+|||+++.+...
T Consensus 162 kl~Dfg~~~~~~~~ 175 (284)
T 2a19_B 162 KIGDFGLVTSLKND 175 (284)
T ss_dssp EECCCTTCEESSCC
T ss_pred EECcchhheecccc
Confidence 99999999887654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.93 E-value=4.5e-26 Score=221.95 Aligned_cols=152 Identities=19% Similarity=0.284 Sum_probs=126.5
Q ss_pred HhcCCCcCCcccccCcccEEEEEeCC------CCEEEEEEEeccchhhH-----------HHHHHHHHHHcCCCCCceec
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQWV-----------DHFFNEVNLISGINHKNLVK 329 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~ 329 (437)
..++|+..++||+|+||.||+|.+.. ++.||||.+........ ..+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34579999999999999999999754 47899999875542211 12445667788899999999
Q ss_pred eeEEEeeC----CeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC
Q 013737 330 LLGCSITG----PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD 405 (437)
Q Consensus 330 l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~ 405 (437)
+++++... ...+|||||+ +++|.+++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99998765 4479999999 9999998854 2356999999999999999999999998 99999999999998
Q ss_pred --CCCcEEEcccCCccccCCC
Q 013737 406 --EEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 406 --~~~~~ki~DFG~a~~~~~~ 424 (437)
.++.+||+|||+++.+...
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~ 207 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPE 207 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGG
T ss_pred cCCCCeEEEEECCcceecccC
Confidence 8899999999999877543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-26 Score=235.56 Aligned_cols=150 Identities=23% Similarity=0.299 Sum_probs=114.7
Q ss_pred ccccCcccEEEEE-eCCCCEEEEEEEecc----------chhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCeeEEEE
Q 013737 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYN----------TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 277 Lg~G~~g~V~~~~-~~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++.|+.|.+..++ ...|+.+++|.+... .....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4555666555544 234888999998643 123456799999999999 6999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||++|++|.+++.. ..+++.. +|+.||+.||+|+|+++ ||||||||+||||++++++||+|||+|+.+..+
T Consensus 322 Eyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999843 3456654 58899999999999998 999999999999999999999999999988665
Q ss_pred CcceeeeecccC
Q 013737 425 ITHISATLAGTL 436 (437)
Q Consensus 425 ~~~~~~~~~Gt~ 436 (437)
.+. .++.+||+
T Consensus 393 ~~~-~~t~vGTp 403 (569)
T 4azs_A 393 CSW-PTNLVQSF 403 (569)
T ss_dssp -CC-SHHHHHHH
T ss_pred Ccc-ccCceech
Confidence 432 22345654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.3e-26 Score=213.77 Aligned_cols=152 Identities=28% Similarity=0.385 Sum_probs=130.2
Q ss_pred HhcCCCcCCcccccCcccEEEEEeCC----CCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeE
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (437)
..++|...+.||+|+||.||+|.+.. +..||+|.+... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34678889999999999999998632 346999998765 34456789999999999999999999998764 4578
Q ss_pred EEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 999999999999988543 345899999999999999999999998 999999999999999999999999999877
Q ss_pred CCC
Q 013737 422 PED 424 (437)
Q Consensus 422 ~~~ 424 (437)
...
T Consensus 164 ~~~ 166 (281)
T 3cc6_A 164 EDE 166 (281)
T ss_dssp ---
T ss_pred ccc
Confidence 544
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.1e-26 Score=218.57 Aligned_cols=157 Identities=27% Similarity=0.383 Sum_probs=135.8
Q ss_pred HHhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCC-CCceeceeEEEe--------
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSI-------- 335 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~-------- 335 (437)
....+|+..++||+|+||.||++.+ .+++.||||++........+.+.+|+.++.++. ||||+++++++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 3345788999999999999999997 468999999997777677788999999999996 999999999984
Q ss_pred eCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 013737 336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415 (437)
Q Consensus 336 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DF 415 (437)
.....++||||++ |+|.+++.......++++..++.++.||+.||.|||+.+ ++|+||||||+|||++.++.+||+||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecC
Confidence 3345789999996 789888865445567999999999999999999999875 35999999999999999999999999
Q ss_pred CCccccCCC
Q 013737 416 GLVRLFPED 424 (437)
Q Consensus 416 G~a~~~~~~ 424 (437)
|+++.+...
T Consensus 183 g~~~~~~~~ 191 (337)
T 3ll6_A 183 GSATTISHY 191 (337)
T ss_dssp TTCBCCSSC
T ss_pred ccceecccc
Confidence 999887643
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.4e-26 Score=213.17 Aligned_cols=153 Identities=26% Similarity=0.354 Sum_probs=134.9
Q ss_pred HHhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc---------hhhHHHHHHHHHHHcCCC-CCceeceeEEE
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---------TQWVDHFFNEVNLISGIN-HKNLVKLLGCS 334 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 334 (437)
...++|+..+.||+|+||.||++... +++.||||.+.... ....+.+.+|++++.++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34577899999999999999999975 58899999996542 123467889999999996 99999999999
Q ss_pred eeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 013737 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIAD 414 (437)
Q Consensus 335 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~D 414 (437)
...+..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence 999999999999999999998853 245899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCC
Q 013737 415 FGLVRLFPED 424 (437)
Q Consensus 415 FG~a~~~~~~ 424 (437)
||+++.+...
T Consensus 168 fg~~~~~~~~ 177 (298)
T 1phk_A 168 FGFSCQLDPG 177 (298)
T ss_dssp CTTCEECCTT
T ss_pred ccchhhcCCC
Confidence 9999876543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=215.97 Aligned_cols=150 Identities=31% Similarity=0.473 Sum_probs=129.4
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCE--EEEEEEecc-chhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCeeEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEA--VAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 343 (437)
++|+..+.||+|+||.||++.+. ++.. +++|.+... .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 56888999999999999999964 4554 499988653 334456789999999999 899999999999999999999
Q ss_pred EeccCCCCccccccccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 013737 344 YEFVPNQSLLDNLFVRQ-------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ 410 (437)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999885432 2346899999999999999999999998 9999999999999999999
Q ss_pred EEcccCCcccc
Q 013737 411 KIADFGLVRLF 421 (437)
Q Consensus 411 ki~DFG~a~~~ 421 (437)
||+|||+++..
T Consensus 182 kL~Dfg~~~~~ 192 (327)
T 1fvr_A 182 KIADFGLSRGQ 192 (327)
T ss_dssp EECCTTCEESS
T ss_pred EEcccCcCccc
Confidence 99999999854
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=6e-26 Score=217.81 Aligned_cols=151 Identities=27% Similarity=0.493 Sum_probs=125.5
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCE----EEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEA----VAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (437)
.++|+..++||+|+||.||+|.+. +++. |++|.+... .....+.+.+|+.++++++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 356888999999999999999964 4543 577777543 3445678999999999999999999999998754 78
Q ss_pred EEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
+|+||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999988543 345899999999999999999999998 999999999999999999999999999887
Q ss_pred CCC
Q 013737 422 PED 424 (437)
Q Consensus 422 ~~~ 424 (437)
...
T Consensus 168 ~~~ 170 (327)
T 3lzb_A 168 GAE 170 (327)
T ss_dssp ---
T ss_pred cCc
Confidence 543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=215.56 Aligned_cols=150 Identities=25% Similarity=0.337 Sum_probs=127.0
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc--------hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--------TQWVDHFFNEVNLISGINHKNLVKLLGCSITGP 338 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 338 (437)
.++|...+.||+|+||.||++... +++.||||.+.... ......+.+|++++++++||||+++++++..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 456889999999999999999974 58899999986432 122345889999999999999999999987654
Q ss_pred eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCc---EEEccc
Q 013737 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT---AKIADF 415 (437)
Q Consensus 339 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~---~ki~DF 415 (437)
.++||||+++++|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+||
T Consensus 89 -~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp -EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred -eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 899999999999998873 3456899999999999999999999998 999999999999987654 999999
Q ss_pred CCccccCCC
Q 013737 416 GLVRLFPED 424 (437)
Q Consensus 416 G~a~~~~~~ 424 (437)
|+++.+...
T Consensus 162 g~~~~~~~~ 170 (322)
T 2ycf_A 162 GHSKILGET 170 (322)
T ss_dssp TTCEECCCC
T ss_pred ccceecccc
Confidence 999877543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.1e-26 Score=216.32 Aligned_cols=150 Identities=29% Similarity=0.386 Sum_probs=124.8
Q ss_pred cCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccC
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (437)
++|+..+.||+|+||.||++++. ++.||||.+... ...+.+.+|++++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 46788899999999999999986 688999998643 34578999999999999999999999876 45899999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCc-EEEcccCCccccCC
Q 013737 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT-AKIADFGLVRLFPE 423 (437)
Q Consensus 349 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~-~ki~DFG~a~~~~~ 423 (437)
+++|.+++........+++..++.++.|+++||.|||+.+..+|+||||||+|||++.++. +||+|||+++....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 9999999865544446889999999999999999999932234999999999999988876 79999999986643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-25 Score=215.60 Aligned_cols=156 Identities=29% Similarity=0.397 Sum_probs=134.4
Q ss_pred cCHHHHHHHhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcC--CCCCceeceeEEEee
Q 013737 259 FSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISG--INHKNLVKLLGCSIT 336 (437)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~ 336 (437)
..........++|...+.||+|+||.||++++. ++.||||.+... ..+.+.+|.+++.. ++||||+++++++..
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 344444556678999999999999999999985 889999998643 34567788888876 789999999999987
Q ss_pred CC----eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCCCeeeCCCCCCCeee
Q 013737 337 GP----ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH--------EESKLRIIHRDIKLSNILL 404 (437)
Q Consensus 337 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH--------~~~~~~iiHrDlk~~NIll 404 (437)
.. ..++||||+++++|.+++.. ..+++..++.++.|++.||.||| +.+ |+||||||+|||+
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll 180 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILV 180 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEE
T ss_pred cCCccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEE
Confidence 76 78999999999999998843 35899999999999999999999 666 9999999999999
Q ss_pred CCCCcEEEcccCCccccCCCC
Q 013737 405 DEEFTAKIADFGLVRLFPEDI 425 (437)
Q Consensus 405 ~~~~~~ki~DFG~a~~~~~~~ 425 (437)
+.++.+||+|||+++......
T Consensus 181 ~~~~~~kL~Dfg~~~~~~~~~ 201 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHDSAT 201 (342)
T ss_dssp CTTSCEEECCCTTCEEEETTT
T ss_pred CCCCCEEEEECCCceeccccc
Confidence 999999999999998776543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.4e-26 Score=236.48 Aligned_cols=144 Identities=28% Similarity=0.406 Sum_probs=125.8
Q ss_pred CcccccCcccEEEEEe---CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCC
Q 013737 275 NKLGQGGSGSVYKGTL---PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN 349 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (437)
++||+|+||.||+|.+ .+++.||||+++.. .....+++.+|+++|.+++||||+++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 4799999999999975 34678999999754 3345678999999999999999999999986 4568899999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCC
Q 013737 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (437)
Q Consensus 350 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~ 425 (437)
|+|.+++.. ...+++..++.|+.||+.||.|||+++ |+||||||+||||++++.+||+|||+++.+..+.
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence 999998843 345899999999999999999999998 9999999999999999999999999999876543
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=212.81 Aligned_cols=150 Identities=33% Similarity=0.521 Sum_probs=129.7
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc--hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
++|+..+.||+|+||.||++... +++.||||.+.... ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence 56888999999999999999975 68999999986542 2234678899999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|++ ++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 83 ~~~-~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 155 (299)
T 2r3i_A 83 FLH-QDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155 (299)
T ss_dssp CCS-EEHHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ccc-CCHHHHHHhh-hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHeEEcCCCCEEECcchhhhhccC
Confidence 997 6898887543 3345899999999999999999999998 99999999999999999999999999987653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4e-26 Score=216.08 Aligned_cols=157 Identities=28% Similarity=0.413 Sum_probs=120.9
Q ss_pred HHHHhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeE
Q 013737 264 LEKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (437)
Q Consensus 264 ~~~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (437)
+....++|+..+.||+|+||.||++.. .+++.||||.+.... ....+++.+|+.++.+++||||+++++++...+..+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 344567899999999999999999996 468999999886542 344567889999999999999999999999999999
Q ss_pred EEEeccCCCCcccccccc-----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccC
Q 013737 342 LVYEFVPNQSLLDNLFVR-----QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~-----~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG 416 (437)
+||||+++++|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEecc
Confidence 999999999999987531 13456899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCC
Q 013737 417 LVRLFPE 423 (437)
Q Consensus 417 ~a~~~~~ 423 (437)
+++.+..
T Consensus 167 ~~~~~~~ 173 (303)
T 2vwi_A 167 VSAFLAT 173 (303)
T ss_dssp HHHHCC-
T ss_pred chheecc
Confidence 9987653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=220.70 Aligned_cols=152 Identities=23% Similarity=0.358 Sum_probs=125.4
Q ss_pred HHHhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeC------
Q 013737 265 EKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITG------ 337 (437)
Q Consensus 265 ~~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 337 (437)
+...++|+..+.||+|+||.||+|.+ .+++.||||++...... ..+|+++|+.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 45567899999999999999999996 56899999998654322 24799999999999999999998543
Q ss_pred --------------------------------CeeEEEEeccCCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHh
Q 013737 338 --------------------------------PESLLVYEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYL 384 (437)
Q Consensus 338 --------------------------------~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yL 384 (437)
...++||||++ ++|.+.+... .....+++..+..++.||+.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34789999998 5777666431 2345699999999999999999999
Q ss_pred hcCCCCCeeeCCCCCCCeeeC-CCCcEEEcccCCccccCCC
Q 013737 385 HEESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 385 H~~~~~~iiHrDlk~~NIll~-~~~~~ki~DFG~a~~~~~~ 424 (437)
|+.+ |+||||||+|||++ +++.+||+|||+|+.+...
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 195 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS 195 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCC
Confidence 9988 99999999999997 6889999999999977544
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-25 Score=236.22 Aligned_cols=147 Identities=23% Similarity=0.331 Sum_probs=128.4
Q ss_pred cCCCcCCcccccCcccEEEEEeC--CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCe-----e
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP--GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE-----S 340 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~ 340 (437)
++|++.+.||+|+||.||++.+. +++.||||.+... .......+.+|++++.+++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 67899999999999999999975 5899999998644 34556788999999999999999999999987665 6
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
+|||||+++++|.+++. ..+++.+++.++.||+.||.|||+++ |+||||||+|||++++ .+||+|||+++.
T Consensus 160 ~lv~E~~~g~~L~~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence 99999999999988662 26899999999999999999999998 9999999999999986 999999999998
Q ss_pred cCCC
Q 013737 421 FPED 424 (437)
Q Consensus 421 ~~~~ 424 (437)
....
T Consensus 231 ~~~~ 234 (681)
T 2pzi_A 231 INSF 234 (681)
T ss_dssp TTCC
T ss_pred cccC
Confidence 7654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.6e-26 Score=218.03 Aligned_cols=145 Identities=34% Similarity=0.539 Sum_probs=120.9
Q ss_pred hcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHH--HHcCCCCCceeceeEEEee-----CCee
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVN--LISGINHKNLVKLLGCSIT-----GPES 340 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~--~l~~l~h~niv~l~~~~~~-----~~~~ 340 (437)
.++|+..+.||+|+||.||+|+. +++.||||++..... ..+..|.+ .+..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46788999999999999999987 478999999965432 33444444 4556899999999985542 2356
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcC---------CCCCeeeCCCCCCCeeeCCCCcEE
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE---------SKLRIIHRDIKLSNILLDEEFTAK 411 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~---------~~~~iiHrDlk~~NIll~~~~~~k 411 (437)
++||||+++|+|.+++.. ...++..+..++.||+.||.|||+. + |+||||||+|||++.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 899999999999998843 2358899999999999999999998 6 99999999999999999999
Q ss_pred EcccCCccccCC
Q 013737 412 IADFGLVRLFPE 423 (437)
Q Consensus 412 i~DFG~a~~~~~ 423 (437)
|+|||+++.+..
T Consensus 161 L~DFG~a~~~~~ 172 (336)
T 3g2f_A 161 ISDFGLSMRLTG 172 (336)
T ss_dssp ECCCTTCEECSS
T ss_pred Eeeccceeeccc
Confidence 999999987754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-25 Score=214.47 Aligned_cols=162 Identities=23% Similarity=0.338 Sum_probs=136.9
Q ss_pred cCHHHHHHHhcCCCcC-CcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCC-CCceeceeEE
Q 013737 259 FSYETLEKATNYFHES-NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGIN-HKNLVKLLGC 333 (437)
Q Consensus 259 ~~~~~~~~~~~~~~~~-~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~ 333 (437)
..++..+...+.|... +.||+|+||.||++... +++.||+|.+... .......+.+|+.++..+. ||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3444455666667776 88999999999999975 5899999998754 2334678999999999995 6999999999
Q ss_pred EeeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC---CCcE
Q 013737 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---EFTA 410 (437)
Q Consensus 334 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~---~~~~ 410 (437)
+...+..++||||+++++|.+++.. .....+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcE
Confidence 9999999999999999999998743 23456999999999999999999999998 999999999999987 7899
Q ss_pred EEcccCCccccCCC
Q 013737 411 KIADFGLVRLFPED 424 (437)
Q Consensus 411 ki~DFG~a~~~~~~ 424 (437)
||+|||+++.+...
T Consensus 174 kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 174 KIVDFGMSRKIGHA 187 (327)
T ss_dssp EECCGGGCEEC---
T ss_pred EEeeCccccccCCc
Confidence 99999999877543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-25 Score=213.42 Aligned_cols=152 Identities=32% Similarity=0.470 Sum_probs=129.7
Q ss_pred HHhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
...+.|+..+.||+|+||.||++... +++.||+|.+.... ..+.+.+|+.++..++||||+++++++...+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 44567999999999999999999975 58999999997543 3467889999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.+...
T Consensus 104 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999998743 2346899999999999999999999998 999999999999999999999999999877544
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-25 Score=210.53 Aligned_cols=149 Identities=20% Similarity=0.281 Sum_probs=131.1
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCeeEEEEe
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 345 (437)
.++|+..+.||+|+||.||+|.. .+++.||||.+.... ..+.+.+|+.++..+ +|+|++++++++......++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 45788999999999999999996 568999999986443 234578899999999 79999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCc-----EEEcccCCccc
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT-----AKIADFGLVRL 420 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~-----~ki~DFG~a~~ 420 (437)
|+ +++|.+++... ..++++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999988543 345899999999999999999999988 999999999999987765 99999999998
Q ss_pred cCCC
Q 013737 421 FPED 424 (437)
Q Consensus 421 ~~~~ 424 (437)
+...
T Consensus 161 ~~~~ 164 (298)
T 1csn_A 161 YRDP 164 (298)
T ss_dssp SBCT
T ss_pred cccc
Confidence 7654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=219.18 Aligned_cols=149 Identities=23% Similarity=0.385 Sum_probs=130.6
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeC-----Cee
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG-----PES 340 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 340 (437)
.++|+..+.||+|+||.||++... +++.||||++... .....+.+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457899999999999999999974 6889999999754 344557899999999999999999999998765 368
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
++||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999997 588887732 35899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCC
Q 013737 421 FPED 424 (437)
Q Consensus 421 ~~~~ 424 (437)
....
T Consensus 178 ~~~~ 181 (364)
T 3qyz_A 178 ADPD 181 (364)
T ss_dssp CCGG
T ss_pred cCCC
Confidence 7543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-25 Score=209.80 Aligned_cols=143 Identities=13% Similarity=0.004 Sum_probs=127.0
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc---hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..+.||+|+||.||+|.+. +++.||||.+.... ....+.+.+|+.++.+++||||+++++++...+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 56889999999999999999975 48999999997542 344578999999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcc
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~ 419 (437)
||+++++|.+++.. . ....++..++.|++.||.|||+++ |+||||||+|||+++++.+||+++|...
T Consensus 111 e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~~ 177 (286)
T 3uqc_A 111 EWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATMP 177 (286)
T ss_dssp ECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred EecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccccC
Confidence 99999999998832 2 355678999999999999999998 9999999999999999999999887654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=215.97 Aligned_cols=153 Identities=31% Similarity=0.391 Sum_probs=130.3
Q ss_pred HhcCCCcCCcccccCcccEEEEEe------CCCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCe
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTL------PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE 339 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 339 (437)
..++|+..+.||+|+||.||+|.+ .+++.||||.+... ......++.+|+.++++++||||+++++++...+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 346799999999999999999984 34778999999644 34556689999999999999999999999999999
Q ss_pred eEEEEeccCCCCccccccccCC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC---CCcEEE
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQD----VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---EFTAKI 412 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~---~~~~ki 412 (437)
.++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999998865432 245899999999999999999999998 999999999999984 456999
Q ss_pred cccCCccccC
Q 013737 413 ADFGLVRLFP 422 (437)
Q Consensus 413 ~DFG~a~~~~ 422 (437)
+|||+++...
T Consensus 185 ~Dfg~~~~~~ 194 (327)
T 2yfx_A 185 GDFGMARDIY 194 (327)
T ss_dssp CCCHHHHHHH
T ss_pred Cccccccccc
Confidence 9999998653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-25 Score=216.95 Aligned_cols=149 Identities=19% Similarity=0.241 Sum_probs=122.8
Q ss_pred hcCCCcCCcccccCcccEEEEEeC----CCCEEEEEEEeccchhh-----------HHHHHHHHHHHcCCCCCceeceeE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP----GGEAVAVKRLFYNTTQW-----------VDHFFNEVNLISGINHKNLVKLLG 332 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~~ 332 (437)
.++|...+.||+|+||.||+|.+. ++..+|||.+....... ...+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357889999999999999999975 57889999987543211 124678889999999999999999
Q ss_pred EEee----CCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC
Q 013737 333 CSIT----GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408 (437)
Q Consensus 333 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~ 408 (437)
++.. ....++||||+ +++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9987 67889999999 99999988543 26899999999999999999999998 99999999999998877
Q ss_pred --cEEEcccCCccccCC
Q 013737 409 --TAKIADFGLVRLFPE 423 (437)
Q Consensus 409 --~~ki~DFG~a~~~~~ 423 (437)
.+||+|||+++.+..
T Consensus 189 ~~~~kL~Dfg~a~~~~~ 205 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCP 205 (345)
T ss_dssp TTSEEECCCTTCEESSG
T ss_pred CCcEEEEeCCCceeccc
Confidence 999999999987753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-25 Score=213.12 Aligned_cols=144 Identities=23% Similarity=0.353 Sum_probs=128.4
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCC-CCceeceeEEEee--CCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSIT--GPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~ 344 (437)
++|+..++||+|+||.||+|.. .+++.||||.+.... .+.+.+|+.++.+++ ||||+++++++.. ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5688999999999999999986 568999999986433 467889999999997 9999999999987 56789999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC-cEEEcccCCccccCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRLFPE 423 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~-~~ki~DFG~a~~~~~ 423 (437)
||+++++|.+++. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++.+..
T Consensus 113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999988772 3889999999999999999999998 99999999999999776 899999999987654
Q ss_pred C
Q 013737 424 D 424 (437)
Q Consensus 424 ~ 424 (437)
.
T Consensus 184 ~ 184 (330)
T 3nsz_A 184 G 184 (330)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.9e-26 Score=217.46 Aligned_cols=160 Identities=28% Similarity=0.392 Sum_probs=135.0
Q ss_pred cCHHHHHHHhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCC-CCCceeceeEEEee
Q 013737 259 FSYETLEKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSIT 336 (437)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 336 (437)
++...+....++|+..+.||+|+||.||+|.+ .+++.||||.+..... ..+.+.+|+.++.++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 33444556678899999999999999999997 4689999999875432 346788999999998 79999999999987
Q ss_pred ------CCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 013737 337 ------GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410 (437)
Q Consensus 337 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ 410 (437)
.+..++||||+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence 46789999999999999988543 2346899999999999999999999998 9999999999999999999
Q ss_pred EEcccCCccccCC
Q 013737 411 KIADFGLVRLFPE 423 (437)
Q Consensus 411 ki~DFG~a~~~~~ 423 (437)
||+|||+++.+..
T Consensus 169 kl~Dfg~~~~~~~ 181 (326)
T 2x7f_A 169 KLVDFGVSAQLDR 181 (326)
T ss_dssp EECCCTTTC----
T ss_pred EEeeCcCceecCc
Confidence 9999999987654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=210.59 Aligned_cols=157 Identities=25% Similarity=0.374 Sum_probs=131.9
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEee--CCeeEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT--GPESLL 342 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 342 (437)
.++|+..+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357888999999999999999975 6899999999754 34456789999999999999999999998754 567899
Q ss_pred EEeccCCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCC--CCCeeeCCCCCCCeeeCCCCcEEEcccCCcc
Q 013737 343 VYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEES--KLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~ 419 (437)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999885432 2345899999999999999999999975 1239999999999999999999999999998
Q ss_pred ccCCC
Q 013737 420 LFPED 424 (437)
Q Consensus 420 ~~~~~ 424 (437)
.....
T Consensus 165 ~~~~~ 169 (279)
T 2w5a_A 165 ILNHD 169 (279)
T ss_dssp HC---
T ss_pred eeccc
Confidence 77543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.92 E-value=9.9e-26 Score=221.86 Aligned_cols=150 Identities=24% Similarity=0.365 Sum_probs=123.7
Q ss_pred hcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCe------eE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE------SL 341 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~ 341 (437)
..+|+..++||+|+||.||+|++..+..+|+|++...... ..+|+++++.++||||+++++++...+. .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 3468899999999999999999877777999988654322 2369999999999999999999865443 78
Q ss_pred EEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC-CCCcEEEcccCCccc
Q 013737 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRL 420 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~-~~~~~ki~DFG~a~~ 420 (437)
+||||++++.+............+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+|+.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999986544332222233456899999999999999999999998 99999999999999 789999999999987
Q ss_pred cCCC
Q 013737 421 FPED 424 (437)
Q Consensus 421 ~~~~ 424 (437)
+...
T Consensus 192 ~~~~ 195 (394)
T 4e7w_A 192 LIAG 195 (394)
T ss_dssp CCTT
T ss_pred ccCC
Confidence 7543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-25 Score=216.19 Aligned_cols=147 Identities=28% Similarity=0.397 Sum_probs=124.8
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC------
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP------ 338 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 338 (437)
.++|+..+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 367899999999999999999964 5889999999753 3445677899999999999999999999987665
Q ss_pred eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCc
Q 013737 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (437)
Q Consensus 339 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a 418 (437)
..++||||+++ +|.+.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 67999999974 7777663 24889999999999999999999998 999999999999999999999999999
Q ss_pred cccCC
Q 013737 419 RLFPE 423 (437)
Q Consensus 419 ~~~~~ 423 (437)
+....
T Consensus 175 ~~~~~ 179 (371)
T 2xrw_A 175 RTAGT 179 (371)
T ss_dssp -----
T ss_pred ccccc
Confidence 87654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-25 Score=210.42 Aligned_cols=153 Identities=24% Similarity=0.323 Sum_probs=121.1
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc-h-hhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT-T-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
.++|+..+.||+|+||.||++.. .+++.||+|++.... . ...+.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46788999999999999999997 568999999997542 2 22334455555688899999999999999999999999
Q ss_pred eccCCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 345 EFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 345 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
||++ ++|.+++... .....+++..+..++.|++.||.|||++ + |+||||||+|||++.++.+||+|||+++...
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 4887766432 2345699999999999999999999997 7 9999999999999999999999999998775
Q ss_pred CC
Q 013737 423 ED 424 (437)
Q Consensus 423 ~~ 424 (437)
..
T Consensus 162 ~~ 163 (290)
T 3fme_A 162 DD 163 (290)
T ss_dssp --
T ss_pred cc
Confidence 44
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-25 Score=232.26 Aligned_cols=154 Identities=25% Similarity=0.342 Sum_probs=131.8
Q ss_pred HHhcCCCcCCcccccCcccEEEEEeCC----CCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCee
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES 340 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 340 (437)
...++|+..+.||+|+||.||+|.+.. +..||||.+... .....+.+.+|+.++++++||||+++++++. .+..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 334567788899999999999998742 457999998654 3445578999999999999999999999884 4678
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
++||||+++|+|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 466 ~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCee
Confidence 9999999999999988532 345899999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCC
Q 013737 421 FPEDI 425 (437)
Q Consensus 421 ~~~~~ 425 (437)
+....
T Consensus 541 ~~~~~ 545 (656)
T 2j0j_A 541 MEDST 545 (656)
T ss_dssp CCC--
T ss_pred cCCCc
Confidence 76543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.3e-25 Score=207.05 Aligned_cols=153 Identities=28% Similarity=0.421 Sum_probs=134.5
Q ss_pred HHhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
...++|+..+.||+|+||.||++... +++.||+|.+... .....+.+.+|++++++++||||+++++++...+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 33467999999999999999999975 6899999998654 23456789999999999999999999999999999999
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC---CcEEEcccCCcc
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE---FTAKIADFGLVR 419 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~---~~~ki~DFG~a~ 419 (437)
||||+++++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||+++
T Consensus 99 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 99999999998887433 35899999999999999999999998 9999999999999754 479999999998
Q ss_pred ccCCC
Q 013737 420 LFPED 424 (437)
Q Consensus 420 ~~~~~ 424 (437)
.....
T Consensus 173 ~~~~~ 177 (287)
T 2wei_A 173 CFQQN 177 (287)
T ss_dssp TBCCC
T ss_pred eecCC
Confidence 77544
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-25 Score=210.94 Aligned_cols=149 Identities=30% Similarity=0.472 Sum_probs=124.8
Q ss_pred hcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeC-CeeEEEEec
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITG-PESLLVYEF 346 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~ 346 (437)
.++|+..+.||+|+||.||++... ++.||||.+.... ..+.+.+|+.++++++||||+++++++... +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 467888999999999999999875 7899999986543 456799999999999999999999987654 478999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 97 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred CCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 99999999884321 223789999999999999999999998 99999999999999999999999999986654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-25 Score=210.65 Aligned_cols=152 Identities=35% Similarity=0.542 Sum_probs=124.5
Q ss_pred hcCCCcCCcccccCcccEEEEEeC--CCC--EEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCee
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP--GGE--AVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES 340 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 340 (437)
.++|+..+.||+|+||.||+|.+. +++ .||||.+... .....+.+.+|++++.+++||||+++++++..+. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 356888999999999999999853 333 6899988653 3345678999999999999999999999988755 8
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
++||||+++++|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999988543 245899999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCC
Q 013737 421 FPEDI 425 (437)
Q Consensus 421 ~~~~~ 425 (437)
+....
T Consensus 171 ~~~~~ 175 (291)
T 1u46_A 171 LPQND 175 (291)
T ss_dssp CCC-C
T ss_pred ccccc
Confidence 76543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-25 Score=221.48 Aligned_cols=148 Identities=26% Similarity=0.401 Sum_probs=121.6
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeC----C--eeE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITG----P--ESL 341 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~--~~~ 341 (437)
..|+..+.||+|+||.||+|++. +++.||||++..... .+.+|+++|+.++||||+++++++... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 35888899999999999999984 589999999865432 234799999999999999999988542 2 357
Q ss_pred EEEeccCCCCccccccc-cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC-CcEEEcccCCcc
Q 013737 342 LVYEFVPNQSLLDNLFV-RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVR 419 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~-~~~ki~DFG~a~ 419 (437)
+||||+++ +|.+.+.. ......+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999975 55554432 123456999999999999999999999988 9999999999999955 678999999999
Q ss_pred ccCCC
Q 013737 420 LFPED 424 (437)
Q Consensus 420 ~~~~~ 424 (437)
.+...
T Consensus 206 ~~~~~ 210 (420)
T 1j1b_A 206 QLVRG 210 (420)
T ss_dssp ECCTT
T ss_pred hcccC
Confidence 76543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-25 Score=219.89 Aligned_cols=148 Identities=26% Similarity=0.433 Sum_probs=114.6
Q ss_pred CCc-CCcccccCcccEEEEEeC---CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEee--CCeeEEEE
Q 013737 271 FHE-SNKLGQGGSGSVYKGTLP---GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT--GPESLLVY 344 (437)
Q Consensus 271 ~~~-~~~Lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 344 (437)
|.. .++||+|+||.||+|++. +++.||||++..... ...+.+|+.+|++++||||+++++++.. ....++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 444 568999999999999965 578999999864432 3468899999999999999999999954 66889999
Q ss_pred eccCCCCcccccccc------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee----CCCCcEEEcc
Q 013737 345 EFVPNQSLLDNLFVR------QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIAD 414 (437)
Q Consensus 345 e~~~~g~L~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll----~~~~~~ki~D 414 (437)
||++ ++|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||| +.++.+||+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9996 5777766422 12235899999999999999999999998 9999999999999 6778999999
Q ss_pred cCCccccCCC
Q 013737 415 FGLVRLFPED 424 (437)
Q Consensus 415 FG~a~~~~~~ 424 (437)
||+|+.+...
T Consensus 176 fg~a~~~~~~ 185 (405)
T 3rgf_A 176 MGFARLFNSP 185 (405)
T ss_dssp TTCCC-----
T ss_pred CCCceecCCC
Confidence 9999987643
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.92 E-value=5e-25 Score=215.12 Aligned_cols=148 Identities=27% Similarity=0.444 Sum_probs=126.3
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCee----
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES---- 340 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 340 (437)
.++|...+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 467888999999999999999974 6899999999754 334467889999999999999999999999877655
Q ss_pred --EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCc
Q 013737 341 --LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (437)
Q Consensus 341 --~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a 418 (437)
++||||++ ++|.+.+ ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIM-----GMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999997 5777766 234899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCC
Q 013737 419 RLFPED 424 (437)
Q Consensus 419 ~~~~~~ 424 (437)
+.....
T Consensus 192 ~~~~~~ 197 (371)
T 4exu_A 192 RHADAE 197 (371)
T ss_dssp ------
T ss_pred cccccC
Confidence 876543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.3e-25 Score=213.84 Aligned_cols=148 Identities=26% Similarity=0.423 Sum_probs=130.1
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeC-----Cee
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG-----PES 340 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 340 (437)
.++|...+.||+|+||.||+|.+. +++.||||.+... ......++.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467889999999999999999975 6889999999644 344566788999999999999999999987754 678
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
++||||++ ++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 588887743 35899999999999999999999998 99999999999999999999999999997
Q ss_pred cCC
Q 013737 421 FPE 423 (437)
Q Consensus 421 ~~~ 423 (437)
+..
T Consensus 162 ~~~ 164 (353)
T 2b9h_A 162 IDE 164 (353)
T ss_dssp CC-
T ss_pred ccc
Confidence 754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=8.2e-25 Score=212.06 Aligned_cols=147 Identities=27% Similarity=0.433 Sum_probs=127.2
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCe-----
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE----- 339 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 339 (437)
.++|...+.||+|+||.||+|.+. +|+.||||.+... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 357888999999999999999974 6899999999653 33446788999999999999999999999987654
Q ss_pred -eEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCc
Q 013737 340 -SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (437)
Q Consensus 340 -~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a 418 (437)
.++||||++ ++|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 58877662 24899999999999999999999998 999999999999999999999999999
Q ss_pred cccCC
Q 013737 419 RLFPE 423 (437)
Q Consensus 419 ~~~~~ 423 (437)
+....
T Consensus 174 ~~~~~ 178 (353)
T 3coi_A 174 RHADA 178 (353)
T ss_dssp TC---
T ss_pred cCCCC
Confidence 87654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7e-25 Score=207.56 Aligned_cols=146 Identities=24% Similarity=0.293 Sum_probs=125.9
Q ss_pred cCCCcC-CcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHH-cCCCCCceeceeEEEee----CCeeE
Q 013737 269 NYFHES-NKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLI-SGINHKNLVKLLGCSIT----GPESL 341 (437)
Q Consensus 269 ~~~~~~-~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~ 341 (437)
++|... +.||+|+||.||++.. .+++.||+|.+... ..+.+|++++ +.++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 445555 7799999999999997 56899999998642 3567888887 66689999999999876 66789
Q ss_pred EEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC---CCcEEEcccCCc
Q 013737 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---EFTAKIADFGLV 418 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~---~~~~ki~DFG~a 418 (437)
+||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999988543 3346999999999999999999999998 999999999999998 789999999999
Q ss_pred cccCC
Q 013737 419 RLFPE 423 (437)
Q Consensus 419 ~~~~~ 423 (437)
+....
T Consensus 168 ~~~~~ 172 (299)
T 3m2w_A 168 KETTG 172 (299)
T ss_dssp EECTT
T ss_pred ccccc
Confidence 87654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-25 Score=218.31 Aligned_cols=146 Identities=19% Similarity=0.270 Sum_probs=126.6
Q ss_pred hcCCCcCCcccccCcccEEEEEeCC---------CCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceec---------
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPG---------GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK--------- 329 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 329 (437)
.++|...+.||+|+||.||+|.... ++.||+|.+... +.+.+|++++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3678999999999999999999753 789999998754 35789999999999999988
Q ss_pred ------eeEEEee-CCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCe
Q 013737 330 ------LLGCSIT-GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNI 402 (437)
Q Consensus 330 ------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NI 402 (437)
+++++.. .+..++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6777766 67889999999 99999998543 2356999999999999999999999998 99999999999
Q ss_pred eeCCCC--cEEEcccCCccccCC
Q 013737 403 LLDEEF--TAKIADFGLVRLFPE 423 (437)
Q Consensus 403 ll~~~~--~~ki~DFG~a~~~~~ 423 (437)
|++.++ .+||+|||+++.+..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~ 213 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCP 213 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSG
T ss_pred EEcCCCCceEEEecCcceeeccC
Confidence 999998 999999999987754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-25 Score=213.91 Aligned_cols=156 Identities=21% Similarity=0.321 Sum_probs=133.2
Q ss_pred HHHHHHHhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCC--CCceeceeEEEee
Q 013737 261 YETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGIN--HKNLVKLLGCSIT 336 (437)
Q Consensus 261 ~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~ 336 (437)
++.+....++|+..+.||+|+||.||++...+++.||||.+... .....+.+.+|+.++.+++ ||||+++++++..
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 33344456779999999999999999999988999999998654 3445678999999999997 5999999999999
Q ss_pred CCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccC
Q 013737 337 GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (437)
Q Consensus 337 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG 416 (437)
.+..++||| +.+++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++ +.+||+|||
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCS
T ss_pred CCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecc
Confidence 999999999 568899998853 346899999999999999999999998 999999999999965 799999999
Q ss_pred CccccCCC
Q 013737 417 LVRLFPED 424 (437)
Q Consensus 417 ~a~~~~~~ 424 (437)
+++.+...
T Consensus 172 ~~~~~~~~ 179 (313)
T 3cek_A 172 IANQMQPD 179 (313)
T ss_dssp SSCC----
T ss_pred ccccccCc
Confidence 99877544
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=216.77 Aligned_cols=150 Identities=22% Similarity=0.280 Sum_probs=128.4
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCC------CCCceeceeEEEeeCCee
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGI------NHKNLVKLLGCSITGPES 340 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~ 340 (437)
..+|+..++||+|+||.||+|... +++.||||++... ....+.+.+|+.++..+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 356888999999999999999874 5889999999654 33445677788777665 678999999999999999
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCc--EEEcccCCc
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT--AKIADFGLV 418 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~--~ki~DFG~a 418 (437)
++||||+. ++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 6898887543 3345899999999999999999999998 999999999999999887 999999999
Q ss_pred cccCC
Q 013737 419 RLFPE 423 (437)
Q Consensus 419 ~~~~~ 423 (437)
+....
T Consensus 250 ~~~~~ 254 (429)
T 3kvw_A 250 CYEHQ 254 (429)
T ss_dssp EETTC
T ss_pred eecCC
Confidence 86654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.91 E-value=8e-25 Score=212.50 Aligned_cols=160 Identities=24% Similarity=0.315 Sum_probs=120.7
Q ss_pred HHHHHHHhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCe
Q 013737 261 YETLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE 339 (437)
Q Consensus 261 ~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 339 (437)
........++|+..+.||+|+||.||+|.+. +++.||||++.... .....+.+|++.+..++||||+++++++...+.
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 3455666788999999999999999999974 68999999986543 223456778888899999999999999876443
Q ss_pred -------eEEEEeccCCCCccccccc-cCCCCCCCHHHHHHHHHHHHHHHHHhh--cCCCCCeeeCCCCCCCeeeCC-CC
Q 013737 340 -------SLLVYEFVPNQSLLDNLFV-RQDVEPLSWEVRYKIILSTAEGLAYLH--EESKLRIIHRDIKLSNILLDE-EF 408 (437)
Q Consensus 340 -------~~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~yLH--~~~~~~iiHrDlk~~NIll~~-~~ 408 (437)
.++||||+++ +|.+.+.. ......+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCC
Confidence 7899999986 44443321 234556899999999999999999999 776 999999999999996 89
Q ss_pred cEEEcccCCccccCCCC
Q 013737 409 TAKIADFGLVRLFPEDI 425 (437)
Q Consensus 409 ~~ki~DFG~a~~~~~~~ 425 (437)
.+||+|||+++.+....
T Consensus 170 ~~kl~Dfg~a~~~~~~~ 186 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSE 186 (360)
T ss_dssp EEEECCCTTCBCCCTTS
T ss_pred cEEEeeCCCceecCCCC
Confidence 99999999999876543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.91 E-value=5.4e-25 Score=210.70 Aligned_cols=152 Identities=30% Similarity=0.445 Sum_probs=127.0
Q ss_pred HhcCCCcCCcccccCcccEEEEEe--CCCCEEEEEEEeccc--hhhHHHHHHHHHHHcCC---CCCceeceeEEEe----
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTL--PGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGI---NHKNLVKLLGCSI---- 335 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---- 335 (437)
..++|+..+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457799999999999999999997 457899999986432 22223466777766655 8999999999987
Q ss_pred -eCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 013737 336 -TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIAD 414 (437)
Q Consensus 336 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~D 414 (437)
.....++||||++ ++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999997 6998887543 2345899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCC
Q 013737 415 FGLVRLFPE 423 (437)
Q Consensus 415 FG~a~~~~~ 423 (437)
||+++....
T Consensus 164 fg~~~~~~~ 172 (326)
T 1blx_A 164 FGLARIYSF 172 (326)
T ss_dssp CCSCCCCCG
T ss_pred CcccccccC
Confidence 999987653
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-25 Score=212.71 Aligned_cols=155 Identities=28% Similarity=0.348 Sum_probs=124.1
Q ss_pred HHHHhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccch------hhHHHHHHHHHHHcCC----CCCceeceeE
Q 013737 264 LEKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTT------QWVDHFFNEVNLISGI----NHKNLVKLLG 332 (437)
Q Consensus 264 ~~~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~~ 332 (437)
.+...++|+..+.||+|+||.||++.. .+++.||||.+..... .....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 445567899999999999999999986 4688999999865432 1223456788888888 8999999999
Q ss_pred EEeeCCeeEEEEec-cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC-CCCcE
Q 013737 333 CSITGPESLLVYEF-VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD-EEFTA 410 (437)
Q Consensus 333 ~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~-~~~~~ 410 (437)
++...+..++|||+ +++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++ +++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence 99999999999999 7899999988542 35899999999999999999999998 99999999999999 88999
Q ss_pred EEcccCCccccCCC
Q 013737 411 KIADFGLVRLFPED 424 (437)
Q Consensus 411 ki~DFG~a~~~~~~ 424 (437)
||+|||+++.+...
T Consensus 180 kl~dfg~~~~~~~~ 193 (312)
T 2iwi_A 180 KLIDFGSGALLHDE 193 (312)
T ss_dssp EECCCSSCEECCSS
T ss_pred EEEEcchhhhcccC
Confidence 99999999877643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-24 Score=204.98 Aligned_cols=152 Identities=24% Similarity=0.352 Sum_probs=125.0
Q ss_pred HHhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEE-eeCCeeEEE
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS-ITGPESLLV 343 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv 343 (437)
...++|+..+.||+|+||.||++.+ .+++.||||.+..... .+++.+|+.++..++|++++..+..+ ...+..++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 3457899999999999999999996 5688999998754422 23578899999999988877766655 667788999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee---CCCCcEEEcccCCccc
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRL 420 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll---~~~~~~ki~DFG~a~~ 420 (437)
|||+ +++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ ++++.+||+|||+++.
T Consensus 84 ~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEcc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 9999 99999988432 345899999999999999999999998 9999999999999 7889999999999998
Q ss_pred cCCCC
Q 013737 421 FPEDI 425 (437)
Q Consensus 421 ~~~~~ 425 (437)
+....
T Consensus 158 ~~~~~ 162 (296)
T 4hgt_A 158 YRDAR 162 (296)
T ss_dssp CBCTT
T ss_pred ccCcc
Confidence 76543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.5e-24 Score=206.30 Aligned_cols=153 Identities=26% Similarity=0.366 Sum_probs=127.1
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc-chhhHHHHHHHHH-HHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVN-LISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
.++|+..+.||+|+||.||++... +++.||||.+... ......++..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467888999999999999999974 6899999999764 3334455666666 778889999999999999999999999
Q ss_pred eccCCCCccccccc--cCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 345 EFVPNQSLLDNLFV--RQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 345 e~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
||+++ +|.+++.. ......+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++.+
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 77666532 12245689999999999999999999997 7 999999999999999999999999999877
Q ss_pred CCC
Q 013737 422 PED 424 (437)
Q Consensus 422 ~~~ 424 (437)
...
T Consensus 177 ~~~ 179 (327)
T 3aln_A 177 VDS 179 (327)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-25 Score=212.71 Aligned_cols=154 Identities=23% Similarity=0.386 Sum_probs=129.8
Q ss_pred HHHHHHHhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC
Q 013737 261 YETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP 338 (437)
Q Consensus 261 ~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 338 (437)
.+.++...++|+..+.||+|+||.||+|.+.+ .+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34445556789999999999999999999864 4999998643 2333456789999999999999999999999999
Q ss_pred eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCc
Q 013737 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (437)
Q Consensus 339 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a 418 (437)
..++||||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||++
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred ceEEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCc
Confidence 99999999999999998843 2346899999999999999999999998 99999999999998 679999999998
Q ss_pred cccC
Q 013737 419 RLFP 422 (437)
Q Consensus 419 ~~~~ 422 (437)
+...
T Consensus 177 ~~~~ 180 (319)
T 2y4i_B 177 SISG 180 (319)
T ss_dssp C---
T ss_pred cccc
Confidence 7653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.8e-25 Score=214.66 Aligned_cols=149 Identities=10% Similarity=0.030 Sum_probs=112.0
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc---hhhHHHHHHHH---HHHcCCCCCceecee-------EE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEV---NLISGINHKNLVKLL-------GC 333 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~ 333 (437)
...|...+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+ .+|.. +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 455888999999999999999974 68999999997643 23456677884 55666 799988755 44
Q ss_pred EeeC-----------------CeeEEEEeccCCCCccccccccCCCCCCCHHHH------HHHHHHHHHHHHHhhcCCCC
Q 013737 334 SITG-----------------PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVR------YKIILSTAEGLAYLHEESKL 390 (437)
Q Consensus 334 ~~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~------~~i~~~i~~~l~yLH~~~~~ 390 (437)
+... ...+|||||++ ++|.+++..... .+++..+ ..++.||+.||.|||+++
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-- 214 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG-- 214 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence 4433 23799999998 899999854322 2344445 677899999999999998
Q ss_pred CeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 391 ~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|+||||||+|||++.++.+||+|||+|+....
T Consensus 215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~ 246 (371)
T 3q60_A 215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246 (371)
T ss_dssp -EEETTCSGGGEEECTTSCEEECCGGGEEETTC
T ss_pred -CccCcCCHHHEEECCCCCEEEEecceeeecCC
Confidence 99999999999999999999999999997754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3e-24 Score=202.54 Aligned_cols=150 Identities=24% Similarity=0.350 Sum_probs=128.1
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEE-eeCCeeEEEEe
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS-ITGPESLLVYE 345 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e 345 (437)
.++|+..+.||+|+||.||+|.. .+++.||||.+..... .+++.+|+.++..++|++++..+..+ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46789999999999999999997 5689999999865432 23688999999999988876666554 56778899999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee---CCCCcEEEcccCCccccC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll---~~~~~~ki~DFG~a~~~~ 422 (437)
|+ +++|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||+ ++++.+||+|||+++.+.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 89999988432 346899999999999999999999998 9999999999999 478899999999999876
Q ss_pred CCC
Q 013737 423 EDI 425 (437)
Q Consensus 423 ~~~ 425 (437)
...
T Consensus 160 ~~~ 162 (296)
T 3uzp_A 160 DAR 162 (296)
T ss_dssp CTT
T ss_pred ccc
Confidence 543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.3e-24 Score=214.84 Aligned_cols=150 Identities=25% Similarity=0.356 Sum_probs=128.3
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCC-CceeceeEEEeeCCeeEEEEe
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH-KNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 345 (437)
.++|+..++||+|+||.||+|.+ .+++.||||++..... ..++.+|++++..++| ++|..+..+....+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46789999999999999999996 5689999998865432 2357889999999987 556666667778888999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee---CCCCcEEEcccCCccccC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll---~~~~~~ki~DFG~a~~~~ 422 (437)
|+ +++|.+++... ...+++..++.|+.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999988532 346999999999999999999999998 9999999999999 588899999999999876
Q ss_pred CCC
Q 013737 423 EDI 425 (437)
Q Consensus 423 ~~~ 425 (437)
...
T Consensus 158 ~~~ 160 (483)
T 3sv0_A 158 DTS 160 (483)
T ss_dssp CTT
T ss_pred CCc
Confidence 543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=8.9e-25 Score=225.28 Aligned_cols=154 Identities=26% Similarity=0.350 Sum_probs=132.7
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEee------CCe
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT------GPE 339 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 339 (437)
.++|+..+.||+|+||.||++.+ .+|+.||||++... .....+.+.+|++++.+++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 36799999999999999999997 46899999998654 44556789999999999999999999998765 667
Q ss_pred eEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCc---EEEcccC
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT---AKIADFG 416 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~---~ki~DFG 416 (437)
.++||||+++++|.+++........+++..+..++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999866555556899999999999999999999998 999999999999987664 9999999
Q ss_pred CccccCCC
Q 013737 417 LVRLFPED 424 (437)
Q Consensus 417 ~a~~~~~~ 424 (437)
+++.....
T Consensus 170 ~a~~~~~~ 177 (676)
T 3qa8_A 170 YAKELDQG 177 (676)
T ss_dssp CCCBTTSC
T ss_pred cccccccc
Confidence 99987544
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=215.91 Aligned_cols=149 Identities=27% Similarity=0.347 Sum_probs=119.6
Q ss_pred CCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCeeEEEEeccC
Q 013737 270 YFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVP 348 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (437)
.|...+.||+|+||+||.+...+|+.||||++.... .+.+.+|+.++.++ +||||+++++++.+++..++||||++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 344568899999999987777779999999986532 35678999999876 89999999999999999999999996
Q ss_pred CCCccccccccCCCCC----CCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC-------------CcEE
Q 013737 349 NQSLLDNLFVRQDVEP----LSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-------------FTAK 411 (437)
Q Consensus 349 ~g~L~~~l~~~~~~~~----l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~-------------~~~k 411 (437)
|+|.+++........ .++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 699998854322111 133346789999999999999998 9999999999999654 4899
Q ss_pred EcccCCccccCCCC
Q 013737 412 IADFGLVRLFPEDI 425 (437)
Q Consensus 412 i~DFG~a~~~~~~~ 425 (437)
|+|||+++.+....
T Consensus 169 L~DFG~a~~~~~~~ 182 (434)
T 2rio_A 169 ISDFGLCKKLDSGQ 182 (434)
T ss_dssp ECCCTTCEECCC--
T ss_pred EcccccceecCCCC
Confidence 99999999876543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.7e-24 Score=205.61 Aligned_cols=151 Identities=23% Similarity=0.334 Sum_probs=130.2
Q ss_pred hcCCCcCCcccccCcccEEEEEe--CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCC------ceeceeEEEeeCCe
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL--PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHK------NLVKLLGCSITGPE 339 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~~ 339 (437)
.++|+..+.||+|+||.||++.. .+++.||||++... ....+.+.+|+.++..++|+ +++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 45788999999999999999986 35889999998643 34456788999998888655 49999999999999
Q ss_pred eEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC-------------
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE------------- 406 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~------------- 406 (437)
.++||||+ +++|.+++... ...++++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 88999988543 3346899999999999999999999998 999999999999987
Q ss_pred ------CCcEEEcccCCccccCCC
Q 013737 407 ------EFTAKIADFGLVRLFPED 424 (437)
Q Consensus 407 ------~~~~ki~DFG~a~~~~~~ 424 (437)
++.+||+|||+++.....
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~ 190 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH 190 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC
T ss_pred ccccccCCCceEeeCcccccCccc
Confidence 668999999999876543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.9e-24 Score=212.41 Aligned_cols=135 Identities=29% Similarity=0.413 Sum_probs=114.4
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCC--------CCceeceeEEEe---
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN--------HKNLVKLLGCSI--- 335 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~--- 335 (437)
.++|+..++||+|+||.||+|.. .+++.||||++... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 46789999999999999999986 45889999999643 344677889999998885 788999999987
Q ss_pred -eCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeeeCCCCCCCeeeCCCC
Q 013737 336 -TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEF 408 (437)
Q Consensus 336 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiHrDlk~~NIll~~~~ 408 (437)
.....++||||+ +++|.+.+... ....+++..+..++.||+.||.|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~ 184 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNE 184 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccc
Confidence 455789999999 56776666432 335699999999999999999999998 7 99999999999999775
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=6.4e-25 Score=209.96 Aligned_cols=154 Identities=27% Similarity=0.325 Sum_probs=132.0
Q ss_pred HHHhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccch------hhHHHHHHHHHHHcCCC--CCceeceeEEEe
Q 013737 265 EKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTT------QWVDHFFNEVNLISGIN--HKNLVKLLGCSI 335 (437)
Q Consensus 265 ~~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~ 335 (437)
+...++|+..+.||+|+||.||+|.. .+++.||||.+..... ...+.+.+|+.++++++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34457799999999999999999996 5688999999865421 12245678999999986 599999999999
Q ss_pred eCCeeEEEEeccCC-CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC-CCCcEEEc
Q 013737 336 TGPESLLVYEFVPN-QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD-EEFTAKIA 413 (437)
Q Consensus 336 ~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~-~~~~~ki~ 413 (437)
.++..++|||++.+ ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ +++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999976 899888743 345899999999999999999999998 99999999999999 78899999
Q ss_pred ccCCccccCCC
Q 013737 414 DFGLVRLFPED 424 (437)
Q Consensus 414 DFG~a~~~~~~ 424 (437)
|||+++.+...
T Consensus 193 Dfg~~~~~~~~ 203 (320)
T 3a99_A 193 DFGSGALLKDT 203 (320)
T ss_dssp CCTTCEECCSS
T ss_pred eCccccccccc
Confidence 99999877643
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-24 Score=221.45 Aligned_cols=137 Identities=16% Similarity=0.213 Sum_probs=109.4
Q ss_pred CcCCcccccCcccEEEEEeCCCCEEEEEEEeccc--------hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEE
Q 013737 272 HESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT--------TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 272 ~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
...++||+|+||.||++... ++.+++|+..... ....+++.+|++++++++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 45679999999999999544 7888999864321 11245689999999999999999777777788888999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|||+++++|.+++.. +..++.|+++||.|||+++ |+||||||+|||+++ ++||+|||+|+....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999998832 5689999999999999998 999999999999999 999999999998865
Q ss_pred CC
Q 013737 424 DI 425 (437)
Q Consensus 424 ~~ 425 (437)
..
T Consensus 482 ~~ 483 (540)
T 3en9_A 482 DE 483 (540)
T ss_dssp HH
T ss_pred cc
Confidence 43
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=6.9e-24 Score=204.18 Aligned_cols=148 Identities=21% Similarity=0.294 Sum_probs=119.8
Q ss_pred hcCCCcC-CcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEee----CCeeE
Q 013737 268 TNYFHES-NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT----GPESL 341 (437)
Q Consensus 268 ~~~~~~~-~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 341 (437)
.++|... +.||+|+||.||++.+. +++.||||++.... ... .+....+..++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-KAR---QEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-HHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-HHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 4567774 46999999999999975 68999999986532 111 222334566799999999999876 44589
Q ss_pred EEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC---CCcEEEcccCCc
Q 013737 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---EFTAKIADFGLV 418 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~---~~~~ki~DFG~a 418 (437)
+||||+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 103 lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 999999999999988543 3346999999999999999999999998 999999999999976 456999999999
Q ss_pred cccCC
Q 013737 419 RLFPE 423 (437)
Q Consensus 419 ~~~~~ 423 (437)
+....
T Consensus 179 ~~~~~ 183 (336)
T 3fhr_A 179 KETTQ 183 (336)
T ss_dssp EEC--
T ss_pred eeccc
Confidence 87654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.7e-24 Score=213.90 Aligned_cols=148 Identities=25% Similarity=0.342 Sum_probs=120.7
Q ss_pred hcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCeeEEEEec
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
..+|...+.||+|+||+|+.....+++.||||++...... .+.+|+.+|+++ +||||+++++++.+....++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 3458888999999999976655667899999998654322 356899999998 799999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC-----CCcEEEcccCCcccc
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-----EFTAKIADFGLVRLF 421 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~-----~~~~ki~DFG~a~~~ 421 (437)
++ |+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++. ...+||+|||+++.+
T Consensus 100 ~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 96 59988885432 23445566789999999999999998 999999999999953 346889999999987
Q ss_pred CCC
Q 013737 422 PED 424 (437)
Q Consensus 422 ~~~ 424 (437)
...
T Consensus 174 ~~~ 176 (432)
T 3p23_A 174 AVG 176 (432)
T ss_dssp ---
T ss_pred cCC
Confidence 644
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.7e-24 Score=198.15 Aligned_cols=144 Identities=17% Similarity=0.145 Sum_probs=116.3
Q ss_pred HHHHHhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccch------------------hhHHHHHHHHHHHcCCCC
Q 013737 263 TLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT------------------QWVDHFFNEVNLISGINH 324 (437)
Q Consensus 263 ~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h 324 (437)
.+......|...+.||+|+||.||+|.+.+|+.||||.+..... .....+.+|+.+|++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 34444556777799999999999999997799999999864321 13467899999999999
Q ss_pred CceeceeEEEeeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee
Q 013737 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL 404 (437)
Q Consensus 325 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll 404 (437)
| +++.+++.. +..++||||+++++|.+ +.. .....++.|++.||.|||+.+ |+||||||+|||+
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl 226 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV 226 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEE
Confidence 4 666665433 56799999999999988 411 124579999999999999998 9999999999999
Q ss_pred CCCCcEEEcccCCccccCCC
Q 013737 405 DEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 405 ~~~~~~ki~DFG~a~~~~~~ 424 (437)
+ ++.+||+|||+|+.....
T Consensus 227 ~-~~~vkl~DFG~a~~~~~~ 245 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVEVGEE 245 (282)
T ss_dssp E-TTEEEECCCTTCEETTST
T ss_pred E-CCcEEEEECCCCeECCCC
Confidence 9 999999999999977554
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=8e-24 Score=201.72 Aligned_cols=150 Identities=25% Similarity=0.381 Sum_probs=115.1
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc-hhh-HHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQW-VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
.++|+..+.||+|+||.||++.+. +++.||||.+.... ... .+.+.++..+++.++||||+++++++..++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 456888899999999999999975 68999999997543 222 333445556788899999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
||+ ++.+..+. .. ....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++.+..
T Consensus 104 e~~-~~~~~~l~-~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLK-KR-MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHH-HH-HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHH-HH-hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 44444333 22 235689999999999999999999985 7 99999999999999999999999999987654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2e-23 Score=201.92 Aligned_cols=151 Identities=21% Similarity=0.305 Sum_probs=128.1
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CC-CEEEEEEEeccchhhHHHHHHHHHHHcCCCCCc------eeceeEEEeeCCe
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GG-EAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN------LVKLLGCSITGPE 339 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 339 (437)
.++|+..+.||+|+||.||++... ++ +.||+|.+... ....+.+.+|+.+++.++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 467899999999999999999974 34 68999998643 344567888999998887665 9999999999999
Q ss_pred eEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeee---------------
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL--------------- 404 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll--------------- 404 (437)
.++||||+ +++|.+.+.. .....+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~-~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKE-NNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 6677776643 23356899999999999999999999987 9999999999999
Q ss_pred ----CCCCcEEEcccCCccccCCC
Q 013737 405 ----DEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 405 ----~~~~~~ki~DFG~a~~~~~~ 424 (437)
+.++.+||+|||+++.....
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~ 195 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH 195 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC
T ss_pred cccccCCCcEEEeecCcccccccc
Confidence 56789999999999876543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.7e-23 Score=203.67 Aligned_cols=156 Identities=28% Similarity=0.325 Sum_probs=129.4
Q ss_pred HHHhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCC-CC-----ceeceeEEEeeC
Q 013737 265 EKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HK-----NLVKLLGCSITG 337 (437)
Q Consensus 265 ~~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~ 337 (437)
+...++|+..+.||+|+||.||+|... +++.||||++... ....+++.+|+.++..++ |+ +|+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 344578999999999999999999975 5889999999743 334567788888887775 44 599999999999
Q ss_pred CeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC--CCCcEEEccc
Q 013737 338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD--EEFTAKIADF 415 (437)
Q Consensus 338 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~--~~~~~ki~DF 415 (437)
+..++||||++ ++|.+++... ....+++..+..++.|++.||.|||++. .+|+||||||+|||++ .++.+||+||
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred CceEEEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 99999999996 5999888543 2345899999999999999999999631 2499999999999995 4778999999
Q ss_pred CCccccCCC
Q 013737 416 GLVRLFPED 424 (437)
Q Consensus 416 G~a~~~~~~ 424 (437)
|+++.....
T Consensus 206 G~a~~~~~~ 214 (382)
T 2vx3_A 206 GSSCQLGQR 214 (382)
T ss_dssp TTCEETTCC
T ss_pred cCceecccc
Confidence 999887543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-23 Score=205.15 Aligned_cols=151 Identities=25% Similarity=0.333 Sum_probs=128.1
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCC-----------CCceeceeEEEe
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-----------HKNLVKLLGCSI 335 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 335 (437)
.++|...+.||+|+||.||+|.. .+++.||||.+... ....+.+.+|+.++.+++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35788999999999999999997 56889999998643 334567889999988876 899999999988
Q ss_pred eCC----eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeeeCCCCCCCeeeC-----
Q 013737 336 TGP----ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLD----- 405 (437)
Q Consensus 336 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiHrDlk~~NIll~----- 405 (437)
..+ ..++||||+ +++|.+++... ....+++..+..++.||+.||.|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 689999999 88999988543 234589999999999999999999998 7 99999999999994
Q ss_pred -CCCcEEEcccCCccccCCC
Q 013737 406 -EEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 406 -~~~~~ki~DFG~a~~~~~~ 424 (437)
..+.+||+|||+++.....
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~ 191 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH 191 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC
T ss_pred cCcceEEEcccccccccCCC
Confidence 4458999999999877543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.85 E-value=4.1e-22 Score=197.19 Aligned_cols=153 Identities=17% Similarity=0.170 Sum_probs=115.1
Q ss_pred HhcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc---hhhHHHHHHHHHHHcCCCC-Ccee---------cee-
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINH-KNLV---------KLL- 331 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv---------~l~- 331 (437)
..+.|...+.||+|+||.||+|.+ .+|+.||||++.... ....+.+.+|+.++..++| +|.. ...
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 345577788999999999999996 569999999987432 2235789999999999987 2211 111
Q ss_pred -----------EEEee-----CCeeEEEEeccCCCCccccccc----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 013737 332 -----------GCSIT-----GPESLLVYEFVPNQSLLDNLFV----RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391 (437)
Q Consensus 332 -----------~~~~~-----~~~~~lv~e~~~~g~L~~~l~~----~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ 391 (437)
.+... ....+++|+++ +++|.+++.. ......+++..++.++.||+.||.|||+++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 11111 12356777765 6888887731 122345788899999999999999999998
Q ss_pred eeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 392 iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|+||||||+||||+.++.+||+|||+++....
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~ 263 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTE
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCC
Confidence 99999999999999999999999999987643
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.85 E-value=2.5e-21 Score=152.71 Aligned_cols=102 Identities=23% Similarity=0.444 Sum_probs=86.7
Q ss_pred ccceeecCCccCCCchhhhHHHHHHHHHHHHHhhcC-CceeeeeecccCCCceEEEeeeccCCCChhhHHHHHHHHHhhh
Q 013737 88 QDRTVCGSKDFGGNNTVFGANAIELVRNLSVQAVKN-DGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRI 166 (437)
Q Consensus 88 ~~~~~~~~~~~~~~~~~f~~~~~~ll~~l~~~a~~~-~~~~~~~~~~~~~~~~vygl~QC~~dl~~~~C~~Cl~~~~~~~ 166 (437)
..+..|+..+++ +++.|+.+++.||..|+..|+.+ .+|+++..+. .++++||||+||+|||++.+|..||+.++.++
T Consensus 5 ~v~~~Cn~~~~t-~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~-~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~ 82 (108)
T 3a2e_A 5 FVSSACNTQKIP-SGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGS-GGAPTAYGRATCKQSISQSDCTACLSNLVNRI 82 (108)
T ss_dssp EEEEEECSSBCC-TTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCS-TTCCCEEEEEEECTTSCHHHHHHHHHHHHTTH
T ss_pred eeeeecCCCccC-CCChHHHHHHHHHHHHHhhCccccCCceEeeccC-CCCceEEEEEEEcCCCCHHHHHHHHHHHHHHH
Confidence 445778877665 57889999999999999988754 4566665542 45689999999999999999999999999999
Q ss_pred hc-ccCCCCceecCCccccccccccc
Q 013737 167 AS-CTQKEEGRVLNAGCYLRYSTQRF 191 (437)
Q Consensus 167 ~~-c~~~~~g~v~~~~C~~ry~~~~f 191 (437)
++ |.++.+|+++.++|++||++++|
T Consensus 83 ~~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 83 FSICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp HHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred HHHCCCCceEEEECCCEEEEEeCCcC
Confidence 87 66789999999999999999987
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=7.9e-22 Score=182.49 Aligned_cols=140 Identities=16% Similarity=0.146 Sum_probs=107.1
Q ss_pred CCCcCCcccccCcccEEEEEe-CCCCE--EEEEEEeccchh------------------------hHHHHHHHHHHHcCC
Q 013737 270 YFHESNKLGQGGSGSVYKGTL-PGGEA--VAVKRLFYNTTQ------------------------WVDHFFNEVNLISGI 322 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l 322 (437)
-|...+.||+|+||.||+|.+ .+|+. ||||.++..... ....+.+|+.+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 356778999999999999998 67888 999987543111 123688999999999
Q ss_pred CCCce--eceeEEEeeCCeeEEEEeccCC-C----CccccccccCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCCCeee
Q 013737 323 NHKNL--VKLLGCSITGPESLLVYEFVPN-Q----SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH-EESKLRIIH 394 (437)
Q Consensus 323 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH-~~~~~~iiH 394 (437)
.|+++ +.++.. +..+|||||+.+ | +|.+.... .++..+..++.|++.+|.||| +.+ |+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 88764 344432 356899999942 4 44433211 234467789999999999999 887 999
Q ss_pred CCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 395 RDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 395 rDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
|||||+|||+++ .++|+|||+|.....+
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~~~~ 222 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTLRHP 222 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEETTST
T ss_pred CCCCHHHEEEcC--cEEEEECcccccCCCc
Confidence 999999999998 9999999999877544
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.84 E-value=2.2e-21 Score=153.08 Aligned_cols=76 Identities=21% Similarity=0.478 Sum_probs=66.5
Q ss_pred CCccchhhcc--ccEEEeec-CCCCcEEEEEEcCCCCChhhhHHHHHHHHHHHHhhCCCCCCcccEEEEccceEEEEecc
Q 013737 2 DIVTPLIARQ--RYAAVVNG-TGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFYDGCYLRYDDY 78 (437)
Q Consensus 2 ~~l~~~~~~~--~~~~~~~g-~~~~~vyg~~~C~~d~~~~~C~~Cl~~~~~~~~~~c~~~~~~~~~~~~~~~C~~ry~~~ 78 (437)
++|+++++.+ +|+++..| .++++||||+|||||+++++|..||+.++.+++++||++ +||+||+++|+||||++
T Consensus 30 ~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~~~~C~~~---~g~~i~~~~C~lRY~~~ 106 (108)
T 3a2e_A 30 ADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRIFSICNNA---IGARVQLVDCFIQYEQR 106 (108)
T ss_dssp HHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTHHHHTTSB---SSEEEEETTEEEEEESS
T ss_pred HHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHHHHHCCCC---ceEEEECCCEEEEEeCC
Confidence 4566677655 56666655 456999999999999999999999999999999999986 99999999999999999
Q ss_pred Cc
Q 013737 79 DF 80 (437)
Q Consensus 79 ~f 80 (437)
+|
T Consensus 107 ~F 108 (108)
T 3a2e_A 107 SF 108 (108)
T ss_dssp CC
T ss_pred cC
Confidence 98
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.75 E-value=4e-19 Score=171.23 Aligned_cols=143 Identities=13% Similarity=0.126 Sum_probs=100.2
Q ss_pred HHHhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccch--------------hhHHH--------HHHHHHHHcCC
Q 013737 265 EKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT--------------QWVDH--------FFNEVNLISGI 322 (437)
Q Consensus 265 ~~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~E~~~l~~l 322 (437)
.....-|.+.+.||+|+||.||+|...+|+.||||+++.... ..... ..+|...|.++
T Consensus 91 ~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL 170 (397)
T 4gyi_A 91 AARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL 170 (397)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence 333334888999999999999999998999999998753210 00111 23455555555
Q ss_pred CCCceeceeEEEeeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCe
Q 013737 323 NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNI 402 (437)
Q Consensus 323 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NI 402 (437)
.+.++....-+.. ...+|||||+++++|.++.. . .....++.|++.+|.+||+.+ ||||||||.||
T Consensus 171 ~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NI 236 (397)
T 4gyi_A 171 YEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAKHG---LIHGDFNEFNI 236 (397)
T ss_dssp HHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred HhcCCCCCeeeec--cCceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHE
Confidence 4333322111111 12379999999888866441 1 123567899999999999988 99999999999
Q ss_pred eeCCCC----------cEEEcccCCcccc
Q 013737 403 LLDEEF----------TAKIADFGLVRLF 421 (437)
Q Consensus 403 ll~~~~----------~~ki~DFG~a~~~ 421 (437)
|+++++ .+.|+||+-+-..
T Consensus 237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 237 LIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred EEeCCCCcccccccccceEEEEeCCcccC
Confidence 998776 3899999977543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=2.1e-13 Score=125.86 Aligned_cols=145 Identities=17% Similarity=0.055 Sum_probs=112.4
Q ss_pred HhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCC-CCceeceeEEEeeCCeeEEEEe
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 345 (437)
.-..|+....++.|+.+.||+.... +..+++|............+.+|+++++.+. |..+++++++....+..++|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 3456777778888888999999865 6889999986532222345888999998884 6788899999998889999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-------------------------------------
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES------------------------------------- 388 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------------------------------------- 388 (437)
|++|.+|.+.+. +......++.+++++|..||+..
T Consensus 91 ~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 91 EADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp CCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred ecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 999998876531 11223467889999999999821
Q ss_pred -------------------CCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 389 -------------------KLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 389 -------------------~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
+..++|+|++|.|||++++..+.|+||+.+..
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13489999999999998765667999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.27 E-value=2.6e-12 Score=118.15 Aligned_cols=130 Identities=19% Similarity=0.219 Sum_probs=98.0
Q ss_pred cccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCc--eeceeEEEeeCCeeEEEEeccCCCCcccc
Q 013737 278 GQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN--LVKLLGCSITGPESLLVYEFVPNQSLLDN 355 (437)
Q Consensus 278 g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 355 (437)
+.|..+.||+....+|..+++|..... ....+.+|+.+++.+.+.+ +++++++...++..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 455568999998877888999987543 2245778888888875444 567888888777889999999998873
Q ss_pred ccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----------------------------------------------
Q 013737 356 LFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES----------------------------------------------- 388 (437)
Q Consensus 356 l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~----------------------------------------------- 388 (437)
.. . .+ ...++.++++.|..||+..
T Consensus 104 ~~---~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 104 SS---H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp TS---C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred cC---c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 21 1 12 2356778888888888753
Q ss_pred --------CCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 389 --------KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 389 --------~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
+..++|+|++|.|||++++..+.|+||+.+...
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 122999999999999988766779999998654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.19 E-value=6.2e-11 Score=114.55 Aligned_cols=142 Identities=18% Similarity=0.245 Sum_probs=106.7
Q ss_pred cCCcccccCcccEEEEEeCCCCEEEEEEEe--ccc-hhhHHHHHHHHHHHcCCC--CCceeceeEEEeeC---CeeEEEE
Q 013737 273 ESNKLGQGGSGSVYKGTLPGGEAVAVKRLF--YNT-TQWVDHFFNEVNLISGIN--HKNLVKLLGCSITG---PESLLVY 344 (437)
Q Consensus 273 ~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~ 344 (437)
..+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|..+++.+. +..+++++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 45678999999999998764 578888765 322 122346788999998886 45688899888766 3489999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC------------------------------------
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES------------------------------------ 388 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------------------------------------ 388 (437)
||++|..+.+.. ...++..+...++.++++.|..||...
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999988775422 234678888999999999999999831
Q ss_pred -------------------CCCeeeCCCCCCCeeeCCCCc--EEEcccCCccc
Q 013737 389 -------------------KLRIIHRDIKLSNILLDEEFT--AKIADFGLVRL 420 (437)
Q Consensus 389 -------------------~~~iiHrDlk~~NIll~~~~~--~ki~DFG~a~~ 420 (437)
+..++|+|++|.|||+++++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.73 E-value=2e-08 Score=94.41 Aligned_cols=137 Identities=20% Similarity=0.216 Sum_probs=99.3
Q ss_pred CCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCC-CCc--eeceeEEEeeCC---eeEEEEecc
Q 013737 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKN--LVKLLGCSITGP---ESLLVYEFV 347 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~ 347 (437)
.+.++.|....||+.. ..+++|..... .....+.+|.++|..+. +.. +++++......+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999863 56888886432 34567889999988773 332 445555543333 348999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE---------------------------------------- 387 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~---------------------------------------- 387 (437)
+|.+|.+... ..++..+...++.++++.|..||+.
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9988865321 2367777788888888888888862
Q ss_pred ---------------CCCCeeeCCCCCCCeeeCC--CCcEEEcccCCcccc
Q 013737 388 ---------------SKLRIIHRDIKLSNILLDE--EFTAKIADFGLVRLF 421 (437)
Q Consensus 388 ---------------~~~~iiHrDlk~~NIll~~--~~~~ki~DFG~a~~~ 421 (437)
.++.++|+|++|.||++++ ...+.|+||+.+..-
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 1235899999999999998 456889999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=1.7e-07 Score=88.21 Aligned_cols=137 Identities=19% Similarity=0.171 Sum_probs=94.8
Q ss_pred CCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCC---ceeceeEEEe-eCCeeEEEEeccCC
Q 013737 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHK---NLVKLLGCSI-TGPESLLVYEFVPN 349 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~ 349 (437)
.+.++.|....||+. +..+++|... .......+.+|.++|..+.+. .+++.+.+.. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456788888899988 5678888742 233456789999999988642 3667777664 34567899999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcC------------------------------------------
Q 013737 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE------------------------------------------ 387 (437)
Q Consensus 350 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~------------------------------------------ 387 (437)
..+.+... ..++..+...++.++++.|..||+.
T Consensus 98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 88765221 1234445555555555555555543
Q ss_pred ---------------CCCCeeeCCCCCCCeeeCC---CCc-EEEcccCCcccc
Q 013737 388 ---------------SKLRIIHRDIKLSNILLDE---EFT-AKIADFGLVRLF 421 (437)
Q Consensus 388 ---------------~~~~iiHrDlk~~NIll~~---~~~-~ki~DFG~a~~~ 421 (437)
.++.++|+|++|.|||+++ ++. ..|+||+.+..-
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2234799999999999987 455 589999987643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=3.1e-07 Score=84.63 Aligned_cols=135 Identities=19% Similarity=0.160 Sum_probs=94.2
Q ss_pred cccccCcc-cEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCC-CCceeceeEEEeeCCeeEEEEeccCCCCc
Q 013737 276 KLGQGGSG-SVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVYEFVPNQSL 352 (437)
Q Consensus 276 ~Lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L 352 (437)
.+..|..+ .||+.... ++..+++|+-... ....+.+|...|+.+. +--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556555 58988764 4667889986533 3456778988887764 44477889999999999999999998776
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcC---------------------------------------------
Q 013737 353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE--------------------------------------------- 387 (437)
Q Consensus 353 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~--------------------------------------------- 387 (437)
.+.... .......+..+++..|.-||..
T Consensus 108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 554311 1112234455555555555542
Q ss_pred ----------CCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 388 ----------SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 388 ----------~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
.++.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112379999999999999887778999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=1.8e-07 Score=89.88 Aligned_cols=81 Identities=10% Similarity=0.014 Sum_probs=55.4
Q ss_pred CCcc-cccCcccEEEEEeC-------CCCEEEEEEEeccc---hhhHHHHHHHHHHHcCCC-C--CceeceeEEEeeC--
Q 013737 274 SNKL-GQGGSGSVYKGTLP-------GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGIN-H--KNLVKLLGCSITG-- 337 (437)
Q Consensus 274 ~~~L-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~-- 337 (437)
.+.| +.|....+|+.... ++..+++|...... ......+.+|..+++.+. + ..+++++.+..+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 78888999998764 25678888764332 101235677888887774 2 3577788877655
Q ss_pred -CeeEEEEeccCCCCccc
Q 013737 338 -PESLLVYEFVPNQSLLD 354 (437)
Q Consensus 338 -~~~~lv~e~~~~g~L~~ 354 (437)
+..++|||+++|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999877764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=3.7e-06 Score=82.01 Aligned_cols=75 Identities=12% Similarity=0.083 Sum_probs=49.8
Q ss_pred CCcccccCcccEEEEEeC-CCCEEEEEEEeccch-------hhHHHHHHHHHHHcCCCC---CceeceeEEEeeCCeeEE
Q 013737 274 SNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT-------QWVDHFFNEVNLISGINH---KNLVKLLGCSITGPESLL 342 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~l 342 (437)
.+.||.|.++.||++... +++.++||....... ...+++..|.+++..+.. ..+++++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467999999999999864 468899998643211 123456778888876632 344566654 4556789
Q ss_pred EEeccCCC
Q 013737 343 VYEFVPNQ 350 (437)
Q Consensus 343 v~e~~~~g 350 (437)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.08 E-value=7.5e-06 Score=77.78 Aligned_cols=141 Identities=18% Similarity=0.212 Sum_probs=78.5
Q ss_pred CcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCC-----CCCceecee-E--EEeeCCeeEEEEec
Q 013737 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-----NHKNLVKLL-G--CSITGPESLLVYEF 346 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~-~--~~~~~~~~~lv~e~ 346 (437)
+.|+.|..+.||+....++ .+++|+..... .++..|..++..| ..|.++... | +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677889999987655 48899886521 2333444444433 234444311 1 12346678999999
Q ss_pred cCCCCccc--------------ccccc-CC---C-------CCCCHHHHH------------------------------
Q 013737 347 VPNQSLLD--------------NLFVR-QD---V-------EPLSWEVRY------------------------------ 371 (437)
Q Consensus 347 ~~~g~L~~--------------~l~~~-~~---~-------~~l~~~~~~------------------------------ 371 (437)
++|..+.. .++.. .. . ..-.|....
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 99865531 01100 00 0 011232110
Q ss_pred -HHHHHHHHHHHHhhc----------CCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 372 -KIILSTAEGLAYLHE----------ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 372 -~i~~~i~~~l~yLH~----------~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
.+...+..++.+|+. ..+..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111223345666653 0234699999999999998888999999998753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.92 E-value=0.00012 Score=68.73 Aligned_cols=140 Identities=16% Similarity=0.136 Sum_probs=93.2
Q ss_pred CcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCC---CCceeceeEEEeeCCeeEEEEeccC
Q 013737 272 HESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN---HKNLVKLLGCSITGPESLLVYEFVP 348 (437)
Q Consensus 272 ~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~ 348 (437)
...+.|+.|....+|+.... +..+++|..... ....+..|.+.|+.|. ...+++++.+....+..++||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 34567899999999999864 667888887543 3556888988887773 3678889988887888999999999
Q ss_pred CCCcccc-----------ccccCC-------------------CCCCCHHHHH---HHH----------------HHHHH
Q 013737 349 NQSLLDN-----------LFVRQD-------------------VEPLSWEVRY---KII----------------LSTAE 379 (437)
Q Consensus 349 ~g~L~~~-----------l~~~~~-------------------~~~l~~~~~~---~i~----------------~~i~~ 379 (437)
+..+... |+.... ...-+|.... ++. ..+..
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 8765321 111111 0012454332 111 11121
Q ss_pred HH-HHhhc-CCCCCeeeCCCCCCCeeeCCCCcEEEcccC
Q 013737 380 GL-AYLHE-ESKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (437)
Q Consensus 380 ~l-~yLH~-~~~~~iiHrDlk~~NIll~~~~~~ki~DFG 416 (437)
-+ ..|.. ..++.++|+|+.+.|++++.++ +.|.||.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 22 23432 2346799999999999999887 8999984
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.91 E-value=1.7e-05 Score=73.68 Aligned_cols=79 Identities=16% Similarity=0.179 Sum_probs=57.1
Q ss_pred CCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCC-C--CceeceeEEEeeCCeeEEEEec
Q 013737 270 YFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-H--KNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv~e~ 346 (437)
.....+.+|.|..+.||+.+..+|+.+++|+...........|..|...|+.|. . -.+++++++. ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 345567899999999999999999999999876544443456788988887764 2 2345555542 34799999
Q ss_pred cCCCCc
Q 013737 347 VPNQSL 352 (437)
Q Consensus 347 ~~~g~L 352 (437)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.78 E-value=6e-05 Score=74.00 Aligned_cols=74 Identities=9% Similarity=0.105 Sum_probs=46.4
Q ss_pred cCCcccccCcccEEEEEeCCCCEEEEEEEecc----chh-----hHHHHHHHHHHHc-CCCCCceeceeEEEeeCCeeEE
Q 013737 273 ESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN----TTQ-----WVDHFFNEVNLIS-GINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 273 ~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~----~~~-----~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~l 342 (437)
..+.||.|..+.||++.. ++..++||..... ... ....++.|+..+. ...+..+++++.+. .+..++
T Consensus 38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 356789999999999975 4678999943211 111 2233444443332 22234667777765 567799
Q ss_pred EEecc-CC
Q 013737 343 VYEFV-PN 349 (437)
Q Consensus 343 v~e~~-~~ 349 (437)
|||++ ++
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 76
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00031 Score=65.48 Aligned_cols=72 Identities=11% Similarity=0.115 Sum_probs=43.6
Q ss_pred cCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCce-eceeEEEeeCCeeEEEEecc-CCC
Q 013737 273 ESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL-VKLLGCSITGPESLLVYEFV-PNQ 350 (437)
Q Consensus 273 ~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g 350 (437)
..+.|+.|....+|+. ..+++|+........ ....+|..++..+...++ +++++. ..+.-++++||+ ++.
T Consensus 22 ~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 22 GPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ 93 (301)
T ss_dssp SCEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred ceeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence 3678889999999998 568888775432211 122457766665532222 455554 344457999999 655
Q ss_pred Cc
Q 013737 351 SL 352 (437)
Q Consensus 351 ~L 352 (437)
++
T Consensus 94 ~l 95 (301)
T 3dxq_A 94 TM 95 (301)
T ss_dssp EC
T ss_pred cC
Confidence 44
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00089 Score=62.82 Aligned_cols=158 Identities=12% Similarity=0.131 Sum_probs=84.6
Q ss_pred cCHHHHHHHhcCCCc-----CCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCC--ceecee
Q 013737 259 FSYETLEKATNYFHE-----SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHK--NLVKLL 331 (437)
Q Consensus 259 ~~~~~~~~~~~~~~~-----~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~ 331 (437)
++.+++......|.. .+.|+.|....+|+....++ .+++|...... ..+.+..|..++..+... .+++++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 444555555555544 23466787889999987655 57888876421 112345566666555311 133333
Q ss_pred EE------EeeCCeeEEEEeccCCCCcccc--------------ccccC-C---C--CCC---CHHHHHH----------
Q 013737 332 GC------SITGPESLLVYEFVPNQSLLDN--------------LFVRQ-D---V--EPL---SWEVRYK---------- 372 (437)
Q Consensus 332 ~~------~~~~~~~~lv~e~~~~g~L~~~--------------l~~~~-~---~--~~l---~~~~~~~---------- 372 (437)
.. ....+..++++||++|..+... ++... . . ... .|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 1234567899999998664321 11100 0 0 001 1222110
Q ss_pred --HHHHHHHHHHHhhcC----CCCCeeeCCCCCCCeeeCCCCcEEEcccCCcc
Q 013737 373 --IILSTAEGLAYLHEE----SKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (437)
Q Consensus 373 --i~~~i~~~l~yLH~~----~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~ 419 (437)
+...+...++.++.. .+..++|+|+.+.|||++++..+.|+||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 001133445555421 23459999999999999987666899999775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.49 E-value=0.0012 Score=62.11 Aligned_cols=158 Identities=13% Similarity=0.044 Sum_probs=86.7
Q ss_pred cCHHHHHHHhcCCC-----cCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCC--Cceecee
Q 013737 259 FSYETLEKATNYFH-----ESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH--KNLVKLL 331 (437)
Q Consensus 259 ~~~~~~~~~~~~~~-----~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~ 331 (437)
.+.+.+...-+.|. ....|+ |....||+....+|+.+++|...... .....+..|..++..+.. -.+++++
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~ 88 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPV 88 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeeccee
Confidence 44444544444332 223466 77789999887777789999986331 123456667777666531 1244444
Q ss_pred EE-----EeeCCeeEEEEeccCCCCcccc--------------cccc---C---CCCCCCHHHH----------------
Q 013737 332 GC-----SITGPESLLVYEFVPNQSLLDN--------------LFVR---Q---DVEPLSWEVR---------------- 370 (437)
Q Consensus 332 ~~-----~~~~~~~~lv~e~~~~g~L~~~--------------l~~~---~---~~~~l~~~~~---------------- 370 (437)
.. ....+..+++||+++|..+... ++.. . .....++...
T Consensus 89 ~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 168 (328)
T 1zyl_A 89 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS 168 (328)
T ss_dssp CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred ecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCH
Confidence 32 1224566889999987654310 0000 0 0011222211
Q ss_pred ------HHHHHHHHHHHHHhhc-CCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 371 ------YKIILSTAEGLAYLHE-ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 371 ------~~i~~~i~~~l~yLH~-~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
...+..++..+.-+.. ..+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 169 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 169 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1111122222222211 1234589999999999999 4 899999988764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00046 Score=66.45 Aligned_cols=142 Identities=18% Similarity=0.178 Sum_probs=82.7
Q ss_pred CCcccccCcccEEEEEeCC--------CCEEEEEEEeccchhhHHHHHHHHHHHcCCC-CCceeceeEEEeeCCeeEEEE
Q 013737 274 SNKLGQGGSGSVYKGTLPG--------GEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 344 (437)
.+.|..|-...+|+....+ ++.+++|+.... ........+|..+++.|. +.-.+++++.+.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 3567778888999998752 468888885322 223455678988887764 2223566766543 2999
Q ss_pred eccCCCCcccc-c----------------cccC--CCCCC--CHHHHHHHHHHHHH-------------------HHHH-
Q 013737 345 EFVPNQSLLDN-L----------------FVRQ--DVEPL--SWEVRYKIILSTAE-------------------GLAY- 383 (437)
Q Consensus 345 e~~~~g~L~~~-l----------------~~~~--~~~~l--~~~~~~~i~~~i~~-------------------~l~y- 383 (437)
||++|..|... + +... -..+. -+.++.++..++.. .+..
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998665421 1 0000 01112 23455555444321 1222
Q ss_pred ---hhcC-CCCCeeeCCCCCCCeeeCCC----CcEEEcccCCccc
Q 013737 384 ---LHEE-SKLRIIHRDIKLSNILLDEE----FTAKIADFGLVRL 420 (437)
Q Consensus 384 ---LH~~-~~~~iiHrDlk~~NIll~~~----~~~ki~DFG~a~~ 420 (437)
|... .+..++|+|+.+.|||++++ +.+.|+||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2221 23458999999999999876 7899999998763
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00017 Score=70.94 Aligned_cols=74 Identities=18% Similarity=0.228 Sum_probs=49.2
Q ss_pred CCcccccCcccEEEEEeCC--------CCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCc-eeceeEEEeeCCeeEEEE
Q 013737 274 SNKLGQGGSGSVYKGTLPG--------GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN-LVKLLGCSITGPESLLVY 344 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 344 (437)
.+.|+.|-...+|+...++ +..+++|+..... ..+.+.+|..++..+...+ .+++++.+. + .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 3567888889999998753 4788888874321 1145567888887774333 356776553 2 3899
Q ss_pred eccCCCCcc
Q 013737 345 EFVPNQSLL 353 (437)
Q Consensus 345 e~~~~g~L~ 353 (437)
||++|.+|.
T Consensus 152 e~l~G~~l~ 160 (429)
T 1nw1_A 152 EYIPSRPLS 160 (429)
T ss_dssp CCCCEEECC
T ss_pred EEeCCcccC
Confidence 999875543
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00054 Score=64.76 Aligned_cols=32 Identities=28% Similarity=0.446 Sum_probs=27.5
Q ss_pred CCCeeeCCCCCCCeeeCCC----CcEEEcccCCccc
Q 013737 389 KLRIIHRDIKLSNILLDEE----FTAKIADFGLVRL 420 (437)
Q Consensus 389 ~~~iiHrDlk~~NIll~~~----~~~ki~DFG~a~~ 420 (437)
+..++|+|+.+.|||++.+ ..+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3469999999999999874 6899999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00069 Score=66.98 Aligned_cols=75 Identities=13% Similarity=0.012 Sum_probs=47.3
Q ss_pred CCcccccCcccEEEEEeCC-CCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCce-eceeEEEeeCCeeEEEEeccCCCC
Q 013737 274 SNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL-VKLLGCSITGPESLLVYEFVPNQS 351 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~ 351 (437)
.+.|+.|-...+|+....+ +..+++|+......... .-.+|..++..|...++ +++++.+. + .+||||++|..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4568888889999998765 46788887643322211 12478888877764444 56777662 2 35999999765
Q ss_pred cc
Q 013737 352 LL 353 (437)
Q Consensus 352 L~ 353 (437)
|.
T Consensus 188 l~ 189 (458)
T 2qg7_A 188 LS 189 (458)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.07 E-value=0.00081 Score=64.56 Aligned_cols=74 Identities=11% Similarity=0.111 Sum_probs=43.4
Q ss_pred CCcccccCcccEEEEEeCC---------CCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCc-eeceeEEEeeCCeeEEE
Q 013737 274 SNKLGQGGSGSVYKGTLPG---------GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN-LVKLLGCSITGPESLLV 343 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv 343 (437)
.+.|+.|....+|+....+ +..+++|+....... ......|..++..+...+ .+++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 3467778888999998654 267888876543222 112356777777664223 44666544 2 3789
Q ss_pred EeccCCCCc
Q 013737 344 YEFVPNQSL 352 (437)
Q Consensus 344 ~e~~~~g~L 352 (437)
|||++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0075 Score=57.05 Aligned_cols=31 Identities=29% Similarity=0.381 Sum_probs=27.5
Q ss_pred CCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 390 ~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4699999999999999888899999987664
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.94 E-value=0.024 Score=55.21 Aligned_cols=141 Identities=13% Similarity=0.163 Sum_probs=82.1
Q ss_pred CCcccccCcccEEEEEeCC--------CCEEEEEEEeccchhhHHHHHHHHHHHcCCC-CCceeceeEEEeeCCeeEEEE
Q 013737 274 SNKLGQGGSGSVYKGTLPG--------GEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 344 (437)
.+.|..|-...+|+....+ +..+++|+........ -.-.+|..+++.+. +.-.+++++.+ . -++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 3467778888999998753 5788888864432221 12346777776664 22245566533 2 37899
Q ss_pred eccCCCCcccc-cc-------------------c-----cC--CCCCCCHHHHHHHHHHH-------------------H
Q 013737 345 EFVPNQSLLDN-LF-------------------V-----RQ--DVEPLSWEVRYKIILST-------------------A 378 (437)
Q Consensus 345 e~~~~g~L~~~-l~-------------------~-----~~--~~~~l~~~~~~~i~~~i-------------------~ 378 (437)
||++|..|..- +. . .. ...+.-+.++.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 99998664321 10 0 00 11122244444443322 1
Q ss_pred HHHHHhh---------------------cCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 379 EGLAYLH---------------------EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 379 ~~l~yLH---------------------~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
..+.+|. ...+..++|+|+.+.||+ ++++.+.|+||..|..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2223322 112345899999999999 7788999999998763
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.82 E-value=0.23 Score=47.86 Aligned_cols=29 Identities=31% Similarity=0.422 Sum_probs=24.7
Q ss_pred eeeCCCCCCCeee------CCCCcEEEcccCCccc
Q 013737 392 IIHRDIKLSNILL------DEEFTAKIADFGLVRL 420 (437)
Q Consensus 392 iiHrDlk~~NIll------~~~~~~ki~DFG~a~~ 420 (437)
++|+|+.+.|||+ +++..++++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4566899999998763
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=90.07 E-value=0.65 Score=40.26 Aligned_cols=97 Identities=6% Similarity=0.006 Sum_probs=67.3
Q ss_pred HHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeee
Q 013737 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394 (437)
Q Consensus 315 E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH 394 (437)
|+.+|.. .||+.+.. .+-.+.+.+.+.++.-+. ...+- .-..++...+++++..|+.-..+++. -+|
T Consensus 36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~~--~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~t 102 (215)
T 4ann_A 36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDINDN--HTPFD----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYT 102 (215)
T ss_dssp GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCTT--SEEGG----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEE
T ss_pred HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCcc--cCCHH----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceE
Confidence 4444443 67888765 455566666666665432 22221 12346788999999999887766654 378
Q ss_pred CCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 395 RDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 395 rDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
--|.|+||+++.++.++|.-.|+-..+++.
T Consensus 103 f~L~P~NL~f~~~~~p~i~~RGik~~l~P~ 132 (215)
T 4ann_A 103 FVLAPDELFFTRDGLPIAKTRGLQNVVDPL 132 (215)
T ss_dssp CCCSGGGEEECTTSCEEESCCEETTTBSCC
T ss_pred EEEecceEEEcCCCCEEEEEccCccCCCCC
Confidence 889999999999999999999986655443
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.02 E-value=0.15 Score=31.89 Aligned_cols=11 Identities=27% Similarity=0.135 Sum_probs=4.0
Q ss_pred HHHHHHHHHHH
Q 013737 223 VFSLVAFFVRR 233 (437)
Q Consensus 223 ~~~~~~~~~~~ 233 (437)
++++.++++.|
T Consensus 26 ii~~~~~~~~R 36 (44)
T 2ks1_B 26 VVALGIGLFMR 36 (44)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHhh
Confidence 33333333333
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.01 E-value=0.7 Score=40.21 Aligned_cols=88 Identities=7% Similarity=0.061 Sum_probs=62.3
Q ss_pred CCCceeceeEEEeeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHH-HhhcCCCCCeeeCCCCCCC
Q 013737 323 NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA-YLHEESKLRIIHRDIKLSN 401 (437)
Q Consensus 323 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~-yLH~~~~~~iiHrDlk~~N 401 (437)
.||++ -...-.+.+.+.+.++.-+++.-...+ ..++...+++++..|+.-.. +++. -+|--|.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 57777 333445666766666655433222222 23678899999998887666 5554 4788899999
Q ss_pred eeeCCCCcEEEcccCCccccCC
Q 013737 402 ILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 402 Ill~~~~~~ki~DFG~a~~~~~ 423 (437)
|+++.++.++|.-.|+-..+++
T Consensus 115 L~f~~~~~p~i~hRGi~~~lpP 136 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKESLPP 136 (219)
T ss_dssp EEECTTCCEEESCCEETTTBSS
T ss_pred EEEeCCCcEEEEEcCCcccCCC
Confidence 9999999999999998666644
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=88.26 E-value=0.079 Score=52.27 Aligned_cols=61 Identities=7% Similarity=0.009 Sum_probs=18.6
Q ss_pred CcCCcccccCcccEEEEEeCC-CCEEEE------EEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEe
Q 013737 272 HESNKLGQGGSGSVYKGTLPG-GEAVAV------KRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335 (437)
Q Consensus 272 ~~~~~Lg~G~~g~V~~~~~~~-~~~vav------K~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 335 (437)
...+.|| ||.||++.+.. ..+||| |..+.. .......|.+|..++..++|||+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 3456676 99999999864 467888 766542 2233456888999999999999999998765
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.49 E-value=0.29 Score=30.52 Aligned_cols=9 Identities=11% Similarity=0.076 Sum_probs=3.3
Q ss_pred HHHHHHHHH
Q 013737 223 VFSLVAFFV 231 (437)
Q Consensus 223 ~~~~~~~~~ 231 (437)
++.+.++++
T Consensus 25 ii~~~~~~~ 33 (44)
T 2l2t_A 25 IVGLTFAVY 33 (44)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 333333333
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 437 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-45 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-43 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-42 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-42 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-42 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-42 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-41 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-41 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-41 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-40 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-40 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-38 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-38 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-37 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-37 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-37 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-36 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-36 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-36 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-36 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-36 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-36 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-35 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-35 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-35 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-34 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-33 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-33 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-33 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-33 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-33 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-32 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-32 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-32 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-30 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-30 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-30 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-30 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-30 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-29 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-29 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-29 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-29 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-28 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-27 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-27 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-27 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-26 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-26 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-25 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-25 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-25 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-25 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-24 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-23 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-22 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-22 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-20 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-20 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-19 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-19 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-16 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 4e-45
Identities = 54/163 (33%), Positives = 83/163 (50%), Gaps = 7/163 (4%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
++G G G+VYKG G AV + + T Q + F NEV ++ H N++ +G S
Sbjct: 14 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
T P+ +V ++ SL +L + + I TA+G+ YLH +S IIH
Sbjct: 74 -TAPQLAIVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPE-DITHISATLAGTL 436
RD+K +NI L E+ T KI DFGL + +H L+G++
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 2e-43
Identities = 42/174 (24%), Positives = 79/174 (45%), Gaps = 10/174 (5%)
Query: 264 LEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWV-DHFFNEVNLISG 321
+E + F + ++LG G G V+K + P G +A K + + + E+ ++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 322 INHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGL 381
N +V G + E + E + SL L + + ++ K+ ++ +GL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
YL K +I+HRD+K SNIL++ K+ DFG+ + + + + GT
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGT 166
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 3e-42
Identities = 44/166 (26%), Positives = 73/166 (43%), Gaps = 6/166 (3%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
++G G G V+ G + VA+K + + F E ++ ++H LV+L
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
G + LV+EF+ + L D ++R + E + L EG+AYL E
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEA--- 120
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
+IHRD+ N L+ E K++DFG+ R +D S +
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 166
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (376), Expect = 3e-42
Identities = 43/171 (25%), Positives = 76/171 (44%), Gaps = 9/171 (5%)
Query: 261 YETLEKATN---YFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEV 316
YE + + N ++ +LG G G VYK A K + + + ++ + E+
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS 376
++++ +H N+VKLL ++ EF ++ + + PL+ +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE--RPLTESQIQVVCKQ 118
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
T + L YLH+ +IIHRD+K NIL + K+ADFG+ I
Sbjct: 119 TLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 166
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 4e-42
Identities = 50/168 (29%), Positives = 78/168 (46%), Gaps = 6/168 (3%)
Query: 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV 328
+LG G G V+ G G VAVK L + D F E NL+ + H+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLV 71
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
+L P ++ E++ N SL+D L + L+ + AEG+A++ E +
Sbjct: 72 RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEERN 129
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
IHRD++ +NIL+ + + KIADFGL RL ++ +
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 174
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (375), Expect = 6e-42
Identities = 41/165 (24%), Positives = 69/165 (41%), Gaps = 10/165 (6%)
Query: 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGIN 323
F + ++G G G+VY + E VA+K++ + + EV + +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 324 HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
H N ++ GC + + LV E+ + ++ PL + +GLAY
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAY 130
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428
LH +IHRD+K NILL E K+ DFG + + +
Sbjct: 131 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV 172
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 147 bits (371), Expect = 2e-41
Identities = 47/187 (25%), Positives = 81/187 (43%), Gaps = 19/187 (10%)
Query: 259 FSYETLEKATNYFHES---------NKLGQGGSGSVYKGTLPG----GEAVAVKRLFYNT 305
F++E +A F + +G G G V G L VA+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 306 T-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP 364
T + F +E +++ +H N++ L G +++ EF+ N SL F+RQ+
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS--FLRQNDGQ 124
Query: 365 LSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
+ ++ A G+ YL + +HRD+ NIL++ K++DFGL R +D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 425 ITHISAT 431
+ + T
Sbjct: 182 TSDPTYT 188
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 4e-41
Identities = 39/166 (23%), Positives = 71/166 (42%), Gaps = 6/166 (3%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
+LG G G V G G VA+K + + D F E ++ ++H+ LV+L
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
G ++ E++ N LL+ L + + ++ E + YL +
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK--- 119
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
+ +HRD+ N L++++ K++DFGL R +D S +
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV 165
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 9e-41
Identities = 48/178 (26%), Positives = 79/178 (44%), Gaps = 6/178 (3%)
Query: 259 FSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNL 318
+ + E KLGQG G V+ GT G VA+K L T + F E +
Sbjct: 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQV 65
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA 378
+ + H+ LV+L ++ +V E++ SLLD + + L + A
Sbjct: 66 MKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIA 123
Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
G+AY+ ++ +HRD++ +NIL+ E K+ADFGL RL ++ +
Sbjct: 124 SGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 178
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (363), Expect = 2e-40
Identities = 56/179 (31%), Positives = 80/179 (44%), Gaps = 6/179 (3%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNL 318
+Y+ E +KLG G G VY+G VAVK L +T + V+ F E +
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 66
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA 378
+ I H NLV+LLG P ++ EF+ +LLD L + + +S V + +
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQIS 125
Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLF 437
+ YL K IHRD+ N L+ E K+ADFGL RL D A +
Sbjct: 126 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 181
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (361), Expect = 4e-40
Identities = 56/210 (26%), Positives = 82/210 (39%), Gaps = 32/210 (15%)
Query: 257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQWV- 309
LN +LE N +G+G G V++ PG VAVK L + +
Sbjct: 1 LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60
Query: 310 DHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF------------ 357
F E L++ ++ N+VKLLG G L++E++ L + L
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 358 ---------VRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408
PLS + I A G+AYL E + +HRD+ N L+ E
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENM 177
Query: 409 TAKIADFGLVR-LFPEDITHISATLAGTLF 437
KIADFGL R ++ D A +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIR 207
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 2e-38
Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 8/162 (4%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
+G+G G V G G + VAVK + F E ++++ + H NLV+L
Sbjct: 9 LKLLQTIGKGEFGDVMLGDYRGNK-VAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQL 65
Query: 331 LGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
LG + L +V E++ SL+D L + L + K L E + YL
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEGN-- 122
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
+HRD+ N+L+ E+ AK++DFGL +
Sbjct: 123 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 163
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 4e-38
Identities = 49/170 (28%), Positives = 67/170 (39%), Gaps = 13/170 (7%)
Query: 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKN 326
F LG+G G+VY +A+K L EV + S + H N
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
+++L G L+ E+ P ++ L Q + + I A L+Y H
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHS 124
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
R+IHRDIK N+LL KIADFG P TL GTL
Sbjct: 125 ---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTL 168
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-37
Identities = 45/174 (25%), Positives = 76/174 (43%), Gaps = 10/174 (5%)
Query: 266 KATNYFHESNKLGQGGSGSVYKGTL---PGGEAVAVKRLFYNTTQW-VDHFFNEVNLISG 321
K N +LG G GSV +G VA+K L T + + E ++
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 322 INHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGL 381
+++ +V+L+G +LV E L F+ E + +++ + G+
Sbjct: 66 LDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHK--FLVGKREEIPVSNVAELLHQVSMGM 122
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
YL E++ +HRD+ N+LL AKI+DFGL + D ++ +A AG
Sbjct: 123 KYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 5e-37
Identities = 42/170 (24%), Positives = 70/170 (41%), Gaps = 9/170 (5%)
Query: 266 KATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGI 322
+A +Y +G G G K G+ + K L Y T +EVNL+ +
Sbjct: 2 RAEDY-EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 323 NHKNLVKLLGCSITGPESLL--VYEFVPNQSLLDNLF-VRQDVEPLSWEVRYKIILSTAE 379
H N+V+ I + L V E+ L + ++ + L E +++
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 380 GLAYLHEESK--LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
L H S ++HRD+K +N+ LD + K+ DFGL R+ D +
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF 170
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 9e-37
Identities = 42/176 (23%), Positives = 68/176 (38%), Gaps = 15/176 (8%)
Query: 270 YFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKN 326
+ ++G+G +VYKG VA L T F E ++ G+ H N
Sbjct: 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 327 LVKLLGCSITGPES----LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
+V+ + + +LV E + + +L L + + +V +GL
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQ 126
Query: 383 YLHEESKLRIIHRDIKLSNILL-DEEFTAKIADFGLVRLFPEDITHISATLAGTLF 437
+LH + IIHRD+K NI + + KI D GL L + GT
Sbjct: 127 FLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPE 178
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 2e-36
Identities = 48/169 (28%), Positives = 70/169 (41%), Gaps = 9/169 (5%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL-FYNTTQWVDHFFNEVNLISGINHKNLV 328
+ LG+G G V EAVAVK + ++ E+ + +NH+N+V
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
K G G L E+ L D + + + G+ YLH
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG-- 121
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTL 436
+ I HRDIK N+LLDE KI+DFGL +F + + + GTL
Sbjct: 122 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 169
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 2e-36
Identities = 52/174 (29%), Positives = 77/174 (44%), Gaps = 20/174 (11%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFF-NEVNLISGINHKNLVKLLGCS 334
+G+G G V++G G E VAVK ++ + F E+ + H+N++ +
Sbjct: 10 SIGKGRFGEVWRGKWRG-EEVAVKIF--SSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 335 I----TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE--- 387
T + LV ++ + SL D L + ++ E K+ LSTA GLA+LH E
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 388 --SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA---TLAGTL 436
K I HRD+K NIL+ + T IAD GL I GT
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 3e-36
Identities = 43/184 (23%), Positives = 72/184 (39%), Gaps = 31/184 (16%)
Query: 276 KLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQ-WVDHFFNEVNLISGI-NHKNL 327
LG G G V T G VAVK L + +E+ +++ + +H+N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVR--------------------QDVEPLSW 367
V LLG L++E+ LL+ L + +D+ L++
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
E A+G+ +L + +HRD+ N+L+ KI DFGL R D +
Sbjct: 164 EDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 428 ISAT 431
+
Sbjct: 221 VVRG 224
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 4e-36
Identities = 54/205 (26%), Positives = 84/205 (40%), Gaps = 27/205 (13%)
Query: 250 VAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFY 303
V ++ ++L + ++ E N LG G G V + T G VAVK L
Sbjct: 5 VYIDPTQLPYDHK-WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP 63
Query: 304 NTTQW-VDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQD 361
+ + +E+ ++S + NH N+V LLG G +L++ E+ LL+ L ++D
Sbjct: 64 SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 123
Query: 362 VE---------------PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE 406
L E A+G+A+L + IHRD+ NILL
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTH 180
Query: 407 EFTAKIADFGLVRLFPEDITHISAT 431
KI DFGL R D ++
Sbjct: 181 GRITKICDFGLARDIKNDSNYVVKG 205
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 5e-36
Identities = 55/168 (32%), Positives = 77/168 (45%), Gaps = 13/168 (7%)
Query: 271 FHESNKLGQGGSGSVYKGTLPG----GEAVAVKRL---FYNTTQWVDHFFNEVNLISGIN 323
KLG G G V +G +VAVK L + + +D F EVN + ++
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 324 HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
H+NL++L G +T P +V E P SLLD L Q + + AEG+ Y
Sbjct: 70 HRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGY 126
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
L + R IHRD+ N+LL KI DFGL+R P++ H
Sbjct: 127 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ 171
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 6e-36
Identities = 43/168 (25%), Positives = 71/168 (42%), Gaps = 12/168 (7%)
Query: 273 ESNKLGQGGSGSVYKGTLPG---GEAVAVKRLFYNTTQ--WVDHFFNEVNLISGINHKNL 327
E +LG G G+V KG + VAVK L D E N++ +++ +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
V+++G +LV E L L + + + +++ + G+ YL E
Sbjct: 71 VRMIGI-CEAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES 126
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
+HRD+ N+LL + AKI+DFGL + D + A G
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 4e-35
Identities = 44/164 (26%), Positives = 76/164 (46%), Gaps = 9/164 (5%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
K+GQG SG+VY + G+ VA++++ + NE+ ++ + N+V L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
+ G E +V E++ SL D + + + + L +LH ++I
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLF 437
HRDIK NILL + + K+ DFG + + S T+ GT +
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS-TMVGTPY 181
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 4e-35
Identities = 41/167 (24%), Positives = 67/167 (40%), Gaps = 11/167 (6%)
Query: 276 KLGQGGSGSVYKGTLPG----GEAVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKL 330
+G+G G V++G AVA+K T+ V + F E + +H ++VKL
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
+G IT ++ E L F++ L + LAYL
Sbjct: 74 IGV-ITENPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYLES---K 127
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLF 437
R +HRDI N+L+ K+ DFGL R + + ++ +
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 7e-35
Identities = 48/180 (26%), Positives = 75/180 (41%), Gaps = 21/180 (11%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGG---EAVAVKRL-FYNTTQWVDHFFNEVNLISGI-NHK 325
+ +G+G G V K + A+KR+ Y + F E+ ++ + +H
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVE-------------PLSWEVRYK 372
N++ LLG L E+ P+ +LLD L + +E LS +
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
A G+ YL + + IHRD+ NIL+ E + AKIADFGL R + L
Sbjct: 132 FAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 188
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 130 bits (327), Expect = 1e-34
Identities = 36/159 (22%), Positives = 63/159 (39%), Gaps = 8/159 (5%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+LG G G V++ T G A K + + E+ +S + H LV L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
E +++YEF+ L + + + +S + + + +GL ++HE +H
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHEN---NYVH 147
Query: 395 RDIKLSNILL--DEEFTAKIADFGLVRLFPEDITHISAT 431
D+K NI+ K+ DFGL + T
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT 186
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 1e-33
Identities = 46/179 (25%), Positives = 76/179 (42%), Gaps = 11/179 (6%)
Query: 263 TLEKATNYFHESNKLGQGGSGSVYKGTLPGGE-----AVAVKRLFYNTTQW-VDHFFNEV 316
T E + +G G G VYKG L VA+K L T+ F E
Sbjct: 1 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60
Query: 317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS 376
++ +H N+++L G +++ E++ N +L F+R+ S ++
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRG 118
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
A G+ YL + +HRD+ NIL++ K++DFGL R+ +D T G
Sbjct: 119 IAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 174
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 127 bits (320), Expect = 1e-33
Identities = 40/168 (23%), Positives = 64/168 (38%), Gaps = 13/168 (7%)
Query: 269 NYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRL---FYNTTQWVDHFFNEVNLIS---G 321
N F +G+GG G VY G+ A+K L Q NE ++S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 322 INHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGL 381
+ +V + T + + + + L +L S GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAEIILGL 120
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429
++H +++RD+K +NILLDE +I+D GL F + H S
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 165
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 1e-33
Identities = 39/165 (23%), Positives = 59/165 (35%), Gaps = 10/165 (6%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKN 326
F LG+G +V L A+K L V + E +++S ++H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
VKL + + N LL + + L YLH
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHG 126
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
IIHRD+K NILL+E+ +I DFG ++ + A
Sbjct: 127 ---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 168
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 1e-33
Identities = 50/176 (28%), Positives = 80/176 (45%), Gaps = 14/176 (7%)
Query: 270 YFHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINH 324
H + +G+G G VY GTL AVK L T V F E ++ +H
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 325 KNLVKLLGCSITGPES-LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
N++ LLG + S L+V ++ + L + F+R + + + L A+G+ +
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKF 145
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE---DITHISATLAGTL 436
L + + +HRD+ N +LDE+FT K+ADFGL R + D H +
Sbjct: 146 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 198
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 2e-33
Identities = 46/167 (27%), Positives = 81/167 (48%), Gaps = 12/167 (7%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTT-QWVDHFFNEVNLISGINH 324
F + LG G G+VYKG +P GE VA+K L T+ + +E +++ +++
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
++ +LLG +T L+ + +P LLD + +D + + + A+G+ YL
Sbjct: 71 PHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYL 127
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
+ R++HRD+ N+L+ KI DFGL +L + A
Sbjct: 128 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 171
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 3e-32
Identities = 34/164 (20%), Positives = 66/164 (40%), Gaps = 5/164 (3%)
Query: 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL-FYNTTQWVDHFFNEVNLISGINHK 325
+ + +G+G G V VA+K++ + + E+ ++ H+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
N++ + + ++ + +L+ + LS + + GL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429
++HRD+K SN+LL+ KI DFGL R+ D H
Sbjct: 127 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 167
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 123 bits (309), Expect = 3e-32
Identities = 38/152 (25%), Positives = 64/152 (42%), Gaps = 8/152 (5%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+LG G G V++ G K + NE+++++ ++H L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
E +L+ EF+ L D + + +S + EGL ++HE I+H
Sbjct: 96 EDKYEMVLILEFLSGGELFD--RIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVH 150
Query: 395 RDIKLSNILLD--EEFTAKIADFGLVRLFPED 424
DIK NI+ + + + KI DFGL D
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPD 182
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 4e-32
Identities = 47/175 (26%), Positives = 77/175 (44%), Gaps = 17/175 (9%)
Query: 271 FHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQW-VDHFFNEVNLISGIN 323
S +LGQG G VY+G G VA+K + + F NE +++ N
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 324 HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQD-------VEPLSWEVRYKIILS 376
++V+LLG G +L++ E + L L + + P S ++
Sbjct: 82 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
A+G+AYL+ + +HRD+ N ++ E+FT KI DFG+ R E +
Sbjct: 142 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 2e-30
Identities = 31/155 (20%), Positives = 59/155 (38%), Gaps = 9/155 (5%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
LG+G G V++ + K + T E+++++ H+N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
+ E ++++EF+ + + + L+ + E L +LH I H
Sbjct: 71 ESMEELVMIFEFISGLDIFE--RINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 395 RDIKLSNILLD--EEFTAKIADFGLVRLFPEDITH 427
DI+ NI+ T KI +FG R
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 2e-30
Identities = 42/167 (25%), Positives = 70/167 (41%), Gaps = 15/167 (8%)
Query: 271 FHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+ ++ +G G G VY+ L GE VA+K++ Q E+ ++ ++H N+V+
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 330 LLGCSITGPES------LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
L + E LV ++VP + + L + LAY
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 384 LHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFPEDITHIS 429
+H I HRDIK N+LLD + K+ DFG + ++S
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (293), Expect = 3e-30
Identities = 36/162 (22%), Positives = 62/162 (38%), Gaps = 10/162 (6%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKN 326
F LG G G V+ G A+K L + V+H +E ++S + H
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
++++ G + ++ +++ L L Q + + L
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC------LALEY 119
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428
II+RD+K NILLD+ KI DFG + P+ +
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL 161
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 115 bits (289), Expect = 4e-30
Identities = 45/159 (28%), Positives = 70/159 (44%), Gaps = 8/159 (5%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLV 328
+H K+G+G G VYK GE A+K++ E++++ + H N+V
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
KL T +LV+E + L +L G+AY H+
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHD-- 118
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
R++HRD+K N+L++ E KIADFGL R F +
Sbjct: 119 -RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 115 bits (289), Expect = 4e-30
Identities = 42/168 (25%), Positives = 71/168 (42%), Gaps = 17/168 (10%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTT---------QWVDHFFNEVNLIS 320
+ LG+G S V + P + AVK + + + EV+++
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 321 GIN-HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
++ H N+++L T LV++ + L D L + LS + KI+ + E
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALLE 121
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
+ LH+ L I+HRD+K NILLD++ K+ DFG
Sbjct: 122 VICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL 166
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 1e-29
Identities = 51/162 (31%), Positives = 78/162 (48%), Gaps = 8/162 (4%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K RL T E++L+ +NH N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
VKLL T + LV+EF+ L + + + + +GLA+ H
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429
R++HRD+K N+L++ E K+ADFGL R F + +
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 160
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 1e-29
Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 12/159 (7%)
Query: 275 NKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVD-----HFFNEVNLISGINHKNLV 328
+ LG+G +VYK + VA+K++ E+ L+ ++H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
LL LV++F+ + ++ + L+ +L T +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
I+HRD+K +N+LLDE K+ADFGL + F
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 2e-29
Identities = 46/185 (24%), Positives = 71/185 (38%), Gaps = 26/185 (14%)
Query: 275 NKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQW-VDHFFNEVNLISGINHKNL 327
LG+G G V + G VAVK L T +E+ ++ I H
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 328 VKLLG--CSITGPESLLVYEFVPNQSLLDNLFVRQDV-------------EPLSWEVRYK 372
V L C+ G +++ EF +L L +++ + L+ E
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI-SAT 431
A+G+ +L + IHRD+ NILL E+ KI DFGL R +D ++
Sbjct: 139 YSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 432 LAGTL 436
L
Sbjct: 196 ARLPL 200
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (287), Expect = 2e-29
Identities = 38/179 (21%), Positives = 70/179 (39%), Gaps = 7/179 (3%)
Query: 261 YETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQW-VDHFFNEVNL 318
++ E + + + LG G V + VA+K + + NE+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA 378
+ I H N+V L +G L+ + V L D + + + ++I
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVL 117
Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLF 437
+ + YLH+ + + L LDE+ I+DFGL ++ ED + +T GT
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPG 174
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 1e-28
Identities = 46/176 (26%), Positives = 70/176 (39%), Gaps = 26/176 (14%)
Query: 275 NKLGQGGSGSVYKGTLPG--------GEAVAVKRLFYNTTQW-VDHFFNEVNLISGI-NH 324
LG+G G V G VAVK L + T+ + +E+ ++ I H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVR-------------QDVEPLSWEVRY 371
KN++ LLG ++ E+ +L + L R E LS +
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
A G+ YL + + IHRD+ N+L+ E+ KIADFGL R +
Sbjct: 139 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 108 bits (270), Expect = 2e-27
Identities = 43/178 (24%), Positives = 74/178 (41%), Gaps = 16/178 (8%)
Query: 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGIN 323
++ + LG GG V+ L VAVK L + F E + +N
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 324 HKNLVKLLGCSIT----GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
H +V + GP +V E+V +L D + P++ + ++I +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQ 122
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI--SATLAGT 435
L + H+ IIHRD+K +NI++ K+ DFG+ R + + +A + GT
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 5e-27
Identities = 41/182 (22%), Positives = 73/182 (40%), Gaps = 15/182 (8%)
Query: 266 KATNYFHESNKLGQGGSGSVYKGT--LPGGEAVAVKRLFYNTTQ--WVDHFFNEVNL--- 318
+A + ++G+G G V+K GG VA+KR+ T + EV +
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLL---DNLFVRQDVEPLSWEVRYKIIL 375
+ H N+V+L + + + + + E ++
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 376 STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
GL +LH R++HRD+K NIL+ K+ADFGL R++ + ++ T
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT--SVVVT 178
Query: 436 LF 437
L+
Sbjct: 179 LW 180
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 9e-27
Identities = 41/162 (25%), Positives = 73/162 (45%), Gaps = 9/162 (5%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFY--NTTQWVDHFFNEVNLISGINHKNL 327
+ + K+G+G G+V+K E VA+KR+ + E+ L+ + HKN+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
V+L + + LV+EF D++ E+ + +GL + H
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFCHSR 120
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429
++HRD+K N+L++ K+A+FGL R F + S
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (264), Expect = 3e-26
Identities = 42/170 (24%), Positives = 64/170 (37%), Gaps = 12/170 (7%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLIS-GINHK 325
F LG+G G V+ + A+K L V+ E ++S H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
L + T V E++ L+ ++ Q GL +LH
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGLQFLH 120
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
I++RD+KL NILLD++ KIADFG+ + + T GT
Sbjct: 121 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN-TFCGT 166
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 106 bits (265), Expect = 3e-26
Identities = 41/200 (20%), Positives = 74/200 (37%), Gaps = 21/200 (10%)
Query: 233 RKLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LP 291
++ L K +E + N ++L+ ++ ++ LG G G V
Sbjct: 16 KEFLAKAKEDFLKKWETPSQNTAQLD-QFDRIKT----------LGTGSFGRVMLVKHKE 64
Query: 292 GGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348
G A+K L + ++H NE ++ +N LVKL +V E+V
Sbjct: 65 SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408
+ +L S YLH L +I+RD+K N+L+D++
Sbjct: 125 GGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQG 178
Query: 409 TAKIADFGLVRLFPEDITHI 428
++ DFG + +
Sbjct: 179 YIQVTDFGFAKRVKGRTWTL 198
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 9e-26
Identities = 44/170 (25%), Positives = 59/170 (34%), Gaps = 11/170 (6%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKN 326
F LG+G G V G A+K L V H E ++ H
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
L L T V E+ L +L + E L YLH
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHS 123
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
+++RDIKL N++LD++ KI DFGL + D T GT
Sbjct: 124 ---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTP 169
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 2e-25
Identities = 40/180 (22%), Positives = 75/180 (41%), Gaps = 11/180 (6%)
Query: 256 KLNFSYETLEKAT----NYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLF--YNTTQW 308
+ F + + K + + +G G G+V G VA+K+L+ + + +
Sbjct: 1 RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVR-QDVEPLSW 367
+ E+ L+ + H+N++ LL +F + + E L
Sbjct: 61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGE 120
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
+ ++ +GL Y+H IIHRD+K N+ ++E+ KI DFGL R ++T
Sbjct: 121 DRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG 177
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (256), Expect = 3e-25
Identities = 42/180 (23%), Positives = 75/180 (41%), Gaps = 20/180 (11%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNL 327
+ + K+GQG G V+K G+ VA+K++ + E+ ++ + H+N+
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 328 VKLLGCSITGPES--------LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
V L+ T LV++F + V + +++
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLN 128
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDITHISATLAGTL 436
GL Y+H +I+HRD+K +N+L+ + K+ADFGL R F + TL
Sbjct: 129 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 4e-25
Identities = 36/170 (21%), Positives = 60/170 (35%), Gaps = 18/170 (10%)
Query: 269 NYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVN-LISGINHKN 326
+Y S LG G +G V + E A+K L Q EV +
Sbjct: 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPH 66
Query: 327 LVKLLGCSITGPES----LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
+V+++ L+V E + L + + + +I+ S E +
Sbjct: 67 IVRIVDVYENLYAGRKCLLIVMECLDGGELFS-RIQDRGDQAFTEREASEIMKSIGEAIQ 125
Query: 383 YLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITHIS 429
YLH + I HRD+K N+L K+ DFG + + +
Sbjct: 126 YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 172
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 4e-25
Identities = 40/172 (23%), Positives = 63/172 (36%), Gaps = 18/172 (10%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLF------YNTTQWVDHFFNEVNLISGIN--HKN 326
LG GG GSVY G + VA+K + + EV L+ ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
+++LL +L+ E L + + L E+ E + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHN 128
Query: 387 ESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFPEDITHISATLAGTLF 437
++HRDIK NIL+D K+ DFG L + + GT
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT---DFDGTRV 174
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 2e-24
Identities = 43/177 (24%), Positives = 68/177 (38%), Gaps = 20/177 (11%)
Query: 259 FSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL------FYNTTQWVDH 311
F E ++ +Y+ +LG G V K G A K + +
Sbjct: 3 FRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 59
Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY 371
EV+++ I H N++ L + +L+ E V L D L ++ L+ E
Sbjct: 60 IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEAT 116
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE----FTAKIADFGLVRLFPED 424
+ + G+ YLH L+I H D+K NI+L + KI DFGL
Sbjct: 117 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 170
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 97.2 bits (241), Expect = 2e-23
Identities = 36/157 (22%), Positives = 58/157 (36%), Gaps = 13/157 (8%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG-C 333
K+G G G +Y GT + GE VA+K T E + + + + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
G +++V E + F + S + + + Y+H I
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHS---KNFI 125
Query: 394 HRDIKLSNIL---LDEEFTAKIADFGLVRLFPEDITH 427
HRD+K N L + I DFGL + + + TH
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 94.5 bits (234), Expect = 2e-22
Identities = 27/159 (16%), Positives = 57/159 (35%), Gaps = 15/159 (9%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH-KNLVKLLGC 333
++G+G G +++GT L + VA+K +E + + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
G ++LV + + + S + + +HE ++
Sbjct: 70 GQEGLHNVLVIDLLGP---SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLV 123
Query: 394 HRDIKLSNILLDEEF-----TAKIADFGLVRLFPEDITH 427
+RDIK N L+ + DFG+V+ + + +T
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 162
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.4 bits (231), Expect = 8e-22
Identities = 44/169 (26%), Positives = 66/169 (39%), Gaps = 15/169 (8%)
Query: 275 NKLGQGGSGSVYKGTLPG----GEAVAVKRL----FYNTTQWVDHFFNEVNLISGINHK- 325
LG G G V+ G+ A+K L + +H E ++ I
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
LV L T + L+ +++ L +L R+ + + L +LH
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLH 146
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG 434
+ L II+RDIKL NILLD + DFGL + F D T + G
Sbjct: 147 K---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 192
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 89.9 bits (222), Expect = 1e-20
Identities = 36/187 (19%), Positives = 68/187 (36%), Gaps = 20/187 (10%)
Query: 249 QVAVNKSKLNFSYETLEKATNY---FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYN 304
V ++ + + YE+ + KLG+G V++ + E V VK L
Sbjct: 12 DVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL--- 68
Query: 305 TTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESL--LVYEFVPNQSLLDNLFVRQD 361
E+ ++ + N++ L LV+E V N
Sbjct: 69 KPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----- 123
Query: 362 VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRL 420
+ L+ + + L Y H + I+HRD+K N+++D E ++ D+GL
Sbjct: 124 -QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179
Query: 421 FPEDITH 427
+ +
Sbjct: 180 YHPGQEY 186
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.0 bits (222), Expect = 2e-20
Identities = 40/160 (25%), Positives = 62/160 (38%), Gaps = 6/160 (3%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNL 327
+ +G G G V VA+K+L + + E+ L+ +NHKN+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
+ LL + L+D + L E ++ G+ +LH
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 138
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
IIHRD+K SNI++ + T KI DFGL R
Sbjct: 139 ---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 175
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 83.7 bits (206), Expect = 2e-19
Identities = 27/155 (17%), Positives = 51/155 (32%), Gaps = 20/155 (12%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVD----------HFFNEVNLISGINH 324
+G+G +V+ VK T + HF +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
+ L KL G ++ P+ +L L +++ + E +++ E +A
Sbjct: 66 RALQKLQGLAV--PKVYAWEGNA----VLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
+ I+H D+ N+L+ E I DF
Sbjct: 120 YHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.9 bits (214), Expect = 2e-19
Identities = 47/186 (25%), Positives = 83/186 (44%), Gaps = 18/186 (9%)
Query: 254 KSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLF--YNTTQWVD 310
+ +LN +T+ + + + +G G GSV G VAVK+L + +
Sbjct: 6 RQELN---KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 62
Query: 311 HFFNEVNLISGINHKNLVKLLGC-----SITGPESLLVYEFVPNQSLLDNLFVRQDVEPL 365
+ E+ L+ + H+N++ LL S+ + + + L + + L
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKL 118
Query: 366 SWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425
+ + +I GL Y+H IIHRD+K SN+ ++E+ KI DFGL R +++
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 175
Query: 426 THISAT 431
T AT
Sbjct: 176 TGYVAT 181
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 76.2 bits (186), Expect = 9e-16
Identities = 35/173 (20%), Positives = 60/173 (34%), Gaps = 23/173 (13%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
KLG G +V+ + VA+K + + + +E+ L+ +N + K
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 335 ITGPESLLVYEFVPNQSLL-------------DNLFVRQDVEPLSWEVRYKIILSTAEGL 381
LL + + + L + + + +I GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEE------FTAKIADFGLVRLFPEDITHI 428
Y+H IIH DIK N+L++ KIAD G + E T+
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 437 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.98 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.98 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.98 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.98 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.98 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.98 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.98 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.97 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.97 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.97 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.97 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.97 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.97 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.97 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.97 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.97 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.97 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.97 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.97 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.97 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.97 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.96 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.96 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.96 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.96 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.96 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.96 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.96 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.96 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.96 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.96 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.96 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.95 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.95 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.95 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.95 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.94 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.94 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.87 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.68 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.27 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.79 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.05 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.76 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.3 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-36 Score=276.09 Aligned_cols=162 Identities=30% Similarity=0.398 Sum_probs=139.8
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
++|+..++||+|+||+||+|++ .+|+.||||++.... ....+++.+|+++|++++|||||++++++.+++..+|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 5688899999999999999997 468999999997543 33456789999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCCc
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~~ 426 (437)
+++|+|.+++. ....+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999884 3456999999999999999999999998 99999999999999999999999999998764432
Q ss_pred -ceeeeecccC
Q 013737 427 -HISATLAGTL 436 (437)
Q Consensus 427 -~~~~~~~Gt~ 436 (437)
...++.+||+
T Consensus 159 ~~~~~~~~GT~ 169 (271)
T d1nvra_ 159 ERLLNKMCGTL 169 (271)
T ss_dssp ECCBCCCCSCG
T ss_pred cccccceeeCc
Confidence 2334667886
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-36 Score=281.53 Aligned_cols=172 Identities=32% Similarity=0.450 Sum_probs=147.4
Q ss_pred CHHHHHHHhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC
Q 013737 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP 338 (437)
Q Consensus 260 ~~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 338 (437)
.+++++...++|+..++||+|+||+||+|.+. +++.||||+++.+. ...++|.+|+++|++++|||||++++++.+++
T Consensus 8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 86 (287)
T ss_dssp TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence 33445555678889999999999999999975 58899999987543 34678999999999999999999999999999
Q ss_pred eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCc
Q 013737 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (437)
Q Consensus 339 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a 418 (437)
..++||||+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a 162 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLS 162 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred eeEEEeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccce
Confidence 999999999999999988543 3456899999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCCcceeeeecccC
Q 013737 419 RLFPEDITHISATLAGTL 436 (437)
Q Consensus 419 ~~~~~~~~~~~~~~~Gt~ 436 (437)
+....+.....+...||+
T Consensus 163 ~~~~~~~~~~~~~~~g~~ 180 (287)
T d1opja_ 163 RLMTGDTYTAHAGAKFPI 180 (287)
T ss_dssp TTCCSSSSEEETTEEECG
T ss_pred eecCCCCceeeccccccc
Confidence 988765544433444553
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-35 Score=272.42 Aligned_cols=161 Identities=27% Similarity=0.425 Sum_probs=142.5
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
.++|+..++||+|+||+||+|.. .+|+.||||++........+.+.+|+++|++++|||||++++++.+++..+|||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 35799999999999999999996 56999999999866555677899999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCCc
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~~ 426 (437)
+++|+|.+++.. ..+++.++..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+|+.+..+..
T Consensus 99 ~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred cCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 999999987632 35899999999999999999999998 99999999999999999999999999998765433
Q ss_pred ceeeeecccC
Q 013737 427 HISATLAGTL 436 (437)
Q Consensus 427 ~~~~~~~Gt~ 436 (437)
. ....+||+
T Consensus 172 ~-~~~~~gt~ 180 (293)
T d1yhwa1 172 K-RSTMVGTP 180 (293)
T ss_dssp C-BCCCCSCG
T ss_pred c-ccccccCC
Confidence 2 23456775
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-35 Score=270.37 Aligned_cols=162 Identities=27% Similarity=0.401 Sum_probs=131.1
Q ss_pred cCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccC
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (437)
++|+..++||+|+||.||+|.+.+++.||||++.... ...++|.+|++++++++||||++++|++..++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4678889999999999999999888899999987543 345689999999999999999999999999999999999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCCcce
Q 013737 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428 (437)
Q Consensus 349 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~~~~ 428 (437)
+|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+|+.+.......
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 9999998743 3456899999999999999999999987 9999999999999999999999999999886654444
Q ss_pred eeeecccC
Q 013737 429 SATLAGTL 436 (437)
Q Consensus 429 ~~~~~Gt~ 436 (437)
.....||+
T Consensus 159 ~~~~~gt~ 166 (263)
T d1sm2a_ 159 STGTKFPV 166 (263)
T ss_dssp ------CT
T ss_pred ecceecCc
Confidence 44455664
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-35 Score=273.74 Aligned_cols=165 Identities=30% Similarity=0.447 Sum_probs=140.6
Q ss_pred HHhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
...++|+..++||+|+||.||+|.+++++.||||++.... ...+.|.+|+++|++++|||||+++|++.+ +..++|||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 3456788899999999999999999888899999997543 345689999999999999999999998754 56799999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~ 425 (437)
|+++|+|.+++... ...++++..++.|+.||++||.|||+++ |+||||||+||||++++.+||+|||+|+.+.+..
T Consensus 88 y~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 88 YMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred eCCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 99999999877433 2235899999999999999999999987 9999999999999999999999999999887654
Q ss_pred cceeeeecccC
Q 013737 426 THISATLAGTL 436 (437)
Q Consensus 426 ~~~~~~~~Gt~ 436 (437)
....+...||+
T Consensus 164 ~~~~~~~~gt~ 174 (272)
T d1qpca_ 164 YTAREGAKFPI 174 (272)
T ss_dssp EECCTTCCCCT
T ss_pred cccccccCCcc
Confidence 43333445554
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-35 Score=270.14 Aligned_cols=162 Identities=34% Similarity=0.512 Sum_probs=133.6
Q ss_pred HhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
..++|+..++||+|+||+||+|++++ .||||+++.. .....+.|.+|+.+|++++|||||++++++.+ +..+|||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 45779999999999999999998753 6999998643 45567889999999999999999999998754 5689999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||+++|+|.+++.. ...++++..++.++.||++||+|||+++ ||||||||+||||++++.+||+|||+|+.....
T Consensus 83 Ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 83 QWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp ECCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred ecCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 99999999998853 2346999999999999999999999987 999999999999999999999999999987643
Q ss_pred Ccc-eeeeecccC
Q 013737 425 ITH-ISATLAGTL 436 (437)
Q Consensus 425 ~~~-~~~~~~Gt~ 436 (437)
... ..++..||+
T Consensus 158 ~~~~~~~~~~gt~ 170 (276)
T d1uwha_ 158 SGSHQFEQLSGSI 170 (276)
T ss_dssp --------CCCCG
T ss_pred CCcccccccccCc
Confidence 322 333566775
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-34 Score=266.06 Aligned_cols=159 Identities=30% Similarity=0.415 Sum_probs=139.7
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..+.||+|+||.||+|++. +++.||+|++... .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888999999999999999974 6899999998643 3344678999999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999998843 345899999999999999999999998 999999999999999999999999999877654
Q ss_pred CcceeeeecccC
Q 013737 425 ITHISATLAGTL 436 (437)
Q Consensus 425 ~~~~~~~~~Gt~ 436 (437)
.. ....||+
T Consensus 160 ~~---~~~~Gt~ 168 (263)
T d2j4za1 160 RR---TTLCGTL 168 (263)
T ss_dssp CC---EETTEEG
T ss_pred cc---cccCCCC
Confidence 32 2456665
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-35 Score=272.60 Aligned_cols=162 Identities=26% Similarity=0.405 Sum_probs=141.2
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEecc
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (437)
+.|+..+.||+|+||.||+|++ .+++.||||++........+.+.+|+++|++++|||||++++++.+++..+|||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 5688899999999999999997 468999999998776666788999999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCCcc
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~~~ 427 (437)
++|+|.+++... ..++++.++..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+|+........
T Consensus 92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 166 (288)
T ss_dssp TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence 999999887432 346999999999999999999999998 999999999999999999999999999866432211
Q ss_pred eeeeecccC
Q 013737 428 ISATLAGTL 436 (437)
Q Consensus 428 ~~~~~~Gt~ 436 (437)
..+..||+
T Consensus 167 -~~~~~Gt~ 174 (288)
T d2jfla1 167 -RDSFIGTP 174 (288)
T ss_dssp -HTCCCSCC
T ss_pred -cccccccc
Confidence 12345665
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-35 Score=277.05 Aligned_cols=161 Identities=25% Similarity=0.404 Sum_probs=139.9
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
.++|+..++||+|+||.||+|.+ .+|+.||+|+++.. .....+++.+|+.+|++++|||||++++++.+++..+||||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 56799999999999999999997 46899999999754 34456789999999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
|+++|+|.+++... ..+++..+..++.|++.||.|||++ + |+||||||+||||++++++||+|||+|+.+.+.
T Consensus 85 y~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 99999999988543 4589999999999999999999974 6 999999999999999999999999999976533
Q ss_pred CcceeeeecccCC
Q 013737 425 ITHISATLAGTLF 437 (437)
Q Consensus 425 ~~~~~~~~~Gt~~ 437 (437)
. .++.+||++
T Consensus 159 ~---~~~~~GT~~ 168 (322)
T d1s9ja_ 159 M---ANSFVGTRS 168 (322)
T ss_dssp T---C---CCSSC
T ss_pred c---cccccCCcc
Confidence 2 235677764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-34 Score=261.17 Aligned_cols=162 Identities=24% Similarity=0.357 Sum_probs=142.1
Q ss_pred cCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccC
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (437)
++|+..++||+|+||+||+|++++++.||||.++.... ..++|++|+.++++++||||++++|++.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 67899999999999999999998888999999976543 35689999999999999999999999999999999999999
Q ss_pred CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCCcce
Q 013737 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428 (437)
Q Consensus 349 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~~~~ 428 (437)
+|+|.+++... ...+++..+.+++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.+.....
T Consensus 83 ~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 83 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp TEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 99998886433 346899999999999999999999987 9999999999999999999999999999876554443
Q ss_pred eeeecccC
Q 013737 429 SATLAGTL 436 (437)
Q Consensus 429 ~~~~~Gt~ 436 (437)
.+...||+
T Consensus 158 ~~~~~~t~ 165 (258)
T d1k2pa_ 158 SVGSKFPV 165 (258)
T ss_dssp CCCSCCCG
T ss_pred ecccCCCC
Confidence 33444554
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-34 Score=268.05 Aligned_cols=162 Identities=24% Similarity=0.321 Sum_probs=138.3
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..+.||+|+||+||+|+. .+++.||||++... .....+.+.+|+++|++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5689999999999999999997 46899999999643 2344678999999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999988743 346999999999999999999999998 999999999999999999999999999988644
Q ss_pred Ccc-eeeeecccC
Q 013737 425 ITH-ISATLAGTL 436 (437)
Q Consensus 425 ~~~-~~~~~~Gt~ 436 (437)
... ..++.+||+
T Consensus 162 ~~~~~~~~~~GT~ 174 (288)
T d1uu3a_ 162 SKQARANSFVGTA 174 (288)
T ss_dssp --------CCCCG
T ss_pred CcccccccccCCc
Confidence 322 333567875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.1e-34 Score=268.40 Aligned_cols=152 Identities=27% Similarity=0.437 Sum_probs=125.4
Q ss_pred cCCCcCCcccccCcccEEEEEeCC-C---CEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLPG-G---EAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
++|+..++||+|+||+||+|.+.. + ..||||.+... .....++|.+|+++|++++|||||+++|++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 345667899999999999999742 3 25889988654 445567899999999999999999999999999999999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|||+++|+|.+++.. ....+++.+++.++.||++||.|||+++ |+||||||+||||+.++++||+|||+|+.+..
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999987743 3456999999999999999999999987 99999999999999999999999999998765
Q ss_pred CC
Q 013737 424 DI 425 (437)
Q Consensus 424 ~~ 425 (437)
..
T Consensus 181 ~~ 182 (299)
T d1jpaa_ 181 DT 182 (299)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.3e-33 Score=267.71 Aligned_cols=161 Identities=25% Similarity=0.340 Sum_probs=141.6
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEecc
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (437)
++|+..++||+|+||.||+|.. .+|+.||||++........+.+.+|+++|++++|||||++++++.+++..+|||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5689999999999999999997 569999999998766666678999999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC--CCCcEEEcccCCccccCCCC
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD--EEFTAKIADFGLVRLFPEDI 425 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~--~~~~~ki~DFG~a~~~~~~~ 425 (437)
++|+|.+.+. ....++++.++..|+.||+.||.|||+++ |+||||||+||||+ .++.+||+|||+|+.+..+.
T Consensus 109 ~gg~L~~~~~--~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTT--CTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 9999988763 23456999999999999999999999998 99999999999998 67899999999999887643
Q ss_pred cceeeeecccC
Q 013737 426 THISATLAGTL 436 (437)
Q Consensus 426 ~~~~~~~~Gt~ 436 (437)
. ..+..||+
T Consensus 184 ~--~~~~~gt~ 192 (352)
T d1koba_ 184 I--VKVTTATA 192 (352)
T ss_dssp C--EEEECSSG
T ss_pred c--eeeccCcc
Confidence 2 23455654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-33 Score=260.21 Aligned_cols=159 Identities=26% Similarity=0.344 Sum_probs=134.3
Q ss_pred CCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEee----CCeeEEE
Q 013737 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT----GPESLLV 343 (437)
Q Consensus 271 ~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv 343 (437)
|+..++||+|+||+||+|.+. +++.||+|.+... .....+.|.+|+++|++++|||||++++++.+ +...++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 355678999999999999974 6889999998654 34456789999999999999999999999865 3457999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC-CCCcEEEcccCCccccC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRLFP 422 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~-~~~~~ki~DFG~a~~~~ 422 (437)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ ++|+||||||+|||++ +++.+||+|||+|+...
T Consensus 91 mE~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999998843 346899999999999999999999975 4599999999999996 57899999999998765
Q ss_pred CCCcceeeeecccC
Q 013737 423 EDITHISATLAGTL 436 (437)
Q Consensus 423 ~~~~~~~~~~~Gt~ 436 (437)
.... .+..||+
T Consensus 167 ~~~~---~~~~GT~ 177 (270)
T d1t4ha_ 167 ASFA---KAVIGTP 177 (270)
T ss_dssp TTSB---EESCSSC
T ss_pred CCcc---CCcccCc
Confidence 4332 3567876
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.8e-33 Score=268.06 Aligned_cols=161 Identities=23% Similarity=0.347 Sum_probs=142.5
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEecc
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (437)
++|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+++..+|||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999997 468999999998776666788999999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC--CCCcEEEcccCCccccCCCC
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD--EEFTAKIADFGLVRLFPEDI 425 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~--~~~~~ki~DFG~a~~~~~~~ 425 (437)
++|+|.+++.. ....+++..+..++.||+.||.|||+++ ||||||||+|||++ .++.+||+|||+|+.+....
T Consensus 106 ~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999998743 3356999999999999999999999998 99999999999996 45789999999999886544
Q ss_pred cceeeeecccC
Q 013737 426 THISATLAGTL 436 (437)
Q Consensus 426 ~~~~~~~~Gt~ 436 (437)
. ..+..||+
T Consensus 181 ~--~~~~~gT~ 189 (350)
T d1koaa2 181 S--VKVTTGTA 189 (350)
T ss_dssp C--EEEECSCT
T ss_pred c--cceecCcc
Confidence 3 23566775
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7e-34 Score=267.73 Aligned_cols=149 Identities=28% Similarity=0.458 Sum_probs=132.9
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc---hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
+.|+..++||+|+||.||+|++ .+++.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4588899999999999999996 568899999997542 344567999999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
||+++|+|..++. ...++++.++..++.||+.||.|||+++ |+||||||+||||++++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999998866553 2356999999999999999999999998 99999999999999999999999999987654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-34 Score=264.66 Aligned_cols=167 Identities=25% Similarity=0.380 Sum_probs=129.2
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEee--CCeeEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT--GPESLLV 343 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 343 (437)
++|+..+.||+|+||.||+|+. .+|+.||||.+... .....+.+.+|+++|++++|||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5788999999999999999997 46899999998654 34456789999999999999999999998865 4568999
Q ss_pred EeccCCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCC--CCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 344 YEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESK--LRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~--~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
|||+++|+|.+++... .....+++..++.++.||+.||.|||+++. .+|+||||||+||||++++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999988533 234569999999999999999999998641 3599999999999999999999999999998
Q ss_pred cCCCCcceeeeecccC
Q 013737 421 FPEDITHISATLAGTL 436 (437)
Q Consensus 421 ~~~~~~~~~~~~~Gt~ 436 (437)
+..+... .....||+
T Consensus 164 ~~~~~~~-~~~~~gt~ 178 (269)
T d2java1 164 LNHDTSF-AKAFVGTP 178 (269)
T ss_dssp C------------CCC
T ss_pred cccCCCc-cccCCCCc
Confidence 8654332 23567776
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-33 Score=266.92 Aligned_cols=161 Identities=28% Similarity=0.273 Sum_probs=141.4
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5688999999999999999997 56999999999753 2345678899999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 99999999998743 345899999999999999999999998 999999999999999999999999999977544
Q ss_pred CcceeeeecccC
Q 013737 425 ITHISATLAGTL 436 (437)
Q Consensus 425 ~~~~~~~~~Gt~ 436 (437)
.. ...+.+||+
T Consensus 159 ~~-~~~~~~GT~ 169 (337)
T d1o6la_ 159 GA-TMKTFCGTP 169 (337)
T ss_dssp TC-CBCCCEECG
T ss_pred Cc-ccccceeCH
Confidence 33 233567776
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-33 Score=264.36 Aligned_cols=162 Identities=24% Similarity=0.328 Sum_probs=124.2
Q ss_pred HhcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc-hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 267 ~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
..+.|+..+.||+|+||+||+|++. +++.||||.+.... ....+.+.+|+.+|++++|||||++++++.+++..+|||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3466899999999999999999974 68999999997543 233457889999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC---CCCcEEEcccCCcccc
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLF 421 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~---~~~~~ki~DFG~a~~~ 421 (437)
||+++|+|.+++.. ...+++.++..++.||+.||.|||+++ |+||||||+|||+. +++.+||+|||+|+..
T Consensus 87 E~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99999999998843 456999999999999999999999998 99999999999994 5789999999999977
Q ss_pred CCCCcceeeeecccC
Q 013737 422 PEDITHISATLAGTL 436 (437)
Q Consensus 422 ~~~~~~~~~~~~Gt~ 436 (437)
..... ..+.+||+
T Consensus 161 ~~~~~--~~~~~GT~ 173 (307)
T d1a06a_ 161 DPGSV--LSTACGTP 173 (307)
T ss_dssp --------------C
T ss_pred cCCCe--eeeeeeCc
Confidence 54432 23456775
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.4e-33 Score=262.54 Aligned_cols=163 Identities=29% Similarity=0.416 Sum_probs=132.6
Q ss_pred hcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEecc
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (437)
.++|+..+.||+|+||+||+|.+++++.||||++.... ...+.|.+|+.+|++++|||||++++++. .+..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence 46788999999999999999999888899999986543 34578999999999999999999999985 46689999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCCcc
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~~~ 427 (437)
++|+|.+++.... ...++|.+++.++.||+.||.|||+.+ |+||||||+||||++++++||+|||+|+.+.+....
T Consensus 94 ~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 94 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp TTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 9999988875432 345999999999999999999999998 999999999999999999999999999987655443
Q ss_pred eeeeecccC
Q 013737 428 ISATLAGTL 436 (437)
Q Consensus 428 ~~~~~~Gt~ 436 (437)
..+...||+
T Consensus 170 ~~~~~~gt~ 178 (285)
T d1fmka3 170 ARQGAKFPI 178 (285)
T ss_dssp ------CCG
T ss_pred eeccccccc
Confidence 333445553
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=4.3e-33 Score=259.42 Aligned_cols=151 Identities=26% Similarity=0.392 Sum_probs=130.5
Q ss_pred cCCCcCC-cccccCcccEEEEEeC---CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEE
Q 013737 269 NYFHESN-KLGQGGSGSVYKGTLP---GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 269 ~~~~~~~-~Lg~G~~g~V~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (437)
++|...+ +||+|+||.||+|.++ ++..||||.++.. .....++|.+|+++|++++|||||+++|++.+ +..+||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 3455556 4999999999999864 3557999999754 44556789999999999999999999999865 568999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|||+++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999998732 3456999999999999999999999987 99999999999999999999999999998865
Q ss_pred CC
Q 013737 424 DI 425 (437)
Q Consensus 424 ~~ 425 (437)
..
T Consensus 162 ~~ 163 (285)
T d1u59a_ 162 DD 163 (285)
T ss_dssp CS
T ss_pred cc
Confidence 44
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=4.2e-33 Score=259.67 Aligned_cols=152 Identities=27% Similarity=0.430 Sum_probs=128.1
Q ss_pred cCCCcCCcccccCcccEEEEEeCCC-----CEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLPGG-----EAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
+.|+..++||+|+||.||+|.+++. ..||||++... ......+|.+|+++|++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577889999999999999997532 37999999754 34455679999999999999999999999999999999
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
||||+.++++.+.+.. ....+++.+++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999887643 3356999999999999999999999987 9999999999999999999999999999876
Q ss_pred CCC
Q 013737 423 EDI 425 (437)
Q Consensus 423 ~~~ 425 (437)
...
T Consensus 162 ~~~ 164 (283)
T d1mqba_ 162 DDP 164 (283)
T ss_dssp ---
T ss_pred CCC
Confidence 543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=4.8e-33 Score=258.22 Aligned_cols=155 Identities=26% Similarity=0.363 Sum_probs=129.1
Q ss_pred CcccccCcccEEEEEeCC---CCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEeccCC
Q 013737 275 NKLGQGGSGSVYKGTLPG---GEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN 349 (437)
Q Consensus 275 ~~Lg~G~~g~V~~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (437)
++||+|+||.||+|.+++ ++.||||+++.. +....++|.+|+++|++++|||||++++++.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998643 468999998643 33446789999999999999999999999865 567899999999
Q ss_pred CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCCccee
Q 013737 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429 (437)
Q Consensus 350 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~~~~~ 429 (437)
|+|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+........
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999998843 346999999999999999999999987 99999999999999999999999999998765543322
Q ss_pred e--eecccC
Q 013737 430 A--TLAGTL 436 (437)
Q Consensus 430 ~--~~~Gt~ 436 (437)
+ ...||+
T Consensus 166 ~~~~~~gt~ 174 (277)
T d1xbba_ 166 AQTHGKWPV 174 (277)
T ss_dssp C----CCCG
T ss_pred cccccCCCc
Confidence 2 345654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.98 E-value=5.9e-33 Score=262.28 Aligned_cols=158 Identities=27% Similarity=0.363 Sum_probs=139.4
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..+.||+|+||+||+|++ .+|+.||||++... .....+.+.+|+.+|+.++||||+++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4688899999999999999997 56999999999743 3345678999999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||+++|+|..++. ....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+...+.
T Consensus 84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999988774 3345788999999999999999999998 999999999999999999999999999987654
Q ss_pred CcceeeeecccC
Q 013737 425 ITHISATLAGTL 436 (437)
Q Consensus 425 ~~~~~~~~~Gt~ 436 (437)
. ++.+||+
T Consensus 158 ~----~~~~Gt~ 165 (316)
T d1fota_ 158 T----YTLCGTP 165 (316)
T ss_dssp B----CCCCSCT
T ss_pred c----ccccCcc
Confidence 3 2456775
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=2.6e-33 Score=266.22 Aligned_cols=169 Identities=26% Similarity=0.393 Sum_probs=138.0
Q ss_pred HHHhcCCCcCCcccccCcccEEEEEeCC-C-----CEEEEEEEecc-chhhHHHHHHHHHHHcCC-CCCceeceeEEEee
Q 013737 265 EKATNYFHESNKLGQGGSGSVYKGTLPG-G-----EAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSIT 336 (437)
Q Consensus 265 ~~~~~~~~~~~~Lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 336 (437)
+...++|+..++||+|+||+||+|++.. + ..||+|.+... .......+.+|+.+|.++ +|||||++++++.+
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 3445778899999999999999998642 2 36899998654 334456789999999998 89999999999999
Q ss_pred CCeeEEEEeccCCCCccccccccCC--------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCC
Q 013737 337 GPESLLVYEFVPNQSLLDNLFVRQD--------------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRD 396 (437)
Q Consensus 337 ~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrD 396 (437)
.+..++||||+++|+|.+++..+.. ...+++..++.++.||+.||.|||+++ |||||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRD 189 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD 189 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecc
Confidence 9999999999999999999865432 235899999999999999999999987 99999
Q ss_pred CCCCCeeeCCCCcEEEcccCCccccCCCCcce-eeeecccC
Q 013737 397 IKLSNILLDEEFTAKIADFGLVRLFPEDITHI-SATLAGTL 436 (437)
Q Consensus 397 lk~~NIll~~~~~~ki~DFG~a~~~~~~~~~~-~~~~~Gt~ 436 (437)
|||+|||++.++.+||+|||+|+......... ..+..||+
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~ 230 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPV 230 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECG
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCC
Confidence 99999999999999999999999876554332 22455664
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.98 E-value=8.2e-33 Score=256.42 Aligned_cols=160 Identities=27% Similarity=0.375 Sum_probs=139.2
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc---------hhhHHHHHHHHHHHcCCC-CCceeceeEEEeeC
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT---------TQWVDHFFNEVNLISGIN-HKNLVKLLGCSITG 337 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 337 (437)
++|+..+.||+|+||+||+|+. .+++.+|||++.... ....+.+.+|+.+|++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6788999999999999999997 568999999986542 122356889999999997 99999999999999
Q ss_pred CeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCC
Q 013737 338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417 (437)
Q Consensus 338 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~ 417 (437)
+..||||||+++|+|.+++.. ..++++.++..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 999999999999999999853 346999999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCcceeeeecccC
Q 013737 418 VRLFPEDITHISATLAGTL 436 (437)
Q Consensus 418 a~~~~~~~~~~~~~~~Gt~ 436 (437)
++.+.+.... +...||+
T Consensus 157 a~~~~~~~~~--~~~~gt~ 173 (277)
T d1phka_ 157 SCQLDPGEKL--REVCGTP 173 (277)
T ss_dssp CEECCTTCCB--CCCCSCG
T ss_pred eeEccCCCce--eeeeccC
Confidence 9988654322 3345654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=3.9e-33 Score=262.31 Aligned_cols=172 Identities=30% Similarity=0.402 Sum_probs=143.0
Q ss_pred HHHHHHhcCCCcCCcccccCcccEEEEEeC------CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEE
Q 013737 262 ETLEKATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCS 334 (437)
Q Consensus 262 ~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 334 (437)
.+++.+.++|+..+.||+|+||.||+|+++ +++.||||++... .....++|.+|+++|++++||||+++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 445557788999999999999999999864 3568999998754 344567899999999999999999999999
Q ss_pred eeCCeeEEEEeccCCCCccccccccC---------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCee
Q 013737 335 ITGPESLLVYEFVPNQSLLDNLFVRQ---------------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393 (437)
Q Consensus 335 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ii 393 (437)
...+..+++|||+++|+|.+++.... ....+++..++.|+.|++.||+|||+++ ||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence 99999999999999999999885432 1235899999999999999999999988 99
Q ss_pred eCCCCCCCeeeCCCCcEEEcccCCccccCCCCcc-eeeeecccC
Q 013737 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH-ISATLAGTL 436 (437)
Q Consensus 394 HrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~~~-~~~~~~Gt~ 436 (437)
||||||+||||+.++++||+|||+|+.+.+.... ..++..||+
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~ 206 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPI 206 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCG
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCc
Confidence 9999999999999999999999999877544322 222445554
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.8e-32 Score=254.55 Aligned_cols=151 Identities=27% Similarity=0.354 Sum_probs=134.8
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc------hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCee
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT------TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES 340 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 340 (437)
.+.|+..+.||+|+||+||+|.+ .+|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46789999999999999999997 568999999986431 22467899999999999999999999999999999
Q ss_pred EEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC----cEEEcccC
Q 013737 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF----TAKIADFG 416 (437)
Q Consensus 341 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~----~~ki~DFG 416 (437)
+|||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 9999999999999988443 46999999999999999999999998 99999999999998776 59999999
Q ss_pred CccccCCC
Q 013737 417 LVRLFPED 424 (437)
Q Consensus 417 ~a~~~~~~ 424 (437)
+|+.+...
T Consensus 163 ~a~~~~~~ 170 (293)
T d1jksa_ 163 LAHKIDFG 170 (293)
T ss_dssp TCEECTTS
T ss_pred hhhhcCCC
Confidence 99987644
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=2.8e-32 Score=261.19 Aligned_cols=158 Identities=25% Similarity=0.310 Sum_probs=139.5
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (437)
++|+..+.||+|+||.||+|++ .+|+.||||++... .....+.+.+|+.+|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 4789999999999999999997 46999999998643 2344678999999999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 999999999988543 45899999999999999999999998 999999999999999999999999999987643
Q ss_pred CcceeeeecccC
Q 013737 425 ITHISATLAGTL 436 (437)
Q Consensus 425 ~~~~~~~~~Gt~ 436 (437)
. .+..||+
T Consensus 195 ~----~~~~Gt~ 202 (350)
T d1rdqe_ 195 T----WTLCGTP 202 (350)
T ss_dssp B----CCCEECG
T ss_pred c----ccccCcc
Confidence 2 2345665
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.1e-31 Score=254.16 Aligned_cols=152 Identities=20% Similarity=0.268 Sum_probs=134.3
Q ss_pred hcCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
.++|++.+.||+|+||+||+|.+. +++.||||.++.... ....+.+|+++|+.++|||||++++++.+++..||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 467889999999999999999974 688999999976543 345688999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCC--CcEEEcccCCccccCCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE--FTAKIADFGLVRLFPED 424 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~--~~~ki~DFG~a~~~~~~ 424 (437)
+++|+|.+++.. ...++++.++..++.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999998843 2346999999999999999999999998 9999999999999854 58999999999987654
Q ss_pred C
Q 013737 425 I 425 (437)
Q Consensus 425 ~ 425 (437)
.
T Consensus 158 ~ 158 (321)
T d1tkia_ 158 D 158 (321)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.1e-32 Score=255.64 Aligned_cols=163 Identities=23% Similarity=0.298 Sum_probs=125.4
Q ss_pred hcCCCcCCcccccCcccEEEEEeCC----CCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
.++|+..+.||+|+||.||+|.+.. +..||||.++.. .....+.|.+|+++|++++||||+++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4678889999999999999998642 346889988644 4445678999999999999999999999985 467899
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
||||+++|+|.+++.. ....+++..++.++.||++||.|||+++ |+||||||+|||+++++.+||+|||+|+.+.
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999887643 3456899999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCcceeeeecccC
Q 013737 423 EDITHISATLAGTL 436 (437)
Q Consensus 423 ~~~~~~~~~~~Gt~ 436 (437)
.......+...||+
T Consensus 160 ~~~~~~~~~~~gt~ 173 (273)
T d1mp8a_ 160 DSTYYKASKGKLPI 173 (273)
T ss_dssp -----------CCG
T ss_pred CCcceeccceecCc
Confidence 55444444556664
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.97 E-value=7.2e-32 Score=259.66 Aligned_cols=159 Identities=25% Similarity=0.213 Sum_probs=134.7
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccc---hhhHHHH---HHHHHHHcCCCCCceeceeEEEeeCCeeE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHF---FNEVNLISGINHKNLVKLLGCSITGPESL 341 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (437)
++|++.++||+|+||.||+|+.. +|+.||||++.... ......+ .+|+.+++.++|||||++++++.+++..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57889999999999999999974 69999999986431 1122233 44577888999999999999999999999
Q ss_pred EEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 99999999999998843 345889999999999999999999998 999999999999999999999999999987
Q ss_pred CCCCcceeeeecccC
Q 013737 422 PEDITHISATLAGTL 436 (437)
Q Consensus 422 ~~~~~~~~~~~~Gt~ 436 (437)
..... ....||+
T Consensus 158 ~~~~~---~~~~GT~ 169 (364)
T d1omwa3 158 SKKKP---HASVGTH 169 (364)
T ss_dssp SSSCC---CSCCSCG
T ss_pred CCCcc---ccccccc
Confidence 65432 2345665
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.9e-32 Score=252.65 Aligned_cols=152 Identities=32% Similarity=0.513 Sum_probs=130.6
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccc--hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
++|+..++||+|+||+||+|.+ .+|+.||||+++... ....+++.+|+++|++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788999999999999999997 568999999996542 2345789999999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~ 425 (437)
|+.++ +.+++.. .....+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~-~~~~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQD-LKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEE-HHHHHHH-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCc-hhhhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99754 4444422 34456999999999999999999999998 9999999999999999999999999998876543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.8e-32 Score=255.38 Aligned_cols=175 Identities=27% Similarity=0.341 Sum_probs=134.0
Q ss_pred cCHHHHHHHhcCCCcCCcccccCcccEEEEEeC------CCCEEEEEEEecc-chhhHHHHHHHHHHHcCC-CCCceece
Q 013737 259 FSYETLEKATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKL 330 (437)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l 330 (437)
++...++...++|+..++||+|+||.||+|.+. +++.||||+++.. .....+.+.+|..++.++ +|+||+.+
T Consensus 3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 345566666678999999999999999999863 2468999998754 344566788888888776 68999999
Q ss_pred eEEEeeCC-eeEEEEeccCCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCC
Q 013737 331 LGCSITGP-ESLLVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRD 396 (437)
Q Consensus 331 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrD 396 (437)
++++...+ ..++||||+++|+|.+++..... ...+++.+++.++.||+.||.|||+++ |+|||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCc
Confidence 99877654 68999999999999999854321 245899999999999999999999998 99999
Q ss_pred CCCCCeeeCCCCcEEEcccCCccccCCCCcce-eeeecccC
Q 013737 397 IKLSNILLDEEFTAKIADFGLVRLFPEDITHI-SATLAGTL 436 (437)
Q Consensus 397 lk~~NIll~~~~~~ki~DFG~a~~~~~~~~~~-~~~~~Gt~ 436 (437)
|||+||||++++.+||+|||+|+......... .+...||+
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~ 200 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 200 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGG
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCc
Confidence 99999999999999999999999776544332 23456764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.97 E-value=8.9e-32 Score=251.27 Aligned_cols=150 Identities=29% Similarity=0.421 Sum_probs=134.0
Q ss_pred cCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccc--hhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEec
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (437)
++|+..++||+|+||+||+|++++|+.||||++.... ....+++.+|+.+|++++||||+++++++..++..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788899999999999999999999999999996542 33357899999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
+.++.+..+. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|......
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9877666554 33466999999999999999999999987 999999999999999999999999999887654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.4e-31 Score=253.40 Aligned_cols=162 Identities=25% Similarity=0.441 Sum_probs=131.2
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCC----EEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGE----AVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (437)
.+|+..++||+|+||+||+|.+. +|+ +||+|++... .....++|.+|+++|++++|||||+++|++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35888999999999999999864 444 5899988643 445577899999999999999999999999764 5678
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccC
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~ 422 (437)
++||+.+++|.+.+.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999887743 3456899999999999999999999987 9999999999999999999999999999886
Q ss_pred CCCccee-eeecccC
Q 013737 423 EDITHIS-ATLAGTL 436 (437)
Q Consensus 423 ~~~~~~~-~~~~Gt~ 436 (437)
....... ....||+
T Consensus 163 ~~~~~~~~~~~~gt~ 177 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPI 177 (317)
T ss_dssp TTCC--------CCT
T ss_pred cccccccccccccCc
Confidence 5544332 2445664
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.7e-31 Score=252.72 Aligned_cols=161 Identities=25% Similarity=0.332 Sum_probs=137.4
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc---chhhHHHHHHHHHHHc-CCCCCceeceeEEEeeCCeeEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLIS-GINHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 343 (437)
++|...+.||+|+||+||+|+.. +++.||||++... .....+.+.+|..++. .++|||||++++++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 56888999999999999999974 6899999999753 2334566777777665 68999999999999999999999
Q ss_pred EeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
|||+++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999998843 345899999999999999999999998 99999999999999999999999999997654
Q ss_pred CCcceeeeecccC
Q 013737 424 DITHISATLAGTL 436 (437)
Q Consensus 424 ~~~~~~~~~~Gt~ 436 (437)
.... .+...||+
T Consensus 156 ~~~~-~~~~~gt~ 167 (320)
T d1xjda_ 156 GDAK-TNTFCGTP 167 (320)
T ss_dssp TTCC-BCCCCSCG
T ss_pred cccc-ccccCCCC
Confidence 4332 23456765
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.8e-31 Score=250.80 Aligned_cols=156 Identities=28% Similarity=0.371 Sum_probs=129.5
Q ss_pred CCcccccCcccEEEEEe-CCCCEEEEEEEeccchh-----hHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEecc
Q 013737 274 SNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQ-----WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (437)
.++||+|+||+||+|++ .+|+.||||++...... ..+.+.+|+.+|++++|||||++++++.+++..+|||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 57899999999999997 46899999998644221 2346889999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCCcc
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~~~ 427 (437)
+++++..+. .....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+........
T Consensus 83 ~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp SEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred cchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 988776554 34456889999999999999999999998 999999999999999999999999999887654332
Q ss_pred eeeeecccC
Q 013737 428 ISATLAGTL 436 (437)
Q Consensus 428 ~~~~~~Gt~ 436 (437)
. ...+||+
T Consensus 157 ~-~~~~gt~ 164 (299)
T d1ua2a_ 157 Y-THQVVTR 164 (299)
T ss_dssp C-CCSCCCC
T ss_pred c-cceecCh
Confidence 2 2345665
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.9e-32 Score=253.66 Aligned_cols=160 Identities=30% Similarity=0.440 Sum_probs=138.2
Q ss_pred HHHHHhcCCCcCCcccccCcccEEEEEeC------CCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEe
Q 013737 263 TLEKATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335 (437)
Q Consensus 263 ~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 335 (437)
+++...++|+..++||+|+||.||+|.+. ++..||||+++.. .......|.+|+.++++++||||+++++++.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 34445577888999999999999999863 2578999999754 3445567999999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCcccccccc-------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC
Q 013737 336 TGPESLLVYEFVPNQSLLDNLFVR-------QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408 (437)
Q Consensus 336 ~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~ 408 (437)
.++..++||||+++|+|.+++... .....+++..+..++.|+++||.|||+++ |+||||||+|||+++++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCc
Confidence 999999999999999999987532 22345799999999999999999999987 99999999999999999
Q ss_pred cEEEcccCCccccCCCC
Q 013737 409 TAKIADFGLVRLFPEDI 425 (437)
Q Consensus 409 ~~ki~DFG~a~~~~~~~ 425 (437)
++||+|||+|+.+.+..
T Consensus 171 ~~Kl~DFGla~~~~~~~ 187 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETD 187 (308)
T ss_dssp CEEECCTTCCCGGGGGG
T ss_pred eEEEeecccceeccCCc
Confidence 99999999999775543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.97 E-value=2.4e-31 Score=247.07 Aligned_cols=163 Identities=25% Similarity=0.365 Sum_probs=132.3
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC----e
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP----E 339 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 339 (437)
.++|++.+.||+|+||.||+|++ .+|+.||||.++.. +....+++.+|+++++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46789999999999999999996 56899999999754 3445668999999999999999999999987654 3
Q ss_pred eEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcc
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~ 419 (437)
.||||||+++++|.+++.. ..++++.++..++.||+.||+|||+++ |+||||||+|||++.++..+|+|||.++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 7899999999999987743 346899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCc--ceeeeecccC
Q 013737 420 LFPEDIT--HISATLAGTL 436 (437)
Q Consensus 420 ~~~~~~~--~~~~~~~Gt~ 436 (437)
....... .......||+
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~ 178 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTA 178 (277)
T ss_dssp ECC----------------
T ss_pred hhccccccccccccccCcc
Confidence 7643322 2233556765
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.4e-31 Score=247.74 Aligned_cols=152 Identities=35% Similarity=0.538 Sum_probs=124.6
Q ss_pred cCCCcCCcccccCcccEEEEEeC--CC--CEEEEEEEecc---chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP--GG--EAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (437)
++|+..+.||+|+||.||+|++. ++ ..||||++... .....++|.+|+.+|++++||||++++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56888999999999999999863 23 37899988643 34456789999999999999999999999976 4678
Q ss_pred EEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
+||||+++|++.+.+..+ ..++++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 999999999999877543 345999999999999999999999987 999999999999999999999999999988
Q ss_pred CCCCc
Q 013737 422 PEDIT 426 (437)
Q Consensus 422 ~~~~~ 426 (437)
.....
T Consensus 162 ~~~~~ 166 (273)
T d1u46a_ 162 PQNDD 166 (273)
T ss_dssp CC-CC
T ss_pred ccCCC
Confidence 65543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.4e-31 Score=249.07 Aligned_cols=152 Identities=31% Similarity=0.457 Sum_probs=131.0
Q ss_pred cCCCcCCcccccCcccEEEEEeCC-CC--EEEEEEEecc-chhhHHHHHHHHHHHcCC-CCCceeceeEEEeeCCeeEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLPG-GE--AVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLV 343 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 343 (437)
++|+..++||+|+||.||+|.+++ +. .||||++... .....+.|.+|+++|.++ +|||||++++++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 568888999999999999999753 43 5788887643 344567899999999999 799999999999999999999
Q ss_pred EeccCCCCcccccccc-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 013737 344 YEFVPNQSLLDNLFVR-------------QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410 (437)
Q Consensus 344 ~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ 410 (437)
|||+++|+|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998543 23456999999999999999999999987 9999999999999999999
Q ss_pred EEcccCCccccCC
Q 013737 411 KIADFGLVRLFPE 423 (437)
Q Consensus 411 ki~DFG~a~~~~~ 423 (437)
||+|||+|+....
T Consensus 167 kl~DfG~a~~~~~ 179 (309)
T d1fvra_ 167 KIADFGLSRGQEV 179 (309)
T ss_dssp EECCTTCEESSCE
T ss_pred EEccccccccccc
Confidence 9999999987653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.4e-31 Score=251.07 Aligned_cols=170 Identities=30% Similarity=0.391 Sum_probs=142.8
Q ss_pred HHHHhcCCCcCCcccccCcccEEEEEe------CCCCEEEEEEEecc-chhhHHHHHHHHHHHcCC-CCCceeceeEEEe
Q 013737 264 LEKATNYFHESNKLGQGGSGSVYKGTL------PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSI 335 (437)
Q Consensus 264 ~~~~~~~~~~~~~Lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 335 (437)
++...++|+..++||+|+||.||+|++ .+++.||||+++.. ......+|.+|+.+++++ +|||||++++++.
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 444557888899999999999999985 23568999999764 344566899999999998 6999999999999
Q ss_pred eCCeeEEEEeccCCCCccccccccC---------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCC
Q 013737 336 TGPESLLVYEFVPNQSLLDNLFVRQ---------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLS 400 (437)
Q Consensus 336 ~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~ 400 (437)
+++..++||||+++|+|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~ 174 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR 174 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccc
Confidence 9999999999999999999886433 2236899999999999999999999998 999999999
Q ss_pred CeeeCCCCcEEEcccCCccccCCCCcce-eeeecccC
Q 013737 401 NILLDEEFTAKIADFGLVRLFPEDITHI-SATLAGTL 436 (437)
Q Consensus 401 NIll~~~~~~ki~DFG~a~~~~~~~~~~-~~~~~Gt~ 436 (437)
|||++.++.+||+|||+++...+..... .+...||+
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~ 211 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV 211 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECG
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccCh
Confidence 9999999999999999999887554332 22345554
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.1e-30 Score=244.26 Aligned_cols=146 Identities=29% Similarity=0.461 Sum_probs=127.5
Q ss_pred CCcccccCcccEEEEEeCCC----CEEEEEEEec-cchhhHHHHHHHHHHHcCCCCCceeceeEEEee-CCeeEEEEecc
Q 013737 274 SNKLGQGGSGSVYKGTLPGG----EAVAVKRLFY-NTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT-GPESLLVYEFV 347 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 347 (437)
.++||+|+||+||+|.+..+ ..||||++.. ......++|.+|+++|++++||||++++|++.. ++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999997432 3689999964 355567889999999999999999999999876 45889999999
Q ss_pred CCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCC
Q 013737 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (437)
Q Consensus 348 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~ 424 (437)
++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||||++++.+||+|||+++.....
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 99999998743 3455788999999999999999999987 999999999999999999999999999987654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.4e-30 Score=244.83 Aligned_cols=162 Identities=31% Similarity=0.351 Sum_probs=128.9
Q ss_pred cCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC----eeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP----ESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 344 (437)
++|...+.||+|+||.||+|++. |+.||||++...... ....+.|+..+.+++||||+++++++.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 45667789999999999999974 789999998644321 222344555667889999999999998654 578999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCCeeeCCCCCCCeeeCCCCcEEEcccCCcc
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES-----KLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-----~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~ 419 (437)
||+++|+|.+++.. ..++|..++.++.|++.||.|||+.. ..+|+||||||+||||++++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999953 35899999999999999999999741 2359999999999999999999999999999
Q ss_pred ccCCCCcce---eeeecccC
Q 013737 420 LFPEDITHI---SATLAGTL 436 (437)
Q Consensus 420 ~~~~~~~~~---~~~~~Gt~ 436 (437)
.+....... .....||+
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~ 176 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTK 176 (303)
T ss_dssp EEETTTTEECC----CCSCG
T ss_pred cccCCCcceeccccceeccc
Confidence 876544322 22456665
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.9e-31 Score=242.34 Aligned_cols=149 Identities=30% Similarity=0.472 Sum_probs=125.0
Q ss_pred hcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEee-CCeeEEEEec
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT-GPESLLVYEF 346 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~ 346 (437)
.++|+..+.||+|+||.||+|.++ |..||||+++.+ ...+.|.+|++++++++||||++++|++.+ .+..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 356778899999999999999985 778999999654 345679999999999999999999998865 4568999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~ 423 (437)
+++|+|.+++..+ ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred cCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC
Confidence 9999999998543 2235899999999999999999999987 99999999999999999999999999997654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.1e-30 Score=246.69 Aligned_cols=157 Identities=24% Similarity=0.254 Sum_probs=130.3
Q ss_pred cCCCcCC-cccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcC-CCCCceeceeEEEee----CCeeE
Q 013737 269 NYFHESN-KLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISG-INHKNLVKLLGCSIT----GPESL 341 (437)
Q Consensus 269 ~~~~~~~-~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~~ 341 (437)
++|.+.+ .||+|+||.||+|.+ .+++.||||++... ..+.+|++++.+ .+|||||++++++.+ ....|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 5677664 699999999999997 56899999998632 356789988655 589999999999875 35689
Q ss_pred EEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC---CCcEEEcccCCc
Q 013737 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---EFTAKIADFGLV 418 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~---~~~~ki~DFG~a 418 (437)
|||||+++|+|.+++..+ ....+++.++..|+.||+.||+|||+.+ |+||||||+|||+++ ++.+||+|||+|
T Consensus 86 ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 999999999999998543 3356999999999999999999999998 999999999999985 467999999999
Q ss_pred cccCCCCcceeeeecccC
Q 013737 419 RLFPEDITHISATLAGTL 436 (437)
Q Consensus 419 ~~~~~~~~~~~~~~~Gt~ 436 (437)
+....... .....||+
T Consensus 162 ~~~~~~~~--~~~~~gt~ 177 (335)
T d2ozaa1 162 KETTSHNS--LTTPCYTP 177 (335)
T ss_dssp EECCCCCC--CCCCSCCC
T ss_pred eeccCCCc--cccccCCc
Confidence 98765433 23456665
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.1e-30 Score=243.23 Aligned_cols=157 Identities=29% Similarity=0.391 Sum_probs=131.3
Q ss_pred HHhcCCCcCCcccccCcccEEEEEeCC--------CCEEEEEEEeccc-hhhHHHHHHHHHHHcCC-CCCceeceeEEEe
Q 013737 266 KATNYFHESNKLGQGGSGSVYKGTLPG--------GEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLVKLLGCSI 335 (437)
Q Consensus 266 ~~~~~~~~~~~Lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 335 (437)
...++|...+.||+|+||.||+|+..+ +..||||+++.+. .....++.+|...+.++ +|||||++++++.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 345678889999999999999998532 2479999997653 44567889999998888 7999999999999
Q ss_pred eCCeeEEEEeccCCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCe
Q 013737 336 TGPESLLVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNI 402 (437)
Q Consensus 336 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NI 402 (437)
+++..++||||+++|+|.+++..+.. ...+++.+++.++.||+.||+|||+.+ ||||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccce
Confidence 99999999999999999999865432 245899999999999999999999998 99999999999
Q ss_pred eeCCCCcEEEcccCCccccCCCC
Q 013737 403 LLDEEFTAKIADFGLVRLFPEDI 425 (437)
Q Consensus 403 ll~~~~~~ki~DFG~a~~~~~~~ 425 (437)
|++.++.+||+|||+++......
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~ 189 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHID 189 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCC
T ss_pred eecCCCCeEeccchhhccccccc
Confidence 99999999999999999876543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.5e-30 Score=239.68 Aligned_cols=151 Identities=26% Similarity=0.406 Sum_probs=135.3
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCCeeEEEEe
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (437)
++|+..++||+|+||+||+|++ .+++.||||+++.. .....+++.+|+.+|+.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5788999999999999999997 56899999999654 33456789999999999999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCccccCCCC
Q 013737 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (437)
Q Consensus 346 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~~~~~ 425 (437)
++.+++|..++. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.|+......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999988877663 3456899999999999999999999998 9999999999999999999999999999876543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=7.7e-31 Score=242.95 Aligned_cols=160 Identities=26% Similarity=0.323 Sum_probs=132.6
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccch------hhHHHHHHHHHHHcCCC--CCceeceeEEEeeCC
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTT------QWVDHFFNEVNLISGIN--HKNLVKLLGCSITGP 338 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 338 (437)
.++|++.++||+|+||.||+|+. .+|+.||||++..... ....++.+|+.+|++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 35788999999999999999997 5689999999864311 12234678999999886 899999999999999
Q ss_pred eeEEEEeccCC-CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC-CCcEEEcccC
Q 013737 339 ESLLVYEFVPN-QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFG 416 (437)
Q Consensus 339 ~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~-~~~~ki~DFG 416 (437)
..++||||+.+ +++.+++.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999976 566666532 346899999999999999999999998 999999999999985 4799999999
Q ss_pred CccccCCCCcceeeeecccC
Q 013737 417 LVRLFPEDITHISATLAGTL 436 (437)
Q Consensus 417 ~a~~~~~~~~~~~~~~~Gt~ 436 (437)
+|+...... .++..||+
T Consensus 157 ~a~~~~~~~---~~~~~GT~ 173 (273)
T d1xwsa_ 157 SGALLKDTV---YTDFDGTR 173 (273)
T ss_dssp TCEECCSSC---BCCCCSCG
T ss_pred cceeccccc---ccccccCC
Confidence 998765432 23456775
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.4e-30 Score=245.36 Aligned_cols=150 Identities=23% Similarity=0.363 Sum_probs=126.7
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc-chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC----eeE
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP----ESL 341 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 341 (437)
+++|+..++||+|+||+||+|.. .+|+.||||++... .....+++.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45688999999999999999986 57999999999654 3455678999999999999999999999987653 234
Q ss_pred EEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcccc
Q 013737 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (437)
Q Consensus 342 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~~ 421 (437)
+++||+.+|+|.+++.. ..+++..+..++.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+..
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 55566779999998843 35899999999999999999999998 999999999999999999999999999876
Q ss_pred CCC
Q 013737 422 PED 424 (437)
Q Consensus 422 ~~~ 424 (437)
...
T Consensus 160 ~~~ 162 (345)
T d1pmea_ 160 DPD 162 (345)
T ss_dssp CGG
T ss_pred cCC
Confidence 543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=6.3e-30 Score=245.40 Aligned_cols=149 Identities=26% Similarity=0.385 Sum_probs=123.9
Q ss_pred CCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCceeceeEEEeeC------CeeEE
Q 013737 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITG------PESLL 342 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 342 (437)
+|+..++||+|+||+||+|++ .+|+.||||++...... +.+|+++|++++||||+++++++... ...+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 477889999999999999997 46999999999755332 34799999999999999999998643 24689
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC-cEEEcccCCcccc
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRLF 421 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~-~~ki~DFG~a~~~ 421 (437)
||||++++.+..+.........+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999986644433322334567999999999999999999999988 99999999999999775 8999999999987
Q ss_pred CCCC
Q 013737 422 PEDI 425 (437)
Q Consensus 422 ~~~~ 425 (437)
....
T Consensus 174 ~~~~ 177 (350)
T d1q5ka_ 174 VRGE 177 (350)
T ss_dssp CTTS
T ss_pred cCCc
Confidence 6543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.96 E-value=2.7e-29 Score=238.98 Aligned_cols=145 Identities=23% Similarity=0.352 Sum_probs=127.0
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCC-CCceeceeEEEeeC--CeeEEEE
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITG--PESLLVY 344 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 344 (437)
++|++.++||+|+||+||+|+. .+++.||||+++... .+++.+|+++|.+++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999997 568999999986543 457889999999995 99999999998744 4689999
Q ss_pred eccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCC-cEEEcccCCccccCC
Q 013737 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRLFPE 423 (437)
Q Consensus 345 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~-~~ki~DFG~a~~~~~ 423 (437)
||+++++|..+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999987654 35899999999999999999999998 99999999999998654 699999999998765
Q ss_pred CC
Q 013737 424 DI 425 (437)
Q Consensus 424 ~~ 425 (437)
..
T Consensus 183 ~~ 184 (328)
T d3bqca1 183 GQ 184 (328)
T ss_dssp TC
T ss_pred CC
Confidence 43
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.8e-30 Score=243.65 Aligned_cols=162 Identities=28% Similarity=0.326 Sum_probs=137.7
Q ss_pred cCCCcCCcccccCcccEEEEEe----CCCCEEEEEEEecc----chhhHHHHHHHHHHHcCCCC-CceeceeEEEeeCCe
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYN----TTQWVDHFFNEVNLISGINH-KNLVKLLGCSITGPE 339 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 339 (437)
++|+..+.||+|+||+||+|+. .+|+.||||.+... .....+.+.+|+++|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999985 24789999998543 22345678899999999976 899999999999999
Q ss_pred eEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcc
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~ 419 (437)
.+++|||+.+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 99999999999999988433 34788899999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCcceeeeecccC
Q 013737 420 LFPEDITHISATLAGTL 436 (437)
Q Consensus 420 ~~~~~~~~~~~~~~Gt~ 436 (437)
.+.........+..||+
T Consensus 178 ~~~~~~~~~~~~~~g~~ 194 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTI 194 (322)
T ss_dssp ECCGGGGGGGCGGGSCC
T ss_pred hhccccccccccccccc
Confidence 87654444333445554
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.8e-29 Score=237.84 Aligned_cols=150 Identities=26% Similarity=0.438 Sum_probs=126.9
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEee--------C
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT--------G 337 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 337 (437)
++|+..++||+|+||+||+|++ .+|+.||||++... .....+++.+|+.+|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6789999999999999999997 57999999998543 33445778999999999999999999998765 3
Q ss_pred CeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCC
Q 013737 338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417 (437)
Q Consensus 338 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~ 417 (437)
+..++||||++++.+.... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 4578999999877665443 34456899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCC
Q 013737 418 VRLFPED 424 (437)
Q Consensus 418 a~~~~~~ 424 (437)
++.+...
T Consensus 164 ~~~~~~~ 170 (318)
T d3blha1 164 ARAFSLA 170 (318)
T ss_dssp CEECCC-
T ss_pred eeecccc
Confidence 9877643
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.4e-29 Score=240.01 Aligned_cols=150 Identities=27% Similarity=0.460 Sum_probs=124.7
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeCC------
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP------ 338 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 338 (437)
.++|+..++||+|+||+||+|.+ .+|+.||||++... .....+.+.+|+++|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46789999999999999999997 56999999999743 3445678999999999999999999999998665
Q ss_pred eeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCc
Q 013737 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (437)
Q Consensus 339 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a 418 (437)
..++||||+ +.+|..+.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 469999999 556666542 245999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCC
Q 013737 419 RLFPEDI 425 (437)
Q Consensus 419 ~~~~~~~ 425 (437)
+......
T Consensus 169 ~~~~~~~ 175 (346)
T d1cm8a_ 169 RQADSEM 175 (346)
T ss_dssp EECCSSC
T ss_pred eccCCcc
Confidence 9876543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=8.7e-29 Score=232.98 Aligned_cols=162 Identities=25% Similarity=0.387 Sum_probs=128.3
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CC-CCEEEEEEEecc--chhhHHHHHHHHHHHcCC---CCCceeceeEEEee----
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PG-GEAVAVKRLFYN--TTQWVDHFFNEVNLISGI---NHKNLVKLLGCSIT---- 336 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 336 (437)
.++|+..++||+|+||+||+|++ .+ ++.||||++... .......+.+|+.+|+.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999997 44 567999998643 222233456777766555 89999999998853
Q ss_pred -CCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 013737 337 -GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415 (437)
Q Consensus 337 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DF 415 (437)
....+++|||++++++.... ......+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~--~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLD--KVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHH--HSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhh--hccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 24678999999887664333 234456899999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCCcceeeeecccC
Q 013737 416 GLVRLFPEDITHISATLAGTL 436 (437)
Q Consensus 416 G~a~~~~~~~~~~~~~~~Gt~ 436 (437)
|+++...... ......||+
T Consensus 161 g~~~~~~~~~--~~~~~~gT~ 179 (305)
T d1blxa_ 161 GLARIYSFQM--ALTSVVVTL 179 (305)
T ss_dssp CSCCCCCGGG--GGCCCCCCC
T ss_pred hhhhhhcccc--cCCCcccCh
Confidence 9998765433 223456775
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.6e-28 Score=234.01 Aligned_cols=149 Identities=27% Similarity=0.398 Sum_probs=126.4
Q ss_pred hcCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeC-----Ce
Q 013737 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG-----PE 339 (437)
Q Consensus 268 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 339 (437)
.++|+..++||+|+||+||+|.+ .+|+.||||++... +....+++.+|+++|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56799999999999999999996 56999999999754 334556789999999999999999999998643 34
Q ss_pred eEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcc
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~ 419 (437)
.++++||+.+|+|.+++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 467778888999999883 245999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCC
Q 013737 420 LFPE 423 (437)
Q Consensus 420 ~~~~ 423 (437)
....
T Consensus 170 ~~~~ 173 (348)
T d2gfsa1 170 HTDD 173 (348)
T ss_dssp CCTG
T ss_pred ccCc
Confidence 6643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.95 E-value=8.4e-28 Score=224.67 Aligned_cols=160 Identities=21% Similarity=0.303 Sum_probs=132.9
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEeccchhhHHHHHHHHHHHcCCCC-CceeceeEEEeeCCeeEEEEec
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH-KNLVKLLGCSITGPESLLVYEF 346 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~ 346 (437)
++|++.++||+|+||.||+|++. +|+.||||.+..... ...+.+|++.+..++| +|++.+++++..+...++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 57889999999999999999974 689999998864422 2346788888988875 8999999999999999999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCC-----CCcEEEcccCCcccc
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-----EFTAKIADFGLVRLF 421 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~-----~~~~ki~DFG~a~~~ 421 (437)
+ +++|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+|+.+
T Consensus 83 ~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 83 L-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred c-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 9 6899887743 3346899999999999999999999998 999999999999974 568999999999987
Q ss_pred CCCCcc------eeeeecccC
Q 013737 422 PEDITH------ISATLAGTL 436 (437)
Q Consensus 422 ~~~~~~------~~~~~~Gt~ 436 (437)
.+.... ...++.||+
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~ 177 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTA 177 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCT
T ss_pred ccCccccceeecccCceEEch
Confidence 643321 122467876
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.2e-27 Score=229.91 Aligned_cols=147 Identities=28% Similarity=0.395 Sum_probs=121.1
Q ss_pred cCCCcCCcccccCcccEEEEEeC-CCCEEEEEEEecc--chhhHHHHHHHHHHHcCCCCCceeceeEEEeeC------Ce
Q 013737 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG------PE 339 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 339 (437)
++|++.++||+|+||+||+|.+. +|+.||||++... .....+++.+|+.++++++||||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57899999999999999999975 6999999999754 344566799999999999999999999998643 57
Q ss_pred eEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccCCcc
Q 013737 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (437)
Q Consensus 340 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~ 419 (437)
.|+||||+.++.+ +.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~-~~~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHH-HHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHH-Hhhh-----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 8999999976544 4441 34899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCC
Q 013737 420 LFPED 424 (437)
Q Consensus 420 ~~~~~ 424 (437)
.....
T Consensus 168 ~~~~~ 172 (355)
T d2b1pa1 168 TAGTS 172 (355)
T ss_dssp -----
T ss_pred ccccc
Confidence 76543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.94 E-value=2.6e-27 Score=222.14 Aligned_cols=149 Identities=25% Similarity=0.373 Sum_probs=122.7
Q ss_pred cCCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCcee-ceeEEEeeCCeeEEEEec
Q 013737 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV-KLLGCSITGPESLLVYEF 346 (437)
Q Consensus 269 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~ 346 (437)
++|+..++||+|+||.||+|++ .+|+.||||.+..... .+++.+|+++++.++|+|++ .+..+..+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5689999999999999999997 5689999999875432 23578899999999877655 555666788889999999
Q ss_pred cCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeC---CCCcEEEcccCCccccCC
Q 013737 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPE 423 (437)
Q Consensus 347 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~---~~~~~ki~DFG~a~~~~~ 423 (437)
+ +++|.+.+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+.+.+
T Consensus 85 ~-~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 L-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred c-CCchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9 4566665532 3456899999999999999999999998 99999999999985 455799999999998765
Q ss_pred CC
Q 013737 424 DI 425 (437)
Q Consensus 424 ~~ 425 (437)
..
T Consensus 159 ~~ 160 (299)
T d1ckia_ 159 AR 160 (299)
T ss_dssp TT
T ss_pred cc
Confidence 43
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=5.6e-24 Score=185.74 Aligned_cols=135 Identities=19% Similarity=0.185 Sum_probs=107.0
Q ss_pred CcCCcccccCcccEEEEEeCCCCEEEEEEEeccch------------------hhHHHHHHHHHHHcCCCCCceeceeEE
Q 013737 272 HESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT------------------QWVDHFFNEVNLISGINHKNLVKLLGC 333 (437)
Q Consensus 272 ~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~ 333 (437)
...++||+|+||.||+|.+.+|+.||||.++.... .......+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 35689999999999999998899999998753211 112345678889999999999998865
Q ss_pred EeeCCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 013737 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIA 413 (437)
Q Consensus 334 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~ki~ 413 (437)
. ..+++|||+++..+.+ +++.....++.|++++|.|||+++ |+||||||+|||++++ .++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence 3 2379999998765533 223345678999999999999998 9999999999999976 58999
Q ss_pred ccCCccccCCC
Q 013737 414 DFGLVRLFPED 424 (437)
Q Consensus 414 DFG~a~~~~~~ 424 (437)
|||+|+....+
T Consensus 145 DFG~a~~~~~~ 155 (191)
T d1zara2 145 DFPQSVEVGEE 155 (191)
T ss_dssp CCTTCEETTST
T ss_pred ECCCcccCCCC
Confidence 99999877544
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.87 E-value=8.8e-23 Score=196.13 Aligned_cols=151 Identities=25% Similarity=0.261 Sum_probs=121.4
Q ss_pred CCCcCCcccccCcccEEEEEe-CCCCEEEEEEEeccchhhHHHHHHHHHHHcCCC-----------CCceeceeEEEee-
Q 013737 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-----------HKNLVKLLGCSIT- 336 (437)
Q Consensus 270 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~- 336 (437)
+|++.++||+|+||+||+|+. .+|+.||||++.... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 488999999999999999997 569999999997543 33567788988887765 5789999988764
Q ss_pred -CCeeEEEEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeeeCCCCCCCeeeCCCC------
Q 013737 337 -GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE-ESKLRIIHRDIKLSNILLDEEF------ 408 (437)
Q Consensus 337 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiHrDlk~~NIll~~~~------ 408 (437)
....+++++++..+..............+++..+..++.||+.||.|||+ .+ |+||||||+||||+.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccc
Confidence 34567777777665544444444556678999999999999999999998 65 99999999999998654
Q ss_pred cEEEcccCCccccCCC
Q 013737 409 TAKIADFGLVRLFPED 424 (437)
Q Consensus 409 ~~ki~DFG~a~~~~~~ 424 (437)
.+|++|||.|+.....
T Consensus 170 ~~kl~dfg~s~~~~~~ 185 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH 185 (362)
T ss_dssp EEEECCCTTCEETTBC
T ss_pred eeeEeecccccccccc
Confidence 4999999999876543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.68 E-value=3.9e-08 Score=88.03 Aligned_cols=148 Identities=18% Similarity=0.075 Sum_probs=96.8
Q ss_pred HHHHhcCCCcCCcccccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCC-CCceeceeEEEeeCCeeEE
Q 013737 264 LEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 264 ~~~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 342 (437)
+...-+.|+..+..+-++.+.||+.... ++.+++|+...........+.+|...+..+. +--+.+++.+...++..++
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 3444455555554444445689988754 5667888876554444445677888776653 4446788888888889999
Q ss_pred EEeccCCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-----------------------------------
Q 013737 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE----------------------------------- 387 (437)
Q Consensus 343 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~----------------------------------- 387 (437)
|||++++.++.+..... .. ...++.++++.+..||+.
T Consensus 88 v~~~l~G~~~~~~~~~~-----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDE-----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEECCSSEEHHHHTTTC-----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEeccccccccccccc-----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 99999988775543110 11 222344455555555542
Q ss_pred ---------------------CCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 388 ---------------------SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 388 ---------------------~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
.+..++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 012278999999999999876778999998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.27 E-value=2.5e-06 Score=75.39 Aligned_cols=131 Identities=21% Similarity=0.251 Sum_probs=86.0
Q ss_pred cccccCc-ccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCC--CCceeceeEEEeeCCeeEEEEeccCCCCc
Q 013737 276 KLGQGGS-GSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN--HKNLVKLLGCSITGPESLLVYEFVPNQSL 352 (437)
Q Consensus 276 ~Lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L 352 (437)
.+..|.. +.||+....++..+++|........ .+..|...++.+. .-.+++++.+..+++..++|||+++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4455544 5789999888888899987554332 3556776665553 33467788888888889999999998766
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHHHHHhhc----------------------------------------------
Q 013737 353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE---------------------------------------------- 386 (437)
Q Consensus 353 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~---------------------------------------------- 386 (437)
.+.. .... .++.++++.|.-||+
T Consensus 94 ~~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 4421 1111 112222333333332
Q ss_pred -----C----CCCCeeeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 387 -----E----SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 387 -----~----~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
. .++.++|+|+.|.|||++++..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 1 122379999999999999886778999998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.79 E-value=2.3e-05 Score=73.92 Aligned_cols=77 Identities=12% Similarity=0.072 Sum_probs=49.5
Q ss_pred CCcccccCcccEEEEEeCC-CCEEEEEEEecc-------chhhHHHHHHHHHHHcCCC---CCceeceeEEEeeCCeeEE
Q 013737 274 SNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYN-------TTQWVDHFFNEVNLISGIN---HKNLVKLLGCSITGPESLL 342 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l 342 (437)
.+.||.|....||+....+ ++.++||.-... -+...++...|.+.|..+. ...+++++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4568999999999998754 678999975321 1112344556777776542 2456666654 4556789
Q ss_pred EEeccCCCCc
Q 013737 343 VYEFVPNQSL 352 (437)
Q Consensus 343 v~e~~~~g~L 352 (437)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999976543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.05 E-value=0.0013 Score=59.66 Aligned_cols=135 Identities=13% Similarity=0.038 Sum_probs=76.5
Q ss_pred ccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCce--ecee-----EEEeeCCeeEEEEeccCCCCcccc
Q 013737 283 GSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL--VKLL-----GCSITGPESLLVYEFVPNQSLLDN 355 (437)
Q Consensus 283 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~g~L~~~ 355 (437)
-.||++..++|+.+++|....... ..+++..|...+..|....+ +..+ ......+..+.++++++|..+...
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 579999999999999999865422 34567778877766542221 1111 122345667889999976544211
Q ss_pred c--------------c----c--cCCCCCCCH----------------------HHHHHHHHHHHHHHHHh-hcCCCCCe
Q 013737 356 L--------------F----V--RQDVEPLSW----------------------EVRYKIILSTAEGLAYL-HEESKLRI 392 (437)
Q Consensus 356 l--------------~----~--~~~~~~l~~----------------------~~~~~i~~~i~~~l~yL-H~~~~~~i 392 (437)
- + . ......+++ ......+.++...+.-+ .+..+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0 0 0 000011111 11122233333333222 22223458
Q ss_pred eeCCCCCCCeeeCCCCcEEEcccCCccc
Q 013737 393 IHRDIKLSNILLDEEFTAKIADFGLVRL 420 (437)
Q Consensus 393 iHrDlk~~NIll~~~~~~ki~DFG~a~~ 420 (437)
||+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.76 E-value=0.0011 Score=61.86 Aligned_cols=74 Identities=19% Similarity=0.239 Sum_probs=47.8
Q ss_pred CCcccccCcccEEEEEeCCC--------CEEEEEEEeccchhhHHHHHHHHHHHcCCC-CCceeceeEEEeeCCeeEEEE
Q 013737 274 SNKLGQGGSGSVYKGTLPGG--------EAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVY 344 (437)
Q Consensus 274 ~~~Lg~G~~g~V~~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 344 (437)
.+.|+.|-.-.+|+...+++ +.|.+++.- .... .....+|..+++.+. +.-.+++++++.. .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 35677788889999986532 446665543 3222 234567888887774 3334577777642 6899
Q ss_pred eccCCCCcc
Q 013737 345 EFVPNQSLL 353 (437)
Q Consensus 345 e~~~~g~L~ 353 (437)
||+++..+.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEeccccCC
Confidence 999875543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.30 E-value=0.019 Score=51.18 Aligned_cols=158 Identities=12% Similarity=0.026 Sum_probs=80.7
Q ss_pred cCHHHHHHHhcCCCcCCcc-----cccCcccEEEEEeCCCCEEEEEEEeccchhhHHHHHHHHHHHcCCCCCc--eecee
Q 013737 259 FSYETLEKATNYFHESNKL-----GQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN--LVKLL 331 (437)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~L-----g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~ 331 (437)
.+.++++....+|...+.. ..|---+.|+.+..+|+ +++|+...... .+++..|++++..|.+.+ ++..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence 4566777777888765443 35555678999877665 78888754321 223445565655553221 11111
Q ss_pred E------EEeeCCeeEEEEeccCCCCcccccc--------------------ccCCCCCCC------------------H
Q 013737 332 G------CSITGPESLLVYEFVPNQSLLDNLF--------------------VRQDVEPLS------------------W 367 (437)
Q Consensus 332 ~------~~~~~~~~~lv~e~~~~g~L~~~l~--------------------~~~~~~~l~------------------~ 367 (437)
- +.........++.++.+........ ......... .
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 1122344566677766543322110 000000000 0
Q ss_pred HHHHHHHHHHHHHHHHhhcC-CCCCeeeCCCCCCCeeeCCCCcEEEcccCCcc
Q 013737 368 EVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (437)
Q Consensus 368 ~~~~~i~~~i~~~l~yLH~~-~~~~iiHrDlk~~NIll~~~~~~ki~DFG~a~ 419 (437)
......+..+...+.-.+.. -+..+||+|+.+.||+++++...-|+||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 11111122222223322221 12459999999999999998777899999875
|